data_1c54_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1c54 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.7 t . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -78.08 12.88 1.62 Allowed 'General case' 0 N--CA 1.48 1.065 0 O-C-N 124.182 0.927 . . . . 0.0 113.342 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.97 179.05 23.55 Favored Glycine 0 N--CA 1.468 0.797 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 m -80.9 173.83 12.22 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 122.174 0.988 . . . . 0.0 110.746 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.4 p -143.6 110.45 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -174.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 86.7 m -46.57 128.89 10.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 111.853 -2.431 . . . . 0.0 110.101 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -33.27 66.01 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.586 -177.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.4 t -65.99 -27.44 68.14 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.786 173.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.71 -20.48 58.33 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.44 0.696 . . . . 0.0 111.396 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.7 mt -86.25 158.66 54.92 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -69.34 167.44 23.88 Favored 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 122.174 1.916 . . . . 0.0 112.375 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.72 -14.01 38.28 Favored 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 122.626 2.217 . . . . 0.0 114.292 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -92.91 -6.16 49.2 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.844 1.258 . . . . 0.0 113.955 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.58 -43.24 18.94 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.717 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -59.1 -28.99 67.03 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.566 174.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -51.09 -58.07 7.06 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 124.258 1.023 . . . . 0.0 110.149 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.1 m -54.6 -50.03 69.0 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 176.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.5 mt -55.0 -35.33 64.26 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 123.627 0.579 . . . . 0.0 112.518 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -71.28 -39.42 71.54 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.892 173.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.1 mt -70.22 -32.67 70.65 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 123.086 0.554 . . . . 0.0 111.104 175.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.9 mt -72.7 -38.22 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 119.959 -1.713 . . . . 0.0 111.356 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.16 -42.65 62.57 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.693 -1.14 . . . . 0.0 112.303 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.39 8.66 39.63 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.661 1.184 . . . . 0.0 111.877 177.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.7 t0 39.77 49.97 2.22 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.078 1.351 . . . . 0.0 111.932 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.95 -166.92 39.48 Favored Glycine 0 N--CA 1.47 0.924 0 CA-C-N 113.056 -1.884 . . . . 0.0 115.598 -173.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.24 141.61 70.83 Favored 'Cis proline' 0 N--CA 1.48 0.71 0 O-C-N 124.014 1.534 . . . . 0.0 111.346 -0.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -93.98 136.43 23.74 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 113.822 -1.536 . . . . 0.0 111.426 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -75.71 -61.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.478 0.573 0 C-N-CA 122.813 2.342 . . . . 0.0 110.719 -176.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -59.59 158.87 9.22 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.417 175.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 m -71.58 -15.21 62.26 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.938 0.875 . . . . 0.0 112.755 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.408 ' NE2' HH12 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -88.26 95.41 10.17 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.09 -176.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 166.58 136.1 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 111.813 -2.449 . . . . 0.0 115.35 -173.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.96 38.34 8.0 Favored Glycine 0 CA--C 1.54 1.619 0 CA-C-N 113.39 -1.732 . . . . 0.0 111.118 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.39 148.88 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 113.536 -1.332 . . . . 0.0 109.445 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.6 t -85.87 154.78 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 O-C-N 126.081 2.113 . . . . 0.0 109.875 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -135.15 89.54 2.53 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.428 176.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.5 tm0? -70.28 54.1 0.14 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 120.103 1.32 . . . . 0.0 111.695 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 25.47 52.33 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 127.837 2.455 . . . . 0.0 110.813 -175.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.82 -21.18 27.08 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.27 -173.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -78.39 -12.04 59.98 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 112.956 -1.929 . . . . 0.0 115.094 172.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.7 t 45.4 39.17 4.24 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 124.081 1.896 . . . . 0.0 112.014 -177.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.3 t -110.57 -13.32 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-O 123.634 1.683 . . . . 0.0 110.583 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 114.124 -1.398 . . . . 0.0 107.268 -172.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 9.1 t80 . . . . . 0 N--CA 1.468 0.462 0 CA-C-O 121.375 0.607 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.94 8.66 78.53 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.664 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -81.83 13.4 3.27 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.813 1.245 . . . . 0.0 111.085 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -149.43 156.52 42.15 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -173.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -152.15 154.99 36.94 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 125.49 1.744 . . . . 0.0 111.349 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -110.02 145.06 37.66 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.064 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -161.32 62.13 0.27 Allowed 'General case' 0 N--CA 1.475 0.788 0 O-C-N 125.882 1.989 . . . . 0.0 110.75 -174.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -40.14 129.61 2.22 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 122.485 1.136 . . . . 0.0 111.952 177.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.0 m -83.65 121.15 35.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 111.515 -2.584 . . . . 0.0 108.72 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -42.3 162.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 O-C-N 125.363 1.665 . . . . 0.0 109.884 171.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.488 ' HG1' ' NE ' ' A' ' 68' ' ' ARG . 1.4 m -157.01 138.52 9.83 Favored Pre-proline 0 N--CA 1.482 1.146 0 O-C-N 125.374 1.672 . . . . 0.0 111.649 176.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.36 144.33 32.6 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.096 2.531 . . . . 0.0 109.463 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.61 26.64 39.55 Favored Glycine 0 CA--C 1.545 1.909 0 CA-C-N 113.081 -1.872 . . . . 0.0 112.01 -175.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.95 89.06 7.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -40.16 -31.89 0.15 Allowed 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.908 176.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.6 p -129.79 -162.3 1.19 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.587 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.0 mtm105 -59.51 -14.63 13.54 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 172.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.0 137.12 0.08 OUTLIER Glycine 0 N--CA 1.467 0.722 0 N-CA-C 107.442 -2.263 . . . . 0.0 107.442 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.1 p -46.16 -28.69 1.31 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 113.43 -1.385 . . . . 0.0 113.077 174.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.488 ' NE ' ' HG1' ' A' ' 59' ' ' THR . 20.8 mtm-85 -50.27 139.14 15.41 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 121.02 -1.05 . . . . 0.0 113.045 170.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.408 HH12 ' NE2' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -165.14 137.94 4.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.099 -1.864 . . . . 0.0 109.15 -179.487 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.2 mt -105.1 138.48 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 112.694 -2.048 . . . . 0.0 109.548 173.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.8 mm -127.86 103.39 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 112.628 -2.078 . . . . 0.0 108.365 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.1 p -88.41 162.86 16.28 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.972 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -104.22 -171.46 25.04 Favored Glycine 0 N--CA 1.48 1.605 0 O-C-N 125.273 1.608 . . . . 0.0 110.152 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.26 -11.07 53.31 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.533 0.682 . . . . 0.0 112.157 175.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.69 132.14 54.48 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 176.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.1 m -49.09 144.72 4.66 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.026 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 81.24 56.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 126.006 2.066 . . . . 0.0 109.856 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -166.44 54.93 0.09 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 113.222 -1.808 . . . . 0.0 114.247 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.68 93.2 4.31 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.939 1.296 . . . . 0.0 110.788 -177.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -74.18 135.91 42.81 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 124.508 1.123 . . . . 0.0 110.325 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -121.56 91.9 3.62 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -44.49 -75.94 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 113.638 -1.619 . . . . 0.0 112.856 171.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.63 8.32 86.09 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-N 113.361 -1.745 . . . . 0.0 112.435 -175.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -139.79 17.51 2.5 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 176.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 69.09 83.83 0.15 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.685 1.594 . . . . 0.0 111.815 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 50.12 25.92 1.92 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 113.189 -1.823 . . . . 0.0 113.894 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.93 -57.96 2.29 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 120.43 -1.419 . . . . 0.0 110.825 -173.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.401 ' O ' ' CG ' ' A' ' 89' ' ' PHE . 27.7 p -112.02 178.62 4.25 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.401 ' CG ' ' O ' ' A' ' 88' ' ' THR . 95.6 m-85 -161.56 122.21 2.7 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -175.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.7 m -140.39 107.93 5.59 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 126.169 2.168 . . . . 0.0 108.694 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 13.1 mt -43.22 161.89 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.87 122.34 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 120.96 -1.087 . . . . 0.0 109.54 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.21 97.21 8.33 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 113.231 -1.804 . . . . 0.0 108.792 175.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -60.04 -40.23 88.65 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 125.321 1.638 . . . . 0.0 111.125 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.3 t -53.38 -37.45 62.46 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 114.354 -1.293 . . . . 0.0 112.651 172.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 12.0 t . . . . . 0 C--O 1.249 1.074 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.343 175.13 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.7 t . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.66 5.21 5.1 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 124.323 1.014 . . . . 0.0 112.824 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.74 -165.67 16.47 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.183 1.373 . . . . 0.0 109.831 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 m -99.81 170.79 8.3 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.936 -1.132 . . . . 0.0 109.829 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.2 p -140.85 109.28 2.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -175.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 82.0 m -44.99 133.42 6.39 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.016 -1.902 . . . . 0.0 111.068 177.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -31.65 67.79 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.676 0.61 . . . . 0.0 111.66 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -65.4 -28.69 69.44 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.538 173.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.16 -30.96 60.88 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.598 0.759 . . . . 0.0 111.432 175.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.7 mt -81.22 161.45 62.54 Favored Pre-proline 0 N--CA 1.475 0.784 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -66.94 168.67 16.56 Favored 'Trans proline' 0 CA--C 1.544 1.004 0 C-N-CA 122.671 2.247 . . . . 0.0 112.759 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.82 -32.36 18.46 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.768 2.312 . . . . 0.0 112.447 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.87 -5.96 44.26 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.448 1.099 . . . . 0.0 112.017 176.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.28 -57.03 4.86 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.418 1.087 . . . . 0.0 112.487 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.81 -24.2 49.14 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 174.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -49.08 -55.32 12.54 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.671 1.189 . . . . 0.0 111.527 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 94.9 m -66.28 -43.02 87.57 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.6 mt -52.36 -35.5 51.45 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 173.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -67.35 -41.14 85.63 Favored 'General case' 0 C--O 1.207 -1.181 0 CA-C-N 113.868 -1.515 . . . . 0.0 110.77 175.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.5 mt -67.2 -36.17 81.17 Favored 'General case' 0 C--O 1.213 -0.857 0 CA-C-O 118.12 -0.943 . . . . 0.0 112.093 175.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.4 mt -64.33 -43.0 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 118.852 0.751 . . . . 0.0 111.616 172.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.36 -46.56 63.84 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.689 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.1 t -72.76 -12.03 60.84 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.267 1.827 . . . . 0.0 111.542 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 t0 54.52 40.62 31.96 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.256 1.422 . . . . 0.0 110.289 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.03 -170.52 39.68 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 113.055 -1.884 . . . . 0.0 115.969 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -74.67 139.81 63.78 Favored 'Cis proline' 0 C--N 1.347 0.454 0 O-C-N 124.096 1.577 . . . . 0.0 111.976 -1.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -90.55 135.53 29.2 Favored Pre-proline 0 N--CA 1.481 1.085 0 CA-C-N 113.723 -1.58 . . . . 0.0 110.849 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -72.5 -61.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.475 0.423 0 C-N-CA 123.216 2.611 . . . . 0.0 112.073 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -64.15 146.95 53.37 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 118.847 -0.597 . . . . 0.0 110.658 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.6 t -65.38 -13.69 59.18 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 125.4 1.688 . . . . 0.0 112.956 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -80.96 77.38 7.87 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 122.734 1.254 . . . . 0.0 112.355 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -177.54 148.5 0.57 Allowed 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 111.104 -2.771 . . . . 0.0 113.307 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.4 31.98 29.35 Favored Glycine 0 N--CA 1.479 1.521 0 CA-C-N 113.084 -1.871 . . . . 0.0 111.306 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.64 146.85 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.218 1.007 . . . . 0.0 109.905 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.0 t -86.58 152.87 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 125.949 2.031 . . . . 0.0 110.014 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -130.28 93.75 3.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 113.518 -1.674 . . . . 0.0 108.838 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.6 tm0? -71.93 54.0 0.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.087 -1.008 . . . . 0.0 111.969 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 26.18 56.12 0.05 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.413 2.285 . . . . 0.0 111.035 -176.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -25.87 55.22 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.03 -172.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -78.0 -13.26 59.94 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-N 112.981 -1.918 . . . . 0.0 115.125 172.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.9 t 45.24 41.67 6.29 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 123.847 1.784 . . . . 0.0 111.886 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.2 t -107.72 -14.14 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 113.732 -1.577 . . . . 0.0 110.126 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.317 -0.819 0 CA-C-O 117.662 -1.161 . . . . 0.0 108.451 -171.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 9.8 t80 . . . . . 0 N--CA 1.478 0.95 0 CA-C-O 121.075 0.464 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.06 9.99 77.17 Favored Glycine 0 CA--C 1.542 1.773 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.851 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -82.09 8.79 9.86 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.474 1.109 . . . . 0.0 111.391 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -146.73 145.84 30.1 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -174.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -141.36 157.2 45.5 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 126.541 2.401 . . . . 0.0 110.883 178.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -110.4 143.07 41.21 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.864 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -158.78 69.67 0.49 Allowed 'General case' 0 N--CA 1.471 0.579 0 O-C-N 126.107 2.13 . . . . 0.0 110.144 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.3 m -43.37 129.06 5.0 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 122.971 1.367 . . . . 0.0 112.197 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.8 p -89.3 118.12 33.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 111.109 -2.769 . . . . 0.0 109.965 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -43.32 151.69 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.227 170.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.662 ' HG1' ' CG ' ' A' ' 68' ' ' ARG . 3.4 m -145.29 142.85 18.78 Favored Pre-proline 0 N--CA 1.475 0.823 0 CA-C-N 113.64 -1.618 . . . . 0.0 111.647 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.57 145.12 29.21 Favored 'Trans proline' 0 N--CA 1.479 0.658 0 C-N-CA 121.824 1.683 . . . . 0.0 110.216 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.86 28.16 57.16 Favored Glycine 0 CA--C 1.546 2.01 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.189 -175.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.7 92.44 6.58 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -39.41 -33.64 0.17 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 114.204 -1.362 . . . . 0.0 113.296 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 57.7 p -130.57 -160.56 1.05 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.888 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.2 mtm180 -56.08 -19.79 14.49 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 172.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.16 167.55 3.19 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 123.889 1.827 . . . . 0.0 109.379 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.7 p -71.27 -5.26 30.85 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 112.423 -1.888 . . . . 0.0 113.286 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.662 ' CG ' ' HG1' ' A' ' 59' ' ' THR . 0.2 OUTLIER -73.0 117.03 14.23 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.561 1.172 . . . . 0.0 110.161 177.624 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -140.24 133.8 30.16 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 113.865 -1.516 . . . . 0.0 109.191 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.7 mt -105.42 133.67 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 125.923 2.014 . . . . 0.0 107.835 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.3 mm -123.5 107.16 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 113.525 -1.67 . . . . 0.0 107.415 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.5 p -93.5 163.87 13.4 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 120.969 0.414 . . . . 0.0 110.696 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.57 -172.17 23.8 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.256 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.64 -14.15 60.0 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.322 0.582 . . . . 0.0 112.158 175.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -115.93 131.57 56.9 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.5 m -56.34 151.53 12.77 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.836 175.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 74.82 32.97 0.8 Allowed 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 123.508 1.623 . . . . 0.0 110.766 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -138.76 57.09 1.69 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 113.547 -1.66 . . . . 0.0 112.479 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -101.98 130.03 48.41 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 113.882 -1.508 . . . . 0.0 108.461 174.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -102.27 129.15 48.6 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.714 -1.584 . . . . 0.0 109.465 175.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -108.21 124.37 50.18 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 113.641 -1.618 . . . . 0.0 109.001 -177.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . 0.265 0.5 OUTLIER -86.0 -68.4 0.74 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 113.09 -1.868 . . . . 0.0 112.037 176.161 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.87 1.65 26.04 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 114.605 -1.179 . . . . 0.0 113.876 -172.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -129.7 12.13 5.78 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.392 1.077 . . . . 0.0 113.631 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 61.92 81.28 0.2 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.513 2.325 . . . . 0.0 111.647 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 54.2 33.29 17.73 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 114.424 -1.262 . . . . 0.0 113.997 -175.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -111.71 -6.76 14.3 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.5 p -163.91 165.17 22.98 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.768 1.627 . . . . 0.0 108.122 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -159.55 117.91 2.79 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 -174.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.52 106.5 5.97 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.357 -1.747 . . . . 0.0 108.432 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.1 mt -40.47 157.29 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.638 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.29 133.18 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.045 -1.035 . . . . 0.0 109.517 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.99 89.37 2.98 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 113.329 -1.76 . . . . 0.0 109.338 177.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -63.7 -40.46 96.85 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.409 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 t -51.39 -40.01 58.35 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 125.295 1.622 . . . . 0.0 112.813 172.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 8.4 t . . . . . 0 C--O 1.258 1.51 0 CA-C-O 116.733 -1.604 . . . . 0.0 110.747 178.445 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.6 m -64.37 -8.26 12.57 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 175.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.46 169.46 12.68 Favored Glycine 0 N--CA 1.474 1.196 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -78.76 172.02 14.33 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.566 -0.817 . . . . 0.0 110.782 -178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 p -145.65 108.06 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -174.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 57.6 m -42.9 138.32 2.05 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 113.266 -1.788 . . . . 0.0 111.658 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -33.03 71.24 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.756 0.66 . . . . 0.0 111.962 -178.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.4 t -70.85 -15.79 62.66 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.773 174.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.13 -37.45 46.14 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.65 0.738 . . . . 0.0 111.832 176.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.3 mt -77.83 166.28 44.83 Favored Pre-proline 0 N--CA 1.475 0.788 0 C-N-CA 124.531 1.133 . . . . 0.0 111.111 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.67 169.89 15.02 Favored 'Trans proline' 0 CA--C 1.553 1.471 0 C-N-CA 122.713 2.275 . . . . 0.0 113.353 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.3 -15.88 39.12 Favored 'Trans proline' 0 N--CA 1.484 0.932 0 C-N-CA 122.305 2.004 . . . . 0.0 113.437 175.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -93.81 4.81 53.37 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.935 0.894 . . . . 0.0 112.111 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.86 -48.11 12.86 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.96 176.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -58.28 -23.03 54.92 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.413 -1.267 . . . . 0.0 112.701 174.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -49.97 -58.01 6.34 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.289 1.035 . . . . 0.0 110.324 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.7 m -56.63 -49.49 74.84 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.8 mt -55.53 -35.73 65.98 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 123.805 0.69 . . . . 0.0 111.693 178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -68.34 -38.48 81.53 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.015 173.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.9 mt -69.19 -34.8 75.48 Favored 'General case' 0 C--O 1.212 -0.874 0 CA-C-O 118.746 -0.645 . . . . 0.0 110.954 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.76 -40.73 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 120.186 1.357 . . . . 0.0 111.312 172.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.8 -42.48 67.02 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.023 -0.989 . . . . 0.0 112.291 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.27 7.55 42.21 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.116 0.966 . . . . 0.0 111.35 177.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.0 t0 39.52 52.5 2.34 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 123.209 1.48 . . . . 0.0 112.156 -178.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.3 -164.77 40.44 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 112.721 -2.036 . . . . 0.0 115.659 -173.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.9 141.44 71.75 Favored 'Cis proline' 0 C--N 1.346 0.415 0 O-C-N 124.678 1.883 . . . . 0.0 111.849 -2.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -94.52 132.92 27.78 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.248 -176.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -75.12 -59.55 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.546 2.164 . . . . 0.0 111.24 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -60.69 157.76 14.01 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.486 0.66 . . . . 0.0 112.436 175.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.4 t -77.43 -10.58 59.55 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 122.524 1.154 . . . . 0.0 112.215 175.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.431 HE21 ' HG1' ' A' ' 56' ' ' THR . 0.5 OUTLIER -91.6 87.56 6.4 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.624 0.726 . . . . 0.0 112.21 -178.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 172.29 136.33 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 111.517 -2.583 . . . . 0.0 114.259 -174.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.08 28.75 16.9 Favored Glycine 0 N--CA 1.48 1.602 0 CA-C-N 113.189 -1.823 . . . . 0.0 111.729 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.2 m -123.48 146.59 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 113.6 -1.3 . . . . 0.0 109.713 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.0 t -81.95 156.79 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 125.536 1.772 . . . . 0.0 109.724 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -139.23 86.28 2.12 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.634 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -69.66 52.86 0.11 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 122.401 1.096 . . . . 0.0 113.629 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.2 t30 31.23 55.17 0.23 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 127.057 2.143 . . . . 0.0 109.399 -172.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.56 -31.32 62.05 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 122.454 1.121 . . . . 0.0 111.766 -175.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -79.06 -8.15 58.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 112.928 -1.942 . . . . 0.0 114.3 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 39.9 t 43.82 42.66 4.61 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 124.132 1.92 . . . . 0.0 111.975 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.7 t -107.36 -18.05 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 113.301 -1.772 . . . . 0.0 109.704 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.32 -0.679 0 O-C-N 121.189 -0.944 . . . . 0.0 108.657 -176.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.6 t80 . . . . . 0 N--CA 1.464 0.253 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.08 -22.71 33.04 Favored Glycine 0 N--CA 1.476 1.318 0 O-C-N 125.708 1.88 . . . . 0.0 111.691 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.46 -13.9 45.19 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 124.325 1.05 . . . . 0.0 112.924 175.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -116.78 162.44 17.69 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.412 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -158.92 159.81 35.36 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 112.515 -2.13 . . . . 0.0 111.686 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -117.64 136.39 53.34 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.85 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -151.6 75.52 1.17 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 113.622 -1.626 . . . . 0.0 110.212 -176.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.431 ' HG1' HE21 ' A' ' 32' ' ' GLN . 52.8 m -42.91 138.56 1.98 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 122.438 1.113 . . . . 0.0 112.516 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.36 106.89 19.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 112.195 -2.275 . . . . 0.0 110.073 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -39.36 147.04 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.266 172.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.2 m -144.44 140.65 16.9 Favored Pre-proline 0 N--CA 1.473 0.722 0 O-C-N 125.465 1.728 . . . . 0.0 112.018 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.34 146.31 35.44 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.066 1.844 . . . . 0.0 110.177 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.63 25.42 55.48 Favored Glycine 0 N--CA 1.485 1.937 0 CA-C-N 114.22 -1.355 . . . . 0.0 112.196 -175.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.71 91.38 6.99 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -39.96 -32.22 0.15 Allowed 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 113.585 -1.643 . . . . 0.0 113.325 176.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.0 p -131.26 -159.0 0.93 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.505 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -18.05 31.82 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.968 -1.015 . . . . 0.0 113.585 171.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.33 162.5 0.59 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-O 123.697 1.721 . . . . 0.0 109.59 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.3 p -65.65 -10.73 38.72 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 113.137 -1.531 . . . . 0.0 113.241 174.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.437 ' NE ' ' HH ' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -64.94 124.46 22.1 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 123.279 1.514 . . . . 0.0 110.715 175.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.51 HH21 ' HH ' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -149.24 144.76 26.73 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 112.866 -1.97 . . . . 0.0 110.588 -179.305 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.4 mt -120.44 137.04 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 125.398 1.686 . . . . 0.0 108.673 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.7 mm -127.57 102.41 8.93 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 CA-C-N 112.737 -2.029 . . . . 0.0 107.758 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.7 p -90.16 163.37 14.85 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.667 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -116.77 165.67 12.35 Favored Glycine 0 N--CA 1.471 0.981 0 CA-C-N 113.534 -1.666 . . . . 0.0 109.357 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.49 -14.9 62.9 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.701 0.763 . . . . 0.0 111.687 176.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -106.27 131.04 53.97 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 m -55.34 143.14 29.48 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 113.776 -1.556 . . . . 0.0 108.361 174.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 79.6 34.57 0.18 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.936 2.095 . . . . 0.0 111.224 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -129.79 49.95 2.22 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 123.232 1.491 . . . . 0.0 112.299 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.55 100.99 10.36 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 113.607 -1.633 . . . . 0.0 110.307 -176.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -89.83 135.2 33.77 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 113.996 -1.457 . . . . 0.0 109.319 -175.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.437 ' HH ' ' NE ' ' A' ' 68' ' ' ARG . 11.0 t80 -115.2 127.42 55.51 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.947 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . 0.251 0.4 OUTLIER -86.77 -68.87 0.71 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 113.012 -1.904 . . . . 0.0 111.417 176.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.01 1.7 27.26 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 114.047 -1.433 . . . . 0.0 113.544 -172.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -129.9 10.47 5.49 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.237 1.015 . . . . 0.0 113.595 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 64.88 80.13 0.24 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 128.081 2.552 . . . . 0.0 110.698 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.51 ' HH ' HH21 ' A' ' 69' ' ' ARG . 17.0 m-85 55.82 26.19 9.32 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 122.928 1.347 . . . . 0.0 113.413 -174.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.51 -8.86 20.69 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.54 -1.35 . . . . 0.0 112.766 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.5 p -163.14 169.37 19.47 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.621 1.568 . . . . 0.0 108.859 -176.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -158.5 115.14 2.78 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -174.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.49 107.04 8.61 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 113.203 -1.817 . . . . 0.0 109.483 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.0 mt -42.8 160.94 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 mp -110.05 113.72 45.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 O-C-N 120.982 -1.074 . . . . 0.0 109.194 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.09 87.21 7.35 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 113.833 -1.53 . . . . 0.0 109.686 176.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -67.65 -31.41 71.39 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.643 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.6 t -55.64 -27.96 52.72 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.849 173.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.4 t . . . . . 0 C--O 1.253 1.265 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.887 177.691 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.0 t . . . . . 0 N--CA 1.469 0.518 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 m -72.79 4.76 3.74 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 125.021 1.45 . . . . 0.0 113.095 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.09 168.89 13.18 Favored Glycine 0 C--O 1.216 -1.014 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.4 m -76.68 174.62 10.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.653 -1.273 . . . . 0.0 110.159 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.36 109.38 3.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -175.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 74.9 m -47.19 125.37 7.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 112.669 -2.06 . . . . 0.0 109.367 176.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -49.81 -36.26 25.85 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 118.771 -0.633 . . . . 0.0 111.745 175.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.9 t -65.07 -28.52 69.52 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.889 0.852 . . . . 0.0 112.503 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.22 -23.96 57.67 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.714 175.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.0 mt -83.52 160.44 59.14 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -69.04 170.44 15.72 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.237 1.958 . . . . 0.0 112.826 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.35 -13.43 33.19 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.723 2.282 . . . . 0.0 114.235 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -95.28 -3.45 47.43 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.642 175.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.6 -50.45 25.24 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.909 177.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.21 -24.97 45.39 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.284 -1.326 . . . . 0.0 112.204 175.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -51.44 -60.18 3.42 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.374 1.046 . . . . 0.0 110.012 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.2 m -55.95 -52.24 64.86 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.647 0.592 . . . . 0.0 112.426 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.1 mt -52.72 -34.15 51.17 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.517 0.51 . . . . 0.0 111.837 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -70.39 -40.72 73.76 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 124.102 0.961 . . . . 0.0 110.818 174.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.5 mt -67.79 -32.21 72.63 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 119.095 -0.478 . . . . 0.0 110.23 175.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.9 -43.08 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 120.597 1.544 . . . . 0.0 111.684 172.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.01 -42.76 72.58 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 125.034 1.459 . . . . 0.0 111.844 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.78 7.41 39.86 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.482 1.113 . . . . 0.0 111.748 177.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.6 t70 40.6 50.24 2.84 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 125.283 1.433 . . . . 0.0 110.977 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.59 -166.77 45.77 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 113.616 -1.629 . . . . 0.0 114.864 -173.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.53 141.03 69.91 Favored 'Cis proline' 0 N--CA 1.48 0.732 0 O-C-N 124.209 1.637 . . . . 0.0 111.19 0.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -91.21 136.23 27.41 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 113.051 -1.886 . . . . 0.0 111.656 -177.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -74.76 -63.63 0.03 OUTLIER 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 122.463 2.108 . . . . 0.0 111.076 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -59.59 150.62 26.76 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.548 0.689 . . . . 0.0 111.596 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.69 -5.71 42.26 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.024 176.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.661 ' NE2' ' HG1' ' A' ' 56' ' ' THR . 13.4 mt-30 -97.38 88.89 4.54 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.957 0.884 . . . . 0.0 112.261 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 169.99 134.16 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 112.115 -2.311 . . . . 0.0 113.751 -175.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.65 17.26 33.87 Favored Glycine 0 N--CA 1.484 1.872 0 CA-C-N 112.706 -2.043 . . . . 0.0 111.846 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.9 m -109.62 150.75 12.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 123.634 0.774 . . . . 0.0 109.502 176.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.3 t -84.01 154.47 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 O-C-N 125.674 1.859 . . . . 0.0 110.473 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -131.92 92.5 3.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.549 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -68.93 47.69 0.06 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.398 1.094 . . . . 0.0 112.96 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 40.4 t30 28.91 53.0 0.08 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.459 1.503 . . . . 0.0 110.628 -173.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.89 -23.46 53.27 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 113.912 -1.494 . . . . 0.0 110.984 -172.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -86.77 -12.86 46.89 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 112.684 -2.053 . . . . 0.0 113.868 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.4 t 43.75 43.53 5.02 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 124.605 2.145 . . . . 0.0 111.663 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 79.5 t -105.75 -17.74 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 112.689 -2.051 . . . . 0.0 110.007 -178.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.51 0 CA-C-O 117.691 -1.147 . . . . 0.0 108.878 -175.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.9 t80 . . . . . 0 N--CA 1.463 0.202 0 CA-C-O 120.05 -0.024 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.58 -16.78 38.5 Favored Glycine 0 N--CA 1.479 1.559 0 O-C-N 125.022 1.451 . . . . 0.0 111.904 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -68.13 -9.79 49.22 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.63 0.772 . . . . 0.0 112.149 176.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -121.3 169.4 10.62 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 124.298 1.039 . . . . 0.0 109.791 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -159.79 164.13 33.99 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 113.237 -1.801 . . . . 0.0 110.659 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -118.98 139.73 51.19 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.846 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -153.09 61.9 0.77 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 125.81 1.944 . . . . 0.0 111.36 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.661 ' HG1' ' NE2' ' A' ' 32' ' ' GLN . 23.3 m -38.24 124.39 1.22 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.362 1.077 . . . . 0.0 112.089 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.66 108.74 18.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 111.901 -2.409 . . . . 0.0 108.767 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -38.23 146.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.443 172.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.648 ' HG1' ' CG ' ' A' ' 68' ' ' ARG . 3.4 m -137.29 140.26 30.29 Favored Pre-proline 0 C--N 1.324 -0.53 0 O-C-N 125.157 1.535 . . . . 0.0 111.654 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.25 150.05 41.45 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.188 2.592 . . . . 0.0 109.502 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 49.73 30.96 15.18 Favored Glycine 0 N--CA 1.479 1.523 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.904 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.01 88.87 5.39 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -41.8 -29.72 0.21 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.247 -1.342 . . . . 0.0 112.794 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.7 p -126.24 -163.69 1.25 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.997 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -59.43 -15.75 19.19 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 173.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.55 153.67 0.8 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.6 p -67.23 -8.86 34.9 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 112.671 -1.765 . . . . 0.0 112.761 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.648 ' CG ' ' HG1' ' A' ' 59' ' ' THR . 0.0 OUTLIER -70.14 116.04 10.04 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.54 1.136 . . . . 0.0 110.413 177.039 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.05 137.96 35.01 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.887 -1.506 . . . . 0.0 109.452 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.7 mt -109.05 141.08 25.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 113.644 -1.616 . . . . 0.0 109.097 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.404 ' O ' ' CD2' ' A' ' 80' ' ' TYR . 19.0 mm -129.42 107.03 14.61 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 CA-C-N 113.808 -1.542 . . . . 0.0 109.309 -177.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.05 167.45 17.87 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 123.348 0.659 . . . . 0.0 110.861 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -120.34 173.18 15.23 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.03 -14.84 63.29 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 113.866 -1.167 . . . . 0.0 111.691 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.31 128.48 54.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.434 175.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.3 m -59.06 141.81 53.03 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 113.506 -1.679 . . . . 0.0 106.98 175.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 81.28 32.04 0.13 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 126.193 2.183 . . . . 0.0 111.002 178.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -133.45 57.47 1.81 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.786 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.74 122.16 42.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.53 -1.668 . . . . 0.0 110.19 178.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.404 ' CD2' ' O ' ' A' ' 71' ' ' ILE . 40.4 m-85 -95.55 137.68 34.29 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 124.914 1.286 . . . . 0.0 109.373 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -116.64 123.74 48.05 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.717 -177.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.93 -66.21 0.93 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 113.663 -1.608 . . . . 0.0 110.734 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.08 2.31 17.56 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-N 113.598 -1.637 . . . . 0.0 113.092 -173.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -129.63 8.6 5.39 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 67.76 80.81 0.2 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 128.213 2.605 . . . . 0.0 110.556 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 55.67 24.3 7.0 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 123.695 1.712 . . . . 0.0 112.99 -175.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -99.74 -10.07 22.3 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 117.954 -1.498 . . . . 0.0 112.391 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.5 p -162.89 171.98 15.82 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -159.91 114.17 2.27 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -174.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.01 104.91 7.09 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 113.854 -1.521 . . . . 0.0 108.682 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.0 mt -42.05 164.66 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 O-C-N 124.209 0.943 . . . . 0.0 112.101 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.41 134.5 53.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 O-C-N 120.699 -1.251 . . . . 0.0 108.996 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.29 93.91 4.67 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.661 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -56.39 -38.09 71.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 123.976 0.798 . . . . 0.0 112.102 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.3 t -54.71 -46.49 74.18 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.047 1.339 . . . . 0.0 112.67 173.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 24.7 t . . . . . 0 C--O 1.249 1.029 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.43 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.9 t . . . . . 0 N--CA 1.472 0.659 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 t -69.59 -2.36 11.32 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 124.731 1.269 . . . . 0.0 112.96 176.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 124.36 169.03 12.99 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.517 1.532 . . . . 0.0 109.474 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -81.77 169.46 16.9 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.839 0.828 . . . . 0.0 110.377 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 p -140.47 107.77 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -174.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 61.5 m -47.09 136.6 8.54 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 113.542 -1.663 . . . . 0.0 111.063 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.89 -32.17 65.61 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.837 -178.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.1 t -66.77 -29.02 68.87 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.863 173.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.13 -29.76 60.62 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.396 0.679 . . . . 0.0 111.523 175.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.5 mt -77.98 160.64 73.4 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -68.72 168.01 21.33 Favored 'Trans proline' 0 CA--C 1.554 1.482 0 C-N-CA 122.559 2.173 . . . . 0.0 112.799 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.29 -12.41 34.88 Favored 'Trans proline' 0 CA--C 1.55 1.306 0 C-N-CA 123.156 2.57 . . . . 0.0 113.944 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -93.38 -11.84 31.32 Favored 'General case' 0 C--O 1.216 -0.705 0 C-N-CA 124.998 1.319 . . . . 0.0 113.188 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.15 -50.08 67.4 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.05 -26.44 49.22 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.937 173.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -54.98 -56.84 15.27 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.153 0.981 . . . . 0.0 110.132 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.5 m -57.15 -49.1 77.01 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 176.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.8 mt -55.85 -35.72 66.74 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.898 0.749 . . . . 0.0 111.806 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -67.91 -37.36 81.6 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.63 174.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 28.2 mt -69.17 -32.01 71.04 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 118.494 -0.765 . . . . 0.0 111.629 173.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.42 -43.85 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 119.668 1.122 . . . . 0.0 111.969 171.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.13 -42.99 71.87 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.119 -1.4 . . . . 0.0 112.863 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.17 4.49 50.34 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.454 1.102 . . . . 0.0 112.084 177.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.7 t0 40.94 50.39 3.1 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.495 1.518 . . . . 0.0 111.383 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.18 -164.93 28.73 Favored Glycine 0 N--CA 1.473 1.149 0 CA-C-N 111.932 -2.395 . . . . 0.0 116.524 -174.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -74.08 141.56 72.11 Favored 'Cis proline' 0 C--N 1.348 0.524 0 O-C-N 124.462 1.769 . . . . 0.0 111.79 -3.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -96.9 116.5 66.09 Favored Pre-proline 0 N--CA 1.47 0.57 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.208 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.94 -48.17 0.3 Allowed 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 122.865 2.377 . . . . 0.0 111.927 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.3 132.44 47.73 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.104 176.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.8 m -70.76 56.9 0.19 Allowed 'General case' 0 N--CA 1.477 0.925 0 O-C-N 125.17 1.544 . . . . 0.0 112.771 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -157.08 73.65 0.76 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 113.566 -1.652 . . . . 0.0 111.863 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.57 144.74 1.14 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 110.987 -2.824 . . . . 0.0 113.481 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.91 23.67 37.8 Favored Glycine 0 CA--C 1.538 1.526 0 CA-C-N 113.237 -1.801 . . . . 0.0 111.839 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.8 m -122.08 145.22 29.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 C-N-CA 124.748 1.219 . . . . 0.0 110.203 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.3 t -81.44 154.13 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 O-C-N 125.969 2.043 . . . . 0.0 110.165 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -131.34 91.7 3.06 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 113.565 -1.652 . . . . 0.0 109.324 175.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.91 51.6 0.15 Allowed 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 119.614 1.097 . . . . 0.0 113.23 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 28.66 52.95 0.07 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 126.81 2.044 . . . . 0.0 110.252 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -26.21 60.75 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 121.771 0.796 . . . . 0.0 112.858 -172.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -74.95 -16.79 60.63 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 112.621 -2.081 . . . . 0.0 114.593 171.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.8 t 45.86 41.1 7.39 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 124.024 1.869 . . . . 0.0 111.388 -177.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 89.1 t -104.21 -11.38 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 112.758 -2.019 . . . . 0.0 109.65 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.547 0.832 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.523 -174.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.6 t80 . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.48 -17.33 39.81 Favored Glycine 0 N--CA 1.474 1.205 0 CA-C-N 114.03 -1.441 . . . . 0.0 112.721 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.62 -1.08 20.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.013 1.325 . . . . 0.0 113.867 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -129.77 151.51 50.28 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.489 1.116 . . . . 0.0 109.598 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -147.29 155.4 42.0 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 126.278 2.236 . . . . 0.0 110.581 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -108.96 132.93 53.61 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.298 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -145.75 62.95 1.26 Allowed 'General case' 0 N--CA 1.471 0.584 0 O-C-N 125.64 1.838 . . . . 0.0 110.715 -176.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -38.53 127.79 1.46 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 122.194 0.997 . . . . 0.0 112.85 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.1 p -90.8 113.24 26.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 111.783 -2.462 . . . . 0.0 109.201 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -36.89 145.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 114.022 -1.444 . . . . 0.0 110.506 171.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.517 ' HG1' ' CG ' ' A' ' 68' ' ' ARG . 3.4 m -136.66 140.16 31.29 Favored Pre-proline 0 N--CA 1.476 0.839 0 O-C-N 125.472 1.733 . . . . 0.0 112.48 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.99 145.18 31.16 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.375 2.05 . . . . 0.0 109.236 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.12 32.16 49.79 Favored Glycine 0 CA--C 1.539 1.532 0 CA-C-N 113.247 -1.797 . . . . 0.0 112.186 -176.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.72 94.42 7.28 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -40.89 -33.15 0.28 Allowed 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 113.768 -1.56 . . . . 0.0 113.913 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.7 p -124.97 -155.15 0.66 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 113.655 -1.612 . . . . 0.0 108.755 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.4 mtm-85 -55.5 -19.75 10.71 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 171.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.32 135.48 0.08 OUTLIER Glycine 0 CA--C 1.524 0.599 0 N-CA-C 107.717 -2.153 . . . . 0.0 107.717 -176.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 77.1 p -41.28 -33.62 0.4 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 113.429 -1.385 . . . . 0.0 113.727 175.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.517 ' CG ' ' HG1' ' A' ' 59' ' ' THR . 0.2 OUTLIER -39.35 128.78 1.82 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 122.719 1.247 . . . . 0.0 113.83 169.746 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.458 HH21 ' HH ' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -158.69 133.78 8.42 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 111.702 -2.499 . . . . 0.0 110.159 -176.335 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.0 mt -112.14 132.7 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 125.817 1.948 . . . . 0.0 107.791 176.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.9 mm -121.12 102.88 12.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 112.753 -2.021 . . . . 0.0 107.522 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.4 p -88.86 161.31 16.78 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.501 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -116.42 164.23 12.34 Favored Glycine 0 N--CA 1.475 1.262 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.444 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.15 -15.81 62.82 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 176.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -103.71 130.96 51.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.612 173.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 m -55.97 142.7 34.85 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 175.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 78.98 31.74 0.3 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 126.892 2.077 . . . . 0.0 111.499 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -125.49 48.81 1.99 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 123.083 1.42 . . . . 0.0 112.569 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.52 107.9 18.94 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.205 1.402 . . . . 0.0 109.39 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -96.99 132.3 42.93 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 124.885 1.366 . . . . 0.0 109.48 -177.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -110.39 126.18 54.01 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.089 -176.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . 0.27 0.3 OUTLIER -87.84 -68.66 0.74 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.011 -1.45 . . . . 0.0 112.211 176.399 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.86 2.12 21.72 Favored Glycine 0 N--CA 1.482 1.726 0 CA-C-N 114.607 -1.179 . . . . 0.0 113.414 -172.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -129.82 13.17 5.82 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.349 1.059 . . . . 0.0 112.531 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 64.08 84.86 0.14 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.329 1.852 . . . . 0.0 111.579 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.458 ' HH ' HH21 ' A' ' 69' ' ' ARG . 7.4 m-85 50.81 29.54 4.4 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -175.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -112.21 -3.78 14.55 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.0 p -164.5 161.32 21.22 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.958 1.703 . . . . 0.0 108.305 -174.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -157.83 112.01 2.58 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.023 0.929 . . . . 0.0 108.88 -174.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.3 m -131.47 106.71 8.4 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 112.863 -1.971 . . . . 0.0 109.57 -178.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 17.5 mt -42.13 155.61 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.972 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.9 mp -102.76 111.12 31.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 O-C-N 120.489 -1.382 . . . . 0.0 108.837 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.14 85.81 6.72 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.769 0.795 . . . . 0.0 110.156 175.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.53 -32.56 70.06 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.002 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.4 t -56.19 -23.05 32.9 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.525 1.53 . . . . 0.0 113.267 173.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.6 t . . . . . 0 CA--C 1.554 1.105 0 CA-C-O 116.48 -1.724 . . . . 0.0 110.85 177.764 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.1 t . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 m -75.14 6.59 4.11 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 124.544 1.152 . . . . 0.0 113.776 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 121.22 -165.54 14.25 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 m -95.79 170.14 9.52 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.986 -1.107 . . . . 0.0 110.277 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -137.47 111.85 9.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -176.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 97.0 m -49.37 129.48 18.67 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 111.874 -2.421 . . . . 0.0 109.83 177.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.78 -33.21 66.4 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 119.217 -0.42 . . . . 0.0 111.437 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.8 t -67.24 -28.39 68.01 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.348 0.659 . . . . 0.0 112.384 174.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.33 -20.76 58.87 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.781 174.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.2 mt -83.18 158.94 63.35 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 175.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.03 167.02 24.69 Favored 'Trans proline' 0 CA--C 1.551 1.371 0 C-N-CA 121.964 1.776 . . . . 0.0 112.456 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.18 -17.45 45.25 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.384 2.056 . . . . 0.0 113.682 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.4 pm0 -87.65 -13.78 41.73 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.697 1.199 . . . . 0.0 112.674 174.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.78 -49.9 73.16 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.02 0.528 . . . . 0.0 112.098 176.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.11 -26.23 48.97 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.633 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -57.57 -57.48 12.53 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.805 0.842 . . . . 0.0 110.34 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.8 m -57.23 -49.1 77.1 Favored 'General case' 0 C--O 1.217 -0.621 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 175.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.0 mt -56.02 -35.13 66.49 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 124.253 0.971 . . . . 0.0 111.77 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -67.59 -39.16 84.82 Favored 'General case' 0 C--O 1.212 -0.891 0 C-N-CA 124.54 1.136 . . . . 0.0 110.957 174.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.0 mt -68.53 -34.76 76.43 Favored 'General case' 0 C--O 1.211 -0.926 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.596 175.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.93 -38.73 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 120.069 1.304 . . . . 0.0 111.872 171.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.47 -48.52 48.73 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.86 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 m -85.46 5.93 29.04 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.173 0.989 . . . . 0.0 113.314 176.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.38 36.08 1.51 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 122.748 1.261 . . . . 0.0 112.22 -176.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.44 -166.9 16.26 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.443 1.497 . . . . 0.0 115.706 -174.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.78 139.87 64.15 Favored 'Cis proline' 0 C--N 1.347 0.485 0 O-C-N 124.285 1.676 . . . . 0.0 111.255 -2.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -90.95 135.72 28.37 Favored Pre-proline 0 N--CA 1.474 0.732 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.705 -177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -74.34 -61.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.469 2.779 . . . . 0.0 111.433 -178.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.3 m-30 -63.35 159.72 17.52 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 175.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.8 m -80.53 9.28 6.22 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 124.173 0.921 . . . . 0.0 113.476 173.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.61 78.99 1.76 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 122.022 0.915 . . . . 0.0 111.46 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -177.14 146.16 0.49 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 111.721 -2.49 . . . . 0.0 115.056 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.69 27.98 36.84 Favored Glycine 0 N--CA 1.479 1.535 0 CA-C-N 112.87 -1.968 . . . . 0.0 110.853 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.5 m -122.12 146.24 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.453 1.101 . . . . 0.0 109.54 177.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.4 t -84.39 154.07 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 125.903 2.002 . . . . 0.0 109.855 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -137.11 85.88 2.16 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 113.844 -1.525 . . . . 0.0 110.828 175.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -69.38 51.91 0.1 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.9 t30 27.52 55.65 0.07 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.779 2.032 . . . . 0.0 109.634 -172.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -28.37 54.85 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 122.332 1.063 . . . . 0.0 111.463 -175.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -74.72 -11.37 60.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 113.138 -1.846 . . . . 0.0 114.962 173.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 31.4 t 45.38 43.12 8.21 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 123.874 1.797 . . . . 0.0 111.844 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.8 t -108.77 -20.92 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 113.78 -1.555 . . . . 0.0 110.432 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.627 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -175.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.4 t80 . . . . . 0 N--CA 1.469 0.501 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.63 -18.84 27.73 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 113.813 -1.539 . . . . 0.0 112.258 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -67.47 -9.09 38.76 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.228 1.011 . . . . 0.0 112.396 176.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -122.99 162.4 22.41 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 124.279 1.032 . . . . 0.0 109.772 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -159.51 155.85 27.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 112.296 -2.229 . . . . 0.0 111.39 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -110.68 142.34 42.72 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.758 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -156.57 67.11 0.56 Allowed 'General case' 0 N--CA 1.477 0.918 0 O-C-N 126.328 2.267 . . . . 0.0 110.524 -175.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 m -38.47 123.06 1.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 122.689 1.233 . . . . 0.0 112.808 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -81.82 114.1 22.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 112.109 -2.314 . . . . 0.0 108.73 177.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -41.33 150.82 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 124.806 1.316 . . . . 0.0 109.107 171.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.531 ' HG1' ' CG ' ' A' ' 68' ' ' ARG . 23.8 m -150.99 137.76 11.56 Favored Pre-proline 0 N--CA 1.481 1.106 0 O-C-N 125.851 1.969 . . . . 0.0 110.684 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -72.48 151.4 53.19 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 123.646 2.897 . . . . 0.0 110.588 177.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.36 20.72 30.75 Favored Glycine 0 N--CA 1.48 1.623 0 CA-C-N 114.015 -1.448 . . . . 0.0 112.88 -174.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.87 87.64 5.47 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -44.39 -30.52 0.86 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 113.99 -1.459 . . . . 0.0 112.683 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.8 p -133.03 -170.87 2.54 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.866 -1.515 . . . . 0.0 108.638 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.1 mtm-85 -46.87 -29.3 1.92 Allowed 'General case' 0 N--CA 1.484 1.254 0 O-C-N 124.273 0.983 . . . . 0.0 112.921 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.27 148.78 0.09 OUTLIER Glycine 0 N--CA 1.465 0.59 0 N-CA-C 107.26 -2.336 . . . . 0.0 107.26 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.6 p -42.86 -29.73 0.34 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.052 -1.574 . . . . 0.0 113.423 172.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.531 ' CG ' ' HG1' ' A' ' 59' ' ' THR . 3.1 mmm180 -37.64 116.91 0.52 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 166.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.49 135.02 10.52 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 112.435 -2.166 . . . . 0.0 112.938 -176.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.9 mt -113.7 141.05 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 112.784 -2.007 . . . . 0.0 108.471 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.4 mm -127.52 114.09 34.49 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 O-C-N 126.199 2.187 . . . . 0.0 108.203 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.5 p -101.05 163.92 12.05 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.248 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.67 164.87 12.04 Favored Glycine 0 CA--C 1.531 1.082 0 O-C-N 125.639 1.837 . . . . 0.0 109.694 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.86 -17.43 63.15 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.302 0.641 . . . . 0.0 112.117 175.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -104.55 128.51 52.53 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.8 m -55.54 145.82 22.06 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 114.096 -1.411 . . . . 0.0 107.354 174.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 82.39 32.84 0.09 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 126.299 1.839 . . . . 0.0 111.218 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -135.83 46.46 2.33 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 123.058 1.409 . . . . 0.0 112.744 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.2 88.61 3.54 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 113.174 -1.83 . . . . 0.0 109.843 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -57.79 178.06 0.09 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.287 174.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.483 ' CE2' ' NH1' ' A' ' 68' ' ' ARG . 9.0 t80 -158.01 113.92 2.77 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.685 -176.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . 0.318 0.1 OUTLIER -87.87 -80.45 0.27 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.045 -1.434 . . . . 0.0 113.72 177.813 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.02 -5.31 59.15 Favored Glycine 0 N--CA 1.471 0.99 0 CA-C-N 115.25 -0.886 . . . . 0.0 114.382 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.64 20.02 11.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.398 -0.901 . . . . 0.0 111.985 173.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 58.47 87.02 0.08 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.25 1.82 . . . . 0.0 110.203 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 49.08 41.32 19.16 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 113.639 -1.619 . . . . 0.0 114.518 -174.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -112.46 -32.64 6.42 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.102 -1.624 . . . . 0.0 112.806 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.3 p -135.95 166.79 22.52 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.646 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -156.79 110.13 2.61 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -175.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.71 106.46 9.15 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 113.884 -1.507 . . . . 0.0 108.354 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 51.1 mt -44.08 161.72 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.76 131.97 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 120.881 -1.137 . . . . 0.0 108.926 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.87 94.99 5.31 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 113.204 -1.816 . . . . 0.0 107.911 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -57.41 -37.1 72.21 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 124.731 1.269 . . . . 0.0 111.912 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.3 t -58.34 -45.66 87.71 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.821 -1.082 . . . . 0.0 112.469 174.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 11.6 t . . . . . 0 C--O 1.245 0.829 0 CA-C-O 118.489 -0.767 . . . . 0.0 110.929 175.091 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.4 t . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.1 m -77.74 5.69 8.9 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.787 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 120.53 -177.23 16.36 Favored Glycine 0 N--CA 1.473 1.115 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.4 m -90.96 173.69 7.83 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 122.354 1.073 . . . . 0.0 109.2 -178.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.73 112.64 5.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -175.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 73.3 m -50.08 124.66 10.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 111.894 -2.412 . . . . 0.0 109.601 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.73 -35.39 31.2 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.719 0.807 . . . . 0.0 112.232 174.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.9 t -63.81 -30.97 72.01 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.518 0.511 . . . . 0.0 111.992 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.48 -17.65 59.18 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.632 0.773 . . . . 0.0 111.913 174.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.1 mt -90.05 162.35 35.46 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 176.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.48 169.53 15.48 Favored 'Trans proline' 0 CA--C 1.547 1.135 0 C-N-CA 122.606 2.204 . . . . 0.0 112.988 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.3 -17.95 49.99 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.561 2.174 . . . . 0.0 113.058 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -85.05 -25.22 27.76 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 175.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -48.84 -37.07 18.37 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 175.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.49 -35.27 68.14 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.873 -1.512 . . . . 0.0 112.943 173.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -54.46 -53.33 55.63 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.06 0.944 . . . . 0.0 109.828 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.1 m -59.54 -48.24 82.43 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 175.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.6 mt -56.81 -28.57 61.66 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -73.75 -40.35 63.57 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.704 173.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 25.3 mt -69.5 -31.16 69.24 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 119.271 -0.395 . . . . 0.0 111.026 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.74 -38.38 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 120.143 1.338 . . . . 0.0 111.508 171.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.46 -47.61 32.39 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 124.562 1.164 . . . . 0.0 111.873 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.7 m -85.91 8.4 20.45 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.42 1.488 . . . . 0.0 112.645 175.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 41.51 46.54 3.05 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 122.725 1.25 . . . . 0.0 112.525 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.48 -166.13 43.37 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-N 113.928 -1.487 . . . . 0.0 116.265 -171.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -74.25 140.6 68.17 Favored 'Cis proline' 0 N--CA 1.483 0.887 0 O-C-N 124.758 1.925 . . . . 0.0 111.543 -1.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -92.21 142.67 26.44 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 113.897 -1.501 . . . . 0.0 111.679 -176.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -74.62 -65.29 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 123.283 2.655 . . . . 0.0 111.42 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 -57.56 163.0 2.63 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.834 0.826 . . . . 0.0 112.226 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 t -82.08 9.44 8.5 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 123.238 1.494 . . . . 0.0 112.269 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.11 99.54 8.14 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.302 -177.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 166.64 140.17 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 O-C-N 126.626 2.454 . . . . 0.0 115.404 -172.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.45 30.38 22.02 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-N 113.616 -1.629 . . . . 0.0 111.172 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.7 m -122.36 147.39 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 114.275 -0.963 . . . . 0.0 109.512 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.0 t -85.15 156.95 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 125.248 1.593 . . . . 0.0 109.631 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -141.26 86.26 2.01 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.811 175.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.72 55.44 0.26 Allowed 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 122.631 1.205 . . . . 0.0 113.318 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 45.7 t30 29.73 53.62 0.12 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.474 2.31 . . . . 0.0 109.305 -173.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.18 -22.97 53.8 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.701 -174.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -83.02 -8.28 59.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 113.207 -1.815 . . . . 0.0 114.669 173.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 43.9 t 44.0 41.92 4.37 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 124.326 2.012 . . . . 0.0 111.733 -177.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.5 t -109.81 -12.4 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 113.592 -1.64 . . . . 0.0 109.663 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.545 0.775 0 O-C-N 120.721 -1.237 . . . . 0.0 108.687 -175.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.3 t80 . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.43 -21.53 28.43 Favored Glycine 0 N--CA 1.479 1.521 0 O-C-N 125.181 1.551 . . . . 0.0 112.009 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -64.44 -13.47 51.62 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.505 1.122 . . . . 0.0 112.294 176.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -116.25 163.08 16.52 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.718 0.807 . . . . 0.0 109.535 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -159.65 159.65 33.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 112.016 -2.357 . . . . 0.0 111.184 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -117.31 144.7 44.6 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.645 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -158.96 63.92 0.41 Allowed 'General case' 0 N--CA 1.48 1.047 0 O-C-N 126.495 2.372 . . . . 0.0 111.104 -174.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 m -35.35 120.89 0.57 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 122.352 1.072 . . . . 0.0 112.556 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.78 117.72 28.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 112.738 -2.028 . . . . 0.0 108.609 177.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -42.99 158.39 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 173.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.629 ' HG1' ' CG ' ' A' ' 68' ' ' ARG . 2.5 m -153.09 142.45 14.74 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 113.273 -1.785 . . . . 0.0 111.387 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.56 146.03 48.5 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.594 2.196 . . . . 0.0 110.971 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.25 22.1 55.08 Favored Glycine 0 N--CA 1.48 1.611 0 CA-C-N 113.759 -1.564 . . . . 0.0 112.459 -175.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.2 87.05 7.34 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -47.61 -26.57 1.52 Allowed 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.912 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.1 p -128.03 -158.62 0.89 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.037 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.6 mtm105 -57.06 -18.18 13.25 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 174.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.41 125.4 0.02 OUTLIER Glycine 0 N--CA 1.465 0.593 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.0 p -39.72 -31.09 0.09 Allowed 'General case' 0 CA--C 1.557 1.234 0 CA-C-N 113.699 -1.251 . . . . 0.0 113.523 175.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.629 ' CG ' ' HG1' ' A' ' 59' ' ' THR . 0.3 OUTLIER -46.05 105.61 0.07 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 123.417 1.579 . . . . 0.0 112.711 170.137 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.42 141.36 49.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 112.816 -1.993 . . . . 0.0 109.989 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.9 mt -117.3 135.9 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 112.681 -2.054 . . . . 0.0 108.33 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.9 mm -124.91 101.87 9.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 CA-C-N 112.848 -1.978 . . . . 0.0 108.608 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.9 p -89.68 163.1 15.26 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.502 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -115.29 166.84 12.24 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-N 113.32 -1.764 . . . . 0.0 109.665 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.24 -14.09 62.58 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.355 -0.922 . . . . 0.0 111.843 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.58 130.95 55.29 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.129 174.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.4 m -55.23 143.8 26.66 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.124 -1.398 . . . . 0.0 107.495 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 80.06 33.82 0.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 126.127 2.142 . . . . 0.0 111.037 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -129.33 49.12 2.28 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 113.596 -1.638 . . . . 0.0 113.616 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.13 103.77 13.25 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.341 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -91.64 131.13 37.26 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 125.28 1.613 . . . . 0.0 109.916 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -110.29 123.92 50.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.24 -1.345 . . . . 0.0 109.894 -176.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.437 ' HG1' ' N ' ' A' ' 86' ' ' TYR 0.262 0.2 OUTLIER -89.74 -71.18 0.62 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 113.502 -1.681 . . . . 0.0 112.464 177.315 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.09 -8.81 56.65 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-N 113.118 -1.856 . . . . 0.0 112.197 -175.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -112.01 9.71 20.43 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 117.252 0.526 . . . . 0.0 111.838 174.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 87.15 -20.93 0.2 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.928 1.691 . . . . 0.0 113.076 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.437 ' N ' ' HG1' ' A' ' 82' ' ' THR . 1.2 m-30 161.19 55.35 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 O-C-N 128.16 3.412 . . . . 0.0 113.684 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -120.06 -41.33 2.65 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 118.994 -1.083 . . . . 0.0 113.748 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 18.4 p -128.29 165.55 20.32 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.399 -1.273 . . . . 0.0 108.402 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -157.41 112.7 2.78 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -173.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.2 m -131.21 112.25 12.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 113.261 -1.791 . . . . 0.0 109.286 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 25.1 mt -42.39 162.82 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 O-C-N 124.214 0.946 . . . . 0.0 112.428 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.19 130.74 65.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 O-C-N 120.778 -1.201 . . . . 0.0 108.823 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.04 94.14 4.94 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.257 -1.792 . . . . 0.0 108.624 176.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -53.39 -37.22 62.26 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 124.107 0.88 . . . . 0.0 112.467 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.9 t -56.74 -49.29 75.65 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 113.801 -1.545 . . . . 0.0 113.595 174.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 34.3 t . . . . . 0 C--O 1.246 0.886 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 179.07 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.92 5.82 10.67 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.883 0.849 . . . . 0.0 112.639 177.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.38 -174.37 16.55 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.447 1.498 . . . . 0.0 109.988 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -94.18 169.39 10.28 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 122.016 0.912 . . . . 0.0 109.239 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 p -137.84 111.26 7.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 122.752 1.263 . . . . 0.0 107.882 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 71.6 m -48.96 128.16 15.47 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 112.256 -2.247 . . . . 0.0 109.364 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -34.65 57.41 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.805 176.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.1 t -64.68 -29.77 70.77 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 174.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.14 -26.11 58.9 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.451 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.1 mt -83.92 162.57 51.94 Favored Pre-proline 0 N--CA 1.478 0.952 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 177.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.17 168.11 18.39 Favored 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 122.308 2.005 . . . . 0.0 112.952 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -65.28 -18.95 62.0 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.847 2.365 . . . . 0.0 112.666 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -83.62 -26.41 29.98 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.439 -0.801 . . . . 0.0 113.066 175.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -47.62 -38.87 15.54 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.38 -34.73 72.91 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.551 -1.659 . . . . 0.0 113.328 174.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -54.52 -57.0 13.12 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 117.408 -1.282 . . . . 0.0 109.465 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 m -55.87 -48.42 75.59 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 174.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.1 mt -57.42 -33.36 67.81 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -67.75 -33.41 74.81 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.336 174.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.3 mt -75.93 -31.3 59.06 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 118.773 -0.632 . . . . 0.0 110.924 176.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.9 -40.81 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 120.267 1.394 . . . . 0.0 111.453 170.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.84 -41.78 64.46 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 125.02 1.45 . . . . 0.0 112.521 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.31 7.23 45.22 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.321 1.049 . . . . 0.0 111.781 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 44.46 34.98 1.19 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.035 1.334 . . . . 0.0 112.556 -176.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.9 -168.15 20.14 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-N 113.379 -1.737 . . . . 0.0 115.83 -174.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -74.53 140.5 67.66 Favored 'Cis proline' 0 N--CA 1.479 0.622 0 O-C-N 124.043 1.549 . . . . 0.0 111.261 -3.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -89.86 136.99 28.57 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.57 -176.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -72.68 -63.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.475 0.415 0 C-N-CA 123.563 2.842 . . . . 0.0 111.413 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 -62.99 159.4 17.13 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.411 0.684 . . . . 0.0 112.744 175.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.85 8.5 5.4 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 124.714 1.259 . . . . 0.0 113.588 174.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.409 ' NE2' ' NH1' ' A' ' 69' ' ' ARG . 1.8 mt-30 -105.01 82.89 1.91 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 122.372 1.082 . . . . 0.0 111.819 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -177.32 150.83 0.74 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 110.779 -2.919 . . . . 0.0 114.999 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.01 35.43 27.58 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-N 112.52 -2.127 . . . . 0.0 110.275 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -131.88 147.1 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.546 1.138 . . . . 0.0 109.72 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.4 t -84.41 154.4 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 O-C-N 125.944 2.027 . . . . 0.0 109.868 175.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -132.31 91.33 2.92 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 113.846 -1.525 . . . . 0.0 108.419 174.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.5 tm0? -72.12 55.63 0.31 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 119.81 1.187 . . . . 0.0 112.361 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 26.06 55.83 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.793 2.437 . . . . 0.0 110.854 -175.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.38 -25.97 51.42 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 122.17 0.986 . . . . 0.0 111.938 -171.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -76.35 -14.33 60.09 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 113.09 -1.868 . . . . 0.0 115.598 172.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 31.6 t 45.06 41.81 5.91 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 124.183 1.945 . . . . 0.0 111.924 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.6 t -110.8 -10.42 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-N 113.151 -1.841 . . . . 0.0 110.739 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 C--N 1.319 -0.76 0 CA-C-O 117.372 -1.299 . . . . 0.0 109.29 -176.662 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.1 t80 . . . . . 0 CA--C 1.539 0.524 0 N-CA-C 110.437 -0.208 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.76 5.99 70.62 Favored Glycine 0 N--CA 1.48 1.584 0 O-C-N 125.332 1.645 . . . . 0.0 112.657 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.39 15.31 3.72 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -151.04 150.76 31.12 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.156 0.983 . . . . 0.0 109.305 -173.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -147.12 155.44 42.17 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 126.074 2.109 . . . . 0.0 111.632 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -109.13 145.17 36.16 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.829 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -159.82 68.28 0.39 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 126.826 2.579 . . . . 0.0 110.64 -174.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -41.19 133.92 2.22 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 122.767 1.27 . . . . 0.0 111.814 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -95.86 118.97 43.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 112.07 -2.332 . . . . 0.0 107.939 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -40.73 153.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 CA-C-O 121.853 0.835 . . . . 0.0 108.955 173.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.7 m -140.04 139.74 22.15 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 112.951 -1.931 . . . . 0.0 111.688 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.73 145.18 50.84 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 121.93 1.754 . . . . 0.0 111.007 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 51.77 28.48 23.37 Favored Glycine 0 CA--C 1.548 2.137 0 O-C-N 125.289 1.618 . . . . 0.0 111.895 -174.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.98 90.28 4.57 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -46.57 -27.65 1.2 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 113.603 -1.635 . . . . 0.0 113.197 176.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.2 p -126.0 -173.67 2.91 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.846 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.6 mtm105 -52.94 -20.72 3.6 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 175.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.22 171.27 11.89 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 124.38 2.1 . . . . 0.0 109.201 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.0 p -75.95 0.74 17.33 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 111.275 -2.463 . . . . 0.0 113.004 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.11 116.9 21.89 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 122.925 1.345 . . . . 0.0 111.203 176.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.409 ' NH1' ' NE2' ' A' ' 32' ' ' GLN . 0.1 OUTLIER -142.35 135.67 28.87 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 112.771 -2.013 . . . . 0.0 109.323 178.444 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.2 mt -104.5 144.81 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 113.463 -1.699 . . . . 0.0 108.741 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.4 mm -132.73 114.75 23.04 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.737 0 CA-C-N 112.486 -2.143 . . . . 0.0 107.895 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.8 p -99.45 162.86 12.79 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.791 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -107.61 -178.26 22.39 Favored Glycine 0 N--CA 1.477 1.433 0 O-C-N 124.968 1.417 . . . . 0.0 109.953 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.8 -13.22 59.96 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 114.348 -0.926 . . . . 0.0 113.024 174.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -113.73 130.78 56.38 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 176.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.4 m -54.0 147.97 11.53 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.083 174.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 80.63 31.76 0.17 Allowed 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 126.585 1.954 . . . . 0.0 110.942 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -134.59 48.78 2.28 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 123.89 1.805 . . . . 0.0 113.708 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.34 86.74 2.58 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 113.071 -1.877 . . . . 0.0 109.417 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -57.35 177.88 0.08 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 125.275 1.43 . . . . 0.0 110.339 174.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -162.87 126.23 2.85 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 113.817 -1.538 . . . . 0.0 109.84 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.12 -71.97 0.6 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 112.672 -2.058 . . . . 0.0 111.702 176.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.46 1.08 34.38 Favored Glycine 0 CA--C 1.55 2.228 0 CA-C-N 113.094 -1.866 . . . . 0.0 114.835 -173.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -127.79 15.8 6.92 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.386 0.675 . . . . 0.0 112.619 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 61.28 83.79 0.14 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 127.093 2.157 . . . . 0.0 110.591 -178.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 51.84 38.23 22.74 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 113.83 -1.532 . . . . 0.0 113.342 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -109.74 -13.22 14.52 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.5 p -161.37 165.96 28.14 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.037 1.335 . . . . 0.0 107.81 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -157.29 113.55 2.93 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -176.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.4 m -132.33 115.94 16.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.748 -1.569 . . . . 0.0 109.399 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 35.0 mt -47.28 164.21 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.379 0.672 . . . . 0.0 111.946 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.63 128.96 69.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 120.824 -1.173 . . . . 0.0 108.434 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.87 92.05 4.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 113.472 -1.695 . . . . 0.0 108.551 175.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -52.62 -36.4 56.4 Favored 'General case' 0 N--CA 1.484 1.225 0 O-C-N 124.173 0.92 . . . . 0.0 112.778 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.2 t -58.27 -47.05 84.82 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 114.054 -1.43 . . . . 0.0 113.387 173.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 24.3 t . . . . . 0 C--O 1.244 0.791 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.171 178.365 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 71.2 t . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.5 m -70.48 3.8 2.78 Favored 'General case' 0 CA--C 1.55 0.952 0 O-C-N 125.151 1.532 . . . . 0.0 112.526 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 111.2 -179.25 19.86 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 m -77.0 170.14 17.07 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.128 -1.036 . . . . 0.0 110.423 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 p -138.49 108.6 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 78.8 m -43.55 123.51 3.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 112.565 -2.107 . . . . 0.0 109.964 176.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.74 -37.06 39.69 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.742 177.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.9 t -65.69 -28.11 68.83 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.099 0.56 . . . . 0.0 112.073 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.43 -20.55 58.8 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.83 174.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.7 mt -85.77 159.59 54.67 Favored Pre-proline 0 CA--C 1.539 0.519 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 176.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.52 169.16 19.25 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 121.953 1.769 . . . . 0.0 113.081 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.48 -13.93 38.63 Favored 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 122.627 2.218 . . . . 0.0 114.549 177.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.8 pm0 -93.43 -4.93 50.43 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.559 -1.201 . . . . 0.0 113.29 176.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.59 -50.7 11.06 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.797 175.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.96 -28.22 56.06 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.67 -1.15 . . . . 0.0 112.271 174.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -53.45 -58.63 6.47 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.428 1.08 . . . . 0.0 109.969 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 m -53.57 -50.43 65.59 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.612 0.968 . . . . 0.0 113.612 175.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.4 mt -56.15 -37.38 69.42 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.885 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -64.63 -33.26 75.52 Favored 'General case' 0 C--O 1.214 -0.787 0 C-N-CA 123.962 0.905 . . . . 0.0 110.691 173.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.8 mt -76.35 -30.43 57.6 Favored 'General case' 0 C--O 1.209 -1.048 0 CA-C-O 118.364 -0.826 . . . . 0.0 110.78 176.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.8 mp -70.65 -40.63 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 120.217 1.371 . . . . 0.0 111.722 171.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.39 -40.97 63.9 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.006 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.18 7.72 44.25 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.355 178.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 42.99 34.84 0.67 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.577 1.151 . . . . 0.0 112.733 -176.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.67 -169.48 18.22 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 113.521 -1.672 . . . . 0.0 115.969 -173.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.57 140.76 69.1 Favored 'Cis proline' 0 CA--C 1.537 0.655 0 O-C-N 123.775 1.408 . . . . 0.0 111.102 -2.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -91.66 136.3 26.72 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 113.686 -1.597 . . . . 0.0 111.573 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -73.58 -62.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.475 0.439 0 C-N-CA 122.947 2.431 . . . . 0.0 111.942 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.8 m-30 -69.3 146.35 52.31 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 118.494 -0.765 . . . . 0.0 110.793 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.4 m -62.4 -15.26 48.0 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 125.385 1.678 . . . . 0.0 113.141 174.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.464 ' NE2' HH12 ' A' ' 69' ' ' ARG . 2.0 mt-30 -78.64 77.96 5.11 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 122.678 1.227 . . . . 0.0 111.516 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -178.12 142.21 0.27 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 110.783 -2.917 . . . . 0.0 113.869 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.0 24.43 37.72 Favored Glycine 0 N--CA 1.481 1.656 0 CA-C-N 112.952 -1.931 . . . . 0.0 111.399 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.4 m -120.52 146.89 24.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 124.384 1.073 . . . . 0.0 109.481 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.3 t -83.57 154.37 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 126.096 2.123 . . . . 0.0 110.206 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -135.03 88.53 2.43 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 113.842 -1.526 . . . . 0.0 109.988 175.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -70.91 52.44 0.15 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 122.684 1.231 . . . . 0.0 113.753 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 37.5 t30 28.43 54.26 0.08 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.06 2.144 . . . . 0.0 109.566 -172.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -56.31 -26.29 51.72 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.702 -1.136 . . . . 0.0 111.035 -175.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -76.61 -11.83 59.92 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.61 -1.632 . . . . 0.0 114.562 174.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.2 t 45.54 40.9 6.29 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 123.54 1.638 . . . . 0.0 111.973 -177.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.4 t -109.34 -18.58 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 114.16 -1.382 . . . . 0.0 110.852 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.469 0.497 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.762 -175.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.5 t80 . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.26 -18.68 21.91 Favored Glycine 0 N--CA 1.483 1.82 0 O-C-N 124.971 1.419 . . . . 0.0 113.136 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.98 1.63 12.43 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.214 1.406 . . . . 0.0 113.135 177.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -131.05 162.88 28.83 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 123.904 0.882 . . . . 0.0 109.873 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -159.18 156.8 29.62 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 125.647 1.842 . . . . 0.0 110.899 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -114.94 137.33 52.11 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.454 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -152.48 65.85 0.82 Allowed 'General case' 0 N--CA 1.475 0.789 0 O-C-N 125.837 1.961 . . . . 0.0 111.345 -175.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.4 m -39.16 134.65 1.07 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 122.811 1.291 . . . . 0.0 113.061 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -86.97 109.0 18.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 111.354 -2.657 . . . . 0.0 107.529 178.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -43.19 157.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 125.635 1.834 . . . . 0.0 109.339 168.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.616 ' HG1' ' NE ' ' A' ' 68' ' ' ARG . 2.6 m -156.61 141.75 12.38 Favored Pre-proline 0 C--N 1.322 -0.613 0 O-C-N 126.063 2.102 . . . . 0.0 112.501 176.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.84 145.56 45.98 Favored 'Trans proline' 0 N--CA 1.475 0.407 0 C-N-CA 122.549 2.166 . . . . 0.0 110.955 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.81 28.72 57.66 Favored Glycine 0 CA--C 1.539 1.586 0 CA-C-N 113.358 -1.746 . . . . 0.0 112.422 -175.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.11 89.92 7.89 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -39.71 -32.83 0.15 Allowed 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 113.864 -1.516 . . . . 0.0 113.167 176.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.6 p -130.7 -160.65 1.06 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 113.879 -1.509 . . . . 0.0 109.755 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.6 mtm105 -60.21 -14.74 19.17 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 172.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.18 139.53 0.07 OUTLIER Glycine 0 C--N 1.334 0.433 0 N-CA-C 107.57 -2.212 . . . . 0.0 107.57 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.2 p -47.08 -27.9 1.53 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 113.306 -1.447 . . . . 0.0 113.428 174.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.616 ' NE ' ' HG1' ' A' ' 59' ' ' THR . 33.9 mtm-85 -50.27 133.37 23.96 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 123.575 1.655 . . . . 0.0 112.954 170.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.464 HH12 ' NE2' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -159.36 133.29 7.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 111.834 -2.439 . . . . 0.0 109.99 -179.585 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.3 mt -104.34 140.18 23.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 113.591 -1.64 . . . . 0.0 109.099 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.2 mm -129.22 111.37 22.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 112.362 -2.199 . . . . 0.0 108.88 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.2 p -98.68 163.27 12.71 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.443 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -108.03 179.95 21.84 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.083 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.52 -12.19 59.99 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.735 0.779 . . . . 0.0 111.888 175.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -117.47 129.86 56.08 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 175.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.3 m -53.88 151.25 6.73 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.537 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 83.79 32.38 0.06 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 125.936 2.022 . . . . 0.0 110.549 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -146.28 52.83 1.13 Allowed 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 123.187 1.47 . . . . 0.0 112.468 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.37 90.97 3.46 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 113.654 -1.612 . . . . 0.0 109.591 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -59.63 176.48 0.27 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.268 1.027 . . . . 0.0 109.679 176.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -164.76 89.57 0.51 Allowed 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 114.44 -1.254 . . . . 0.0 109.078 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.09 -74.26 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.321 -1.309 . . . . 0.0 112.558 172.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.47 -9.44 42.12 Favored Glycine 0 CA--C 1.545 1.953 0 CA-C-N 113.872 -1.513 . . . . 0.0 112.131 -175.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -122.71 16.49 10.27 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.414 0.686 . . . . 0.0 112.555 175.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 66.69 87.37 0.12 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.749 1.619 . . . . 0.0 111.507 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 48.94 28.64 2.05 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 113.279 -1.782 . . . . 0.0 113.471 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -108.25 -24.29 11.57 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 120.758 -1.214 . . . . 0.0 111.824 -174.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.41 ' O ' ' CG ' ' A' ' 89' ' ' PHE . 12.6 p -143.82 172.63 12.58 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -178.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.41 ' CG ' ' O ' ' A' ' 88' ' ' THR . 94.9 m-85 -163.23 121.02 1.93 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -175.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.1 m -139.64 107.81 5.77 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.531 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.5 mt -44.01 164.18 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.178 0.924 . . . . 0.0 111.701 178.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.83 135.56 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 120.424 -1.422 . . . . 0.0 109.517 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.24 100.15 8.84 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.264 -1.334 . . . . 0.0 108.873 176.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -62.39 -38.97 91.67 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 123.573 0.546 . . . . 0.0 111.608 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.3 t -54.98 -45.49 75.0 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.179 1.391 . . . . 0.0 112.814 173.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 35.1 t . . . . . 0 C--O 1.25 1.105 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.653 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.478 0.947 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.5 t -79.95 4.8 15.71 Favored 'General case' 0 CA--C 1.55 0.958 0 O-C-N 124.468 1.105 . . . . 0.0 112.405 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.59 176.25 14.36 Favored Glycine 0 N--CA 1.474 1.232 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m -92.91 173.04 7.95 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.519 -0.84 . . . . 0.0 109.143 -176.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -137.51 108.37 5.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -175.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.5 m -46.05 126.66 7.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.236 -1.802 . . . . 0.0 109.977 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.98 -34.11 63.08 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.8 177.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -64.59 -29.4 70.42 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 123.774 0.671 . . . . 0.0 112.231 173.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.6 -23.06 56.4 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.938 0.895 . . . . 0.0 111.63 174.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.1 mt -83.96 164.69 43.02 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.26 172.08 12.79 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 122.412 2.074 . . . . 0.0 111.975 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.81 -18.63 36.65 Favored 'Trans proline' 0 N--CA 1.48 0.728 0 C-N-CA 122.99 2.46 . . . . 0.0 112.627 176.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -85.57 -24.73 27.1 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.791 175.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -48.04 -39.19 19.15 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.44 -36.98 79.82 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 113.682 -1.599 . . . . 0.0 113.323 174.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -51.46 -54.69 24.39 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.754 0.822 . . . . 0.0 110.088 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.8 m -57.91 -50.61 72.75 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.6 mt -52.38 -30.4 28.87 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 174.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -75.46 -38.43 59.66 Favored 'General case' 0 C--O 1.209 -1.061 0 CA-C-N 114.221 -1.354 . . . . 0.0 110.134 175.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 24.6 mt -71.2 -32.27 68.63 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 118.983 -0.532 . . . . 0.0 110.537 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.6 mp -70.64 -39.58 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-N 120.382 1.447 . . . . 0.0 111.657 172.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.22 -42.49 59.67 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.574 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.53 7.98 38.74 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.296 1.039 . . . . 0.0 111.366 177.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.8 t70 41.13 50.46 3.29 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.616 1.166 . . . . 0.0 111.105 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.56 -168.61 48.1 Favored Glycine 0 CA--C 1.538 1.493 0 CA-C-N 114.216 -1.356 . . . . 0.0 115.211 -173.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -75.42 141.2 70.56 Favored 'Cis proline' 0 N--CA 1.49 1.296 0 O-C-N 125.001 2.053 . . . . 0.0 111.33 -0.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -92.93 139.59 23.27 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 113.598 -1.637 . . . . 0.0 111.564 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -75.2 -64.5 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.066 2.51 . . . . 0.0 110.788 -177.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -58.98 160.45 5.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.667 175.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.8 m -80.77 9.89 5.68 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 122.304 1.049 . . . . 0.0 112.608 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.403 ' NE2' ' NH1' ' A' ' 69' ' ' ARG . 1.0 OUTLIER -105.52 86.88 2.48 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 122.078 0.942 . . . . 0.0 110.837 -178.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 176.96 144.58 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 111.342 -2.663 . . . . 0.0 113.772 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.54 30.76 23.53 Favored Glycine 0 N--CA 1.478 1.487 0 O-C-N 126.199 2.187 . . . . 0.0 110.732 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.46 149.91 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.2 t -88.27 157.05 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 O-C-N 125.164 1.54 . . . . 0.0 110.039 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -135.39 93.79 3.02 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.314 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -70.88 53.86 0.16 Allowed 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 118.991 0.814 . . . . 0.0 112.309 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 26.96 54.36 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.863 2.465 . . . . 0.0 110.046 -176.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.54 -24.41 55.94 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 122.364 1.078 . . . . 0.0 111.232 -171.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -76.5 -11.48 59.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 112.66 -2.063 . . . . 0.0 114.168 173.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.1 t 43.81 39.85 2.8 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 124.9 2.286 . . . . 0.0 110.904 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.0 t -107.69 -14.86 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 113.196 -1.82 . . . . 0.0 109.984 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.244 0.784 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.225 -172.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.7 t80 . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.996 0.426 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.76 12.0 80.79 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 114.394 -1.275 . . . . 0.0 112.14 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -87.17 15.9 5.72 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.596 0.759 . . . . 0.0 112.346 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -150.64 145.5 25.9 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.057 -175.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -142.84 157.55 44.49 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 126.533 2.395 . . . . 0.0 111.147 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -111.11 147.47 34.79 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.054 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -160.99 63.73 0.29 Allowed 'General case' 0 CA--C 1.543 0.677 0 O-C-N 125.823 1.952 . . . . 0.0 110.289 -175.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -39.04 127.27 1.65 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 122.088 0.947 . . . . 0.0 112.07 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -83.99 120.62 35.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 111.502 -2.59 . . . . 0.0 108.708 178.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -45.76 165.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 124.593 1.183 . . . . 0.0 108.199 173.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.62 ' HG1' ' CD ' ' A' ' 68' ' ' ARG . 2.5 m -158.97 145.8 12.82 Favored Pre-proline 0 C--O 1.24 0.556 0 CA-C-N 112.86 -1.973 . . . . 0.0 112.841 177.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.01 149.79 47.41 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 121.99 1.793 . . . . 0.0 111.764 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.86 21.18 22.28 Favored Glycine 0 N--CA 1.483 1.811 0 O-C-N 125.185 1.553 . . . . 0.0 112.458 -175.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.45 86.25 7.33 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -45.15 -27.76 0.65 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 113.276 -1.784 . . . . 0.0 112.146 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.4 p -128.08 -163.24 1.25 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.639 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.7 mtm105 -56.62 -18.08 10.85 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 174.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.58 131.43 0.03 OUTLIER Glycine 0 N--CA 1.465 0.59 0 N-CA-C 107.274 -2.33 . . . . 0.0 107.274 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.6 p -44.37 -41.54 6.19 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 112.044 -2.078 . . . . 0.0 113.031 176.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.62 ' CD ' ' HG1' ' A' ' 59' ' ' THR . 2.6 mtp85 -40.1 102.39 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 122.968 1.366 . . . . 0.0 113.172 173.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.403 ' NH1' ' NE2' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -128.05 136.43 51.22 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 112.207 -2.27 . . . . 0.0 109.002 -177.271 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.0 mt -105.67 140.99 22.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 112.413 -2.176 . . . . 0.0 108.818 176.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.424 ' O ' ' CD2' ' A' ' 80' ' ' TYR . 23.3 mm -130.16 105.42 11.73 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 CA-C-N 113.268 -1.787 . . . . 0.0 108.384 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.7 p -92.46 163.8 13.7 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.211 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -110.9 -172.59 19.75 Favored Glycine 0 N--CA 1.471 1.024 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.681 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.1 -15.77 60.03 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.41 -0.895 . . . . 0.0 112.303 174.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.72 132.14 54.24 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.338 1.066 . . . . 0.0 108.514 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.5 m -59.3 152.3 21.33 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.086 -1.415 . . . . 0.0 108.618 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 71.46 32.16 2.14 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 123.523 1.63 . . . . 0.0 109.889 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -136.8 68.42 1.43 Allowed 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.847 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -111.31 129.8 55.87 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-N 113.192 -1.822 . . . . 0.0 107.718 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.424 ' CD2' ' O ' ' A' ' 71' ' ' ILE . 14.4 m-85 -100.36 133.92 44.07 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 125.102 1.361 . . . . 0.0 109.919 175.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -111.75 127.41 55.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.458 -1.246 . . . . 0.0 108.961 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.423 ' HG1' ' N ' ' A' ' 86' ' ' TYR . 0.5 OUTLIER -91.03 -68.74 0.77 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 112.839 -1.982 . . . . 0.0 111.959 178.039 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.08 -11.15 50.29 Favored Glycine 0 CA--C 1.542 1.741 0 CA-C-N 113.346 -1.752 . . . . 0.0 112.675 -175.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -111.37 6.39 20.36 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 175.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 86.76 -16.98 0.38 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 116.051 -1.928 . . . . 0.0 113.177 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.423 ' N ' ' HG1' ' A' ' 82' ' ' THR . 1.1 m-30 160.6 51.25 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 128.455 3.597 . . . . 0.0 114.804 -176.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -120.1 -44.86 2.48 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 119.406 -0.918 . . . . 0.0 112.913 177.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.4 p -127.43 168.29 15.07 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.67 -177.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -159.29 115.73 2.61 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -173.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.1 m -135.34 113.81 11.6 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.423 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 29.7 mt -40.81 161.83 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.123 0 O-C-N 124.693 1.246 . . . . 0.0 111.452 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 mp -106.05 129.59 58.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 O-C-N 120.902 -1.123 . . . . 0.0 108.246 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.68 92.25 4.54 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.65 -1.614 . . . . 0.0 108.021 177.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -55.93 -37.75 69.36 Favored 'General case' 0 N--CA 1.484 1.225 0 O-C-N 123.981 0.8 . . . . 0.0 112.253 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.9 t -57.96 -49.67 75.99 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.783 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 21.0 t . . . . . 0 N--CA 1.476 0.874 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.873 179.102 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.1 t . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 m -81.52 22.81 0.68 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.499 1.12 . . . . 0.0 112.379 176.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.16 -154.06 20.11 Favored Glycine 0 N--CA 1.479 1.557 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -107.56 170.07 8.2 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.956 -1.122 . . . . 0.0 110.407 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -142.41 108.77 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -174.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 94.9 m -46.2 133.66 9.13 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 113.581 -1.645 . . . . 0.0 111.038 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.06 -32.44 69.77 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.638 -177.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.2 t -67.39 -27.79 67.39 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.612 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.28 -29.64 62.87 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.642 0.777 . . . . 0.0 111.61 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.3 mt -81.37 161.72 61.19 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 176.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.35 168.25 18.36 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.999 2.466 . . . . 0.0 112.545 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.15 -23.11 39.88 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.236 1.957 . . . . 0.0 113.544 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -83.76 -4.39 58.6 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.884 0.874 . . . . 0.0 111.827 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.72 -49.32 40.39 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.793 0.837 . . . . 0.0 112.278 175.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.3 -25.88 37.05 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.579 174.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -53.46 -57.77 9.47 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 124.32 1.013 . . . . 0.0 110.408 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.4 m -56.28 -50.59 70.93 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 175.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.9 mt -55.1 -35.14 64.29 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.279 0.987 . . . . 0.0 111.734 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -67.65 -39.75 84.55 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 124.163 0.985 . . . . 0.0 110.769 173.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 25.8 mt -68.7 -31.95 71.4 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 122.779 0.431 . . . . 0.0 111.088 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.7 mt -71.31 -42.86 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 120.103 1.32 . . . . 0.0 111.534 172.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.7 -41.43 75.41 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 124.39 1.056 . . . . 0.0 112.4 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.38 5.92 48.86 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.272 1.029 . . . . 0.0 111.419 177.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 t0 42.4 44.77 3.56 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.524 1.53 . . . . 0.0 111.685 -178.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.29 -166.78 29.74 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 112.834 -1.985 . . . . 0.0 115.265 -174.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -74.87 139.74 63.4 Favored 'Cis proline' 0 N--CA 1.481 0.758 0 O-C-N 124.275 1.671 . . . . 0.0 111.342 -2.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -90.94 139.06 25.86 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 113.244 -1.798 . . . . 0.0 111.534 -176.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -75.73 -63.13 0.03 OUTLIER 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.975 2.45 . . . . 0.0 111.474 -177.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -61.85 157.79 17.45 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.141 -0.482 . . . . 0.0 112.087 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.6 t -81.17 4.83 18.79 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 122.941 1.353 . . . . 0.0 112.101 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.58 ' NE2' ' HG1' ' A' ' 56' ' ' THR . 7.3 mt-30 -104.86 86.56 2.48 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.232 1.015 . . . . 0.0 111.484 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 177.96 140.31 0.09 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 110.712 -2.949 . . . . 0.0 113.715 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.71 3.22 66.51 Favored Glycine 0 N--CA 1.484 1.883 0 CA-C-N 113.017 -1.902 . . . . 0.0 112.263 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.8 m -96.91 144.78 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.342 1.057 . . . . 0.0 110.257 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.2 t -79.63 155.69 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 O-C-N 126.089 2.118 . . . . 0.0 108.865 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -137.71 86.32 2.17 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.645 -1.616 . . . . 0.0 108.618 174.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -72.03 51.76 0.23 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.203 -1.56 . . . . 0.0 112.414 178.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 26.6 t30 28.83 53.61 0.08 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.682 1.193 . . . . 0.0 111.778 -172.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -20.69 18.7 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 113.243 -1.799 . . . . 0.0 112.285 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.87 -4.75 58.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 113.443 -1.708 . . . . 0.0 114.832 174.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.2 t 44.05 47.11 7.29 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 123.7 1.715 . . . . 0.0 112.688 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.0 t -124.11 -6.96 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 113.4 -1.727 . . . . 0.0 111.199 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 N--CA 1.475 0.789 0 O-C-N 121.41 -0.806 . . . . 0.0 112.994 176.311 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.3 t80 . . . . . 0 CA--C 1.537 0.469 0 CA-C-O 121.093 0.473 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.99 8.23 82.62 Favored Glycine 0 N--CA 1.479 1.532 0 CA-C-N 113.327 -1.76 . . . . 0.0 112.807 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.61 -1.64 22.51 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.794 0.838 . . . . 0.0 112.509 175.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -136.63 171.23 14.81 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.029 1.332 . . . . 0.0 110.094 -177.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -161.01 163.71 31.48 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 113.257 -1.792 . . . . 0.0 110.382 -177.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -120.03 139.43 52.54 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.096 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -153.01 59.33 0.79 Allowed 'General case' 0 N--CA 1.471 0.603 0 O-C-N 126.187 2.179 . . . . 0.0 110.741 -174.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.58 ' HG1' ' NE2' ' A' ' 32' ' ' GLN . 58.5 m -36.69 116.14 0.41 Allowed 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 122.957 1.36 . . . . 0.0 112.519 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.9 p -81.65 110.82 17.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 111.021 -2.809 . . . . 0.0 109.443 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -38.64 147.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 113.722 -1.581 . . . . 0.0 111.296 171.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.702 ' HG1' ' CD ' ' A' ' 68' ' ' ARG . 6.1 m -136.5 141.62 36.3 Favored Pre-proline 0 N--CA 1.468 0.453 0 O-C-N 125.772 1.92 . . . . 0.0 112.901 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.53 143.71 27.74 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 121.619 1.546 . . . . 0.0 109.963 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.82 29.32 54.59 Favored Glycine 0 CA--C 1.544 1.882 0 CA-C-N 113.867 -1.515 . . . . 0.0 112.033 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.87 89.89 4.75 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -43.33 -30.61 0.54 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 113.324 -1.762 . . . . 0.0 113.152 177.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.0 p -128.88 -170.78 2.33 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.889 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 -47.45 -27.32 1.66 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 174.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.11 144.96 0.12 Allowed Glycine 0 N--CA 1.464 0.522 0 N-CA-C 106.676 -2.57 . . . . 0.0 106.676 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.3 p -42.72 -29.05 0.28 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.247 -1.477 . . . . 0.0 114.673 173.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.702 ' CD ' ' HG1' ' A' ' 59' ' ' THR . 1.0 OUTLIER -45.17 130.0 7.84 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.763 1.625 . . . . 0.0 111.574 170.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.81 136.49 4.32 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 111.864 -2.426 . . . . 0.0 109.339 -176.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.4 mt -111.99 142.7 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 125.933 2.021 . . . . 0.0 108.063 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 25.5 mm -131.1 128.78 62.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 111.703 -2.499 . . . . 0.0 108.019 178.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.5 p -104.86 163.87 12.2 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 122.238 -0.289 . . . . 0.0 111.33 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -110.5 -178.54 20.7 Favored Glycine 0 CA--C 1.537 1.41 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.58 -15.22 58.8 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 121.646 0.736 . . . . 0.0 111.937 176.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.23 129.78 55.66 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.0 m -54.54 145.88 17.67 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 114.122 -1.399 . . . . 0.0 107.611 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 81.8 33.34 0.1 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 126.705 2.002 . . . . 0.0 110.577 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -135.28 54.55 1.92 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 123.498 1.618 . . . . 0.0 112.407 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.24 80.96 2.16 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 113.479 -1.692 . . . . 0.0 108.837 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -51.18 178.99 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 125.455 1.502 . . . . 0.0 110.401 173.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -167.03 128.03 1.58 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.595 -1.639 . . . . 0.0 110.441 -175.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.64 -70.07 0.7 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 112.588 -2.096 . . . . 0.0 112.0 175.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.22 -5.69 25.81 Favored Glycine 0 CA--C 1.542 1.769 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.692 -175.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -125.49 17.05 8.23 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.264 1.425 . . . . 0.0 113.7 176.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 63.25 88.07 0.1 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.393 2.277 . . . . 0.0 111.496 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 49.57 26.36 1.72 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.053 -1.43 . . . . 0.0 113.997 -176.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.77 -22.08 17.74 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 120.76 -1.213 . . . . 0.0 111.731 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 26.5 p -157.17 173.71 16.58 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.178 1.391 . . . . 0.0 108.494 -177.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -155.52 118.63 4.34 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 m -135.06 116.5 14.67 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 66.1 mt -47.81 164.93 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.775 0.83 . . . . 0.0 111.424 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.62 107.41 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 121.207 -0.933 . . . . 0.0 109.304 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.16 89.04 3.63 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.035 -1.439 . . . . 0.0 109.088 175.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -79.22 5.71 11.55 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 113.602 -1.635 . . . . 0.0 111.868 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.0 t -121.75 -0.98 9.53 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 126.036 1.734 . . . . 0.0 112.581 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 42.7 t . . . . . 0 C--O 1.256 1.424 0 CA-C-O 116.268 -1.825 . . . . 0.0 112.888 178.981 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 m -75.25 5.21 5.8 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 177.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.37 170.56 12.73 Favored Glycine 0 CA--C 1.536 1.365 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -86.99 172.76 9.76 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.069 -1.065 . . . . 0.0 109.103 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.1 t -138.82 106.71 3.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 122.978 1.37 . . . . 0.0 107.869 -175.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.3 m -49.35 126.06 12.31 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 112.62 -2.082 . . . . 0.0 109.902 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.4 tp -57.06 -34.18 67.99 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 118.938 -0.553 . . . . 0.0 111.353 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.7 t -62.21 -30.23 70.94 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.624 171.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.17 -27.81 53.86 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.64 0.776 . . . . 0.0 112.349 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.3 mt -75.4 160.8 78.92 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 174.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.65 168.32 20.32 Favored 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 122.715 2.276 . . . . 0.0 112.201 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.09 -15.27 39.44 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.416 2.077 . . . . 0.0 113.087 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -92.89 2.11 56.95 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.273 1.029 . . . . 0.0 111.843 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.95 -50.0 13.04 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.214 1.006 . . . . 0.0 112.169 177.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -58.49 -22.2 54.25 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.217 174.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -51.26 -59.73 3.89 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.128 0.971 . . . . 0.0 110.306 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.9 m -64.14 -44.66 91.49 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.523 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.97 -33.48 62.43 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 175.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -73.9 -38.63 64.3 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.995 174.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.1 mt -69.12 -33.78 74.0 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 175.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.9 mt -68.75 -41.91 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 123.365 0.666 . . . . 0.0 111.268 172.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.89 -43.76 64.87 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.468 1.105 . . . . 0.0 112.436 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.72 -10.1 59.65 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.058 1.343 . . . . 0.0 111.793 177.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.74 43.26 25.53 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 122.714 1.245 . . . . 0.0 110.718 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.67 -166.92 43.83 Favored Glycine 0 CA--C 1.541 1.676 0 CA-C-N 113.247 -1.797 . . . . 0.0 115.044 -175.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.51 140.5 67.63 Favored 'Cis proline' 0 CA--C 1.537 0.629 0 O-C-N 124.558 1.82 . . . . 0.0 111.058 -1.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -90.95 136.55 27.43 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 112.996 -1.911 . . . . 0.0 111.185 -176.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.07 -62.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.188 2.592 . . . . 0.0 111.701 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -59.84 155.07 17.0 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.82 176.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.76 2.29 20.25 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 122.812 1.291 . . . . 0.0 112.313 175.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.4 78.53 2.7 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.622 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -178.48 142.37 0.24 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 112.069 -2.332 . . . . 0.0 113.871 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.14 30.94 12.7 Favored Glycine 0 CA--C 1.537 1.467 0 O-C-N 125.212 1.57 . . . . 0.0 111.645 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.2 m -124.26 146.03 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 113.982 -1.109 . . . . 0.0 109.591 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.7 t -84.06 156.32 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 125.743 1.902 . . . . 0.0 109.768 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -137.66 87.89 2.29 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 113.968 -1.469 . . . . 0.0 108.791 174.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -69.91 53.45 0.12 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.808 -1.183 . . . . 0.0 112.648 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 50.7 t30 29.21 51.19 0.06 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.418 1.487 . . . . 0.0 111.081 -173.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.15 -20.75 43.09 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.522 -175.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -84.31 -8.06 59.13 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 113.087 -1.869 . . . . 0.0 114.668 172.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.9 t 43.45 42.58 3.94 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 123.917 1.818 . . . . 0.0 112.135 -177.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 86.3 t -112.39 -12.52 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 113.322 -1.763 . . . . 0.0 109.728 -178.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.317 -0.814 0 O-C-N 120.979 -1.075 . . . . 0.0 108.436 -175.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.9 t80 . . . . . 0 N--CA 1.473 0.708 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.14 -8.63 44.36 Favored Glycine 0 N--CA 1.482 1.758 0 O-C-N 125.098 1.499 . . . . 0.0 113.301 177.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -75.77 0.45 17.9 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.267 1.027 . . . . 0.0 112.508 177.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -136.95 165.38 26.13 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.47 1.108 . . . . 0.0 109.103 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -159.66 158.86 32.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 112.647 -2.069 . . . . 0.0 111.463 -178.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -113.95 143.01 45.42 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.592 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -159.97 68.52 0.39 Allowed 'General case' 0 N--CA 1.475 0.796 0 O-C-N 126.244 2.215 . . . . 0.0 109.466 -174.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -36.86 141.51 0.12 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 176.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -97.77 115.45 37.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 112.9 -1.955 . . . . 0.0 109.385 175.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -43.17 151.31 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.662 170.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -150.23 140.84 14.32 Favored Pre-proline 0 N--CA 1.476 0.849 0 O-C-N 125.459 1.725 . . . . 0.0 111.733 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -73.72 147.14 39.47 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 121.622 1.548 . . . . 0.0 109.735 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 52.48 34.96 43.32 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.023 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.65 92.67 6.33 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -42.0 -31.39 0.34 Allowed 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 113.641 -1.618 . . . . 0.0 113.323 176.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.5 p -123.36 -164.05 1.18 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.968 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -59.88 -14.0 13.39 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 173.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.62 146.01 3.72 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.214 -1.955 . . . . 0.0 108.214 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.0 p -69.93 -5.51 26.62 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 111.772 -2.214 . . . . 0.0 113.105 176.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.02 85.27 5.63 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 123.939 1.828 . . . . 0.0 110.384 178.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.84 142.58 34.14 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 112.581 -2.1 . . . . 0.0 109.342 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.6 mt -117.76 132.62 67.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 125.601 1.813 . . . . 0.0 109.404 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.5 mm -125.82 106.67 16.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 O-C-N 125.27 1.606 . . . . 0.0 109.048 -176.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.39 165.99 19.81 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.301 -0.874 . . . . 0.0 111.194 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -120.73 171.44 14.74 Favored Glycine 0 N--CA 1.469 0.881 0 CA-C-N 113.424 -1.717 . . . . 0.0 109.799 177.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.45 -14.54 61.17 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.756 0.789 . . . . 0.0 112.251 174.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.18 129.76 53.5 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 122.361 1.077 . . . . 0.0 108.233 174.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -61.87 142.55 57.3 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 113.833 -1.531 . . . . 0.0 107.575 175.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 77.78 29.36 0.51 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 126.618 1.967 . . . . 0.0 111.279 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -126.98 56.04 1.53 Allowed 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 123.083 1.421 . . . . 0.0 111.92 177.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.63 119.59 38.33 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 113.267 -1.788 . . . . 0.0 109.287 178.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -92.71 139.41 30.58 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.14 1.376 . . . . 0.0 108.943 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -118.43 121.48 40.41 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.665 -175.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.88 -64.53 1.17 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 113.317 -1.765 . . . . 0.0 110.761 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.37 -6.04 6.28 Favored Glycine 0 CA--C 1.545 1.943 0 CA-C-N 114.886 -1.052 . . . . 0.0 113.104 -173.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -126.58 6.19 6.85 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 66.59 82.57 0.18 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 128.256 2.622 . . . . 0.0 110.374 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 57.28 17.69 3.82 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 113.428 -1.715 . . . . 0.0 114.247 -174.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -99.84 -3.54 32.37 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.177 -0.952 . . . . 0.0 112.595 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.2 p -167.75 168.85 12.15 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.016 1.727 . . . . 0.0 109.161 -176.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -160.41 109.83 1.73 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.068 0.947 . . . . 0.0 108.972 -173.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.8 m -128.23 108.4 10.58 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.991 -176.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 21.7 mt -42.73 161.14 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.4 mp -107.3 129.45 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 O-C-N 120.671 -1.268 . . . . 0.0 108.792 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.47 94.18 5.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.376 178.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.92 -8.46 44.56 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 124.94 1.4 . . . . 0.0 112.524 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 t -93.18 -41.9 9.66 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 127.141 2.176 . . . . 0.0 113.1 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 45.2 t . . . . . 0 C--O 1.25 1.105 0 CA-C-O 117.695 -1.145 . . . . 0.0 110.931 179.402 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.5 m -77.34 7.97 4.68 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 177.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 119.42 -172.49 14.71 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.27 1.414 . . . . 0.0 109.735 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -90.22 169.51 11.07 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 122.452 1.12 . . . . 0.0 109.735 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 p -143.12 112.0 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 114.222 -1.354 . . . . 0.0 108.285 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 73.7 m -50.22 133.42 23.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 112.427 -2.169 . . . . 0.0 109.592 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.51 -35.92 66.13 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 119.156 -0.449 . . . . 0.0 111.933 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.1 t -69.0 -15.48 63.49 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.246 174.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.65 -33.27 35.76 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.396 0.678 . . . . 0.0 112.182 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.2 mt -83.64 176.41 3.81 Favored Pre-proline 0 CA--C 1.558 1.272 0 C-N-CA 125.72 1.608 . . . . 0.0 111.095 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.51 167.12 17.66 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.285 1.99 . . . . 0.0 113.417 174.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -64.77 -21.4 64.76 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 C-N-CA 122.515 2.143 . . . . 0.0 113.064 174.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -82.23 -19.25 40.07 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 175.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.11 -25.5 8.97 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 173.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -79.48 -33.98 41.79 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 172.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -49.83 -53.78 23.37 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.222 1.009 . . . . 0.0 110.059 -177.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.5 m -53.99 -52.46 60.69 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.6 mt -54.67 -37.61 65.97 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 124.624 1.202 . . . . 0.0 111.746 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -64.69 -38.01 89.53 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.629 0.772 . . . . 0.0 111.724 173.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.8 mt -73.16 -32.87 65.14 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 118.518 -0.754 . . . . 0.0 111.312 176.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.1 mp -66.39 -39.35 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-N 120.37 1.441 . . . . 0.0 111.61 169.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.78 -48.42 46.69 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.198 0.999 . . . . 0.0 112.316 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 m -86.11 6.39 29.35 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.916 1.286 . . . . 0.0 113.547 175.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 43.74 36.0 1.18 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.333 1.453 . . . . 0.0 112.532 -174.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.96 -168.48 18.12 Favored Glycine 0 CA--C 1.542 1.773 0 CA-C-N 113.296 -1.774 . . . . 0.0 115.504 -175.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -75.0 138.29 55.21 Favored 'Cis proline' 0 N--CA 1.488 1.203 0 O-C-N 123.868 1.457 . . . . 0.0 111.412 -3.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -85.83 149.79 51.67 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-N 113.02 -1.9 . . . . 0.0 112.461 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.97 -69.77 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 123.127 2.551 . . . . 0.0 111.717 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -74.45 168.84 18.92 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.56 0.744 . . . . 0.0 110.355 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.3 m -72.6 -3.87 27.41 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 122.138 0.971 . . . . 0.0 113.603 174.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -83.28 82.48 8.25 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.751 -1.113 . . . . 0.0 112.083 -178.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 179.0 145.64 0.15 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 110.393 -3.094 . . . . 0.0 116.117 -176.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.18 33.64 39.64 Favored Glycine 0 N--CA 1.473 1.135 0 CA-C-N 112.191 -2.277 . . . . 0.0 110.951 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.1 m -129.88 144.52 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 113.574 -1.313 . . . . 0.0 109.917 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.1 t -83.87 151.18 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 O-C-N 126.66 2.475 . . . . 0.0 109.76 176.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -128.92 95.7 4.16 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.004 173.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -74.13 52.03 0.44 Allowed 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.158 -0.964 . . . . 0.0 111.622 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 26.78 55.56 0.06 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.73 2.412 . . . . 0.0 111.684 -174.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.17 -22.59 41.51 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.26 -173.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -75.84 -15.01 60.29 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 172.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.2 t 48.16 35.61 5.58 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 123.989 1.852 . . . . 0.0 112.336 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.3 t -110.84 -14.47 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-O 123.368 1.556 . . . . 0.0 110.555 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 CA--C 1.547 0.862 0 CA-C-O 117.098 -1.43 . . . . 0.0 108.274 -174.684 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 54.6 t80 . . . . . 0 N--CA 1.471 0.609 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.04 11.88 52.96 Favored Glycine 0 N--CA 1.483 1.773 0 CA-C-N 114.937 -1.028 . . . . 0.0 112.95 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.98 13.11 8.04 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.448 1.099 . . . . 0.0 112.54 -178.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -151.39 148.48 28.17 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 125.33 1.452 . . . . 0.0 109.732 -173.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -145.11 159.91 42.24 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 125.417 1.698 . . . . 0.0 111.31 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -117.24 140.88 48.99 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.391 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -157.96 67.96 0.49 Allowed 'General case' 0 C--O 1.239 0.517 0 O-C-N 125.696 1.872 . . . . 0.0 110.982 -173.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.8 m -41.95 119.16 1.26 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 123.563 1.649 . . . . 0.0 112.884 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -78.83 116.28 22.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 110.192 -3.185 . . . . 0.0 108.673 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.4 mt -40.49 148.26 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-O 122.655 1.216 . . . . 0.0 108.642 174.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.52 ' HG1' ' CB ' ' A' ' 68' ' ' ARG . 20.9 m -133.1 138.93 32.82 Favored Pre-proline 0 C--O 1.24 0.558 0 CA-C-N 112.16 -2.291 . . . . 0.0 112.45 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.83 143.06 49.3 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.033 1.822 . . . . 0.0 109.943 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.47 30.19 40.94 Favored Glycine 0 CA--C 1.54 1.645 0 CA-C-N 114.313 -1.312 . . . . 0.0 113.113 -176.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.77 94.5 6.37 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -40.63 -35.16 0.44 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.336 176.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.8 p -127.17 -155.59 0.7 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.075 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.3 mtm180 -53.11 -23.87 9.03 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 170.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.76 156.5 0.33 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 -176.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 81.4 p -47.9 -29.35 3.25 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 112.901 -1.65 . . . . 0.0 112.518 173.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.52 ' CB ' ' HG1' ' A' ' 59' ' ' THR . 0.0 OUTLIER -47.15 139.28 6.13 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 122.199 0.999 . . . . 0.0 112.724 173.629 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.0 139.41 2.88 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 112.1 -2.318 . . . . 0.0 109.76 -176.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.8 mt -115.99 144.99 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 112.596 -2.093 . . . . 0.0 108.66 175.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.6 mm -131.49 121.36 48.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 O-C-N 126.319 2.262 . . . . 0.0 107.326 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.0 p -104.06 163.34 12.45 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.271 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -108.6 177.55 20.67 Favored Glycine 0 N--CA 1.477 1.406 0 O-C-N 125.211 1.569 . . . . 0.0 110.562 178.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.89 -14.91 60.71 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 122.124 0.964 . . . . 0.0 113.055 175.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -112.77 129.94 56.25 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 175.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.9 m -53.67 149.59 8.13 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 114.27 -1.332 . . . . 0.0 108.041 174.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 81.03 32.84 0.13 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 126.53 1.932 . . . . 0.0 111.425 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -139.17 51.73 1.78 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 123.764 1.745 . . . . 0.0 112.716 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.9 83.91 2.18 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 113.552 -1.658 . . . . 0.0 109.1 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -56.02 173.67 0.15 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.912 1.685 . . . . 0.0 110.673 174.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -158.41 126.92 5.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.426 -176.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . 0.275 0.1 OUTLIER -91.73 -69.25 0.75 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 112.657 -2.065 . . . . 0.0 112.643 173.391 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.36 17.86 62.38 Favored Glycine 0 CA--C 1.54 1.617 0 CA-C-N 115.124 -0.944 . . . . 0.0 113.219 -173.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -148.0 26.19 1.0 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.732 1.213 . . . . 0.0 112.417 175.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 56.8 83.55 0.1 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.586 1.555 . . . . 0.0 110.968 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 47.97 51.17 14.85 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 113.333 -1.758 . . . . 0.0 114.681 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -120.84 -35.88 3.26 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.175 -1.375 . . . . 0.0 113.948 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 16.3 p -136.77 166.6 23.22 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.653 1.181 . . . . 0.0 108.095 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -156.9 111.83 2.8 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -174.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.2 m -133.76 115.34 14.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.292 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.5 mt -46.31 160.77 0.06 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.721 0.808 . . . . 0.0 111.989 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.52 127.37 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 120.667 -1.27 . . . . 0.0 109.433 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.45 95.22 5.67 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 113.567 -1.652 . . . . 0.0 108.985 175.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -58.95 -42.35 89.6 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 124.502 1.126 . . . . 0.0 111.55 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.2 t -50.91 -31.95 19.13 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.692 1.597 . . . . 0.0 113.446 171.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 19.1 t . . . . . 0 CA--C 1.554 1.126 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.795 177.35 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.468 0.443 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.1 p -78.38 14.21 1.3 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 122.396 1.094 . . . . 0.0 113.487 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 120.83 -163.31 14.39 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.439 1.495 . . . . 0.0 109.719 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -100.98 171.06 7.87 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 112.63 -1.785 . . . . 0.0 109.741 -177.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.27 107.22 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.627 -1.169 . . . . 0.0 107.947 -175.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 86.0 m -45.76 128.44 8.68 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 111.986 -2.37 . . . . 0.0 109.126 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.5 tp -53.16 -36.95 61.42 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.778 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -65.03 -19.72 66.14 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.984 172.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.09 -31.88 44.47 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.197 0.522 . . . . 0.0 111.731 175.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.4 mt -83.5 173.55 7.27 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 125.26 1.424 . . . . 0.0 110.221 179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.3 169.38 19.73 Favored 'Trans proline' 0 CA--C 1.555 1.534 0 C-N-CA 122.008 1.805 . . . . 0.0 113.817 176.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.87 -15.99 40.91 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.745 2.297 . . . . 0.0 114.257 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.8 pm0 -87.05 2.8 48.47 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.061 1.344 . . . . 0.0 113.306 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.48 -55.3 5.66 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.155 0.982 . . . . 0.0 111.585 176.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -53.8 -29.11 38.97 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 114.827 -1.079 . . . . 0.0 112.363 174.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -51.12 -58.04 7.15 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 125.129 1.518 . . . . 0.0 110.514 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.0 m -55.26 -51.1 67.75 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.5 mt -56.7 -35.02 68.0 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 123.782 0.676 . . . . 0.0 112.678 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -66.95 -36.55 82.46 Favored 'General case' 0 C--O 1.217 -0.634 0 C-N-CA 124.478 1.111 . . . . 0.0 110.386 174.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.2 mt -72.84 -32.67 65.63 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 119.025 -0.512 . . . . 0.0 111.137 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.43 -40.34 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 120.325 1.42 . . . . 0.0 111.881 171.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.28 -42.16 65.87 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 124.602 1.189 . . . . 0.0 112.474 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.32 7.47 44.28 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.505 178.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 42.99 37.32 1.08 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 123.158 1.456 . . . . 0.0 112.539 -177.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.52 -167.26 17.57 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 112.959 -1.928 . . . . 0.0 116.036 -173.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -74.44 139.44 61.65 Favored 'Cis proline' 0 N--CA 1.488 1.154 0 O-C-N 123.917 1.483 . . . . 0.0 111.639 -2.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -91.22 135.23 28.55 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.583 -177.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -76.45 -58.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.634 2.223 . . . . 0.0 111.936 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -66.13 159.56 25.92 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.102 0.561 . . . . 0.0 112.063 175.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.1 m -77.14 1.31 18.64 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 173.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.58 84.95 4.05 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 122.055 0.931 . . . . 0.0 111.489 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 178.2 147.72 0.16 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 110.665 -2.97 . . . . 0.0 115.113 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.94 30.81 37.29 Favored Glycine 0 N--CA 1.478 1.476 0 CA-C-N 112.373 -2.194 . . . . 0.0 110.997 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.1 146.76 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.468 1.107 . . . . 0.0 109.797 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.2 t -83.59 153.93 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 126.49 2.369 . . . . 0.0 110.299 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -129.39 94.31 3.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 113.557 -1.656 . . . . 0.0 109.44 175.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.1 50.14 0.27 Allowed 'General case' 0 N--CA 1.484 1.229 0 O-C-N 120.923 -1.111 . . . . 0.0 112.938 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.8 t30 22.86 60.51 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.526 1.931 . . . . 0.0 111.611 -173.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -25.5 62.76 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 113.477 -1.692 . . . . 0.0 111.389 -175.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -75.46 -7.93 55.4 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.023 -1.444 . . . . 0.0 114.633 174.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.7 t 44.18 42.86 5.35 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 124.387 2.041 . . . . 0.0 112.188 -177.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.8 t -110.76 -21.97 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 113.543 -1.662 . . . . 0.0 110.448 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.32 -0.678 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.815 -173.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.8 t80 . . . . . 0 N--CA 1.465 0.286 0 CA-C-O 120.745 0.307 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.63 6.7 88.3 Favored Glycine 0 N--CA 1.478 1.474 0 CA-C-N 114.469 -1.241 . . . . 0.0 113.365 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -79.81 7.52 8.53 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.419 1.087 . . . . 0.0 112.824 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -143.91 144.26 31.64 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -174.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -142.32 157.01 45.28 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 126.297 2.248 . . . . 0.0 110.29 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -113.48 143.71 44.05 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.863 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -159.26 70.47 0.48 Allowed 'General case' 0 N--CA 1.472 0.645 0 O-C-N 125.378 1.674 . . . . 0.0 111.043 -175.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -39.49 126.98 1.87 Allowed 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 122.332 1.063 . . . . 0.0 112.772 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.12 108.18 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 111.632 -2.531 . . . . 0.0 108.468 176.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -39.37 153.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 CA-C-N 115.307 -0.86 . . . . 0.0 108.878 170.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.5 m -156.35 140.02 11.32 Favored Pre-proline 0 N--CA 1.48 1.052 0 O-C-N 125.658 1.849 . . . . 0.0 110.78 177.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.62 152.16 53.32 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.944 2.429 . . . . 0.0 110.18 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 52.41 26.71 23.24 Favored Glycine 0 N--CA 1.481 1.69 0 CA-C-N 113.993 -1.458 . . . . 0.0 112.144 -175.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.43 89.72 7.98 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -40.42 -31.83 0.16 Allowed 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 113.72 -1.582 . . . . 0.0 112.764 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.4 p -134.23 -145.11 0.23 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.618 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 60.3 mtm180 -72.81 -18.67 61.44 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 173.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.08 142.61 0.02 OUTLIER Glycine 0 CA--C 1.531 1.053 0 N-CA-C 108.929 -1.669 . . . . 0.0 108.929 -175.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.2 p -41.85 -32.43 0.41 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 113.887 -1.157 . . . . 0.0 114.057 174.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -44.58 120.02 2.1 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 122.723 1.249 . . . . 0.0 112.461 170.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -149.26 128.46 12.84 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 112.337 -2.21 . . . . 0.0 109.048 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.2 mt -103.79 143.47 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 113.646 -1.615 . . . . 0.0 108.965 173.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.8 mm -129.84 102.55 7.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 112.777 -2.011 . . . . 0.0 108.35 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.9 p -94.71 165.19 12.62 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.655 0.741 . . . . 0.0 110.371 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -118.88 167.54 13.14 Favored Glycine 0 N--CA 1.473 1.162 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.231 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -61.61 -19.05 61.81 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.579 0.704 . . . . 0.0 111.886 174.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.78 129.56 49.47 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.013 175.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.2 m -60.04 144.17 50.1 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 114.114 -1.403 . . . . 0.0 107.311 175.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 80.46 33.19 0.16 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 126.82 2.048 . . . . 0.0 111.696 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -134.55 52.65 2.04 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 113.51 -1.677 . . . . 0.0 112.994 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.95 94.29 4.99 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 113.648 -1.614 . . . . 0.0 110.062 -178.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -82.74 129.07 34.91 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 125.017 1.327 . . . . 0.0 109.642 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -113.66 136.61 52.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.103 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.43 -67.27 0.86 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 112.196 -2.275 . . . . 0.0 112.001 176.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.88 -0.95 26.37 Favored Glycine 0 CA--C 1.549 2.21 0 CA-C-N 114.031 -1.441 . . . . 0.0 113.496 -174.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -127.98 17.17 6.74 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 63.13 86.25 0.12 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.666 1.986 . . . . 0.0 111.12 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 6.1 m-30 49.48 30.56 3.48 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 113.944 -1.48 . . . . 0.0 114.776 -176.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -99.74 -18.78 17.07 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.733 -0.787 . . . . 0.0 112.561 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 25.2 p -158.93 171.06 20.73 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.623 1.569 . . . . 0.0 108.868 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -157.15 116.54 3.38 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.157 0.983 . . . . 0.0 108.818 -174.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.61 109.91 7.86 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 113.583 -1.644 . . . . 0.0 106.93 -178.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 52.2 mt -41.75 158.81 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.653 177.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.92 121.86 65.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 120.789 -1.194 . . . . 0.0 109.218 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.27 96.76 7.67 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 113.226 -1.806 . . . . 0.0 108.78 176.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -60.86 -39.2 88.26 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 124.879 1.362 . . . . 0.0 111.803 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.7 t -52.54 -32.01 38.56 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.068 -1.423 . . . . 0.0 113.533 172.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 19.9 t . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.407 176.743 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.467 0.409 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.81 7.9 5.26 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.682 1.239 . . . . 0.0 112.196 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.22 -166.73 21.48 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.001 1.286 . . . . 0.0 110.471 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 m -101.64 172.91 6.67 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.231 -1.484 . . . . 0.0 108.942 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.27 107.69 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 -175.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 88.5 m -47.1 132.48 12.2 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 112.92 -1.946 . . . . 0.0 109.586 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -33.61 64.0 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.962 -178.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.0 t -64.82 -28.86 69.84 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.634 173.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.46 -31.49 62.26 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.605 0.762 . . . . 0.0 111.194 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.4 mt -74.63 162.26 74.42 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 175.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.65 167.51 22.62 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.567 2.178 . . . . 0.0 111.948 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.86 -16.14 32.92 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.837 2.358 . . . . 0.0 112.632 177.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -93.71 -2.57 53.65 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.324 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.94 -39.43 18.16 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.757 175.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -60.82 -28.75 69.03 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.195 175.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -54.24 -51.94 62.89 Favored 'General case' 0 C--O 1.213 -0.835 0 O-C-N 124.881 1.363 . . . . 0.0 110.146 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.587 ' HG1' ' CG1' ' A' ' 57' ' ' VAL . 28.2 m -64.06 -49.26 73.02 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.572 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 19.6 mt -53.52 -31.41 46.09 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.972 0.795 . . . . 0.0 112.529 175.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -71.93 -42.44 66.64 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.373 173.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.8 mt -67.79 -35.59 78.93 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.993 176.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.1 mt -65.64 -40.03 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 119.73 1.15 . . . . 0.0 110.806 172.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.75 -46.34 46.44 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 124.043 0.839 . . . . 0.0 111.9 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.78 -1.18 37.57 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.327 1.051 . . . . 0.0 111.413 176.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 49.48 39.25 16.28 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 122.555 1.169 . . . . 0.0 110.913 -178.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.57 -169.34 37.25 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-N 113.66 -1.609 . . . . 0.0 115.23 -174.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -75.15 140.73 68.78 Favored 'Cis proline' 0 CA--C 1.535 0.546 0 O-C-N 124.911 2.006 . . . . 0.0 111.51 -0.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -89.51 137.6 28.79 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 113.32 -1.764 . . . . 0.0 111.034 -176.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -74.29 -62.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.528 2.819 . . . . 0.0 111.296 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.18 155.57 6.52 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.964 0.79 . . . . 0.0 110.604 177.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.31 7.13 14.77 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 122.186 0.993 . . . . 0.0 111.592 175.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.441 HE22 ' CZ ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -106.31 82.56 1.76 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 122.081 0.943 . . . . 0.0 111.558 -179.329 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -179.22 146.03 0.28 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 112.616 -2.084 . . . . 0.0 112.972 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.39 36.1 10.04 Favored Glycine 0 N--CA 1.484 1.879 0 O-C-N 126.312 2.257 . . . . 0.0 110.756 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.9 m -135.58 151.03 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 114.388 -0.906 . . . . 0.0 109.216 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.3 t -86.86 157.46 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 125.619 1.825 . . . . 0.0 109.534 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -136.08 88.97 2.43 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 113.695 -1.593 . . . . 0.0 108.713 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -72.24 51.29 0.24 Allowed 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.313 -0.867 . . . . 0.0 111.683 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.2 t30 25.32 57.42 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.977 2.111 . . . . 0.0 110.667 -173.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -21.43 22.44 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 113.265 -1.789 . . . . 0.0 111.406 -177.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -83.71 -4.72 58.85 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 114.074 -1.421 . . . . 0.0 113.894 174.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.3 t 43.02 46.36 4.74 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 124.535 2.112 . . . . 0.0 112.623 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.0 t -115.73 -23.82 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 113.989 -1.46 . . . . 0.0 109.687 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.471 0.598 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.98 -175.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 18.6 t80 . . . . . 0 CA--C 1.536 0.428 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.71 10.98 56.48 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.743 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.96 10.17 10.51 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.485 1.114 . . . . 0.0 112.274 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -144.0 143.52 31.25 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -175.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -144.07 155.69 44.07 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 126.395 2.309 . . . . 0.0 110.857 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -110.22 142.27 42.03 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.68 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -155.66 64.16 0.6 Allowed 'General case' 0 N--CA 1.467 0.388 0 O-C-N 125.796 1.935 . . . . 0.0 110.462 -176.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -41.44 136.32 1.79 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 122.322 1.058 . . . . 0.0 112.911 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.587 ' CG1' ' HG1' ' A' ' 18' ' ' THR . 9.7 m -95.55 117.43 39.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 112.18 -2.282 . . . . 0.0 108.082 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -42.86 149.02 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 O-C-N 125.527 1.767 . . . . 0.0 109.949 173.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.424 ' HG1' ' CG ' ' A' ' 68' ' ' ARG . 8.3 m -139.96 142.3 30.21 Favored Pre-proline 0 N--CA 1.48 1.052 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.414 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -76.01 145.49 28.16 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.066 1.844 . . . . 0.0 109.916 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.87 25.13 44.12 Favored Glycine 0 CA--C 1.542 1.767 0 CA-C-N 114.061 -1.427 . . . . 0.0 112.274 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.98 90.96 5.76 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -38.4 -33.87 0.11 Allowed 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.359 177.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.4 p -140.32 -148.77 0.26 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.143 -1.39 . . . . 0.0 109.077 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -69.71 -6.85 34.57 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 174.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.23 -129.15 13.37 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.212 1.387 . . . . 0.0 109.635 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.0 p -112.72 -34.13 5.9 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 112.26 -1.97 . . . . 0.0 113.384 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.424 ' CG ' ' HG1' ' A' ' 59' ' ' THR . 0.1 OUTLIER -41.33 133.29 2.47 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.277 -1.329 . . . . 0.0 111.581 174.645 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.441 ' CZ ' HE22 ' A' ' 32' ' ' GLN . 0.0 OUTLIER -167.44 141.54 3.66 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 112.5 -2.137 . . . . 0.0 110.869 -176.317 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.42 133.31 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 126.72 2.512 . . . . 0.0 109.165 176.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.3 mm -122.52 101.47 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 113.25 -1.796 . . . . 0.0 107.857 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.7 p -87.43 161.92 17.58 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.635 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -108.12 -176.51 22.12 Favored Glycine 0 N--CA 1.471 0.97 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.303 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.3 -11.45 59.94 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.404 175.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -122.05 131.55 54.04 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.9 m -51.12 149.24 3.86 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.624 176.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 83.59 33.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 125.505 1.753 . . . . 0.0 110.467 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -140.86 49.29 1.68 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.133 -1.394 . . . . 0.0 113.038 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.47 90.7 3.49 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.458 -178.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -75.28 131.93 40.67 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.144 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -114.02 128.5 56.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.941 -177.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -90.0 -67.97 0.81 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.122 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.81 2.95 19.34 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-N 113.897 -1.502 . . . . 0.0 113.077 -173.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -130.55 14.73 5.47 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.666 0.786 . . . . 0.0 112.118 175.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 64.1 85.83 0.13 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.071 1.748 . . . . 0.0 111.044 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 50.2 28.62 3.2 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 114.274 -1.33 . . . . 0.0 114.398 -177.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -105.77 -19.37 13.77 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.296 -1.32 . . . . 0.0 111.256 -175.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.7 p -153.59 169.01 24.29 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.327 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -158.45 113.16 2.56 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -173.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -132.35 105.05 7.06 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 113.968 -1.469 . . . . 0.0 107.328 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 23.0 mt -41.04 163.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.62 177.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.99 135.78 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 120.383 -1.448 . . . . 0.0 109.738 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -113.74 92.33 3.95 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 113.906 -1.497 . . . . 0.0 108.765 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.05 -37.11 85.9 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.236 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 t -54.61 -24.67 22.39 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 114.484 -1.235 . . . . 0.0 113.414 171.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 5.6 t . . . . . 0 C--O 1.261 1.7 0 CA-C-O 117.624 -1.179 . . . . 0.0 111.118 175.71 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.17 8.1 4.35 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 124.886 1.366 . . . . 0.0 113.099 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 121.04 -162.56 14.73 Favored Glycine 0 N--CA 1.478 1.44 0 C-N-CA 125.499 1.523 . . . . 0.0 109.653 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 m -103.49 170.13 8.13 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 113.765 -1.217 . . . . 0.0 109.455 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 p -141.33 113.94 4.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -176.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.5 m -50.77 132.82 26.51 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 112.149 -2.296 . . . . 0.0 110.132 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -31.75 69.71 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.921 -178.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.0 t -64.63 -29.49 70.5 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.083 0.953 . . . . 0.0 113.224 173.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.38 -24.47 54.12 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.844 174.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.6 mt -83.4 160.58 59.15 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.42 166.17 22.52 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.546 2.164 . . . . 0.0 113.123 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -67.42 -35.43 23.5 Favored 'Trans proline' 0 N--CA 1.485 1.001 0 C-N-CA 122.572 2.182 . . . . 0.0 112.292 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.35 -8.77 57.81 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.512 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.61 -43.45 76.39 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.867 0.867 . . . . 0.0 112.013 172.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.13 -32.98 74.49 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.156 174.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -50.01 -49.12 51.8 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.019 0.928 . . . . 0.0 110.262 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 m -58.99 -50.52 73.78 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 174.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.0 mt -51.81 -32.79 32.97 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 175.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.01 -43.97 64.19 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.225 1.01 . . . . 0.0 111.858 172.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 68.4 mt -65.16 -34.32 78.1 Favored 'General case' 0 C--O 1.211 -0.946 0 C-N-CA 123.768 0.827 . . . . 0.0 112.092 176.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.6 mt -67.87 -42.52 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 120.567 -1.333 . . . . 0.0 111.55 171.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.76 -47.69 62.05 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 124.29 0.994 . . . . 0.0 112.682 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 m -84.87 5.93 26.84 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.63 1.172 . . . . 0.0 113.904 175.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 44.78 39.92 3.85 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.926 1.29 . . . . 0.0 112.025 -177.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.71 -164.28 14.57 Favored Glycine 0 CA--C 1.541 1.718 0 C-N-CA 125.572 1.558 . . . . 0.0 114.461 -174.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.21 135.66 41.29 Favored 'Cis proline' 0 N--CA 1.485 0.996 0 CA-C-O 122.927 1.136 . . . . 0.0 110.947 -2.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -85.0 153.41 60.05 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 111.509 -2.587 . . . . 0.0 111.879 -176.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.28 -59.13 0.07 OUTLIER 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.111 1.874 . . . . 0.0 113.409 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.02 -179.97 3.92 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.452 1.501 . . . . 0.0 110.547 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.0 m -68.0 -8.5 37.95 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 175.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -73.74 54.04 0.47 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 122.741 1.258 . . . . 0.0 113.238 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 172.67 127.39 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 111.81 -2.45 . . . . 0.0 113.432 -176.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.25 -14.61 20.93 Favored Glycine 0 N--CA 1.482 1.746 0 CA-C-N 113.698 -1.592 . . . . 0.0 112.535 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 m -90.79 150.39 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-O 121.896 0.855 . . . . 0.0 109.908 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.6 t -75.01 155.51 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 114.172 -1.377 . . . . 0.0 110.39 175.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -128.11 93.34 3.64 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 113.402 -1.726 . . . . 0.0 109.69 175.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -71.29 47.8 0.12 Allowed 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.699 1.238 . . . . 0.0 112.984 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 35.8 t30 29.49 56.32 0.14 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.188 1.395 . . . . 0.0 111.151 -173.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.31 -30.06 59.47 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.853 -175.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -75.97 -7.46 54.67 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 112.924 -1.944 . . . . 0.0 114.646 175.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.8 t 45.56 37.85 3.47 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 123.482 1.611 . . . . 0.0 112.292 -176.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 70.8 t -109.55 -20.0 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.938 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.544 0.714 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.172 -173.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.8 t80 . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 120.802 0.334 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.62 -21.67 24.84 Favored Glycine 0 CA--C 1.542 1.73 0 CA-C-N 114.361 -1.29 . . . . 0.0 113.135 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -71.15 -7.54 47.35 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.568 1.147 . . . . 0.0 113.751 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -119.91 162.85 18.46 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 125.515 1.526 . . . . 0.0 109.327 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -160.19 165.56 31.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 112.678 -2.056 . . . . 0.0 110.715 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -120.42 152.27 38.17 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.786 0.834 . . . . 0.0 109.461 -177.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -163.12 66.39 0.19 Allowed 'General case' 0 N--CA 1.473 0.708 0 O-C-N 123.982 0.801 . . . . 0.0 109.646 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -38.78 135.24 0.87 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.45 -0.781 . . . . 0.0 112.887 177.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.8 m -91.66 123.53 43.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 112.539 -2.119 . . . . 0.0 109.212 178.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -51.74 159.12 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 113.83 -1.532 . . . . 0.0 110.189 173.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.4 m -153.61 141.61 13.88 Favored Pre-proline 0 N--CA 1.475 0.793 0 O-C-N 124.625 1.203 . . . . 0.0 110.762 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.07 141.59 33.08 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 121.765 1.643 . . . . 0.0 110.676 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.7 26.94 65.62 Favored Glycine 0 CA--C 1.54 1.635 0 CA-C-N 114.022 -1.444 . . . . 0.0 112.857 -174.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.21 91.59 6.75 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 177.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -42.45 -30.96 0.37 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.516 -1.22 . . . . 0.0 113.448 176.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 59.3 p -128.22 -113.41 0.27 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 113.814 -1.539 . . . . 0.0 109.166 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -115.51 -12.47 11.66 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.78 1.632 . . . . 0.0 111.563 177.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.98 167.34 7.35 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 123.722 1.734 . . . . 0.0 110.441 -176.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.5 p -74.43 -6.63 49.33 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 112.349 -1.926 . . . . 0.0 112.941 176.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.73 134.61 50.05 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 120.927 -1.108 . . . . 0.0 109.816 176.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.79 139.96 11.78 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.139 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.1 mt -113.97 139.22 40.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 O-C-N 125.223 1.577 . . . . 0.0 108.808 176.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.5 mm -129.25 106.42 13.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 O-C-N 125.287 1.617 . . . . 0.0 108.582 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.9 p -94.69 162.83 13.62 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.436 -0.79 . . . . 0.0 110.937 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.32 -175.19 21.26 Favored Glycine 0 CA--C 1.538 1.477 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.832 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.66 -14.62 62.1 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.955 0.883 . . . . 0.0 112.896 175.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.28 128.6 55.2 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 30.1 m -61.65 151.19 34.24 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.374 175.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 75.71 31.79 0.71 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 126.527 1.931 . . . . 0.0 110.821 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -138.98 60.09 1.6 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 113.1 -1.864 . . . . 0.0 112.702 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.77 123.19 45.33 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 112.71 -2.041 . . . . 0.0 107.973 175.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -92.6 126.69 37.8 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 124.715 1.26 . . . . 0.0 109.209 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -108.85 121.58 45.38 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.017 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . 0.291 0.1 OUTLIER -79.99 -70.92 0.48 Allowed 'General case' 0 N--CA 1.485 1.293 0 O-C-N 125.497 1.748 . . . . 0.0 113.014 173.604 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.34 16.93 65.64 Favored Glycine 0 CA--C 1.539 1.578 0 CA-C-N 114.253 -1.339 . . . . 0.0 113.069 -173.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -146.5 24.82 1.23 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.567 1.147 . . . . 0.0 112.483 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 56.35 83.55 0.1 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.002 2.121 . . . . 0.0 110.813 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 46.38 53.58 9.49 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 113.009 -1.905 . . . . 0.0 114.022 -175.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -123.88 -34.83 2.94 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.381 -1.281 . . . . 0.0 114.024 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.3 p -135.37 168.01 19.98 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.47 1.108 . . . . 0.0 108.493 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -159.54 115.83 2.55 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -174.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.5 m -135.65 111.07 9.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 112.82 -1.991 . . . . 0.0 108.586 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 16.9 mt -41.68 159.96 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.441 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.6 mp -110.7 129.47 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 121.38 -0.825 . . . . 0.0 109.592 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.09 92.02 3.88 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 113.157 -1.838 . . . . 0.0 109.172 176.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -60.1 -31.77 70.35 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 114.218 -1.356 . . . . 0.0 111.199 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.3 t -54.98 -34.87 63.75 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.656 1.582 . . . . 0.0 112.972 172.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 8.6 t . . . . . 0 C--O 1.254 1.299 0 CA-C-O 117.813 -1.089 . . . . 0.0 110.824 178.773 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.7 t . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.6 m -80.85 19.58 0.84 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.085 -0.962 . . . . 0.0 113.014 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.86 -175.18 29.76 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -85.29 174.61 9.47 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.445 0.641 . . . . 0.0 110.517 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.93 115.28 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -174.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.0 m -48.05 128.23 13.45 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 111.807 -2.451 . . . . 0.0 111.126 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.418 ' N ' ' OXT' ' A' ' 96' ' ' CYS . 0.0 OUTLIER -46.38 -38.52 9.02 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.603 1.161 . . . . 0.0 112.721 173.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.8 t -70.04 -14.52 62.72 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 172.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.36 -26.3 38.71 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.359 0.664 . . . . 0.0 111.865 175.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.47 169.7 9.78 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 124.17 0.988 . . . . 0.0 111.404 178.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.88 169.29 15.06 Favored 'Trans proline' 0 CA--C 1.548 1.179 0 C-N-CA 122.4 2.067 . . . . 0.0 113.405 176.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -69.72 -21.97 32.91 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 122.276 1.984 . . . . 0.0 113.055 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.43 -10.24 54.65 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.857 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.87 -37.49 81.86 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.007 0.923 . . . . 0.0 112.478 172.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -40.16 83.62 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.423 175.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -45.74 -44.77 14.01 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.68 -177.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.531 ' HG1' ' CG1' ' A' ' 57' ' ' VAL . 1.3 m -65.58 -51.69 57.83 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.066 -1.425 . . . . 0.0 111.593 177.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.6 mt -49.88 -33.36 16.89 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 174.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.31 -48.01 58.53 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.637 0.775 . . . . 0.0 111.941 171.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.6 mt -62.4 -34.37 76.6 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-O 118.73 -0.652 . . . . 0.0 112.243 175.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.74 -43.95 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 119.497 1.044 . . . . 0.0 111.389 172.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.15 -43.7 81.67 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 124.455 1.097 . . . . 0.0 111.876 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.5 t -85.4 0.47 52.09 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.809 1.244 . . . . 0.0 112.293 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 46.3 35.82 2.95 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 122.368 1.08 . . . . 0.0 112.344 -176.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.47 -172.35 14.67 Favored Glycine 0 CA--C 1.548 2.129 0 CA-C-N 113.711 -1.586 . . . . 0.0 114.309 -175.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -73.29 135.8 41.57 Favored 'Cis proline' 0 CA--C 1.534 0.515 0 O-C-N 123.003 1.002 . . . . 0.0 111.091 -2.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -84.98 103.12 2.88 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 112.81 -1.995 . . . . 0.0 111.722 -177.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.2 -36.7 5.32 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.624 2.216 . . . . 0.0 111.581 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -77.43 168.69 19.59 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 124.052 0.845 . . . . 0.0 111.991 175.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.57 17.74 22.88 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 122.461 1.124 . . . . 0.0 112.911 172.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.91 13.98 20.91 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.734 -1.121 . . . . 0.0 113.67 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -130.86 107.58 9.23 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.764 -1.562 . . . . 0.0 112.556 -174.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.5 -0.2 7.41 Favored Glycine 0 N--CA 1.485 1.937 0 CA-C-N 113.045 -1.889 . . . . 0.0 113.324 -175.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.9 m -92.41 145.96 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.651 0.781 . . . . 0.0 110.072 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.5 t -77.12 157.6 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 125.141 1.526 . . . . 0.0 109.8 176.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -138.56 87.32 2.22 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 113.927 -1.488 . . . . 0.0 109.442 176.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -72.59 50.16 0.23 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 122.537 1.161 . . . . 0.0 113.301 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 34.9 t30 29.51 54.21 0.12 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.286 1.834 . . . . 0.0 110.873 -173.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.89 -21.89 33.03 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 113.712 -1.586 . . . . 0.0 112.266 -177.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -80.93 -7.6 59.54 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 113.819 -1.537 . . . . 0.0 114.12 173.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.4 t 43.83 37.91 1.87 Allowed 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 123.997 1.856 . . . . 0.0 112.204 -175.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.1 t -114.36 -16.75 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-N 113.472 -1.695 . . . . 0.0 111.18 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.536 0.408 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.228 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.7 t80 . . . . . 0 N--CA 1.471 0.596 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.16 -20.81 9.27 Favored Glycine 0 CA--C 1.537 1.46 0 O-C-N 124.863 1.352 . . . . 0.0 113.35 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -59.77 -19.68 51.9 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.402 1.081 . . . . 0.0 113.423 176.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -104.2 166.62 10.28 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 125.091 1.356 . . . . 0.0 109.168 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -166.22 166.21 17.02 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 112.301 -2.227 . . . . 0.0 111.206 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -124.55 143.44 50.68 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.239 1.016 . . . . 0.0 110.063 -175.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.455 ' CE1' ' OG1' ' A' ' 72' ' ' THR . 39.8 m-85 -157.68 72.2 0.65 Allowed 'General case' 0 N--CA 1.469 0.477 0 O-C-N 126.28 2.237 . . . . 0.0 109.723 -174.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -44.36 144.26 1.06 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.612 0.72 . . . . 0.0 112.405 177.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.531 ' CG1' ' HG1' ' A' ' 18' ' ' THR . 30.4 m -94.72 113.69 29.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.605 176.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -43.11 157.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 125.057 1.473 . . . . 0.0 109.096 173.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.431 ' HG1' ' CD ' ' A' ' 68' ' ' ARG . 1.4 m -153.63 143.41 15.23 Favored Pre-proline 0 N--CA 1.477 0.916 0 O-C-N 124.443 1.09 . . . . 0.0 111.226 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -74.54 144.04 31.52 Favored 'Trans proline' 0 N--CA 1.479 0.66 0 C-N-CA 121.575 1.516 . . . . 0.0 110.788 176.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.51 22.05 30.1 Favored Glycine 0 CA--C 1.544 1.848 0 CA-C-N 114.35 -1.296 . . . . 0.0 112.525 -175.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.53 89.8 6.7 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 178.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -40.97 -30.48 0.13 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.696 -1.593 . . . . 0.0 112.953 176.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.8 p -124.93 -146.25 0.35 Allowed 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 113.776 -1.556 . . . . 0.0 109.569 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -82.31 -2.01 51.4 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 174.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.48 142.41 0.02 OUTLIER Glycine 0 N--CA 1.475 1.25 0 CA-C-O 123.717 1.732 . . . . 0.0 108.879 -173.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.8 p -52.85 -27.65 19.32 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 123.209 1.481 . . . . 0.0 112.165 174.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.431 ' CD ' ' HG1' ' A' ' 59' ' ' THR . 0.6 OUTLIER -54.23 127.65 27.89 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 120.009 -1.682 . . . . 0.0 111.786 174.445 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.02 149.88 37.37 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.321 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.9 mt -122.37 140.17 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 126.04 2.087 . . . . 0.0 109.247 176.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.1 mm -132.43 108.84 14.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 O-C-N 125.6 1.812 . . . . 0.0 107.173 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.455 ' OG1' ' CE1' ' A' ' 55' ' ' TYR . 14.8 p -102.92 162.97 12.49 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.422 0.63 . . . . 0.0 110.363 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -115.3 171.26 13.62 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.996 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.58 -16.89 63.39 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 114.479 -0.86 . . . . 0.0 112.214 174.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.36 129.42 48.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 122.33 1.062 . . . . 0.0 108.866 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.1 m -61.49 147.57 44.86 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 113.776 -1.556 . . . . 0.0 107.494 175.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 80.7 31.48 0.17 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 127.0 2.12 . . . . 0.0 111.078 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -135.73 50.41 2.1 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 113.622 -1.626 . . . . 0.0 113.385 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.63 83.9 2.1 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 113.418 -1.719 . . . . 0.0 110.845 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -68.53 131.53 45.41 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.558 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -122.12 130.43 53.23 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.554 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.2 -66.87 0.85 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 111.626 -2.533 . . . . 0.0 112.383 175.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.49 22.35 76.47 Favored Glycine 0 N--CA 1.48 1.577 0 CA-C-N 112.996 -1.911 . . . . 0.0 113.58 -174.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -157.66 24.56 0.28 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.015 1.326 . . . . 0.0 113.278 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 61.66 83.17 0.15 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.324 1.85 . . . . 0.0 112.013 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 46.81 38.87 6.46 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 113.424 -1.716 . . . . 0.0 114.057 -176.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -99.96 -18.37 17.1 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.029 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 p -164.46 176.99 8.51 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.325 1.45 . . . . 0.0 108.358 -175.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -160.06 115.73 2.38 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -175.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.5 m -135.51 111.46 9.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 112.828 -1.987 . . . . 0.0 108.864 -179.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 15.4 mt -41.58 159.92 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.654 0.596 . . . . 0.0 112.325 177.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.6 mp -107.24 123.94 62.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 O-C-N 120.715 -1.241 . . . . 0.0 110.022 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.06 93.49 7.87 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 113.756 -1.566 . . . . 0.0 107.722 177.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -54.81 -42.47 71.9 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.6 t -52.88 -30.1 32.04 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 113.438 -1.71 . . . . 0.0 114.45 173.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.418 ' OXT' ' N ' ' A' ' 8' ' ' LEU . 49.7 t . . . . . 0 C--O 1.246 0.911 0 CA-C-O 123.323 1.535 . . . . 0.0 107.014 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.4 t . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.2 m -56.34 -13.01 1.88 Allowed 'General case' 0 N--CA 1.474 0.762 0 O-C-N 125.006 1.441 . . . . 0.0 114.553 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.71 -169.74 19.39 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 176.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -84.41 168.77 15.24 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 122.28 1.038 . . . . 0.0 111.048 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.4 p -146.49 110.8 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 114.361 -1.291 . . . . 0.0 107.588 -176.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 70.9 m -43.34 131.04 4.86 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 111.946 -2.388 . . . . 0.0 109.74 177.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.41 -36.55 54.49 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.3 177.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.5 t -67.42 -17.02 64.55 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.338 1.055 . . . . 0.0 113.3 174.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.01 -33.8 33.38 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.918 0.487 . . . . 0.0 111.731 176.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.0 mt -81.07 173.23 8.04 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 125.683 1.593 . . . . 0.0 110.557 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.95 166.47 22.66 Favored 'Trans proline' 0 CA--C 1.551 1.342 0 C-N-CA 121.847 1.698 . . . . 0.0 113.885 175.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -66.68 -22.45 50.33 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.983 2.456 . . . . 0.0 113.715 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.97 -8.58 59.55 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 173.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.32 -29.61 70.37 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 174.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -73.88 -29.41 62.07 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.816 173.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -52.66 -54.49 32.68 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.781 0.676 . . . . 0.0 109.534 -176.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.4 m -54.78 -49.31 71.22 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 175.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.5 mt -56.01 -34.78 66.13 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -70.58 -41.05 72.89 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.471 172.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.9 mt -66.77 -33.98 76.82 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 123.272 0.629 . . . . 0.0 112.16 175.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.8 mt -69.22 -44.41 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 119.486 1.039 . . . . 0.0 111.161 172.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.48 -43.94 75.87 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 124.665 1.228 . . . . 0.0 112.24 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.42 5.85 47.74 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.105 0.962 . . . . 0.0 112.041 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 43.77 36.64 1.36 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.997 1.319 . . . . 0.0 112.528 -176.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.96 -165.28 13.24 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 113.667 -1.606 . . . . 0.0 115.619 -175.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -73.95 137.67 51.32 Favored 'Cis proline' 0 CA--C 1.537 0.644 0 O-C-N 124.644 1.865 . . . . 0.0 112.424 -4.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -85.74 153.17 57.85 Favored Pre-proline 0 N--CA 1.472 0.632 0 CA-C-N 113.301 -1.772 . . . . 0.0 112.611 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.02 -56.9 0.14 Allowed 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.409 2.072 . . . . 0.0 113.344 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.97 168.93 9.29 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.438 1.495 . . . . 0.0 110.531 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.7 m -71.42 56.98 0.25 Allowed 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 123.55 1.643 . . . . 0.0 114.015 174.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.669 ' NE2' ' HG1' ' A' ' 56' ' ' THR . 3.9 mt-30 -131.1 67.6 1.51 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 123.497 1.618 . . . . 0.0 112.066 177.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -173.7 155.22 2.63 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 110.19 -3.187 . . . . 0.0 114.733 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 71.82 10.83 72.91 Favored Glycine 0 N--CA 1.481 1.641 0 CA-C-N 112.181 -2.281 . . . . 0.0 111.635 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.0 m -97.74 142.22 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.402 1.081 . . . . 0.0 109.72 174.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.6 t -87.59 155.24 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 O-C-N 125.867 1.979 . . . . 0.0 110.276 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -121.45 103.03 8.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.392 173.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.83 45.17 0.19 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.199 0.6 . . . . 0.0 112.037 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 21.07 57.82 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 124.116 1.912 . . . . 0.0 113.359 -174.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.19 7.0 8.34 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 113.527 -1.67 . . . . 0.0 112.297 -175.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -111.55 -17.05 13.14 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.479 -1.691 . . . . 0.0 113.847 177.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.9 t 46.22 39.66 6.44 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 123.99 1.852 . . . . 0.0 112.972 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 89.1 t -111.35 -15.97 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.438 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.549 0.907 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -173.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.8 t80 . . . . . 0 N--CA 1.469 0.511 0 CA-C-O 120.579 0.228 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.23 -24.85 25.18 Favored Glycine 0 N--CA 1.476 1.334 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.842 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -61.82 -14.2 31.01 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.844 1.258 . . . . 0.0 112.789 175.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -121.59 147.14 46.23 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.675 1.19 . . . . 0.0 109.789 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -141.73 160.04 41.0 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 113.706 -1.588 . . . . 0.0 111.79 177.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -114.94 138.57 50.66 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.918 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -155.54 73.63 0.85 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 112.739 -2.028 . . . . 0.0 110.079 -176.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.669 ' HG1' ' NE2' ' A' ' 32' ' ' GLN . 24.6 m -45.04 130.88 7.59 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 122.246 1.022 . . . . 0.0 111.534 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.485 ' CG1' ' HH ' ' A' ' 81' ' ' TYR . 0.8 OUTLIER -86.59 125.4 40.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 111.52 -2.582 . . . . 0.0 110.102 179.384 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -48.12 148.77 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 O-C-N 125.734 1.896 . . . . 0.0 108.99 174.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.546 ' HG1' ' CG ' ' A' ' 68' ' ' ARG . 2.6 m -148.31 140.63 14.69 Favored Pre-proline 0 N--CA 1.471 0.613 0 O-C-N 125.981 2.05 . . . . 0.0 110.999 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.64 145.55 41.91 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.784 2.323 . . . . 0.0 110.034 176.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.04 22.74 56.01 Favored Glycine 0 CA--C 1.543 1.816 0 CA-C-N 113.681 -1.599 . . . . 0.0 113.321 -174.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -89.05 90.88 8.59 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 176.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.5 -33.29 0.42 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 113.711 -1.586 . . . . 0.0 113.623 176.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.0 p -133.66 -149.23 0.36 Allowed 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 113.624 -1.625 . . . . 0.0 107.848 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -60.52 -18.83 54.59 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 125.282 1.433 . . . . 0.0 111.813 173.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.76 167.27 1.43 Allowed Glycine 0 CA--C 1.532 1.139 0 CA-C-O 123.747 1.748 . . . . 0.0 110.017 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 46.6 p -65.11 -17.36 64.4 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 112.977 -1.612 . . . . 0.0 112.393 173.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.546 ' CG ' ' HG1' ' A' ' 59' ' ' THR . 0.1 OUTLIER -63.41 126.72 28.41 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 120.937 -1.102 . . . . 0.0 110.34 176.843 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.419 HH21 ' HH ' ' A' ' 86' ' ' TYR . 1.3 tpt180 -151.56 132.95 14.62 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.349 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.1 mt -105.8 138.91 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 173.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.7 mm -123.5 106.2 16.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 112.697 -2.047 . . . . 0.0 107.417 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.9 p -92.07 164.37 13.63 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.094 0.473 . . . . 0.0 111.604 177.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -104.46 -175.81 25.09 Favored Glycine 0 N--CA 1.471 1.026 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.298 178.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -80.62 -14.83 57.84 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.544 -0.828 . . . . 0.0 112.172 177.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.3 130.86 55.61 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 175.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 53.7 m -49.76 149.17 2.64 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.645 173.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 81.19 34.33 0.11 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 126.561 1.945 . . . . 0.0 111.057 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -139.26 50.38 1.8 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 113.474 -1.693 . . . . 0.0 113.578 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.45 95.56 5.75 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.365 1.466 . . . . 0.0 110.678 -176.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -81.62 123.19 28.47 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 126.058 1.743 . . . . 0.0 110.255 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.485 ' HH ' ' CG1' ' A' ' 57' ' ' VAL . 5.8 t80 -104.81 127.79 52.74 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.052 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . 0.301 0.0 OUTLIER -88.24 -71.62 0.57 Allowed 'General case' 0 C--N 1.323 -0.569 0 O-C-N 125.948 2.03 . . . . 0.0 113.713 172.641 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.06 16.37 68.54 Favored Glycine 0 N--CA 1.476 1.332 0 CA-C-N 113.898 -1.501 . . . . 0.0 113.979 -173.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -145.93 22.7 1.4 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.795 1.238 . . . . 0.0 113.041 176.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 57.89 82.27 0.13 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 127.177 2.191 . . . . 0.0 111.289 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.419 ' HH ' HH21 ' A' ' 69' ' ' ARG . 25.1 m-85 49.55 54.28 11.27 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 113.514 -1.676 . . . . 0.0 113.387 -174.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -120.16 -41.06 2.65 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.6 p -130.91 163.52 27.29 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.043 0.937 . . . . 0.0 108.73 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -154.95 119.79 4.86 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -175.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.5 m -140.76 113.82 8.45 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 112.312 -2.222 . . . . 0.0 108.906 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 14.7 mt -43.61 156.57 0.06 Allowed 'General case' 0 N--CA 1.48 1.074 0 O-C-N 124.109 0.881 . . . . 0.0 112.369 175.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.14 137.65 42.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 122.15 0.976 . . . . 0.0 108.456 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -113.01 99.08 7.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 113.14 -1.845 . . . . 0.0 108.746 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -58.74 -41.42 86.42 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.89 0.744 . . . . 0.0 112.033 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 t -54.94 -44.5 74.36 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 114.471 -1.24 . . . . 0.0 113.437 175.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 35.3 t . . . . . 0 C--O 1.241 0.643 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.21 178.596 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.487 1.377 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 m -77.61 5.86 8.35 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 124.723 1.264 . . . . 0.0 114.303 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.34 169.28 12.59 Favored Glycine 0 N--CA 1.474 1.171 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 m -86.67 171.48 10.94 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.312 -0.944 . . . . 0.0 109.818 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p -138.14 113.48 9.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 -176.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 71.4 m -50.73 125.03 12.22 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 112.05 -2.341 . . . . 0.0 109.854 177.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.81 -36.93 63.02 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.883 175.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.7 t -65.61 -29.05 69.59 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.361 0.6 . . . . 0.0 112.511 174.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.28 -22.81 47.72 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.759 174.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.7 mt -80.68 164.13 52.82 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.318 176.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -67.01 173.96 7.57 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.019 2.48 . . . . 0.0 115.056 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -71.67 -53.62 0.17 Allowed 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.813 2.342 . . . . 0.0 112.771 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -60.2 -12.49 8.86 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.528 172.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.11 -41.85 79.75 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.725 -0.609 . . . . 0.0 111.9 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.16 -22.6 66.94 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 113.634 -1.621 . . . . 0.0 112.893 174.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -55.03 -58.02 9.35 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.582 0.753 . . . . 0.0 109.896 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.5 m -54.5 -47.31 73.21 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 176.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.3 mt -54.05 -37.11 63.8 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 175.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -69.57 -37.73 77.11 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.226 173.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.659 ' CD1' ' HG ' ' A' ' 31' ' ' SER . 30.1 mt -72.52 -33.02 66.59 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 118.689 -0.672 . . . . 0.0 111.202 176.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 mp -68.9 -41.26 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 120.117 1.326 . . . . 0.0 111.613 171.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.32 -43.39 67.15 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 124.279 0.987 . . . . 0.0 112.164 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.39 5.09 48.92 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.363 1.065 . . . . 0.0 111.293 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.5 t70 41.15 49.77 3.22 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.203 1.401 . . . . 0.0 111.288 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.68 -164.76 30.49 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 112.767 -2.015 . . . . 0.0 116.165 -173.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -75.1 142.85 75.87 Favored 'Cis proline' 0 C--N 1.35 0.639 0 O-C-N 124.419 1.747 . . . . 0.0 111.656 -2.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -99.27 123.26 49.26 Favored Pre-proline 0 N--CA 1.471 0.625 0 CA-C-N 113.419 -1.719 . . . . 0.0 111.102 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.91 -56.74 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.01 1.807 . . . . 0.0 111.629 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -158.78 21.99 0.21 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.864 0.866 . . . . 0.0 112.096 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.659 ' HG ' ' CD1' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -76.98 43.7 0.36 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.118 -178.635 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 20.15 64.72 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 128.968 2.907 . . . . 0.0 112.686 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -103.31 175.34 5.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 110.883 -2.871 . . . . 0.0 111.458 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.29 44.95 97.42 Favored Glycine 0 N--CA 1.478 1.494 0 CA-C-N 112.731 -2.031 . . . . 0.0 110.082 176.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.0 m -142.3 147.12 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 114.007 -1.097 . . . . 0.0 108.665 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.0 t -90.81 154.92 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 125.642 1.839 . . . . 0.0 109.798 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -137.96 91.61 2.59 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.851 174.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -70.46 51.34 0.13 Allowed 'General case' 0 N--CA 1.483 1.214 0 O-C-N 120.945 -1.097 . . . . 0.0 112.97 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 29.23 52.58 0.08 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.611 1.964 . . . . 0.0 110.499 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.75 -24.25 56.11 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.886 -169.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -76.84 -7.15 54.93 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 112.05 -2.341 . . . . 0.0 114.933 172.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.9 t 45.68 39.03 4.62 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 123.72 1.724 . . . . 0.0 111.585 -178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.5 t -112.73 -12.15 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 123.361 1.553 . . . . 0.0 110.369 -178.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.243 0.719 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 -172.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.3 t80 . . . . . 0 CA--C 1.534 0.338 0 CA-C-O 120.923 0.392 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.4 -24.78 9.07 Favored Glycine 0 N--CA 1.472 1.096 0 CA-C-N 114.084 -1.417 . . . . 0.0 112.14 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -60.45 -20.46 59.94 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 174.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -104.38 147.75 27.19 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.449 -1.25 . . . . 0.0 108.804 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -147.28 152.84 38.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 112.934 -1.939 . . . . 0.0 111.218 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -105.36 143.07 34.03 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.435 -178.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -149.81 65.57 0.99 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 112.216 -2.265 . . . . 0.0 111.36 -176.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.5 m -33.99 130.01 0.33 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.602 1.192 . . . . 0.0 112.382 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.5 p -88.98 98.66 8.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 C-N-CA 118.574 -1.251 . . . . 0.0 110.11 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.1 mp -25.76 128.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.773 176.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.42 ' HG1' ' CD ' ' A' ' 68' ' ' ARG . 4.1 m -127.05 141.76 41.66 Favored Pre-proline 0 N--CA 1.479 1.025 0 CA-C-N 118.529 0.604 . . . . 0.0 111.723 -177.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.59 148.05 46.8 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.129 1.886 . . . . 0.0 110.441 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 52.74 22.67 12.32 Favored Glycine 0 CA--C 1.543 1.807 0 CA-C-N 114.278 -1.328 . . . . 0.0 113.03 -175.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.37 90.67 6.85 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -39.12 -33.68 0.14 Allowed 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 112.987 -1.915 . . . . 0.0 112.61 175.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.8 p -129.13 -143.22 0.26 Allowed 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 113.695 -1.593 . . . . 0.0 108.84 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 64.9 mtm-85 -79.69 -14.03 59.05 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 172.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 57.33 -177.82 1.09 Allowed Glycine 0 CA--C 1.534 1.245 0 CA-C-O 123.892 1.829 . . . . 0.0 110.602 -173.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 46.0 p -66.31 -36.34 82.7 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 112.462 -1.869 . . . . 0.0 112.845 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.42 ' CD ' ' HG1' ' A' ' 59' ' ' THR . 1.1 mtp85 -44.36 125.54 4.7 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.705 174.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.09 139.61 14.88 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 112.916 -1.947 . . . . 0.0 109.715 -177.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.6 mt -114.74 136.45 51.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 111.321 -2.672 . . . . 0.0 108.162 177.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.2 mm -124.9 106.1 16.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 113.057 -1.883 . . . . 0.0 107.701 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.0 p -99.5 163.07 12.66 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.319 0.581 . . . . 0.0 110.507 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -118.38 167.08 12.91 Favored Glycine 0 N--CA 1.476 1.334 0 CA-C-N 114.181 -1.372 . . . . 0.0 109.728 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.79 -22.67 25.67 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 114.691 -0.754 . . . . 0.0 112.338 172.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.91 129.49 34.82 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.581 1.181 . . . . 0.0 109.702 173.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.7 m -63.4 146.84 52.74 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.931 -1.486 . . . . 0.0 109.976 176.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 62.69 49.92 3.64 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.98 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -145.89 61.1 1.26 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.346 -1.752 . . . . 0.0 111.901 -177.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -106.28 119.82 40.25 Favored 'General case' 0 C--O 1.212 -0.887 0 CA-C-N 113.084 -1.871 . . . . 0.0 108.187 175.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -92.51 127.75 38.11 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 125.341 1.651 . . . . 0.0 109.392 175.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -107.4 126.63 52.72 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 114.077 -1.42 . . . . 0.0 109.631 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.407 ' HG1' ' N ' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -89.77 -67.24 0.86 Allowed 'General case' 0 N--CA 1.484 1.229 0 O-C-N 125.709 1.88 . . . . 0.0 112.551 175.323 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.02 21.42 61.39 Favored Glycine 0 CA--C 1.539 1.558 0 CA-C-N 114.148 -1.387 . . . . 0.0 112.444 -173.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -147.42 20.04 1.2 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.794 1.238 . . . . 0.0 112.621 176.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 56.79 80.41 0.16 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.844 1.657 . . . . 0.0 110.251 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.407 ' N ' ' HG1' ' A' ' 82' ' ' THR . 15.4 m-30 48.87 54.27 11.08 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 113.321 -1.763 . . . . 0.0 113.837 -175.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -120.73 -32.66 3.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.276 -1.329 . . . . 0.0 113.065 176.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 17.2 p -140.32 166.64 24.15 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -156.72 118.11 3.78 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -173.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.2 m -139.41 107.8 5.83 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 125.871 1.982 . . . . 0.0 110.047 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.7 mt -40.86 159.29 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.123 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -108.67 128.74 64.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 O-C-N 120.612 -1.305 . . . . 0.0 109.415 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.35 95.58 5.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 113.836 -1.529 . . . . 0.0 108.698 177.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.5 -36.81 67.07 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 124.312 1.007 . . . . 0.0 112.044 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.1 t -56.59 -48.59 77.07 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.901 1.28 . . . . 0.0 113.232 174.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 44.0 t . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.779 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.8 m -80.39 -3.24 48.89 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 176.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.87 179.94 17.57 Favored Glycine 0 N--CA 1.473 1.162 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 m -89.33 174.46 7.81 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 122.109 0.957 . . . . 0.0 109.783 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -142.96 112.31 2.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 122.659 1.218 . . . . 0.0 107.834 -176.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.1 m -52.12 133.71 33.25 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 112.152 -2.295 . . . . 0.0 109.887 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -31.53 68.02 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.083 0.864 . . . . 0.0 111.878 -178.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.4 t -66.08 -28.76 69.07 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.661 0.784 . . . . 0.0 112.902 173.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.52 -18.54 56.93 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.712 0.805 . . . . 0.0 111.81 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.0 mt -86.34 161.28 49.32 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 175.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -69.67 170.24 16.93 Favored 'Trans proline' 0 CA--C 1.552 1.393 0 C-N-CA 122.192 1.928 . . . . 0.0 112.484 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.04 -34.83 12.9 Favored 'Trans proline' 0 N--CA 1.482 0.827 0 C-N-CA 122.652 2.234 . . . . 0.0 113.024 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.73 -9.43 58.66 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 114.695 -1.139 . . . . 0.0 114.069 175.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.48 -40.4 89.28 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.052 173.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.55 -33.13 74.32 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.081 175.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -54.02 -49.85 67.97 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.792 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.44 ' HG1' ' CG1' ' A' ' 57' ' ' VAL . 2.2 m -64.69 -49.3 71.47 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-O 117.953 -1.022 . . . . 0.0 112.479 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.5 mt -52.05 -34.22 42.38 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 124.293 0.996 . . . . 0.0 111.794 175.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.27 -45.68 54.34 Favored 'General case' 0 C--O 1.213 -0.867 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.262 173.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.3 mt -64.21 -33.7 76.41 Favored 'General case' 0 C--O 1.212 -0.913 0 C-N-CA 122.956 0.502 . . . . 0.0 111.964 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.9 mt -71.16 -41.72 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 O-C-N 119.716 -1.865 . . . . 0.0 110.424 174.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.65 -43.14 66.63 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 124.68 1.238 . . . . 0.0 111.932 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.5 8.48 33.68 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.762 1.225 . . . . 0.0 112.057 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.8 t70 41.12 53.66 3.41 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 123.109 1.433 . . . . 0.0 111.952 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.09 -165.89 14.46 Favored Glycine 0 CA--C 1.538 1.53 0 CA-C-N 113.456 -1.702 . . . . 0.0 113.804 -175.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.77 138.16 54.09 Favored 'Cis proline' 0 N--CA 1.481 0.785 0 O-C-N 123.54 1.284 . . . . 0.0 111.768 -2.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -94.81 106.52 25.24 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 113.316 -1.765 . . . . 0.0 111.952 -176.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -71.13 -46.3 0.72 Allowed 'Trans proline' 0 N--CA 1.477 0.531 0 C-N-CA 122.033 1.822 . . . . 0.0 111.742 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.459 ' C ' ' H ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -173.67 23.1 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.463 1.105 . . . . 0.0 112.805 -179.548 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.2 m -69.34 37.25 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.494 -174.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.459 ' H ' ' C ' ' A' ' 30' ' ' TYR . 0.0 OUTLIER 32.13 42.63 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.191 2.596 . . . . 0.0 112.975 -176.941 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -105.35 174.47 5.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 110.986 -2.825 . . . . 0.0 111.157 -172.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.91 -2.15 75.96 Favored Glycine 0 N--CA 1.482 1.704 0 O-C-N 126.195 2.185 . . . . 0.0 111.137 -175.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.2 m -102.21 143.93 14.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.935 0.894 . . . . 0.0 110.465 175.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.08 153.34 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 125.386 1.679 . . . . 0.0 109.588 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -131.65 89.26 2.68 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 112.936 -1.938 . . . . 0.0 109.878 176.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -72.54 51.25 0.26 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 118.692 0.678 . . . . 0.0 112.67 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 29.43 51.49 0.08 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.022 2.529 . . . . 0.0 109.397 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -21.81 31.11 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.121 -173.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -78.27 -6.52 55.24 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.405 -1.725 . . . . 0.0 114.787 172.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 43.5 t 44.85 35.91 1.67 Allowed 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 124.782 2.23 . . . . 0.0 112.269 -176.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 70.9 t -111.74 -9.87 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 113.376 -1.738 . . . . 0.0 109.758 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.318 -0.767 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -175.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.0 t80 . . . . . 0 N--CA 1.47 0.569 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.87 -19.12 17.54 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 124.712 1.258 . . . . 0.0 113.548 176.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -65.59 -13.89 59.98 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.363 1.065 . . . . 0.0 113.214 176.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -108.58 155.25 20.87 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.362 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -154.03 161.14 42.15 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 112.968 -1.923 . . . . 0.0 110.832 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -116.86 149.4 40.12 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.516 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.402 ' CE1' ' OG1' ' A' ' 72' ' ' THR . 76.2 m-85 -159.96 82.4 0.72 Allowed 'General case' 0 CA--C 1.545 0.758 0 O-C-N 125.239 1.587 . . . . 0.0 109.335 -172.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.5 m -49.83 146.33 4.61 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 123.086 1.422 . . . . 0.0 111.434 175.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.44 ' CG1' ' HG1' ' A' ' 18' ' ' THR . 1.2 m -105.81 19.0 5.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 113.01 -1.904 . . . . 0.0 113.019 -173.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 53.32 179.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 O-C-N 124.827 1.329 . . . . 0.0 108.857 -165.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.3 m -156.11 139.99 11.43 Favored Pre-proline 0 N--CA 1.477 0.905 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.801 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.2 142.91 31.22 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.002 2.468 . . . . 0.0 110.023 178.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 48.01 27.99 5.46 Favored Glycine 0 CA--C 1.541 1.718 0 CA-C-N 114.188 -1.369 . . . . 0.0 112.623 -176.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.09 95.07 6.59 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.69 -29.2 0.72 Allowed 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 111.603 -2.544 . . . . 0.0 112.428 175.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.8 p -112.07 -165.18 0.97 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.514 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.7 mtm105 -66.54 -12.11 56.08 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 174.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.63 165.54 7.18 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-O 123.838 1.799 . . . . 0.0 110.335 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.8 p -74.2 -15.49 61.01 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 112.631 -1.785 . . . . 0.0 112.439 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.557 ' NE ' ' HH ' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -66.85 136.53 55.55 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 120.931 -1.106 . . . . 0.0 110.245 177.082 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.53 156.12 29.64 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.418 -1.719 . . . . 0.0 110.447 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.16 140.96 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 O-C-N 125.325 1.641 . . . . 0.0 109.215 176.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.6 mm -128.87 106.11 13.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 113.22 -1.809 . . . . 0.0 107.82 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.402 ' OG1' ' CE1' ' A' ' 55' ' ' TYR . 20.7 p -98.61 162.16 13.28 Favored 'General case' 0 C--N 1.314 -0.971 0 O-C-N 121.477 -0.765 . . . . 0.0 110.584 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.21 166.61 12.52 Favored Glycine 0 N--CA 1.48 1.605 0 CA-C-N 113.663 -1.608 . . . . 0.0 109.469 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.37 -18.25 57.84 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.562 -0.819 . . . . 0.0 112.6 174.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -101.03 129.99 46.96 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.578 174.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 m -59.82 143.75 50.37 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 113.675 -1.602 . . . . 0.0 107.883 175.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 80.74 35.99 0.11 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.741 2.016 . . . . 0.0 110.474 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -134.02 47.43 2.43 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 113.45 -1.705 . . . . 0.0 113.204 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.64 89.29 3.3 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.884 1.274 . . . . 0.0 110.19 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -78.45 131.88 37.06 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 125.228 1.411 . . . . 0.0 109.553 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.557 ' HH ' ' NE ' ' A' ' 68' ' ' ARG . 16.2 t80 -116.5 132.44 56.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.726 -1.124 . . . . 0.0 109.513 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.76 -72.28 0.51 Allowed 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 112.468 -2.151 . . . . 0.0 112.687 175.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.13 21.24 78.4 Favored Glycine 0 N--CA 1.473 1.119 0 CA-C-N 112.926 -1.943 . . . . 0.0 113.277 -175.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -154.41 23.01 0.48 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.811 1.245 . . . . 0.0 112.963 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 23.0 t-80 56.8 82.67 0.11 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.896 2.078 . . . . 0.0 110.005 178.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 7.7 m-30 51.2 48.67 22.6 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 113.04 -1.891 . . . . 0.0 114.163 -176.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -115.2 -30.59 6.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.823 179.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.3 p -147.97 169.67 19.38 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -157.88 116.31 3.12 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -173.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.8 m -137.95 113.2 9.32 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 125.858 1.974 . . . . 0.0 110.099 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 14.7 mt -41.56 160.52 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 O-C-N 124.465 1.103 . . . . 0.0 112.812 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.6 mp -110.08 128.32 66.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 O-C-N 121.58 -0.7 . . . . 0.0 109.38 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.69 92.19 3.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 113.721 -1.581 . . . . 0.0 108.812 176.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.23 -30.13 69.2 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.935 178.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.1 t -56.31 -33.21 65.35 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.077 -1.419 . . . . 0.0 112.851 172.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 6.4 t . . . . . 0 C--O 1.257 1.464 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.973 178.621 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.4 p30 . . . . . 0 CA--C 1.548 0.878 0 CA-C-O 120.874 0.368 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.7 t -41.91 142.04 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.347 1.059 . . . . 0.0 109.315 175.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -78.08 12.88 1.62 Allowed 'General case' 0 N--CA 1.48 1.065 0 O-C-N 124.182 0.927 . . . . 0.0 113.342 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.97 179.05 23.55 Favored Glycine 0 N--CA 1.468 0.797 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 m -80.9 173.83 12.22 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 122.174 0.988 . . . . 0.0 110.746 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.4 p -143.6 110.45 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -174.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 86.7 m -46.57 128.89 10.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 111.853 -2.431 . . . . 0.0 110.101 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -33.27 66.01 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.586 -177.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.4 t -65.99 -27.44 68.14 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.786 173.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.71 -20.48 58.33 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.44 0.696 . . . . 0.0 111.396 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.7 mt -86.25 158.66 54.92 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -69.34 167.44 23.88 Favored 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 122.174 1.916 . . . . 0.0 112.375 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.72 -14.01 38.28 Favored 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 122.626 2.217 . . . . 0.0 114.292 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -92.91 -6.16 49.2 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.844 1.258 . . . . 0.0 113.955 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.58 -43.24 18.94 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.717 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -59.1 -28.99 67.03 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.566 174.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -51.09 -58.07 7.06 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 124.258 1.023 . . . . 0.0 110.149 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.1 m -54.6 -50.03 69.0 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 176.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.5 mt -55.0 -35.33 64.26 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 123.627 0.579 . . . . 0.0 112.518 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -71.28 -39.42 71.54 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.892 173.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.1 mt -70.22 -32.67 70.65 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 123.086 0.554 . . . . 0.0 111.104 175.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.9 mt -72.7 -38.22 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 119.959 -1.713 . . . . 0.0 111.356 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.16 -42.65 62.57 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.693 -1.14 . . . . 0.0 112.303 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.39 8.66 39.63 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.661 1.184 . . . . 0.0 111.877 177.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.7 t0 39.77 49.97 2.22 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.078 1.351 . . . . 0.0 111.932 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.95 -166.92 39.48 Favored Glycine 0 N--CA 1.47 0.924 0 CA-C-N 113.056 -1.884 . . . . 0.0 115.598 -173.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.24 141.61 70.83 Favored 'Cis proline' 0 N--CA 1.48 0.71 0 O-C-N 124.014 1.534 . . . . 0.0 111.346 -0.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -93.98 136.43 23.74 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 113.822 -1.536 . . . . 0.0 111.426 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -75.71 -61.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.478 0.573 0 C-N-CA 122.813 2.342 . . . . 0.0 110.719 -176.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -59.59 158.87 9.22 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.417 175.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 m -71.58 -15.21 62.26 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.938 0.875 . . . . 0.0 112.755 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.408 ' NE2' HH12 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -88.26 95.41 10.17 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.09 -176.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 166.58 136.1 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 111.813 -2.449 . . . . 0.0 115.35 -173.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.96 38.34 8.0 Favored Glycine 0 CA--C 1.54 1.619 0 CA-C-N 113.39 -1.732 . . . . 0.0 111.118 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.39 148.88 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 113.536 -1.332 . . . . 0.0 109.445 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.6 t -85.87 154.78 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 O-C-N 126.081 2.113 . . . . 0.0 109.875 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -135.15 89.54 2.53 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.428 176.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.5 tm0? -70.28 54.1 0.14 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 120.103 1.32 . . . . 0.0 111.695 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.658 ' CB ' ' HG1' ' A' ' 46' ' ' THR . 15.1 p-10 25.47 52.33 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 127.837 2.455 . . . . 0.0 110.813 -175.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.82 -21.18 27.08 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.27 -173.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -78.39 -12.04 59.98 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 112.956 -1.929 . . . . 0.0 115.094 172.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.7 t 45.4 39.17 4.24 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 124.081 1.896 . . . . 0.0 112.014 -177.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.3 t -110.57 -13.32 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-O 123.634 1.683 . . . . 0.0 110.583 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.26 148.93 36.73 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 114.124 -1.398 . . . . 0.0 107.268 -172.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.44 56.08 3.82 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 124.03 3.153 . . . . 0.0 111.462 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.658 ' HG1' ' CB ' ' A' ' 39' ' ' ASN . 3.2 m -80.83 -162.29 0.47 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.363 -1.744 . . . . 0.0 107.252 177.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.528 ' H ' ' CG2' ' A' ' 46' ' ' THR . 12.0 tt0 170.7 -39.66 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.855 1.662 . . . . 0.0 110.495 -175.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.4 p -115.06 162.9 16.38 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 122.497 1.141 . . . . 0.0 111.241 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -91.73 138.65 31.39 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 112.956 -1.929 . . . . 0.0 110.09 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.94 8.66 78.53 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.664 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -81.83 13.4 3.27 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.813 1.245 . . . . 0.0 111.085 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -149.43 156.52 42.15 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -173.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -152.15 154.99 36.94 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 125.49 1.744 . . . . 0.0 111.349 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -110.02 145.06 37.66 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.064 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -161.32 62.13 0.27 Allowed 'General case' 0 N--CA 1.475 0.788 0 O-C-N 125.882 1.989 . . . . 0.0 110.75 -174.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -40.14 129.61 2.22 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 122.485 1.136 . . . . 0.0 111.952 177.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.0 m -83.65 121.15 35.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 111.515 -2.584 . . . . 0.0 108.72 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -42.3 162.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 O-C-N 125.363 1.665 . . . . 0.0 109.884 171.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.488 ' HG1' ' NE ' ' A' ' 68' ' ' ARG . 1.4 m -157.01 138.52 9.83 Favored Pre-proline 0 N--CA 1.482 1.146 0 O-C-N 125.374 1.672 . . . . 0.0 111.649 176.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.36 144.33 32.6 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.096 2.531 . . . . 0.0 109.463 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.61 26.64 39.55 Favored Glycine 0 CA--C 1.545 1.909 0 CA-C-N 113.081 -1.872 . . . . 0.0 112.01 -175.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.95 89.06 7.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -40.16 -31.89 0.15 Allowed 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.908 176.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.6 p -129.79 -162.3 1.19 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.587 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.0 mtm105 -59.51 -14.63 13.54 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 172.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.0 137.12 0.08 OUTLIER Glycine 0 N--CA 1.467 0.722 0 N-CA-C 107.442 -2.263 . . . . 0.0 107.442 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.1 p -46.16 -28.69 1.31 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 113.43 -1.385 . . . . 0.0 113.077 174.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.488 ' NE ' ' HG1' ' A' ' 59' ' ' THR . 20.8 mtm-85 -50.27 139.14 15.41 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 121.02 -1.05 . . . . 0.0 113.045 170.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.408 HH12 ' NE2' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -165.14 137.94 4.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.099 -1.864 . . . . 0.0 109.15 -179.487 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.2 mt -105.1 138.48 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 112.694 -2.048 . . . . 0.0 109.548 173.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.8 mm -127.86 103.39 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 112.628 -2.078 . . . . 0.0 108.365 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.1 p -88.41 162.86 16.28 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.972 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -104.22 -171.46 25.04 Favored Glycine 0 N--CA 1.48 1.605 0 O-C-N 125.273 1.608 . . . . 0.0 110.152 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.26 -11.07 53.31 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.533 0.682 . . . . 0.0 112.157 175.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.69 132.14 54.48 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 176.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.1 m -49.09 144.72 4.66 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.026 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 81.24 56.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 126.006 2.066 . . . . 0.0 109.856 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -166.44 54.93 0.09 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 113.222 -1.808 . . . . 0.0 114.247 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.68 93.2 4.31 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.939 1.296 . . . . 0.0 110.788 -177.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -74.18 135.91 42.81 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 124.508 1.123 . . . . 0.0 110.325 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -121.56 91.9 3.62 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -44.49 -75.94 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 113.638 -1.619 . . . . 0.0 112.856 171.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.63 8.32 86.09 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-N 113.361 -1.745 . . . . 0.0 112.435 -175.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -139.79 17.51 2.5 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 176.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 69.09 83.83 0.15 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.685 1.594 . . . . 0.0 111.815 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 50.12 25.92 1.92 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 113.189 -1.823 . . . . 0.0 113.894 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.93 -57.96 2.29 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 120.43 -1.419 . . . . 0.0 110.825 -173.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.401 ' O ' ' CG ' ' A' ' 89' ' ' PHE . 27.7 p -112.02 178.62 4.25 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.401 ' CG ' ' O ' ' A' ' 88' ' ' THR . 95.6 m-85 -161.56 122.21 2.7 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -175.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.7 m -140.39 107.93 5.59 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 126.169 2.168 . . . . 0.0 108.694 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 13.1 mt -43.22 161.89 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.87 122.34 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 120.96 -1.087 . . . . 0.0 109.54 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.21 97.21 8.33 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 113.231 -1.804 . . . . 0.0 108.792 175.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -60.04 -40.23 88.65 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 125.321 1.638 . . . . 0.0 111.125 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.3 t -53.38 -37.45 62.46 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 114.354 -1.293 . . . . 0.0 112.651 172.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 12.0 t . . . . . 0 C--O 1.249 1.074 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.343 175.13 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.7 t -37.34 135.21 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.494 1.518 . . . . 0.0 109.751 173.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.66 5.21 5.1 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 124.323 1.014 . . . . 0.0 112.824 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.74 -165.67 16.47 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.183 1.373 . . . . 0.0 109.831 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 m -99.81 170.79 8.3 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.936 -1.132 . . . . 0.0 109.829 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.2 p -140.85 109.28 2.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -175.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 82.0 m -44.99 133.42 6.39 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.016 -1.902 . . . . 0.0 111.068 177.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -31.65 67.79 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.676 0.61 . . . . 0.0 111.66 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -65.4 -28.69 69.44 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.538 173.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.16 -30.96 60.88 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.598 0.759 . . . . 0.0 111.432 175.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.7 mt -81.22 161.45 62.54 Favored Pre-proline 0 N--CA 1.475 0.784 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -66.94 168.67 16.56 Favored 'Trans proline' 0 CA--C 1.544 1.004 0 C-N-CA 122.671 2.247 . . . . 0.0 112.759 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.82 -32.36 18.46 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.768 2.312 . . . . 0.0 112.447 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.87 -5.96 44.26 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.448 1.099 . . . . 0.0 112.017 176.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.28 -57.03 4.86 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.418 1.087 . . . . 0.0 112.487 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.81 -24.2 49.14 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 174.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -49.08 -55.32 12.54 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.671 1.189 . . . . 0.0 111.527 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 94.9 m -66.28 -43.02 87.57 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.6 mt -52.36 -35.5 51.45 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 173.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -67.35 -41.14 85.63 Favored 'General case' 0 C--O 1.207 -1.181 0 CA-C-N 113.868 -1.515 . . . . 0.0 110.77 175.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.5 mt -67.2 -36.17 81.17 Favored 'General case' 0 C--O 1.213 -0.857 0 CA-C-O 118.12 -0.943 . . . . 0.0 112.093 175.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.4 mt -64.33 -43.0 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 118.852 0.751 . . . . 0.0 111.616 172.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.36 -46.56 63.84 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.689 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.1 t -72.76 -12.03 60.84 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.267 1.827 . . . . 0.0 111.542 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 t0 54.52 40.62 31.96 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.256 1.422 . . . . 0.0 110.289 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.03 -170.52 39.68 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 113.055 -1.884 . . . . 0.0 115.969 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -74.67 139.81 63.78 Favored 'Cis proline' 0 C--N 1.347 0.454 0 O-C-N 124.096 1.577 . . . . 0.0 111.976 -1.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -90.55 135.53 29.2 Favored Pre-proline 0 N--CA 1.481 1.085 0 CA-C-N 113.723 -1.58 . . . . 0.0 110.849 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -72.5 -61.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.475 0.423 0 C-N-CA 123.216 2.611 . . . . 0.0 112.073 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -64.15 146.95 53.37 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 118.847 -0.597 . . . . 0.0 110.658 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.6 t -65.38 -13.69 59.18 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 125.4 1.688 . . . . 0.0 112.956 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -80.96 77.38 7.87 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 122.734 1.254 . . . . 0.0 112.355 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -177.54 148.5 0.57 Allowed 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 111.104 -2.771 . . . . 0.0 113.307 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.4 31.98 29.35 Favored Glycine 0 N--CA 1.479 1.521 0 CA-C-N 113.084 -1.871 . . . . 0.0 111.306 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.64 146.85 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.218 1.007 . . . . 0.0 109.905 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.0 t -86.58 152.87 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 125.949 2.031 . . . . 0.0 110.014 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -130.28 93.75 3.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 113.518 -1.674 . . . . 0.0 108.838 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.6 tm0? -71.93 54.0 0.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.087 -1.008 . . . . 0.0 111.969 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.546 ' CB ' ' HG1' ' A' ' 46' ' ' THR . 16.5 p-10 26.18 56.12 0.05 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.413 2.285 . . . . 0.0 111.035 -176.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -25.87 55.22 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.03 -172.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -78.0 -13.26 59.94 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-N 112.981 -1.918 . . . . 0.0 115.125 172.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.9 t 45.24 41.67 6.29 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 123.847 1.784 . . . . 0.0 111.886 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.2 t -107.72 -14.14 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 113.732 -1.577 . . . . 0.0 110.126 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.82 148.75 36.6 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-O 117.662 -1.161 . . . . 0.0 108.451 -171.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -73.85 56.77 3.64 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.278 2.652 . . . . 0.0 111.898 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.546 ' HG1' ' CB ' ' A' ' 39' ' ' ASN . 3.1 m -75.43 -165.2 0.39 Allowed 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 113.612 -1.631 . . . . 0.0 107.564 176.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.492 ' H ' ' CG2' ' A' ' 46' ' ' THR . 5.6 tm0? 168.5 -38.81 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 126.608 1.963 . . . . 0.0 110.453 -175.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.2 p -114.33 160.23 19.33 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.166 0.984 . . . . 0.0 112.158 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -88.84 139.85 30.04 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 113.032 -1.895 . . . . 0.0 110.117 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.06 9.99 77.17 Favored Glycine 0 CA--C 1.542 1.773 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.851 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -82.09 8.79 9.86 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.474 1.109 . . . . 0.0 111.391 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -146.73 145.84 30.1 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -174.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -141.36 157.2 45.5 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 126.541 2.401 . . . . 0.0 110.883 178.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -110.4 143.07 41.21 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.864 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -158.78 69.67 0.49 Allowed 'General case' 0 N--CA 1.471 0.579 0 O-C-N 126.107 2.13 . . . . 0.0 110.144 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.3 m -43.37 129.06 5.0 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 122.971 1.367 . . . . 0.0 112.197 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.8 p -89.3 118.12 33.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 111.109 -2.769 . . . . 0.0 109.965 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -43.32 151.69 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.227 170.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.662 ' HG1' ' CG ' ' A' ' 68' ' ' ARG . 3.4 m -145.29 142.85 18.78 Favored Pre-proline 0 N--CA 1.475 0.823 0 CA-C-N 113.64 -1.618 . . . . 0.0 111.647 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.57 145.12 29.21 Favored 'Trans proline' 0 N--CA 1.479 0.658 0 C-N-CA 121.824 1.683 . . . . 0.0 110.216 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.86 28.16 57.16 Favored Glycine 0 CA--C 1.546 2.01 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.189 -175.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.7 92.44 6.58 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -39.41 -33.64 0.17 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 114.204 -1.362 . . . . 0.0 113.296 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 57.7 p -130.57 -160.56 1.05 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.888 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.2 mtm180 -56.08 -19.79 14.49 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 172.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.16 167.55 3.19 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 123.889 1.827 . . . . 0.0 109.379 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.7 p -71.27 -5.26 30.85 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 112.423 -1.888 . . . . 0.0 113.286 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.662 ' CG ' ' HG1' ' A' ' 59' ' ' THR . 0.2 OUTLIER -73.0 117.03 14.23 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.561 1.172 . . . . 0.0 110.161 177.624 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -140.24 133.8 30.16 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 113.865 -1.516 . . . . 0.0 109.191 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.7 mt -105.42 133.67 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 125.923 2.014 . . . . 0.0 107.835 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.3 mm -123.5 107.16 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 113.525 -1.67 . . . . 0.0 107.415 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.5 p -93.5 163.87 13.4 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 120.969 0.414 . . . . 0.0 110.696 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.57 -172.17 23.8 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.256 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.64 -14.15 60.0 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.322 0.582 . . . . 0.0 112.158 175.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -115.93 131.57 56.9 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.5 m -56.34 151.53 12.77 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.836 175.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 74.82 32.97 0.8 Allowed 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 123.508 1.623 . . . . 0.0 110.766 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -138.76 57.09 1.69 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 113.547 -1.66 . . . . 0.0 112.479 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -101.98 130.03 48.41 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 113.882 -1.508 . . . . 0.0 108.461 174.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -102.27 129.15 48.6 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.714 -1.584 . . . . 0.0 109.465 175.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -108.21 124.37 50.18 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 113.641 -1.618 . . . . 0.0 109.001 -177.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . 0.265 0.5 OUTLIER -86.0 -68.4 0.74 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 113.09 -1.868 . . . . 0.0 112.037 176.161 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.87 1.65 26.04 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 114.605 -1.179 . . . . 0.0 113.876 -172.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -129.7 12.13 5.78 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.392 1.077 . . . . 0.0 113.631 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 61.92 81.28 0.2 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.513 2.325 . . . . 0.0 111.647 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 54.2 33.29 17.73 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 114.424 -1.262 . . . . 0.0 113.997 -175.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -111.71 -6.76 14.3 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.5 p -163.91 165.17 22.98 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.768 1.627 . . . . 0.0 108.122 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -159.55 117.91 2.79 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 -174.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.52 106.5 5.97 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.357 -1.747 . . . . 0.0 108.432 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.1 mt -40.47 157.29 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.638 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.29 133.18 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.045 -1.035 . . . . 0.0 109.517 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.99 89.37 2.98 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 113.329 -1.76 . . . . 0.0 109.338 177.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -63.7 -40.46 96.85 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.409 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 t -51.39 -40.01 58.35 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 125.295 1.622 . . . . 0.0 112.813 172.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 8.4 t . . . . . 0 C--O 1.258 1.51 0 CA-C-O 116.733 -1.604 . . . . 0.0 110.747 178.445 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.8 p30 . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 122.212 1.006 . . . . 0.0 112.669 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 t -78.87 134.29 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.6 m -64.37 -8.26 12.57 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 175.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.46 169.46 12.68 Favored Glycine 0 N--CA 1.474 1.196 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -78.76 172.02 14.33 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.566 -0.817 . . . . 0.0 110.782 -178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 p -145.65 108.06 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -174.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 57.6 m -42.9 138.32 2.05 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 113.266 -1.788 . . . . 0.0 111.658 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -33.03 71.24 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.756 0.66 . . . . 0.0 111.962 -178.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.4 t -70.85 -15.79 62.66 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.773 174.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.13 -37.45 46.14 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.65 0.738 . . . . 0.0 111.832 176.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.3 mt -77.83 166.28 44.83 Favored Pre-proline 0 N--CA 1.475 0.788 0 C-N-CA 124.531 1.133 . . . . 0.0 111.111 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.67 169.89 15.02 Favored 'Trans proline' 0 CA--C 1.553 1.471 0 C-N-CA 122.713 2.275 . . . . 0.0 113.353 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.3 -15.88 39.12 Favored 'Trans proline' 0 N--CA 1.484 0.932 0 C-N-CA 122.305 2.004 . . . . 0.0 113.437 175.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -93.81 4.81 53.37 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.935 0.894 . . . . 0.0 112.111 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.86 -48.11 12.86 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.96 176.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -58.28 -23.03 54.92 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.413 -1.267 . . . . 0.0 112.701 174.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -49.97 -58.01 6.34 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.289 1.035 . . . . 0.0 110.324 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.7 m -56.63 -49.49 74.84 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.8 mt -55.53 -35.73 65.98 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 123.805 0.69 . . . . 0.0 111.693 178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -68.34 -38.48 81.53 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.015 173.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.9 mt -69.19 -34.8 75.48 Favored 'General case' 0 C--O 1.212 -0.874 0 CA-C-O 118.746 -0.645 . . . . 0.0 110.954 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.76 -40.73 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 120.186 1.357 . . . . 0.0 111.312 172.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.8 -42.48 67.02 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.023 -0.989 . . . . 0.0 112.291 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.27 7.55 42.21 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.116 0.966 . . . . 0.0 111.35 177.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.0 t0 39.52 52.5 2.34 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 123.209 1.48 . . . . 0.0 112.156 -178.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.3 -164.77 40.44 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 112.721 -2.036 . . . . 0.0 115.659 -173.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.9 141.44 71.75 Favored 'Cis proline' 0 C--N 1.346 0.415 0 O-C-N 124.678 1.883 . . . . 0.0 111.849 -2.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -94.52 132.92 27.78 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.248 -176.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -75.12 -59.55 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.546 2.164 . . . . 0.0 111.24 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -60.69 157.76 14.01 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.486 0.66 . . . . 0.0 112.436 175.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.4 t -77.43 -10.58 59.55 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 122.524 1.154 . . . . 0.0 112.215 175.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.431 HE21 ' HG1' ' A' ' 56' ' ' THR . 0.5 OUTLIER -91.6 87.56 6.4 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.624 0.726 . . . . 0.0 112.21 -178.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 172.29 136.33 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 111.517 -2.583 . . . . 0.0 114.259 -174.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.08 28.75 16.9 Favored Glycine 0 N--CA 1.48 1.602 0 CA-C-N 113.189 -1.823 . . . . 0.0 111.729 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.2 m -123.48 146.59 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 113.6 -1.3 . . . . 0.0 109.713 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.0 t -81.95 156.79 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 125.536 1.772 . . . . 0.0 109.724 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -139.23 86.28 2.12 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.634 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -69.66 52.86 0.11 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 122.401 1.096 . . . . 0.0 113.629 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.2 t30 31.23 55.17 0.23 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 127.057 2.143 . . . . 0.0 109.399 -172.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.56 -31.32 62.05 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 122.454 1.121 . . . . 0.0 111.766 -175.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -79.06 -8.15 58.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 112.928 -1.942 . . . . 0.0 114.3 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 39.9 t 43.82 42.66 4.61 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 124.132 1.92 . . . . 0.0 111.975 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.7 t -107.36 -18.05 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 113.301 -1.772 . . . . 0.0 109.704 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.94 147.86 38.32 Favored Pre-proline 0 C--N 1.32 -0.679 0 O-C-N 121.189 -0.944 . . . . 0.0 108.657 -176.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.94 57.03 5.59 Favored 'Trans proline' 0 N--CA 1.478 0.614 0 C-N-CA 122.311 2.007 . . . . 0.0 112.073 -176.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -156.52 -144.91 0.14 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.366 -1.288 . . . . 0.0 107.718 -178.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 168.63 -35.98 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 126.412 1.885 . . . . 0.0 110.429 -173.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.4 p -37.87 148.88 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 122.608 1.194 . . . . 0.0 113.811 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -103.53 121.97 43.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 113.23 -1.805 . . . . 0.0 111.725 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.08 -22.71 33.04 Favored Glycine 0 N--CA 1.476 1.318 0 O-C-N 125.708 1.88 . . . . 0.0 111.691 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.46 -13.9 45.19 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 124.325 1.05 . . . . 0.0 112.924 175.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -116.78 162.44 17.69 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.412 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -158.92 159.81 35.36 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 112.515 -2.13 . . . . 0.0 111.686 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -117.64 136.39 53.34 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.85 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -151.6 75.52 1.17 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 113.622 -1.626 . . . . 0.0 110.212 -176.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.431 ' HG1' HE21 ' A' ' 32' ' ' GLN . 52.8 m -42.91 138.56 1.98 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 122.438 1.113 . . . . 0.0 112.516 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.36 106.89 19.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 112.195 -2.275 . . . . 0.0 110.073 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -39.36 147.04 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.266 172.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.2 m -144.44 140.65 16.9 Favored Pre-proline 0 N--CA 1.473 0.722 0 O-C-N 125.465 1.728 . . . . 0.0 112.018 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.34 146.31 35.44 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.066 1.844 . . . . 0.0 110.177 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.63 25.42 55.48 Favored Glycine 0 N--CA 1.485 1.937 0 CA-C-N 114.22 -1.355 . . . . 0.0 112.196 -175.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.71 91.38 6.99 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -39.96 -32.22 0.15 Allowed 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 113.585 -1.643 . . . . 0.0 113.325 176.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.0 p -131.26 -159.0 0.93 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.505 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -18.05 31.82 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.968 -1.015 . . . . 0.0 113.585 171.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.33 162.5 0.59 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-O 123.697 1.721 . . . . 0.0 109.59 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.3 p -65.65 -10.73 38.72 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 113.137 -1.531 . . . . 0.0 113.241 174.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.437 ' NE ' ' HH ' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -64.94 124.46 22.1 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 123.279 1.514 . . . . 0.0 110.715 175.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.51 HH21 ' HH ' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -149.24 144.76 26.73 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 112.866 -1.97 . . . . 0.0 110.588 -179.305 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.4 mt -120.44 137.04 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 125.398 1.686 . . . . 0.0 108.673 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.7 mm -127.57 102.41 8.93 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 CA-C-N 112.737 -2.029 . . . . 0.0 107.758 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.7 p -90.16 163.37 14.85 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.667 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -116.77 165.67 12.35 Favored Glycine 0 N--CA 1.471 0.981 0 CA-C-N 113.534 -1.666 . . . . 0.0 109.357 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.49 -14.9 62.9 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.701 0.763 . . . . 0.0 111.687 176.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -106.27 131.04 53.97 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 m -55.34 143.14 29.48 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 113.776 -1.556 . . . . 0.0 108.361 174.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 79.6 34.57 0.18 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.936 2.095 . . . . 0.0 111.224 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -129.79 49.95 2.22 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 123.232 1.491 . . . . 0.0 112.299 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.55 100.99 10.36 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 113.607 -1.633 . . . . 0.0 110.307 -176.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -89.83 135.2 33.77 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 113.996 -1.457 . . . . 0.0 109.319 -175.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.437 ' HH ' ' NE ' ' A' ' 68' ' ' ARG . 11.0 t80 -115.2 127.42 55.51 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.947 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . 0.251 0.4 OUTLIER -86.77 -68.87 0.71 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 113.012 -1.904 . . . . 0.0 111.417 176.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.01 1.7 27.26 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 114.047 -1.433 . . . . 0.0 113.544 -172.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -129.9 10.47 5.49 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.237 1.015 . . . . 0.0 113.595 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 64.88 80.13 0.24 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 128.081 2.552 . . . . 0.0 110.698 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.51 ' HH ' HH21 ' A' ' 69' ' ' ARG . 17.0 m-85 55.82 26.19 9.32 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 122.928 1.347 . . . . 0.0 113.413 -174.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.51 -8.86 20.69 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.54 -1.35 . . . . 0.0 112.766 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.5 p -163.14 169.37 19.47 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.621 1.568 . . . . 0.0 108.859 -176.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -158.5 115.14 2.78 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -174.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.49 107.04 8.61 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 113.203 -1.817 . . . . 0.0 109.483 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.0 mt -42.8 160.94 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 mp -110.05 113.72 45.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 O-C-N 120.982 -1.074 . . . . 0.0 109.194 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.09 87.21 7.35 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 113.833 -1.53 . . . . 0.0 109.686 176.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -67.65 -31.41 71.39 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.643 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.6 t -55.64 -27.96 52.72 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.849 173.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.4 t . . . . . 0 C--O 1.253 1.265 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.887 177.691 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 p30 . . . . . 0 N--CA 1.474 0.73 0 CA-C-O 121.163 0.506 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.0 t -46.87 128.45 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.64 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 m -72.79 4.76 3.74 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 125.021 1.45 . . . . 0.0 113.095 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.09 168.89 13.18 Favored Glycine 0 C--O 1.216 -1.014 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.4 m -76.68 174.62 10.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.653 -1.273 . . . . 0.0 110.159 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.36 109.38 3.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -175.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 74.9 m -47.19 125.37 7.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 112.669 -2.06 . . . . 0.0 109.367 176.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -49.81 -36.26 25.85 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 118.771 -0.633 . . . . 0.0 111.745 175.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.9 t -65.07 -28.52 69.52 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.889 0.852 . . . . 0.0 112.503 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.22 -23.96 57.67 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.714 175.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.0 mt -83.52 160.44 59.14 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -69.04 170.44 15.72 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.237 1.958 . . . . 0.0 112.826 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.35 -13.43 33.19 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.723 2.282 . . . . 0.0 114.235 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -95.28 -3.45 47.43 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.642 175.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.6 -50.45 25.24 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.909 177.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.21 -24.97 45.39 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.284 -1.326 . . . . 0.0 112.204 175.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -51.44 -60.18 3.42 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.374 1.046 . . . . 0.0 110.012 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.2 m -55.95 -52.24 64.86 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.647 0.592 . . . . 0.0 112.426 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.1 mt -52.72 -34.15 51.17 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.517 0.51 . . . . 0.0 111.837 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -70.39 -40.72 73.76 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 124.102 0.961 . . . . 0.0 110.818 174.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.5 mt -67.79 -32.21 72.63 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 119.095 -0.478 . . . . 0.0 110.23 175.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.9 -43.08 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 120.597 1.544 . . . . 0.0 111.684 172.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.01 -42.76 72.58 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 125.034 1.459 . . . . 0.0 111.844 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.78 7.41 39.86 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.482 1.113 . . . . 0.0 111.748 177.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.6 t70 40.6 50.24 2.84 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 125.283 1.433 . . . . 0.0 110.977 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.59 -166.77 45.77 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 113.616 -1.629 . . . . 0.0 114.864 -173.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.53 141.03 69.91 Favored 'Cis proline' 0 N--CA 1.48 0.732 0 O-C-N 124.209 1.637 . . . . 0.0 111.19 0.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -91.21 136.23 27.41 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 113.051 -1.886 . . . . 0.0 111.656 -177.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -74.76 -63.63 0.03 OUTLIER 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 122.463 2.108 . . . . 0.0 111.076 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -59.59 150.62 26.76 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.548 0.689 . . . . 0.0 111.596 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.69 -5.71 42.26 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.024 176.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.661 ' NE2' ' HG1' ' A' ' 56' ' ' THR . 13.4 mt-30 -97.38 88.89 4.54 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.957 0.884 . . . . 0.0 112.261 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 169.99 134.16 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 112.115 -2.311 . . . . 0.0 113.751 -175.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.65 17.26 33.87 Favored Glycine 0 N--CA 1.484 1.872 0 CA-C-N 112.706 -2.043 . . . . 0.0 111.846 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.9 m -109.62 150.75 12.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 123.634 0.774 . . . . 0.0 109.502 176.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.3 t -84.01 154.47 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 O-C-N 125.674 1.859 . . . . 0.0 110.473 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -131.92 92.5 3.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.549 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -68.93 47.69 0.06 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.398 1.094 . . . . 0.0 112.96 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 40.4 t30 28.91 53.0 0.08 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.459 1.503 . . . . 0.0 110.628 -173.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.89 -23.46 53.27 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 113.912 -1.494 . . . . 0.0 110.984 -172.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -86.77 -12.86 46.89 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 112.684 -2.053 . . . . 0.0 113.868 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.4 t 43.75 43.53 5.02 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 124.605 2.145 . . . . 0.0 111.663 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 79.5 t -105.75 -17.74 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 112.689 -2.051 . . . . 0.0 110.007 -178.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.23 153.98 56.98 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 117.691 -1.147 . . . . 0.0 108.878 -175.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.0 50.18 2.46 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.071 2.514 . . . . 0.0 112.452 -178.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.3 m -155.84 -138.08 0.07 Allowed 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 161.85 -34.58 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.545 1.938 . . . . 0.0 110.626 -173.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.3 p -42.95 155.52 0.05 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 123.602 1.668 . . . . 0.0 111.935 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -104.35 131.0 52.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 113.338 -1.755 . . . . 0.0 110.981 -175.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.58 -16.78 38.5 Favored Glycine 0 N--CA 1.479 1.559 0 O-C-N 125.022 1.451 . . . . 0.0 111.904 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -68.13 -9.79 49.22 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.63 0.772 . . . . 0.0 112.149 176.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -121.3 169.4 10.62 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 124.298 1.039 . . . . 0.0 109.791 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -159.79 164.13 33.99 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 113.237 -1.801 . . . . 0.0 110.659 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -118.98 139.73 51.19 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.846 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -153.09 61.9 0.77 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 125.81 1.944 . . . . 0.0 111.36 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.661 ' HG1' ' NE2' ' A' ' 32' ' ' GLN . 23.3 m -38.24 124.39 1.22 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.362 1.077 . . . . 0.0 112.089 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.66 108.74 18.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 111.901 -2.409 . . . . 0.0 108.767 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -38.23 146.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.443 172.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.648 ' HG1' ' CG ' ' A' ' 68' ' ' ARG . 3.4 m -137.29 140.26 30.29 Favored Pre-proline 0 C--N 1.324 -0.53 0 O-C-N 125.157 1.535 . . . . 0.0 111.654 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.25 150.05 41.45 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.188 2.592 . . . . 0.0 109.502 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 49.73 30.96 15.18 Favored Glycine 0 N--CA 1.479 1.523 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.904 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.01 88.87 5.39 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -41.8 -29.72 0.21 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.247 -1.342 . . . . 0.0 112.794 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.7 p -126.24 -163.69 1.25 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.997 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -59.43 -15.75 19.19 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 173.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.55 153.67 0.8 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.6 p -67.23 -8.86 34.9 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 112.671 -1.765 . . . . 0.0 112.761 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.648 ' CG ' ' HG1' ' A' ' 59' ' ' THR . 0.0 OUTLIER -70.14 116.04 10.04 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.54 1.136 . . . . 0.0 110.413 177.039 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.05 137.96 35.01 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.887 -1.506 . . . . 0.0 109.452 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.7 mt -109.05 141.08 25.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 113.644 -1.616 . . . . 0.0 109.097 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.404 ' O ' ' CD2' ' A' ' 80' ' ' TYR . 19.0 mm -129.42 107.03 14.61 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 CA-C-N 113.808 -1.542 . . . . 0.0 109.309 -177.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.05 167.45 17.87 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 123.348 0.659 . . . . 0.0 110.861 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -120.34 173.18 15.23 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.03 -14.84 63.29 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 113.866 -1.167 . . . . 0.0 111.691 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.31 128.48 54.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.434 175.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.3 m -59.06 141.81 53.03 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 113.506 -1.679 . . . . 0.0 106.98 175.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 81.28 32.04 0.13 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 126.193 2.183 . . . . 0.0 111.002 178.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -133.45 57.47 1.81 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.786 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.74 122.16 42.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.53 -1.668 . . . . 0.0 110.19 178.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.404 ' CD2' ' O ' ' A' ' 71' ' ' ILE . 40.4 m-85 -95.55 137.68 34.29 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 124.914 1.286 . . . . 0.0 109.373 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -116.64 123.74 48.05 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.717 -177.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.93 -66.21 0.93 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 113.663 -1.608 . . . . 0.0 110.734 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.08 2.31 17.56 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-N 113.598 -1.637 . . . . 0.0 113.092 -173.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -129.63 8.6 5.39 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 67.76 80.81 0.2 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 128.213 2.605 . . . . 0.0 110.556 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 55.67 24.3 7.0 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 123.695 1.712 . . . . 0.0 112.99 -175.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -99.74 -10.07 22.3 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 117.954 -1.498 . . . . 0.0 112.391 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.5 p -162.89 171.98 15.82 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -159.91 114.17 2.27 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -174.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.01 104.91 7.09 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 113.854 -1.521 . . . . 0.0 108.682 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.0 mt -42.05 164.66 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 O-C-N 124.209 0.943 . . . . 0.0 112.101 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.41 134.5 53.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 O-C-N 120.699 -1.251 . . . . 0.0 108.996 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.29 93.91 4.67 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.661 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -56.39 -38.09 71.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 123.976 0.798 . . . . 0.0 112.102 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.3 t -54.71 -46.49 74.18 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.047 1.339 . . . . 0.0 112.67 173.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 24.7 t . . . . . 0 C--O 1.249 1.029 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.43 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 . . . . . 0 CA--C 1.547 0.855 0 CA-C-O 123.464 1.602 . . . . 0.0 114.998 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.9 t -107.42 139.21 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 t -69.59 -2.36 11.32 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 124.731 1.269 . . . . 0.0 112.96 176.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 124.36 169.03 12.99 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.517 1.532 . . . . 0.0 109.474 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -81.77 169.46 16.9 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.839 0.828 . . . . 0.0 110.377 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 p -140.47 107.77 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -174.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 61.5 m -47.09 136.6 8.54 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 113.542 -1.663 . . . . 0.0 111.063 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.89 -32.17 65.61 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.837 -178.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.1 t -66.77 -29.02 68.87 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.863 173.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.13 -29.76 60.62 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.396 0.679 . . . . 0.0 111.523 175.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.5 mt -77.98 160.64 73.4 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -68.72 168.01 21.33 Favored 'Trans proline' 0 CA--C 1.554 1.482 0 C-N-CA 122.559 2.173 . . . . 0.0 112.799 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.29 -12.41 34.88 Favored 'Trans proline' 0 CA--C 1.55 1.306 0 C-N-CA 123.156 2.57 . . . . 0.0 113.944 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -93.38 -11.84 31.32 Favored 'General case' 0 C--O 1.216 -0.705 0 C-N-CA 124.998 1.319 . . . . 0.0 113.188 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.15 -50.08 67.4 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.05 -26.44 49.22 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.937 173.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -54.98 -56.84 15.27 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.153 0.981 . . . . 0.0 110.132 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.5 m -57.15 -49.1 77.01 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 176.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.8 mt -55.85 -35.72 66.74 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.898 0.749 . . . . 0.0 111.806 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -67.91 -37.36 81.6 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.63 174.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 28.2 mt -69.17 -32.01 71.04 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 118.494 -0.765 . . . . 0.0 111.629 173.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.42 -43.85 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 119.668 1.122 . . . . 0.0 111.969 171.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.13 -42.99 71.87 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.119 -1.4 . . . . 0.0 112.863 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.17 4.49 50.34 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.454 1.102 . . . . 0.0 112.084 177.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.7 t0 40.94 50.39 3.1 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.495 1.518 . . . . 0.0 111.383 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.18 -164.93 28.73 Favored Glycine 0 N--CA 1.473 1.149 0 CA-C-N 111.932 -2.395 . . . . 0.0 116.524 -174.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -74.08 141.56 72.11 Favored 'Cis proline' 0 C--N 1.348 0.524 0 O-C-N 124.462 1.769 . . . . 0.0 111.79 -3.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -96.9 116.5 66.09 Favored Pre-proline 0 N--CA 1.47 0.57 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.208 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.94 -48.17 0.3 Allowed 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 122.865 2.377 . . . . 0.0 111.927 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.3 132.44 47.73 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.104 176.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.8 m -70.76 56.9 0.19 Allowed 'General case' 0 N--CA 1.477 0.925 0 O-C-N 125.17 1.544 . . . . 0.0 112.771 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -157.08 73.65 0.76 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 113.566 -1.652 . . . . 0.0 111.863 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.57 144.74 1.14 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 110.987 -2.824 . . . . 0.0 113.481 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.91 23.67 37.8 Favored Glycine 0 CA--C 1.538 1.526 0 CA-C-N 113.237 -1.801 . . . . 0.0 111.839 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.8 m -122.08 145.22 29.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 C-N-CA 124.748 1.219 . . . . 0.0 110.203 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.3 t -81.44 154.13 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 O-C-N 125.969 2.043 . . . . 0.0 110.165 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -131.34 91.7 3.06 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 113.565 -1.652 . . . . 0.0 109.324 175.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.91 51.6 0.15 Allowed 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 119.614 1.097 . . . . 0.0 113.23 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 28.66 52.95 0.07 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 126.81 2.044 . . . . 0.0 110.252 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -26.21 60.75 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 121.771 0.796 . . . . 0.0 112.858 -172.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -74.95 -16.79 60.63 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 112.621 -2.081 . . . . 0.0 114.593 171.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.8 t 45.86 41.1 7.39 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 124.024 1.869 . . . . 0.0 111.388 -177.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 89.1 t -104.21 -11.38 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 112.758 -2.019 . . . . 0.0 109.65 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.5 148.88 35.07 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.523 -174.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.87 56.21 5.23 Favored 'Trans proline' 0 N--CA 1.478 0.616 0 C-N-CA 122.925 2.416 . . . . 0.0 112.343 -174.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.6 m -158.37 -152.0 0.31 Allowed 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 114.293 -1.321 . . . . 0.0 107.626 -175.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 175.56 -37.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 126.204 1.802 . . . . 0.0 110.966 -174.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.6 p -40.0 147.82 0.09 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 122.585 1.183 . . . . 0.0 113.483 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -104.01 133.69 48.53 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 113.672 -1.604 . . . . 0.0 109.823 -174.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.48 -17.33 39.81 Favored Glycine 0 N--CA 1.474 1.205 0 CA-C-N 114.03 -1.441 . . . . 0.0 112.721 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.62 -1.08 20.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.013 1.325 . . . . 0.0 113.867 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -129.77 151.51 50.28 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.489 1.116 . . . . 0.0 109.598 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -147.29 155.4 42.0 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 126.278 2.236 . . . . 0.0 110.581 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -108.96 132.93 53.61 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.298 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -145.75 62.95 1.26 Allowed 'General case' 0 N--CA 1.471 0.584 0 O-C-N 125.64 1.838 . . . . 0.0 110.715 -176.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -38.53 127.79 1.46 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 122.194 0.997 . . . . 0.0 112.85 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.1 p -90.8 113.24 26.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 111.783 -2.462 . . . . 0.0 109.201 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -36.89 145.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 114.022 -1.444 . . . . 0.0 110.506 171.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.517 ' HG1' ' CG ' ' A' ' 68' ' ' ARG . 3.4 m -136.66 140.16 31.29 Favored Pre-proline 0 N--CA 1.476 0.839 0 O-C-N 125.472 1.733 . . . . 0.0 112.48 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.99 145.18 31.16 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.375 2.05 . . . . 0.0 109.236 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.12 32.16 49.79 Favored Glycine 0 CA--C 1.539 1.532 0 CA-C-N 113.247 -1.797 . . . . 0.0 112.186 -176.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.72 94.42 7.28 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -40.89 -33.15 0.28 Allowed 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 113.768 -1.56 . . . . 0.0 113.913 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.7 p -124.97 -155.15 0.66 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 113.655 -1.612 . . . . 0.0 108.755 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.4 mtm-85 -55.5 -19.75 10.71 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 171.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.32 135.48 0.08 OUTLIER Glycine 0 CA--C 1.524 0.599 0 N-CA-C 107.717 -2.153 . . . . 0.0 107.717 -176.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 77.1 p -41.28 -33.62 0.4 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 113.429 -1.385 . . . . 0.0 113.727 175.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.517 ' CG ' ' HG1' ' A' ' 59' ' ' THR . 0.2 OUTLIER -39.35 128.78 1.82 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 122.719 1.247 . . . . 0.0 113.83 169.746 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.458 HH21 ' HH ' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -158.69 133.78 8.42 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 111.702 -2.499 . . . . 0.0 110.159 -176.335 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.0 mt -112.14 132.7 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 125.817 1.948 . . . . 0.0 107.791 176.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.9 mm -121.12 102.88 12.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 112.753 -2.021 . . . . 0.0 107.522 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.4 p -88.86 161.31 16.78 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.501 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -116.42 164.23 12.34 Favored Glycine 0 N--CA 1.475 1.262 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.444 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.15 -15.81 62.82 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 176.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -103.71 130.96 51.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.612 173.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 m -55.97 142.7 34.85 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 175.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 78.98 31.74 0.3 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 126.892 2.077 . . . . 0.0 111.499 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -125.49 48.81 1.99 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 123.083 1.42 . . . . 0.0 112.569 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.52 107.9 18.94 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.205 1.402 . . . . 0.0 109.39 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -96.99 132.3 42.93 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 124.885 1.366 . . . . 0.0 109.48 -177.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -110.39 126.18 54.01 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.089 -176.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . 0.27 0.3 OUTLIER -87.84 -68.66 0.74 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.011 -1.45 . . . . 0.0 112.211 176.399 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.86 2.12 21.72 Favored Glycine 0 N--CA 1.482 1.726 0 CA-C-N 114.607 -1.179 . . . . 0.0 113.414 -172.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -129.82 13.17 5.82 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.349 1.059 . . . . 0.0 112.531 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 64.08 84.86 0.14 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.329 1.852 . . . . 0.0 111.579 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.458 ' HH ' HH21 ' A' ' 69' ' ' ARG . 7.4 m-85 50.81 29.54 4.4 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -175.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -112.21 -3.78 14.55 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.0 p -164.5 161.32 21.22 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.958 1.703 . . . . 0.0 108.305 -174.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -157.83 112.01 2.58 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.023 0.929 . . . . 0.0 108.88 -174.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.3 m -131.47 106.71 8.4 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 112.863 -1.971 . . . . 0.0 109.57 -178.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 17.5 mt -42.13 155.61 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.972 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.9 mp -102.76 111.12 31.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 O-C-N 120.489 -1.382 . . . . 0.0 108.837 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.14 85.81 6.72 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.769 0.795 . . . . 0.0 110.156 175.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.53 -32.56 70.06 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.002 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.4 t -56.19 -23.05 32.9 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.525 1.53 . . . . 0.0 113.267 173.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.6 t . . . . . 0 CA--C 1.554 1.105 0 CA-C-O 116.48 -1.724 . . . . 0.0 110.85 177.764 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.1 t -55.16 127.1 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 m -75.14 6.59 4.11 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 124.544 1.152 . . . . 0.0 113.776 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 121.22 -165.54 14.25 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 m -95.79 170.14 9.52 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.986 -1.107 . . . . 0.0 110.277 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -137.47 111.85 9.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -176.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 97.0 m -49.37 129.48 18.67 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 111.874 -2.421 . . . . 0.0 109.83 177.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.78 -33.21 66.4 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 119.217 -0.42 . . . . 0.0 111.437 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.8 t -67.24 -28.39 68.01 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.348 0.659 . . . . 0.0 112.384 174.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.33 -20.76 58.87 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.781 174.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.2 mt -83.18 158.94 63.35 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 175.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.03 167.02 24.69 Favored 'Trans proline' 0 CA--C 1.551 1.371 0 C-N-CA 121.964 1.776 . . . . 0.0 112.456 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.18 -17.45 45.25 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.384 2.056 . . . . 0.0 113.682 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.4 pm0 -87.65 -13.78 41.73 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.697 1.199 . . . . 0.0 112.674 174.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.78 -49.9 73.16 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.02 0.528 . . . . 0.0 112.098 176.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.11 -26.23 48.97 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.633 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -57.57 -57.48 12.53 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.805 0.842 . . . . 0.0 110.34 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.8 m -57.23 -49.1 77.1 Favored 'General case' 0 C--O 1.217 -0.621 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 175.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.0 mt -56.02 -35.13 66.49 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 124.253 0.971 . . . . 0.0 111.77 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -67.59 -39.16 84.82 Favored 'General case' 0 C--O 1.212 -0.891 0 C-N-CA 124.54 1.136 . . . . 0.0 110.957 174.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.0 mt -68.53 -34.76 76.43 Favored 'General case' 0 C--O 1.211 -0.926 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.596 175.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.93 -38.73 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 120.069 1.304 . . . . 0.0 111.872 171.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.47 -48.52 48.73 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.86 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 m -85.46 5.93 29.04 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.173 0.989 . . . . 0.0 113.314 176.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.38 36.08 1.51 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 122.748 1.261 . . . . 0.0 112.22 -176.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.44 -166.9 16.26 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.443 1.497 . . . . 0.0 115.706 -174.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.78 139.87 64.15 Favored 'Cis proline' 0 C--N 1.347 0.485 0 O-C-N 124.285 1.676 . . . . 0.0 111.255 -2.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -90.95 135.72 28.37 Favored Pre-proline 0 N--CA 1.474 0.732 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.705 -177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -74.34 -61.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.469 2.779 . . . . 0.0 111.433 -178.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.3 m-30 -63.35 159.72 17.52 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 175.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.8 m -80.53 9.28 6.22 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 124.173 0.921 . . . . 0.0 113.476 173.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.61 78.99 1.76 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 122.022 0.915 . . . . 0.0 111.46 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -177.14 146.16 0.49 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 111.721 -2.49 . . . . 0.0 115.056 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.69 27.98 36.84 Favored Glycine 0 N--CA 1.479 1.535 0 CA-C-N 112.87 -1.968 . . . . 0.0 110.853 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.5 m -122.12 146.24 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.453 1.101 . . . . 0.0 109.54 177.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.4 t -84.39 154.07 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 125.903 2.002 . . . . 0.0 109.855 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -137.11 85.88 2.16 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 113.844 -1.525 . . . . 0.0 110.828 175.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -69.38 51.91 0.1 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.9 t30 27.52 55.65 0.07 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.779 2.032 . . . . 0.0 109.634 -172.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -28.37 54.85 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 122.332 1.063 . . . . 0.0 111.463 -175.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -74.72 -11.37 60.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 113.138 -1.846 . . . . 0.0 114.962 173.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 31.4 t 45.38 43.12 8.21 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 123.874 1.797 . . . . 0.0 111.844 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.8 t -108.77 -20.92 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 113.78 -1.555 . . . . 0.0 110.432 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.25 147.26 39.85 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -175.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.75 54.62 4.06 Favored 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 123.3 2.666 . . . . 0.0 112.081 -176.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -157.66 -149.27 0.23 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 114.023 -1.444 . . . . 0.0 107.745 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 173.36 -35.78 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.012 1.725 . . . . 0.0 110.955 -173.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.8 p -38.06 146.35 0.06 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 122.771 1.272 . . . . 0.0 114.099 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -102.54 129.21 49.01 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 113.208 -1.814 . . . . 0.0 111.744 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.63 -18.84 27.73 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 113.813 -1.539 . . . . 0.0 112.258 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -67.47 -9.09 38.76 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.228 1.011 . . . . 0.0 112.396 176.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -122.99 162.4 22.41 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 124.279 1.032 . . . . 0.0 109.772 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -159.51 155.85 27.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 112.296 -2.229 . . . . 0.0 111.39 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -110.68 142.34 42.72 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.758 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -156.57 67.11 0.56 Allowed 'General case' 0 N--CA 1.477 0.918 0 O-C-N 126.328 2.267 . . . . 0.0 110.524 -175.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 m -38.47 123.06 1.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 122.689 1.233 . . . . 0.0 112.808 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -81.82 114.1 22.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 112.109 -2.314 . . . . 0.0 108.73 177.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -41.33 150.82 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 124.806 1.316 . . . . 0.0 109.107 171.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.531 ' HG1' ' CG ' ' A' ' 68' ' ' ARG . 23.8 m -150.99 137.76 11.56 Favored Pre-proline 0 N--CA 1.481 1.106 0 O-C-N 125.851 1.969 . . . . 0.0 110.684 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -72.48 151.4 53.19 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 123.646 2.897 . . . . 0.0 110.588 177.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.36 20.72 30.75 Favored Glycine 0 N--CA 1.48 1.623 0 CA-C-N 114.015 -1.448 . . . . 0.0 112.88 -174.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.87 87.64 5.47 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -44.39 -30.52 0.86 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 113.99 -1.459 . . . . 0.0 112.683 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.8 p -133.03 -170.87 2.54 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.866 -1.515 . . . . 0.0 108.638 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.1 mtm-85 -46.87 -29.3 1.92 Allowed 'General case' 0 N--CA 1.484 1.254 0 O-C-N 124.273 0.983 . . . . 0.0 112.921 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.27 148.78 0.09 OUTLIER Glycine 0 N--CA 1.465 0.59 0 N-CA-C 107.26 -2.336 . . . . 0.0 107.26 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.6 p -42.86 -29.73 0.34 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.052 -1.574 . . . . 0.0 113.423 172.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.531 ' CG ' ' HG1' ' A' ' 59' ' ' THR . 3.1 mmm180 -37.64 116.91 0.52 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 166.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.49 135.02 10.52 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 112.435 -2.166 . . . . 0.0 112.938 -176.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.9 mt -113.7 141.05 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 112.784 -2.007 . . . . 0.0 108.471 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.4 mm -127.52 114.09 34.49 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 O-C-N 126.199 2.187 . . . . 0.0 108.203 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.5 p -101.05 163.92 12.05 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.248 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.67 164.87 12.04 Favored Glycine 0 CA--C 1.531 1.082 0 O-C-N 125.639 1.837 . . . . 0.0 109.694 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.86 -17.43 63.15 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.302 0.641 . . . . 0.0 112.117 175.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -104.55 128.51 52.53 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.8 m -55.54 145.82 22.06 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 114.096 -1.411 . . . . 0.0 107.354 174.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 82.39 32.84 0.09 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 126.299 1.839 . . . . 0.0 111.218 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -135.83 46.46 2.33 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 123.058 1.409 . . . . 0.0 112.744 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.2 88.61 3.54 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 113.174 -1.83 . . . . 0.0 109.843 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -57.79 178.06 0.09 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.287 174.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.483 ' CE2' ' NH1' ' A' ' 68' ' ' ARG . 9.0 t80 -158.01 113.92 2.77 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.685 -176.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . 0.318 0.1 OUTLIER -87.87 -80.45 0.27 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.045 -1.434 . . . . 0.0 113.72 177.813 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.02 -5.31 59.15 Favored Glycine 0 N--CA 1.471 0.99 0 CA-C-N 115.25 -0.886 . . . . 0.0 114.382 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.64 20.02 11.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.398 -0.901 . . . . 0.0 111.985 173.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 58.47 87.02 0.08 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.25 1.82 . . . . 0.0 110.203 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 49.08 41.32 19.16 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 113.639 -1.619 . . . . 0.0 114.518 -174.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -112.46 -32.64 6.42 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.102 -1.624 . . . . 0.0 112.806 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.3 p -135.95 166.79 22.52 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.646 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -156.79 110.13 2.61 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -175.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.71 106.46 9.15 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 113.884 -1.507 . . . . 0.0 108.354 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 51.1 mt -44.08 161.72 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.76 131.97 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 120.881 -1.137 . . . . 0.0 108.926 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.87 94.99 5.31 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 113.204 -1.816 . . . . 0.0 107.911 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -57.41 -37.1 72.21 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 124.731 1.269 . . . . 0.0 111.912 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.3 t -58.34 -45.66 87.71 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.821 -1.082 . . . . 0.0 112.469 174.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 11.6 t . . . . . 0 C--O 1.245 0.829 0 CA-C-O 118.489 -0.767 . . . . 0.0 110.929 175.091 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.477 0.893 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.4 t -95.08 142.87 12.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.1 m -77.74 5.69 8.9 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.787 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 120.53 -177.23 16.36 Favored Glycine 0 N--CA 1.473 1.115 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.4 m -90.96 173.69 7.83 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 122.354 1.073 . . . . 0.0 109.2 -178.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.73 112.64 5.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -175.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 73.3 m -50.08 124.66 10.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 111.894 -2.412 . . . . 0.0 109.601 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.73 -35.39 31.2 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.719 0.807 . . . . 0.0 112.232 174.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.9 t -63.81 -30.97 72.01 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.518 0.511 . . . . 0.0 111.992 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.48 -17.65 59.18 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.632 0.773 . . . . 0.0 111.913 174.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.1 mt -90.05 162.35 35.46 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 176.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.48 169.53 15.48 Favored 'Trans proline' 0 CA--C 1.547 1.135 0 C-N-CA 122.606 2.204 . . . . 0.0 112.988 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.3 -17.95 49.99 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.561 2.174 . . . . 0.0 113.058 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -85.05 -25.22 27.76 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 175.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -48.84 -37.07 18.37 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 175.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.49 -35.27 68.14 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.873 -1.512 . . . . 0.0 112.943 173.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -54.46 -53.33 55.63 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.06 0.944 . . . . 0.0 109.828 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.1 m -59.54 -48.24 82.43 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 175.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.6 mt -56.81 -28.57 61.66 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -73.75 -40.35 63.57 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.704 173.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 25.3 mt -69.5 -31.16 69.24 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 119.271 -0.395 . . . . 0.0 111.026 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.74 -38.38 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 120.143 1.338 . . . . 0.0 111.508 171.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.46 -47.61 32.39 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 124.562 1.164 . . . . 0.0 111.873 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.7 m -85.91 8.4 20.45 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.42 1.488 . . . . 0.0 112.645 175.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 41.51 46.54 3.05 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 122.725 1.25 . . . . 0.0 112.525 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.48 -166.13 43.37 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-N 113.928 -1.487 . . . . 0.0 116.265 -171.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -74.25 140.6 68.17 Favored 'Cis proline' 0 N--CA 1.483 0.887 0 O-C-N 124.758 1.925 . . . . 0.0 111.543 -1.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -92.21 142.67 26.44 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 113.897 -1.501 . . . . 0.0 111.679 -176.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -74.62 -65.29 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 123.283 2.655 . . . . 0.0 111.42 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 -57.56 163.0 2.63 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.834 0.826 . . . . 0.0 112.226 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 t -82.08 9.44 8.5 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 123.238 1.494 . . . . 0.0 112.269 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.11 99.54 8.14 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.302 -177.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 166.64 140.17 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 O-C-N 126.626 2.454 . . . . 0.0 115.404 -172.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.45 30.38 22.02 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-N 113.616 -1.629 . . . . 0.0 111.172 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.7 m -122.36 147.39 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 114.275 -0.963 . . . . 0.0 109.512 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.0 t -85.15 156.95 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 125.248 1.593 . . . . 0.0 109.631 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -141.26 86.26 2.01 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.811 175.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.72 55.44 0.26 Allowed 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 122.631 1.205 . . . . 0.0 113.318 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 45.7 t30 29.73 53.62 0.12 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.474 2.31 . . . . 0.0 109.305 -173.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.18 -22.97 53.8 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.701 -174.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -83.02 -8.28 59.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 113.207 -1.815 . . . . 0.0 114.669 173.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 43.9 t 44.0 41.92 4.37 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 124.326 2.012 . . . . 0.0 111.733 -177.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.5 t -109.81 -12.4 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 113.592 -1.64 . . . . 0.0 109.663 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.92 148.43 34.8 Favored Pre-proline 0 CA--C 1.545 0.775 0 O-C-N 120.721 -1.237 . . . . 0.0 108.687 -175.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.5 59.09 7.02 Favored 'Trans proline' 0 N--CA 1.477 0.551 0 C-N-CA 122.815 2.343 . . . . 0.0 111.156 -174.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.4 m -157.17 -147.49 0.19 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 113.829 -1.532 . . . . 0.0 107.505 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 171.7 -35.97 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.911 1.684 . . . . 0.0 111.04 -173.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.6 p -40.89 152.23 0.05 Allowed 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 123.116 1.436 . . . . 0.0 112.917 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -106.18 126.71 52.55 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 113.178 -1.828 . . . . 0.0 109.937 -175.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.43 -21.53 28.43 Favored Glycine 0 N--CA 1.479 1.521 0 O-C-N 125.181 1.551 . . . . 0.0 112.009 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -64.44 -13.47 51.62 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.505 1.122 . . . . 0.0 112.294 176.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -116.25 163.08 16.52 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.718 0.807 . . . . 0.0 109.535 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -159.65 159.65 33.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 112.016 -2.357 . . . . 0.0 111.184 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -117.31 144.7 44.6 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.645 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -158.96 63.92 0.41 Allowed 'General case' 0 N--CA 1.48 1.047 0 O-C-N 126.495 2.372 . . . . 0.0 111.104 -174.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 m -35.35 120.89 0.57 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 122.352 1.072 . . . . 0.0 112.556 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.78 117.72 28.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 112.738 -2.028 . . . . 0.0 108.609 177.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -42.99 158.39 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 173.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.629 ' HG1' ' CG ' ' A' ' 68' ' ' ARG . 2.5 m -153.09 142.45 14.74 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 113.273 -1.785 . . . . 0.0 111.387 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.56 146.03 48.5 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.594 2.196 . . . . 0.0 110.971 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.25 22.1 55.08 Favored Glycine 0 N--CA 1.48 1.611 0 CA-C-N 113.759 -1.564 . . . . 0.0 112.459 -175.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.2 87.05 7.34 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -47.61 -26.57 1.52 Allowed 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.912 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.1 p -128.03 -158.62 0.89 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.037 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.6 mtm105 -57.06 -18.18 13.25 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 174.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.41 125.4 0.02 OUTLIER Glycine 0 N--CA 1.465 0.593 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.0 p -39.72 -31.09 0.09 Allowed 'General case' 0 CA--C 1.557 1.234 0 CA-C-N 113.699 -1.251 . . . . 0.0 113.523 175.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.629 ' CG ' ' HG1' ' A' ' 59' ' ' THR . 0.3 OUTLIER -46.05 105.61 0.07 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 123.417 1.579 . . . . 0.0 112.711 170.137 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.42 141.36 49.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 112.816 -1.993 . . . . 0.0 109.989 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.9 mt -117.3 135.9 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 112.681 -2.054 . . . . 0.0 108.33 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.9 mm -124.91 101.87 9.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 CA-C-N 112.848 -1.978 . . . . 0.0 108.608 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.9 p -89.68 163.1 15.26 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.502 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -115.29 166.84 12.24 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-N 113.32 -1.764 . . . . 0.0 109.665 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.24 -14.09 62.58 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.355 -0.922 . . . . 0.0 111.843 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.58 130.95 55.29 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.129 174.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.4 m -55.23 143.8 26.66 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.124 -1.398 . . . . 0.0 107.495 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 80.06 33.82 0.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 126.127 2.142 . . . . 0.0 111.037 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -129.33 49.12 2.28 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 113.596 -1.638 . . . . 0.0 113.616 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.13 103.77 13.25 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.341 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -91.64 131.13 37.26 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 125.28 1.613 . . . . 0.0 109.916 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -110.29 123.92 50.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.24 -1.345 . . . . 0.0 109.894 -176.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.437 ' HG1' ' N ' ' A' ' 86' ' ' TYR 0.262 0.2 OUTLIER -89.74 -71.18 0.62 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 113.502 -1.681 . . . . 0.0 112.464 177.315 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.09 -8.81 56.65 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-N 113.118 -1.856 . . . . 0.0 112.197 -175.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -112.01 9.71 20.43 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 117.252 0.526 . . . . 0.0 111.838 174.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 87.15 -20.93 0.2 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.928 1.691 . . . . 0.0 113.076 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.437 ' N ' ' HG1' ' A' ' 82' ' ' THR . 1.2 m-30 161.19 55.35 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 O-C-N 128.16 3.412 . . . . 0.0 113.684 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -120.06 -41.33 2.65 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 118.994 -1.083 . . . . 0.0 113.748 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 18.4 p -128.29 165.55 20.32 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.399 -1.273 . . . . 0.0 108.402 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -157.41 112.7 2.78 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -173.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.2 m -131.21 112.25 12.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 113.261 -1.791 . . . . 0.0 109.286 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 25.1 mt -42.39 162.82 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 O-C-N 124.214 0.946 . . . . 0.0 112.428 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.19 130.74 65.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 O-C-N 120.778 -1.201 . . . . 0.0 108.823 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.04 94.14 4.94 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.257 -1.792 . . . . 0.0 108.624 176.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -53.39 -37.22 62.26 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 124.107 0.88 . . . . 0.0 112.467 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.9 t -56.74 -49.29 75.65 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 113.801 -1.545 . . . . 0.0 113.595 174.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 34.3 t . . . . . 0 C--O 1.246 0.886 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 179.07 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.9 p30 . . . . . 0 CA--C 1.551 1.011 0 CA-C-O 122.146 0.974 . . . . 0.0 112.986 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 t -84.05 141.81 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.92 5.82 10.67 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.883 0.849 . . . . 0.0 112.639 177.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.38 -174.37 16.55 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.447 1.498 . . . . 0.0 109.988 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -94.18 169.39 10.28 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 122.016 0.912 . . . . 0.0 109.239 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 p -137.84 111.26 7.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 122.752 1.263 . . . . 0.0 107.882 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 71.6 m -48.96 128.16 15.47 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 112.256 -2.247 . . . . 0.0 109.364 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -34.65 57.41 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.805 176.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.1 t -64.68 -29.77 70.77 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 174.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.14 -26.11 58.9 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.451 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.1 mt -83.92 162.57 51.94 Favored Pre-proline 0 N--CA 1.478 0.952 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 177.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.17 168.11 18.39 Favored 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 122.308 2.005 . . . . 0.0 112.952 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -65.28 -18.95 62.0 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.847 2.365 . . . . 0.0 112.666 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -83.62 -26.41 29.98 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.439 -0.801 . . . . 0.0 113.066 175.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -47.62 -38.87 15.54 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.38 -34.73 72.91 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.551 -1.659 . . . . 0.0 113.328 174.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -54.52 -57.0 13.12 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 117.408 -1.282 . . . . 0.0 109.465 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 m -55.87 -48.42 75.59 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 174.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.1 mt -57.42 -33.36 67.81 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -67.75 -33.41 74.81 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.336 174.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.3 mt -75.93 -31.3 59.06 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 118.773 -0.632 . . . . 0.0 110.924 176.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.9 -40.81 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 120.267 1.394 . . . . 0.0 111.453 170.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.84 -41.78 64.46 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 125.02 1.45 . . . . 0.0 112.521 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.31 7.23 45.22 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.321 1.049 . . . . 0.0 111.781 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 44.46 34.98 1.19 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.035 1.334 . . . . 0.0 112.556 -176.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.9 -168.15 20.14 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-N 113.379 -1.737 . . . . 0.0 115.83 -174.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -74.53 140.5 67.66 Favored 'Cis proline' 0 N--CA 1.479 0.622 0 O-C-N 124.043 1.549 . . . . 0.0 111.261 -3.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -89.86 136.99 28.57 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.57 -176.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -72.68 -63.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.475 0.415 0 C-N-CA 123.563 2.842 . . . . 0.0 111.413 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 -62.99 159.4 17.13 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.411 0.684 . . . . 0.0 112.744 175.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.85 8.5 5.4 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 124.714 1.259 . . . . 0.0 113.588 174.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.409 ' NE2' ' NH1' ' A' ' 69' ' ' ARG . 1.8 mt-30 -105.01 82.89 1.91 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 122.372 1.082 . . . . 0.0 111.819 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -177.32 150.83 0.74 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 110.779 -2.919 . . . . 0.0 114.999 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.01 35.43 27.58 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-N 112.52 -2.127 . . . . 0.0 110.275 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -131.88 147.1 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.546 1.138 . . . . 0.0 109.72 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.4 t -84.41 154.4 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 O-C-N 125.944 2.027 . . . . 0.0 109.868 175.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -132.31 91.33 2.92 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 113.846 -1.525 . . . . 0.0 108.419 174.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.5 tm0? -72.12 55.63 0.31 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 119.81 1.187 . . . . 0.0 112.361 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.581 ' CB ' ' HG1' ' A' ' 46' ' ' THR . 16.8 p-10 26.06 55.83 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.793 2.437 . . . . 0.0 110.854 -175.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.38 -25.97 51.42 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 122.17 0.986 . . . . 0.0 111.938 -171.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -76.35 -14.33 60.09 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 113.09 -1.868 . . . . 0.0 115.598 172.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 31.6 t 45.06 41.81 5.91 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 124.183 1.945 . . . . 0.0 111.924 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.6 t -110.8 -10.42 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-N 113.151 -1.841 . . . . 0.0 110.739 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -103.91 150.35 38.14 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-O 117.372 -1.299 . . . . 0.0 109.29 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.87 60.41 5.33 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.215 2.61 . . . . 0.0 111.42 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.581 ' HG1' ' CB ' ' A' ' 39' ' ' ASN . 3.6 m -82.25 -165.2 0.96 Allowed 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 112.915 -1.948 . . . . 0.0 107.628 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.521 ' H ' ' CG2' ' A' ' 46' ' ' THR . 12.9 tt0 175.86 -43.71 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.004 1.722 . . . . 0.0 110.282 -176.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.8 p -114.86 161.45 18.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.693 -176.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -90.01 129.39 36.34 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 113.312 -1.767 . . . . 0.0 110.437 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.76 5.99 70.62 Favored Glycine 0 N--CA 1.48 1.584 0 O-C-N 125.332 1.645 . . . . 0.0 112.657 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.39 15.31 3.72 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -151.04 150.76 31.12 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.156 0.983 . . . . 0.0 109.305 -173.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -147.12 155.44 42.17 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 126.074 2.109 . . . . 0.0 111.632 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -109.13 145.17 36.16 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.829 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -159.82 68.28 0.39 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 126.826 2.579 . . . . 0.0 110.64 -174.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -41.19 133.92 2.22 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 122.767 1.27 . . . . 0.0 111.814 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -95.86 118.97 43.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 112.07 -2.332 . . . . 0.0 107.939 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -40.73 153.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 CA-C-O 121.853 0.835 . . . . 0.0 108.955 173.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.7 m -140.04 139.74 22.15 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 112.951 -1.931 . . . . 0.0 111.688 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.73 145.18 50.84 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 121.93 1.754 . . . . 0.0 111.007 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 51.77 28.48 23.37 Favored Glycine 0 CA--C 1.548 2.137 0 O-C-N 125.289 1.618 . . . . 0.0 111.895 -174.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.98 90.28 4.57 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -46.57 -27.65 1.2 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 113.603 -1.635 . . . . 0.0 113.197 176.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.2 p -126.0 -173.67 2.91 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.846 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.6 mtm105 -52.94 -20.72 3.6 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 175.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.22 171.27 11.89 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 124.38 2.1 . . . . 0.0 109.201 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.0 p -75.95 0.74 17.33 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 111.275 -2.463 . . . . 0.0 113.004 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.11 116.9 21.89 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 122.925 1.345 . . . . 0.0 111.203 176.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.409 ' NH1' ' NE2' ' A' ' 32' ' ' GLN . 0.1 OUTLIER -142.35 135.67 28.87 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 112.771 -2.013 . . . . 0.0 109.323 178.444 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.2 mt -104.5 144.81 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 113.463 -1.699 . . . . 0.0 108.741 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.4 mm -132.73 114.75 23.04 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.737 0 CA-C-N 112.486 -2.143 . . . . 0.0 107.895 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.8 p -99.45 162.86 12.79 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.791 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -107.61 -178.26 22.39 Favored Glycine 0 N--CA 1.477 1.433 0 O-C-N 124.968 1.417 . . . . 0.0 109.953 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.8 -13.22 59.96 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 114.348 -0.926 . . . . 0.0 113.024 174.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -113.73 130.78 56.38 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 176.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.4 m -54.0 147.97 11.53 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.083 174.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 80.63 31.76 0.17 Allowed 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 126.585 1.954 . . . . 0.0 110.942 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -134.59 48.78 2.28 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 123.89 1.805 . . . . 0.0 113.708 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.34 86.74 2.58 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 113.071 -1.877 . . . . 0.0 109.417 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -57.35 177.88 0.08 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 125.275 1.43 . . . . 0.0 110.339 174.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -162.87 126.23 2.85 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 113.817 -1.538 . . . . 0.0 109.84 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.12 -71.97 0.6 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 112.672 -2.058 . . . . 0.0 111.702 176.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.46 1.08 34.38 Favored Glycine 0 CA--C 1.55 2.228 0 CA-C-N 113.094 -1.866 . . . . 0.0 114.835 -173.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -127.79 15.8 6.92 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.386 0.675 . . . . 0.0 112.619 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 61.28 83.79 0.14 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 127.093 2.157 . . . . 0.0 110.591 -178.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 51.84 38.23 22.74 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 113.83 -1.532 . . . . 0.0 113.342 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -109.74 -13.22 14.52 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.5 p -161.37 165.96 28.14 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.037 1.335 . . . . 0.0 107.81 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -157.29 113.55 2.93 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -176.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.4 m -132.33 115.94 16.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.748 -1.569 . . . . 0.0 109.399 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 35.0 mt -47.28 164.21 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.379 0.672 . . . . 0.0 111.946 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.63 128.96 69.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 120.824 -1.173 . . . . 0.0 108.434 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.87 92.05 4.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 113.472 -1.695 . . . . 0.0 108.551 175.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -52.62 -36.4 56.4 Favored 'General case' 0 N--CA 1.484 1.225 0 O-C-N 124.173 0.92 . . . . 0.0 112.778 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.2 t -58.27 -47.05 84.82 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 114.054 -1.43 . . . . 0.0 113.387 173.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 24.3 t . . . . . 0 C--O 1.244 0.791 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.171 178.365 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 71.2 t -37.66 136.5 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 125.57 1.548 . . . . 0.0 109.409 171.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.5 m -70.48 3.8 2.78 Favored 'General case' 0 CA--C 1.55 0.952 0 O-C-N 125.151 1.532 . . . . 0.0 112.526 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 111.2 -179.25 19.86 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 m -77.0 170.14 17.07 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.128 -1.036 . . . . 0.0 110.423 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 p -138.49 108.6 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 78.8 m -43.55 123.51 3.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 112.565 -2.107 . . . . 0.0 109.964 176.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.74 -37.06 39.69 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.742 177.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.9 t -65.69 -28.11 68.83 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.099 0.56 . . . . 0.0 112.073 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.43 -20.55 58.8 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.83 174.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.7 mt -85.77 159.59 54.67 Favored Pre-proline 0 CA--C 1.539 0.519 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 176.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.52 169.16 19.25 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 121.953 1.769 . . . . 0.0 113.081 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.48 -13.93 38.63 Favored 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 122.627 2.218 . . . . 0.0 114.549 177.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.8 pm0 -93.43 -4.93 50.43 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.559 -1.201 . . . . 0.0 113.29 176.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.59 -50.7 11.06 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.797 175.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.96 -28.22 56.06 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.67 -1.15 . . . . 0.0 112.271 174.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -53.45 -58.63 6.47 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.428 1.08 . . . . 0.0 109.969 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 m -53.57 -50.43 65.59 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.612 0.968 . . . . 0.0 113.612 175.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.4 mt -56.15 -37.38 69.42 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.885 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -64.63 -33.26 75.52 Favored 'General case' 0 C--O 1.214 -0.787 0 C-N-CA 123.962 0.905 . . . . 0.0 110.691 173.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.8 mt -76.35 -30.43 57.6 Favored 'General case' 0 C--O 1.209 -1.048 0 CA-C-O 118.364 -0.826 . . . . 0.0 110.78 176.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.8 mp -70.65 -40.63 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 120.217 1.371 . . . . 0.0 111.722 171.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.39 -40.97 63.9 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.006 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.18 7.72 44.25 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.355 178.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 42.99 34.84 0.67 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.577 1.151 . . . . 0.0 112.733 -176.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.67 -169.48 18.22 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 113.521 -1.672 . . . . 0.0 115.969 -173.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.57 140.76 69.1 Favored 'Cis proline' 0 CA--C 1.537 0.655 0 O-C-N 123.775 1.408 . . . . 0.0 111.102 -2.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -91.66 136.3 26.72 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 113.686 -1.597 . . . . 0.0 111.573 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -73.58 -62.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.475 0.439 0 C-N-CA 122.947 2.431 . . . . 0.0 111.942 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.8 m-30 -69.3 146.35 52.31 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 118.494 -0.765 . . . . 0.0 110.793 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.4 m -62.4 -15.26 48.0 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 125.385 1.678 . . . . 0.0 113.141 174.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.464 ' NE2' HH12 ' A' ' 69' ' ' ARG . 2.0 mt-30 -78.64 77.96 5.11 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 122.678 1.227 . . . . 0.0 111.516 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -178.12 142.21 0.27 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 110.783 -2.917 . . . . 0.0 113.869 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.0 24.43 37.72 Favored Glycine 0 N--CA 1.481 1.656 0 CA-C-N 112.952 -1.931 . . . . 0.0 111.399 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.4 m -120.52 146.89 24.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 124.384 1.073 . . . . 0.0 109.481 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.3 t -83.57 154.37 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 126.096 2.123 . . . . 0.0 110.206 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -135.03 88.53 2.43 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 113.842 -1.526 . . . . 0.0 109.988 175.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -70.91 52.44 0.15 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 122.684 1.231 . . . . 0.0 113.753 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 37.5 t30 28.43 54.26 0.08 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.06 2.144 . . . . 0.0 109.566 -172.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -56.31 -26.29 51.72 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.702 -1.136 . . . . 0.0 111.035 -175.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -76.61 -11.83 59.92 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.61 -1.632 . . . . 0.0 114.562 174.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.2 t 45.54 40.9 6.29 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 123.54 1.638 . . . . 0.0 111.973 -177.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.4 t -109.34 -18.58 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 114.16 -1.382 . . . . 0.0 110.852 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.51 149.78 45.08 Favored Pre-proline 0 N--CA 1.469 0.497 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.762 -175.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -75.51 52.31 3.21 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 122.958 2.439 . . . . 0.0 112.062 -178.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 m -157.6 -148.19 0.2 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 169.54 -35.56 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.301 1.84 . . . . 0.0 110.676 -173.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.6 p -38.74 149.21 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 122.274 1.035 . . . . 0.0 113.657 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -103.26 132.41 49.54 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 113.613 -1.631 . . . . 0.0 109.186 -175.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.26 -18.68 21.91 Favored Glycine 0 N--CA 1.483 1.82 0 O-C-N 124.971 1.419 . . . . 0.0 113.136 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.98 1.63 12.43 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.214 1.406 . . . . 0.0 113.135 177.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -131.05 162.88 28.83 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 123.904 0.882 . . . . 0.0 109.873 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -159.18 156.8 29.62 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 125.647 1.842 . . . . 0.0 110.899 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -114.94 137.33 52.11 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.454 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -152.48 65.85 0.82 Allowed 'General case' 0 N--CA 1.475 0.789 0 O-C-N 125.837 1.961 . . . . 0.0 111.345 -175.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.4 m -39.16 134.65 1.07 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 122.811 1.291 . . . . 0.0 113.061 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -86.97 109.0 18.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 111.354 -2.657 . . . . 0.0 107.529 178.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -43.19 157.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 125.635 1.834 . . . . 0.0 109.339 168.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.616 ' HG1' ' NE ' ' A' ' 68' ' ' ARG . 2.6 m -156.61 141.75 12.38 Favored Pre-proline 0 C--N 1.322 -0.613 0 O-C-N 126.063 2.102 . . . . 0.0 112.501 176.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.84 145.56 45.98 Favored 'Trans proline' 0 N--CA 1.475 0.407 0 C-N-CA 122.549 2.166 . . . . 0.0 110.955 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.81 28.72 57.66 Favored Glycine 0 CA--C 1.539 1.586 0 CA-C-N 113.358 -1.746 . . . . 0.0 112.422 -175.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.11 89.92 7.89 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -39.71 -32.83 0.15 Allowed 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 113.864 -1.516 . . . . 0.0 113.167 176.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.6 p -130.7 -160.65 1.06 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 113.879 -1.509 . . . . 0.0 109.755 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.6 mtm105 -60.21 -14.74 19.17 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 172.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.18 139.53 0.07 OUTLIER Glycine 0 C--N 1.334 0.433 0 N-CA-C 107.57 -2.212 . . . . 0.0 107.57 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.2 p -47.08 -27.9 1.53 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 113.306 -1.447 . . . . 0.0 113.428 174.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.616 ' NE ' ' HG1' ' A' ' 59' ' ' THR . 33.9 mtm-85 -50.27 133.37 23.96 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 123.575 1.655 . . . . 0.0 112.954 170.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.464 HH12 ' NE2' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -159.36 133.29 7.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 111.834 -2.439 . . . . 0.0 109.99 -179.585 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.3 mt -104.34 140.18 23.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 113.591 -1.64 . . . . 0.0 109.099 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.2 mm -129.22 111.37 22.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 112.362 -2.199 . . . . 0.0 108.88 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.2 p -98.68 163.27 12.71 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.443 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -108.03 179.95 21.84 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.083 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.52 -12.19 59.99 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.735 0.779 . . . . 0.0 111.888 175.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -117.47 129.86 56.08 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 175.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.3 m -53.88 151.25 6.73 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.537 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 83.79 32.38 0.06 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 125.936 2.022 . . . . 0.0 110.549 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -146.28 52.83 1.13 Allowed 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 123.187 1.47 . . . . 0.0 112.468 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.37 90.97 3.46 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 113.654 -1.612 . . . . 0.0 109.591 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -59.63 176.48 0.27 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.268 1.027 . . . . 0.0 109.679 176.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -164.76 89.57 0.51 Allowed 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 114.44 -1.254 . . . . 0.0 109.078 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.09 -74.26 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.321 -1.309 . . . . 0.0 112.558 172.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.47 -9.44 42.12 Favored Glycine 0 CA--C 1.545 1.953 0 CA-C-N 113.872 -1.513 . . . . 0.0 112.131 -175.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -122.71 16.49 10.27 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.414 0.686 . . . . 0.0 112.555 175.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 66.69 87.37 0.12 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.749 1.619 . . . . 0.0 111.507 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 48.94 28.64 2.05 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 113.279 -1.782 . . . . 0.0 113.471 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -108.25 -24.29 11.57 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 120.758 -1.214 . . . . 0.0 111.824 -174.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.41 ' O ' ' CG ' ' A' ' 89' ' ' PHE . 12.6 p -143.82 172.63 12.58 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -178.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.41 ' CG ' ' O ' ' A' ' 88' ' ' THR . 94.9 m-85 -163.23 121.02 1.93 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -175.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.1 m -139.64 107.81 5.77 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.531 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.5 mt -44.01 164.18 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.178 0.924 . . . . 0.0 111.701 178.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.83 135.56 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 120.424 -1.422 . . . . 0.0 109.517 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.24 100.15 8.84 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.264 -1.334 . . . . 0.0 108.873 176.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -62.39 -38.97 91.67 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 123.573 0.546 . . . . 0.0 111.608 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.3 t -54.98 -45.49 75.0 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.179 1.391 . . . . 0.0 112.814 173.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 35.1 t . . . . . 0 C--O 1.25 1.105 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.653 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.9 p30 . . . . . 0 CA--C 1.541 0.602 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.8 t -42.28 140.0 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.963 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.5 t -79.95 4.8 15.71 Favored 'General case' 0 CA--C 1.55 0.958 0 O-C-N 124.468 1.105 . . . . 0.0 112.405 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.59 176.25 14.36 Favored Glycine 0 N--CA 1.474 1.232 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m -92.91 173.04 7.95 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.519 -0.84 . . . . 0.0 109.143 -176.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -137.51 108.37 5.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -175.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.5 m -46.05 126.66 7.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.236 -1.802 . . . . 0.0 109.977 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.98 -34.11 63.08 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.8 177.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -64.59 -29.4 70.42 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 123.774 0.671 . . . . 0.0 112.231 173.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.6 -23.06 56.4 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.938 0.895 . . . . 0.0 111.63 174.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.1 mt -83.96 164.69 43.02 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.26 172.08 12.79 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 122.412 2.074 . . . . 0.0 111.975 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.81 -18.63 36.65 Favored 'Trans proline' 0 N--CA 1.48 0.728 0 C-N-CA 122.99 2.46 . . . . 0.0 112.627 176.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -85.57 -24.73 27.1 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.791 175.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -48.04 -39.19 19.15 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.44 -36.98 79.82 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 113.682 -1.599 . . . . 0.0 113.323 174.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -51.46 -54.69 24.39 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.754 0.822 . . . . 0.0 110.088 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.8 m -57.91 -50.61 72.75 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.6 mt -52.38 -30.4 28.87 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 174.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -75.46 -38.43 59.66 Favored 'General case' 0 C--O 1.209 -1.061 0 CA-C-N 114.221 -1.354 . . . . 0.0 110.134 175.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 24.6 mt -71.2 -32.27 68.63 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 118.983 -0.532 . . . . 0.0 110.537 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.6 mp -70.64 -39.58 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-N 120.382 1.447 . . . . 0.0 111.657 172.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.22 -42.49 59.67 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.574 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.53 7.98 38.74 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.296 1.039 . . . . 0.0 111.366 177.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.8 t70 41.13 50.46 3.29 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.616 1.166 . . . . 0.0 111.105 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.56 -168.61 48.1 Favored Glycine 0 CA--C 1.538 1.493 0 CA-C-N 114.216 -1.356 . . . . 0.0 115.211 -173.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -75.42 141.2 70.56 Favored 'Cis proline' 0 N--CA 1.49 1.296 0 O-C-N 125.001 2.053 . . . . 0.0 111.33 -0.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -92.93 139.59 23.27 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 113.598 -1.637 . . . . 0.0 111.564 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -75.2 -64.5 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.066 2.51 . . . . 0.0 110.788 -177.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -58.98 160.45 5.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.667 175.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.8 m -80.77 9.89 5.68 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 122.304 1.049 . . . . 0.0 112.608 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.403 ' NE2' ' NH1' ' A' ' 69' ' ' ARG . 1.0 OUTLIER -105.52 86.88 2.48 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 122.078 0.942 . . . . 0.0 110.837 -178.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 176.96 144.58 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 111.342 -2.663 . . . . 0.0 113.772 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.54 30.76 23.53 Favored Glycine 0 N--CA 1.478 1.487 0 O-C-N 126.199 2.187 . . . . 0.0 110.732 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.46 149.91 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.2 t -88.27 157.05 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 O-C-N 125.164 1.54 . . . . 0.0 110.039 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -135.39 93.79 3.02 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.314 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -70.88 53.86 0.16 Allowed 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 118.991 0.814 . . . . 0.0 112.309 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.665 ' CB ' ' HG1' ' A' ' 46' ' ' THR . 18.4 p-10 26.96 54.36 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.863 2.465 . . . . 0.0 110.046 -176.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.54 -24.41 55.94 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 122.364 1.078 . . . . 0.0 111.232 -171.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -76.5 -11.48 59.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 112.66 -2.063 . . . . 0.0 114.168 173.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.1 t 43.81 39.85 2.8 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 124.9 2.286 . . . . 0.0 110.904 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.0 t -107.69 -14.86 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 113.196 -1.82 . . . . 0.0 109.984 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.48 150.67 38.27 Favored Pre-proline 0 C--O 1.244 0.784 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.225 -172.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.03 55.46 3.97 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 123.415 2.743 . . . . 0.0 110.919 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.665 ' HG1' ' CB ' ' A' ' 39' ' ' ASN . 4.2 m -74.09 -162.87 0.16 Allowed 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.512 ' H ' ' CG2' ' A' ' 46' ' ' THR . 7.5 tt0 169.72 -40.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.941 1.697 . . . . 0.0 110.58 -176.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.8 p -113.95 162.96 15.75 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 123.068 1.413 . . . . 0.0 110.618 -177.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -91.7 138.55 31.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 112.958 -1.928 . . . . 0.0 110.801 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.76 12.0 80.79 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 114.394 -1.275 . . . . 0.0 112.14 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -87.17 15.9 5.72 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.596 0.759 . . . . 0.0 112.346 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -150.64 145.5 25.9 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.057 -175.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -142.84 157.55 44.49 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 126.533 2.395 . . . . 0.0 111.147 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -111.11 147.47 34.79 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.054 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -160.99 63.73 0.29 Allowed 'General case' 0 CA--C 1.543 0.677 0 O-C-N 125.823 1.952 . . . . 0.0 110.289 -175.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -39.04 127.27 1.65 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 122.088 0.947 . . . . 0.0 112.07 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -83.99 120.62 35.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 111.502 -2.59 . . . . 0.0 108.708 178.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -45.76 165.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 124.593 1.183 . . . . 0.0 108.199 173.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.62 ' HG1' ' CD ' ' A' ' 68' ' ' ARG . 2.5 m -158.97 145.8 12.82 Favored Pre-proline 0 C--O 1.24 0.556 0 CA-C-N 112.86 -1.973 . . . . 0.0 112.841 177.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.01 149.79 47.41 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 121.99 1.793 . . . . 0.0 111.764 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.86 21.18 22.28 Favored Glycine 0 N--CA 1.483 1.811 0 O-C-N 125.185 1.553 . . . . 0.0 112.458 -175.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.45 86.25 7.33 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -45.15 -27.76 0.65 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 113.276 -1.784 . . . . 0.0 112.146 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.4 p -128.08 -163.24 1.25 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.639 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.7 mtm105 -56.62 -18.08 10.85 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 174.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.58 131.43 0.03 OUTLIER Glycine 0 N--CA 1.465 0.59 0 N-CA-C 107.274 -2.33 . . . . 0.0 107.274 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.6 p -44.37 -41.54 6.19 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 112.044 -2.078 . . . . 0.0 113.031 176.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.62 ' CD ' ' HG1' ' A' ' 59' ' ' THR . 2.6 mtp85 -40.1 102.39 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 122.968 1.366 . . . . 0.0 113.172 173.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.403 ' NH1' ' NE2' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -128.05 136.43 51.22 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 112.207 -2.27 . . . . 0.0 109.002 -177.271 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.0 mt -105.67 140.99 22.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 112.413 -2.176 . . . . 0.0 108.818 176.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.424 ' O ' ' CD2' ' A' ' 80' ' ' TYR . 23.3 mm -130.16 105.42 11.73 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 CA-C-N 113.268 -1.787 . . . . 0.0 108.384 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.7 p -92.46 163.8 13.7 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.211 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -110.9 -172.59 19.75 Favored Glycine 0 N--CA 1.471 1.024 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.681 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.1 -15.77 60.03 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.41 -0.895 . . . . 0.0 112.303 174.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.72 132.14 54.24 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.338 1.066 . . . . 0.0 108.514 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.5 m -59.3 152.3 21.33 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.086 -1.415 . . . . 0.0 108.618 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 71.46 32.16 2.14 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 123.523 1.63 . . . . 0.0 109.889 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -136.8 68.42 1.43 Allowed 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.847 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -111.31 129.8 55.87 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-N 113.192 -1.822 . . . . 0.0 107.718 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.424 ' CD2' ' O ' ' A' ' 71' ' ' ILE . 14.4 m-85 -100.36 133.92 44.07 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 125.102 1.361 . . . . 0.0 109.919 175.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -111.75 127.41 55.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.458 -1.246 . . . . 0.0 108.961 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.423 ' HG1' ' N ' ' A' ' 86' ' ' TYR . 0.5 OUTLIER -91.03 -68.74 0.77 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 112.839 -1.982 . . . . 0.0 111.959 178.039 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.08 -11.15 50.29 Favored Glycine 0 CA--C 1.542 1.741 0 CA-C-N 113.346 -1.752 . . . . 0.0 112.675 -175.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -111.37 6.39 20.36 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 175.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 86.76 -16.98 0.38 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 116.051 -1.928 . . . . 0.0 113.177 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.423 ' N ' ' HG1' ' A' ' 82' ' ' THR . 1.1 m-30 160.6 51.25 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 128.455 3.597 . . . . 0.0 114.804 -176.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -120.1 -44.86 2.48 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 119.406 -0.918 . . . . 0.0 112.913 177.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.4 p -127.43 168.29 15.07 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.67 -177.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -159.29 115.73 2.61 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -173.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.1 m -135.34 113.81 11.6 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.423 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 29.7 mt -40.81 161.83 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.123 0 O-C-N 124.693 1.246 . . . . 0.0 111.452 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 mp -106.05 129.59 58.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 O-C-N 120.902 -1.123 . . . . 0.0 108.246 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.68 92.25 4.54 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.65 -1.614 . . . . 0.0 108.021 177.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -55.93 -37.75 69.36 Favored 'General case' 0 N--CA 1.484 1.225 0 O-C-N 123.981 0.8 . . . . 0.0 112.253 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.9 t -57.96 -49.67 75.99 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.783 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 21.0 t . . . . . 0 N--CA 1.476 0.874 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.873 179.102 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.4 p30 . . . . . 0 N--CA 1.476 0.864 0 CA-C-O 121.045 0.45 . . . . 0.0 111.494 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.1 t -48.88 141.16 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 m -81.52 22.81 0.68 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.499 1.12 . . . . 0.0 112.379 176.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.16 -154.06 20.11 Favored Glycine 0 N--CA 1.479 1.557 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -107.56 170.07 8.2 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.956 -1.122 . . . . 0.0 110.407 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -142.41 108.77 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -174.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 94.9 m -46.2 133.66 9.13 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 113.581 -1.645 . . . . 0.0 111.038 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.06 -32.44 69.77 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.638 -177.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.2 t -67.39 -27.79 67.39 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.612 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.28 -29.64 62.87 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.642 0.777 . . . . 0.0 111.61 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.3 mt -81.37 161.72 61.19 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 176.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.35 168.25 18.36 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.999 2.466 . . . . 0.0 112.545 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.15 -23.11 39.88 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.236 1.957 . . . . 0.0 113.544 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -83.76 -4.39 58.6 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.884 0.874 . . . . 0.0 111.827 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.72 -49.32 40.39 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.793 0.837 . . . . 0.0 112.278 175.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.3 -25.88 37.05 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.579 174.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -53.46 -57.77 9.47 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 124.32 1.013 . . . . 0.0 110.408 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.4 m -56.28 -50.59 70.93 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 175.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.9 mt -55.1 -35.14 64.29 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.279 0.987 . . . . 0.0 111.734 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -67.65 -39.75 84.55 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 124.163 0.985 . . . . 0.0 110.769 173.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 25.8 mt -68.7 -31.95 71.4 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 122.779 0.431 . . . . 0.0 111.088 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.7 mt -71.31 -42.86 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 120.103 1.32 . . . . 0.0 111.534 172.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.7 -41.43 75.41 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 124.39 1.056 . . . . 0.0 112.4 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.38 5.92 48.86 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.272 1.029 . . . . 0.0 111.419 177.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 t0 42.4 44.77 3.56 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.524 1.53 . . . . 0.0 111.685 -178.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.29 -166.78 29.74 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 112.834 -1.985 . . . . 0.0 115.265 -174.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -74.87 139.74 63.4 Favored 'Cis proline' 0 N--CA 1.481 0.758 0 O-C-N 124.275 1.671 . . . . 0.0 111.342 -2.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -90.94 139.06 25.86 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 113.244 -1.798 . . . . 0.0 111.534 -176.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -75.73 -63.13 0.03 OUTLIER 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.975 2.45 . . . . 0.0 111.474 -177.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -61.85 157.79 17.45 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.141 -0.482 . . . . 0.0 112.087 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.6 t -81.17 4.83 18.79 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 122.941 1.353 . . . . 0.0 112.101 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.58 ' NE2' ' HG1' ' A' ' 56' ' ' THR . 7.3 mt-30 -104.86 86.56 2.48 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.232 1.015 . . . . 0.0 111.484 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 177.96 140.31 0.09 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 110.712 -2.949 . . . . 0.0 113.715 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.71 3.22 66.51 Favored Glycine 0 N--CA 1.484 1.883 0 CA-C-N 113.017 -1.902 . . . . 0.0 112.263 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.8 m -96.91 144.78 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.342 1.057 . . . . 0.0 110.257 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.2 t -79.63 155.69 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 O-C-N 126.089 2.118 . . . . 0.0 108.865 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -137.71 86.32 2.17 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.645 -1.616 . . . . 0.0 108.618 174.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -72.03 51.76 0.23 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.203 -1.56 . . . . 0.0 112.414 178.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.679 ' CB ' ' HG1' ' A' ' 46' ' ' THR . 26.6 t30 28.83 53.61 0.08 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.682 1.193 . . . . 0.0 111.778 -172.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -20.69 18.7 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 113.243 -1.799 . . . . 0.0 112.285 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.87 -4.75 58.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 113.443 -1.708 . . . . 0.0 114.832 174.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.2 t 44.05 47.11 7.29 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 123.7 1.715 . . . . 0.0 112.688 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.0 t -124.11 -6.96 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 113.4 -1.727 . . . . 0.0 111.199 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 mp -110.23 155.85 41.17 Favored Pre-proline 0 N--CA 1.475 0.789 0 O-C-N 121.41 -0.806 . . . . 0.0 112.994 176.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.38 68.62 7.93 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.021 1.814 . . . . 0.0 109.749 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.679 ' HG1' ' CB ' ' A' ' 39' ' ' ASN . 6.8 m -88.97 -163.43 0.99 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 112.947 -1.933 . . . . 0.0 107.131 178.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.488 ' H ' ' CG2' ' A' ' 46' ' ' THR . 2.0 tt0 173.53 -48.48 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.977 1.711 . . . . 0.0 109.896 -176.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.5 p -109.72 162.82 14.08 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.293 -175.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -93.85 127.18 39.46 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 112.956 -1.929 . . . . 0.0 110.976 -177.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.99 8.23 82.62 Favored Glycine 0 N--CA 1.479 1.532 0 CA-C-N 113.327 -1.76 . . . . 0.0 112.807 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.61 -1.64 22.51 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.794 0.838 . . . . 0.0 112.509 175.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -136.63 171.23 14.81 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.029 1.332 . . . . 0.0 110.094 -177.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -161.01 163.71 31.48 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 113.257 -1.792 . . . . 0.0 110.382 -177.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -120.03 139.43 52.54 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.096 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -153.01 59.33 0.79 Allowed 'General case' 0 N--CA 1.471 0.603 0 O-C-N 126.187 2.179 . . . . 0.0 110.741 -174.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.58 ' HG1' ' NE2' ' A' ' 32' ' ' GLN . 58.5 m -36.69 116.14 0.41 Allowed 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 122.957 1.36 . . . . 0.0 112.519 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.9 p -81.65 110.82 17.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 111.021 -2.809 . . . . 0.0 109.443 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -38.64 147.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 113.722 -1.581 . . . . 0.0 111.296 171.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.702 ' HG1' ' CD ' ' A' ' 68' ' ' ARG . 6.1 m -136.5 141.62 36.3 Favored Pre-proline 0 N--CA 1.468 0.453 0 O-C-N 125.772 1.92 . . . . 0.0 112.901 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.53 143.71 27.74 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 121.619 1.546 . . . . 0.0 109.963 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.82 29.32 54.59 Favored Glycine 0 CA--C 1.544 1.882 0 CA-C-N 113.867 -1.515 . . . . 0.0 112.033 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.87 89.89 4.75 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -43.33 -30.61 0.54 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 113.324 -1.762 . . . . 0.0 113.152 177.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.0 p -128.88 -170.78 2.33 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.889 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 -47.45 -27.32 1.66 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 174.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.11 144.96 0.12 Allowed Glycine 0 N--CA 1.464 0.522 0 N-CA-C 106.676 -2.57 . . . . 0.0 106.676 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.3 p -42.72 -29.05 0.28 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.247 -1.477 . . . . 0.0 114.673 173.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.702 ' CD ' ' HG1' ' A' ' 59' ' ' THR . 1.0 OUTLIER -45.17 130.0 7.84 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.763 1.625 . . . . 0.0 111.574 170.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.81 136.49 4.32 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 111.864 -2.426 . . . . 0.0 109.339 -176.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.4 mt -111.99 142.7 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 125.933 2.021 . . . . 0.0 108.063 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 25.5 mm -131.1 128.78 62.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 111.703 -2.499 . . . . 0.0 108.019 178.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.5 p -104.86 163.87 12.2 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 122.238 -0.289 . . . . 0.0 111.33 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -110.5 -178.54 20.7 Favored Glycine 0 CA--C 1.537 1.41 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.58 -15.22 58.8 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 121.646 0.736 . . . . 0.0 111.937 176.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.23 129.78 55.66 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.0 m -54.54 145.88 17.67 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 114.122 -1.399 . . . . 0.0 107.611 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 81.8 33.34 0.1 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 126.705 2.002 . . . . 0.0 110.577 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -135.28 54.55 1.92 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 123.498 1.618 . . . . 0.0 112.407 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.24 80.96 2.16 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 113.479 -1.692 . . . . 0.0 108.837 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -51.18 178.99 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 125.455 1.502 . . . . 0.0 110.401 173.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -167.03 128.03 1.58 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.595 -1.639 . . . . 0.0 110.441 -175.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.64 -70.07 0.7 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 112.588 -2.096 . . . . 0.0 112.0 175.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.22 -5.69 25.81 Favored Glycine 0 CA--C 1.542 1.769 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.692 -175.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -125.49 17.05 8.23 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.264 1.425 . . . . 0.0 113.7 176.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 63.25 88.07 0.1 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.393 2.277 . . . . 0.0 111.496 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 49.57 26.36 1.72 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.053 -1.43 . . . . 0.0 113.997 -176.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.77 -22.08 17.74 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 120.76 -1.213 . . . . 0.0 111.731 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 26.5 p -157.17 173.71 16.58 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.178 1.391 . . . . 0.0 108.494 -177.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -155.52 118.63 4.34 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 m -135.06 116.5 14.67 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 66.1 mt -47.81 164.93 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.775 0.83 . . . . 0.0 111.424 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.62 107.41 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 121.207 -0.933 . . . . 0.0 109.304 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.16 89.04 3.63 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.035 -1.439 . . . . 0.0 109.088 175.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -79.22 5.71 11.55 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 113.602 -1.635 . . . . 0.0 111.868 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.0 t -121.75 -0.98 9.53 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 126.036 1.734 . . . . 0.0 112.581 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 42.7 t . . . . . 0 C--O 1.256 1.424 0 CA-C-O 116.268 -1.825 . . . . 0.0 112.888 178.981 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 p30 . . . . . 0 N--CA 1.473 0.701 0 CA-C-O 121.88 0.847 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.9 t -51.45 128.9 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.358 175.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 m -75.25 5.21 5.8 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 177.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.37 170.56 12.73 Favored Glycine 0 CA--C 1.536 1.365 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -86.99 172.76 9.76 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.069 -1.065 . . . . 0.0 109.103 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.1 t -138.82 106.71 3.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 122.978 1.37 . . . . 0.0 107.869 -175.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.3 m -49.35 126.06 12.31 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 112.62 -2.082 . . . . 0.0 109.902 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.4 tp -57.06 -34.18 67.99 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 118.938 -0.553 . . . . 0.0 111.353 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.7 t -62.21 -30.23 70.94 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.624 171.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.17 -27.81 53.86 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.64 0.776 . . . . 0.0 112.349 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.3 mt -75.4 160.8 78.92 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 174.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.65 168.32 20.32 Favored 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 122.715 2.276 . . . . 0.0 112.201 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.09 -15.27 39.44 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.416 2.077 . . . . 0.0 113.087 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -92.89 2.11 56.95 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.273 1.029 . . . . 0.0 111.843 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.95 -50.0 13.04 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.214 1.006 . . . . 0.0 112.169 177.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -58.49 -22.2 54.25 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.217 174.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -51.26 -59.73 3.89 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.128 0.971 . . . . 0.0 110.306 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.9 m -64.14 -44.66 91.49 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.523 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.97 -33.48 62.43 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 175.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -73.9 -38.63 64.3 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.995 174.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.1 mt -69.12 -33.78 74.0 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 175.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.9 mt -68.75 -41.91 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 123.365 0.666 . . . . 0.0 111.268 172.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.89 -43.76 64.87 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.468 1.105 . . . . 0.0 112.436 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.72 -10.1 59.65 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.058 1.343 . . . . 0.0 111.793 177.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.74 43.26 25.53 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 122.714 1.245 . . . . 0.0 110.718 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.67 -166.92 43.83 Favored Glycine 0 CA--C 1.541 1.676 0 CA-C-N 113.247 -1.797 . . . . 0.0 115.044 -175.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.51 140.5 67.63 Favored 'Cis proline' 0 CA--C 1.537 0.629 0 O-C-N 124.558 1.82 . . . . 0.0 111.058 -1.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -90.95 136.55 27.43 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 112.996 -1.911 . . . . 0.0 111.185 -176.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.07 -62.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.188 2.592 . . . . 0.0 111.701 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -59.84 155.07 17.0 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.82 176.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.76 2.29 20.25 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 122.812 1.291 . . . . 0.0 112.313 175.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.4 78.53 2.7 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.622 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -178.48 142.37 0.24 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 112.069 -2.332 . . . . 0.0 113.871 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.14 30.94 12.7 Favored Glycine 0 CA--C 1.537 1.467 0 O-C-N 125.212 1.57 . . . . 0.0 111.645 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.2 m -124.26 146.03 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 113.982 -1.109 . . . . 0.0 109.591 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.7 t -84.06 156.32 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 125.743 1.902 . . . . 0.0 109.768 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -137.66 87.89 2.29 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 113.968 -1.469 . . . . 0.0 108.791 174.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -69.91 53.45 0.12 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.808 -1.183 . . . . 0.0 112.648 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 50.7 t30 29.21 51.19 0.06 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.418 1.487 . . . . 0.0 111.081 -173.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.15 -20.75 43.09 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.522 -175.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -84.31 -8.06 59.13 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 113.087 -1.869 . . . . 0.0 114.668 172.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.9 t 43.45 42.58 3.94 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 123.917 1.818 . . . . 0.0 112.135 -177.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 86.3 t -112.39 -12.52 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 113.322 -1.763 . . . . 0.0 109.728 -178.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.72 151.46 39.12 Favored Pre-proline 0 C--N 1.317 -0.814 0 O-C-N 120.979 -1.075 . . . . 0.0 108.436 -175.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.82 51.25 3.0 Favored 'Trans proline' 0 N--CA 1.482 0.811 0 C-N-CA 122.948 2.432 . . . . 0.0 112.567 -177.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.4 m -156.23 -142.86 0.11 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 164.94 -35.96 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 126.732 2.013 . . . . 0.0 110.959 -173.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.3 p -42.03 154.74 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 123.026 1.393 . . . . 0.0 113.077 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -99.76 132.04 45.36 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 113.471 -1.695 . . . . 0.0 109.847 -175.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.14 -8.63 44.36 Favored Glycine 0 N--CA 1.482 1.758 0 O-C-N 125.098 1.499 . . . . 0.0 113.301 177.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -75.77 0.45 17.9 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.267 1.027 . . . . 0.0 112.508 177.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -136.95 165.38 26.13 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.47 1.108 . . . . 0.0 109.103 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -159.66 158.86 32.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 112.647 -2.069 . . . . 0.0 111.463 -178.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -113.95 143.01 45.42 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.592 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -159.97 68.52 0.39 Allowed 'General case' 0 N--CA 1.475 0.796 0 O-C-N 126.244 2.215 . . . . 0.0 109.466 -174.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -36.86 141.51 0.12 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 176.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -97.77 115.45 37.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 112.9 -1.955 . . . . 0.0 109.385 175.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -43.17 151.31 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.662 170.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -150.23 140.84 14.32 Favored Pre-proline 0 N--CA 1.476 0.849 0 O-C-N 125.459 1.725 . . . . 0.0 111.733 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -73.72 147.14 39.47 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 121.622 1.548 . . . . 0.0 109.735 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 52.48 34.96 43.32 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.023 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.65 92.67 6.33 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -42.0 -31.39 0.34 Allowed 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 113.641 -1.618 . . . . 0.0 113.323 176.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.5 p -123.36 -164.05 1.18 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.968 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -59.88 -14.0 13.39 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 173.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.62 146.01 3.72 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.214 -1.955 . . . . 0.0 108.214 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.0 p -69.93 -5.51 26.62 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 111.772 -2.214 . . . . 0.0 113.105 176.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.02 85.27 5.63 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 123.939 1.828 . . . . 0.0 110.384 178.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.84 142.58 34.14 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 112.581 -2.1 . . . . 0.0 109.342 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.6 mt -117.76 132.62 67.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 125.601 1.813 . . . . 0.0 109.404 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.5 mm -125.82 106.67 16.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 O-C-N 125.27 1.606 . . . . 0.0 109.048 -176.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.39 165.99 19.81 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.301 -0.874 . . . . 0.0 111.194 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -120.73 171.44 14.74 Favored Glycine 0 N--CA 1.469 0.881 0 CA-C-N 113.424 -1.717 . . . . 0.0 109.799 177.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.45 -14.54 61.17 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.756 0.789 . . . . 0.0 112.251 174.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.18 129.76 53.5 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 122.361 1.077 . . . . 0.0 108.233 174.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -61.87 142.55 57.3 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 113.833 -1.531 . . . . 0.0 107.575 175.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 77.78 29.36 0.51 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 126.618 1.967 . . . . 0.0 111.279 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -126.98 56.04 1.53 Allowed 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 123.083 1.421 . . . . 0.0 111.92 177.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.63 119.59 38.33 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 113.267 -1.788 . . . . 0.0 109.287 178.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -92.71 139.41 30.58 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.14 1.376 . . . . 0.0 108.943 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -118.43 121.48 40.41 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.665 -175.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.88 -64.53 1.17 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 113.317 -1.765 . . . . 0.0 110.761 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.37 -6.04 6.28 Favored Glycine 0 CA--C 1.545 1.943 0 CA-C-N 114.886 -1.052 . . . . 0.0 113.104 -173.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -126.58 6.19 6.85 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 66.59 82.57 0.18 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 128.256 2.622 . . . . 0.0 110.374 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 57.28 17.69 3.82 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 113.428 -1.715 . . . . 0.0 114.247 -174.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -99.84 -3.54 32.37 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.177 -0.952 . . . . 0.0 112.595 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.2 p -167.75 168.85 12.15 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.016 1.727 . . . . 0.0 109.161 -176.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -160.41 109.83 1.73 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.068 0.947 . . . . 0.0 108.972 -173.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.8 m -128.23 108.4 10.58 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.991 -176.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 21.7 mt -42.73 161.14 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.4 mp -107.3 129.45 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 O-C-N 120.671 -1.268 . . . . 0.0 108.792 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.47 94.18 5.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.376 178.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.92 -8.46 44.56 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 124.94 1.4 . . . . 0.0 112.524 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 t -93.18 -41.9 9.66 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 127.141 2.176 . . . . 0.0 113.1 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 45.2 t . . . . . 0 C--O 1.25 1.105 0 CA-C-O 117.695 -1.145 . . . . 0.0 110.931 179.402 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.3 p30 . . . . . 0 N--CA 1.476 0.847 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 t -64.22 135.9 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.5 m -77.34 7.97 4.68 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 177.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 119.42 -172.49 14.71 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.27 1.414 . . . . 0.0 109.735 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -90.22 169.51 11.07 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 122.452 1.12 . . . . 0.0 109.735 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 p -143.12 112.0 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 114.222 -1.354 . . . . 0.0 108.285 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 73.7 m -50.22 133.42 23.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 112.427 -2.169 . . . . 0.0 109.592 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.51 -35.92 66.13 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 119.156 -0.449 . . . . 0.0 111.933 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.1 t -69.0 -15.48 63.49 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.246 174.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.65 -33.27 35.76 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.396 0.678 . . . . 0.0 112.182 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.2 mt -83.64 176.41 3.81 Favored Pre-proline 0 CA--C 1.558 1.272 0 C-N-CA 125.72 1.608 . . . . 0.0 111.095 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.51 167.12 17.66 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.285 1.99 . . . . 0.0 113.417 174.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -64.77 -21.4 64.76 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 C-N-CA 122.515 2.143 . . . . 0.0 113.064 174.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -82.23 -19.25 40.07 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 175.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.11 -25.5 8.97 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 173.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -79.48 -33.98 41.79 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 172.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -49.83 -53.78 23.37 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.222 1.009 . . . . 0.0 110.059 -177.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.5 m -53.99 -52.46 60.69 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.6 mt -54.67 -37.61 65.97 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 124.624 1.202 . . . . 0.0 111.746 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -64.69 -38.01 89.53 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.629 0.772 . . . . 0.0 111.724 173.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.8 mt -73.16 -32.87 65.14 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 118.518 -0.754 . . . . 0.0 111.312 176.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.1 mp -66.39 -39.35 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-N 120.37 1.441 . . . . 0.0 111.61 169.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.78 -48.42 46.69 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.198 0.999 . . . . 0.0 112.316 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 m -86.11 6.39 29.35 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.916 1.286 . . . . 0.0 113.547 175.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 43.74 36.0 1.18 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.333 1.453 . . . . 0.0 112.532 -174.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.96 -168.48 18.12 Favored Glycine 0 CA--C 1.542 1.773 0 CA-C-N 113.296 -1.774 . . . . 0.0 115.504 -175.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -75.0 138.29 55.21 Favored 'Cis proline' 0 N--CA 1.488 1.203 0 O-C-N 123.868 1.457 . . . . 0.0 111.412 -3.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -85.83 149.79 51.67 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-N 113.02 -1.9 . . . . 0.0 112.461 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.97 -69.77 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 123.127 2.551 . . . . 0.0 111.717 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -74.45 168.84 18.92 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.56 0.744 . . . . 0.0 110.355 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.3 m -72.6 -3.87 27.41 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 122.138 0.971 . . . . 0.0 113.603 174.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -83.28 82.48 8.25 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.751 -1.113 . . . . 0.0 112.083 -178.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 179.0 145.64 0.15 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 110.393 -3.094 . . . . 0.0 116.117 -176.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.18 33.64 39.64 Favored Glycine 0 N--CA 1.473 1.135 0 CA-C-N 112.191 -2.277 . . . . 0.0 110.951 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.1 m -129.88 144.52 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 113.574 -1.313 . . . . 0.0 109.917 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.1 t -83.87 151.18 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 O-C-N 126.66 2.475 . . . . 0.0 109.76 176.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -128.92 95.7 4.16 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.004 173.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -74.13 52.03 0.44 Allowed 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.158 -0.964 . . . . 0.0 111.622 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.739 ' CB ' ' HG1' ' A' ' 46' ' ' THR . 13.0 p-10 26.78 55.56 0.06 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.73 2.412 . . . . 0.0 111.684 -174.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.17 -22.59 41.51 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.26 -173.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -75.84 -15.01 60.29 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 172.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.2 t 48.16 35.61 5.58 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 123.989 1.852 . . . . 0.0 112.336 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.3 t -110.84 -14.47 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-O 123.368 1.556 . . . . 0.0 110.555 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -100.44 146.1 31.43 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-O 117.098 -1.43 . . . . 0.0 108.274 -174.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.431 ' CG ' ' HH ' ' A' ' 80' ' ' TYR . 92.4 Cg_endo -74.48 60.09 4.92 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.588 3.525 . . . . 0.0 112.121 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.739 ' HG1' ' CB ' ' A' ' 39' ' ' ASN . 2.2 m -83.56 -171.5 3.62 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 112.244 -2.253 . . . . 0.0 107.626 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.442 ' H ' ' CG2' ' A' ' 46' ' ' THR . 36.1 tt0 176.99 -40.23 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 113.886 -1.506 . . . . 0.0 110.63 -173.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.9 p -118.94 161.95 19.33 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 122.849 1.309 . . . . 0.0 111.715 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -85.02 144.01 28.55 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 112.525 -2.125 . . . . 0.0 110.056 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.04 11.88 52.96 Favored Glycine 0 N--CA 1.483 1.773 0 CA-C-N 114.937 -1.028 . . . . 0.0 112.95 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.98 13.11 8.04 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.448 1.099 . . . . 0.0 112.54 -178.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -151.39 148.48 28.17 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 125.33 1.452 . . . . 0.0 109.732 -173.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -145.11 159.91 42.24 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 125.417 1.698 . . . . 0.0 111.31 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -117.24 140.88 48.99 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.391 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -157.96 67.96 0.49 Allowed 'General case' 0 C--O 1.239 0.517 0 O-C-N 125.696 1.872 . . . . 0.0 110.982 -173.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.8 m -41.95 119.16 1.26 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 123.563 1.649 . . . . 0.0 112.884 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -78.83 116.28 22.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 110.192 -3.185 . . . . 0.0 108.673 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.4 mt -40.49 148.26 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-O 122.655 1.216 . . . . 0.0 108.642 174.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.52 ' HG1' ' CB ' ' A' ' 68' ' ' ARG . 20.9 m -133.1 138.93 32.82 Favored Pre-proline 0 C--O 1.24 0.558 0 CA-C-N 112.16 -2.291 . . . . 0.0 112.45 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.83 143.06 49.3 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.033 1.822 . . . . 0.0 109.943 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.47 30.19 40.94 Favored Glycine 0 CA--C 1.54 1.645 0 CA-C-N 114.313 -1.312 . . . . 0.0 113.113 -176.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.77 94.5 6.37 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -40.63 -35.16 0.44 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.336 176.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.8 p -127.17 -155.59 0.7 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.075 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.3 mtm180 -53.11 -23.87 9.03 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 170.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.76 156.5 0.33 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 -176.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 81.4 p -47.9 -29.35 3.25 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 112.901 -1.65 . . . . 0.0 112.518 173.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.52 ' CB ' ' HG1' ' A' ' 59' ' ' THR . 0.0 OUTLIER -47.15 139.28 6.13 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 122.199 0.999 . . . . 0.0 112.724 173.629 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.0 139.41 2.88 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 112.1 -2.318 . . . . 0.0 109.76 -176.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.8 mt -115.99 144.99 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 112.596 -2.093 . . . . 0.0 108.66 175.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.6 mm -131.49 121.36 48.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 O-C-N 126.319 2.262 . . . . 0.0 107.326 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.0 p -104.06 163.34 12.45 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.271 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -108.6 177.55 20.67 Favored Glycine 0 N--CA 1.477 1.406 0 O-C-N 125.211 1.569 . . . . 0.0 110.562 178.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.89 -14.91 60.71 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 122.124 0.964 . . . . 0.0 113.055 175.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -112.77 129.94 56.25 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 175.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.9 m -53.67 149.59 8.13 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 114.27 -1.332 . . . . 0.0 108.041 174.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 81.03 32.84 0.13 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 126.53 1.932 . . . . 0.0 111.425 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -139.17 51.73 1.78 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 123.764 1.745 . . . . 0.0 112.716 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.9 83.91 2.18 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 113.552 -1.658 . . . . 0.0 109.1 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.431 ' HH ' ' CG ' ' A' ' 45' ' ' PRO . 31.4 m-85 -56.02 173.67 0.15 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.912 1.685 . . . . 0.0 110.673 174.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -158.41 126.92 5.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.426 -176.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . 0.275 0.1 OUTLIER -91.73 -69.25 0.75 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 112.657 -2.065 . . . . 0.0 112.643 173.391 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.36 17.86 62.38 Favored Glycine 0 CA--C 1.54 1.617 0 CA-C-N 115.124 -0.944 . . . . 0.0 113.219 -173.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -148.0 26.19 1.0 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.732 1.213 . . . . 0.0 112.417 175.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 56.8 83.55 0.1 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.586 1.555 . . . . 0.0 110.968 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 47.97 51.17 14.85 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 113.333 -1.758 . . . . 0.0 114.681 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -120.84 -35.88 3.26 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.175 -1.375 . . . . 0.0 113.948 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 16.3 p -136.77 166.6 23.22 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.653 1.181 . . . . 0.0 108.095 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -156.9 111.83 2.8 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -174.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.2 m -133.76 115.34 14.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.292 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.5 mt -46.31 160.77 0.06 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.721 0.808 . . . . 0.0 111.989 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.52 127.37 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 120.667 -1.27 . . . . 0.0 109.433 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.45 95.22 5.67 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 113.567 -1.652 . . . . 0.0 108.985 175.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -58.95 -42.35 89.6 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 124.502 1.126 . . . . 0.0 111.55 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.2 t -50.91 -31.95 19.13 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.692 1.597 . . . . 0.0 113.446 171.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 19.1 t . . . . . 0 CA--C 1.554 1.126 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.795 177.35 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.436 ' H1 ' ' CG1' ' A' ' 43' ' ' VAL . 2.1 p30 . . . . . 0 N--CA 1.474 0.749 0 CA-C-O 122.04 0.924 . . . . 0.0 112.147 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t -68.39 111.14 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.1 p -78.38 14.21 1.3 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 122.396 1.094 . . . . 0.0 113.487 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 120.83 -163.31 14.39 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.439 1.495 . . . . 0.0 109.719 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -100.98 171.06 7.87 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 112.63 -1.785 . . . . 0.0 109.741 -177.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.27 107.22 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.627 -1.169 . . . . 0.0 107.947 -175.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 86.0 m -45.76 128.44 8.68 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 111.986 -2.37 . . . . 0.0 109.126 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.5 tp -53.16 -36.95 61.42 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.778 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -65.03 -19.72 66.14 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.984 172.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.09 -31.88 44.47 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.197 0.522 . . . . 0.0 111.731 175.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.4 mt -83.5 173.55 7.27 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 125.26 1.424 . . . . 0.0 110.221 179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.3 169.38 19.73 Favored 'Trans proline' 0 CA--C 1.555 1.534 0 C-N-CA 122.008 1.805 . . . . 0.0 113.817 176.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.87 -15.99 40.91 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.745 2.297 . . . . 0.0 114.257 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.8 pm0 -87.05 2.8 48.47 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.061 1.344 . . . . 0.0 113.306 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.48 -55.3 5.66 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.155 0.982 . . . . 0.0 111.585 176.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -53.8 -29.11 38.97 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 114.827 -1.079 . . . . 0.0 112.363 174.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -51.12 -58.04 7.15 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 125.129 1.518 . . . . 0.0 110.514 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.0 m -55.26 -51.1 67.75 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.5 mt -56.7 -35.02 68.0 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 123.782 0.676 . . . . 0.0 112.678 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -66.95 -36.55 82.46 Favored 'General case' 0 C--O 1.217 -0.634 0 C-N-CA 124.478 1.111 . . . . 0.0 110.386 174.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.2 mt -72.84 -32.67 65.63 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 119.025 -0.512 . . . . 0.0 111.137 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.43 -40.34 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 120.325 1.42 . . . . 0.0 111.881 171.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.28 -42.16 65.87 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 124.602 1.189 . . . . 0.0 112.474 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.32 7.47 44.28 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.505 178.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 42.99 37.32 1.08 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 123.158 1.456 . . . . 0.0 112.539 -177.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.52 -167.26 17.57 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 112.959 -1.928 . . . . 0.0 116.036 -173.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -74.44 139.44 61.65 Favored 'Cis proline' 0 N--CA 1.488 1.154 0 O-C-N 123.917 1.483 . . . . 0.0 111.639 -2.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -91.22 135.23 28.55 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.583 -177.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -76.45 -58.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.634 2.223 . . . . 0.0 111.936 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -66.13 159.56 25.92 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.102 0.561 . . . . 0.0 112.063 175.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.1 m -77.14 1.31 18.64 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 173.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.58 84.95 4.05 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 122.055 0.931 . . . . 0.0 111.489 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 178.2 147.72 0.16 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 110.665 -2.97 . . . . 0.0 115.113 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.94 30.81 37.29 Favored Glycine 0 N--CA 1.478 1.476 0 CA-C-N 112.373 -2.194 . . . . 0.0 110.997 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.1 146.76 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.468 1.107 . . . . 0.0 109.797 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.2 t -83.59 153.93 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 126.49 2.369 . . . . 0.0 110.299 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -129.39 94.31 3.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 113.557 -1.656 . . . . 0.0 109.44 175.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.1 50.14 0.27 Allowed 'General case' 0 N--CA 1.484 1.229 0 O-C-N 120.923 -1.111 . . . . 0.0 112.938 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.8 t30 22.86 60.51 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.526 1.931 . . . . 0.0 111.611 -173.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -25.5 62.76 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 113.477 -1.692 . . . . 0.0 111.389 -175.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -75.46 -7.93 55.4 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.023 -1.444 . . . . 0.0 114.633 174.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.7 t 44.18 42.86 5.35 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 124.387 2.041 . . . . 0.0 112.188 -177.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.436 ' CG1' ' H1 ' ' A' ' 1' ' ' ASP . 65.8 t -110.76 -21.97 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 113.543 -1.662 . . . . 0.0 110.448 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.71 142.42 24.58 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.815 -173.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.36 68.23 6.86 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 121.288 1.326 . . . . 0.0 110.801 -177.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.483 ' CG2' ' H ' ' A' ' 47' ' ' GLN . 4.4 m -73.49 -166.11 0.32 Allowed 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 113.224 -1.807 . . . . 0.0 107.825 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.483 ' H ' ' CG2' ' A' ' 46' ' ' THR . 48.1 tt0 -179.84 -45.74 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.623 1.569 . . . . 0.0 110.642 -178.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.9 p -117.89 158.48 24.78 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.017 -1.447 . . . . 0.0 111.339 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -85.17 136.84 33.36 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 112.967 -1.924 . . . . 0.0 110.46 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.63 6.7 88.3 Favored Glycine 0 N--CA 1.478 1.474 0 CA-C-N 114.469 -1.241 . . . . 0.0 113.365 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -79.81 7.52 8.53 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.419 1.087 . . . . 0.0 112.824 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -143.91 144.26 31.64 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -174.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -142.32 157.01 45.28 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 126.297 2.248 . . . . 0.0 110.29 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -113.48 143.71 44.05 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.863 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -159.26 70.47 0.48 Allowed 'General case' 0 N--CA 1.472 0.645 0 O-C-N 125.378 1.674 . . . . 0.0 111.043 -175.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -39.49 126.98 1.87 Allowed 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 122.332 1.063 . . . . 0.0 112.772 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.12 108.18 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 111.632 -2.531 . . . . 0.0 108.468 176.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -39.37 153.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 CA-C-N 115.307 -0.86 . . . . 0.0 108.878 170.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.5 m -156.35 140.02 11.32 Favored Pre-proline 0 N--CA 1.48 1.052 0 O-C-N 125.658 1.849 . . . . 0.0 110.78 177.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.62 152.16 53.32 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.944 2.429 . . . . 0.0 110.18 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 52.41 26.71 23.24 Favored Glycine 0 N--CA 1.481 1.69 0 CA-C-N 113.993 -1.458 . . . . 0.0 112.144 -175.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.43 89.72 7.98 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -40.42 -31.83 0.16 Allowed 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 113.72 -1.582 . . . . 0.0 112.764 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.4 p -134.23 -145.11 0.23 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.618 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 60.3 mtm180 -72.81 -18.67 61.44 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 173.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.08 142.61 0.02 OUTLIER Glycine 0 CA--C 1.531 1.053 0 N-CA-C 108.929 -1.669 . . . . 0.0 108.929 -175.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.2 p -41.85 -32.43 0.41 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 113.887 -1.157 . . . . 0.0 114.057 174.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -44.58 120.02 2.1 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 122.723 1.249 . . . . 0.0 112.461 170.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -149.26 128.46 12.84 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 112.337 -2.21 . . . . 0.0 109.048 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.2 mt -103.79 143.47 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 113.646 -1.615 . . . . 0.0 108.965 173.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.8 mm -129.84 102.55 7.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 112.777 -2.011 . . . . 0.0 108.35 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.9 p -94.71 165.19 12.62 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.655 0.741 . . . . 0.0 110.371 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -118.88 167.54 13.14 Favored Glycine 0 N--CA 1.473 1.162 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.231 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -61.61 -19.05 61.81 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.579 0.704 . . . . 0.0 111.886 174.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.78 129.56 49.47 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.013 175.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.2 m -60.04 144.17 50.1 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 114.114 -1.403 . . . . 0.0 107.311 175.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 80.46 33.19 0.16 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 126.82 2.048 . . . . 0.0 111.696 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -134.55 52.65 2.04 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 113.51 -1.677 . . . . 0.0 112.994 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.95 94.29 4.99 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 113.648 -1.614 . . . . 0.0 110.062 -178.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -82.74 129.07 34.91 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 125.017 1.327 . . . . 0.0 109.642 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -113.66 136.61 52.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.103 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.43 -67.27 0.86 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 112.196 -2.275 . . . . 0.0 112.001 176.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.88 -0.95 26.37 Favored Glycine 0 CA--C 1.549 2.21 0 CA-C-N 114.031 -1.441 . . . . 0.0 113.496 -174.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -127.98 17.17 6.74 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 63.13 86.25 0.12 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.666 1.986 . . . . 0.0 111.12 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 6.1 m-30 49.48 30.56 3.48 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 113.944 -1.48 . . . . 0.0 114.776 -176.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -99.74 -18.78 17.07 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.733 -0.787 . . . . 0.0 112.561 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 25.2 p -158.93 171.06 20.73 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.623 1.569 . . . . 0.0 108.868 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -157.15 116.54 3.38 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.157 0.983 . . . . 0.0 108.818 -174.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.61 109.91 7.86 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 113.583 -1.644 . . . . 0.0 106.93 -178.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 52.2 mt -41.75 158.81 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.653 177.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.92 121.86 65.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 120.789 -1.194 . . . . 0.0 109.218 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.27 96.76 7.67 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 113.226 -1.806 . . . . 0.0 108.78 176.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -60.86 -39.2 88.26 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 124.879 1.362 . . . . 0.0 111.803 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.7 t -52.54 -32.01 38.56 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.068 -1.423 . . . . 0.0 113.533 172.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 19.9 t . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.407 176.743 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.607 ' H1 ' ' CG1' ' A' ' 43' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.471 0.625 0 CA-C-O 122.031 0.919 . . . . 0.0 111.91 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 t -74.22 116.16 16.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 113.745 -1.57 . . . . 0.0 107.327 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.81 7.9 5.26 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.682 1.239 . . . . 0.0 112.196 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.22 -166.73 21.48 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.001 1.286 . . . . 0.0 110.471 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 m -101.64 172.91 6.67 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.231 -1.484 . . . . 0.0 108.942 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.27 107.69 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 -175.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 88.5 m -47.1 132.48 12.2 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 112.92 -1.946 . . . . 0.0 109.586 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -33.61 64.0 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.962 -178.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.0 t -64.82 -28.86 69.84 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.634 173.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.46 -31.49 62.26 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.605 0.762 . . . . 0.0 111.194 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.4 mt -74.63 162.26 74.42 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 175.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.65 167.51 22.62 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.567 2.178 . . . . 0.0 111.948 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.86 -16.14 32.92 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.837 2.358 . . . . 0.0 112.632 177.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -93.71 -2.57 53.65 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.324 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.94 -39.43 18.16 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.757 175.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -60.82 -28.75 69.03 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.195 175.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -54.24 -51.94 62.89 Favored 'General case' 0 C--O 1.213 -0.835 0 O-C-N 124.881 1.363 . . . . 0.0 110.146 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.587 ' HG1' ' CG1' ' A' ' 57' ' ' VAL . 28.2 m -64.06 -49.26 73.02 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.572 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 19.6 mt -53.52 -31.41 46.09 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.972 0.795 . . . . 0.0 112.529 175.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -71.93 -42.44 66.64 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.373 173.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.8 mt -67.79 -35.59 78.93 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.993 176.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.1 mt -65.64 -40.03 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 119.73 1.15 . . . . 0.0 110.806 172.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.75 -46.34 46.44 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 124.043 0.839 . . . . 0.0 111.9 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.78 -1.18 37.57 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.327 1.051 . . . . 0.0 111.413 176.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 49.48 39.25 16.28 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 122.555 1.169 . . . . 0.0 110.913 -178.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.57 -169.34 37.25 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-N 113.66 -1.609 . . . . 0.0 115.23 -174.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -75.15 140.73 68.78 Favored 'Cis proline' 0 CA--C 1.535 0.546 0 O-C-N 124.911 2.006 . . . . 0.0 111.51 -0.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -89.51 137.6 28.79 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 113.32 -1.764 . . . . 0.0 111.034 -176.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -74.29 -62.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.528 2.819 . . . . 0.0 111.296 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.18 155.57 6.52 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.964 0.79 . . . . 0.0 110.604 177.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.31 7.13 14.77 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 122.186 0.993 . . . . 0.0 111.592 175.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.441 HE22 ' CZ ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -106.31 82.56 1.76 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 122.081 0.943 . . . . 0.0 111.558 -179.329 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -179.22 146.03 0.28 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 112.616 -2.084 . . . . 0.0 112.972 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.39 36.1 10.04 Favored Glycine 0 N--CA 1.484 1.879 0 O-C-N 126.312 2.257 . . . . 0.0 110.756 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.9 m -135.58 151.03 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 114.388 -0.906 . . . . 0.0 109.216 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.3 t -86.86 157.46 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 125.619 1.825 . . . . 0.0 109.534 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -136.08 88.97 2.43 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 113.695 -1.593 . . . . 0.0 108.713 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -72.24 51.29 0.24 Allowed 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.313 -0.867 . . . . 0.0 111.683 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.2 t30 25.32 57.42 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.977 2.111 . . . . 0.0 110.667 -173.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -21.43 22.44 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 113.265 -1.789 . . . . 0.0 111.406 -177.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -83.71 -4.72 58.85 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 114.074 -1.421 . . . . 0.0 113.894 174.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.3 t 43.02 46.36 4.74 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 124.535 2.112 . . . . 0.0 112.623 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.607 ' CG1' ' H1 ' ' A' ' 1' ' ' ASP . 88.0 t -115.73 -23.82 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 113.989 -1.46 . . . . 0.0 109.687 -176.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.67 138.27 20.38 Favored Pre-proline 0 N--CA 1.471 0.598 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.98 -175.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.06 69.47 6.32 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 121.538 1.492 . . . . 0.0 110.065 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 42.4 p -66.5 -153.56 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 113.061 -1.881 . . . . 0.0 108.236 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 177.34 -43.38 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 122.204 1.002 . . . . 0.0 110.294 178.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.7 p -124.28 160.59 27.66 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 113.866 -1.515 . . . . 0.0 111.036 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -82.46 145.22 29.95 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 113.098 -1.864 . . . . 0.0 109.075 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.71 10.98 56.48 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.743 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.96 10.17 10.51 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.485 1.114 . . . . 0.0 112.274 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -144.0 143.52 31.25 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -175.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -144.07 155.69 44.07 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 126.395 2.309 . . . . 0.0 110.857 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -110.22 142.27 42.03 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.68 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -155.66 64.16 0.6 Allowed 'General case' 0 N--CA 1.467 0.388 0 O-C-N 125.796 1.935 . . . . 0.0 110.462 -176.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -41.44 136.32 1.79 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 122.322 1.058 . . . . 0.0 112.911 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.587 ' CG1' ' HG1' ' A' ' 18' ' ' THR . 9.7 m -95.55 117.43 39.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 112.18 -2.282 . . . . 0.0 108.082 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -42.86 149.02 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 O-C-N 125.527 1.767 . . . . 0.0 109.949 173.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.424 ' HG1' ' CG ' ' A' ' 68' ' ' ARG . 8.3 m -139.96 142.3 30.21 Favored Pre-proline 0 N--CA 1.48 1.052 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.414 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -76.01 145.49 28.16 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.066 1.844 . . . . 0.0 109.916 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.87 25.13 44.12 Favored Glycine 0 CA--C 1.542 1.767 0 CA-C-N 114.061 -1.427 . . . . 0.0 112.274 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.98 90.96 5.76 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -38.4 -33.87 0.11 Allowed 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.359 177.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.4 p -140.32 -148.77 0.26 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.143 -1.39 . . . . 0.0 109.077 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -69.71 -6.85 34.57 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 174.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.23 -129.15 13.37 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.212 1.387 . . . . 0.0 109.635 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.0 p -112.72 -34.13 5.9 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 112.26 -1.97 . . . . 0.0 113.384 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.424 ' CG ' ' HG1' ' A' ' 59' ' ' THR . 0.1 OUTLIER -41.33 133.29 2.47 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.277 -1.329 . . . . 0.0 111.581 174.645 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.441 ' CZ ' HE22 ' A' ' 32' ' ' GLN . 0.0 OUTLIER -167.44 141.54 3.66 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 112.5 -2.137 . . . . 0.0 110.869 -176.317 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.42 133.31 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 126.72 2.512 . . . . 0.0 109.165 176.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.3 mm -122.52 101.47 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 113.25 -1.796 . . . . 0.0 107.857 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.7 p -87.43 161.92 17.58 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.635 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -108.12 -176.51 22.12 Favored Glycine 0 N--CA 1.471 0.97 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.303 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.3 -11.45 59.94 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.404 175.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -122.05 131.55 54.04 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.9 m -51.12 149.24 3.86 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.624 176.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 83.59 33.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 125.505 1.753 . . . . 0.0 110.467 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -140.86 49.29 1.68 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.133 -1.394 . . . . 0.0 113.038 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.47 90.7 3.49 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.458 -178.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -75.28 131.93 40.67 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.144 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -114.02 128.5 56.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.941 -177.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -90.0 -67.97 0.81 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.122 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.81 2.95 19.34 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-N 113.897 -1.502 . . . . 0.0 113.077 -173.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -130.55 14.73 5.47 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.666 0.786 . . . . 0.0 112.118 175.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 64.1 85.83 0.13 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.071 1.748 . . . . 0.0 111.044 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 50.2 28.62 3.2 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 114.274 -1.33 . . . . 0.0 114.398 -177.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -105.77 -19.37 13.77 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.296 -1.32 . . . . 0.0 111.256 -175.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.7 p -153.59 169.01 24.29 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.327 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -158.45 113.16 2.56 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -173.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -132.35 105.05 7.06 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 113.968 -1.469 . . . . 0.0 107.328 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 23.0 mt -41.04 163.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.62 177.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.99 135.78 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 120.383 -1.448 . . . . 0.0 109.738 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -113.74 92.33 3.95 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 113.906 -1.497 . . . . 0.0 108.765 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.05 -37.11 85.9 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.236 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 t -54.61 -24.67 22.39 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 114.484 -1.235 . . . . 0.0 113.414 171.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 5.6 t . . . . . 0 C--O 1.261 1.7 0 CA-C-O 117.624 -1.179 . . . . 0.0 111.118 175.71 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.5 p30 . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.9 t -45.06 130.59 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.209 1.004 . . . . 0.0 108.671 177.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.17 8.1 4.35 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 124.886 1.366 . . . . 0.0 113.099 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 121.04 -162.56 14.73 Favored Glycine 0 N--CA 1.478 1.44 0 C-N-CA 125.499 1.523 . . . . 0.0 109.653 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 m -103.49 170.13 8.13 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 113.765 -1.217 . . . . 0.0 109.455 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 p -141.33 113.94 4.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -176.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.5 m -50.77 132.82 26.51 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 112.149 -2.296 . . . . 0.0 110.132 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -31.75 69.71 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.921 -178.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.0 t -64.63 -29.49 70.5 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.083 0.953 . . . . 0.0 113.224 173.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.38 -24.47 54.12 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.844 174.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.6 mt -83.4 160.58 59.15 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.42 166.17 22.52 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.546 2.164 . . . . 0.0 113.123 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -67.42 -35.43 23.5 Favored 'Trans proline' 0 N--CA 1.485 1.001 0 C-N-CA 122.572 2.182 . . . . 0.0 112.292 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.35 -8.77 57.81 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.512 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.61 -43.45 76.39 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.867 0.867 . . . . 0.0 112.013 172.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.13 -32.98 74.49 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.156 174.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -50.01 -49.12 51.8 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.019 0.928 . . . . 0.0 110.262 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 m -58.99 -50.52 73.78 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 174.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.0 mt -51.81 -32.79 32.97 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 175.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.01 -43.97 64.19 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.225 1.01 . . . . 0.0 111.858 172.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 68.4 mt -65.16 -34.32 78.1 Favored 'General case' 0 C--O 1.211 -0.946 0 C-N-CA 123.768 0.827 . . . . 0.0 112.092 176.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.6 mt -67.87 -42.52 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 120.567 -1.333 . . . . 0.0 111.55 171.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.76 -47.69 62.05 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 124.29 0.994 . . . . 0.0 112.682 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 m -84.87 5.93 26.84 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.63 1.172 . . . . 0.0 113.904 175.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 44.78 39.92 3.85 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.926 1.29 . . . . 0.0 112.025 -177.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.71 -164.28 14.57 Favored Glycine 0 CA--C 1.541 1.718 0 C-N-CA 125.572 1.558 . . . . 0.0 114.461 -174.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.21 135.66 41.29 Favored 'Cis proline' 0 N--CA 1.485 0.996 0 CA-C-O 122.927 1.136 . . . . 0.0 110.947 -2.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -85.0 153.41 60.05 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 111.509 -2.587 . . . . 0.0 111.879 -176.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.28 -59.13 0.07 OUTLIER 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.111 1.874 . . . . 0.0 113.409 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.02 -179.97 3.92 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.452 1.501 . . . . 0.0 110.547 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.0 m -68.0 -8.5 37.95 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 175.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -73.74 54.04 0.47 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 122.741 1.258 . . . . 0.0 113.238 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 172.67 127.39 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 111.81 -2.45 . . . . 0.0 113.432 -176.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.25 -14.61 20.93 Favored Glycine 0 N--CA 1.482 1.746 0 CA-C-N 113.698 -1.592 . . . . 0.0 112.535 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 m -90.79 150.39 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-O 121.896 0.855 . . . . 0.0 109.908 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.6 t -75.01 155.51 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 114.172 -1.377 . . . . 0.0 110.39 175.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -128.11 93.34 3.64 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 113.402 -1.726 . . . . 0.0 109.69 175.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -71.29 47.8 0.12 Allowed 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.699 1.238 . . . . 0.0 112.984 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 35.8 t30 29.49 56.32 0.14 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.188 1.395 . . . . 0.0 111.151 -173.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.31 -30.06 59.47 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.853 -175.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -75.97 -7.46 54.67 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 112.924 -1.944 . . . . 0.0 114.646 175.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.8 t 45.56 37.85 3.47 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 123.482 1.611 . . . . 0.0 112.292 -176.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 70.8 t -109.55 -20.0 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.938 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.52 152.53 41.0 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.172 -173.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -68.88 -165.13 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 121.058 1.172 . . . . 0.0 109.581 178.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m 67.67 -68.14 0.17 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.49 1.516 . . . . 0.0 113.008 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 83.25 -23.26 0.2 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 128.475 2.71 . . . . 0.0 112.837 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.5 p -50.45 158.92 0.55 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 123.549 1.642 . . . . 0.0 110.925 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -103.4 135.11 45.62 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 112.851 -1.977 . . . . 0.0 110.579 -175.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.62 -21.67 24.84 Favored Glycine 0 CA--C 1.542 1.73 0 CA-C-N 114.361 -1.29 . . . . 0.0 113.135 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -71.15 -7.54 47.35 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.568 1.147 . . . . 0.0 113.751 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -119.91 162.85 18.46 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 125.515 1.526 . . . . 0.0 109.327 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -160.19 165.56 31.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 112.678 -2.056 . . . . 0.0 110.715 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -120.42 152.27 38.17 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.786 0.834 . . . . 0.0 109.461 -177.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -163.12 66.39 0.19 Allowed 'General case' 0 N--CA 1.473 0.708 0 O-C-N 123.982 0.801 . . . . 0.0 109.646 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -38.78 135.24 0.87 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.45 -0.781 . . . . 0.0 112.887 177.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.8 m -91.66 123.53 43.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 112.539 -2.119 . . . . 0.0 109.212 178.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -51.74 159.12 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 113.83 -1.532 . . . . 0.0 110.189 173.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.4 m -153.61 141.61 13.88 Favored Pre-proline 0 N--CA 1.475 0.793 0 O-C-N 124.625 1.203 . . . . 0.0 110.762 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.07 141.59 33.08 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 121.765 1.643 . . . . 0.0 110.676 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.7 26.94 65.62 Favored Glycine 0 CA--C 1.54 1.635 0 CA-C-N 114.022 -1.444 . . . . 0.0 112.857 -174.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.21 91.59 6.75 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 177.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -42.45 -30.96 0.37 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.516 -1.22 . . . . 0.0 113.448 176.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 59.3 p -128.22 -113.41 0.27 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 113.814 -1.539 . . . . 0.0 109.166 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -115.51 -12.47 11.66 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.78 1.632 . . . . 0.0 111.563 177.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.98 167.34 7.35 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 123.722 1.734 . . . . 0.0 110.441 -176.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.5 p -74.43 -6.63 49.33 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 112.349 -1.926 . . . . 0.0 112.941 176.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.73 134.61 50.05 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 120.927 -1.108 . . . . 0.0 109.816 176.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.79 139.96 11.78 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.139 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.1 mt -113.97 139.22 40.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 O-C-N 125.223 1.577 . . . . 0.0 108.808 176.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.5 mm -129.25 106.42 13.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 O-C-N 125.287 1.617 . . . . 0.0 108.582 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.9 p -94.69 162.83 13.62 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.436 -0.79 . . . . 0.0 110.937 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.32 -175.19 21.26 Favored Glycine 0 CA--C 1.538 1.477 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.832 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.66 -14.62 62.1 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.955 0.883 . . . . 0.0 112.896 175.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.28 128.6 55.2 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 30.1 m -61.65 151.19 34.24 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.374 175.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 75.71 31.79 0.71 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 126.527 1.931 . . . . 0.0 110.821 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -138.98 60.09 1.6 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 113.1 -1.864 . . . . 0.0 112.702 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.77 123.19 45.33 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 112.71 -2.041 . . . . 0.0 107.973 175.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -92.6 126.69 37.8 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 124.715 1.26 . . . . 0.0 109.209 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -108.85 121.58 45.38 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.017 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . 0.291 0.1 OUTLIER -79.99 -70.92 0.48 Allowed 'General case' 0 N--CA 1.485 1.293 0 O-C-N 125.497 1.748 . . . . 0.0 113.014 173.604 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.34 16.93 65.64 Favored Glycine 0 CA--C 1.539 1.578 0 CA-C-N 114.253 -1.339 . . . . 0.0 113.069 -173.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -146.5 24.82 1.23 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.567 1.147 . . . . 0.0 112.483 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 56.35 83.55 0.1 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.002 2.121 . . . . 0.0 110.813 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 46.38 53.58 9.49 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 113.009 -1.905 . . . . 0.0 114.022 -175.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -123.88 -34.83 2.94 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.381 -1.281 . . . . 0.0 114.024 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.3 p -135.37 168.01 19.98 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.47 1.108 . . . . 0.0 108.493 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -159.54 115.83 2.55 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -174.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.5 m -135.65 111.07 9.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 112.82 -1.991 . . . . 0.0 108.586 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 16.9 mt -41.68 159.96 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.441 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.6 mp -110.7 129.47 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 121.38 -0.825 . . . . 0.0 109.592 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.09 92.02 3.88 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 113.157 -1.838 . . . . 0.0 109.172 176.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -60.1 -31.77 70.35 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 114.218 -1.356 . . . . 0.0 111.199 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.3 t -54.98 -34.87 63.75 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.656 1.582 . . . . 0.0 112.972 172.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 8.6 t . . . . . 0 C--O 1.254 1.299 0 CA-C-O 117.813 -1.089 . . . . 0.0 110.824 178.773 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.4 p30 . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 119.758 -0.163 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.7 t -41.81 137.93 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.643 1.177 . . . . 0.0 109.429 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.6 m -80.85 19.58 0.84 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.085 -0.962 . . . . 0.0 113.014 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.86 -175.18 29.76 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -85.29 174.61 9.47 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.445 0.641 . . . . 0.0 110.517 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.93 115.28 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -174.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.0 m -48.05 128.23 13.45 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 111.807 -2.451 . . . . 0.0 111.126 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.418 ' N ' ' OXT' ' A' ' 96' ' ' CYS . 0.0 OUTLIER -46.38 -38.52 9.02 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.603 1.161 . . . . 0.0 112.721 173.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.8 t -70.04 -14.52 62.72 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 172.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.36 -26.3 38.71 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.359 0.664 . . . . 0.0 111.865 175.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.47 169.7 9.78 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 124.17 0.988 . . . . 0.0 111.404 178.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.88 169.29 15.06 Favored 'Trans proline' 0 CA--C 1.548 1.179 0 C-N-CA 122.4 2.067 . . . . 0.0 113.405 176.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -69.72 -21.97 32.91 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 122.276 1.984 . . . . 0.0 113.055 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.43 -10.24 54.65 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.857 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.87 -37.49 81.86 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.007 0.923 . . . . 0.0 112.478 172.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -40.16 83.62 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.423 175.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -45.74 -44.77 14.01 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.68 -177.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.531 ' HG1' ' CG1' ' A' ' 57' ' ' VAL . 1.3 m -65.58 -51.69 57.83 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.066 -1.425 . . . . 0.0 111.593 177.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.6 mt -49.88 -33.36 16.89 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 174.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.31 -48.01 58.53 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.637 0.775 . . . . 0.0 111.941 171.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.6 mt -62.4 -34.37 76.6 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-O 118.73 -0.652 . . . . 0.0 112.243 175.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.74 -43.95 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 119.497 1.044 . . . . 0.0 111.389 172.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.15 -43.7 81.67 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 124.455 1.097 . . . . 0.0 111.876 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.5 t -85.4 0.47 52.09 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.809 1.244 . . . . 0.0 112.293 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 46.3 35.82 2.95 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 122.368 1.08 . . . . 0.0 112.344 -176.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.47 -172.35 14.67 Favored Glycine 0 CA--C 1.548 2.129 0 CA-C-N 113.711 -1.586 . . . . 0.0 114.309 -175.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -73.29 135.8 41.57 Favored 'Cis proline' 0 CA--C 1.534 0.515 0 O-C-N 123.003 1.002 . . . . 0.0 111.091 -2.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -84.98 103.12 2.88 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 112.81 -1.995 . . . . 0.0 111.722 -177.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.2 -36.7 5.32 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.624 2.216 . . . . 0.0 111.581 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -77.43 168.69 19.59 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 124.052 0.845 . . . . 0.0 111.991 175.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.57 17.74 22.88 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 122.461 1.124 . . . . 0.0 112.911 172.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.91 13.98 20.91 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.734 -1.121 . . . . 0.0 113.67 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -130.86 107.58 9.23 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.764 -1.562 . . . . 0.0 112.556 -174.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.5 -0.2 7.41 Favored Glycine 0 N--CA 1.485 1.937 0 CA-C-N 113.045 -1.889 . . . . 0.0 113.324 -175.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.9 m -92.41 145.96 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.651 0.781 . . . . 0.0 110.072 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.5 t -77.12 157.6 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 125.141 1.526 . . . . 0.0 109.8 176.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -138.56 87.32 2.22 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 113.927 -1.488 . . . . 0.0 109.442 176.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -72.59 50.16 0.23 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 122.537 1.161 . . . . 0.0 113.301 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 34.9 t30 29.51 54.21 0.12 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.286 1.834 . . . . 0.0 110.873 -173.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.89 -21.89 33.03 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 113.712 -1.586 . . . . 0.0 112.266 -177.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -80.93 -7.6 59.54 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 113.819 -1.537 . . . . 0.0 114.12 173.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.4 t 43.83 37.91 1.87 Allowed 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 123.997 1.856 . . . . 0.0 112.204 -175.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.1 t -114.36 -16.75 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-N 113.472 -1.695 . . . . 0.0 111.18 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.7 157.85 48.77 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.228 -178.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.66 -160.07 0.07 OUTLIER 'Trans proline' 0 N--CA 1.477 0.557 0 C-N-CA 121.013 1.142 . . . . 0.0 109.498 178.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.2 m 48.88 -131.34 1.76 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.337 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 168.9 -38.18 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.779 1.631 . . . . 0.0 110.482 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.5 p -35.93 139.44 0.15 Allowed 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 122.589 1.185 . . . . 0.0 112.923 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -87.35 132.62 33.89 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.045 -1.888 . . . . 0.0 108.113 -175.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.16 -20.81 9.27 Favored Glycine 0 CA--C 1.537 1.46 0 O-C-N 124.863 1.352 . . . . 0.0 113.35 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -59.77 -19.68 51.9 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.402 1.081 . . . . 0.0 113.423 176.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -104.2 166.62 10.28 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 125.091 1.356 . . . . 0.0 109.168 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -166.22 166.21 17.02 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 112.301 -2.227 . . . . 0.0 111.206 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -124.55 143.44 50.68 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.239 1.016 . . . . 0.0 110.063 -175.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.455 ' CE1' ' OG1' ' A' ' 72' ' ' THR . 39.8 m-85 -157.68 72.2 0.65 Allowed 'General case' 0 N--CA 1.469 0.477 0 O-C-N 126.28 2.237 . . . . 0.0 109.723 -174.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -44.36 144.26 1.06 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.612 0.72 . . . . 0.0 112.405 177.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.531 ' CG1' ' HG1' ' A' ' 18' ' ' THR . 30.4 m -94.72 113.69 29.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.605 176.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -43.11 157.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 125.057 1.473 . . . . 0.0 109.096 173.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.431 ' HG1' ' CD ' ' A' ' 68' ' ' ARG . 1.4 m -153.63 143.41 15.23 Favored Pre-proline 0 N--CA 1.477 0.916 0 O-C-N 124.443 1.09 . . . . 0.0 111.226 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -74.54 144.04 31.52 Favored 'Trans proline' 0 N--CA 1.479 0.66 0 C-N-CA 121.575 1.516 . . . . 0.0 110.788 176.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.51 22.05 30.1 Favored Glycine 0 CA--C 1.544 1.848 0 CA-C-N 114.35 -1.296 . . . . 0.0 112.525 -175.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.53 89.8 6.7 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 178.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -40.97 -30.48 0.13 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.696 -1.593 . . . . 0.0 112.953 176.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.8 p -124.93 -146.25 0.35 Allowed 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 113.776 -1.556 . . . . 0.0 109.569 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -82.31 -2.01 51.4 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 174.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.48 142.41 0.02 OUTLIER Glycine 0 N--CA 1.475 1.25 0 CA-C-O 123.717 1.732 . . . . 0.0 108.879 -173.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.8 p -52.85 -27.65 19.32 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 123.209 1.481 . . . . 0.0 112.165 174.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.431 ' CD ' ' HG1' ' A' ' 59' ' ' THR . 0.6 OUTLIER -54.23 127.65 27.89 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 120.009 -1.682 . . . . 0.0 111.786 174.445 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.02 149.88 37.37 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.321 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.9 mt -122.37 140.17 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 126.04 2.087 . . . . 0.0 109.247 176.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.1 mm -132.43 108.84 14.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 O-C-N 125.6 1.812 . . . . 0.0 107.173 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.455 ' OG1' ' CE1' ' A' ' 55' ' ' TYR . 14.8 p -102.92 162.97 12.49 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.422 0.63 . . . . 0.0 110.363 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -115.3 171.26 13.62 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.996 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.58 -16.89 63.39 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 114.479 -0.86 . . . . 0.0 112.214 174.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.36 129.42 48.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 122.33 1.062 . . . . 0.0 108.866 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.1 m -61.49 147.57 44.86 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 113.776 -1.556 . . . . 0.0 107.494 175.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 80.7 31.48 0.17 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 127.0 2.12 . . . . 0.0 111.078 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -135.73 50.41 2.1 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 113.622 -1.626 . . . . 0.0 113.385 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.63 83.9 2.1 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 113.418 -1.719 . . . . 0.0 110.845 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -68.53 131.53 45.41 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.558 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -122.12 130.43 53.23 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.554 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.2 -66.87 0.85 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 111.626 -2.533 . . . . 0.0 112.383 175.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.49 22.35 76.47 Favored Glycine 0 N--CA 1.48 1.577 0 CA-C-N 112.996 -1.911 . . . . 0.0 113.58 -174.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -157.66 24.56 0.28 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.015 1.326 . . . . 0.0 113.278 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 61.66 83.17 0.15 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.324 1.85 . . . . 0.0 112.013 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 46.81 38.87 6.46 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 113.424 -1.716 . . . . 0.0 114.057 -176.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -99.96 -18.37 17.1 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.029 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 p -164.46 176.99 8.51 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.325 1.45 . . . . 0.0 108.358 -175.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -160.06 115.73 2.38 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -175.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.5 m -135.51 111.46 9.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 112.828 -1.987 . . . . 0.0 108.864 -179.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 15.4 mt -41.58 159.92 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.654 0.596 . . . . 0.0 112.325 177.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.6 mp -107.24 123.94 62.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 O-C-N 120.715 -1.241 . . . . 0.0 110.022 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.06 93.49 7.87 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 113.756 -1.566 . . . . 0.0 107.722 177.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -54.81 -42.47 71.9 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.6 t -52.88 -30.1 32.04 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 113.438 -1.71 . . . . 0.0 114.45 173.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.418 ' OXT' ' N ' ' A' ' 8' ' ' LEU . 49.7 t . . . . . 0 C--O 1.246 0.911 0 CA-C-O 123.323 1.535 . . . . 0.0 107.014 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 110.733 -0.099 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.4 t -31.85 133.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 126.469 1.908 . . . . 0.0 109.27 169.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.2 m -56.34 -13.01 1.88 Allowed 'General case' 0 N--CA 1.474 0.762 0 O-C-N 125.006 1.441 . . . . 0.0 114.553 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.71 -169.74 19.39 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 176.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -84.41 168.77 15.24 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 122.28 1.038 . . . . 0.0 111.048 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.4 p -146.49 110.8 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 114.361 -1.291 . . . . 0.0 107.588 -176.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 70.9 m -43.34 131.04 4.86 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 111.946 -2.388 . . . . 0.0 109.74 177.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.41 -36.55 54.49 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.3 177.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.5 t -67.42 -17.02 64.55 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.338 1.055 . . . . 0.0 113.3 174.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.01 -33.8 33.38 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.918 0.487 . . . . 0.0 111.731 176.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.0 mt -81.07 173.23 8.04 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 125.683 1.593 . . . . 0.0 110.557 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.95 166.47 22.66 Favored 'Trans proline' 0 CA--C 1.551 1.342 0 C-N-CA 121.847 1.698 . . . . 0.0 113.885 175.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -66.68 -22.45 50.33 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.983 2.456 . . . . 0.0 113.715 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.97 -8.58 59.55 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 173.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.32 -29.61 70.37 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 174.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -73.88 -29.41 62.07 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.816 173.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -52.66 -54.49 32.68 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.781 0.676 . . . . 0.0 109.534 -176.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.4 m -54.78 -49.31 71.22 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 175.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.5 mt -56.01 -34.78 66.13 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -70.58 -41.05 72.89 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.471 172.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.9 mt -66.77 -33.98 76.82 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 123.272 0.629 . . . . 0.0 112.16 175.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.8 mt -69.22 -44.41 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 119.486 1.039 . . . . 0.0 111.161 172.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.48 -43.94 75.87 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 124.665 1.228 . . . . 0.0 112.24 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.42 5.85 47.74 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.105 0.962 . . . . 0.0 112.041 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 43.77 36.64 1.36 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.997 1.319 . . . . 0.0 112.528 -176.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.96 -165.28 13.24 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 113.667 -1.606 . . . . 0.0 115.619 -175.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -73.95 137.67 51.32 Favored 'Cis proline' 0 CA--C 1.537 0.644 0 O-C-N 124.644 1.865 . . . . 0.0 112.424 -4.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -85.74 153.17 57.85 Favored Pre-proline 0 N--CA 1.472 0.632 0 CA-C-N 113.301 -1.772 . . . . 0.0 112.611 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.02 -56.9 0.14 Allowed 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.409 2.072 . . . . 0.0 113.344 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.97 168.93 9.29 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.438 1.495 . . . . 0.0 110.531 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.7 m -71.42 56.98 0.25 Allowed 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 123.55 1.643 . . . . 0.0 114.015 174.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.669 ' NE2' ' HG1' ' A' ' 56' ' ' THR . 3.9 mt-30 -131.1 67.6 1.51 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 123.497 1.618 . . . . 0.0 112.066 177.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -173.7 155.22 2.63 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 110.19 -3.187 . . . . 0.0 114.733 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 71.82 10.83 72.91 Favored Glycine 0 N--CA 1.481 1.641 0 CA-C-N 112.181 -2.281 . . . . 0.0 111.635 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.0 m -97.74 142.22 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.402 1.081 . . . . 0.0 109.72 174.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.6 t -87.59 155.24 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 O-C-N 125.867 1.979 . . . . 0.0 110.276 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -121.45 103.03 8.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.392 173.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.83 45.17 0.19 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.199 0.6 . . . . 0.0 112.037 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 21.07 57.82 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 124.116 1.912 . . . . 0.0 113.359 -174.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.19 7.0 8.34 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 113.527 -1.67 . . . . 0.0 112.297 -175.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -111.55 -17.05 13.14 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.479 -1.691 . . . . 0.0 113.847 177.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.9 t 46.22 39.66 6.44 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 123.99 1.852 . . . . 0.0 112.972 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 89.1 t -111.35 -15.97 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.438 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.15 162.74 19.99 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -173.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -68.1 -160.39 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.423 2.082 . . . . 0.0 110.423 177.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.5 m 43.73 -128.07 0.87 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.27 1.428 . . . . 0.0 108.821 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 165.55 -43.76 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.699 1.999 . . . . 0.0 110.875 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.0 p -39.66 141.25 0.42 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 114.027 -1.442 . . . . 0.0 113.445 -178.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -81.68 135.76 35.51 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 112.584 -2.098 . . . . 0.0 110.642 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.23 -24.85 25.18 Favored Glycine 0 N--CA 1.476 1.334 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.842 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -61.82 -14.2 31.01 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.844 1.258 . . . . 0.0 112.789 175.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -121.59 147.14 46.23 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.675 1.19 . . . . 0.0 109.789 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -141.73 160.04 41.0 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 113.706 -1.588 . . . . 0.0 111.79 177.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -114.94 138.57 50.66 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.918 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -155.54 73.63 0.85 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 112.739 -2.028 . . . . 0.0 110.079 -176.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.669 ' HG1' ' NE2' ' A' ' 32' ' ' GLN . 24.6 m -45.04 130.88 7.59 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 122.246 1.022 . . . . 0.0 111.534 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.485 ' CG1' ' HH ' ' A' ' 81' ' ' TYR . 0.8 OUTLIER -86.59 125.4 40.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 111.52 -2.582 . . . . 0.0 110.102 179.384 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -48.12 148.77 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 O-C-N 125.734 1.896 . . . . 0.0 108.99 174.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.546 ' HG1' ' CG ' ' A' ' 68' ' ' ARG . 2.6 m -148.31 140.63 14.69 Favored Pre-proline 0 N--CA 1.471 0.613 0 O-C-N 125.981 2.05 . . . . 0.0 110.999 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.64 145.55 41.91 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.784 2.323 . . . . 0.0 110.034 176.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.04 22.74 56.01 Favored Glycine 0 CA--C 1.543 1.816 0 CA-C-N 113.681 -1.599 . . . . 0.0 113.321 -174.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -89.05 90.88 8.59 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 176.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.5 -33.29 0.42 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 113.711 -1.586 . . . . 0.0 113.623 176.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.0 p -133.66 -149.23 0.36 Allowed 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 113.624 -1.625 . . . . 0.0 107.848 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -60.52 -18.83 54.59 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 125.282 1.433 . . . . 0.0 111.813 173.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.76 167.27 1.43 Allowed Glycine 0 CA--C 1.532 1.139 0 CA-C-O 123.747 1.748 . . . . 0.0 110.017 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 46.6 p -65.11 -17.36 64.4 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 112.977 -1.612 . . . . 0.0 112.393 173.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.546 ' CG ' ' HG1' ' A' ' 59' ' ' THR . 0.1 OUTLIER -63.41 126.72 28.41 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 120.937 -1.102 . . . . 0.0 110.34 176.843 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.419 HH21 ' HH ' ' A' ' 86' ' ' TYR . 1.3 tpt180 -151.56 132.95 14.62 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.349 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.1 mt -105.8 138.91 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 173.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.7 mm -123.5 106.2 16.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 112.697 -2.047 . . . . 0.0 107.417 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.9 p -92.07 164.37 13.63 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.094 0.473 . . . . 0.0 111.604 177.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -104.46 -175.81 25.09 Favored Glycine 0 N--CA 1.471 1.026 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.298 178.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -80.62 -14.83 57.84 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.544 -0.828 . . . . 0.0 112.172 177.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.3 130.86 55.61 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 175.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 53.7 m -49.76 149.17 2.64 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.645 173.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 81.19 34.33 0.11 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 126.561 1.945 . . . . 0.0 111.057 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -139.26 50.38 1.8 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 113.474 -1.693 . . . . 0.0 113.578 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.45 95.56 5.75 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.365 1.466 . . . . 0.0 110.678 -176.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -81.62 123.19 28.47 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 126.058 1.743 . . . . 0.0 110.255 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.485 ' HH ' ' CG1' ' A' ' 57' ' ' VAL . 5.8 t80 -104.81 127.79 52.74 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.052 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . 0.301 0.0 OUTLIER -88.24 -71.62 0.57 Allowed 'General case' 0 C--N 1.323 -0.569 0 O-C-N 125.948 2.03 . . . . 0.0 113.713 172.641 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.06 16.37 68.54 Favored Glycine 0 N--CA 1.476 1.332 0 CA-C-N 113.898 -1.501 . . . . 0.0 113.979 -173.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -145.93 22.7 1.4 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.795 1.238 . . . . 0.0 113.041 176.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 57.89 82.27 0.13 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 127.177 2.191 . . . . 0.0 111.289 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.419 ' HH ' HH21 ' A' ' 69' ' ' ARG . 25.1 m-85 49.55 54.28 11.27 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 113.514 -1.676 . . . . 0.0 113.387 -174.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -120.16 -41.06 2.65 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.6 p -130.91 163.52 27.29 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.043 0.937 . . . . 0.0 108.73 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -154.95 119.79 4.86 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -175.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.5 m -140.76 113.82 8.45 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 112.312 -2.222 . . . . 0.0 108.906 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 14.7 mt -43.61 156.57 0.06 Allowed 'General case' 0 N--CA 1.48 1.074 0 O-C-N 124.109 0.881 . . . . 0.0 112.369 175.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.14 137.65 42.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 122.15 0.976 . . . . 0.0 108.456 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -113.01 99.08 7.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 113.14 -1.845 . . . . 0.0 108.746 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -58.74 -41.42 86.42 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.89 0.744 . . . . 0.0 112.033 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 t -54.94 -44.5 74.36 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 114.471 -1.24 . . . . 0.0 113.437 175.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 35.3 t . . . . . 0 C--O 1.241 0.643 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.21 178.596 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.8 p30 . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 121.062 0.458 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.1 t -47.71 140.42 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.983 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 m -77.61 5.86 8.35 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 124.723 1.264 . . . . 0.0 114.303 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.34 169.28 12.59 Favored Glycine 0 N--CA 1.474 1.171 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 m -86.67 171.48 10.94 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.312 -0.944 . . . . 0.0 109.818 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p -138.14 113.48 9.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 -176.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 71.4 m -50.73 125.03 12.22 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 112.05 -2.341 . . . . 0.0 109.854 177.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.81 -36.93 63.02 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.883 175.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.7 t -65.61 -29.05 69.59 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.361 0.6 . . . . 0.0 112.511 174.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.28 -22.81 47.72 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.759 174.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.7 mt -80.68 164.13 52.82 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.318 176.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -67.01 173.96 7.57 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.019 2.48 . . . . 0.0 115.056 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -71.67 -53.62 0.17 Allowed 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.813 2.342 . . . . 0.0 112.771 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -60.2 -12.49 8.86 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.528 172.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.11 -41.85 79.75 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.725 -0.609 . . . . 0.0 111.9 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.16 -22.6 66.94 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 113.634 -1.621 . . . . 0.0 112.893 174.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -55.03 -58.02 9.35 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.582 0.753 . . . . 0.0 109.896 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.5 m -54.5 -47.31 73.21 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 176.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.3 mt -54.05 -37.11 63.8 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 175.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -69.57 -37.73 77.11 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.226 173.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.659 ' CD1' ' HG ' ' A' ' 31' ' ' SER . 30.1 mt -72.52 -33.02 66.59 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 118.689 -0.672 . . . . 0.0 111.202 176.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 mp -68.9 -41.26 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 120.117 1.326 . . . . 0.0 111.613 171.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.32 -43.39 67.15 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 124.279 0.987 . . . . 0.0 112.164 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.39 5.09 48.92 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.363 1.065 . . . . 0.0 111.293 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.5 t70 41.15 49.77 3.22 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.203 1.401 . . . . 0.0 111.288 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.68 -164.76 30.49 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 112.767 -2.015 . . . . 0.0 116.165 -173.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -75.1 142.85 75.87 Favored 'Cis proline' 0 C--N 1.35 0.639 0 O-C-N 124.419 1.747 . . . . 0.0 111.656 -2.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -99.27 123.26 49.26 Favored Pre-proline 0 N--CA 1.471 0.625 0 CA-C-N 113.419 -1.719 . . . . 0.0 111.102 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.91 -56.74 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.01 1.807 . . . . 0.0 111.629 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -158.78 21.99 0.21 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.864 0.866 . . . . 0.0 112.096 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.659 ' HG ' ' CD1' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -76.98 43.7 0.36 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.118 -178.635 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 20.15 64.72 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 128.968 2.907 . . . . 0.0 112.686 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -103.31 175.34 5.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 110.883 -2.871 . . . . 0.0 111.458 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.29 44.95 97.42 Favored Glycine 0 N--CA 1.478 1.494 0 CA-C-N 112.731 -2.031 . . . . 0.0 110.082 176.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.0 m -142.3 147.12 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 114.007 -1.097 . . . . 0.0 108.665 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.0 t -90.81 154.92 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 125.642 1.839 . . . . 0.0 109.798 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -137.96 91.61 2.59 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.851 174.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -70.46 51.34 0.13 Allowed 'General case' 0 N--CA 1.483 1.214 0 O-C-N 120.945 -1.097 . . . . 0.0 112.97 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 29.23 52.58 0.08 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.611 1.964 . . . . 0.0 110.499 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.75 -24.25 56.11 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.886 -169.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -76.84 -7.15 54.93 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 112.05 -2.341 . . . . 0.0 114.933 172.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.9 t 45.68 39.03 4.62 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 123.72 1.724 . . . . 0.0 111.585 -178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.5 t -112.73 -12.15 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 123.361 1.553 . . . . 0.0 110.369 -178.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.2 145.4 29.96 Favored Pre-proline 0 C--O 1.243 0.719 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 -172.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -65.41 -166.45 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.051 2.501 . . . . 0.0 110.004 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.6 m 62.86 -71.62 0.05 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.078 1.751 . . . . 0.0 112.203 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 96.17 -24.03 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 128.508 2.723 . . . . 0.0 112.431 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.9 p -48.3 156.08 0.44 Allowed 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 123.216 1.484 . . . . 0.0 111.247 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -101.84 134.03 45.66 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 112.235 -2.257 . . . . 0.0 110.291 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.4 -24.78 9.07 Favored Glycine 0 N--CA 1.472 1.096 0 CA-C-N 114.084 -1.417 . . . . 0.0 112.14 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -60.45 -20.46 59.94 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 174.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -104.38 147.75 27.19 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.449 -1.25 . . . . 0.0 108.804 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -147.28 152.84 38.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 112.934 -1.939 . . . . 0.0 111.218 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -105.36 143.07 34.03 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.435 -178.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -149.81 65.57 0.99 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 112.216 -2.265 . . . . 0.0 111.36 -176.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.5 m -33.99 130.01 0.33 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.602 1.192 . . . . 0.0 112.382 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.5 p -88.98 98.66 8.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 C-N-CA 118.574 -1.251 . . . . 0.0 110.11 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.1 mp -25.76 128.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.773 176.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.42 ' HG1' ' CD ' ' A' ' 68' ' ' ARG . 4.1 m -127.05 141.76 41.66 Favored Pre-proline 0 N--CA 1.479 1.025 0 CA-C-N 118.529 0.604 . . . . 0.0 111.723 -177.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.59 148.05 46.8 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.129 1.886 . . . . 0.0 110.441 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 52.74 22.67 12.32 Favored Glycine 0 CA--C 1.543 1.807 0 CA-C-N 114.278 -1.328 . . . . 0.0 113.03 -175.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.37 90.67 6.85 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -39.12 -33.68 0.14 Allowed 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 112.987 -1.915 . . . . 0.0 112.61 175.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.8 p -129.13 -143.22 0.26 Allowed 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 113.695 -1.593 . . . . 0.0 108.84 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 64.9 mtm-85 -79.69 -14.03 59.05 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 172.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 57.33 -177.82 1.09 Allowed Glycine 0 CA--C 1.534 1.245 0 CA-C-O 123.892 1.829 . . . . 0.0 110.602 -173.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 46.0 p -66.31 -36.34 82.7 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 112.462 -1.869 . . . . 0.0 112.845 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.42 ' CD ' ' HG1' ' A' ' 59' ' ' THR . 1.1 mtp85 -44.36 125.54 4.7 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.705 174.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.09 139.61 14.88 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 112.916 -1.947 . . . . 0.0 109.715 -177.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.6 mt -114.74 136.45 51.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 111.321 -2.672 . . . . 0.0 108.162 177.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.2 mm -124.9 106.1 16.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 113.057 -1.883 . . . . 0.0 107.701 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.0 p -99.5 163.07 12.66 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.319 0.581 . . . . 0.0 110.507 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -118.38 167.08 12.91 Favored Glycine 0 N--CA 1.476 1.334 0 CA-C-N 114.181 -1.372 . . . . 0.0 109.728 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.79 -22.67 25.67 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 114.691 -0.754 . . . . 0.0 112.338 172.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.91 129.49 34.82 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.581 1.181 . . . . 0.0 109.702 173.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.7 m -63.4 146.84 52.74 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.931 -1.486 . . . . 0.0 109.976 176.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 62.69 49.92 3.64 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.98 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -145.89 61.1 1.26 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.346 -1.752 . . . . 0.0 111.901 -177.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -106.28 119.82 40.25 Favored 'General case' 0 C--O 1.212 -0.887 0 CA-C-N 113.084 -1.871 . . . . 0.0 108.187 175.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -92.51 127.75 38.11 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 125.341 1.651 . . . . 0.0 109.392 175.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -107.4 126.63 52.72 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 114.077 -1.42 . . . . 0.0 109.631 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.407 ' HG1' ' N ' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -89.77 -67.24 0.86 Allowed 'General case' 0 N--CA 1.484 1.229 0 O-C-N 125.709 1.88 . . . . 0.0 112.551 175.323 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.02 21.42 61.39 Favored Glycine 0 CA--C 1.539 1.558 0 CA-C-N 114.148 -1.387 . . . . 0.0 112.444 -173.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -147.42 20.04 1.2 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.794 1.238 . . . . 0.0 112.621 176.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 56.79 80.41 0.16 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.844 1.657 . . . . 0.0 110.251 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.407 ' N ' ' HG1' ' A' ' 82' ' ' THR . 15.4 m-30 48.87 54.27 11.08 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 113.321 -1.763 . . . . 0.0 113.837 -175.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -120.73 -32.66 3.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.276 -1.329 . . . . 0.0 113.065 176.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 17.2 p -140.32 166.64 24.15 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -156.72 118.11 3.78 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -173.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.2 m -139.41 107.8 5.83 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 125.871 1.982 . . . . 0.0 110.047 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.7 mt -40.86 159.29 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.123 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -108.67 128.74 64.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 O-C-N 120.612 -1.305 . . . . 0.0 109.415 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.35 95.58 5.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 113.836 -1.529 . . . . 0.0 108.698 177.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.5 -36.81 67.07 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 124.312 1.007 . . . . 0.0 112.044 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.1 t -56.59 -48.59 77.07 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.901 1.28 . . . . 0.0 113.232 174.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 44.0 t . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.779 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 121.381 0.61 . . . . 0.0 111.426 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.7 t -63.91 143.32 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.8 m -80.39 -3.24 48.89 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 176.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.87 179.94 17.57 Favored Glycine 0 N--CA 1.473 1.162 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 m -89.33 174.46 7.81 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 122.109 0.957 . . . . 0.0 109.783 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -142.96 112.31 2.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 122.659 1.218 . . . . 0.0 107.834 -176.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.1 m -52.12 133.71 33.25 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 112.152 -2.295 . . . . 0.0 109.887 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -31.53 68.02 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.083 0.864 . . . . 0.0 111.878 -178.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.4 t -66.08 -28.76 69.07 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.661 0.784 . . . . 0.0 112.902 173.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.52 -18.54 56.93 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.712 0.805 . . . . 0.0 111.81 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.0 mt -86.34 161.28 49.32 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 175.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -69.67 170.24 16.93 Favored 'Trans proline' 0 CA--C 1.552 1.393 0 C-N-CA 122.192 1.928 . . . . 0.0 112.484 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.04 -34.83 12.9 Favored 'Trans proline' 0 N--CA 1.482 0.827 0 C-N-CA 122.652 2.234 . . . . 0.0 113.024 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.73 -9.43 58.66 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 114.695 -1.139 . . . . 0.0 114.069 175.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.48 -40.4 89.28 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.052 173.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.55 -33.13 74.32 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.081 175.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -54.02 -49.85 67.97 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.792 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.44 ' HG1' ' CG1' ' A' ' 57' ' ' VAL . 2.2 m -64.69 -49.3 71.47 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-O 117.953 -1.022 . . . . 0.0 112.479 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.5 mt -52.05 -34.22 42.38 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 124.293 0.996 . . . . 0.0 111.794 175.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.27 -45.68 54.34 Favored 'General case' 0 C--O 1.213 -0.867 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.262 173.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.3 mt -64.21 -33.7 76.41 Favored 'General case' 0 C--O 1.212 -0.913 0 C-N-CA 122.956 0.502 . . . . 0.0 111.964 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.9 mt -71.16 -41.72 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 O-C-N 119.716 -1.865 . . . . 0.0 110.424 174.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.65 -43.14 66.63 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 124.68 1.238 . . . . 0.0 111.932 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.5 8.48 33.68 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.762 1.225 . . . . 0.0 112.057 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.8 t70 41.12 53.66 3.41 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 123.109 1.433 . . . . 0.0 111.952 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.09 -165.89 14.46 Favored Glycine 0 CA--C 1.538 1.53 0 CA-C-N 113.456 -1.702 . . . . 0.0 113.804 -175.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.77 138.16 54.09 Favored 'Cis proline' 0 N--CA 1.481 0.785 0 O-C-N 123.54 1.284 . . . . 0.0 111.768 -2.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -94.81 106.52 25.24 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 113.316 -1.765 . . . . 0.0 111.952 -176.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -71.13 -46.3 0.72 Allowed 'Trans proline' 0 N--CA 1.477 0.531 0 C-N-CA 122.033 1.822 . . . . 0.0 111.742 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.459 ' C ' ' H ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -173.67 23.1 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.463 1.105 . . . . 0.0 112.805 -179.548 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.2 m -69.34 37.25 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.494 -174.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.459 ' H ' ' C ' ' A' ' 30' ' ' TYR . 0.0 OUTLIER 32.13 42.63 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.191 2.596 . . . . 0.0 112.975 -176.941 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -105.35 174.47 5.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 110.986 -2.825 . . . . 0.0 111.157 -172.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.91 -2.15 75.96 Favored Glycine 0 N--CA 1.482 1.704 0 O-C-N 126.195 2.185 . . . . 0.0 111.137 -175.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.2 m -102.21 143.93 14.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.935 0.894 . . . . 0.0 110.465 175.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.08 153.34 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 125.386 1.679 . . . . 0.0 109.588 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -131.65 89.26 2.68 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 112.936 -1.938 . . . . 0.0 109.878 176.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -72.54 51.25 0.26 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 118.692 0.678 . . . . 0.0 112.67 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 29.43 51.49 0.08 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.022 2.529 . . . . 0.0 109.397 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -21.81 31.11 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.121 -173.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -78.27 -6.52 55.24 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.405 -1.725 . . . . 0.0 114.787 172.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 43.5 t 44.85 35.91 1.67 Allowed 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 124.782 2.23 . . . . 0.0 112.269 -176.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 70.9 t -111.74 -9.87 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 113.376 -1.738 . . . . 0.0 109.758 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.5 150.16 36.44 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -175.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.14 -159.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.75 2.3 . . . . 0.0 109.746 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 96.1 m 56.86 -111.26 0.6 Allowed 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 116.342 -1.789 . . . . 0.0 107.779 -177.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 146.33 -43.12 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 127.697 2.399 . . . . 0.0 110.743 -177.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.5 p -37.25 143.44 0.09 Allowed 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 123.687 1.708 . . . . 0.0 112.196 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -90.73 135.4 33.74 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 112.843 -1.981 . . . . 0.0 108.229 -175.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.87 -19.12 17.54 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 124.712 1.258 . . . . 0.0 113.548 176.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -65.59 -13.89 59.98 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.363 1.065 . . . . 0.0 113.214 176.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -108.58 155.25 20.87 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.362 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -154.03 161.14 42.15 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 112.968 -1.923 . . . . 0.0 110.832 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -116.86 149.4 40.12 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.516 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.402 ' CE1' ' OG1' ' A' ' 72' ' ' THR . 76.2 m-85 -159.96 82.4 0.72 Allowed 'General case' 0 CA--C 1.545 0.758 0 O-C-N 125.239 1.587 . . . . 0.0 109.335 -172.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.5 m -49.83 146.33 4.61 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 123.086 1.422 . . . . 0.0 111.434 175.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.44 ' CG1' ' HG1' ' A' ' 18' ' ' THR . 1.2 m -105.81 19.0 5.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 113.01 -1.904 . . . . 0.0 113.019 -173.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 53.32 179.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 O-C-N 124.827 1.329 . . . . 0.0 108.857 -165.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.3 m -156.11 139.99 11.43 Favored Pre-proline 0 N--CA 1.477 0.905 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.801 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.2 142.91 31.22 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.002 2.468 . . . . 0.0 110.023 178.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 48.01 27.99 5.46 Favored Glycine 0 CA--C 1.541 1.718 0 CA-C-N 114.188 -1.369 . . . . 0.0 112.623 -176.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.09 95.07 6.59 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.69 -29.2 0.72 Allowed 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 111.603 -2.544 . . . . 0.0 112.428 175.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.8 p -112.07 -165.18 0.97 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.514 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.7 mtm105 -66.54 -12.11 56.08 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 174.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.63 165.54 7.18 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-O 123.838 1.799 . . . . 0.0 110.335 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.8 p -74.2 -15.49 61.01 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 112.631 -1.785 . . . . 0.0 112.439 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.557 ' NE ' ' HH ' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -66.85 136.53 55.55 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 120.931 -1.106 . . . . 0.0 110.245 177.082 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.53 156.12 29.64 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.418 -1.719 . . . . 0.0 110.447 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.16 140.96 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 O-C-N 125.325 1.641 . . . . 0.0 109.215 176.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.6 mm -128.87 106.11 13.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 113.22 -1.809 . . . . 0.0 107.82 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.402 ' OG1' ' CE1' ' A' ' 55' ' ' TYR . 20.7 p -98.61 162.16 13.28 Favored 'General case' 0 C--N 1.314 -0.971 0 O-C-N 121.477 -0.765 . . . . 0.0 110.584 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.21 166.61 12.52 Favored Glycine 0 N--CA 1.48 1.605 0 CA-C-N 113.663 -1.608 . . . . 0.0 109.469 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.37 -18.25 57.84 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.562 -0.819 . . . . 0.0 112.6 174.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -101.03 129.99 46.96 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.578 174.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 m -59.82 143.75 50.37 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 113.675 -1.602 . . . . 0.0 107.883 175.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 80.74 35.99 0.11 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.741 2.016 . . . . 0.0 110.474 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -134.02 47.43 2.43 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 113.45 -1.705 . . . . 0.0 113.204 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.64 89.29 3.3 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.884 1.274 . . . . 0.0 110.19 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -78.45 131.88 37.06 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 125.228 1.411 . . . . 0.0 109.553 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.557 ' HH ' ' NE ' ' A' ' 68' ' ' ARG . 16.2 t80 -116.5 132.44 56.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.726 -1.124 . . . . 0.0 109.513 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.76 -72.28 0.51 Allowed 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 112.468 -2.151 . . . . 0.0 112.687 175.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.13 21.24 78.4 Favored Glycine 0 N--CA 1.473 1.119 0 CA-C-N 112.926 -1.943 . . . . 0.0 113.277 -175.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -154.41 23.01 0.48 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.811 1.245 . . . . 0.0 112.963 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 23.0 t-80 56.8 82.67 0.11 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.896 2.078 . . . . 0.0 110.005 178.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 7.7 m-30 51.2 48.67 22.6 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 113.04 -1.891 . . . . 0.0 114.163 -176.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -115.2 -30.59 6.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.823 179.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.3 p -147.97 169.67 19.38 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -157.88 116.31 3.12 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -173.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.8 m -137.95 113.2 9.32 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 125.858 1.974 . . . . 0.0 110.099 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 14.7 mt -41.56 160.52 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 O-C-N 124.465 1.103 . . . . 0.0 112.812 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.6 mp -110.08 128.32 66.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 O-C-N 121.58 -0.7 . . . . 0.0 109.38 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.69 92.19 3.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 113.721 -1.581 . . . . 0.0 108.812 176.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.23 -30.13 69.2 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.935 178.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.1 t -56.31 -33.21 65.35 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.077 -1.419 . . . . 0.0 112.851 172.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 6.4 t . . . . . 0 C--O 1.257 1.464 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.973 178.621 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.61 HG21 ' HE1' ' A' ' 80' ' ' TYR . 24.7 t . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -78.08 12.88 1.62 Allowed 'General case' 0 N--CA 1.48 1.065 0 O-C-N 124.182 0.927 . . . . 0.0 113.342 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.97 179.05 23.55 Favored Glycine 0 N--CA 1.468 0.797 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.459 HG22 ' H ' ' A' ' 6' ' ' VAL . 2.9 m -80.9 173.83 12.22 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 122.174 0.988 . . . . 0.0 110.746 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.459 ' H ' HG22 ' A' ' 5' ' ' THR . 1.4 p -143.6 110.45 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -174.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.59 ' HB3' ' OXT' ' A' ' 96' ' ' CYS . 86.7 m -46.57 128.89 10.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 111.853 -2.431 . . . . 0.0 110.101 177.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.466 HD11 ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -56.57 -33.27 66.01 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.586 -177.584 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.4 t -65.99 -27.44 68.14 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.786 173.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.71 -20.48 58.33 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.44 0.696 . . . . 0.0 111.396 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.486 HD13 ' HB1' ' A' ' 15' ' ' ALA . 9.7 mt -86.25 158.66 54.92 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -69.34 167.44 23.88 Favored 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 122.174 1.916 . . . . 0.0 112.375 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.72 -14.01 38.28 Favored 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 122.626 2.217 . . . . 0.0 114.292 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 9.3 pm0 -92.91 -6.16 49.2 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.844 1.258 . . . . 0.0 113.955 176.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.486 ' HB1' HD13 ' A' ' 11' ' ' LEU . . . -81.58 -43.24 18.94 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.717 175.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.466 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -59.1 -28.99 67.03 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.566 174.801 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.527 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 47.3 t0 -51.09 -58.07 7.06 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 124.258 1.023 . . . . 0.0 110.149 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.742 ' HA ' HD12 ' A' ' 21' ' ' LEU . 24.1 m -54.6 -50.03 69.0 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 176.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.586 HD11 HG21 ' A' ' 92' ' ' ILE . 9.5 mt -55.0 -35.33 64.26 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 123.627 0.579 . . . . 0.0 112.518 177.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -71.28 -39.42 71.54 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.892 173.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.742 HD12 ' HA ' ' A' ' 18' ' ' THR . 33.1 mt -70.22 -32.67 70.65 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 123.086 0.554 . . . . 0.0 111.104 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.495 HD13 HG21 ' A' ' 72' ' ' THR . 2.9 mt -72.7 -38.22 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 119.959 -1.713 . . . . 0.0 111.356 172.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.16 -42.65 62.57 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.693 -1.14 . . . . 0.0 112.303 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.39 8.66 39.63 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.661 1.184 . . . . 0.0 111.877 177.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.7 t0 39.77 49.97 2.22 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.078 1.351 . . . . 0.0 111.932 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.95 -166.92 39.48 Favored Glycine 0 N--CA 1.47 0.924 0 CA-C-N 113.056 -1.884 . . . . 0.0 115.598 -173.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.24 141.61 70.83 Favored 'Cis proline' 0 N--CA 1.48 0.71 0 O-C-N 124.014 1.534 . . . . 0.0 111.346 -0.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.504 ' CD2' ' HB3' ' A' ' 21' ' ' LEU . 51.6 m-85 -93.98 136.43 23.74 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 113.822 -1.536 . . . . 0.0 111.426 -175.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.443 ' HG2' ' CD1' ' A' ' 58' ' ' ILE . 29.9 Cg_endo -75.71 -61.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.478 0.573 0 C-N-CA 122.813 2.342 . . . . 0.0 110.719 -176.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.418 ' HD2' HG22 ' A' ' 56' ' ' THR . 0.6 OUTLIER -59.59 158.87 9.22 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.417 175.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 m -71.58 -15.21 62.26 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.938 0.875 . . . . 0.0 112.755 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.448 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -88.26 95.41 10.17 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.09 -176.817 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 166.58 136.1 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 111.813 -2.449 . . . . 0.0 115.35 -173.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.96 38.34 8.0 Favored Glycine 0 CA--C 1.54 1.619 0 CA-C-N 113.39 -1.732 . . . . 0.0 111.118 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.414 HG23 ' OE1' ' A' ' 54' ' ' GLU . 35.7 m -135.39 148.88 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 113.536 -1.332 . . . . 0.0 109.445 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.6 t -85.87 154.78 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 O-C-N 126.081 2.113 . . . . 0.0 109.875 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.498 ' CE2' ' HA ' ' A' ' 39' ' ' ASN . 84.8 t80 -135.15 89.54 2.53 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.428 176.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.432 ' HG3' ' CD1' ' A' ' 49' ' ' TYR . 11.5 tm0? -70.28 54.1 0.14 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 120.103 1.32 . . . . 0.0 111.695 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.498 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 15.1 p-10 25.47 52.33 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 127.837 2.455 . . . . 0.0 110.813 -175.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.82 -21.18 27.08 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.27 -173.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.603 ' O ' HG23 ' A' ' 43' ' ' VAL . 3.2 mt-10 -78.39 -12.04 59.98 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 112.956 -1.929 . . . . 0.0 115.094 172.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.7 t 45.4 39.17 4.24 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 124.081 1.896 . . . . 0.0 112.014 -177.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 41' ' ' GLU . 52.3 t -110.57 -13.32 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-O 123.634 1.683 . . . . 0.0 110.583 -177.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.567 ' HB3' ' OH ' ' A' ' 52' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 114.124 -1.398 . . . . 0.0 107.268 -172.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.432 ' CD1' ' HG3' ' A' ' 38' ' ' GLN . 9.1 t80 . . . . . 0 N--CA 1.468 0.462 0 CA-C-O 121.375 0.607 . . . . 0.0 110.09 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.94 8.66 78.53 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.664 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.478 ' HA ' ' HB2' ' A' ' 74' ' ' GLU . 71.0 t80 -81.83 13.4 3.27 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.813 1.245 . . . . 0.0 111.085 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.567 ' OH ' ' HB3' ' A' ' 44' ' ' LEU . 9.4 m-85 -149.43 156.52 42.15 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -173.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -152.15 154.99 36.94 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 125.49 1.744 . . . . 0.0 111.349 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.414 ' OE1' HG23 ' A' ' 35' ' ' VAL . 1.4 mt-10 -110.02 145.06 37.66 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.064 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.585 ' HB3' HG23 ' A' ' 18' ' ' THR . 76.8 m-85 -161.32 62.13 0.27 Allowed 'General case' 0 N--CA 1.475 0.788 0 O-C-N 125.882 1.989 . . . . 0.0 110.75 -174.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 0.9 OUTLIER -40.14 129.61 2.22 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 122.485 1.136 . . . . 0.0 111.952 177.495 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.618 HG21 ' HE1' ' A' ' 81' ' ' TYR . 14.0 m -83.65 121.15 35.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 111.515 -2.584 . . . . 0.0 108.72 176.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.453 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -42.3 162.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 O-C-N 125.363 1.665 . . . . 0.0 109.884 171.465 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.564 HG22 ' HB2' ' A' ' 62' ' ' ALA . 1.4 m -157.01 138.52 9.83 Favored Pre-proline 0 N--CA 1.482 1.146 0 O-C-N 125.374 1.672 . . . . 0.0 111.649 176.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.36 144.33 32.6 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.096 2.531 . . . . 0.0 109.463 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.61 26.64 39.55 Favored Glycine 0 CA--C 1.545 1.909 0 CA-C-N 113.081 -1.872 . . . . 0.0 112.01 -175.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.564 ' HB2' HG22 ' A' ' 59' ' ' THR . . . -86.95 89.06 7.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -40.16 -31.89 0.15 Allowed 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.908 176.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.6 p -129.79 -162.3 1.19 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.587 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.448 ' HD2' ' OE1' ' A' ' 32' ' ' GLN . 3.0 mtm105 -59.51 -14.63 13.54 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 172.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.0 137.12 0.08 OUTLIER Glycine 0 N--CA 1.467 0.722 0 N-CA-C 107.442 -2.263 . . . . 0.0 107.442 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.1 p -46.16 -28.69 1.31 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 113.43 -1.385 . . . . 0.0 113.077 174.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.422 ' HG2' ' CZ ' ' A' ' 81' ' ' TYR . 20.8 mtm-85 -50.27 139.14 15.41 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 121.02 -1.05 . . . . 0.0 113.045 170.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.527 ' HB3' ' CG2' ' A' ' 82' ' ' THR . 0.0 OUTLIER -165.14 137.94 4.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.099 -1.864 . . . . 0.0 109.15 -179.487 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.428 HD13 HD21 ' A' ' 19' ' ' LEU . 3.2 mt -105.1 138.48 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 112.694 -2.048 . . . . 0.0 109.548 173.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.539 ' O ' ' HD2' ' A' ' 80' ' ' TYR . 21.8 mm -127.86 103.39 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 112.628 -2.078 . . . . 0.0 108.365 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.642 HG22 ' HB3' ' A' ' 79' ' ' ASP . 13.1 p -88.41 162.86 16.28 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.972 178.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -104.22 -171.46 25.04 Favored Glycine 0 N--CA 1.48 1.605 0 O-C-N 125.273 1.608 . . . . 0.0 110.152 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -86.26 -11.07 53.31 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.533 0.682 . . . . 0.0 112.157 175.96 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.69 132.14 54.48 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 176.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.629 HG22 ' HG2' ' A' ' 77' ' ' GLN . 12.1 m -49.09 144.72 4.66 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.026 175.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.629 ' HG2' HG22 ' A' ' 76' ' ' THR . 1.4 mt-30 81.24 56.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 126.006 2.066 . . . . 0.0 109.856 177.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.592 ' HA ' HD22 ' A' ' 91' ' ' LEU . 3.7 mt-10 -166.44 54.93 0.09 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 113.222 -1.808 . . . . 0.0 114.247 -177.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.642 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.2 OUTLIER -112.68 93.2 4.31 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.939 1.296 . . . . 0.0 110.788 -177.845 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.61 ' HE1' HG21 ' A' ' 2' ' ' VAL . 25.2 m-85 -74.18 135.91 42.81 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 124.508 1.123 . . . . 0.0 110.325 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.678 ' HB2' HD11 ' A' ' 92' ' ' ILE . 62.3 t80 -121.56 91.9 3.62 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.527 ' CG2' ' HB3' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -44.49 -75.94 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 113.638 -1.619 . . . . 0.0 112.856 171.608 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.63 8.32 86.09 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-N 113.361 -1.745 . . . . 0.0 112.435 -175.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.533 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 34.6 m-20 -139.79 17.51 2.5 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 176.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 69.09 83.83 0.15 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.685 1.594 . . . . 0.0 111.815 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.43 ' HB3' ' CD ' ' A' ' 41' ' ' GLU . 13.0 m-85 50.12 25.92 1.92 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 113.189 -1.823 . . . . 0.0 113.894 -175.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.533 ' HB3' ' HB2' ' A' ' 84' ' ' ASP . . . -94.93 -57.96 2.29 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 120.43 -1.419 . . . . 0.0 110.825 -173.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 82' ' ' THR . 27.7 p -112.02 178.62 4.25 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.433 ' CE1' HD21 ' A' ' 44' ' ' LEU . 95.6 m-85 -161.56 122.21 2.7 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -175.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.7 m -140.39 107.93 5.59 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 126.169 2.168 . . . . 0.0 108.694 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.592 HD22 ' HA ' ' A' ' 78' ' ' GLU . 13.1 mt -43.22 161.89 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.678 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.7 mp -110.87 122.34 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 120.96 -1.087 . . . . 0.0 109.54 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.21 97.21 8.33 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 113.231 -1.804 . . . . 0.0 108.792 175.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -60.04 -40.23 88.65 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 125.321 1.638 . . . . 0.0 111.125 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.3 t -53.38 -37.45 62.46 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 114.354 -1.293 . . . . 0.0 112.651 172.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.59 ' OXT' ' HB3' ' A' ' 7' ' ' CYS . 12.0 t . . . . . 0 C--O 1.249 1.074 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.343 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.572 HG12 ' H ' ' A' ' 4' ' ' GLY . 47.7 t . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.66 5.21 5.1 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 124.323 1.014 . . . . 0.0 112.824 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.572 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 123.74 -165.67 16.47 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.183 1.373 . . . . 0.0 109.831 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 m -99.81 170.79 8.3 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.936 -1.132 . . . . 0.0 109.829 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 91' ' ' LEU . 2.2 p -140.85 109.28 2.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -175.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 82.0 m -44.99 133.42 6.39 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.016 -1.902 . . . . 0.0 111.068 177.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.52 HD11 ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -58.35 -31.65 67.79 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.676 0.61 . . . . 0.0 111.66 -178.86 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -65.4 -28.69 69.44 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.538 173.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.16 -30.96 60.88 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.598 0.759 . . . . 0.0 111.432 175.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.7 mt -81.22 161.45 62.54 Favored Pre-proline 0 N--CA 1.475 0.784 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -66.94 168.67 16.56 Favored 'Trans proline' 0 CA--C 1.544 1.004 0 C-N-CA 122.671 2.247 . . . . 0.0 112.759 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.82 -32.36 18.46 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.768 2.312 . . . . 0.0 112.447 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.87 -5.96 44.26 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.448 1.099 . . . . 0.0 112.017 176.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.758 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -71.28 -57.03 4.86 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.418 1.087 . . . . 0.0 112.487 176.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.52 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -56.81 -24.2 49.14 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 174.844 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -49.08 -55.32 12.54 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.671 1.189 . . . . 0.0 111.527 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.648 HG21 ' O ' ' A' ' 55' ' ' TYR . 94.9 m -66.28 -43.02 87.57 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 176.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.656 HD21 ' OD2' ' A' ' 79' ' ' ASP . 95.6 mt -52.36 -35.5 51.45 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 173.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -67.35 -41.14 85.63 Favored 'General case' 0 C--O 1.207 -1.181 0 CA-C-N 113.868 -1.515 . . . . 0.0 110.77 175.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 18' ' ' THR . 31.5 mt -67.2 -36.17 81.17 Favored 'General case' 0 C--O 1.213 -0.857 0 CA-C-O 118.12 -0.943 . . . . 0.0 112.093 175.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.581 HD12 ' O ' ' A' ' 18' ' ' THR . 2.4 mt -64.33 -43.0 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 118.852 0.751 . . . . 0.0 111.616 172.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.36 -46.56 63.84 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.689 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.1 t -72.76 -12.03 60.84 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.267 1.827 . . . . 0.0 111.542 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 t0 54.52 40.62 31.96 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.256 1.422 . . . . 0.0 110.289 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.03 -170.52 39.68 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 113.055 -1.884 . . . . 0.0 115.969 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -74.67 139.81 63.78 Favored 'Cis proline' 0 C--N 1.347 0.454 0 O-C-N 124.096 1.577 . . . . 0.0 111.976 -1.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -90.55 135.53 29.2 Favored Pre-proline 0 N--CA 1.481 1.085 0 CA-C-N 113.723 -1.58 . . . . 0.0 110.849 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -72.5 -61.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.475 0.423 0 C-N-CA 123.216 2.611 . . . . 0.0 112.073 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.402 ' CD1' HD11 ' A' ' 58' ' ' ILE . 3.0 m-30 -64.15 146.95 53.37 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 118.847 -0.597 . . . . 0.0 110.658 176.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.6 t -65.38 -13.69 59.18 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 125.4 1.688 . . . . 0.0 112.956 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -80.96 77.38 7.87 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 122.734 1.254 . . . . 0.0 112.355 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -177.54 148.5 0.57 Allowed 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 111.104 -2.771 . . . . 0.0 113.307 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.4 31.98 29.35 Favored Glycine 0 N--CA 1.479 1.521 0 CA-C-N 113.084 -1.871 . . . . 0.0 111.306 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.64 146.85 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.218 1.007 . . . . 0.0 109.905 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.0 t -86.58 152.87 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 125.949 2.031 . . . . 0.0 110.014 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.521 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 44.8 t80 -130.28 93.75 3.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 113.518 -1.674 . . . . 0.0 108.838 175.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.508 ' HG3' ' CD1' ' A' ' 49' ' ' TYR . 7.6 tm0? -71.93 54.0 0.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.087 -1.008 . . . . 0.0 111.969 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.408 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 16.5 p-10 26.18 56.12 0.05 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.413 2.285 . . . . 0.0 111.035 -176.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -25.87 55.22 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.03 -172.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.567 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.8 mt-10 -78.0 -13.26 59.94 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-N 112.981 -1.918 . . . . 0.0 115.125 172.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.9 t 45.24 41.67 6.29 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 123.847 1.784 . . . . 0.0 111.886 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 41' ' ' GLU . 44.2 t -107.72 -14.14 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 113.732 -1.577 . . . . 0.0 110.126 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.812 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.317 -0.819 0 CA-C-O 117.662 -1.161 . . . . 0.0 108.451 -171.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.508 ' CD1' ' HG3' ' A' ' 38' ' ' GLN . 9.8 t80 . . . . . 0 N--CA 1.478 0.95 0 CA-C-O 121.075 0.464 . . . . 0.0 110.117 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.06 9.99 77.17 Favored Glycine 0 CA--C 1.542 1.773 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.851 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.456 ' HD2' ' CE1' ' A' ' 52' ' ' TYR . 57.5 t80 -82.09 8.79 9.86 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.474 1.109 . . . . 0.0 111.391 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.812 ' HE2' HD12 ' A' ' 44' ' ' LEU . 11.7 m-85 -146.73 145.84 30.1 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -141.36 157.2 45.5 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 126.541 2.401 . . . . 0.0 110.883 178.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -110.4 143.07 41.21 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.864 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.648 ' O ' HG21 ' A' ' 18' ' ' THR . 79.6 m-85 -158.78 69.67 0.49 Allowed 'General case' 0 N--CA 1.471 0.579 0 O-C-N 126.107 2.13 . . . . 0.0 110.144 -175.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 6.3 m -43.37 129.06 5.0 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 122.971 1.367 . . . . 0.0 112.197 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.758 HG21 ' HA ' ' A' ' 15' ' ' ALA . 1.8 p -89.3 118.12 33.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 111.109 -2.769 . . . . 0.0 109.965 178.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.402 HD11 ' CD1' ' A' ' 30' ' ' TYR . 0.4 OUTLIER -43.32 151.69 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.227 170.309 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.567 ' OG1' ' HG3' ' A' ' 68' ' ' ARG . 3.4 m -145.29 142.85 18.78 Favored Pre-proline 0 N--CA 1.475 0.823 0 CA-C-N 113.64 -1.618 . . . . 0.0 111.647 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.433 ' HD2' HG23 ' A' ' 59' ' ' THR . 73.4 Cg_endo -75.57 145.12 29.21 Favored 'Trans proline' 0 N--CA 1.479 0.658 0 C-N-CA 121.824 1.683 . . . . 0.0 110.216 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.86 28.16 57.16 Favored Glycine 0 CA--C 1.546 2.01 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.189 -175.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.7 92.44 6.58 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -39.41 -33.64 0.17 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 114.204 -1.362 . . . . 0.0 113.296 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 57.7 p -130.57 -160.56 1.05 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.888 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.2 mtm180 -56.08 -19.79 14.49 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 172.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.16 167.55 3.19 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 123.889 1.827 . . . . 0.0 109.379 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.435 HG22 ' HB2' ' A' ' 85' ' ' HIS . 40.7 p -71.27 -5.26 30.85 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 112.423 -1.888 . . . . 0.0 113.286 176.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.567 ' HG3' ' OG1' ' A' ' 59' ' ' THR . 0.2 OUTLIER -73.0 117.03 14.23 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.561 1.172 . . . . 0.0 110.161 177.624 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 0.8 OUTLIER -140.24 133.8 30.16 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 113.865 -1.516 . . . . 0.0 109.191 179.28 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.526 HG23 ' OD1' ' A' ' 79' ' ' ASP . 4.7 mt -105.42 133.67 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 125.923 2.014 . . . . 0.0 107.835 175.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.505 ' O ' ' HD2' ' A' ' 80' ' ' TYR . 23.3 mm -123.5 107.16 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 113.525 -1.67 . . . . 0.0 107.415 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.5 p -93.5 163.87 13.4 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 120.969 0.414 . . . . 0.0 110.696 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.57 -172.17 23.8 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.256 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.64 -14.15 60.0 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.322 0.582 . . . . 0.0 112.158 175.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -115.93 131.57 56.9 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.553 HG22 ' HG2' ' A' ' 77' ' ' GLN . 7.5 m -56.34 151.53 12.77 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.836 175.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.553 ' HG2' HG22 ' A' ' 76' ' ' THR . 1.0 OUTLIER 74.82 32.97 0.8 Allowed 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 123.508 1.623 . . . . 0.0 110.766 -179.54 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.413 ' HA ' HD22 ' A' ' 91' ' ' LEU . 1.2 mt-10 -138.76 57.09 1.69 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 113.547 -1.66 . . . . 0.0 112.479 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.656 ' OD2' HD21 ' A' ' 19' ' ' LEU . 1.8 t0 -101.98 130.03 48.41 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 113.882 -1.508 . . . . 0.0 108.461 174.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.526 ' CE1' HG21 ' A' ' 2' ' ' VAL . 26.6 m-85 -102.27 129.15 48.6 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.714 -1.584 . . . . 0.0 109.465 175.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.732 ' HB2' HD11 ' A' ' 92' ' ' ILE . 10.1 t80 -108.21 124.37 50.18 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 113.641 -1.618 . . . . 0.0 109.001 -177.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.54 ' HB ' ' O ' ' A' ' 88' ' ' THR 0.265 0.5 OUTLIER -86.0 -68.4 0.74 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 113.09 -1.868 . . . . 0.0 112.037 176.161 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.453 ' HA2' ' HD2' ' A' ' 68' ' ' ARG . . . 68.87 1.65 26.04 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 114.605 -1.179 . . . . 0.0 113.876 -172.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.57 ' CB ' ' HB3' ' A' ' 87' ' ' ALA . 59.0 m-20 -129.7 12.13 5.78 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.392 1.077 . . . . 0.0 113.631 178.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.435 ' HB2' HG22 ' A' ' 67' ' ' THR . 40.4 t-80 61.92 81.28 0.2 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.513 2.325 . . . . 0.0 111.647 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.434 ' HB3' ' OE1' ' A' ' 41' ' ' GLU . 17.0 m-85 54.2 33.29 17.73 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 114.424 -1.262 . . . . 0.0 113.997 -175.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.57 ' HB3' ' CB ' ' A' ' 84' ' ' ASP . . . -111.71 -6.76 14.3 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.54 ' O ' ' HB ' ' A' ' 82' ' ' THR . 6.5 p -163.91 165.17 22.98 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.768 1.627 . . . . 0.0 108.122 -177.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.616 ' CG ' HD21 ' A' ' 44' ' ' LEU . 86.1 m-85 -159.55 117.91 2.79 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 -174.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.52 106.5 5.97 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.357 -1.747 . . . . 0.0 108.432 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 91' ' ' LEU . 18.1 mt -40.47 157.29 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.638 177.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.732 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.7 mp -104.29 133.18 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.045 -1.035 . . . . 0.0 109.517 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.99 89.37 2.98 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 113.329 -1.76 . . . . 0.0 109.338 177.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -63.7 -40.46 96.85 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.409 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 t -51.39 -40.01 58.35 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 125.295 1.622 . . . . 0.0 112.813 172.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 8.4 t . . . . . 0 C--O 1.258 1.51 0 CA-C-O 116.733 -1.604 . . . . 0.0 110.747 178.445 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.6 m -64.37 -8.26 12.57 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 175.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.46 169.46 12.68 Favored Glycine 0 N--CA 1.474 1.196 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.454 HG23 ' HB3' ' A' ' 91' ' ' LEU . 1.8 m -78.76 172.02 14.33 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.566 -0.817 . . . . 0.0 110.782 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 91' ' ' LEU . 3.9 p -145.65 108.06 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -174.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 57.6 m -42.9 138.32 2.05 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 113.266 -1.788 . . . . 0.0 111.658 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.719 ' HA ' HD12 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -59.84 -33.03 71.24 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.756 0.66 . . . . 0.0 111.962 -178.493 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.4 t -70.85 -15.79 62.66 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.773 174.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.13 -37.45 46.14 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.65 0.738 . . . . 0.0 111.832 176.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.719 HD12 ' HA ' ' A' ' 8' ' ' LEU . 2.3 mt -77.83 166.28 44.83 Favored Pre-proline 0 N--CA 1.475 0.788 0 C-N-CA 124.531 1.133 . . . . 0.0 111.111 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.67 169.89 15.02 Favored 'Trans proline' 0 CA--C 1.553 1.471 0 C-N-CA 122.713 2.275 . . . . 0.0 113.353 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.3 -15.88 39.12 Favored 'Trans proline' 0 N--CA 1.484 0.932 0 C-N-CA 122.305 2.004 . . . . 0.0 113.437 175.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.416 ' CD ' ' HD3' ' A' ' 60' ' ' PRO . 1.9 mt-10 -93.81 4.81 53.37 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.935 0.894 . . . . 0.0 112.111 178.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.635 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -80.86 -48.11 12.86 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.96 176.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.568 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -58.28 -23.03 54.92 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.413 -1.267 . . . . 0.0 112.701 174.381 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.461 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 9.9 t0 -49.97 -58.01 6.34 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.289 1.035 . . . . 0.0 110.324 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.696 ' HA ' HD12 ' A' ' 21' ' ' LEU . 44.7 m -56.63 -49.49 74.84 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 177.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.691 HD11 HG21 ' A' ' 92' ' ' ILE . 7.8 mt -55.53 -35.73 65.98 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 123.805 0.69 . . . . 0.0 111.693 178.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -68.34 -38.48 81.53 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.015 173.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.696 HD12 ' HA ' ' A' ' 18' ' ' THR . 33.9 mt -69.19 -34.8 75.48 Favored 'General case' 0 C--O 1.212 -0.874 0 CA-C-O 118.746 -0.645 . . . . 0.0 110.954 175.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.602 HD12 ' O ' ' A' ' 18' ' ' THR . 1.6 mp -69.76 -40.73 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 120.186 1.357 . . . . 0.0 111.312 172.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.8 -42.48 67.02 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.023 -0.989 . . . . 0.0 112.291 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.27 7.55 42.21 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.116 0.966 . . . . 0.0 111.35 177.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.0 t0 39.52 52.5 2.34 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 123.209 1.48 . . . . 0.0 112.156 -178.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.3 -164.77 40.44 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 112.721 -2.036 . . . . 0.0 115.659 -173.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.9 141.44 71.75 Favored 'Cis proline' 0 C--N 1.346 0.415 0 O-C-N 124.678 1.883 . . . . 0.0 111.849 -2.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 21' ' ' LEU . 75.7 m-85 -94.52 132.92 27.78 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.248 -176.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.451 ' HG2' ' CD1' ' A' ' 58' ' ' ILE . 36.6 Cg_endo -75.12 -59.55 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.546 2.164 . . . . 0.0 111.24 -177.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -60.69 157.76 14.01 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.486 0.66 . . . . 0.0 112.436 175.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.4 t -77.43 -10.58 59.55 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 122.524 1.154 . . . . 0.0 112.215 175.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -91.6 87.56 6.4 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.624 0.726 . . . . 0.0 112.21 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 172.29 136.33 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 111.517 -2.583 . . . . 0.0 114.259 -174.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.08 28.75 16.9 Favored Glycine 0 N--CA 1.48 1.602 0 CA-C-N 113.189 -1.823 . . . . 0.0 111.729 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.446 HG23 ' OE1' ' A' ' 54' ' ' GLU . 13.2 m -123.48 146.59 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 113.6 -1.3 . . . . 0.0 109.713 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.0 t -81.95 156.79 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 125.536 1.772 . . . . 0.0 109.724 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.436 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 48.2 t80 -139.23 86.28 2.12 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.634 176.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -69.66 52.86 0.11 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 122.401 1.096 . . . . 0.0 113.629 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.2 t30 31.23 55.17 0.23 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 127.057 2.143 . . . . 0.0 109.399 -172.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.56 -31.32 62.05 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 122.454 1.121 . . . . 0.0 111.766 -175.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.557 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.7 mt-10 -79.06 -8.15 58.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 112.928 -1.942 . . . . 0.0 114.3 174.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 39.9 t 43.82 42.66 4.61 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 124.132 1.92 . . . . 0.0 111.975 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 41' ' ' GLU . 61.7 t -107.36 -18.05 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 113.301 -1.772 . . . . 0.0 109.704 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.538 HD21 ' CD1' ' A' ' 89' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--N 1.32 -0.679 0 O-C-N 121.189 -0.944 . . . . 0.0 108.657 -176.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.6 t80 . . . . . 0 N--CA 1.464 0.253 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.08 -22.71 33.04 Favored Glycine 0 N--CA 1.476 1.318 0 O-C-N 125.708 1.88 . . . . 0.0 111.691 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.46 -13.9 45.19 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 124.325 1.05 . . . . 0.0 112.924 175.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.431 ' OH ' ' HB3' ' A' ' 44' ' ' LEU . 17.4 m-85 -116.78 162.44 17.69 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.412 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -158.92 159.81 35.36 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 112.515 -2.13 . . . . 0.0 111.686 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.446 ' OE1' HG23 ' A' ' 35' ' ' VAL . 1.4 mt-10 -117.64 136.39 53.34 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.85 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.501 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 86.4 m-85 -151.6 75.52 1.17 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 113.622 -1.626 . . . . 0.0 110.212 -176.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.554 HG21 ' HG2' ' A' ' 65' ' ' ARG . 52.8 m -42.91 138.56 1.98 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 122.438 1.113 . . . . 0.0 112.516 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.635 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.5 OUTLIER -98.36 106.89 19.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 112.195 -2.275 . . . . 0.0 110.073 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.451 ' CD1' ' HG2' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -39.36 147.04 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.266 172.126 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.472 HG23 ' HD2' ' A' ' 60' ' ' PRO . 3.2 m -144.44 140.65 16.9 Favored Pre-proline 0 N--CA 1.473 0.722 0 O-C-N 125.465 1.728 . . . . 0.0 112.018 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.472 ' HD2' HG23 ' A' ' 59' ' ' THR . 71.9 Cg_endo -74.34 146.31 35.44 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.066 1.844 . . . . 0.0 110.177 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.63 25.42 55.48 Favored Glycine 0 N--CA 1.485 1.937 0 CA-C-N 114.22 -1.355 . . . . 0.0 112.196 -175.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.71 91.38 6.99 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -39.96 -32.22 0.15 Allowed 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 113.585 -1.643 . . . . 0.0 113.325 176.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.0 p -131.26 -159.0 0.93 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.505 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.554 ' HG2' HG21 ' A' ' 56' ' ' THR . 0.0 OUTLIER -59.09 -18.05 31.82 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.968 -1.015 . . . . 0.0 113.585 171.642 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.33 162.5 0.59 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-O 123.697 1.721 . . . . 0.0 109.59 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.511 HG22 ' HB2' ' A' ' 85' ' ' HIS . 24.3 p -65.65 -10.73 38.72 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 113.137 -1.531 . . . . 0.0 113.241 174.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.49 ' HD2' ' HA2' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -64.94 124.46 22.1 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 123.279 1.514 . . . . 0.0 110.715 175.658 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.24 144.76 26.73 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 112.866 -1.97 . . . . 0.0 110.588 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 55' ' ' TYR . 8.4 mt -120.44 137.04 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 125.398 1.686 . . . . 0.0 108.673 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.47 ' O ' ' HD2' ' A' ' 80' ' ' TYR . 16.7 mm -127.57 102.41 8.93 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 CA-C-N 112.737 -2.029 . . . . 0.0 107.758 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.479 HG22 ' HB3' ' A' ' 79' ' ' ASP . 17.7 p -90.16 163.37 14.85 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.667 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -116.77 165.67 12.35 Favored Glycine 0 N--CA 1.471 0.981 0 CA-C-N 113.534 -1.666 . . . . 0.0 109.357 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.49 -14.9 62.9 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.701 0.763 . . . . 0.0 111.687 176.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.443 ' HB3' ' OE2' ' A' ' 78' ' ' GLU . . . -106.27 131.04 53.97 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.622 HG22 ' HG2' ' A' ' 77' ' ' GLN . 3.0 m -55.34 143.14 29.48 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 113.776 -1.556 . . . . 0.0 108.361 174.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.622 ' HG2' HG22 ' A' ' 76' ' ' THR . 0.0 OUTLIER 79.6 34.57 0.18 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.936 2.095 . . . . 0.0 111.224 179.49 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.443 ' OE2' ' HB3' ' A' ' 75' ' ' ALA . 37.9 mt-10 -129.79 49.95 2.22 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 123.232 1.491 . . . . 0.0 112.299 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.479 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -107.55 100.99 10.36 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 113.607 -1.633 . . . . 0.0 110.307 -176.64 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.47 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 22.2 m-85 -89.83 135.2 33.77 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 113.996 -1.457 . . . . 0.0 109.319 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.725 ' HB2' HD11 ' A' ' 92' ' ' ILE . 11.0 t80 -115.2 127.42 55.51 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.947 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.536 ' HB ' ' O ' ' A' ' 88' ' ' THR 0.251 0.4 OUTLIER -86.77 -68.87 0.71 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 113.012 -1.904 . . . . 0.0 111.417 176.823 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.49 ' HA2' ' HD2' ' A' ' 68' ' ' ARG . . . 69.01 1.7 27.26 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 114.047 -1.433 . . . . 0.0 113.544 -172.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.626 ' CB ' ' HB3' ' A' ' 87' ' ' ALA . 74.0 m-20 -129.9 10.47 5.49 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.237 1.015 . . . . 0.0 113.595 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.511 ' HB2' HG22 ' A' ' 67' ' ' THR . 43.6 t-80 64.88 80.13 0.24 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 128.081 2.552 . . . . 0.0 110.698 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.468 ' HB3' ' CD ' ' A' ' 41' ' ' GLU . 17.0 m-85 55.82 26.19 9.32 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 122.928 1.347 . . . . 0.0 113.413 -174.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.626 ' HB3' ' CB ' ' A' ' 84' ' ' ASP . . . -102.51 -8.86 20.69 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.54 -1.35 . . . . 0.0 112.766 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.536 ' O ' ' HB ' ' A' ' 82' ' ' THR . 12.5 p -163.14 169.37 19.47 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.621 1.568 . . . . 0.0 108.859 -176.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.538 ' CD1' HD21 ' A' ' 44' ' ' LEU . 92.5 m-85 -158.5 115.14 2.78 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -174.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.49 107.04 8.61 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 113.203 -1.817 . . . . 0.0 109.483 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.538 ' O ' HG12 ' A' ' 6' ' ' VAL . 18.0 mt -42.8 160.94 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 177.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.725 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.3 mp -110.05 113.72 45.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 O-C-N 120.982 -1.074 . . . . 0.0 109.194 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.09 87.21 7.35 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 113.833 -1.53 . . . . 0.0 109.686 176.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.529 ' HG3' HG22 ' A' ' 92' ' ' ILE . 2.4 mp0 -67.65 -31.41 71.39 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.643 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.6 t -55.64 -27.96 52.72 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.849 173.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.4 t . . . . . 0 C--O 1.253 1.265 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.887 177.691 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.529 HG12 ' H ' ' A' ' 4' ' ' GLY . 16.0 t . . . . . 0 N--CA 1.469 0.518 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 m -72.79 4.76 3.74 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 125.021 1.45 . . . . 0.0 113.095 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.529 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 123.09 168.89 13.18 Favored Glycine 0 C--O 1.216 -1.014 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 6' ' ' VAL . 3.4 m -76.68 174.62 10.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.653 -1.273 . . . . 0.0 110.159 -178.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.452 ' H ' HG22 ' A' ' 5' ' ' THR . 0.6 OUTLIER -140.36 109.38 3.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -175.108 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 74.9 m -47.19 125.37 7.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 112.669 -2.06 . . . . 0.0 109.367 176.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -49.81 -36.26 25.85 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 118.771 -0.633 . . . . 0.0 111.745 175.404 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.9 t -65.07 -28.52 69.52 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.889 0.852 . . . . 0.0 112.503 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 7' ' ' CYS . . . -75.22 -23.96 57.67 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.714 175.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.563 HD13 ' HB1' ' A' ' 15' ' ' ALA . 12.0 mt -83.52 160.44 59.14 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 176.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.508 ' HB2' ' OE2' ' A' ' 14' ' ' GLU . 79.1 Cg_endo -69.04 170.44 15.72 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.237 1.958 . . . . 0.0 112.826 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.35 -13.43 33.19 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.723 2.282 . . . . 0.0 114.235 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.508 ' OE2' ' HB2' ' A' ' 12' ' ' PRO . 1.5 pm0 -95.28 -3.45 47.43 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.642 175.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.721 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -72.6 -50.45 25.24 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.909 177.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.21 -24.97 45.39 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.284 -1.326 . . . . 0.0 112.204 175.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.477 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 35.0 t0 -51.44 -60.18 3.42 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.374 1.046 . . . . 0.0 110.012 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.789 ' HA ' HD12 ' A' ' 21' ' ' LEU . 16.2 m -55.95 -52.24 64.86 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.647 0.592 . . . . 0.0 112.426 177.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.58 HD11 HG21 ' A' ' 92' ' ' ILE . 6.1 mt -52.72 -34.15 51.17 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.517 0.51 . . . . 0.0 111.837 178.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -70.39 -40.72 73.76 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 124.102 0.961 . . . . 0.0 110.818 174.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.789 HD12 ' HA ' ' A' ' 18' ' ' THR . 26.5 mt -67.79 -32.21 72.63 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 119.095 -0.478 . . . . 0.0 110.23 175.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.723 HD12 ' O ' ' A' ' 18' ' ' THR . 1.6 mp -69.9 -43.08 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 120.597 1.544 . . . . 0.0 111.684 172.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.01 -42.76 72.58 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 125.034 1.459 . . . . 0.0 111.844 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.78 7.41 39.86 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.482 1.113 . . . . 0.0 111.748 177.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.6 t70 40.6 50.24 2.84 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 125.283 1.433 . . . . 0.0 110.977 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.59 -166.77 45.77 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 113.616 -1.629 . . . . 0.0 114.864 -173.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.53 141.03 69.91 Favored 'Cis proline' 0 N--CA 1.48 0.732 0 O-C-N 124.209 1.637 . . . . 0.0 111.19 0.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -91.21 136.23 27.41 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 113.051 -1.886 . . . . 0.0 111.656 -177.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.453 ' HG2' ' CD1' ' A' ' 58' ' ' ILE . 33.5 Cg_endo -74.76 -63.63 0.03 OUTLIER 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 122.463 2.108 . . . . 0.0 111.076 -178.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -59.59 150.62 26.76 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.548 0.689 . . . . 0.0 111.596 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.69 -5.71 42.26 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.024 176.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -97.38 88.89 4.54 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.957 0.884 . . . . 0.0 112.261 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 169.99 134.16 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 112.115 -2.311 . . . . 0.0 113.751 -175.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.65 17.26 33.87 Favored Glycine 0 N--CA 1.484 1.872 0 CA-C-N 112.706 -2.043 . . . . 0.0 111.846 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.466 HG23 ' HB2' ' A' ' 54' ' ' GLU . 15.9 m -109.62 150.75 12.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 123.634 0.774 . . . . 0.0 109.502 176.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.3 t -84.01 154.47 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 O-C-N 125.674 1.859 . . . . 0.0 110.473 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.556 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 57.6 t80 -131.92 92.5 3.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.549 176.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.93 47.69 0.06 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.398 1.094 . . . . 0.0 112.96 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.406 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 40.4 t30 28.91 53.0 0.08 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.459 1.503 . . . . 0.0 110.628 -173.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.89 -23.46 53.27 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 113.912 -1.494 . . . . 0.0 110.984 -172.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.597 ' O ' HG23 ' A' ' 43' ' ' VAL . 4.3 mt-10 -86.77 -12.86 46.89 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 112.684 -2.053 . . . . 0.0 113.868 173.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.4 t 43.75 43.53 5.02 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 124.605 2.145 . . . . 0.0 111.663 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 41' ' ' GLU . 79.5 t -105.75 -17.74 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 112.689 -2.051 . . . . 0.0 110.007 -178.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.552 HD21 ' CD1' ' A' ' 89' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.51 0 CA-C-O 117.691 -1.147 . . . . 0.0 108.878 -175.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.9 t80 . . . . . 0 N--CA 1.463 0.202 0 CA-C-O 120.05 -0.024 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.58 -16.78 38.5 Favored Glycine 0 N--CA 1.479 1.559 0 O-C-N 125.022 1.451 . . . . 0.0 111.904 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -68.13 -9.79 49.22 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.63 0.772 . . . . 0.0 112.149 176.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.556 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 24.6 m-85 -121.3 169.4 10.62 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 124.298 1.039 . . . . 0.0 109.791 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -159.79 164.13 33.99 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 113.237 -1.801 . . . . 0.0 110.659 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.466 ' HB2' HG23 ' A' ' 35' ' ' VAL . 3.5 mp0 -118.98 139.73 51.19 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.846 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.631 ' HB3' HG23 ' A' ' 18' ' ' THR . 26.9 m-85 -153.09 61.9 0.77 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 125.81 1.944 . . . . 0.0 111.36 -175.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 23.3 m -38.24 124.39 1.22 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.362 1.077 . . . . 0.0 112.089 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.721 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -86.66 108.74 18.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 111.901 -2.409 . . . . 0.0 108.767 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.453 ' CD1' ' HG2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -38.23 146.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.443 172.997 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.479 ' OG1' ' HG3' ' A' ' 68' ' ' ARG . 3.4 m -137.29 140.26 30.29 Favored Pre-proline 0 C--N 1.324 -0.53 0 O-C-N 125.157 1.535 . . . . 0.0 111.654 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.499 ' HD3' ' CD ' ' A' ' 14' ' ' GLU . 71.8 Cg_endo -74.25 150.05 41.45 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.188 2.592 . . . . 0.0 109.502 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 49.73 30.96 15.18 Favored Glycine 0 N--CA 1.479 1.523 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.904 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.01 88.87 5.39 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -41.8 -29.72 0.21 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.247 -1.342 . . . . 0.0 112.794 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.7 p -126.24 -163.69 1.25 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.997 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -59.43 -15.75 19.19 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 173.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.55 153.67 0.8 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.535 HG22 ' HB2' ' A' ' 85' ' ' HIS . 24.6 p -67.23 -8.86 34.9 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 112.671 -1.765 . . . . 0.0 112.761 176.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.479 ' HG3' ' OG1' ' A' ' 59' ' ' THR . 0.0 OUTLIER -70.14 116.04 10.04 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.54 1.136 . . . . 0.0 110.413 177.039 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 0.4 OUTLIER -140.05 137.96 35.01 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.887 -1.506 . . . . 0.0 109.452 179.149 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.596 HG23 ' OD1' ' A' ' 79' ' ' ASP . 4.7 mt -109.05 141.08 25.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 113.644 -1.616 . . . . 0.0 109.097 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.492 ' HB ' ' HB2' ' A' ' 80' ' ' TYR . 19.0 mm -129.42 107.03 14.61 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 CA-C-N 113.808 -1.542 . . . . 0.0 109.309 -177.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.527 HG21 HG12 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -83.05 167.45 17.87 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 123.348 0.659 . . . . 0.0 110.861 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -120.34 173.18 15.23 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.03 -14.84 63.29 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 113.866 -1.167 . . . . 0.0 111.691 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.31 128.48 54.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.434 175.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.624 HG22 ' HG2' ' A' ' 77' ' ' GLN . 2.3 m -59.06 141.81 53.03 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 113.506 -1.679 . . . . 0.0 106.98 175.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.624 ' HG2' HG22 ' A' ' 76' ' ' THR . 0.3 OUTLIER 81.28 32.04 0.13 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 126.193 2.183 . . . . 0.0 111.002 178.327 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -133.45 57.47 1.81 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.786 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.596 ' OD1' HG23 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -99.74 122.16 42.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.53 -1.668 . . . . 0.0 110.19 178.211 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.492 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 40.4 m-85 -95.55 137.68 34.29 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 124.914 1.286 . . . . 0.0 109.373 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.71 ' HB2' HD11 ' A' ' 92' ' ' ILE . 7.1 t80 -116.64 123.74 48.05 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.717 -177.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.562 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.5 OUTLIER -86.93 -66.21 0.93 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 113.663 -1.608 . . . . 0.0 110.734 178.187 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.08 2.31 17.56 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-N 113.598 -1.637 . . . . 0.0 113.092 -173.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.642 ' CB ' ' HB3' ' A' ' 87' ' ' ALA . 80.9 m-20 -129.63 8.6 5.39 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.535 ' HB2' HG22 ' A' ' 67' ' ' THR . 45.5 t-80 67.76 80.81 0.2 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 128.213 2.605 . . . . 0.0 110.556 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.409 ' HB3' ' CD ' ' A' ' 41' ' ' GLU . 19.6 m-85 55.67 24.3 7.0 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 123.695 1.712 . . . . 0.0 112.99 -175.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.642 ' HB3' ' CB ' ' A' ' 84' ' ' ASP . . . -99.74 -10.07 22.3 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 117.954 -1.498 . . . . 0.0 112.391 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.562 ' O ' ' HB ' ' A' ' 82' ' ' THR . 15.5 p -162.89 171.98 15.82 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 -177.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.552 ' CD1' HD21 ' A' ' 44' ' ' LEU . 89.7 m-85 -159.91 114.17 2.27 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -174.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.01 104.91 7.09 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 113.854 -1.521 . . . . 0.0 108.682 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 91' ' ' LEU . 19.0 mt -42.05 164.66 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 O-C-N 124.209 0.943 . . . . 0.0 112.101 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.71 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.7 mp -111.41 134.5 53.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 O-C-N 120.699 -1.251 . . . . 0.0 108.996 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.29 93.91 4.67 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.661 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.502 HE21 ' HB2' ' A' ' 94' ' ' GLN . 0.0 OUTLIER -56.39 -38.09 71.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 123.976 0.798 . . . . 0.0 112.102 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.3 t -54.71 -46.49 74.18 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.047 1.339 . . . . 0.0 112.67 173.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 24.7 t . . . . . 0 C--O 1.249 1.029 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.43 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.64 HG12 ' H ' ' A' ' 4' ' ' GLY . 43.9 t . . . . . 0 N--CA 1.472 0.659 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 t -69.59 -2.36 11.32 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 124.731 1.269 . . . . 0.0 112.96 176.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.64 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 124.36 169.03 12.99 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.517 1.532 . . . . 0.0 109.474 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.482 HG23 ' CB ' ' A' ' 91' ' ' LEU . 1.8 m -81.77 169.46 16.9 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.839 0.828 . . . . 0.0 110.377 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 p -140.47 107.77 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -174.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 61.5 m -47.09 136.6 8.54 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 113.542 -1.663 . . . . 0.0 111.063 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.53 HD11 ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -56.89 -32.17 65.61 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.837 -178.866 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.1 t -66.77 -29.02 68.87 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.863 173.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.13 -29.76 60.62 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.396 0.679 . . . . 0.0 111.523 175.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.59 HD13 ' HB1' ' A' ' 15' ' ' ALA . 13.5 mt -77.98 160.64 73.4 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 175.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.643 ' HB2' ' OE2' ' A' ' 14' ' ' GLU . 86.3 Cg_endo -68.72 168.01 21.33 Favored 'Trans proline' 0 CA--C 1.554 1.482 0 C-N-CA 122.559 2.173 . . . . 0.0 112.799 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.29 -12.41 34.88 Favored 'Trans proline' 0 CA--C 1.55 1.306 0 C-N-CA 123.156 2.57 . . . . 0.0 113.944 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.643 ' OE2' ' HB2' ' A' ' 12' ' ' PRO . 1.7 pm0 -93.38 -11.84 31.32 Favored 'General case' 0 C--O 1.216 -0.705 0 C-N-CA 124.998 1.319 . . . . 0.0 113.188 174.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.809 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -65.15 -50.08 67.4 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 175.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.53 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -56.05 -26.44 49.22 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.937 173.558 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.491 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 13.9 t70 -54.98 -56.84 15.27 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.153 0.981 . . . . 0.0 110.132 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.672 ' O ' HD12 ' A' ' 22' ' ' ILE . 5.5 m -57.15 -49.1 77.01 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 176.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.624 HD11 HG21 ' A' ' 92' ' ' ILE . 9.8 mt -55.85 -35.72 66.74 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.898 0.749 . . . . 0.0 111.806 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -67.91 -37.36 81.6 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.63 174.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.644 HD12 ' HA ' ' A' ' 18' ' ' THR . 28.2 mt -69.17 -32.01 71.04 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 118.494 -0.765 . . . . 0.0 111.629 173.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.672 HD12 ' O ' ' A' ' 18' ' ' THR . 1.8 mp -69.42 -43.85 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 119.668 1.122 . . . . 0.0 111.969 171.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.13 -42.99 71.87 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.119 -1.4 . . . . 0.0 112.863 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.17 4.49 50.34 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.454 1.102 . . . . 0.0 112.084 177.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.7 t0 40.94 50.39 3.1 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.495 1.518 . . . . 0.0 111.383 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.18 -164.93 28.73 Favored Glycine 0 N--CA 1.473 1.149 0 CA-C-N 111.932 -2.395 . . . . 0.0 116.524 -174.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -74.08 141.56 72.11 Favored 'Cis proline' 0 C--N 1.348 0.524 0 O-C-N 124.462 1.769 . . . . 0.0 111.79 -3.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -96.9 116.5 66.09 Favored Pre-proline 0 N--CA 1.47 0.57 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.208 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.94 -48.17 0.3 Allowed 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 122.865 2.377 . . . . 0.0 111.927 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.404 ' CE2' ' HG2' ' A' ' 65' ' ' ARG . 0.2 OUTLIER -67.3 132.44 47.73 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.104 176.14 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.8 m -70.76 56.9 0.19 Allowed 'General case' 0 N--CA 1.477 0.925 0 O-C-N 125.17 1.544 . . . . 0.0 112.771 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -157.08 73.65 0.76 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 113.566 -1.652 . . . . 0.0 111.863 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.57 144.74 1.14 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 110.987 -2.824 . . . . 0.0 113.481 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.91 23.67 37.8 Favored Glycine 0 CA--C 1.538 1.526 0 CA-C-N 113.237 -1.801 . . . . 0.0 111.839 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.8 m -122.08 145.22 29.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 C-N-CA 124.748 1.219 . . . . 0.0 110.203 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.3 t -81.44 154.13 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 O-C-N 125.969 2.043 . . . . 0.0 110.165 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.433 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 49.8 t80 -131.34 91.7 3.06 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 113.565 -1.652 . . . . 0.0 109.324 175.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.91 51.6 0.15 Allowed 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 119.614 1.097 . . . . 0.0 113.23 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 28.66 52.95 0.07 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 126.81 2.044 . . . . 0.0 110.252 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -26.21 60.75 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 121.771 0.796 . . . . 0.0 112.858 -172.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.548 ' O ' HG23 ' A' ' 43' ' ' VAL . 3.5 mt-10 -74.95 -16.79 60.63 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 112.621 -2.081 . . . . 0.0 114.593 171.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.8 t 45.86 41.1 7.39 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 124.024 1.869 . . . . 0.0 111.388 -177.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 41' ' ' GLU . 89.1 t -104.21 -11.38 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 112.758 -2.019 . . . . 0.0 109.65 -178.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.565 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.2 OUTLIER . . . . . 0 CA--C 1.547 0.832 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.523 -174.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.6 t80 . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.48 -17.33 39.81 Favored Glycine 0 N--CA 1.474 1.205 0 CA-C-N 114.03 -1.441 . . . . 0.0 112.721 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.62 -1.08 20.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.013 1.325 . . . . 0.0 113.867 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.565 ' HE2' HD12 ' A' ' 44' ' ' LEU . 18.3 m-85 -129.77 151.51 50.28 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.489 1.116 . . . . 0.0 109.598 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -147.29 155.4 42.0 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 126.278 2.236 . . . . 0.0 110.581 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.433 ' HG3' ' HB2' ' A' ' 37' ' ' PHE . 1.9 mt-10 -108.96 132.93 53.61 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.298 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.505 ' HB3' HG23 ' A' ' 18' ' ' THR . 26.4 m-85 -145.75 62.95 1.26 Allowed 'General case' 0 N--CA 1.471 0.584 0 O-C-N 125.64 1.838 . . . . 0.0 110.715 -176.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 1.2 m -38.53 127.79 1.46 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 122.194 0.997 . . . . 0.0 112.85 178.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.809 HG21 ' HA ' ' A' ' 15' ' ' ALA . 1.1 p -90.8 113.24 26.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 111.783 -2.462 . . . . 0.0 109.201 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -36.89 145.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 114.022 -1.444 . . . . 0.0 110.506 171.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.401 HG23 ' HD2' ' A' ' 60' ' ' PRO . 3.4 m -136.66 140.16 31.29 Favored Pre-proline 0 N--CA 1.476 0.839 0 O-C-N 125.472 1.733 . . . . 0.0 112.48 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.511 ' HD3' ' CD ' ' A' ' 14' ' ' GLU . 84.3 Cg_endo -74.99 145.18 31.16 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.375 2.05 . . . . 0.0 109.236 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.12 32.16 49.79 Favored Glycine 0 CA--C 1.539 1.532 0 CA-C-N 113.247 -1.797 . . . . 0.0 112.186 -176.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.72 94.42 7.28 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -40.89 -33.15 0.28 Allowed 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 113.768 -1.56 . . . . 0.0 113.913 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.7 p -124.97 -155.15 0.66 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 113.655 -1.612 . . . . 0.0 108.755 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.404 ' HG2' ' CE2' ' A' ' 30' ' ' TYR . 15.4 mtm-85 -55.5 -19.75 10.71 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 171.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.32 135.48 0.08 OUTLIER Glycine 0 CA--C 1.524 0.599 0 N-CA-C 107.717 -2.153 . . . . 0.0 107.717 -176.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 77.1 p -41.28 -33.62 0.4 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 113.429 -1.385 . . . . 0.0 113.727 175.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -39.35 128.78 1.82 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 122.719 1.247 . . . . 0.0 113.83 169.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -158.69 133.78 8.42 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 111.702 -2.499 . . . . 0.0 110.159 -176.335 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.412 ' HB ' ' O ' ' A' ' 55' ' ' TYR . 8.0 mt -112.14 132.7 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 125.817 1.948 . . . . 0.0 107.791 176.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.496 ' O ' ' HD2' ' A' ' 80' ' ' TYR . 19.9 mm -121.12 102.88 12.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 112.753 -2.021 . . . . 0.0 107.522 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.415 ' HG1' ' HD2' ' A' ' 55' ' ' TYR . 17.4 p -88.86 161.31 16.78 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.501 178.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -116.42 164.23 12.34 Favored Glycine 0 N--CA 1.475 1.262 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.444 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.15 -15.81 62.82 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 176.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.444 ' HB3' ' OE2' ' A' ' 78' ' ' GLU . . . -103.71 130.96 51.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.612 173.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.635 HG22 ' HG2' ' A' ' 77' ' ' GLN . 3.8 m -55.97 142.7 34.85 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.635 ' HG2' HG22 ' A' ' 76' ' ' THR . 0.0 OUTLIER 78.98 31.74 0.3 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 126.892 2.077 . . . . 0.0 111.499 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.444 ' OE2' ' HB3' ' A' ' 75' ' ' ALA . 16.0 mt-10 -125.49 48.81 1.99 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 123.083 1.42 . . . . 0.0 112.569 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -103.52 107.9 18.94 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.205 1.402 . . . . 0.0 109.39 -179.842 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.496 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 32.3 m-85 -96.99 132.3 42.93 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 124.885 1.366 . . . . 0.0 109.48 -177.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.619 ' HB2' HD11 ' A' ' 92' ' ' ILE . 8.5 t80 -110.39 126.18 54.01 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.089 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.537 ' HB ' ' O ' ' A' ' 88' ' ' THR 0.27 0.3 OUTLIER -87.84 -68.66 0.74 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.011 -1.45 . . . . 0.0 112.211 176.399 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.86 2.12 21.72 Favored Glycine 0 N--CA 1.482 1.726 0 CA-C-N 114.607 -1.179 . . . . 0.0 113.414 -172.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.617 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 6.8 t70 -129.82 13.17 5.82 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.349 1.059 . . . . 0.0 112.531 176.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 64.08 84.86 0.14 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.329 1.852 . . . . 0.0 111.579 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.402 ' HB3' ' OE1' ' A' ' 41' ' ' GLU . 7.4 m-85 50.81 29.54 4.4 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -175.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.617 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . . . -112.21 -3.78 14.55 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.537 ' O ' ' HB ' ' A' ' 82' ' ' THR . 2.0 p -164.5 161.32 21.22 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.958 1.703 . . . . 0.0 108.305 -174.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CD1' HD21 ' A' ' 44' ' ' LEU . 88.6 m-85 -157.83 112.01 2.58 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.023 0.929 . . . . 0.0 108.88 -174.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.3 m -131.47 106.71 8.4 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 112.863 -1.971 . . . . 0.0 109.57 -178.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.482 ' CB ' HG23 ' A' ' 5' ' ' THR . 17.5 mt -42.13 155.61 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.972 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.638 HG22 ' HG3' ' A' ' 94' ' ' GLN . 1.9 mp -102.76 111.12 31.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 O-C-N 120.489 -1.382 . . . . 0.0 108.837 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.14 85.81 6.72 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.769 0.795 . . . . 0.0 110.156 175.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.638 ' HG3' HG22 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -70.53 -32.56 70.06 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.002 179.196 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.4 t -56.19 -23.05 32.9 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.525 1.53 . . . . 0.0 113.267 173.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.6 t . . . . . 0 CA--C 1.554 1.105 0 CA-C-O 116.48 -1.724 . . . . 0.0 110.85 177.764 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.528 HG12 ' H ' ' A' ' 4' ' ' GLY . 21.1 t . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 m -75.14 6.59 4.11 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 124.544 1.152 . . . . 0.0 113.776 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.528 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 121.22 -165.54 14.25 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 m -95.79 170.14 9.52 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.986 -1.107 . . . . 0.0 110.277 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -137.47 111.85 9.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -176.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.55 ' HB3' ' OXT' ' A' ' 96' ' ' CYS . 97.0 m -49.37 129.48 18.67 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 111.874 -2.421 . . . . 0.0 109.83 177.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.78 -33.21 66.4 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 119.217 -0.42 . . . . 0.0 111.437 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.8 t -67.24 -28.39 68.01 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.348 0.659 . . . . 0.0 112.384 174.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.33 -20.76 58.87 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.781 174.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.47 HD22 ' CZ ' ' A' ' 81' ' ' TYR . 7.2 mt -83.18 158.94 63.35 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 175.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.514 ' HB2' ' OE2' ' A' ' 14' ' ' GLU . 92.4 Cg_endo -69.03 167.02 24.69 Favored 'Trans proline' 0 CA--C 1.551 1.371 0 C-N-CA 121.964 1.776 . . . . 0.0 112.456 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.18 -17.45 45.25 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.384 2.056 . . . . 0.0 113.682 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.514 ' OE2' ' HB2' ' A' ' 12' ' ' PRO . 8.4 pm0 -87.65 -13.78 41.73 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.697 1.199 . . . . 0.0 112.674 174.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.835 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -62.78 -49.9 73.16 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.02 0.528 . . . . 0.0 112.098 176.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.11 -26.23 48.97 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.633 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.526 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 41.6 t0 -57.57 -57.48 12.53 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.805 0.842 . . . . 0.0 110.34 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.742 ' HA ' HD12 ' A' ' 21' ' ' LEU . 16.8 m -57.23 -49.1 77.1 Favored 'General case' 0 C--O 1.217 -0.621 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 175.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.509 ' CD1' HG21 ' A' ' 92' ' ' ILE . 8.0 mt -56.02 -35.13 66.49 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 124.253 0.971 . . . . 0.0 111.77 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -67.59 -39.16 84.82 Favored 'General case' 0 C--O 1.212 -0.891 0 C-N-CA 124.54 1.136 . . . . 0.0 110.957 174.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.742 HD12 ' HA ' ' A' ' 18' ' ' THR . 41.0 mt -68.53 -34.76 76.43 Favored 'General case' 0 C--O 1.211 -0.926 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.596 175.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.645 HD12 ' O ' ' A' ' 18' ' ' THR . 1.6 mp -68.93 -38.73 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 120.069 1.304 . . . . 0.0 111.872 171.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.47 -48.52 48.73 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.86 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 m -85.46 5.93 29.04 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.173 0.989 . . . . 0.0 113.314 176.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.38 36.08 1.51 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 122.748 1.261 . . . . 0.0 112.22 -176.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.44 -166.9 16.26 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.443 1.497 . . . . 0.0 115.706 -174.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.78 139.87 64.15 Favored 'Cis proline' 0 C--N 1.347 0.485 0 O-C-N 124.285 1.676 . . . . 0.0 111.255 -2.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.469 ' CD2' ' HB3' ' A' ' 21' ' ' LEU . 58.7 m-85 -90.95 135.72 28.37 Favored Pre-proline 0 N--CA 1.474 0.732 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.705 -177.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.459 ' HG2' ' CD1' ' A' ' 58' ' ' ILE . 38.1 Cg_endo -74.34 -61.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.469 2.779 . . . . 0.0 111.433 -178.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.3 m-30 -63.35 159.72 17.52 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 175.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.8 m -80.53 9.28 6.22 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 124.173 0.921 . . . . 0.0 113.476 173.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.61 78.99 1.76 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 122.022 0.915 . . . . 0.0 111.46 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -177.14 146.16 0.49 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 111.721 -2.49 . . . . 0.0 115.056 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.69 27.98 36.84 Favored Glycine 0 N--CA 1.479 1.535 0 CA-C-N 112.87 -1.968 . . . . 0.0 110.853 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.411 HG23 ' HB2' ' A' ' 54' ' ' GLU . 20.5 m -122.12 146.24 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.453 1.101 . . . . 0.0 109.54 177.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.4 t -84.39 154.07 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 125.903 2.002 . . . . 0.0 109.855 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.465 ' CD1' ' HD3' ' A' ' 40' ' ' ARG . 18.6 t80 -137.11 85.88 2.16 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 113.844 -1.525 . . . . 0.0 110.828 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.432 ' HB2' ' CD1' ' A' ' 49' ' ' TYR . 2.2 tm0? -69.38 51.91 0.1 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.9 t30 27.52 55.65 0.07 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.779 2.032 . . . . 0.0 109.634 -172.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.465 ' HD3' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -55.62 -28.37 54.85 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 122.332 1.063 . . . . 0.0 111.463 -175.2 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.555 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.2 mt-10 -74.72 -11.37 60.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 113.138 -1.846 . . . . 0.0 114.962 173.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 31.4 t 45.38 43.12 8.21 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 123.874 1.797 . . . . 0.0 111.844 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 41' ' ' GLU . 95.8 t -108.77 -20.92 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 113.78 -1.555 . . . . 0.0 110.432 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.876 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.627 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -175.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.432 ' CD1' ' HB2' ' A' ' 38' ' ' GLN . 2.4 t80 . . . . . 0 N--CA 1.469 0.501 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.63 -18.84 27.73 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 113.813 -1.539 . . . . 0.0 112.258 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -67.47 -9.09 38.76 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.228 1.011 . . . . 0.0 112.396 176.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.876 ' HE2' HD12 ' A' ' 44' ' ' LEU . 19.0 m-85 -122.99 162.4 22.41 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 124.279 1.032 . . . . 0.0 109.772 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -159.51 155.85 27.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 112.296 -2.229 . . . . 0.0 111.39 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.411 ' HB2' HG23 ' A' ' 35' ' ' VAL . 3.5 mt-10 -110.68 142.34 42.72 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.758 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.415 ' HB3' HG23 ' A' ' 18' ' ' THR . 77.5 m-85 -156.57 67.11 0.56 Allowed 'General case' 0 N--CA 1.477 0.918 0 O-C-N 126.328 2.267 . . . . 0.0 110.524 -175.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.43 ' OG1' ' HD3' ' A' ' 69' ' ' ARG . 1.1 m -38.47 123.06 1.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 122.689 1.233 . . . . 0.0 112.808 176.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.835 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.5 OUTLIER -81.82 114.1 22.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 112.109 -2.314 . . . . 0.0 108.73 177.233 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.459 ' CD1' ' HG2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -41.33 150.82 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 124.806 1.316 . . . . 0.0 109.107 171.58 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.461 ' OG1' ' HG3' ' A' ' 68' ' ' ARG . 23.8 m -150.99 137.76 11.56 Favored Pre-proline 0 N--CA 1.481 1.106 0 O-C-N 125.851 1.969 . . . . 0.0 110.684 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -72.48 151.4 53.19 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 123.646 2.897 . . . . 0.0 110.588 177.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.36 20.72 30.75 Favored Glycine 0 N--CA 1.48 1.623 0 CA-C-N 114.015 -1.448 . . . . 0.0 112.88 -174.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.87 87.64 5.47 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -44.39 -30.52 0.86 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 113.99 -1.459 . . . . 0.0 112.683 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.8 p -133.03 -170.87 2.54 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.866 -1.515 . . . . 0.0 108.638 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.1 mtm-85 -46.87 -29.3 1.92 Allowed 'General case' 0 N--CA 1.484 1.254 0 O-C-N 124.273 0.983 . . . . 0.0 112.921 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.27 148.78 0.09 OUTLIER Glycine 0 N--CA 1.465 0.59 0 N-CA-C 107.26 -2.336 . . . . 0.0 107.26 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.501 HG22 ' HB2' ' A' ' 85' ' ' HIS . 19.6 p -42.86 -29.73 0.34 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.052 -1.574 . . . . 0.0 113.423 172.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.737 ' HE ' HG12 ' A' ' 57' ' ' VAL . 3.1 mmm180 -37.64 116.91 0.52 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 166.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.447 ' HB2' HG23 ' A' ' 82' ' ' THR . 0.0 OUTLIER -157.49 135.02 10.52 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 112.435 -2.166 . . . . 0.0 112.938 -176.368 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.448 ' O ' HD13 ' A' ' 71' ' ' ILE . 5.9 mt -113.7 141.05 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 112.784 -2.007 . . . . 0.0 108.471 177.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.757 HD11 ' HE1' ' A' ' 86' ' ' TYR . 17.4 mm -127.52 114.09 34.49 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 O-C-N 126.199 2.187 . . . . 0.0 108.203 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.599 HG22 ' HB3' ' A' ' 79' ' ' ASP . 19.5 p -101.05 163.92 12.05 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.248 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.67 164.87 12.04 Favored Glycine 0 CA--C 1.531 1.082 0 O-C-N 125.639 1.837 . . . . 0.0 109.694 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.86 -17.43 63.15 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.302 0.641 . . . . 0.0 112.117 175.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -104.55 128.51 52.53 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.626 HG22 ' HG2' ' A' ' 77' ' ' GLN . 24.8 m -55.54 145.82 22.06 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 114.096 -1.411 . . . . 0.0 107.354 174.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.626 ' HG2' HG22 ' A' ' 76' ' ' THR . 2.8 mt-30 82.39 32.84 0.09 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 126.299 1.839 . . . . 0.0 111.218 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -135.83 46.46 2.33 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 123.058 1.409 . . . . 0.0 112.744 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.599 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -101.2 88.61 3.54 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 113.174 -1.83 . . . . 0.0 109.843 179.495 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.472 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 65.8 m-85 -57.79 178.06 0.09 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.287 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.483 ' CE2' ' NH1' ' A' ' 68' ' ' ARG . 9.0 t80 -158.01 113.92 2.77 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.685 -176.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.58 ' HB ' ' O ' ' A' ' 88' ' ' THR 0.318 0.1 OUTLIER -87.87 -80.45 0.27 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.045 -1.434 . . . . 0.0 113.72 177.813 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.02 -5.31 59.15 Favored Glycine 0 N--CA 1.471 0.99 0 CA-C-N 115.25 -0.886 . . . . 0.0 114.382 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.55 ' CB ' ' HB3' ' A' ' 87' ' ' ALA . 1.0 OUTLIER -120.64 20.02 11.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.398 -0.901 . . . . 0.0 111.985 173.545 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.501 ' HB2' HG22 ' A' ' 67' ' ' THR . 22.5 t-80 58.47 87.02 0.08 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.25 1.82 . . . . 0.0 110.203 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.757 ' HE1' HD11 ' A' ' 71' ' ' ILE . 8.3 m-30 49.08 41.32 19.16 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 113.639 -1.619 . . . . 0.0 114.518 -174.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.55 ' HB3' ' CB ' ' A' ' 84' ' ' ASP . . . -112.46 -32.64 6.42 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.102 -1.624 . . . . 0.0 112.806 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.58 ' O ' ' HB ' ' A' ' 82' ' ' THR . 15.3 p -135.95 166.79 22.52 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.646 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -156.79 110.13 2.61 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -175.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.71 106.46 9.15 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 113.884 -1.507 . . . . 0.0 108.354 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 51.1 mt -44.08 161.72 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.576 HD13 ' O ' ' A' ' 79' ' ' ASP . 1.7 mp -110.76 131.97 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 120.881 -1.137 . . . . 0.0 108.926 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.87 94.99 5.31 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 113.204 -1.816 . . . . 0.0 107.911 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -57.41 -37.1 72.21 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 124.731 1.269 . . . . 0.0 111.912 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.3 t -58.34 -45.66 87.71 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.821 -1.082 . . . . 0.0 112.469 174.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.55 ' OXT' ' HB3' ' A' ' 7' ' ' CYS . 11.6 t . . . . . 0 C--O 1.245 0.829 0 CA-C-O 118.489 -0.767 . . . . 0.0 110.929 175.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.645 HG12 ' H ' ' A' ' 4' ' ' GLY . 44.4 t . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.1 m -77.74 5.69 8.9 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.787 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.645 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 120.53 -177.23 16.36 Favored Glycine 0 N--CA 1.473 1.115 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 6' ' ' VAL . 4.4 m -90.96 173.69 7.83 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 122.354 1.073 . . . . 0.0 109.2 -178.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.428 ' H ' HG22 ' A' ' 5' ' ' THR . 0.9 OUTLIER -139.73 112.64 5.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -175.819 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 73.3 m -50.08 124.66 10.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 111.894 -2.412 . . . . 0.0 109.601 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -50.73 -35.39 31.2 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.719 0.807 . . . . 0.0 112.232 174.13 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.9 t -63.81 -30.97 72.01 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.518 0.511 . . . . 0.0 111.992 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.48 -17.65 59.18 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.632 0.773 . . . . 0.0 111.913 174.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.463 ' HB3' ' CB ' ' A' ' 15' ' ' ALA . 7.1 mt -90.05 162.35 35.46 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 176.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.48 169.53 15.48 Favored 'Trans proline' 0 CA--C 1.547 1.135 0 C-N-CA 122.606 2.204 . . . . 0.0 112.988 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.3 -17.95 49.99 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.561 2.174 . . . . 0.0 113.058 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.495 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 26.1 tp10 -85.05 -25.22 27.76 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 175.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.863 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -48.84 -37.07 18.37 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 175.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.49 -35.27 68.14 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.873 -1.512 . . . . 0.0 112.943 173.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.545 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 9.3 t70 -54.46 -53.33 55.63 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.06 0.944 . . . . 0.0 109.828 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.818 ' HA ' HD12 ' A' ' 21' ' ' LEU . 17.1 m -59.54 -48.24 82.43 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 175.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.703 HD11 HG21 ' A' ' 92' ' ' ILE . 5.6 mt -56.81 -28.57 61.66 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 176.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -73.75 -40.35 63.57 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.704 173.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.818 HD12 ' HA ' ' A' ' 18' ' ' THR . 25.3 mt -69.5 -31.16 69.24 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 119.271 -0.395 . . . . 0.0 111.026 176.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.671 HD12 ' O ' ' A' ' 18' ' ' THR . 1.6 mp -69.74 -38.38 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 120.143 1.338 . . . . 0.0 111.508 171.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.46 -47.61 32.39 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 124.562 1.164 . . . . 0.0 111.873 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.7 m -85.91 8.4 20.45 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.42 1.488 . . . . 0.0 112.645 175.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 41.51 46.54 3.05 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 122.725 1.25 . . . . 0.0 112.525 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.48 -166.13 43.37 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-N 113.928 -1.487 . . . . 0.0 116.265 -171.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -74.25 140.6 68.17 Favored 'Cis proline' 0 N--CA 1.483 0.887 0 O-C-N 124.758 1.925 . . . . 0.0 111.543 -1.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.505 ' HA ' HD22 ' A' ' 21' ' ' LEU . 33.9 m-85 -92.21 142.67 26.44 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 113.897 -1.501 . . . . 0.0 111.679 -176.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -74.62 -65.29 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 123.283 2.655 . . . . 0.0 111.42 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 -57.56 163.0 2.63 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.834 0.826 . . . . 0.0 112.226 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 t -82.08 9.44 8.5 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 123.238 1.494 . . . . 0.0 112.269 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.403 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -112.11 99.54 8.14 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.302 -177.411 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 166.64 140.17 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 O-C-N 126.626 2.454 . . . . 0.0 115.404 -172.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.45 30.38 22.02 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-N 113.616 -1.629 . . . . 0.0 111.172 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.507 HG23 ' HB2' ' A' ' 54' ' ' GLU . 20.7 m -122.36 147.39 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 114.275 -0.963 . . . . 0.0 109.512 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.0 t -85.15 156.95 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 125.248 1.593 . . . . 0.0 109.631 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.603 ' CD1' ' HD3' ' A' ' 40' ' ' ARG . 31.0 t80 -141.26 86.26 2.01 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.811 175.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.72 55.44 0.26 Allowed 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 122.631 1.205 . . . . 0.0 113.318 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 45.7 t30 29.73 53.62 0.12 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.474 2.31 . . . . 0.0 109.305 -173.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.603 ' HD3' ' CD1' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -58.18 -22.97 53.8 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.701 -174.925 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.611 ' O ' HG23 ' A' ' 43' ' ' VAL . 3.0 mt-10 -83.02 -8.28 59.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 113.207 -1.815 . . . . 0.0 114.669 173.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 43.9 t 44.0 41.92 4.37 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 124.326 2.012 . . . . 0.0 111.733 -177.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 41' ' ' GLU . 57.5 t -109.81 -12.4 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 113.592 -1.64 . . . . 0.0 109.663 -178.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.494 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.2 OUTLIER . . . . . 0 CA--C 1.545 0.775 0 O-C-N 120.721 -1.237 . . . . 0.0 108.687 -175.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.3 t80 . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.43 -21.53 28.43 Favored Glycine 0 N--CA 1.479 1.521 0 O-C-N 125.181 1.551 . . . . 0.0 112.009 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -64.44 -13.47 51.62 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.505 1.122 . . . . 0.0 112.294 176.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.494 ' HE2' HD12 ' A' ' 44' ' ' LEU . 16.4 m-85 -116.25 163.08 16.52 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.718 0.807 . . . . 0.0 109.535 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -159.65 159.65 33.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 112.016 -2.357 . . . . 0.0 111.184 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.507 ' HB2' HG23 ' A' ' 35' ' ' VAL . 32.2 mt-10 -117.31 144.7 44.6 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.645 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.406 ' HB3' HG23 ' A' ' 18' ' ' THR . 80.1 m-85 -158.96 63.92 0.41 Allowed 'General case' 0 N--CA 1.48 1.047 0 O-C-N 126.495 2.372 . . . . 0.0 111.104 -174.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 32' ' ' GLN . 1.1 m -35.35 120.89 0.57 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 122.352 1.072 . . . . 0.0 112.556 177.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.863 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -81.78 117.72 28.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 112.738 -2.028 . . . . 0.0 108.609 177.313 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.469 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -42.99 158.39 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 173.467 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.495 ' OG1' ' HG3' ' A' ' 68' ' ' ARG . 2.5 m -153.09 142.45 14.74 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 113.273 -1.785 . . . . 0.0 111.387 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.56 146.03 48.5 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.594 2.196 . . . . 0.0 110.971 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.25 22.1 55.08 Favored Glycine 0 N--CA 1.48 1.611 0 CA-C-N 113.759 -1.564 . . . . 0.0 112.459 -175.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.2 87.05 7.34 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -47.61 -26.57 1.52 Allowed 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.912 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.1 p -128.03 -158.62 0.89 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.037 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.6 mtm105 -57.06 -18.18 13.25 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 174.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.41 125.4 0.02 OUTLIER Glycine 0 N--CA 1.465 0.593 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.42 HG22 ' HB2' ' A' ' 85' ' ' HIS . 22.0 p -39.72 -31.09 0.09 Allowed 'General case' 0 CA--C 1.557 1.234 0 CA-C-N 113.699 -1.251 . . . . 0.0 113.523 175.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.495 ' HG3' ' OG1' ' A' ' 59' ' ' THR . 0.3 OUTLIER -46.05 105.61 0.07 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 123.417 1.579 . . . . 0.0 112.711 170.137 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.548 ' HB2' HG23 ' A' ' 82' ' ' THR . 0.3 OUTLIER -131.42 141.36 49.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 112.816 -1.993 . . . . 0.0 109.989 -179.442 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.9 mt -117.3 135.9 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 112.681 -2.054 . . . . 0.0 108.33 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.618 HD11 ' HE1' ' A' ' 86' ' ' TYR . 16.9 mm -124.91 101.87 9.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 CA-C-N 112.848 -1.978 . . . . 0.0 108.608 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.486 HG21 HD13 ' A' ' 22' ' ' ILE . 16.9 p -89.68 163.1 15.26 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.502 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -115.29 166.84 12.24 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-N 113.32 -1.764 . . . . 0.0 109.665 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.24 -14.09 62.58 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.355 -0.922 . . . . 0.0 111.843 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.58 130.95 55.29 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.129 174.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.55 HG22 ' HG2' ' A' ' 77' ' ' GLN . 3.4 m -55.23 143.8 26.66 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.124 -1.398 . . . . 0.0 107.495 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.55 ' HG2' HG22 ' A' ' 76' ' ' THR . 2.2 mt-30 80.06 33.82 0.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 126.127 2.142 . . . . 0.0 111.037 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -129.33 49.12 2.28 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 113.596 -1.638 . . . . 0.0 113.616 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.492 ' OD1' ' HB ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER -107.13 103.77 13.25 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.341 -178.363 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.516 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 23.9 m-85 -91.64 131.13 37.26 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 125.28 1.613 . . . . 0.0 109.916 -177.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.753 ' HB2' HD11 ' A' ' 92' ' ' ILE . 5.5 t80 -110.29 123.92 50.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.24 -1.345 . . . . 0.0 109.894 -176.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.548 HG23 ' HB2' ' A' ' 69' ' ' ARG 0.262 0.2 OUTLIER -89.74 -71.18 0.62 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 113.502 -1.681 . . . . 0.0 112.464 177.315 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.09 -8.81 56.65 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-N 113.118 -1.856 . . . . 0.0 112.197 -175.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 15.6 t70 -112.01 9.71 20.43 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 117.252 0.526 . . . . 0.0 111.838 174.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.42 ' HB2' HG22 ' A' ' 67' ' ' THR . 30.6 t-80 87.15 -20.93 0.2 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.928 1.691 . . . . 0.0 113.076 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.618 ' HE1' HD11 ' A' ' 71' ' ' ILE . 1.2 m-30 161.19 55.35 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 O-C-N 128.16 3.412 . . . . 0.0 113.684 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . . . -120.06 -41.33 2.65 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 118.994 -1.083 . . . . 0.0 113.748 175.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.528 ' O ' ' HB ' ' A' ' 82' ' ' THR . 18.4 p -128.29 165.55 20.32 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.399 -1.273 . . . . 0.0 108.402 -177.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.489 ' CD1' HD21 ' A' ' 44' ' ' LEU . 97.9 m-85 -157.41 112.7 2.78 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -173.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.2 m -131.21 112.25 12.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 113.261 -1.791 . . . . 0.0 109.286 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.474 ' HA ' HD23 ' A' ' 91' ' ' LEU . 25.1 mt -42.39 162.82 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 O-C-N 124.214 0.946 . . . . 0.0 112.428 177.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.753 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.7 mp -112.19 130.74 65.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 O-C-N 120.778 -1.201 . . . . 0.0 108.823 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.04 94.14 4.94 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.257 -1.792 . . . . 0.0 108.624 176.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -53.39 -37.22 62.26 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 124.107 0.88 . . . . 0.0 112.467 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.9 t -56.74 -49.29 75.65 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 113.801 -1.545 . . . . 0.0 113.595 174.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 34.3 t . . . . . 0 C--O 1.246 0.886 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 179.07 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.92 5.82 10.67 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.883 0.849 . . . . 0.0 112.639 177.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.38 -174.37 16.55 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.447 1.498 . . . . 0.0 109.988 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -94.18 169.39 10.28 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 122.016 0.912 . . . . 0.0 109.239 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 91' ' ' LEU . 2.0 p -137.84 111.26 7.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 122.752 1.263 . . . . 0.0 107.882 -177.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 71.6 m -48.96 128.16 15.47 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 112.256 -2.247 . . . . 0.0 109.364 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -53.04 -34.65 57.41 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.805 176.745 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.1 t -64.68 -29.77 70.77 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 174.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.14 -26.11 58.9 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.451 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.487 HD13 ' HB1' ' A' ' 15' ' ' ALA . 7.1 mt -83.92 162.57 51.94 Favored Pre-proline 0 N--CA 1.478 0.952 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.17 168.11 18.39 Favored 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 122.308 2.005 . . . . 0.0 112.952 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -65.28 -18.95 62.0 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.847 2.365 . . . . 0.0 112.666 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.549 ' HG3' HG22 ' A' ' 57' ' ' VAL . 27.4 tp10 -83.62 -26.41 29.98 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.439 -0.801 . . . . 0.0 113.066 175.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.797 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -47.62 -38.87 15.54 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 176.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.38 -34.73 72.91 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.551 -1.659 . . . . 0.0 113.328 174.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.607 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 10.7 t0 -54.52 -57.0 13.12 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 117.408 -1.282 . . . . 0.0 109.465 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.797 ' HA ' HD12 ' A' ' 21' ' ' LEU . 1.4 m -55.87 -48.42 75.59 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 174.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.722 HD11 HG21 ' A' ' 92' ' ' ILE . 7.1 mt -57.42 -33.36 67.81 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -67.75 -33.41 74.81 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.336 174.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.797 HD12 ' HA ' ' A' ' 18' ' ' THR . 18.3 mt -75.93 -31.3 59.06 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 118.773 -0.632 . . . . 0.0 110.924 176.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.679 HD12 ' O ' ' A' ' 18' ' ' THR . 1.7 mp -69.9 -40.81 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 120.267 1.394 . . . . 0.0 111.453 170.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.84 -41.78 64.46 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 125.02 1.45 . . . . 0.0 112.521 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.31 7.23 45.22 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.321 1.049 . . . . 0.0 111.781 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 44.46 34.98 1.19 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.035 1.334 . . . . 0.0 112.556 -176.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.9 -168.15 20.14 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-N 113.379 -1.737 . . . . 0.0 115.83 -174.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -74.53 140.5 67.66 Favored 'Cis proline' 0 N--CA 1.479 0.622 0 O-C-N 124.043 1.549 . . . . 0.0 111.261 -3.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.476 ' HA ' HD22 ' A' ' 21' ' ' LEU . 23.6 m-85 -89.86 136.99 28.57 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.57 -176.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -72.68 -63.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.475 0.415 0 C-N-CA 123.563 2.842 . . . . 0.0 111.413 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 -62.99 159.4 17.13 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.411 0.684 . . . . 0.0 112.744 175.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.85 8.5 5.4 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 124.714 1.259 . . . . 0.0 113.588 174.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.426 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 1.8 mt-30 -105.01 82.89 1.91 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 122.372 1.082 . . . . 0.0 111.819 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -177.32 150.83 0.74 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 110.779 -2.919 . . . . 0.0 114.999 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.01 35.43 27.58 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-N 112.52 -2.127 . . . . 0.0 110.275 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -131.88 147.1 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.546 1.138 . . . . 0.0 109.72 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.4 t -84.41 154.4 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 O-C-N 125.944 2.027 . . . . 0.0 109.868 175.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.484 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 50.0 t80 -132.31 91.33 2.92 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 113.846 -1.525 . . . . 0.0 108.419 174.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.544 ' HG3' ' CD1' ' A' ' 49' ' ' TYR . 6.5 tm0? -72.12 55.63 0.31 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 119.81 1.187 . . . . 0.0 112.361 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 26.06 55.83 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.793 2.437 . . . . 0.0 110.854 -175.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.433 ' HD3' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -56.38 -25.97 51.42 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 122.17 0.986 . . . . 0.0 111.938 -171.754 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.595 ' O ' HG23 ' A' ' 43' ' ' VAL . 4.2 mt-10 -76.35 -14.33 60.09 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 113.09 -1.868 . . . . 0.0 115.598 172.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 31.6 t 45.06 41.81 5.91 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 124.183 1.945 . . . . 0.0 111.924 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 41' ' ' GLU . 76.6 t -110.8 -10.42 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-N 113.151 -1.841 . . . . 0.0 110.739 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.63 ' HB3' ' OH ' ' A' ' 52' ' ' TYR . 4.0 mm? . . . . . 0 C--N 1.319 -0.76 0 CA-C-O 117.372 -1.299 . . . . 0.0 109.29 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.544 ' CD1' ' HG3' ' A' ' 38' ' ' GLN . 4.1 t80 . . . . . 0 CA--C 1.539 0.524 0 N-CA-C 110.437 -0.208 . . . . 0.0 110.437 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.76 5.99 70.62 Favored Glycine 0 N--CA 1.48 1.584 0 O-C-N 125.332 1.645 . . . . 0.0 112.657 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.39 15.31 3.72 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.63 ' OH ' ' HB3' ' A' ' 44' ' ' LEU . 10.7 m-85 -151.04 150.76 31.12 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.156 0.983 . . . . 0.0 109.305 -173.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -147.12 155.44 42.17 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 126.074 2.109 . . . . 0.0 111.632 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.484 ' HG3' ' HB2' ' A' ' 37' ' ' PHE . 27.3 mt-10 -109.13 145.17 36.16 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.829 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.482 ' O ' HG21 ' A' ' 18' ' ' THR . 72.5 m-85 -159.82 68.28 0.39 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 126.826 2.579 . . . . 0.0 110.64 -174.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 0.9 OUTLIER -41.19 133.92 2.22 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 122.767 1.27 . . . . 0.0 111.814 178.741 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.797 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -95.86 118.97 43.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 112.07 -2.332 . . . . 0.0 107.939 178.35 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -40.73 153.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 CA-C-O 121.853 0.835 . . . . 0.0 108.955 173.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.487 ' OG1' ' HD2' ' A' ' 68' ' ' ARG . 15.7 m -140.04 139.74 22.15 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 112.951 -1.931 . . . . 0.0 111.688 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.73 145.18 50.84 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 121.93 1.754 . . . . 0.0 111.007 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 51.77 28.48 23.37 Favored Glycine 0 CA--C 1.548 2.137 0 O-C-N 125.289 1.618 . . . . 0.0 111.895 -174.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.98 90.28 4.57 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -46.57 -27.65 1.2 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 113.603 -1.635 . . . . 0.0 113.197 176.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.2 p -126.0 -173.67 2.91 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.846 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.426 ' HD2' ' OE1' ' A' ' 32' ' ' GLN . 14.6 mtm105 -52.94 -20.72 3.6 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 175.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.22 171.27 11.89 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 124.38 2.1 . . . . 0.0 109.201 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.489 HG22 ' HB2' ' A' ' 85' ' ' HIS . 41.0 p -75.95 0.74 17.33 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 111.275 -2.463 . . . . 0.0 113.004 176.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.487 ' HD2' ' OG1' ' A' ' 59' ' ' THR . 0.0 OUTLIER -82.11 116.9 21.89 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 122.925 1.345 . . . . 0.0 111.203 176.58 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.524 ' HG2' ' HE1' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -142.35 135.67 28.87 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 112.771 -2.013 . . . . 0.0 109.323 178.444 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.2 mt -104.5 144.81 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 113.463 -1.699 . . . . 0.0 108.741 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' A' ' 80' ' ' TYR . 18.4 mm -132.73 114.75 23.04 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.737 0 CA-C-N 112.486 -2.143 . . . . 0.0 107.895 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.565 HG22 ' HB3' ' A' ' 79' ' ' ASP . 18.8 p -99.45 162.86 12.79 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.791 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -107.61 -178.26 22.39 Favored Glycine 0 N--CA 1.477 1.433 0 O-C-N 124.968 1.417 . . . . 0.0 109.953 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.8 -13.22 59.96 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 114.348 -0.926 . . . . 0.0 113.024 174.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -113.73 130.78 56.38 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 176.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.521 HG22 ' HG2' ' A' ' 77' ' ' GLN . 31.4 m -54.0 147.97 11.53 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.083 174.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.521 ' HG2' HG22 ' A' ' 76' ' ' THR . 2.4 mt-30 80.63 31.76 0.17 Allowed 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 126.585 1.954 . . . . 0.0 110.942 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.513 ' HA ' HD22 ' A' ' 91' ' ' LEU . 4.6 mt-10 -134.59 48.78 2.28 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 123.89 1.805 . . . . 0.0 113.708 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.669 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -104.34 86.74 2.58 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 113.071 -1.877 . . . . 0.0 109.417 -179.0 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.41 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 35.2 m-85 -57.35 177.88 0.08 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 125.275 1.43 . . . . 0.0 110.339 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.597 ' HB2' HD11 ' A' ' 92' ' ' ILE . 13.0 t80 -162.87 126.23 2.85 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 113.817 -1.538 . . . . 0.0 109.84 -176.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.2 OUTLIER -91.12 -71.97 0.6 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 112.672 -2.058 . . . . 0.0 111.702 176.271 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.46 1.08 34.38 Favored Glycine 0 CA--C 1.55 2.228 0 CA-C-N 113.094 -1.866 . . . . 0.0 114.835 -173.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.568 ' CB ' ' HB3' ' A' ' 87' ' ' ALA . 1.7 m-20 -127.79 15.8 6.92 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.386 0.675 . . . . 0.0 112.619 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.489 ' HB2' HG22 ' A' ' 67' ' ' THR . 52.7 t-80 61.28 83.79 0.14 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 127.093 2.157 . . . . 0.0 110.591 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.524 ' HE1' ' HG2' ' A' ' 69' ' ' ARG . 3.4 m-30 51.84 38.23 22.74 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 113.83 -1.532 . . . . 0.0 113.342 -176.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.568 ' HB3' ' CB ' ' A' ' 84' ' ' ASP . . . -109.74 -13.22 14.52 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.498 ' O ' ' HB ' ' A' ' 82' ' ' THR . 9.5 p -161.37 165.96 28.14 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.037 1.335 . . . . 0.0 107.81 -176.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.511 ' CD1' HD21 ' A' ' 44' ' ' LEU . 99.6 m-85 -157.29 113.55 2.93 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -176.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.4 m -132.33 115.94 16.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.748 -1.569 . . . . 0.0 109.399 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.513 HD22 ' HA ' ' A' ' 78' ' ' GLU . 35.0 mt -47.28 164.21 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.379 0.672 . . . . 0.0 111.946 177.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.722 HG21 HD11 ' A' ' 19' ' ' LEU . 1.7 mp -112.63 128.96 69.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 120.824 -1.173 . . . . 0.0 108.434 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.87 92.05 4.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 113.472 -1.695 . . . . 0.0 108.551 175.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -52.62 -36.4 56.4 Favored 'General case' 0 N--CA 1.484 1.225 0 O-C-N 124.173 0.92 . . . . 0.0 112.778 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.2 t -58.27 -47.05 84.82 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 114.054 -1.43 . . . . 0.0 113.387 173.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 24.3 t . . . . . 0 C--O 1.244 0.791 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.171 178.365 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.738 HG21 ' HE1' ' A' ' 80' ' ' TYR . 71.2 t . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.5 m -70.48 3.8 2.78 Favored 'General case' 0 CA--C 1.55 0.952 0 O-C-N 125.151 1.532 . . . . 0.0 112.526 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.642 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 111.2 -179.25 19.86 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 m -77.0 170.14 17.07 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.128 -1.036 . . . . 0.0 110.423 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 p -138.49 108.6 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 78.8 m -43.55 123.51 3.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 112.565 -2.107 . . . . 0.0 109.964 176.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.74 -37.06 39.69 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.742 177.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.9 t -65.69 -28.11 68.83 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.099 0.56 . . . . 0.0 112.073 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.43 -20.55 58.8 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.83 174.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.47 HD13 ' HB1' ' A' ' 15' ' ' ALA . 14.7 mt -85.77 159.59 54.67 Favored Pre-proline 0 CA--C 1.539 0.519 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 176.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.52 169.16 19.25 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 121.953 1.769 . . . . 0.0 113.081 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.48 -13.93 38.63 Favored 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 122.627 2.218 . . . . 0.0 114.549 177.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 11.8 pm0 -93.43 -4.93 50.43 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.559 -1.201 . . . . 0.0 113.29 176.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.504 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -78.59 -50.7 11.06 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.797 175.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.96 -28.22 56.06 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.67 -1.15 . . . . 0.0 112.271 174.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.57 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 9.6 t70 -53.45 -58.63 6.47 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.428 1.08 . . . . 0.0 109.969 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.71 ' HA ' HD12 ' A' ' 21' ' ' LEU . 1.8 m -53.57 -50.43 65.59 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.612 0.968 . . . . 0.0 113.612 175.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.529 HD21 HD13 ' A' ' 70' ' ' ILE . 10.4 mt -56.15 -37.38 69.42 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.885 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -64.63 -33.26 75.52 Favored 'General case' 0 C--O 1.214 -0.787 0 C-N-CA 123.962 0.905 . . . . 0.0 110.691 173.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.71 HD12 ' HA ' ' A' ' 18' ' ' THR . 16.8 mt -76.35 -30.43 57.6 Favored 'General case' 0 C--O 1.209 -1.048 0 CA-C-O 118.364 -0.826 . . . . 0.0 110.78 176.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.667 HD12 ' O ' ' A' ' 18' ' ' THR . 1.8 mp -70.65 -40.63 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 120.217 1.371 . . . . 0.0 111.722 171.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.39 -40.97 63.9 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.006 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.18 7.72 44.25 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.355 178.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 42.99 34.84 0.67 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.577 1.151 . . . . 0.0 112.733 -176.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.67 -169.48 18.22 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 113.521 -1.672 . . . . 0.0 115.969 -173.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.57 140.76 69.1 Favored 'Cis proline' 0 CA--C 1.537 0.655 0 O-C-N 123.775 1.408 . . . . 0.0 111.102 -2.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.425 ' CD2' ' HB3' ' A' ' 21' ' ' LEU . 37.9 m-85 -91.66 136.3 26.72 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 113.686 -1.597 . . . . 0.0 111.573 -177.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.418 ' HG2' ' CD1' ' A' ' 58' ' ' ILE . 44.3 Cg_endo -73.58 -62.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.475 0.439 0 C-N-CA 122.947 2.431 . . . . 0.0 111.942 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.8 m-30 -69.3 146.35 52.31 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 118.494 -0.765 . . . . 0.0 110.793 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.4 m -62.4 -15.26 48.0 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 125.385 1.678 . . . . 0.0 113.141 174.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.507 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 2.0 mt-30 -78.64 77.96 5.11 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 122.678 1.227 . . . . 0.0 111.516 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -178.12 142.21 0.27 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 110.783 -2.917 . . . . 0.0 113.869 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.0 24.43 37.72 Favored Glycine 0 N--CA 1.481 1.656 0 CA-C-N 112.952 -1.931 . . . . 0.0 111.399 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.4 m -120.52 146.89 24.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 124.384 1.073 . . . . 0.0 109.481 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 52' ' ' TYR . 5.3 t -83.57 154.37 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 126.096 2.123 . . . . 0.0 110.206 176.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.482 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 27.7 t80 -135.03 88.53 2.43 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 113.842 -1.526 . . . . 0.0 109.988 175.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -70.91 52.44 0.15 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 122.684 1.231 . . . . 0.0 113.753 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 37.5 t30 28.43 54.26 0.08 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.06 2.144 . . . . 0.0 109.566 -172.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -56.31 -26.29 51.72 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.702 -1.136 . . . . 0.0 111.035 -175.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.581 ' O ' HG23 ' A' ' 43' ' ' VAL . 1.3 mt-10 -76.61 -11.83 59.92 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.61 -1.632 . . . . 0.0 114.562 174.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.2 t 45.54 40.9 6.29 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 123.54 1.638 . . . . 0.0 111.973 -177.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 41' ' ' GLU . 62.4 t -109.34 -18.58 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 114.16 -1.382 . . . . 0.0 110.852 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.867 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.469 0.497 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.762 -175.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.5 t80 . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.26 -18.68 21.91 Favored Glycine 0 N--CA 1.483 1.82 0 O-C-N 124.971 1.419 . . . . 0.0 113.136 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.457 ' HA ' ' HB2' ' A' ' 74' ' ' GLU . 0.2 OUTLIER -74.98 1.63 12.43 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.214 1.406 . . . . 0.0 113.135 177.743 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.867 ' HE2' HD12 ' A' ' 44' ' ' LEU . 11.4 m-85 -131.05 162.88 28.83 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 123.904 0.882 . . . . 0.0 109.873 -178.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -159.18 156.8 29.62 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 125.647 1.842 . . . . 0.0 110.899 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.482 ' HG3' ' HB2' ' A' ' 37' ' ' PHE . 2.3 mt-10 -114.94 137.33 52.11 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.454 -177.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.482 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 57.1 m-85 -152.48 65.85 0.82 Allowed 'General case' 0 N--CA 1.475 0.789 0 O-C-N 125.837 1.961 . . . . 0.0 111.345 -175.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 27.4 m -39.16 134.65 1.07 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 122.811 1.291 . . . . 0.0 113.061 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.504 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.9 OUTLIER -86.97 109.0 18.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 111.354 -2.657 . . . . 0.0 107.529 178.018 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -43.19 157.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 125.635 1.834 . . . . 0.0 109.339 168.312 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -156.61 141.75 12.38 Favored Pre-proline 0 C--N 1.322 -0.613 0 O-C-N 126.063 2.102 . . . . 0.0 112.501 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.84 145.56 45.98 Favored 'Trans proline' 0 N--CA 1.475 0.407 0 C-N-CA 122.549 2.166 . . . . 0.0 110.955 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.81 28.72 57.66 Favored Glycine 0 CA--C 1.539 1.586 0 CA-C-N 113.358 -1.746 . . . . 0.0 112.422 -175.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.11 89.92 7.89 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -39.71 -32.83 0.15 Allowed 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 113.864 -1.516 . . . . 0.0 113.167 176.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.6 p -130.7 -160.65 1.06 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 113.879 -1.509 . . . . 0.0 109.755 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.507 ' HD2' ' OE1' ' A' ' 32' ' ' GLN . 3.6 mtm105 -60.21 -14.74 19.17 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 172.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.18 139.53 0.07 OUTLIER Glycine 0 C--N 1.334 0.433 0 N-CA-C 107.57 -2.212 . . . . 0.0 107.57 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.2 p -47.08 -27.9 1.53 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 113.306 -1.447 . . . . 0.0 113.428 174.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.479 ' HG2' ' CE1' ' A' ' 81' ' ' TYR . 33.9 mtm-85 -50.27 133.37 23.96 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 123.575 1.655 . . . . 0.0 112.954 170.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.475 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -159.36 133.29 7.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 111.834 -2.439 . . . . 0.0 109.99 -179.585 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.529 HD13 HD21 ' A' ' 19' ' ' LEU . 3.3 mt -104.34 140.18 23.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 113.591 -1.64 . . . . 0.0 109.099 176.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.523 ' O ' ' HD2' ' A' ' 80' ' ' TYR . 21.2 mm -129.22 111.37 22.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 112.362 -2.199 . . . . 0.0 108.88 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.722 HG22 ' HB3' ' A' ' 79' ' ' ASP . 17.2 p -98.68 163.27 12.71 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.443 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -108.03 179.95 21.84 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.083 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -76.52 -12.19 59.99 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.735 0.779 . . . . 0.0 111.888 175.669 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -117.47 129.86 56.08 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 175.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.67 HG22 ' HG2' ' A' ' 77' ' ' GLN . 17.3 m -53.88 151.25 6.73 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.537 174.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.67 ' HG2' HG22 ' A' ' 76' ' ' THR . 2.0 mt-30 83.79 32.38 0.06 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 125.936 2.022 . . . . 0.0 110.549 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.61 ' HA ' HD22 ' A' ' 91' ' ' LEU . 3.6 mt-10 -146.28 52.83 1.13 Allowed 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 123.187 1.47 . . . . 0.0 112.468 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.722 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -107.37 90.97 3.46 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 113.654 -1.612 . . . . 0.0 109.591 -179.517 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.738 ' HE1' HG21 ' A' ' 2' ' ' VAL . 62.8 m-85 -59.63 176.48 0.27 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.268 1.027 . . . . 0.0 109.679 176.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.676 ' HB2' HD11 ' A' ' 92' ' ' ILE . 8.4 t80 -164.76 89.57 0.51 Allowed 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 114.44 -1.254 . . . . 0.0 109.078 -178.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.0 OUTLIER -48.09 -74.26 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.321 -1.309 . . . . 0.0 112.558 172.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 68' ' ' ARG . . . 79.47 -9.44 42.12 Favored Glycine 0 CA--C 1.545 1.953 0 CA-C-N 113.872 -1.513 . . . . 0.0 112.131 -175.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.739 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 11.0 t70 -122.71 16.49 10.27 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.414 0.686 . . . . 0.0 112.555 175.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 66.69 87.37 0.12 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.749 1.619 . . . . 0.0 111.507 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.474 ' H ' HG21 ' A' ' 82' ' ' THR . 5.2 m-85 48.94 28.64 2.05 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 113.279 -1.782 . . . . 0.0 113.471 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.739 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . . . -108.25 -24.29 11.57 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 120.758 -1.214 . . . . 0.0 111.824 -174.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.531 ' O ' ' HB ' ' A' ' 82' ' ' THR . 12.6 p -143.82 172.63 12.58 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -178.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.477 ' O ' HG13 ' A' ' 2' ' ' VAL . 94.9 m-85 -163.23 121.02 1.93 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -175.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.1 m -139.64 107.81 5.77 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.531 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.61 HD22 ' HA ' ' A' ' 78' ' ' GLU . 90.5 mt -44.01 164.18 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.178 0.924 . . . . 0.0 111.701 178.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.676 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.7 mp -110.83 135.56 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 120.424 -1.422 . . . . 0.0 109.517 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.24 100.15 8.84 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.264 -1.334 . . . . 0.0 108.873 176.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.462 HE21 ' HB2' ' A' ' 94' ' ' GLN . 0.0 OUTLIER -62.39 -38.97 91.67 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 123.573 0.546 . . . . 0.0 111.608 -179.428 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.3 t -54.98 -45.49 75.0 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.179 1.391 . . . . 0.0 112.814 173.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 35.1 t . . . . . 0 C--O 1.25 1.105 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.653 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.589 HG12 ' H ' ' A' ' 4' ' ' GLY . 12.8 t . . . . . 0 N--CA 1.478 0.947 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.5 t -79.95 4.8 15.71 Favored 'General case' 0 CA--C 1.55 0.958 0 O-C-N 124.468 1.105 . . . . 0.0 112.405 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.589 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 129.59 176.25 14.36 Favored Glycine 0 N--CA 1.474 1.232 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.401 HG23 ' CB ' ' A' ' 91' ' ' LEU . 4.3 m -92.91 173.04 7.95 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.519 -0.84 . . . . 0.0 109.143 -176.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -137.51 108.37 5.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -175.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.5 m -46.05 126.66 7.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.236 -1.802 . . . . 0.0 109.977 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.98 -34.11 63.08 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.8 177.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -64.59 -29.4 70.42 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 123.774 0.671 . . . . 0.0 112.231 173.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.6 -23.06 56.4 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.938 0.895 . . . . 0.0 111.63 174.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.479 HD13 ' HB1' ' A' ' 15' ' ' ALA . 9.1 mt -83.96 164.69 43.02 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 176.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 15' ' ' ALA . 71.5 Cg_endo -69.26 172.08 12.79 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 122.412 2.074 . . . . 0.0 111.975 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.81 -18.63 36.65 Favored 'Trans proline' 0 N--CA 1.48 0.728 0 C-N-CA 122.99 2.46 . . . . 0.0 112.627 176.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.531 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 28.9 tp10 -85.57 -24.73 27.1 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.791 175.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.863 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -48.04 -39.19 19.15 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 177.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.44 -36.98 79.82 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 113.682 -1.599 . . . . 0.0 113.323 174.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.539 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 10.5 t70 -51.46 -54.69 24.39 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.754 0.822 . . . . 0.0 110.088 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.778 ' HA ' HD12 ' A' ' 21' ' ' LEU . 18.8 m -57.91 -50.61 72.75 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 176.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.905 HD11 HG21 ' A' ' 92' ' ' ILE . 48.6 mt -52.38 -30.4 28.87 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 174.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -75.46 -38.43 59.66 Favored 'General case' 0 C--O 1.209 -1.061 0 CA-C-N 114.221 -1.354 . . . . 0.0 110.134 175.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.778 HD12 ' HA ' ' A' ' 18' ' ' THR . 24.6 mt -71.2 -32.27 68.63 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 118.983 -0.532 . . . . 0.0 110.537 175.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.668 HD12 ' O ' ' A' ' 18' ' ' THR . 1.6 mp -70.64 -39.58 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-N 120.382 1.447 . . . . 0.0 111.657 172.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.22 -42.49 59.67 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.574 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.53 7.98 38.74 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.296 1.039 . . . . 0.0 111.366 177.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.8 t70 41.13 50.46 3.29 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.616 1.166 . . . . 0.0 111.105 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.56 -168.61 48.1 Favored Glycine 0 CA--C 1.538 1.493 0 CA-C-N 114.216 -1.356 . . . . 0.0 115.211 -173.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -75.42 141.2 70.56 Favored 'Cis proline' 0 N--CA 1.49 1.296 0 O-C-N 125.001 2.053 . . . . 0.0 111.33 -0.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.495 ' HA ' HD22 ' A' ' 21' ' ' LEU . 29.2 m-85 -92.93 139.59 23.27 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 113.598 -1.637 . . . . 0.0 111.564 -177.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -75.2 -64.5 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.066 2.51 . . . . 0.0 110.788 -177.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.446 ' HD2' HG22 ' A' ' 56' ' ' THR . 1.6 m-30 -58.98 160.45 5.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.667 175.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.8 m -80.77 9.89 5.68 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 122.304 1.049 . . . . 0.0 112.608 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.431 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 1.0 OUTLIER -105.52 86.88 2.48 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 122.078 0.942 . . . . 0.0 110.837 -178.926 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 176.96 144.58 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 111.342 -2.663 . . . . 0.0 113.772 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.54 30.76 23.53 Favored Glycine 0 N--CA 1.478 1.487 0 O-C-N 126.199 2.187 . . . . 0.0 110.732 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.46 149.91 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.2 t -88.27 157.05 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 O-C-N 125.164 1.54 . . . . 0.0 110.039 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.532 ' CE1' ' HD3' ' A' ' 40' ' ' ARG . 22.3 t80 -135.39 93.79 3.02 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.314 175.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.42 ' HG3' ' CD1' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -70.88 53.86 0.16 Allowed 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 118.991 0.814 . . . . 0.0 112.309 178.623 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 26.96 54.36 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.863 2.465 . . . . 0.0 110.046 -176.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.532 ' HD3' ' CE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -57.54 -24.41 55.94 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 122.364 1.078 . . . . 0.0 111.232 -171.869 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.56 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.9 mt-10 -76.5 -11.48 59.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 112.66 -2.063 . . . . 0.0 114.168 173.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.1 t 43.81 39.85 2.8 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 124.9 2.286 . . . . 0.0 110.904 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 41' ' ' GLU . 20.0 t -107.69 -14.86 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 113.196 -1.82 . . . . 0.0 109.984 -178.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.77 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--O 1.244 0.784 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.225 -172.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.42 ' CD1' ' HG3' ' A' ' 38' ' ' GLN . 8.7 t80 . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.996 0.426 . . . . 0.0 110.801 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.76 12.0 80.79 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 114.394 -1.275 . . . . 0.0 112.14 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -87.17 15.9 5.72 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.596 0.759 . . . . 0.0 112.346 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.77 ' HE2' HD12 ' A' ' 44' ' ' LEU . 12.6 m-85 -150.64 145.5 25.9 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.057 -175.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -142.84 157.55 44.49 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 126.533 2.395 . . . . 0.0 111.147 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -111.11 147.47 34.79 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.054 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.479 ' HB3' HG23 ' A' ' 18' ' ' THR . 79.1 m-85 -160.99 63.73 0.29 Allowed 'General case' 0 CA--C 1.543 0.677 0 O-C-N 125.823 1.952 . . . . 0.0 110.289 -175.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 0.9 OUTLIER -39.04 127.27 1.65 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 122.088 0.947 . . . . 0.0 112.07 178.854 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.863 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -83.99 120.62 35.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 111.502 -2.59 . . . . 0.0 108.708 178.107 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.514 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 0.1 OUTLIER -45.76 165.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 124.593 1.183 . . . . 0.0 108.199 173.633 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.406 HG23 ' HD2' ' A' ' 60' ' ' PRO . 2.5 m -158.97 145.8 12.82 Favored Pre-proline 0 C--O 1.24 0.556 0 CA-C-N 112.86 -1.973 . . . . 0.0 112.841 177.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.406 ' HD2' HG23 ' A' ' 59' ' ' THR . 60.9 Cg_endo -73.01 149.79 47.41 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 121.99 1.793 . . . . 0.0 111.764 175.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.86 21.18 22.28 Favored Glycine 0 N--CA 1.483 1.811 0 O-C-N 125.185 1.553 . . . . 0.0 112.458 -175.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.45 86.25 7.33 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -45.15 -27.76 0.65 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 113.276 -1.784 . . . . 0.0 112.146 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.4 p -128.08 -163.24 1.25 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.639 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.431 ' HD2' ' OE1' ' A' ' 32' ' ' GLN . 2.7 mtm105 -56.62 -18.08 10.85 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 174.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.58 131.43 0.03 OUTLIER Glycine 0 N--CA 1.465 0.59 0 N-CA-C 107.274 -2.33 . . . . 0.0 107.274 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.581 HG22 ' HB2' ' A' ' 85' ' ' HIS . 17.6 p -44.37 -41.54 6.19 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 112.044 -2.078 . . . . 0.0 113.031 176.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.6 mtp85 -40.1 102.39 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 122.968 1.366 . . . . 0.0 113.172 173.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -128.05 136.43 51.22 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 112.207 -2.27 . . . . 0.0 109.002 -177.271 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.645 HG23 ' OD1' ' A' ' 79' ' ' ASP . 7.0 mt -105.67 140.99 22.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 112.413 -2.176 . . . . 0.0 108.818 176.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.454 ' HB ' ' HB2' ' A' ' 80' ' ' TYR . 23.3 mm -130.16 105.42 11.73 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 CA-C-N 113.268 -1.787 . . . . 0.0 108.384 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.419 HG22 ' HB2' ' A' ' 79' ' ' ASP . 10.7 p -92.46 163.8 13.7 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.211 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -110.9 -172.59 19.75 Favored Glycine 0 N--CA 1.471 1.024 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.681 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.1 -15.77 60.03 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.41 -0.895 . . . . 0.0 112.303 174.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.72 132.14 54.24 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.338 1.066 . . . . 0.0 108.514 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.417 HG22 ' CG ' ' A' ' 77' ' ' GLN . 23.5 m -59.3 152.3 21.33 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.086 -1.415 . . . . 0.0 108.618 176.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.417 ' CG ' HG22 ' A' ' 76' ' ' THR . 10.3 mt-30 71.46 32.16 2.14 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 123.523 1.63 . . . . 0.0 109.889 178.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.521 ' HA ' HD22 ' A' ' 91' ' ' LEU . 3.6 mt-10 -136.8 68.42 1.43 Allowed 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.847 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.7 ' OD2' HD21 ' A' ' 19' ' ' LEU . 3.6 t0 -111.31 129.8 55.87 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-N 113.192 -1.822 . . . . 0.0 107.718 176.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.454 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 14.4 m-85 -100.36 133.92 44.07 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 125.102 1.361 . . . . 0.0 109.919 175.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.589 ' HB2' HD11 ' A' ' 92' ' ' ILE . 9.2 t80 -111.75 127.41 55.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.458 -1.246 . . . . 0.0 108.961 -177.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.5 OUTLIER -91.03 -68.74 0.77 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 112.839 -1.982 . . . . 0.0 111.959 178.039 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.08 -11.15 50.29 Favored Glycine 0 CA--C 1.542 1.741 0 CA-C-N 113.346 -1.752 . . . . 0.0 112.675 -175.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.477 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 13.5 m-20 -111.37 6.39 20.36 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 175.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.581 ' HB2' HG22 ' A' ' 67' ' ' THR . 21.3 t-80 86.76 -16.98 0.38 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 116.051 -1.928 . . . . 0.0 113.177 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.1 m-30 160.6 51.25 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 128.455 3.597 . . . . 0.0 114.804 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.477 ' HB3' ' HB2' ' A' ' 84' ' ' ASP . . . -120.1 -44.86 2.48 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 119.406 -0.918 . . . . 0.0 112.913 177.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.478 ' O ' ' HB ' ' A' ' 82' ' ' THR . 22.4 p -127.43 168.29 15.07 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.67 -177.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.689 ' CG ' HD21 ' A' ' 44' ' ' LEU . 97.7 m-85 -159.29 115.73 2.61 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -173.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.1 m -135.34 113.81 11.6 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.423 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.521 HD22 ' HA ' ' A' ' 78' ' ' GLU . 29.7 mt -40.81 161.83 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.123 0 O-C-N 124.693 1.246 . . . . 0.0 111.452 177.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.905 HG21 HD11 ' A' ' 19' ' ' LEU . 1.3 mp -106.05 129.59 58.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 O-C-N 120.902 -1.123 . . . . 0.0 108.246 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.419 ' HB3' ' HB3' ' A' ' 96' ' ' CYS . 0.3 OUTLIER -102.68 92.25 4.54 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.65 -1.614 . . . . 0.0 108.021 177.082 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -55.93 -37.75 69.36 Favored 'General case' 0 N--CA 1.484 1.225 0 O-C-N 123.981 0.8 . . . . 0.0 112.253 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.9 t -57.96 -49.67 75.99 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.783 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 93' ' ' ASP . 21.0 t . . . . . 0 N--CA 1.476 0.874 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.873 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.419 HG21 ' CE1' ' A' ' 80' ' ' TYR . 12.1 t . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 m -81.52 22.81 0.68 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.499 1.12 . . . . 0.0 112.379 176.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.16 -154.06 20.11 Favored Glycine 0 N--CA 1.479 1.557 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.452 HG23 ' CB ' ' A' ' 91' ' ' LEU . 2.4 m -107.56 170.07 8.2 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.956 -1.122 . . . . 0.0 110.407 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -142.41 108.77 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -174.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 94.9 m -46.2 133.66 9.13 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 113.581 -1.645 . . . . 0.0 111.038 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -59.06 -32.44 69.77 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.638 -177.749 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.2 t -67.39 -27.79 67.39 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.612 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.28 -29.64 62.87 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.642 0.777 . . . . 0.0 111.61 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 11' ' ' LEU . 12.3 mt -81.37 161.72 61.19 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 176.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.35 168.25 18.36 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.999 2.466 . . . . 0.0 112.545 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.15 -23.11 39.88 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.236 1.957 . . . . 0.0 113.544 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -83.76 -4.39 58.6 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.884 0.874 . . . . 0.0 111.827 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.746 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -71.72 -49.32 40.39 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.793 0.837 . . . . 0.0 112.278 175.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.3 -25.88 37.05 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.579 174.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.516 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 45.6 t0 -53.46 -57.77 9.47 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 124.32 1.013 . . . . 0.0 110.408 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.743 ' HA ' HD12 ' A' ' 21' ' ' LEU . 8.4 m -56.28 -50.59 70.93 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 175.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.583 HD11 HG21 ' A' ' 92' ' ' ILE . 7.9 mt -55.1 -35.14 64.29 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.279 0.987 . . . . 0.0 111.734 178.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -67.65 -39.75 84.55 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 124.163 0.985 . . . . 0.0 110.769 173.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.743 HD12 ' HA ' ' A' ' 18' ' ' THR . 25.8 mt -68.7 -31.95 71.4 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 122.779 0.431 . . . . 0.0 111.088 175.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.465 HD12 ' O ' ' A' ' 18' ' ' THR . 3.7 mt -71.31 -42.86 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 120.103 1.32 . . . . 0.0 111.534 172.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.7 -41.43 75.41 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 124.39 1.056 . . . . 0.0 112.4 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.38 5.92 48.86 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.272 1.029 . . . . 0.0 111.419 177.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 t0 42.4 44.77 3.56 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.524 1.53 . . . . 0.0 111.685 -178.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.29 -166.78 29.74 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 112.834 -1.985 . . . . 0.0 115.265 -174.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -74.87 139.74 63.4 Favored 'Cis proline' 0 N--CA 1.481 0.758 0 O-C-N 124.275 1.671 . . . . 0.0 111.342 -2.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.439 ' CD2' ' HB3' ' A' ' 21' ' ' LEU . 61.3 m-85 -90.94 139.06 25.86 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 113.244 -1.798 . . . . 0.0 111.534 -176.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.456 ' HG2' ' CD1' ' A' ' 58' ' ' ILE . 37.3 Cg_endo -75.73 -63.13 0.03 OUTLIER 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.975 2.45 . . . . 0.0 111.474 -177.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -61.85 157.79 17.45 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.141 -0.482 . . . . 0.0 112.087 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.6 t -81.17 4.83 18.79 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 122.941 1.353 . . . . 0.0 112.101 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -104.86 86.56 2.48 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.232 1.015 . . . . 0.0 111.484 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 4.5 p-10 177.96 140.31 0.09 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 110.712 -2.949 . . . . 0.0 113.715 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.71 3.22 66.51 Favored Glycine 0 N--CA 1.484 1.883 0 CA-C-N 113.017 -1.902 . . . . 0.0 112.263 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.624 HG23 ' HB2' ' A' ' 54' ' ' GLU . 7.8 m -96.91 144.78 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.342 1.057 . . . . 0.0 110.257 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.2 t -79.63 155.69 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 O-C-N 126.089 2.118 . . . . 0.0 108.865 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.659 ' HE2' HD13 ' A' ' 44' ' ' LEU . 37.0 t80 -137.71 86.32 2.17 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.645 -1.616 . . . . 0.0 108.618 174.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -72.03 51.76 0.23 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.203 -1.56 . . . . 0.0 112.414 178.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.477 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 26.6 t30 28.83 53.61 0.08 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.682 1.193 . . . . 0.0 111.778 -172.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.497 ' HD3' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -56.14 -20.69 18.7 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 113.243 -1.799 . . . . 0.0 112.285 -177.95 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.585 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -83.87 -4.75 58.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 113.443 -1.708 . . . . 0.0 114.832 174.465 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.2 t 44.05 47.11 7.29 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 123.7 1.715 . . . . 0.0 112.688 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 41' ' ' GLU . 87.0 t -124.11 -6.96 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 113.4 -1.727 . . . . 0.0 111.199 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.659 HD13 ' HE2' ' A' ' 37' ' ' PHE . 1.9 mp . . . . . 0 N--CA 1.475 0.789 0 O-C-N 121.41 -0.806 . . . . 0.0 112.994 176.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.3 t80 . . . . . 0 CA--C 1.537 0.469 0 CA-C-O 121.093 0.473 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.99 8.23 82.62 Favored Glycine 0 N--CA 1.479 1.532 0 CA-C-N 113.327 -1.76 . . . . 0.0 112.807 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.61 -1.64 22.51 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.794 0.838 . . . . 0.0 112.509 175.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.586 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 5.5 m-85 -136.63 171.23 14.81 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.029 1.332 . . . . 0.0 110.094 -177.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -161.01 163.71 31.48 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 113.257 -1.792 . . . . 0.0 110.382 -177.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.624 ' HB2' HG23 ' A' ' 35' ' ' VAL . 1.8 mt-10 -120.03 139.43 52.54 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.096 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.551 ' HB3' HG23 ' A' ' 18' ' ' THR . 58.4 m-85 -153.01 59.33 0.79 Allowed 'General case' 0 N--CA 1.471 0.603 0 O-C-N 126.187 2.179 . . . . 0.0 110.741 -174.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 58.5 m -36.69 116.14 0.41 Allowed 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 122.957 1.36 . . . . 0.0 112.519 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.746 HG21 ' HA ' ' A' ' 15' ' ' ALA . 1.9 p -81.65 110.82 17.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 111.021 -2.809 . . . . 0.0 109.443 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.456 ' CD1' ' HG2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -38.64 147.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 113.722 -1.581 . . . . 0.0 111.296 171.822 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.45 HG23 ' HD2' ' A' ' 60' ' ' PRO . 6.1 m -136.5 141.62 36.3 Favored Pre-proline 0 N--CA 1.468 0.453 0 O-C-N 125.772 1.92 . . . . 0.0 112.901 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.45 ' HD2' HG23 ' A' ' 59' ' ' THR . 72.0 Cg_endo -75.53 143.71 27.74 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 121.619 1.546 . . . . 0.0 109.963 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.82 29.32 54.59 Favored Glycine 0 CA--C 1.544 1.882 0 CA-C-N 113.867 -1.515 . . . . 0.0 112.033 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.87 89.89 4.75 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -43.33 -30.61 0.54 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 113.324 -1.762 . . . . 0.0 113.152 177.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.0 p -128.88 -170.78 2.33 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.889 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 -47.45 -27.32 1.66 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 174.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.11 144.96 0.12 Allowed Glycine 0 N--CA 1.464 0.522 0 N-CA-C 106.676 -2.57 . . . . 0.0 106.676 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.592 HG22 ' HB2' ' A' ' 85' ' ' HIS . 20.3 p -42.72 -29.05 0.28 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.247 -1.477 . . . . 0.0 114.673 173.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.427 ' HA ' ' HA2' ' A' ' 83' ' ' GLY . 1.0 OUTLIER -45.17 130.0 7.84 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.763 1.625 . . . . 0.0 111.574 170.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.439 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -164.81 136.49 4.32 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 111.864 -2.426 . . . . 0.0 109.339 -176.689 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.4 mt -111.99 142.7 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 125.933 2.021 . . . . 0.0 108.063 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.528 ' HB ' ' HB2' ' A' ' 80' ' ' TYR . 25.5 mm -131.1 128.78 62.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 111.703 -2.499 . . . . 0.0 108.019 178.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.5 p -104.86 163.87 12.2 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 122.238 -0.289 . . . . 0.0 111.33 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -110.5 -178.54 20.7 Favored Glycine 0 CA--C 1.537 1.41 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.58 -15.22 58.8 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 121.646 0.736 . . . . 0.0 111.937 176.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.23 129.78 55.66 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.66 HG22 ' HG2' ' A' ' 77' ' ' GLN . 16.0 m -54.54 145.88 17.67 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 114.122 -1.399 . . . . 0.0 107.611 175.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.66 ' HG2' HG22 ' A' ' 76' ' ' THR . 0.0 OUTLIER 81.8 33.34 0.1 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 126.705 2.002 . . . . 0.0 110.577 179.445 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.583 ' HA ' HD22 ' A' ' 91' ' ' LEU . 6.2 mt-10 -135.28 54.55 1.92 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 123.498 1.618 . . . . 0.0 112.407 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.704 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -101.24 80.96 2.16 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 113.479 -1.692 . . . . 0.0 108.837 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.528 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 12.2 m-85 -51.18 178.99 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 125.455 1.502 . . . . 0.0 110.401 173.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.549 ' HB2' HD11 ' A' ' 92' ' ' ILE . 1.7 t80 -167.03 128.03 1.58 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.595 -1.639 . . . . 0.0 110.441 -175.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.557 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -90.64 -70.07 0.7 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 112.588 -2.096 . . . . 0.0 112.0 175.138 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 68' ' ' ARG . . . 74.22 -5.69 25.81 Favored Glycine 0 CA--C 1.542 1.769 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.692 -175.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.521 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 30.6 m-20 -125.49 17.05 8.23 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.264 1.425 . . . . 0.0 113.7 176.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.592 ' HB2' HG22 ' A' ' 67' ' ' THR . 42.2 t-80 63.25 88.07 0.1 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.393 2.277 . . . . 0.0 111.496 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.418 ' H ' HG21 ' A' ' 82' ' ' THR . 4.1 m-85 49.57 26.36 1.72 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.053 -1.43 . . . . 0.0 113.997 -176.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.521 ' HB3' ' HB2' ' A' ' 84' ' ' ASP . . . -95.77 -22.08 17.74 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 120.76 -1.213 . . . . 0.0 111.731 -175.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.557 ' O ' ' HB ' ' A' ' 82' ' ' THR . 26.5 p -157.17 173.71 16.58 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.178 1.391 . . . . 0.0 108.494 -177.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.518 ' CD1' HD11 ' A' ' 44' ' ' LEU . 98.7 m-85 -155.52 118.63 4.34 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 -176.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 m -135.06 116.5 14.67 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.583 HD22 ' HA ' ' A' ' 78' ' ' GLU . 66.1 mt -47.81 164.93 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.775 0.83 . . . . 0.0 111.424 177.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.718 HG22 ' HG3' ' A' ' 94' ' ' GLN . 1.7 mp -112.62 107.41 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 121.207 -0.933 . . . . 0.0 109.304 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.446 ' HB3' ' HB2' ' A' ' 96' ' ' CYS . 0.1 OUTLIER -77.16 89.04 3.63 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.035 -1.439 . . . . 0.0 109.088 175.862 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.718 ' HG3' HG22 ' A' ' 92' ' ' ILE . 2.6 mt-30 -79.22 5.71 11.55 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 113.602 -1.635 . . . . 0.0 111.868 177.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.0 t -121.75 -0.98 9.53 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 126.036 1.734 . . . . 0.0 112.581 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 93' ' ' ASP . 42.7 t . . . . . 0 C--O 1.256 1.424 0 CA-C-O 116.268 -1.825 . . . . 0.0 112.888 178.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 4' ' ' GLY . 6.9 t . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 m -75.25 5.21 5.8 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 177.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.475 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 130.37 170.56 12.73 Favored Glycine 0 CA--C 1.536 1.365 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.436 HG22 ' H ' ' A' ' 6' ' ' VAL . 2.5 m -86.99 172.76 9.76 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.069 -1.065 . . . . 0.0 109.103 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.436 ' H ' HG22 ' A' ' 5' ' ' THR . 1.1 t -138.82 106.71 3.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 122.978 1.37 . . . . 0.0 107.869 -175.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.3 m -49.35 126.06 12.31 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 112.62 -2.082 . . . . 0.0 109.902 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 8' ' ' LEU . 14.4 tp -57.06 -34.18 67.99 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 118.938 -0.553 . . . . 0.0 111.353 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.7 t -62.21 -30.23 70.94 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.624 171.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.17 -27.81 53.86 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.64 0.776 . . . . 0.0 112.349 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.44 HD13 ' HB1' ' A' ' 15' ' ' ALA . 14.3 mt -75.4 160.8 78.92 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 174.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.437 ' HD2' HD22 ' A' ' 11' ' ' LEU . 72.2 Cg_endo -68.65 168.32 20.32 Favored 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 122.715 2.276 . . . . 0.0 112.201 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.09 -15.27 39.44 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.416 2.077 . . . . 0.0 113.087 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.43 ' O ' HG22 ' A' ' 57' ' ' VAL . 1.7 mt-10 -92.89 2.11 56.95 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.273 1.029 . . . . 0.0 111.843 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.759 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -77.95 -50.0 13.04 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.214 1.006 . . . . 0.0 112.169 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 0.4 OUTLIER -58.49 -22.2 54.25 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.217 174.121 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -51.26 -59.73 3.89 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.128 0.971 . . . . 0.0 110.306 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.68 HG21 ' O ' ' A' ' 55' ' ' TYR . 39.9 m -64.14 -44.66 91.49 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.523 178.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.541 ' CD2' HD13 ' A' ' 70' ' ' ILE . 0.5 OUTLIER -54.97 -33.48 62.43 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 175.314 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 16' ' ' THR . 4.0 t-20 -73.9 -38.63 64.3 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.995 174.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.54 HD12 ' HA ' ' A' ' 18' ' ' THR . 51.1 mt -69.12 -33.78 74.0 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 175.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.471 ' CD1' HG22 ' A' ' 18' ' ' THR . 3.9 mt -68.75 -41.91 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 123.365 0.666 . . . . 0.0 111.268 172.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.89 -43.76 64.87 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.468 1.105 . . . . 0.0 112.436 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.72 -10.1 59.65 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.058 1.343 . . . . 0.0 111.793 177.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.74 43.26 25.53 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 122.714 1.245 . . . . 0.0 110.718 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.67 -166.92 43.83 Favored Glycine 0 CA--C 1.541 1.676 0 CA-C-N 113.247 -1.797 . . . . 0.0 115.044 -175.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.51 140.5 67.63 Favored 'Cis proline' 0 CA--C 1.537 0.629 0 O-C-N 124.558 1.82 . . . . 0.0 111.058 -1.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.433 ' CD2' ' HB3' ' A' ' 21' ' ' LEU . 46.0 m-85 -90.95 136.55 27.43 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 112.996 -1.911 . . . . 0.0 111.185 -176.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.07 -62.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.188 2.592 . . . . 0.0 111.701 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -59.84 155.07 17.0 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.82 176.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.76 2.29 20.25 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 122.812 1.291 . . . . 0.0 112.313 175.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.4 78.53 2.7 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.622 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -178.48 142.37 0.24 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 112.069 -2.332 . . . . 0.0 113.871 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.14 30.94 12.7 Favored Glycine 0 CA--C 1.537 1.467 0 O-C-N 125.212 1.57 . . . . 0.0 111.645 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.522 HG23 ' HB2' ' A' ' 54' ' ' GLU . 22.2 m -124.26 146.03 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 113.982 -1.109 . . . . 0.0 109.591 178.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.7 t -84.06 156.32 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 125.743 1.902 . . . . 0.0 109.768 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.526 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 81.2 t80 -137.66 87.89 2.29 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 113.968 -1.469 . . . . 0.0 108.791 174.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.403 ' HG3' ' HA ' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -69.91 53.45 0.12 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.808 -1.183 . . . . 0.0 112.648 179.409 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.4 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 50.7 t30 29.21 51.19 0.06 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.418 1.487 . . . . 0.0 111.081 -173.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.46 ' HD3' ' CD1' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -58.15 -20.75 43.09 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.522 -175.519 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.7 mt-10 -84.31 -8.06 59.13 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 113.087 -1.869 . . . . 0.0 114.668 172.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.9 t 43.45 42.58 3.94 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 123.917 1.818 . . . . 0.0 112.135 -177.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 41' ' ' GLU . 86.3 t -112.39 -12.52 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 113.322 -1.763 . . . . 0.0 109.728 -178.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.511 HD21 ' CD1' ' A' ' 89' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.317 -0.814 0 O-C-N 120.979 -1.075 . . . . 0.0 108.436 -175.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.403 ' HA ' ' HG3' ' A' ' 38' ' ' GLN . 10.9 t80 . . . . . 0 N--CA 1.473 0.708 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.14 -8.63 44.36 Favored Glycine 0 N--CA 1.482 1.758 0 O-C-N 125.098 1.499 . . . . 0.0 113.301 177.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -75.77 0.45 17.9 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.267 1.027 . . . . 0.0 112.508 177.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.526 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 16.6 m-85 -136.95 165.38 26.13 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.47 1.108 . . . . 0.0 109.103 -177.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -159.66 158.86 32.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 112.647 -2.069 . . . . 0.0 111.463 -178.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.522 ' HB2' HG23 ' A' ' 35' ' ' VAL . 12.0 mt-10 -113.95 143.01 45.42 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.592 -178.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.68 ' O ' HG21 ' A' ' 18' ' ' THR . 76.8 m-85 -159.97 68.52 0.39 Allowed 'General case' 0 N--CA 1.475 0.796 0 O-C-N 126.244 2.215 . . . . 0.0 109.466 -174.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -36.86 141.51 0.12 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 176.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.759 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -97.77 115.45 37.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 112.9 -1.955 . . . . 0.0 109.385 175.609 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -43.17 151.31 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.662 170.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.458 HG23 ' HD2' ' A' ' 60' ' ' PRO . 2.4 m -150.23 140.84 14.32 Favored Pre-proline 0 N--CA 1.476 0.849 0 O-C-N 125.459 1.725 . . . . 0.0 111.733 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.458 ' HD2' HG23 ' A' ' 59' ' ' THR . 76.6 Cg_endo -73.72 147.14 39.47 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 121.622 1.548 . . . . 0.0 109.735 178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 52.48 34.96 43.32 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.023 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.65 92.67 6.33 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -42.0 -31.39 0.34 Allowed 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 113.641 -1.618 . . . . 0.0 113.323 176.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.5 p -123.36 -164.05 1.18 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.968 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -59.88 -14.0 13.39 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 173.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.62 146.01 3.72 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.214 -1.955 . . . . 0.0 108.214 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.547 HG22 ' HB2' ' A' ' 85' ' ' HIS . 41.0 p -69.93 -5.51 26.62 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 111.772 -2.214 . . . . 0.0 113.105 176.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.567 ' HD2' ' HA2' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -80.02 85.27 5.63 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 123.939 1.828 . . . . 0.0 110.384 178.777 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.84 142.58 34.14 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 112.581 -2.1 . . . . 0.0 109.342 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.592 HG23 ' OD1' ' A' ' 79' ' ' ASP . 9.6 mt -117.76 132.62 67.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 125.601 1.813 . . . . 0.0 109.404 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.477 ' O ' ' HD2' ' A' ' 80' ' ' TYR . 17.5 mm -125.82 106.67 16.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 O-C-N 125.27 1.606 . . . . 0.0 109.048 -176.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.437 HG21 HG21 ' A' ' 22' ' ' ILE . 0.9 OUTLIER -82.39 165.99 19.81 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.301 -0.874 . . . . 0.0 111.194 179.368 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -120.73 171.44 14.74 Favored Glycine 0 N--CA 1.469 0.881 0 CA-C-N 113.424 -1.717 . . . . 0.0 109.799 177.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.45 -14.54 61.17 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.756 0.789 . . . . 0.0 112.251 174.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.18 129.76 53.5 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 122.361 1.077 . . . . 0.0 108.233 174.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.568 HG22 ' HG2' ' A' ' 77' ' ' GLN . 3.1 m -61.87 142.55 57.3 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 113.833 -1.531 . . . . 0.0 107.575 175.129 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.568 ' HG2' HG22 ' A' ' 76' ' ' THR . 0.5 OUTLIER 77.78 29.36 0.51 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 126.618 1.967 . . . . 0.0 111.279 179.519 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -126.98 56.04 1.53 Allowed 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 123.083 1.421 . . . . 0.0 111.92 177.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.592 ' OD1' HG23 ' A' ' 70' ' ' ILE . 0.5 OUTLIER -99.63 119.59 38.33 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 113.267 -1.788 . . . . 0.0 109.287 178.346 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.477 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 36.5 m-85 -92.71 139.41 30.58 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.14 1.376 . . . . 0.0 108.943 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.643 ' HB2' HD11 ' A' ' 92' ' ' ILE . 27.8 t80 -118.43 121.48 40.41 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.665 -175.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.0 OUTLIER -80.88 -64.53 1.17 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 113.317 -1.765 . . . . 0.0 110.761 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.567 ' HA2' ' HD2' ' A' ' 68' ' ' ARG . . . 70.37 -6.04 6.28 Favored Glycine 0 CA--C 1.545 1.943 0 CA-C-N 114.886 -1.052 . . . . 0.0 113.104 -173.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.578 ' CB ' ' HB3' ' A' ' 87' ' ' ALA . 80.1 m-20 -126.58 6.19 6.85 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.547 ' HB2' HG22 ' A' ' 67' ' ' THR . 48.4 t-80 66.59 82.57 0.18 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 128.256 2.622 . . . . 0.0 110.374 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 57.28 17.69 3.82 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 113.428 -1.715 . . . . 0.0 114.247 -174.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.578 ' HB3' ' CB ' ' A' ' 84' ' ' ASP . . . -99.84 -3.54 32.37 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.177 -0.952 . . . . 0.0 112.595 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.411 ' O ' ' HB ' ' A' ' 82' ' ' THR . 2.2 p -167.75 168.85 12.15 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.016 1.727 . . . . 0.0 109.161 -176.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.511 ' CD1' HD21 ' A' ' 44' ' ' LEU . 80.2 m-85 -160.41 109.83 1.73 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.068 0.947 . . . . 0.0 108.972 -173.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.8 m -128.23 108.4 10.58 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.991 -176.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.424 ' CB ' HG23 ' A' ' 5' ' ' THR . 21.7 mt -42.73 161.14 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.643 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.4 mp -107.3 129.45 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 O-C-N 120.671 -1.268 . . . . 0.0 108.792 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 96' ' ' CYS . 0.3 OUTLIER -103.47 94.18 5.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.376 178.655 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.44 HE22 ' HB3' ' A' ' 77' ' ' GLN . 0.9 OUTLIER -68.92 -8.46 44.56 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 124.94 1.4 . . . . 0.0 112.524 178.614 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 t -93.18 -41.9 9.66 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 127.141 2.176 . . . . 0.0 113.1 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 93' ' ' ASP . 45.2 t . . . . . 0 C--O 1.25 1.105 0 CA-C-O 117.695 -1.145 . . . . 0.0 110.931 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.407 HG12 ' H ' ' A' ' 4' ' ' GLY . 11.1 t . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.5 m -77.34 7.97 4.68 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 177.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.407 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 119.42 -172.49 14.71 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.27 1.414 . . . . 0.0 109.735 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -90.22 169.51 11.07 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 122.452 1.12 . . . . 0.0 109.735 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.635 HG13 HD11 ' A' ' 11' ' ' LEU . 4.9 p -143.12 112.0 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 114.222 -1.354 . . . . 0.0 108.285 -176.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 73.7 m -50.22 133.42 23.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 112.427 -2.169 . . . . 0.0 109.592 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.708 ' HA ' HD12 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -55.51 -35.92 66.13 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 119.156 -0.449 . . . . 0.0 111.933 179.688 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.1 t -69.0 -15.48 63.49 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.246 174.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.65 -33.27 35.76 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.396 0.678 . . . . 0.0 112.182 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.708 HD12 ' HA ' ' A' ' 8' ' ' LEU . 6.2 mt -83.64 176.41 3.81 Favored Pre-proline 0 CA--C 1.558 1.272 0 C-N-CA 125.72 1.608 . . . . 0.0 111.095 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 57.8 Cg_endo -65.51 167.12 17.66 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.285 1.99 . . . . 0.0 113.417 174.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -64.77 -21.4 64.76 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 C-N-CA 122.515 2.143 . . . . 0.0 113.064 174.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 5.0 tp10 -82.23 -19.25 40.07 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 175.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.832 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -52.11 -25.5 8.97 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 173.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.643 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -79.48 -33.98 41.79 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 172.547 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.633 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 11.4 t70 -49.83 -53.78 23.37 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.222 1.009 . . . . 0.0 110.059 -177.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.834 ' HA ' HD12 ' A' ' 21' ' ' LEU . 10.5 m -53.99 -52.46 60.69 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 174.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.646 HD11 HG21 ' A' ' 92' ' ' ILE . 9.6 mt -54.67 -37.61 65.97 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 124.624 1.202 . . . . 0.0 111.746 178.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -64.69 -38.01 89.53 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.629 0.772 . . . . 0.0 111.724 173.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.834 HD12 ' HA ' ' A' ' 18' ' ' THR . 12.8 mt -73.16 -32.87 65.14 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 118.518 -0.754 . . . . 0.0 111.312 176.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.61 HD12 ' O ' ' A' ' 18' ' ' THR . 2.1 mp -66.39 -39.35 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-N 120.37 1.441 . . . . 0.0 111.61 169.198 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.78 -48.42 46.69 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.198 0.999 . . . . 0.0 112.316 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 m -86.11 6.39 29.35 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.916 1.286 . . . . 0.0 113.547 175.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 43.74 36.0 1.18 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.333 1.453 . . . . 0.0 112.532 -174.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.96 -168.48 18.12 Favored Glycine 0 CA--C 1.542 1.773 0 CA-C-N 113.296 -1.774 . . . . 0.0 115.504 -175.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -75.0 138.29 55.21 Favored 'Cis proline' 0 N--CA 1.488 1.203 0 O-C-N 123.868 1.457 . . . . 0.0 111.412 -3.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.499 ' HA ' HD22 ' A' ' 21' ' ' LEU . 63.7 m-85 -85.83 149.79 51.67 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-N 113.02 -1.9 . . . . 0.0 112.461 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.97 -69.77 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 123.127 2.551 . . . . 0.0 111.717 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.576 ' CZ ' HG12 ' A' ' 58' ' ' ILE . 18.9 m-30 -74.45 168.84 18.92 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.56 0.744 . . . . 0.0 110.355 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.3 m -72.6 -3.87 27.41 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 122.138 0.971 . . . . 0.0 113.603 174.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -83.28 82.48 8.25 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.751 -1.113 . . . . 0.0 112.083 -178.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 179.0 145.64 0.15 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 110.393 -3.094 . . . . 0.0 116.117 -176.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.18 33.64 39.64 Favored Glycine 0 N--CA 1.473 1.135 0 CA-C-N 112.191 -2.277 . . . . 0.0 110.951 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.1 m -129.88 144.52 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 113.574 -1.313 . . . . 0.0 109.917 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.1 t -83.87 151.18 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 O-C-N 126.66 2.475 . . . . 0.0 109.76 176.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.402 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 41.0 t80 -128.92 95.7 4.16 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.004 173.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -74.13 52.03 0.44 Allowed 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.158 -0.964 . . . . 0.0 111.622 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 26.78 55.56 0.06 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.73 2.412 . . . . 0.0 111.684 -174.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.17 -22.59 41.51 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.26 -173.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.61 ' O ' HG23 ' A' ' 43' ' ' VAL . 13.5 mt-10 -75.84 -15.01 60.29 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 172.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.2 t 48.16 35.61 5.58 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 123.989 1.852 . . . . 0.0 112.336 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 41' ' ' GLU . 95.3 t -110.84 -14.47 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-O 123.368 1.556 . . . . 0.0 110.555 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.592 ' HB3' ' OH ' ' A' ' 52' ' ' TYR . 2.6 mm? . . . . . 0 CA--C 1.547 0.862 0 CA-C-O 117.098 -1.43 . . . . 0.0 108.274 -174.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 54.6 t80 . . . . . 0 N--CA 1.471 0.609 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.04 11.88 52.96 Favored Glycine 0 N--CA 1.483 1.773 0 CA-C-N 114.937 -1.028 . . . . 0.0 112.95 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.414 ' HA ' ' HB2' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -85.98 13.11 8.04 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.448 1.099 . . . . 0.0 112.54 -178.773 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.592 ' OH ' ' HB3' ' A' ' 44' ' ' LEU . 10.6 m-85 -151.39 148.48 28.17 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 125.33 1.452 . . . . 0.0 109.732 -173.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -145.11 159.91 42.24 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 125.417 1.698 . . . . 0.0 111.31 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.402 ' HG3' ' HB2' ' A' ' 37' ' ' PHE . 1.4 mt-10 -117.24 140.88 48.99 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.391 -177.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.423 ' HE2' ' HG1' ' A' ' 72' ' ' THR . 65.6 m-85 -157.96 67.96 0.49 Allowed 'General case' 0 C--O 1.239 0.517 0 O-C-N 125.696 1.872 . . . . 0.0 110.982 -173.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 52.8 m -41.95 119.16 1.26 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 123.563 1.649 . . . . 0.0 112.884 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.832 HG21 ' HA ' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -78.83 116.28 22.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 110.192 -3.185 . . . . 0.0 108.673 178.757 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.576 HG12 ' CZ ' ' A' ' 30' ' ' TYR . 4.4 mt -40.49 148.26 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-O 122.655 1.216 . . . . 0.0 108.642 174.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.9 m -133.1 138.93 32.82 Favored Pre-proline 0 C--O 1.24 0.558 0 CA-C-N 112.16 -2.291 . . . . 0.0 112.45 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.83 143.06 49.3 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.033 1.822 . . . . 0.0 109.943 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.47 30.19 40.94 Favored Glycine 0 CA--C 1.54 1.645 0 CA-C-N 114.313 -1.312 . . . . 0.0 113.113 -176.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.77 94.5 6.37 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -40.63 -35.16 0.44 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.336 176.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.8 p -127.17 -155.59 0.7 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.075 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.3 mtm180 -53.11 -23.87 9.03 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 170.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.76 156.5 0.33 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 -176.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 81.4 p -47.9 -29.35 3.25 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 112.901 -1.65 . . . . 0.0 112.518 173.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.533 ' HA ' ' HA2' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -47.15 139.28 6.13 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 122.199 0.999 . . . . 0.0 112.724 173.629 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -168.0 139.41 2.88 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 112.1 -2.318 . . . . 0.0 109.76 -176.731 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.8 mt -115.99 144.99 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 112.596 -2.093 . . . . 0.0 108.66 175.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' A' ' 80' ' ' TYR . 11.6 mm -131.49 121.36 48.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 O-C-N 126.319 2.262 . . . . 0.0 107.326 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.493 HG22 ' HB3' ' A' ' 79' ' ' ASP . 22.0 p -104.06 163.34 12.45 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.271 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -108.6 177.55 20.67 Favored Glycine 0 N--CA 1.477 1.406 0 O-C-N 125.211 1.569 . . . . 0.0 110.562 178.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -74.89 -14.91 60.71 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 122.124 0.964 . . . . 0.0 113.055 175.422 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -112.77 129.94 56.25 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 175.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.63 HG22 ' HG2' ' A' ' 77' ' ' GLN . 25.9 m -53.67 149.59 8.13 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 114.27 -1.332 . . . . 0.0 108.041 174.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.63 ' HG2' HG22 ' A' ' 76' ' ' THR . 0.1 OUTLIER 81.03 32.84 0.13 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 126.53 1.932 . . . . 0.0 111.425 179.802 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.582 ' HA ' HD22 ' A' ' 91' ' ' LEU . 10.0 mt-10 -139.17 51.73 1.78 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 123.764 1.745 . . . . 0.0 112.716 179.084 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.531 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -103.9 83.91 2.18 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 113.552 -1.658 . . . . 0.0 109.1 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.426 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 31.4 m-85 -56.02 173.67 0.15 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.912 1.685 . . . . 0.0 110.673 174.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.529 ' HB2' HD11 ' A' ' 92' ' ' ILE . 11.7 t80 -158.41 126.92 5.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.426 -176.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 88' ' ' THR 0.275 0.1 OUTLIER -91.73 -69.25 0.75 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 112.657 -2.065 . . . . 0.0 112.643 173.391 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' A' ' 68' ' ' ARG . . . 64.36 17.86 62.38 Favored Glycine 0 CA--C 1.54 1.617 0 CA-C-N 115.124 -0.944 . . . . 0.0 113.219 -173.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.504 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 38.0 t0 -148.0 26.19 1.0 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.732 1.213 . . . . 0.0 112.417 175.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 56.8 83.55 0.1 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.586 1.555 . . . . 0.0 110.968 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 47.97 51.17 14.85 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 113.333 -1.758 . . . . 0.0 114.681 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . . . -120.84 -35.88 3.26 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.175 -1.375 . . . . 0.0 113.948 -178.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.498 ' O ' ' HB ' ' A' ' 82' ' ' THR . 16.3 p -136.77 166.6 23.22 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.653 1.181 . . . . 0.0 108.095 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.431 ' CD1' HD21 ' A' ' 44' ' ' LEU . 94.9 m-85 -156.9 111.83 2.8 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -174.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.2 m -133.76 115.34 14.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.292 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.582 HD22 ' HA ' ' A' ' 78' ' ' GLU . 87.5 mt -46.31 160.77 0.06 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.721 0.808 . . . . 0.0 111.989 178.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.646 HG21 HD11 ' A' ' 19' ' ' LEU . 1.7 mp -109.52 127.37 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 120.667 -1.27 . . . . 0.0 109.433 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.45 95.22 5.67 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 113.567 -1.652 . . . . 0.0 108.985 175.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -58.95 -42.35 89.6 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 124.502 1.126 . . . . 0.0 111.55 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.2 t -50.91 -31.95 19.13 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.692 1.597 . . . . 0.0 113.446 171.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 19.1 t . . . . . 0 CA--C 1.554 1.126 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.795 177.35 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.598 HG11 ' HG ' ' A' ' 91' ' ' LEU . 2.0 t . . . . . 0 N--CA 1.468 0.443 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.1 p -78.38 14.21 1.3 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 122.396 1.094 . . . . 0.0 113.487 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 120.83 -163.31 14.39 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.439 1.495 . . . . 0.0 109.719 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -100.98 171.06 7.87 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 112.63 -1.785 . . . . 0.0 109.741 -177.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 91' ' ' LEU . 9.8 p -142.27 107.22 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.627 -1.169 . . . . 0.0 107.947 -175.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.425 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 86.0 m -45.76 128.44 8.68 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 111.986 -2.37 . . . . 0.0 109.126 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.782 ' HA ' HD12 ' A' ' 11' ' ' LEU . 15.5 tp -53.16 -36.95 61.42 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.778 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -65.03 -19.72 66.14 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.984 172.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 7' ' ' CYS . . . -79.09 -31.88 44.47 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.197 0.522 . . . . 0.0 111.731 175.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.782 HD12 ' HA ' ' A' ' 8' ' ' LEU . 10.4 mt -83.5 173.55 7.27 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 125.26 1.424 . . . . 0.0 110.221 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 92.2 Cg_endo -70.3 169.38 19.73 Favored 'Trans proline' 0 CA--C 1.555 1.534 0 C-N-CA 122.008 1.805 . . . . 0.0 113.817 176.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.87 -15.99 40.91 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.745 2.297 . . . . 0.0 114.257 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.412 ' HG3' ' HA ' ' A' ' 59' ' ' THR . 10.8 pm0 -87.05 2.8 48.47 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.061 1.344 . . . . 0.0 113.306 175.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.519 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -76.48 -55.3 5.66 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.155 0.982 . . . . 0.0 111.585 176.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.664 ' OG1' HD21 ' A' ' 8' ' ' LEU . 0.5 OUTLIER -53.8 -29.11 38.97 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 114.827 -1.079 . . . . 0.0 112.363 174.175 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.556 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 44.6 t0 -51.12 -58.04 7.15 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 125.129 1.518 . . . . 0.0 110.514 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.738 ' HA ' HD12 ' A' ' 21' ' ' LEU . 18.0 m -55.26 -51.1 67.75 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.914 HD11 HG21 ' A' ' 92' ' ' ILE . 7.5 mt -56.7 -35.02 68.0 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 123.782 0.676 . . . . 0.0 112.678 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -66.95 -36.55 82.46 Favored 'General case' 0 C--O 1.217 -0.634 0 C-N-CA 124.478 1.111 . . . . 0.0 110.386 174.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.738 HD12 ' HA ' ' A' ' 18' ' ' THR . 33.2 mt -72.84 -32.67 65.63 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 119.025 -0.512 . . . . 0.0 111.137 175.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.698 HD12 ' O ' ' A' ' 18' ' ' THR . 1.7 mp -70.43 -40.34 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 120.325 1.42 . . . . 0.0 111.881 171.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.28 -42.16 65.87 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 124.602 1.189 . . . . 0.0 112.474 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.32 7.47 44.28 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.505 178.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 42.99 37.32 1.08 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 123.158 1.456 . . . . 0.0 112.539 -177.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.52 -167.26 17.57 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 112.959 -1.928 . . . . 0.0 116.036 -173.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -74.44 139.44 61.65 Favored 'Cis proline' 0 N--CA 1.488 1.154 0 O-C-N 123.917 1.483 . . . . 0.0 111.639 -2.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.51 ' CD2' ' HB3' ' A' ' 21' ' ' LEU . 65.3 m-85 -91.22 135.23 28.55 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.583 -177.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -76.45 -58.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.634 2.223 . . . . 0.0 111.936 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -66.13 159.56 25.92 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.102 0.561 . . . . 0.0 112.063 175.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.1 m -77.14 1.31 18.64 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 173.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.58 84.95 4.05 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 122.055 0.931 . . . . 0.0 111.489 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 178.2 147.72 0.16 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 110.665 -2.97 . . . . 0.0 115.113 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.94 30.81 37.29 Favored Glycine 0 N--CA 1.478 1.476 0 CA-C-N 112.373 -2.194 . . . . 0.0 110.997 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.1 146.76 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.468 1.107 . . . . 0.0 109.797 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.2 t -83.59 153.93 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 126.49 2.369 . . . . 0.0 110.299 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.519 ' CE1' ' HD3' ' A' ' 40' ' ' ARG . 29.3 t80 -129.39 94.31 3.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 113.557 -1.656 . . . . 0.0 109.44 175.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.497 ' HG3' ' CD1' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -73.1 50.14 0.27 Allowed 'General case' 0 N--CA 1.484 1.229 0 O-C-N 120.923 -1.111 . . . . 0.0 112.938 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.485 ' ND2' ' H ' ' A' ' 44' ' ' LEU . 17.8 t30 22.86 60.51 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.526 1.931 . . . . 0.0 111.611 -173.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.519 ' HD3' ' CE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -58.63 -25.5 62.76 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 113.477 -1.692 . . . . 0.0 111.389 -175.612 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.589 ' O ' HG23 ' A' ' 43' ' ' VAL . 1.4 mt-10 -75.46 -7.93 55.4 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.023 -1.444 . . . . 0.0 114.633 174.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.7 t 44.18 42.86 5.35 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 124.387 2.041 . . . . 0.0 112.188 -177.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 41' ' ' GLU . 65.8 t -110.76 -21.97 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 113.543 -1.662 . . . . 0.0 110.448 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.85 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.32 -0.678 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.815 -173.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.497 ' CD1' ' HG3' ' A' ' 38' ' ' GLN . 8.8 t80 . . . . . 0 N--CA 1.465 0.286 0 CA-C-O 120.745 0.307 . . . . 0.0 110.46 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.63 6.7 88.3 Favored Glycine 0 N--CA 1.478 1.474 0 CA-C-N 114.469 -1.241 . . . . 0.0 113.365 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -79.81 7.52 8.53 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.419 1.087 . . . . 0.0 112.824 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.85 ' HE2' HD12 ' A' ' 44' ' ' LEU . 13.2 m-85 -143.91 144.26 31.64 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -174.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -142.32 157.01 45.28 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 126.297 2.248 . . . . 0.0 110.29 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -113.48 143.71 44.05 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.863 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.421 ' HB3' HG23 ' A' ' 18' ' ' THR . 77.0 m-85 -159.26 70.47 0.48 Allowed 'General case' 0 N--CA 1.472 0.645 0 O-C-N 125.378 1.674 . . . . 0.0 111.043 -175.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 1.2 m -39.49 126.98 1.87 Allowed 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 122.332 1.063 . . . . 0.0 112.772 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.519 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.8 OUTLIER -70.12 108.18 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 111.632 -2.531 . . . . 0.0 108.468 176.402 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -39.37 153.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 CA-C-N 115.307 -0.86 . . . . 0.0 108.878 170.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.412 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 1.5 m -156.35 140.02 11.32 Favored Pre-proline 0 N--CA 1.48 1.052 0 O-C-N 125.658 1.849 . . . . 0.0 110.78 177.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.62 152.16 53.32 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.944 2.429 . . . . 0.0 110.18 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 52.41 26.71 23.24 Favored Glycine 0 N--CA 1.481 1.69 0 CA-C-N 113.993 -1.458 . . . . 0.0 112.144 -175.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.43 89.72 7.98 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -40.42 -31.83 0.16 Allowed 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 113.72 -1.582 . . . . 0.0 112.764 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.4 p -134.23 -145.11 0.23 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.618 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 60.3 mtm180 -72.81 -18.67 61.44 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 173.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.08 142.61 0.02 OUTLIER Glycine 0 CA--C 1.531 1.053 0 N-CA-C 108.929 -1.669 . . . . 0.0 108.929 -175.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.2 p -41.85 -32.43 0.41 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 113.887 -1.157 . . . . 0.0 114.057 174.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.406 ' HG3' ' OH ' ' A' ' 81' ' ' TYR . 2.8 mpt_? -44.58 120.02 2.1 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 122.723 1.249 . . . . 0.0 112.461 170.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.477 ' HB3' HG23 ' A' ' 82' ' ' THR . 1.6 tpt180 -149.26 128.46 12.84 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 112.337 -2.21 . . . . 0.0 109.048 -178.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.423 HD12 HG23 ' A' ' 57' ' ' VAL . 3.2 mt -103.79 143.47 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 113.646 -1.615 . . . . 0.0 108.965 173.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.743 HD11 ' HE1' ' A' ' 86' ' ' TYR . 13.8 mm -129.84 102.55 7.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 112.777 -2.011 . . . . 0.0 108.35 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.675 HG22 ' HB3' ' A' ' 79' ' ' ASP . 24.9 p -94.71 165.19 12.62 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.655 0.741 . . . . 0.0 110.371 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -118.88 167.54 13.14 Favored Glycine 0 N--CA 1.473 1.162 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.231 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -61.61 -19.05 61.81 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.579 0.704 . . . . 0.0 111.886 174.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.78 129.56 49.47 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.013 175.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.563 HG22 ' HG2' ' A' ' 77' ' ' GLN . 19.2 m -60.04 144.17 50.1 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 114.114 -1.403 . . . . 0.0 107.311 175.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.563 ' HG2' HG22 ' A' ' 76' ' ' THR . 1.6 mt-30 80.46 33.19 0.16 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 126.82 2.048 . . . . 0.0 111.696 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.411 ' HA ' HD22 ' A' ' 91' ' ' LEU . 23.9 mt-10 -134.55 52.65 2.04 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 113.51 -1.677 . . . . 0.0 112.994 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.675 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.4 OUTLIER -107.95 94.29 4.99 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 113.648 -1.614 . . . . 0.0 110.062 -178.557 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.502 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 12.0 m-85 -82.74 129.07 34.91 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 125.017 1.327 . . . . 0.0 109.642 -177.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.864 ' HB2' HD11 ' A' ' 92' ' ' ILE . 64.2 t80 -113.66 136.61 52.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.103 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.545 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.6 OUTLIER -95.43 -67.27 0.86 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 112.196 -2.275 . . . . 0.0 112.001 176.137 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.88 -0.95 26.37 Favored Glycine 0 CA--C 1.549 2.21 0 CA-C-N 114.031 -1.441 . . . . 0.0 113.496 -174.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.555 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 80.1 m-20 -127.98 17.17 6.74 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 175.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 63.13 86.25 0.12 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.666 1.986 . . . . 0.0 111.12 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.743 ' HE1' HD11 ' A' ' 71' ' ' ILE . 6.1 m-30 49.48 30.56 3.48 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 113.944 -1.48 . . . . 0.0 114.776 -176.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.555 ' HB3' ' HB2' ' A' ' 84' ' ' ASP . . . -99.74 -18.78 17.07 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.733 -0.787 . . . . 0.0 112.561 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.545 ' O ' ' HB ' ' A' ' 82' ' ' THR . 25.2 p -158.93 171.06 20.73 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.623 1.569 . . . . 0.0 108.868 -177.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.577 ' CG ' HD21 ' A' ' 44' ' ' LEU . 94.0 m-85 -157.15 116.54 3.38 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.157 0.983 . . . . 0.0 108.818 -174.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.61 109.91 7.86 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 113.583 -1.644 . . . . 0.0 106.93 -178.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.598 ' HG ' HG11 ' A' ' 2' ' ' VAL . 52.2 mt -41.75 158.81 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.653 177.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.914 HG21 HD11 ' A' ' 19' ' ' LEU . 1.7 mp -112.92 121.86 65.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 120.789 -1.194 . . . . 0.0 109.218 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.27 96.76 7.67 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 113.226 -1.806 . . . . 0.0 108.78 176.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -60.86 -39.2 88.26 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 124.879 1.362 . . . . 0.0 111.803 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.7 t -52.54 -32.01 38.56 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.068 -1.423 . . . . 0.0 113.533 172.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 19.9 t . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.407 176.743 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.474 HG11 ' HG ' ' A' ' 91' ' ' LEU . 2.1 t . . . . . 0 N--CA 1.467 0.409 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.81 7.9 5.26 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.682 1.239 . . . . 0.0 112.196 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.22 -166.73 21.48 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.001 1.286 . . . . 0.0 110.471 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 6' ' ' VAL . 3.3 m -101.64 172.91 6.67 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.231 -1.484 . . . . 0.0 108.942 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.411 ' H ' HG22 ' A' ' 5' ' ' THR . 0.7 OUTLIER -142.27 107.69 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 -175.217 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 88.5 m -47.1 132.48 12.2 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 112.92 -1.946 . . . . 0.0 109.586 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.423 HD11 ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -55.55 -33.61 64.0 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.962 -178.208 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.0 t -64.82 -28.86 69.84 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.634 173.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.46 -31.49 62.26 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.605 0.762 . . . . 0.0 111.194 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.413 HD11 HD11 ' A' ' 92' ' ' ILE . 12.4 mt -74.63 162.26 74.42 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 175.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.41 ' HD2' HD22 ' A' ' 11' ' ' LEU . 59.4 Cg_endo -68.65 167.51 22.62 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.567 2.178 . . . . 0.0 111.948 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.86 -16.14 32.92 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.837 2.358 . . . . 0.0 112.632 177.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.423 ' CD ' ' HD3' ' A' ' 60' ' ' PRO . 1.7 mt-10 -93.71 -2.57 53.65 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.324 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.94 -39.43 18.16 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.757 175.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.423 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -60.82 -28.75 69.03 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.195 175.037 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.463 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 18.1 t0 -54.24 -51.94 62.89 Favored 'General case' 0 C--O 1.213 -0.835 0 O-C-N 124.881 1.363 . . . . 0.0 110.146 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.669 ' OG1' HG12 ' A' ' 57' ' ' VAL . 28.2 m -64.06 -49.26 73.02 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.572 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.593 HD21 HD13 ' A' ' 70' ' ' ILE . 19.6 mt -53.52 -31.41 46.09 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.972 0.795 . . . . 0.0 112.529 175.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -71.93 -42.44 66.64 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.373 173.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.648 HD12 ' HA ' ' A' ' 18' ' ' THR . 33.8 mt -67.79 -35.59 78.93 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.993 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.564 HD12 ' O ' ' A' ' 18' ' ' THR . 2.1 mt -65.64 -40.03 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 119.73 1.15 . . . . 0.0 110.806 172.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.75 -46.34 46.44 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 124.043 0.839 . . . . 0.0 111.9 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.78 -1.18 37.57 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.327 1.051 . . . . 0.0 111.413 176.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 49.48 39.25 16.28 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 122.555 1.169 . . . . 0.0 110.913 -178.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.57 -169.34 37.25 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-N 113.66 -1.609 . . . . 0.0 115.23 -174.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -75.15 140.73 68.78 Favored 'Cis proline' 0 CA--C 1.535 0.546 0 O-C-N 124.911 2.006 . . . . 0.0 111.51 -0.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.427 ' CD2' ' HB3' ' A' ' 21' ' ' LEU . 20.9 m-85 -89.51 137.6 28.79 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 113.32 -1.764 . . . . 0.0 111.034 -176.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -74.29 -62.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.528 2.819 . . . . 0.0 111.296 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.528 ' CE2' HG13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -56.18 155.57 6.52 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.964 0.79 . . . . 0.0 110.604 177.712 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.31 7.13 14.77 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 122.186 0.993 . . . . 0.0 111.592 175.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.31 82.56 1.76 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 122.081 0.943 . . . . 0.0 111.558 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -179.22 146.03 0.28 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 112.616 -2.084 . . . . 0.0 112.972 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.39 36.1 10.04 Favored Glycine 0 N--CA 1.484 1.879 0 O-C-N 126.312 2.257 . . . . 0.0 110.756 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.9 m -135.58 151.03 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 114.388 -0.906 . . . . 0.0 109.216 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.3 t -86.86 157.46 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 125.619 1.825 . . . . 0.0 109.534 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.536 ' CE2' ' HA ' ' A' ' 39' ' ' ASN . 79.4 t80 -136.08 88.97 2.43 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 113.695 -1.593 . . . . 0.0 108.713 177.065 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -72.24 51.29 0.24 Allowed 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.313 -0.867 . . . . 0.0 111.683 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.536 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 33.2 t30 25.32 57.42 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.977 2.111 . . . . 0.0 110.667 -173.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -21.43 22.44 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 113.265 -1.789 . . . . 0.0 111.406 -177.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.666 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.0 mt-10 -83.71 -4.72 58.85 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 114.074 -1.421 . . . . 0.0 113.894 174.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.416 ' HA ' ' ND2' ' A' ' 39' ' ' ASN . 41.3 t 43.02 46.36 4.74 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 124.535 2.112 . . . . 0.0 112.623 -177.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 41' ' ' GLU . 88.0 t -115.73 -23.82 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 113.989 -1.46 . . . . 0.0 109.687 -176.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.6 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.471 0.598 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.98 -175.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 18.6 t80 . . . . . 0 CA--C 1.536 0.428 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.71 10.98 56.48 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.743 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.96 10.17 10.51 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.485 1.114 . . . . 0.0 112.274 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.6 ' HE2' HD12 ' A' ' 44' ' ' LEU . 10.1 m-85 -144.0 143.52 31.25 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -175.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -144.07 155.69 44.07 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 126.395 2.309 . . . . 0.0 110.857 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -110.22 142.27 42.03 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.68 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.592 ' O ' HG21 ' A' ' 18' ' ' THR . 76.9 m-85 -155.66 64.16 0.6 Allowed 'General case' 0 N--CA 1.467 0.388 0 O-C-N 125.796 1.935 . . . . 0.0 110.462 -176.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.552 HG21 ' CG ' ' A' ' 65' ' ' ARG . 0.3 OUTLIER -41.44 136.32 1.79 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 122.322 1.058 . . . . 0.0 112.911 178.941 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.669 HG12 ' OG1' ' A' ' 18' ' ' THR . 9.7 m -95.55 117.43 39.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 112.18 -2.282 . . . . 0.0 108.082 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.528 HG13 ' CE2' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -42.86 149.02 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 O-C-N 125.527 1.767 . . . . 0.0 109.949 173.856 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.453 HG23 ' HD2' ' A' ' 60' ' ' PRO . 8.3 m -139.96 142.3 30.21 Favored Pre-proline 0 N--CA 1.48 1.052 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.414 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.453 ' HD2' HG23 ' A' ' 59' ' ' THR . 57.2 Cg_endo -76.01 145.49 28.16 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.066 1.844 . . . . 0.0 109.916 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.87 25.13 44.12 Favored Glycine 0 CA--C 1.542 1.767 0 CA-C-N 114.061 -1.427 . . . . 0.0 112.274 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.98 90.96 5.76 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -38.4 -33.87 0.11 Allowed 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.359 177.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.4 p -140.32 -148.77 0.26 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.143 -1.39 . . . . 0.0 109.077 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.552 ' CG ' HG21 ' A' ' 56' ' ' THR . 5.0 ttp180 -69.71 -6.85 34.57 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 174.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.23 -129.15 13.37 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.212 1.387 . . . . 0.0 109.635 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.573 HG22 ' HB2' ' A' ' 85' ' ' HIS . 22.0 p -112.72 -34.13 5.9 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 112.26 -1.97 . . . . 0.0 113.384 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -41.33 133.29 2.47 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.277 -1.329 . . . . 0.0 111.581 174.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.44 141.54 3.66 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 112.5 -2.137 . . . . 0.0 110.869 -176.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.66 HD12 HG11 ' A' ' 57' ' ' VAL . 1.0 OUTLIER -120.42 133.31 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 126.72 2.512 . . . . 0.0 109.165 176.877 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.461 ' O ' ' HD2' ' A' ' 80' ' ' TYR . 13.3 mm -122.52 101.47 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 113.25 -1.796 . . . . 0.0 107.857 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.508 HG22 ' HB3' ' A' ' 79' ' ' ASP . 12.7 p -87.43 161.92 17.58 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.635 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -108.12 -176.51 22.12 Favored Glycine 0 N--CA 1.471 0.97 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.303 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.3 -11.45 59.94 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.404 175.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -122.05 131.55 54.04 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.599 HG22 ' HG2' ' A' ' 77' ' ' GLN . 23.9 m -51.12 149.24 3.86 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.624 176.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.599 ' HG2' HG22 ' A' ' 76' ' ' THR . 2.6 mt-30 83.59 33.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 125.505 1.753 . . . . 0.0 110.467 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -140.86 49.29 1.68 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.133 -1.394 . . . . 0.0 113.038 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.614 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -105.47 90.7 3.49 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.458 -178.212 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.461 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 22.0 m-85 -75.28 131.93 40.67 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.144 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.709 ' HB2' HD11 ' A' ' 92' ' ' ILE . 4.9 t80 -114.02 128.5 56.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.941 -177.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.548 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.5 OUTLIER -90.0 -67.97 0.81 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.122 178.481 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.81 2.95 19.34 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-N 113.897 -1.502 . . . . 0.0 113.077 -173.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.533 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 50.6 t0 -130.55 14.73 5.47 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.666 0.786 . . . . 0.0 112.118 175.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.573 ' HB2' HG22 ' A' ' 67' ' ' THR . 34.4 t-80 64.1 85.83 0.13 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.071 1.748 . . . . 0.0 111.044 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.436 ' HB3' ' CD ' ' A' ' 41' ' ' GLU . 6.6 m-85 50.2 28.62 3.2 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 114.274 -1.33 . . . . 0.0 114.398 -177.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.533 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . . . -105.77 -19.37 13.77 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.296 -1.32 . . . . 0.0 111.256 -175.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.548 ' O ' ' HB ' ' A' ' 82' ' ' THR . 15.7 p -153.59 169.01 24.29 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.327 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.584 ' CD1' HD21 ' A' ' 44' ' ' LEU . 90.0 m-85 -158.45 113.16 2.56 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -173.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -132.35 105.05 7.06 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 113.968 -1.469 . . . . 0.0 107.328 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.474 ' HG ' HG11 ' A' ' 2' ' ' VAL . 23.0 mt -41.04 163.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.62 177.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.709 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.7 mp -112.99 135.78 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 120.383 -1.448 . . . . 0.0 109.738 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -113.74 92.33 3.95 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 113.906 -1.497 . . . . 0.0 108.765 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.05 -37.11 85.9 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.236 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 t -54.61 -24.67 22.39 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 114.484 -1.235 . . . . 0.0 113.414 171.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 5.6 t . . . . . 0 C--O 1.261 1.7 0 CA-C-O 117.624 -1.179 . . . . 0.0 111.118 175.71 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.419 HG21 ' HE1' ' A' ' 80' ' ' TYR . 6.9 t . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.17 8.1 4.35 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 124.886 1.366 . . . . 0.0 113.099 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 121.04 -162.56 14.73 Favored Glycine 0 N--CA 1.478 1.44 0 C-N-CA 125.499 1.523 . . . . 0.0 109.653 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 m -103.49 170.13 8.13 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 113.765 -1.217 . . . . 0.0 109.455 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 p -141.33 113.94 4.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -176.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.5 m -50.77 132.82 26.51 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 112.149 -2.296 . . . . 0.0 110.132 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.495 HD11 ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -59.56 -31.75 69.71 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.921 -178.143 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.0 t -64.63 -29.49 70.5 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.083 0.953 . . . . 0.0 113.224 173.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.38 -24.47 54.12 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.844 174.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 11' ' ' LEU . 8.6 mt -83.4 160.58 59.15 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 176.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.526 ' HG2' ' HB2' ' A' ' 15' ' ' ALA . 57.9 Cg_endo -66.42 166.17 22.52 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.546 2.164 . . . . 0.0 113.123 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -67.42 -35.43 23.5 Favored 'Trans proline' 0 N--CA 1.485 1.001 0 C-N-CA 122.572 2.182 . . . . 0.0 112.292 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.463 ' HB3' HG22 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -76.35 -8.77 57.81 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.512 179.085 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.526 ' HB2' ' HG2' ' A' ' 12' ' ' PRO . . . -68.61 -43.45 76.39 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.867 0.867 . . . . 0.0 112.013 172.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.495 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -63.13 -32.98 74.49 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.156 174.951 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.508 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 22.6 t0 -50.01 -49.12 51.8 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.019 0.928 . . . . 0.0 110.262 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.652 ' HA ' HD12 ' A' ' 21' ' ' LEU . 7.7 m -58.99 -50.52 73.78 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.567 HD21 ' OD2' ' A' ' 79' ' ' ASP . 39.0 mt -51.81 -32.79 32.97 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 175.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.01 -43.97 64.19 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.225 1.01 . . . . 0.0 111.858 172.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.671 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 68.4 mt -65.16 -34.32 78.1 Favored 'General case' 0 C--O 1.211 -0.946 0 C-N-CA 123.768 0.827 . . . . 0.0 112.092 176.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.525 HD13 HG21 ' A' ' 72' ' ' THR . 5.6 mt -67.87 -42.52 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 120.567 -1.333 . . . . 0.0 111.55 171.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.76 -47.69 62.05 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 124.29 0.994 . . . . 0.0 112.682 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 m -84.87 5.93 26.84 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.63 1.172 . . . . 0.0 113.904 175.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 44.78 39.92 3.85 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.926 1.29 . . . . 0.0 112.025 -177.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.71 -164.28 14.57 Favored Glycine 0 CA--C 1.541 1.718 0 C-N-CA 125.572 1.558 . . . . 0.0 114.461 -174.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.21 135.66 41.29 Favored 'Cis proline' 0 N--CA 1.485 0.996 0 CA-C-O 122.927 1.136 . . . . 0.0 110.947 -2.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.671 ' CE1' ' HB3' ' A' ' 21' ' ' LEU . 79.7 m-85 -85.0 153.41 60.05 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 111.509 -2.587 . . . . 0.0 111.879 -176.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.535 ' HG3' HD12 ' A' ' 58' ' ' ILE . 56.0 Cg_endo -71.28 -59.13 0.07 OUTLIER 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.111 1.874 . . . . 0.0 113.409 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.521 ' CZ ' HG22 ' A' ' 56' ' ' THR . 0.1 OUTLIER -118.02 -179.97 3.92 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.452 1.501 . . . . 0.0 110.547 -179.445 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.0 m -68.0 -8.5 37.95 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 175.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.638 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 11.7 mt-30 -73.74 54.04 0.47 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 122.741 1.258 . . . . 0.0 113.238 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 0.8 OUTLIER 172.67 127.39 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 111.81 -2.45 . . . . 0.0 113.432 -176.24 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.25 -14.61 20.93 Favored Glycine 0 N--CA 1.482 1.746 0 CA-C-N 113.698 -1.592 . . . . 0.0 112.535 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.712 HG22 ' CD ' ' A' ' 54' ' ' GLU . 2.1 m -90.79 150.39 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-O 121.896 0.855 . . . . 0.0 109.908 176.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.6 t -75.01 155.51 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 114.172 -1.377 . . . . 0.0 110.39 175.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.465 ' CE1' ' HD3' ' A' ' 40' ' ' ARG . 65.1 t80 -128.11 93.34 3.64 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 113.402 -1.726 . . . . 0.0 109.69 175.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.407 ' HG3' ' CD1' ' A' ' 49' ' ' TYR . 1.3 tm0? -71.29 47.8 0.12 Allowed 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.699 1.238 . . . . 0.0 112.984 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.441 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 35.8 t30 29.49 56.32 0.14 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.188 1.395 . . . . 0.0 111.151 -173.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.465 ' HD3' ' CE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -55.31 -30.06 59.47 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.853 -175.164 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.583 ' O ' HG23 ' A' ' 43' ' ' VAL . 1.3 mt-10 -75.97 -7.46 54.67 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 112.924 -1.944 . . . . 0.0 114.646 175.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.8 t 45.56 37.85 3.47 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 123.482 1.611 . . . . 0.0 112.292 -176.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 41' ' ' GLU . 70.8 t -109.55 -20.0 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.938 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.609 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.3 OUTLIER . . . . . 0 CA--C 1.544 0.714 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.172 -173.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.407 ' CD1' ' HG3' ' A' ' 38' ' ' GLN . 3.8 t80 . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 120.802 0.334 . . . . 0.0 110.579 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.62 -21.67 24.84 Favored Glycine 0 CA--C 1.542 1.73 0 CA-C-N 114.361 -1.29 . . . . 0.0 113.135 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -71.15 -7.54 47.35 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.568 1.147 . . . . 0.0 113.751 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.609 ' HE2' HD12 ' A' ' 44' ' ' LEU . 21.9 m-85 -119.91 162.85 18.46 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 125.515 1.526 . . . . 0.0 109.327 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -160.19 165.56 31.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 112.678 -2.056 . . . . 0.0 110.715 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.712 ' CD ' HG22 ' A' ' 35' ' ' VAL . 1.5 pm0 -120.42 152.27 38.17 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.786 0.834 . . . . 0.0 109.461 -177.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.412 ' CB ' HG23 ' A' ' 18' ' ' THR . 48.3 m-85 -163.12 66.39 0.19 Allowed 'General case' 0 N--CA 1.473 0.708 0 O-C-N 123.982 0.801 . . . . 0.0 109.646 -178.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.638 ' HB ' ' HB3' ' A' ' 32' ' ' GLN . 0.9 OUTLIER -38.78 135.24 0.87 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.45 -0.781 . . . . 0.0 112.887 177.715 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.453 HG11 ' HA ' ' A' ' 15' ' ' ALA . 26.8 m -91.66 123.53 43.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 112.539 -2.119 . . . . 0.0 109.212 178.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.535 HD12 ' HG3' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -51.74 159.12 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 113.83 -1.532 . . . . 0.0 110.189 173.125 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.4 m -153.61 141.61 13.88 Favored Pre-proline 0 N--CA 1.475 0.793 0 O-C-N 124.625 1.203 . . . . 0.0 110.762 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.07 141.59 33.08 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 121.765 1.643 . . . . 0.0 110.676 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.7 26.94 65.62 Favored Glycine 0 CA--C 1.54 1.635 0 CA-C-N 114.022 -1.444 . . . . 0.0 112.857 -174.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.21 91.59 6.75 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 177.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -42.45 -30.96 0.37 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.516 -1.22 . . . . 0.0 113.448 176.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 59.3 p -128.22 -113.41 0.27 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 113.814 -1.539 . . . . 0.0 109.166 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -115.51 -12.47 11.66 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.78 1.632 . . . . 0.0 111.563 177.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.98 167.34 7.35 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 123.722 1.734 . . . . 0.0 110.441 -176.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.431 HG22 ' HB2' ' A' ' 85' ' ' HIS . 42.5 p -74.43 -6.63 49.33 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 112.349 -1.926 . . . . 0.0 112.941 176.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.437 ' HD2' ' HA2' ' A' ' 83' ' ' GLY . 0.1 OUTLIER -68.73 134.61 50.05 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 120.927 -1.108 . . . . 0.0 109.816 176.199 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.461 ' NH1' ' HG2' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -159.79 139.96 11.78 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.139 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.524 HG23 ' OD1' ' A' ' 79' ' ' ASP . 3.1 mt -113.97 139.22 40.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 O-C-N 125.223 1.577 . . . . 0.0 108.808 176.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 70' ' ' ILE . 20.5 mm -129.25 106.42 13.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 O-C-N 125.287 1.617 . . . . 0.0 108.582 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.525 HG21 HD13 ' A' ' 22' ' ' ILE . 7.9 p -94.69 162.83 13.62 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.436 -0.79 . . . . 0.0 110.937 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.32 -175.19 21.26 Favored Glycine 0 CA--C 1.538 1.477 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.832 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.66 -14.62 62.1 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.955 0.883 . . . . 0.0 112.896 175.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.28 128.6 55.2 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.428 HG22 ' HG2' ' A' ' 77' ' ' GLN . 30.1 m -61.65 151.19 34.24 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.374 175.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.428 ' HG2' HG22 ' A' ' 76' ' ' THR . 4.3 mt-30 75.71 31.79 0.71 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 126.527 1.931 . . . . 0.0 110.821 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.596 ' HA ' HD22 ' A' ' 91' ' ' LEU . 18.0 mt-10 -138.98 60.09 1.6 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 113.1 -1.864 . . . . 0.0 112.702 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.567 ' OD2' HD21 ' A' ' 19' ' ' LEU . 0.6 OUTLIER -101.77 123.19 45.33 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 112.71 -2.041 . . . . 0.0 107.973 175.002 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.466 ' HB3' ' HB3' ' A' ' 89' ' ' PHE . 23.0 m-85 -92.6 126.69 37.8 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 124.715 1.26 . . . . 0.0 109.209 174.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.789 ' HB2' HD11 ' A' ' 92' ' ' ILE . 27.3 t80 -108.85 121.58 45.38 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.017 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.533 ' HB ' ' O ' ' A' ' 88' ' ' THR 0.291 0.1 OUTLIER -79.99 -70.92 0.48 Allowed 'General case' 0 N--CA 1.485 1.293 0 O-C-N 125.497 1.748 . . . . 0.0 113.014 173.604 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.437 ' HA2' ' HD2' ' A' ' 68' ' ' ARG . . . 66.34 16.93 65.64 Favored Glycine 0 CA--C 1.539 1.578 0 CA-C-N 114.253 -1.339 . . . . 0.0 113.069 -173.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.505 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 45.0 t0 -146.5 24.82 1.23 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.567 1.147 . . . . 0.0 112.483 175.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.431 ' HB2' HG22 ' A' ' 67' ' ' THR . 41.1 t-80 56.35 83.55 0.1 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.002 2.121 . . . . 0.0 110.813 177.204 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 46.38 53.58 9.49 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 113.009 -1.905 . . . . 0.0 114.022 -175.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . . . -123.88 -34.83 2.94 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.381 -1.281 . . . . 0.0 114.024 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.533 ' O ' ' HB ' ' A' ' 82' ' ' THR . 11.3 p -135.37 168.01 19.98 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.47 1.108 . . . . 0.0 108.493 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.49 ' CG ' HD21 ' A' ' 44' ' ' LEU . 98.6 m-85 -159.54 115.83 2.55 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -174.186 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.5 m -135.65 111.07 9.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 112.82 -1.991 . . . . 0.0 108.586 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.596 HD22 ' HA ' ' A' ' 78' ' ' GLU . 16.9 mt -41.68 159.96 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.441 176.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.789 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.6 mp -110.7 129.47 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 121.38 -0.825 . . . . 0.0 109.592 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.09 92.02 3.88 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 113.157 -1.838 . . . . 0.0 109.172 176.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -60.1 -31.77 70.35 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 114.218 -1.356 . . . . 0.0 111.199 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.3 t -54.98 -34.87 63.75 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.656 1.582 . . . . 0.0 112.972 172.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 8.6 t . . . . . 0 C--O 1.254 1.299 0 CA-C-O 117.813 -1.089 . . . . 0.0 110.824 178.773 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.7 t . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.6 m -80.85 19.58 0.84 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.085 -0.962 . . . . 0.0 113.014 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.86 -175.18 29.76 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.505 HG22 ' H ' ' A' ' 6' ' ' VAL . 2.4 m -85.29 174.61 9.47 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.445 0.641 . . . . 0.0 110.517 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.526 HG13 HD11 ' A' ' 11' ' ' LEU . 0.3 OUTLIER -148.93 115.28 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -174.657 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.448 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 72.0 m -48.05 128.23 13.45 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 111.807 -2.451 . . . . 0.0 111.126 177.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.67 HD11 ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -46.38 -38.52 9.02 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.603 1.161 . . . . 0.0 112.721 173.704 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.8 t -70.04 -14.52 62.72 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 172.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 7' ' ' CYS . . . -80.36 -26.3 38.71 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.359 0.664 . . . . 0.0 111.865 175.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.635 HD12 ' HA ' ' A' ' 8' ' ' LEU . 0.9 OUTLIER -93.47 169.7 9.78 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 124.17 0.988 . . . . 0.0 111.404 178.701 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 59.6 Cg_endo -66.88 169.29 15.06 Favored 'Trans proline' 0 CA--C 1.548 1.179 0 C-N-CA 122.4 2.067 . . . . 0.0 113.405 176.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -69.72 -21.97 32.91 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 122.276 1.984 . . . . 0.0 113.055 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -86.43 -10.24 54.65 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.857 178.923 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.448 ' HA ' ' CG1' ' A' ' 57' ' ' VAL . . . -67.87 -37.49 81.86 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.007 0.923 . . . . 0.0 112.478 172.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.67 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -67.87 -40.16 83.62 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.423 175.35 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.484 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 7.4 t70 -45.74 -44.77 14.01 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.68 -177.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.717 ' OG1' HG12 ' A' ' 57' ' ' VAL . 1.3 m -65.58 -51.69 57.83 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.066 -1.425 . . . . 0.0 111.593 177.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.595 HD11 HG21 ' A' ' 92' ' ' ILE . 17.6 mt -49.88 -33.36 16.89 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 174.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.31 -48.01 58.53 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.637 0.775 . . . . 0.0 111.941 171.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.502 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 66.6 mt -62.4 -34.37 76.6 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-O 118.73 -0.652 . . . . 0.0 112.243 175.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.607 HD12 ' O ' ' A' ' 18' ' ' THR . 1.8 mp -69.74 -43.95 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 119.497 1.044 . . . . 0.0 111.389 172.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.15 -43.7 81.67 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 124.455 1.097 . . . . 0.0 111.876 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.5 t -85.4 0.47 52.09 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.809 1.244 . . . . 0.0 112.293 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 46.3 35.82 2.95 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 122.368 1.08 . . . . 0.0 112.344 -176.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.47 -172.35 14.67 Favored Glycine 0 CA--C 1.548 2.129 0 CA-C-N 113.711 -1.586 . . . . 0.0 114.309 -175.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.451 ' O ' HD22 ' A' ' 21' ' ' LEU . 55.4 Cg_endo -73.29 135.8 41.57 Favored 'Cis proline' 0 CA--C 1.534 0.515 0 O-C-N 123.003 1.002 . . . . 0.0 111.091 -2.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.502 ' CE1' ' HB3' ' A' ' 21' ' ' LEU . 16.5 m-85 -84.98 103.12 2.88 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 112.81 -1.995 . . . . 0.0 111.722 -177.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.2 -36.7 5.32 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.624 2.216 . . . . 0.0 111.581 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.522 ' CE2' HG13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -77.43 168.69 19.59 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 124.052 0.845 . . . . 0.0 111.991 175.52 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.57 17.74 22.88 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 122.461 1.124 . . . . 0.0 112.911 172.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.91 13.98 20.91 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.734 -1.121 . . . . 0.0 113.67 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -130.86 107.58 9.23 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.764 -1.562 . . . . 0.0 112.556 -174.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.5 -0.2 7.41 Favored Glycine 0 N--CA 1.485 1.937 0 CA-C-N 113.045 -1.889 . . . . 0.0 113.324 -175.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.9 m -92.41 145.96 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.651 0.781 . . . . 0.0 110.072 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.5 t -77.12 157.6 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 125.141 1.526 . . . . 0.0 109.8 176.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.575 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 81.0 t80 -138.56 87.32 2.22 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 113.927 -1.488 . . . . 0.0 109.442 176.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.503 ' HG3' ' CD2' ' A' ' 49' ' ' TYR . 1.7 tt0 -72.59 50.16 0.23 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 122.537 1.161 . . . . 0.0 113.301 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.565 ' CG ' ' HB2' ' A' ' 44' ' ' LEU . 34.9 t30 29.51 54.21 0.12 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.286 1.834 . . . . 0.0 110.873 -173.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.89 -21.89 33.03 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 113.712 -1.586 . . . . 0.0 112.266 -177.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.613 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.1 mt-10 -80.93 -7.6 59.54 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 113.819 -1.537 . . . . 0.0 114.12 173.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.4 t 43.83 37.91 1.87 Allowed 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 123.997 1.856 . . . . 0.0 112.204 -175.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 41' ' ' GLU . 72.1 t -114.36 -16.75 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-N 113.472 -1.695 . . . . 0.0 111.18 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.75 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.5 OUTLIER . . . . . 0 CA--C 1.536 0.408 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.228 -178.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.503 ' CD2' ' HG3' ' A' ' 38' ' ' GLN . 8.7 t80 . . . . . 0 N--CA 1.471 0.596 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.16 -20.81 9.27 Favored Glycine 0 CA--C 1.537 1.46 0 O-C-N 124.863 1.352 . . . . 0.0 113.35 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 74' ' ' GLU . 0.5 OUTLIER -59.77 -19.68 51.9 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.402 1.081 . . . . 0.0 113.423 176.081 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.75 ' HE2' HD12 ' A' ' 44' ' ' LEU . 26.7 m-85 -104.2 166.62 10.28 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 125.091 1.356 . . . . 0.0 109.168 178.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -166.22 166.21 17.02 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 112.301 -2.227 . . . . 0.0 111.206 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.575 ' HG3' ' HB2' ' A' ' 37' ' ' PHE . 28.8 mt-10 -124.55 143.44 50.68 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.239 1.016 . . . . 0.0 110.063 -175.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.661 ' O ' HG21 ' A' ' 18' ' ' THR . 39.8 m-85 -157.68 72.2 0.65 Allowed 'General case' 0 N--CA 1.469 0.477 0 O-C-N 126.28 2.237 . . . . 0.0 109.723 -174.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.415 HG21 ' HG2' ' A' ' 65' ' ' ARG . 0.5 OUTLIER -44.36 144.26 1.06 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.612 0.72 . . . . 0.0 112.405 177.371 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.717 HG12 ' OG1' ' A' ' 18' ' ' THR . 30.4 m -94.72 113.69 29.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.605 176.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.522 HG13 ' CE2' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -43.11 157.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 125.057 1.473 . . . . 0.0 109.096 173.385 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.581 HG22 ' HB2' ' A' ' 62' ' ' ALA . 1.4 m -153.63 143.41 15.23 Favored Pre-proline 0 N--CA 1.477 0.916 0 O-C-N 124.443 1.09 . . . . 0.0 111.226 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.405 ' HD2' HG23 ' A' ' 59' ' ' THR . 64.9 Cg_endo -74.54 144.04 31.52 Favored 'Trans proline' 0 N--CA 1.479 0.66 0 C-N-CA 121.575 1.516 . . . . 0.0 110.788 176.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.51 22.05 30.1 Favored Glycine 0 CA--C 1.544 1.848 0 CA-C-N 114.35 -1.296 . . . . 0.0 112.525 -175.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.581 ' HB2' HG22 ' A' ' 59' ' ' THR . . . -82.53 89.8 6.7 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 178.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -40.97 -30.48 0.13 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.696 -1.593 . . . . 0.0 112.953 176.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.8 p -124.93 -146.25 0.35 Allowed 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 113.776 -1.556 . . . . 0.0 109.569 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.415 ' HG2' HG21 ' A' ' 56' ' ' THR . 18.2 mtm180 -82.31 -2.01 51.4 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 174.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.48 142.41 0.02 OUTLIER Glycine 0 N--CA 1.475 1.25 0 CA-C-O 123.717 1.732 . . . . 0.0 108.879 -173.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.8 p -52.85 -27.65 19.32 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 123.209 1.481 . . . . 0.0 112.165 174.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.529 ' NH1' HG21 ' A' ' 59' ' ' THR . 0.6 OUTLIER -54.23 127.65 27.89 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 120.009 -1.682 . . . . 0.0 111.786 174.445 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.547 ' HB2' HG23 ' A' ' 82' ' ' THR . 0.0 OUTLIER -144.02 149.88 37.37 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.321 179.899 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.475 ' O ' HD13 ' A' ' 71' ' ' ILE . 2.9 mt -122.37 140.17 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 126.04 2.087 . . . . 0.0 109.247 176.083 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.66 HD11 ' HE1' ' A' ' 86' ' ' TYR . 17.1 mm -132.43 108.84 14.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 O-C-N 125.6 1.812 . . . . 0.0 107.173 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.721 HG22 ' HB3' ' A' ' 79' ' ' ASP . 14.8 p -102.92 162.97 12.49 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.422 0.63 . . . . 0.0 110.363 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -115.3 171.26 13.62 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.996 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.418 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -64.58 -16.89 63.39 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 114.479 -0.86 . . . . 0.0 112.214 174.829 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.36 129.42 48.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 122.33 1.062 . . . . 0.0 108.866 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.593 HG22 ' HG2' ' A' ' 77' ' ' GLN . 24.1 m -61.49 147.57 44.86 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 113.776 -1.556 . . . . 0.0 107.494 175.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.593 ' HG2' HG22 ' A' ' 76' ' ' THR . 2.2 mt-30 80.7 31.48 0.17 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 127.0 2.12 . . . . 0.0 111.078 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.581 ' HA ' HD22 ' A' ' 91' ' ' LEU . 34.6 mt-10 -135.73 50.41 2.1 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 113.622 -1.626 . . . . 0.0 113.385 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.721 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.2 OUTLIER -104.63 83.9 2.1 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 113.418 -1.719 . . . . 0.0 110.845 -179.646 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.455 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 8.9 m-85 -68.53 131.53 45.41 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.558 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.576 ' HB2' HD11 ' A' ' 92' ' ' ILE . 68.8 t80 -122.12 130.43 53.23 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.554 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.558 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.5 OUTLIER -85.2 -66.87 0.85 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 111.626 -2.533 . . . . 0.0 112.383 175.595 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 68' ' ' ARG . . . 69.49 22.35 76.47 Favored Glycine 0 N--CA 1.48 1.577 0 CA-C-N 112.996 -1.911 . . . . 0.0 113.58 -174.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.497 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 54.6 m-20 -157.66 24.56 0.28 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.015 1.326 . . . . 0.0 113.278 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 61.66 83.17 0.15 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.324 1.85 . . . . 0.0 112.013 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.66 ' HE1' HD11 ' A' ' 71' ' ' ILE . 11.6 m-30 46.81 38.87 6.46 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 113.424 -1.716 . . . . 0.0 114.057 -176.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' ' 84' ' ' ASP . . . -99.96 -18.37 17.1 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.029 -176.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.558 ' O ' ' HB ' ' A' ' 82' ' ' THR . 5.4 p -164.46 176.99 8.51 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.325 1.45 . . . . 0.0 108.358 -175.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.559 ' CD1' HD21 ' A' ' 44' ' ' LEU . 96.1 m-85 -160.06 115.73 2.38 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -175.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.5 m -135.51 111.46 9.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 112.828 -1.987 . . . . 0.0 108.864 -179.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.581 HD22 ' HA ' ' A' ' 78' ' ' GLU . 15.4 mt -41.58 159.92 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.654 0.596 . . . . 0.0 112.325 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.625 HD13 ' O ' ' A' ' 79' ' ' ASP . 1.6 mp -107.24 123.94 62.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 O-C-N 120.715 -1.241 . . . . 0.0 110.022 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.06 93.49 7.87 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 113.756 -1.566 . . . . 0.0 107.722 177.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -54.81 -42.47 71.9 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.6 t -52.88 -30.1 32.04 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 113.438 -1.71 . . . . 0.0 114.45 173.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.418 ' OXT' ' N ' ' A' ' 8' ' ' LEU . 49.7 t . . . . . 0 C--O 1.246 0.911 0 CA-C-O 123.323 1.535 . . . . 0.0 107.014 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.517 HG21 ' CE1' ' A' ' 80' ' ' TYR . 54.4 t . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.2 m -56.34 -13.01 1.88 Allowed 'General case' 0 N--CA 1.474 0.762 0 O-C-N 125.006 1.441 . . . . 0.0 114.553 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.471 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 127.71 -169.74 19.39 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 176.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -84.41 168.77 15.24 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 122.28 1.038 . . . . 0.0 111.048 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.579 HG12 ' O ' ' A' ' 91' ' ' LEU . 8.4 p -146.49 110.8 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 114.361 -1.291 . . . . 0.0 107.588 -176.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 70.9 m -43.34 131.04 4.86 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 111.946 -2.388 . . . . 0.0 109.74 177.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.795 ' HA ' HD12 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -52.41 -36.55 54.49 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.3 177.42 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.5 t -67.42 -17.02 64.55 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.338 1.055 . . . . 0.0 113.3 174.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.01 -33.8 33.38 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.918 0.487 . . . . 0.0 111.731 176.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.795 HD12 ' HA ' ' A' ' 8' ' ' LEU . 4.0 mt -81.07 173.23 8.04 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 125.683 1.593 . . . . 0.0 110.557 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.557 ' HB2' ' OE2' ' A' ' 14' ' ' GLU . 72.7 Cg_endo -66.95 166.47 22.66 Favored 'Trans proline' 0 CA--C 1.551 1.342 0 C-N-CA 121.847 1.698 . . . . 0.0 113.885 175.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -66.68 -22.45 50.33 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.983 2.456 . . . . 0.0 113.715 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.557 ' OE2' ' HB2' ' A' ' 12' ' ' PRO . 1.0 OUTLIER -82.97 -8.58 59.55 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 173.984 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.811 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -65.32 -29.61 70.37 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 174.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.616 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -73.88 -29.41 62.07 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.816 173.513 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.485 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 45.7 t0 -52.66 -54.49 32.68 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.781 0.676 . . . . 0.0 109.534 -176.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.627 ' HA ' HD12 ' A' ' 21' ' ' LEU . 24.4 m -54.78 -49.31 71.22 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 175.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.859 HD11 HG21 ' A' ' 92' ' ' ILE . 11.5 mt -56.01 -34.78 66.13 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 177.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -70.58 -41.05 72.89 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.471 172.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.627 HD12 ' HA ' ' A' ' 18' ' ' THR . 48.9 mt -66.77 -33.98 76.82 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 123.272 0.629 . . . . 0.0 112.16 175.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.66 HD13 HG21 ' A' ' 72' ' ' THR . 5.8 mt -69.22 -44.41 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 119.486 1.039 . . . . 0.0 111.161 172.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.48 -43.94 75.87 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 124.665 1.228 . . . . 0.0 112.24 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.42 5.85 47.74 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.105 0.962 . . . . 0.0 112.041 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 43.77 36.64 1.36 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.997 1.319 . . . . 0.0 112.528 -176.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.96 -165.28 13.24 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 113.667 -1.606 . . . . 0.0 115.619 -175.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -73.95 137.67 51.32 Favored 'Cis proline' 0 CA--C 1.537 0.644 0 O-C-N 124.644 1.865 . . . . 0.0 112.424 -4.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.522 ' CE2' ' HB3' ' A' ' 21' ' ' LEU . 81.4 m-85 -85.74 153.17 57.85 Favored Pre-proline 0 N--CA 1.472 0.632 0 CA-C-N 113.301 -1.772 . . . . 0.0 112.611 -178.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.02 -56.9 0.14 Allowed 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.409 2.072 . . . . 0.0 113.344 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.48 ' CD1' ' HB2' ' A' ' 32' ' ' GLN . 0.1 OUTLIER -112.97 168.93 9.29 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.438 1.495 . . . . 0.0 110.531 179.344 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.7 m -71.42 56.98 0.25 Allowed 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 123.55 1.643 . . . . 0.0 114.015 174.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.48 ' HB2' ' CD1' ' A' ' 30' ' ' TYR . 3.9 mt-30 -131.1 67.6 1.51 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 123.497 1.618 . . . . 0.0 112.066 177.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -173.7 155.22 2.63 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 110.19 -3.187 . . . . 0.0 114.733 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 71.82 10.83 72.91 Favored Glycine 0 N--CA 1.481 1.641 0 CA-C-N 112.181 -2.281 . . . . 0.0 111.635 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.678 HG23 ' HB2' ' A' ' 54' ' ' GLU . 13.0 m -97.74 142.22 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.402 1.081 . . . . 0.0 109.72 174.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.6 t -87.59 155.24 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 O-C-N 125.867 1.979 . . . . 0.0 110.276 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.51 ' HB3' ' HB3' ' A' ' 52' ' ' TYR . 51.6 t80 -121.45 103.03 8.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.392 173.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.83 45.17 0.19 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.199 0.6 . . . . 0.0 112.037 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 21.07 57.82 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 124.116 1.912 . . . . 0.0 113.359 -174.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.503 ' HD3' ' CE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -79.19 7.0 8.34 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 113.527 -1.67 . . . . 0.0 112.297 -175.835 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.566 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.2 mt-10 -111.55 -17.05 13.14 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.479 -1.691 . . . . 0.0 113.847 177.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.9 t 46.22 39.66 6.44 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 123.99 1.852 . . . . 0.0 112.972 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 41' ' ' GLU . 89.1 t -111.35 -15.97 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.438 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.484 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.5 OUTLIER . . . . . 0 CA--C 1.549 0.907 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -173.213 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.8 t80 . . . . . 0 N--CA 1.469 0.511 0 CA-C-O 120.579 0.228 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.23 -24.85 25.18 Favored Glycine 0 N--CA 1.476 1.334 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.842 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -61.82 -14.2 31.01 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.844 1.258 . . . . 0.0 112.789 175.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.51 ' HB3' ' HB3' ' A' ' 37' ' ' PHE . 28.3 m-85 -121.59 147.14 46.23 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.675 1.19 . . . . 0.0 109.789 -178.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -141.73 160.04 41.0 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 113.706 -1.588 . . . . 0.0 111.79 177.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.678 ' HB2' HG23 ' A' ' 35' ' ' VAL . 8.0 mt-10 -114.94 138.57 50.66 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.918 -178.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.436 ' HB3' HG23 ' A' ' 18' ' ' THR . 90.8 m-85 -155.54 73.63 0.85 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 112.739 -2.028 . . . . 0.0 110.079 -176.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 68' ' ' ARG . 24.6 m -45.04 130.88 7.59 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 122.246 1.022 . . . . 0.0 111.534 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.811 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.8 OUTLIER -86.59 125.4 40.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 111.52 -2.582 . . . . 0.0 110.102 179.384 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.424 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -48.12 148.77 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 O-C-N 125.734 1.896 . . . . 0.0 108.99 174.046 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.492 ' OG1' ' HG3' ' A' ' 68' ' ' ARG . 2.6 m -148.31 140.63 14.69 Favored Pre-proline 0 N--CA 1.471 0.613 0 O-C-N 125.981 2.05 . . . . 0.0 110.999 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.462 ' HD3' ' CD ' ' A' ' 14' ' ' GLU . 73.4 Cg_endo -72.64 145.55 41.91 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.784 2.323 . . . . 0.0 110.034 176.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.04 22.74 56.01 Favored Glycine 0 CA--C 1.543 1.816 0 CA-C-N 113.681 -1.599 . . . . 0.0 113.321 -174.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -89.05 90.88 8.59 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 176.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.5 -33.29 0.42 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 113.711 -1.586 . . . . 0.0 113.623 176.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.0 p -133.66 -149.23 0.36 Allowed 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 113.624 -1.625 . . . . 0.0 107.848 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -60.52 -18.83 54.59 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 125.282 1.433 . . . . 0.0 111.813 173.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.76 167.27 1.43 Allowed Glycine 0 CA--C 1.532 1.139 0 CA-C-O 123.747 1.748 . . . . 0.0 110.017 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 46.6 p -65.11 -17.36 64.4 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 112.977 -1.612 . . . . 0.0 112.393 173.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.553 ' O ' HG23 ' A' ' 56' ' ' THR . 0.1 OUTLIER -63.41 126.72 28.41 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 120.937 -1.102 . . . . 0.0 110.34 176.843 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 1.3 tpt180 -151.56 132.95 14.62 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.349 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.431 ' HB ' ' O ' ' A' ' 55' ' ' TYR . 4.1 mt -105.8 138.91 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 173.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.7 mm -123.5 106.2 16.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 112.697 -2.047 . . . . 0.0 107.417 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.66 HG21 HD13 ' A' ' 22' ' ' ILE . 13.9 p -92.07 164.37 13.63 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.094 0.473 . . . . 0.0 111.604 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -104.46 -175.81 25.09 Favored Glycine 0 N--CA 1.471 1.026 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.298 178.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -80.62 -14.83 57.84 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.544 -0.828 . . . . 0.0 112.172 177.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.3 130.86 55.61 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 175.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.429 HG22 ' HG2' ' A' ' 77' ' ' GLN . 53.7 m -49.76 149.17 2.64 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.645 173.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.429 ' HG2' HG22 ' A' ' 76' ' ' THR . 4.4 mt-30 81.19 34.33 0.11 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 126.561 1.945 . . . . 0.0 111.057 -178.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.548 ' HA ' HD22 ' A' ' 91' ' ' LEU . 43.9 mt-10 -139.26 50.38 1.8 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 113.474 -1.693 . . . . 0.0 113.578 -178.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.482 ' OD2' HD22 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -108.45 95.56 5.75 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.365 1.466 . . . . 0.0 110.678 -176.692 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.517 ' CE1' HG21 ' A' ' 2' ' ' VAL . 15.9 m-85 -81.62 123.19 28.47 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 126.058 1.743 . . . . 0.0 110.255 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.853 ' HB2' HD11 ' A' ' 92' ' ' ILE . 5.8 t80 -104.81 127.79 52.74 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.052 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 88' ' ' THR 0.301 0.0 OUTLIER -88.24 -71.62 0.57 Allowed 'General case' 0 C--N 1.323 -0.569 0 O-C-N 125.948 2.03 . . . . 0.0 113.713 172.641 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 68' ' ' ARG . . . 68.06 16.37 68.54 Favored Glycine 0 N--CA 1.476 1.332 0 CA-C-N 113.898 -1.501 . . . . 0.0 113.979 -173.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.558 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 75.1 m-20 -145.93 22.7 1.4 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.795 1.238 . . . . 0.0 113.041 176.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 57.89 82.27 0.13 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 127.177 2.191 . . . . 0.0 111.289 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.449 ' HB3' ' OE2' ' A' ' 41' ' ' GLU . 25.1 m-85 49.55 54.28 11.27 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 113.514 -1.676 . . . . 0.0 113.387 -174.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.558 ' HB3' ' HB2' ' A' ' 84' ' ' ASP . . . -120.16 -41.06 2.65 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.454 ' O ' ' HB ' ' A' ' 82' ' ' THR . 15.6 p -130.91 163.52 27.29 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.043 0.937 . . . . 0.0 108.73 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.434 ' HB3' ' HB3' ' A' ' 80' ' ' TYR . 97.5 m-85 -154.95 119.79 4.86 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -175.165 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.5 m -140.76 113.82 8.45 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 112.312 -2.222 . . . . 0.0 108.906 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.579 ' O ' HG12 ' A' ' 6' ' ' VAL . 14.7 mt -43.61 156.57 0.06 Allowed 'General case' 0 N--CA 1.48 1.074 0 O-C-N 124.109 0.881 . . . . 0.0 112.369 175.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.859 HG21 HD11 ' A' ' 19' ' ' LEU . 1.7 mp -111.14 137.65 42.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 122.15 0.976 . . . . 0.0 108.456 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -113.01 99.08 7.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 113.14 -1.845 . . . . 0.0 108.746 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -58.74 -41.42 86.42 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.89 0.744 . . . . 0.0 112.033 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 t -54.94 -44.5 74.36 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 114.471 -1.24 . . . . 0.0 113.437 175.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 35.3 t . . . . . 0 C--O 1.241 0.643 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.21 178.596 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.562 HG11 ' H ' ' A' ' 91' ' ' LEU . 4.1 t . . . . . 0 N--CA 1.487 1.377 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 m -77.61 5.86 8.35 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 124.723 1.264 . . . . 0.0 114.303 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.34 169.28 12.59 Favored Glycine 0 N--CA 1.474 1.171 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 m -86.67 171.48 10.94 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.312 -0.944 . . . . 0.0 109.818 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p -138.14 113.48 9.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 -176.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 71.4 m -50.73 125.03 12.22 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 112.05 -2.341 . . . . 0.0 109.854 177.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -53.81 -36.93 63.02 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.883 175.013 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.7 t -65.61 -29.05 69.59 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.361 0.6 . . . . 0.0 112.511 174.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.28 -22.81 47.72 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.759 174.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.433 HD22 ' HD2' ' A' ' 12' ' ' PRO . 10.7 mt -80.68 164.13 52.82 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.318 176.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.761 ' HG2' ' HB2' ' A' ' 15' ' ' ALA . 69.0 Cg_endo -67.01 173.96 7.57 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.019 2.48 . . . . 0.0 115.056 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -71.67 -53.62 0.17 Allowed 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.813 2.342 . . . . 0.0 112.771 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.464 ' HG2' ' HD3' ' A' ' 60' ' ' PRO . 1.9 pp20? -60.2 -12.49 8.86 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.528 172.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.761 ' HB2' ' HG2' ' A' ' 12' ' ' PRO . . . -57.11 -41.85 79.75 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.725 -0.609 . . . . 0.0 111.9 176.462 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.16 -22.6 66.94 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 113.634 -1.621 . . . . 0.0 112.893 174.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.577 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 63.7 t0 -55.03 -58.02 9.35 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.582 0.753 . . . . 0.0 109.896 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.567 ' O ' HD12 ' A' ' 22' ' ' ILE . 61.5 m -54.5 -47.31 73.21 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 176.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.547 HD21 ' OD2' ' A' ' 79' ' ' ASP . 17.3 mt -54.05 -37.11 63.8 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 175.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -69.57 -37.73 77.11 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.226 173.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 17' ' ' ASP . 30.1 mt -72.52 -33.02 66.59 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 118.689 -0.672 . . . . 0.0 111.202 176.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.567 HD12 ' O ' ' A' ' 18' ' ' THR . 1.3 mp -68.9 -41.26 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 120.117 1.326 . . . . 0.0 111.613 171.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.32 -43.39 67.15 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 124.279 0.987 . . . . 0.0 112.164 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.39 5.09 48.92 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.363 1.065 . . . . 0.0 111.293 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.5 t70 41.15 49.77 3.22 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.203 1.401 . . . . 0.0 111.288 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.68 -164.76 30.49 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 112.767 -2.015 . . . . 0.0 116.165 -173.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -75.1 142.85 75.87 Favored 'Cis proline' 0 C--N 1.35 0.639 0 O-C-N 124.419 1.747 . . . . 0.0 111.656 -2.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.416 ' CE2' ' HB3' ' A' ' 21' ' ' LEU . 78.5 m-85 -99.27 123.26 49.26 Favored Pre-proline 0 N--CA 1.471 0.625 0 CA-C-N 113.419 -1.719 . . . . 0.0 111.102 -176.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.91 -56.74 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.01 1.807 . . . . 0.0 111.629 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -158.78 21.99 0.21 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.864 0.866 . . . . 0.0 112.096 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.508 ' HB3' HD12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -76.98 43.7 0.36 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.118 -178.635 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.53 ' HB2' ' HD2' ' A' ' 65' ' ' ARG . 1.4 tt0 20.15 64.72 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 128.968 2.907 . . . . 0.0 112.686 -175.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -103.31 175.34 5.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 110.883 -2.871 . . . . 0.0 111.458 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.29 44.95 97.42 Favored Glycine 0 N--CA 1.478 1.494 0 CA-C-N 112.731 -2.031 . . . . 0.0 110.082 176.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.0 m -142.3 147.12 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 114.007 -1.097 . . . . 0.0 108.665 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.0 t -90.81 154.92 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 125.642 1.839 . . . . 0.0 109.798 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -137.96 91.61 2.59 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.851 174.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.453 ' HG3' ' CD1' ' A' ' 49' ' ' TYR . 2.2 tm0? -70.46 51.34 0.13 Allowed 'General case' 0 N--CA 1.483 1.214 0 O-C-N 120.945 -1.097 . . . . 0.0 112.97 178.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.409 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 15.8 p-10 29.23 52.58 0.08 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.611 1.964 . . . . 0.0 110.499 -177.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.75 -24.25 56.11 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.886 -169.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.609 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.0 mt-10 -76.84 -7.15 54.93 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 112.05 -2.341 . . . . 0.0 114.933 172.048 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.9 t 45.68 39.03 4.62 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 123.72 1.724 . . . . 0.0 111.585 -178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 41' ' ' GLU . 54.5 t -112.73 -12.15 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 123.361 1.553 . . . . 0.0 110.369 -178.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.495 HD12 ' CE1' ' A' ' 52' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.243 0.719 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 -172.257 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.453 ' CD1' ' HG3' ' A' ' 38' ' ' GLN . 4.3 t80 . . . . . 0 CA--C 1.534 0.338 0 CA-C-O 120.923 0.392 . . . . 0.0 110.291 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.4 -24.78 9.07 Favored Glycine 0 N--CA 1.472 1.096 0 CA-C-N 114.084 -1.417 . . . . 0.0 112.14 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -60.45 -20.46 59.94 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 174.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.495 ' CE1' HD12 ' A' ' 44' ' ' LEU . 26.4 m-85 -104.38 147.75 27.19 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.449 -1.25 . . . . 0.0 108.804 -178.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -147.28 152.84 38.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 112.934 -1.939 . . . . 0.0 111.218 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -105.36 143.07 34.03 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.435 -178.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.431 ' HB3' HG23 ' A' ' 18' ' ' THR . 99.9 m-85 -149.81 65.57 0.99 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 112.216 -2.265 . . . . 0.0 111.36 -176.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.5 m -33.99 130.01 0.33 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.602 1.192 . . . . 0.0 112.382 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.72 HG21 ' HA ' ' A' ' 15' ' ' ALA . 1.5 p -88.98 98.66 8.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 C-N-CA 118.574 -1.251 . . . . 0.0 110.11 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.508 HD12 ' HB3' ' A' ' 31' ' ' SER . 1.1 mp -25.76 128.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.773 176.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.432 HG22 ' HB2' ' A' ' 62' ' ' ALA . 4.1 m -127.05 141.76 41.66 Favored Pre-proline 0 N--CA 1.479 1.025 0 CA-C-N 118.529 0.604 . . . . 0.0 111.723 -177.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.464 ' HD3' ' HG2' ' A' ' 14' ' ' GLU . 74.2 Cg_endo -72.59 148.05 46.8 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.129 1.886 . . . . 0.0 110.441 176.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 52.74 22.67 12.32 Favored Glycine 0 CA--C 1.543 1.807 0 CA-C-N 114.278 -1.328 . . . . 0.0 113.03 -175.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.432 ' HB2' HG22 ' A' ' 59' ' ' THR . . . -93.37 90.67 6.85 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -39.12 -33.68 0.14 Allowed 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 112.987 -1.915 . . . . 0.0 112.61 175.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.8 p -129.13 -143.22 0.26 Allowed 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 113.695 -1.593 . . . . 0.0 108.84 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.53 ' HD2' ' HB2' ' A' ' 32' ' ' GLN . 64.9 mtm-85 -79.69 -14.03 59.05 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 172.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 57.33 -177.82 1.09 Allowed Glycine 0 CA--C 1.534 1.245 0 CA-C-O 123.892 1.829 . . . . 0.0 110.602 -173.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.421 ' HA ' ' HB2' ' A' ' 85' ' ' HIS . 46.0 p -66.31 -36.34 82.7 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 112.462 -1.869 . . . . 0.0 112.845 177.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.42 ' HA ' ' HA2' ' A' ' 83' ' ' GLY . 1.1 mtp85 -44.36 125.54 4.7 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.705 174.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.09 139.61 14.88 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 112.916 -1.947 . . . . 0.0 109.715 -177.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.654 HG23 ' OD1' ' A' ' 79' ' ' ASP . 4.6 mt -114.74 136.45 51.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 111.321 -2.672 . . . . 0.0 108.162 177.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.721 HD11 ' HE1' ' A' ' 86' ' ' TYR . 20.2 mm -124.9 106.1 16.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 113.057 -1.883 . . . . 0.0 107.701 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.623 HG22 ' HB2' ' A' ' 79' ' ' ASP . 32.0 p -99.5 163.07 12.66 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.319 0.581 . . . . 0.0 110.507 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -118.38 167.08 12.91 Favored Glycine 0 N--CA 1.476 1.334 0 CA-C-N 114.181 -1.372 . . . . 0.0 109.728 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.79 -22.67 25.67 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 114.691 -0.754 . . . . 0.0 112.338 172.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.91 129.49 34.82 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.581 1.181 . . . . 0.0 109.702 173.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.604 HG22 ' HG3' ' A' ' 77' ' ' GLN . 2.7 m -63.4 146.84 52.74 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.931 -1.486 . . . . 0.0 109.976 176.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.604 ' HG3' HG22 ' A' ' 76' ' ' THR . 61.8 mt-30 62.69 49.92 3.64 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.98 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.498 ' HA ' HD22 ' A' ' 91' ' ' LEU . 4.2 mt-10 -145.89 61.1 1.26 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.346 -1.752 . . . . 0.0 111.901 -177.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.654 ' OD1' HG23 ' A' ' 70' ' ' ILE . 5.9 t0 -106.28 119.82 40.25 Favored 'General case' 0 C--O 1.212 -0.887 0 CA-C-N 113.084 -1.871 . . . . 0.0 108.187 175.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.472 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 16.8 m-85 -92.51 127.75 38.11 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 125.341 1.651 . . . . 0.0 109.392 175.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.73 ' HB2' HD11 ' A' ' 92' ' ' ILE . 2.7 t80 -107.4 126.63 52.72 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 114.077 -1.42 . . . . 0.0 109.631 -178.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -89.77 -67.24 0.86 Allowed 'General case' 0 N--CA 1.484 1.229 0 O-C-N 125.709 1.88 . . . . 0.0 112.551 175.323 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 68' ' ' ARG . . . 62.02 21.42 61.39 Favored Glycine 0 CA--C 1.539 1.558 0 CA-C-N 114.148 -1.387 . . . . 0.0 112.444 -173.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.561 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 58.0 m-20 -147.42 20.04 1.2 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.794 1.238 . . . . 0.0 112.621 176.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 67' ' ' THR . 21.9 t-80 56.79 80.41 0.16 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.844 1.657 . . . . 0.0 110.251 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.721 ' HE1' HD11 ' A' ' 71' ' ' ILE . 15.4 m-30 48.87 54.27 11.08 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 113.321 -1.763 . . . . 0.0 113.837 -175.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 84' ' ' ASP . . . -120.73 -32.66 3.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.276 -1.329 . . . . 0.0 113.065 176.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.501 ' O ' ' HB ' ' A' ' 82' ' ' THR . 17.2 p -140.32 166.64 24.15 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.453 ' CD1' HD21 ' A' ' 44' ' ' LEU . 93.5 m-85 -156.72 118.11 3.78 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -173.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.2 m -139.41 107.8 5.83 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 125.871 1.982 . . . . 0.0 110.047 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.562 ' H ' HG11 ' A' ' 2' ' ' VAL . 22.7 mt -40.86 159.29 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.123 178.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.73 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.7 mp -108.67 128.74 64.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 O-C-N 120.612 -1.305 . . . . 0.0 109.415 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.35 95.58 5.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 113.836 -1.529 . . . . 0.0 108.698 177.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.5 -36.81 67.07 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 124.312 1.007 . . . . 0.0 112.044 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.1 t -56.59 -48.59 77.07 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.901 1.28 . . . . 0.0 113.232 174.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 44.0 t . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.779 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.48 HG12 ' H ' ' A' ' 4' ' ' GLY . 3.7 t . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.8 m -80.39 -3.24 48.89 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 176.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.48 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 137.87 179.94 17.57 Favored Glycine 0 N--CA 1.473 1.162 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 6' ' ' VAL . 3.0 m -89.33 174.46 7.81 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 122.109 0.957 . . . . 0.0 109.783 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.435 ' H ' HG22 ' A' ' 5' ' ' THR . 1.0 OUTLIER -142.96 112.31 2.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 122.659 1.218 . . . . 0.0 107.834 -176.387 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.4 ' HA ' ' HB3' ' A' ' 96' ' ' CYS . 93.1 m -52.12 133.71 33.25 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 112.152 -2.295 . . . . 0.0 109.887 177.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -31.53 68.02 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.083 0.864 . . . . 0.0 111.878 -178.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.4 t -66.08 -28.76 69.07 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.661 0.784 . . . . 0.0 112.902 173.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.52 -18.54 56.93 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.712 0.805 . . . . 0.0 111.81 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 11' ' ' LEU . 7.0 mt -86.34 161.28 49.32 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 175.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.552 ' HB2' ' OE2' ' A' ' 14' ' ' GLU . 98.3 Cg_endo -69.67 170.24 16.93 Favored 'Trans proline' 0 CA--C 1.552 1.393 0 C-N-CA 122.192 1.928 . . . . 0.0 112.484 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.04 -34.83 12.9 Favored 'Trans proline' 0 N--CA 1.482 0.827 0 C-N-CA 122.652 2.234 . . . . 0.0 113.024 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.661 ' HB2' HG22 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -73.73 -9.43 58.66 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 114.695 -1.139 . . . . 0.0 114.069 175.2 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.412 ' HB2' ' HG2' ' A' ' 12' ' ' PRO . . . -66.48 -40.4 89.28 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.052 173.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.55 -33.13 74.32 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.081 175.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.434 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 5.5 t0 -54.02 -49.85 67.97 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.792 -178.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.632 HG21 ' O ' ' A' ' 55' ' ' TYR . 2.2 m -64.69 -49.3 71.47 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-O 117.953 -1.022 . . . . 0.0 112.479 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.5 mt -52.05 -34.22 42.38 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 124.293 0.996 . . . . 0.0 111.794 175.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.27 -45.68 54.34 Favored 'General case' 0 C--O 1.213 -0.867 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.262 173.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.565 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 55.3 mt -64.21 -33.7 76.41 Favored 'General case' 0 C--O 1.212 -0.913 0 C-N-CA 122.956 0.502 . . . . 0.0 111.964 174.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.521 HG21 HG21 ' A' ' 72' ' ' THR . 5.9 mt -71.16 -41.72 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 O-C-N 119.716 -1.865 . . . . 0.0 110.424 174.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.65 -43.14 66.63 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 124.68 1.238 . . . . 0.0 111.932 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.5 8.48 33.68 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.762 1.225 . . . . 0.0 112.057 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.8 t70 41.12 53.66 3.41 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 123.109 1.433 . . . . 0.0 111.952 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.09 -165.89 14.46 Favored Glycine 0 CA--C 1.538 1.53 0 CA-C-N 113.456 -1.702 . . . . 0.0 113.804 -175.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.529 ' O ' HD22 ' A' ' 21' ' ' LEU . 59.3 Cg_endo -73.77 138.16 54.09 Favored 'Cis proline' 0 N--CA 1.481 0.785 0 O-C-N 123.54 1.284 . . . . 0.0 111.768 -2.01 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.565 ' CE1' ' HB3' ' A' ' 21' ' ' LEU . 49.4 m-85 -94.81 106.52 25.24 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 113.316 -1.765 . . . . 0.0 111.952 -176.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -71.13 -46.3 0.72 Allowed 'Trans proline' 0 N--CA 1.477 0.531 0 C-N-CA 122.033 1.822 . . . . 0.0 111.742 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.463 ' C ' ' H ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -173.67 23.1 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.463 1.105 . . . . 0.0 112.805 -179.548 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.2 m -69.34 37.25 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.494 -174.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.463 ' H ' ' C ' ' A' ' 30' ' ' TYR . 0.0 OUTLIER 32.13 42.63 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.191 2.596 . . . . 0.0 112.975 -176.941 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.535 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 2.7 p30 -105.35 174.47 5.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 110.986 -2.825 . . . . 0.0 111.157 -172.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.91 -2.15 75.96 Favored Glycine 0 N--CA 1.482 1.704 0 O-C-N 126.195 2.185 . . . . 0.0 111.137 -175.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.412 HG23 ' OE1' ' A' ' 54' ' ' GLU . 27.2 m -102.21 143.93 14.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.935 0.894 . . . . 0.0 110.465 175.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.08 153.34 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 125.386 1.679 . . . . 0.0 109.588 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.491 ' CD2' HG21 ' A' ' 71' ' ' ILE . 44.9 t80 -131.65 89.26 2.68 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 112.936 -1.938 . . . . 0.0 109.878 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -72.54 51.25 0.26 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 118.692 0.678 . . . . 0.0 112.67 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 14.1 p-10 29.43 51.49 0.08 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.022 2.529 . . . . 0.0 109.397 -177.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.459 ' HD3' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -56.76 -21.81 31.11 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.121 -173.766 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.631 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.8 mt-10 -78.27 -6.52 55.24 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.405 -1.725 . . . . 0.0 114.787 172.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 43.5 t 44.85 35.91 1.67 Allowed 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 124.782 2.23 . . . . 0.0 112.269 -176.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 41' ' ' GLU . 70.9 t -111.74 -9.87 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 113.376 -1.738 . . . . 0.0 109.758 -178.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.573 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.318 -0.767 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -175.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.0 t80 . . . . . 0 N--CA 1.47 0.569 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.87 -19.12 17.54 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 124.712 1.258 . . . . 0.0 113.548 176.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.458 ' CE2' ' HB3' ' A' ' 74' ' ' GLU . 1.3 t80 -65.59 -13.89 59.98 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.363 1.065 . . . . 0.0 113.214 176.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.573 ' HE2' HD12 ' A' ' 44' ' ' LEU . 23.6 m-85 -108.58 155.25 20.87 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.362 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -154.03 161.14 42.15 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 112.968 -1.923 . . . . 0.0 110.832 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' A' ' 33' ' ' ASP . 1.7 mp0 -116.86 149.4 40.12 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.516 -177.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.632 ' O ' HG21 ' A' ' 18' ' ' THR . 76.2 m-85 -159.96 82.4 0.72 Allowed 'General case' 0 CA--C 1.545 0.758 0 O-C-N 125.239 1.587 . . . . 0.0 109.335 -172.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.559 HG22 ' H ' ' A' ' 58' ' ' ILE . 88.5 m -49.83 146.33 4.61 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 123.086 1.422 . . . . 0.0 111.434 175.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.497 ' CG1' HD12 ' A' ' 70' ' ' ILE . 1.2 m -105.81 19.0 5.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 113.01 -1.904 . . . . 0.0 113.019 -173.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.661 HG22 ' HB2' ' A' ' 14' ' ' GLU . 0.1 OUTLIER 53.32 179.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 O-C-N 124.827 1.329 . . . . 0.0 108.857 -165.833 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.3 m -156.11 139.99 11.43 Favored Pre-proline 0 N--CA 1.477 0.905 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.801 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.623 ' HD3' ' CD ' ' A' ' 14' ' ' GLU . 71.3 Cg_endo -74.2 142.91 31.22 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.002 2.468 . . . . 0.0 110.023 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 48.01 27.99 5.46 Favored Glycine 0 CA--C 1.541 1.718 0 CA-C-N 114.188 -1.369 . . . . 0.0 112.623 -176.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.09 95.07 6.59 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.69 -29.2 0.72 Allowed 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 111.603 -2.544 . . . . 0.0 112.428 175.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.8 p -112.07 -165.18 0.97 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.514 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.7 mtm105 -66.54 -12.11 56.08 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 174.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.63 165.54 7.18 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-O 123.838 1.799 . . . . 0.0 110.335 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.442 ' HA ' ' HB2' ' A' ' 85' ' ' HIS . 40.8 p -74.2 -15.49 61.01 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 112.631 -1.785 . . . . 0.0 112.439 178.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.521 ' HD2' ' HA2' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -66.85 136.53 55.55 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 120.931 -1.106 . . . . 0.0 110.245 177.082 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.462 ' HB2' HG23 ' A' ' 82' ' ' THR . 0.0 OUTLIER -158.53 156.12 29.64 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.418 -1.719 . . . . 0.0 110.447 -178.839 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.497 HD12 ' CG1' ' A' ' 57' ' ' VAL . 1.0 OUTLIER -130.16 140.96 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 O-C-N 125.325 1.641 . . . . 0.0 109.215 176.802 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.491 HG21 ' CD2' ' A' ' 37' ' ' PHE . 13.6 mm -128.87 106.11 13.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 113.22 -1.809 . . . . 0.0 107.82 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.64 HG22 ' HB3' ' A' ' 79' ' ' ASP . 20.7 p -98.61 162.16 13.28 Favored 'General case' 0 C--N 1.314 -0.971 0 O-C-N 121.477 -0.765 . . . . 0.0 110.584 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.21 166.61 12.52 Favored Glycine 0 N--CA 1.48 1.605 0 CA-C-N 113.663 -1.608 . . . . 0.0 109.469 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.458 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -61.37 -18.25 57.84 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.562 -0.819 . . . . 0.0 112.6 174.471 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -101.03 129.99 46.96 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.578 174.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.65 HG22 ' HG2' ' A' ' 77' ' ' GLN . 3.0 m -59.82 143.75 50.37 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 113.675 -1.602 . . . . 0.0 107.883 175.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.65 ' HG2' HG22 ' A' ' 76' ' ' THR . 0.0 OUTLIER 80.74 35.99 0.11 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.741 2.016 . . . . 0.0 110.474 179.035 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.447 ' HA ' ' CD2' ' A' ' 91' ' ' LEU . 3.7 mt-10 -134.02 47.43 2.43 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 113.45 -1.705 . . . . 0.0 113.204 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.64 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.1 OUTLIER -103.64 89.29 3.3 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.884 1.274 . . . . 0.0 110.19 -178.997 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.454 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 8.2 m-85 -78.45 131.88 37.06 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 125.228 1.411 . . . . 0.0 109.553 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.79 ' HB2' HD11 ' A' ' 92' ' ' ILE . 16.2 t80 -116.5 132.44 56.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.726 -1.124 . . . . 0.0 109.513 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -86.76 -72.28 0.51 Allowed 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 112.468 -2.151 . . . . 0.0 112.687 175.596 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.521 ' HA2' ' HD2' ' A' ' 68' ' ' ARG . . . 71.13 21.24 78.4 Favored Glycine 0 N--CA 1.473 1.119 0 CA-C-N 112.926 -1.943 . . . . 0.0 113.277 -175.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.612 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 63.0 m-20 -154.41 23.01 0.48 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.811 1.245 . . . . 0.0 112.963 177.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.442 ' HB2' ' HA ' ' A' ' 67' ' ' THR . 23.0 t-80 56.8 82.67 0.11 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.896 2.078 . . . . 0.0 110.005 178.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 7.7 m-30 51.2 48.67 22.6 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 113.04 -1.891 . . . . 0.0 114.163 -176.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.612 ' HB3' ' HB2' ' A' ' 84' ' ' ASP . . . -115.2 -30.59 6.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.823 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.498 ' O ' ' HB ' ' A' ' 82' ' ' THR . 22.3 p -147.97 169.67 19.38 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -178.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.502 ' CD1' HD21 ' A' ' 44' ' ' LEU . 89.5 m-85 -157.88 116.31 3.12 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -173.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.8 m -137.95 113.2 9.32 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 125.858 1.974 . . . . 0.0 110.099 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 91' ' ' LEU . 14.7 mt -41.56 160.52 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 O-C-N 124.465 1.103 . . . . 0.0 112.812 178.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.79 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.6 mp -110.08 128.32 66.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 O-C-N 121.58 -0.7 . . . . 0.0 109.38 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.69 92.19 3.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 113.721 -1.581 . . . . 0.0 108.812 176.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.23 -30.13 69.2 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.935 178.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.1 t -56.31 -33.21 65.35 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.077 -1.419 . . . . 0.0 112.851 172.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.4 ' HB3' ' HA ' ' A' ' 7' ' ' CYS . 6.4 t . . . . . 0 C--O 1.257 1.464 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.973 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.4 p30 . . . . . 0 CA--C 1.548 0.878 0 CA-C-O 120.874 0.368 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.61 HG21 ' HE1' ' A' ' 80' ' ' TYR . 24.7 t -41.91 142.04 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.347 1.059 . . . . 0.0 109.315 175.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -78.08 12.88 1.62 Allowed 'General case' 0 N--CA 1.48 1.065 0 O-C-N 124.182 0.927 . . . . 0.0 113.342 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.97 179.05 23.55 Favored Glycine 0 N--CA 1.468 0.797 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.459 HG22 ' H ' ' A' ' 6' ' ' VAL . 2.9 m -80.9 173.83 12.22 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 122.174 0.988 . . . . 0.0 110.746 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.459 ' H ' HG22 ' A' ' 5' ' ' THR . 1.4 p -143.6 110.45 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -174.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.59 ' HB3' ' OXT' ' A' ' 96' ' ' CYS . 86.7 m -46.57 128.89 10.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 111.853 -2.431 . . . . 0.0 110.101 177.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.466 HD11 ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -56.57 -33.27 66.01 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.586 -177.584 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.4 t -65.99 -27.44 68.14 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.786 173.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.71 -20.48 58.33 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.44 0.696 . . . . 0.0 111.396 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.486 HD13 ' HB1' ' A' ' 15' ' ' ALA . 9.7 mt -86.25 158.66 54.92 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -69.34 167.44 23.88 Favored 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 122.174 1.916 . . . . 0.0 112.375 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.72 -14.01 38.28 Favored 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 122.626 2.217 . . . . 0.0 114.292 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 9.3 pm0 -92.91 -6.16 49.2 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.844 1.258 . . . . 0.0 113.955 176.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.486 ' HB1' HD13 ' A' ' 11' ' ' LEU . . . -81.58 -43.24 18.94 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.717 175.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.466 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -59.1 -28.99 67.03 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.566 174.801 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.527 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 47.3 t0 -51.09 -58.07 7.06 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 124.258 1.023 . . . . 0.0 110.149 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.742 ' HA ' HD12 ' A' ' 21' ' ' LEU . 24.1 m -54.6 -50.03 69.0 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 176.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.586 HD11 HG21 ' A' ' 92' ' ' ILE . 9.5 mt -55.0 -35.33 64.26 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 123.627 0.579 . . . . 0.0 112.518 177.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -71.28 -39.42 71.54 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.892 173.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.742 HD12 ' HA ' ' A' ' 18' ' ' THR . 33.1 mt -70.22 -32.67 70.65 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 123.086 0.554 . . . . 0.0 111.104 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.495 HD13 HG21 ' A' ' 72' ' ' THR . 2.9 mt -72.7 -38.22 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 119.959 -1.713 . . . . 0.0 111.356 172.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.16 -42.65 62.57 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.693 -1.14 . . . . 0.0 112.303 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.39 8.66 39.63 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.661 1.184 . . . . 0.0 111.877 177.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.7 t0 39.77 49.97 2.22 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.078 1.351 . . . . 0.0 111.932 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.95 -166.92 39.48 Favored Glycine 0 N--CA 1.47 0.924 0 CA-C-N 113.056 -1.884 . . . . 0.0 115.598 -173.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.24 141.61 70.83 Favored 'Cis proline' 0 N--CA 1.48 0.71 0 O-C-N 124.014 1.534 . . . . 0.0 111.346 -0.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.504 ' CD2' ' HB3' ' A' ' 21' ' ' LEU . 51.6 m-85 -93.98 136.43 23.74 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 113.822 -1.536 . . . . 0.0 111.426 -175.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.443 ' HG2' ' CD1' ' A' ' 58' ' ' ILE . 29.9 Cg_endo -75.71 -61.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.478 0.573 0 C-N-CA 122.813 2.342 . . . . 0.0 110.719 -176.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.418 ' HD2' HG22 ' A' ' 56' ' ' THR . 0.6 OUTLIER -59.59 158.87 9.22 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.417 175.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 m -71.58 -15.21 62.26 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.938 0.875 . . . . 0.0 112.755 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.448 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -88.26 95.41 10.17 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.09 -176.817 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 166.58 136.1 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 111.813 -2.449 . . . . 0.0 115.35 -173.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.96 38.34 8.0 Favored Glycine 0 CA--C 1.54 1.619 0 CA-C-N 113.39 -1.732 . . . . 0.0 111.118 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.414 HG23 ' OE1' ' A' ' 54' ' ' GLU . 35.7 m -135.39 148.88 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 113.536 -1.332 . . . . 0.0 109.445 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.6 t -85.87 154.78 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 O-C-N 126.081 2.113 . . . . 0.0 109.875 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.498 ' CE2' ' HA ' ' A' ' 39' ' ' ASN . 84.8 t80 -135.15 89.54 2.53 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.428 176.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.432 ' HG3' ' CD1' ' A' ' 49' ' ' TYR . 11.5 tm0? -70.28 54.1 0.14 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 120.103 1.32 . . . . 0.0 111.695 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.498 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 15.1 p-10 25.47 52.33 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 127.837 2.455 . . . . 0.0 110.813 -175.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.82 -21.18 27.08 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.27 -173.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.603 ' O ' HG23 ' A' ' 43' ' ' VAL . 3.2 mt-10 -78.39 -12.04 59.98 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 112.956 -1.929 . . . . 0.0 115.094 172.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.7 t 45.4 39.17 4.24 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 124.081 1.896 . . . . 0.0 112.014 -177.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 41' ' ' GLU . 52.3 t -110.57 -13.32 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-O 123.634 1.683 . . . . 0.0 110.583 -177.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.567 ' HB3' ' OH ' ' A' ' 52' ' ' TYR . 0.3 OUTLIER -104.26 148.93 36.73 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 114.124 -1.398 . . . . 0.0 107.268 -172.081 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.555 ' HD3' HG23 ' A' ' 2' ' ' VAL . 90.8 Cg_endo -74.44 56.08 3.82 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 124.03 3.153 . . . . 0.0 111.462 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.841 HG22 ' H ' ' A' ' 47' ' ' GLN . 3.2 m -80.83 -162.29 0.47 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.363 -1.744 . . . . 0.0 107.252 177.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.841 ' H ' HG22 ' A' ' 46' ' ' THR . 12.0 tt0 170.7 -39.66 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.855 1.662 . . . . 0.0 110.495 -175.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.4 p -115.06 162.9 16.38 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 122.497 1.141 . . . . 0.0 111.241 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.432 ' CD1' ' HG3' ' A' ' 38' ' ' GLN . 9.1 t80 -91.73 138.65 31.39 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 112.956 -1.929 . . . . 0.0 110.09 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.94 8.66 78.53 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.664 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.478 ' HA ' ' HB2' ' A' ' 74' ' ' GLU . 71.0 t80 -81.83 13.4 3.27 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.813 1.245 . . . . 0.0 111.085 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.567 ' OH ' ' HB3' ' A' ' 44' ' ' LEU . 9.4 m-85 -149.43 156.52 42.15 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -173.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -152.15 154.99 36.94 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 125.49 1.744 . . . . 0.0 111.349 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.414 ' OE1' HG23 ' A' ' 35' ' ' VAL . 1.4 mt-10 -110.02 145.06 37.66 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.064 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.585 ' HB3' HG23 ' A' ' 18' ' ' THR . 76.8 m-85 -161.32 62.13 0.27 Allowed 'General case' 0 N--CA 1.475 0.788 0 O-C-N 125.882 1.989 . . . . 0.0 110.75 -174.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 0.9 OUTLIER -40.14 129.61 2.22 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 122.485 1.136 . . . . 0.0 111.952 177.495 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.618 HG21 ' HE1' ' A' ' 81' ' ' TYR . 14.0 m -83.65 121.15 35.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 111.515 -2.584 . . . . 0.0 108.72 176.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.453 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -42.3 162.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 O-C-N 125.363 1.665 . . . . 0.0 109.884 171.465 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.564 HG22 ' HB2' ' A' ' 62' ' ' ALA . 1.4 m -157.01 138.52 9.83 Favored Pre-proline 0 N--CA 1.482 1.146 0 O-C-N 125.374 1.672 . . . . 0.0 111.649 176.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.36 144.33 32.6 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.096 2.531 . . . . 0.0 109.463 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.61 26.64 39.55 Favored Glycine 0 CA--C 1.545 1.909 0 CA-C-N 113.081 -1.872 . . . . 0.0 112.01 -175.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.564 ' HB2' HG22 ' A' ' 59' ' ' THR . . . -86.95 89.06 7.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -40.16 -31.89 0.15 Allowed 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.908 176.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.6 p -129.79 -162.3 1.19 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.587 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.448 ' HD2' ' OE1' ' A' ' 32' ' ' GLN . 3.0 mtm105 -59.51 -14.63 13.54 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 172.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.0 137.12 0.08 OUTLIER Glycine 0 N--CA 1.467 0.722 0 N-CA-C 107.442 -2.263 . . . . 0.0 107.442 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.1 p -46.16 -28.69 1.31 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 113.43 -1.385 . . . . 0.0 113.077 174.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.422 ' HG2' ' CZ ' ' A' ' 81' ' ' TYR . 20.8 mtm-85 -50.27 139.14 15.41 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 121.02 -1.05 . . . . 0.0 113.045 170.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.527 ' HB3' ' CG2' ' A' ' 82' ' ' THR . 0.0 OUTLIER -165.14 137.94 4.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.099 -1.864 . . . . 0.0 109.15 -179.487 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.428 HD13 HD21 ' A' ' 19' ' ' LEU . 3.2 mt -105.1 138.48 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 112.694 -2.048 . . . . 0.0 109.548 173.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.539 ' O ' ' HD2' ' A' ' 80' ' ' TYR . 21.8 mm -127.86 103.39 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 112.628 -2.078 . . . . 0.0 108.365 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.642 HG22 ' HB3' ' A' ' 79' ' ' ASP . 13.1 p -88.41 162.86 16.28 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.972 178.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -104.22 -171.46 25.04 Favored Glycine 0 N--CA 1.48 1.605 0 O-C-N 125.273 1.608 . . . . 0.0 110.152 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -86.26 -11.07 53.31 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.533 0.682 . . . . 0.0 112.157 175.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.69 132.14 54.48 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 176.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.629 HG22 ' HG2' ' A' ' 77' ' ' GLN . 12.1 m -49.09 144.72 4.66 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.026 175.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.629 ' HG2' HG22 ' A' ' 76' ' ' THR . 1.4 mt-30 81.24 56.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 126.006 2.066 . . . . 0.0 109.856 177.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.592 ' HA ' HD22 ' A' ' 91' ' ' LEU . 3.7 mt-10 -166.44 54.93 0.09 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 113.222 -1.808 . . . . 0.0 114.247 -177.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.642 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.2 OUTLIER -112.68 93.2 4.31 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.939 1.296 . . . . 0.0 110.788 -177.845 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.61 ' HE1' HG21 ' A' ' 2' ' ' VAL . 25.2 m-85 -74.18 135.91 42.81 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 124.508 1.123 . . . . 0.0 110.325 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.678 ' HB2' HD11 ' A' ' 92' ' ' ILE . 62.3 t80 -121.56 91.9 3.62 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.527 ' CG2' ' HB3' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -44.49 -75.94 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 113.638 -1.619 . . . . 0.0 112.856 171.608 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.63 8.32 86.09 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-N 113.361 -1.745 . . . . 0.0 112.435 -175.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.533 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 34.6 m-20 -139.79 17.51 2.5 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 176.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 69.09 83.83 0.15 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.685 1.594 . . . . 0.0 111.815 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.43 ' HB3' ' CD ' ' A' ' 41' ' ' GLU . 13.0 m-85 50.12 25.92 1.92 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 113.189 -1.823 . . . . 0.0 113.894 -175.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.533 ' HB3' ' HB2' ' A' ' 84' ' ' ASP . . . -94.93 -57.96 2.29 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 120.43 -1.419 . . . . 0.0 110.825 -173.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 82' ' ' THR . 27.7 p -112.02 178.62 4.25 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.433 ' CE1' HD21 ' A' ' 44' ' ' LEU . 95.6 m-85 -161.56 122.21 2.7 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -175.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.7 m -140.39 107.93 5.59 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 126.169 2.168 . . . . 0.0 108.694 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.592 HD22 ' HA ' ' A' ' 78' ' ' GLU . 13.1 mt -43.22 161.89 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.678 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.7 mp -110.87 122.34 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 120.96 -1.087 . . . . 0.0 109.54 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.21 97.21 8.33 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 113.231 -1.804 . . . . 0.0 108.792 175.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -60.04 -40.23 88.65 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 125.321 1.638 . . . . 0.0 111.125 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.3 t -53.38 -37.45 62.46 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 114.354 -1.293 . . . . 0.0 112.651 172.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.59 ' OXT' ' HB3' ' A' ' 7' ' ' CYS . 12.0 t . . . . . 0 C--O 1.249 1.074 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.343 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 6.0 p-10 . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.572 HG12 ' H ' ' A' ' 4' ' ' GLY . 47.7 t -37.34 135.21 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.494 1.518 . . . . 0.0 109.751 173.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.66 5.21 5.1 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 124.323 1.014 . . . . 0.0 112.824 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.572 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 123.74 -165.67 16.47 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.183 1.373 . . . . 0.0 109.831 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 m -99.81 170.79 8.3 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.936 -1.132 . . . . 0.0 109.829 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 91' ' ' LEU . 2.2 p -140.85 109.28 2.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -175.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 82.0 m -44.99 133.42 6.39 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.016 -1.902 . . . . 0.0 111.068 177.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.52 HD11 ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -58.35 -31.65 67.79 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.676 0.61 . . . . 0.0 111.66 -178.86 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -65.4 -28.69 69.44 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.538 173.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.16 -30.96 60.88 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.598 0.759 . . . . 0.0 111.432 175.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.7 mt -81.22 161.45 62.54 Favored Pre-proline 0 N--CA 1.475 0.784 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -66.94 168.67 16.56 Favored 'Trans proline' 0 CA--C 1.544 1.004 0 C-N-CA 122.671 2.247 . . . . 0.0 112.759 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.82 -32.36 18.46 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.768 2.312 . . . . 0.0 112.447 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.87 -5.96 44.26 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.448 1.099 . . . . 0.0 112.017 176.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.758 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -71.28 -57.03 4.86 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.418 1.087 . . . . 0.0 112.487 176.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.52 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -56.81 -24.2 49.14 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 174.844 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -49.08 -55.32 12.54 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.671 1.189 . . . . 0.0 111.527 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.648 HG21 ' O ' ' A' ' 55' ' ' TYR . 94.9 m -66.28 -43.02 87.57 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 176.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.656 HD21 ' OD2' ' A' ' 79' ' ' ASP . 95.6 mt -52.36 -35.5 51.45 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 173.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -67.35 -41.14 85.63 Favored 'General case' 0 C--O 1.207 -1.181 0 CA-C-N 113.868 -1.515 . . . . 0.0 110.77 175.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 18' ' ' THR . 31.5 mt -67.2 -36.17 81.17 Favored 'General case' 0 C--O 1.213 -0.857 0 CA-C-O 118.12 -0.943 . . . . 0.0 112.093 175.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.581 HD12 ' O ' ' A' ' 18' ' ' THR . 2.4 mt -64.33 -43.0 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 118.852 0.751 . . . . 0.0 111.616 172.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.36 -46.56 63.84 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.689 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.1 t -72.76 -12.03 60.84 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.267 1.827 . . . . 0.0 111.542 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 t0 54.52 40.62 31.96 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.256 1.422 . . . . 0.0 110.289 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.03 -170.52 39.68 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 113.055 -1.884 . . . . 0.0 115.969 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -74.67 139.81 63.78 Favored 'Cis proline' 0 C--N 1.347 0.454 0 O-C-N 124.096 1.577 . . . . 0.0 111.976 -1.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -90.55 135.53 29.2 Favored Pre-proline 0 N--CA 1.481 1.085 0 CA-C-N 113.723 -1.58 . . . . 0.0 110.849 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -72.5 -61.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.475 0.423 0 C-N-CA 123.216 2.611 . . . . 0.0 112.073 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.402 ' CD1' HD11 ' A' ' 58' ' ' ILE . 3.0 m-30 -64.15 146.95 53.37 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 118.847 -0.597 . . . . 0.0 110.658 176.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.6 t -65.38 -13.69 59.18 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 125.4 1.688 . . . . 0.0 112.956 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -80.96 77.38 7.87 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 122.734 1.254 . . . . 0.0 112.355 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -177.54 148.5 0.57 Allowed 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 111.104 -2.771 . . . . 0.0 113.307 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.4 31.98 29.35 Favored Glycine 0 N--CA 1.479 1.521 0 CA-C-N 113.084 -1.871 . . . . 0.0 111.306 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.64 146.85 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.218 1.007 . . . . 0.0 109.905 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.0 t -86.58 152.87 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 125.949 2.031 . . . . 0.0 110.014 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.521 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 44.8 t80 -130.28 93.75 3.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 113.518 -1.674 . . . . 0.0 108.838 175.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.508 ' HG3' ' CD1' ' A' ' 49' ' ' TYR . 7.6 tm0? -71.93 54.0 0.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.087 -1.008 . . . . 0.0 111.969 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.408 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 16.5 p-10 26.18 56.12 0.05 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.413 2.285 . . . . 0.0 111.035 -176.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -25.87 55.22 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.03 -172.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.567 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.8 mt-10 -78.0 -13.26 59.94 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-N 112.981 -1.918 . . . . 0.0 115.125 172.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.9 t 45.24 41.67 6.29 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 123.847 1.784 . . . . 0.0 111.886 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 41' ' ' GLU . 44.2 t -107.72 -14.14 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 113.732 -1.577 . . . . 0.0 110.126 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.812 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -104.82 148.75 36.6 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-O 117.662 -1.161 . . . . 0.0 108.451 -171.128 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.442 ' HD3' HG23 ' A' ' 2' ' ' VAL . 90.1 Cg_endo -73.85 56.77 3.64 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.278 2.652 . . . . 0.0 111.898 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.807 HG22 ' H ' ' A' ' 47' ' ' GLN . 3.1 m -75.43 -165.2 0.39 Allowed 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 113.612 -1.631 . . . . 0.0 107.564 176.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.807 ' H ' HG22 ' A' ' 46' ' ' THR . 5.6 tm0? 168.5 -38.81 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 126.608 1.963 . . . . 0.0 110.453 -175.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.2 p -114.33 160.23 19.33 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.166 0.984 . . . . 0.0 112.158 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.508 ' CD1' ' HG3' ' A' ' 38' ' ' GLN . 9.8 t80 -88.84 139.85 30.04 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 113.032 -1.895 . . . . 0.0 110.117 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.06 9.99 77.17 Favored Glycine 0 CA--C 1.542 1.773 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.851 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.456 ' HD2' ' CE1' ' A' ' 52' ' ' TYR . 57.5 t80 -82.09 8.79 9.86 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.474 1.109 . . . . 0.0 111.391 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.812 ' HE2' HD12 ' A' ' 44' ' ' LEU . 11.7 m-85 -146.73 145.84 30.1 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -141.36 157.2 45.5 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 126.541 2.401 . . . . 0.0 110.883 178.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -110.4 143.07 41.21 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.864 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.648 ' O ' HG21 ' A' ' 18' ' ' THR . 79.6 m-85 -158.78 69.67 0.49 Allowed 'General case' 0 N--CA 1.471 0.579 0 O-C-N 126.107 2.13 . . . . 0.0 110.144 -175.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 6.3 m -43.37 129.06 5.0 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 122.971 1.367 . . . . 0.0 112.197 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.758 HG21 ' HA ' ' A' ' 15' ' ' ALA . 1.8 p -89.3 118.12 33.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 111.109 -2.769 . . . . 0.0 109.965 178.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.402 HD11 ' CD1' ' A' ' 30' ' ' TYR . 0.4 OUTLIER -43.32 151.69 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.227 170.309 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.567 ' OG1' ' HG3' ' A' ' 68' ' ' ARG . 3.4 m -145.29 142.85 18.78 Favored Pre-proline 0 N--CA 1.475 0.823 0 CA-C-N 113.64 -1.618 . . . . 0.0 111.647 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.433 ' HD2' HG23 ' A' ' 59' ' ' THR . 73.4 Cg_endo -75.57 145.12 29.21 Favored 'Trans proline' 0 N--CA 1.479 0.658 0 C-N-CA 121.824 1.683 . . . . 0.0 110.216 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.86 28.16 57.16 Favored Glycine 0 CA--C 1.546 2.01 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.189 -175.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.7 92.44 6.58 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -39.41 -33.64 0.17 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 114.204 -1.362 . . . . 0.0 113.296 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 57.7 p -130.57 -160.56 1.05 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.888 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.2 mtm180 -56.08 -19.79 14.49 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 172.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.16 167.55 3.19 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 123.889 1.827 . . . . 0.0 109.379 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.435 HG22 ' HB2' ' A' ' 85' ' ' HIS . 40.7 p -71.27 -5.26 30.85 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 112.423 -1.888 . . . . 0.0 113.286 176.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.567 ' HG3' ' OG1' ' A' ' 59' ' ' THR . 0.2 OUTLIER -73.0 117.03 14.23 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.561 1.172 . . . . 0.0 110.161 177.624 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 0.8 OUTLIER -140.24 133.8 30.16 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 113.865 -1.516 . . . . 0.0 109.191 179.28 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.526 HG23 ' OD1' ' A' ' 79' ' ' ASP . 4.7 mt -105.42 133.67 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 125.923 2.014 . . . . 0.0 107.835 175.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.505 ' O ' ' HD2' ' A' ' 80' ' ' TYR . 23.3 mm -123.5 107.16 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 113.525 -1.67 . . . . 0.0 107.415 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.5 p -93.5 163.87 13.4 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 120.969 0.414 . . . . 0.0 110.696 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.57 -172.17 23.8 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.256 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.64 -14.15 60.0 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.322 0.582 . . . . 0.0 112.158 175.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -115.93 131.57 56.9 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.553 HG22 ' HG2' ' A' ' 77' ' ' GLN . 7.5 m -56.34 151.53 12.77 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.836 175.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.553 ' HG2' HG22 ' A' ' 76' ' ' THR . 1.0 OUTLIER 74.82 32.97 0.8 Allowed 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 123.508 1.623 . . . . 0.0 110.766 -179.54 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.413 ' HA ' HD22 ' A' ' 91' ' ' LEU . 1.2 mt-10 -138.76 57.09 1.69 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 113.547 -1.66 . . . . 0.0 112.479 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.656 ' OD2' HD21 ' A' ' 19' ' ' LEU . 1.8 t0 -101.98 130.03 48.41 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 113.882 -1.508 . . . . 0.0 108.461 174.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.526 ' CE1' HG21 ' A' ' 2' ' ' VAL . 26.6 m-85 -102.27 129.15 48.6 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.714 -1.584 . . . . 0.0 109.465 175.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.732 ' HB2' HD11 ' A' ' 92' ' ' ILE . 10.1 t80 -108.21 124.37 50.18 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 113.641 -1.618 . . . . 0.0 109.001 -177.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.54 ' HB ' ' O ' ' A' ' 88' ' ' THR 0.265 0.5 OUTLIER -86.0 -68.4 0.74 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 113.09 -1.868 . . . . 0.0 112.037 176.161 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.453 ' HA2' ' HD2' ' A' ' 68' ' ' ARG . . . 68.87 1.65 26.04 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 114.605 -1.179 . . . . 0.0 113.876 -172.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.57 ' CB ' ' HB3' ' A' ' 87' ' ' ALA . 59.0 m-20 -129.7 12.13 5.78 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.392 1.077 . . . . 0.0 113.631 178.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.435 ' HB2' HG22 ' A' ' 67' ' ' THR . 40.4 t-80 61.92 81.28 0.2 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.513 2.325 . . . . 0.0 111.647 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.434 ' HB3' ' OE1' ' A' ' 41' ' ' GLU . 17.0 m-85 54.2 33.29 17.73 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 114.424 -1.262 . . . . 0.0 113.997 -175.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.57 ' HB3' ' CB ' ' A' ' 84' ' ' ASP . . . -111.71 -6.76 14.3 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.54 ' O ' ' HB ' ' A' ' 82' ' ' THR . 6.5 p -163.91 165.17 22.98 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.768 1.627 . . . . 0.0 108.122 -177.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.616 ' CG ' HD21 ' A' ' 44' ' ' LEU . 86.1 m-85 -159.55 117.91 2.79 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 -174.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.52 106.5 5.97 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.357 -1.747 . . . . 0.0 108.432 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 91' ' ' LEU . 18.1 mt -40.47 157.29 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.638 177.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.732 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.7 mp -104.29 133.18 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.045 -1.035 . . . . 0.0 109.517 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.99 89.37 2.98 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 113.329 -1.76 . . . . 0.0 109.338 177.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -63.7 -40.46 96.85 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.409 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 t -51.39 -40.01 58.35 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 125.295 1.622 . . . . 0.0 112.813 172.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 8.4 t . . . . . 0 C--O 1.258 1.51 0 CA-C-O 116.733 -1.604 . . . . 0.0 110.747 178.445 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.8 p30 . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 122.212 1.006 . . . . 0.0 112.669 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 t -78.87 134.29 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.6 m -64.37 -8.26 12.57 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 175.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.46 169.46 12.68 Favored Glycine 0 N--CA 1.474 1.196 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.454 HG23 ' HB3' ' A' ' 91' ' ' LEU . 1.8 m -78.76 172.02 14.33 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.566 -0.817 . . . . 0.0 110.782 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 91' ' ' LEU . 3.9 p -145.65 108.06 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -174.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 57.6 m -42.9 138.32 2.05 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 113.266 -1.788 . . . . 0.0 111.658 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.719 ' HA ' HD12 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -59.84 -33.03 71.24 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.756 0.66 . . . . 0.0 111.962 -178.493 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.4 t -70.85 -15.79 62.66 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.773 174.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.13 -37.45 46.14 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.65 0.738 . . . . 0.0 111.832 176.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.719 HD12 ' HA ' ' A' ' 8' ' ' LEU . 2.3 mt -77.83 166.28 44.83 Favored Pre-proline 0 N--CA 1.475 0.788 0 C-N-CA 124.531 1.133 . . . . 0.0 111.111 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.67 169.89 15.02 Favored 'Trans proline' 0 CA--C 1.553 1.471 0 C-N-CA 122.713 2.275 . . . . 0.0 113.353 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.3 -15.88 39.12 Favored 'Trans proline' 0 N--CA 1.484 0.932 0 C-N-CA 122.305 2.004 . . . . 0.0 113.437 175.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.416 ' CD ' ' HD3' ' A' ' 60' ' ' PRO . 1.9 mt-10 -93.81 4.81 53.37 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.935 0.894 . . . . 0.0 112.111 178.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.635 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -80.86 -48.11 12.86 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.96 176.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.568 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -58.28 -23.03 54.92 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.413 -1.267 . . . . 0.0 112.701 174.381 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.461 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 9.9 t0 -49.97 -58.01 6.34 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.289 1.035 . . . . 0.0 110.324 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.696 ' HA ' HD12 ' A' ' 21' ' ' LEU . 44.7 m -56.63 -49.49 74.84 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 177.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.691 HD11 HG21 ' A' ' 92' ' ' ILE . 7.8 mt -55.53 -35.73 65.98 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 123.805 0.69 . . . . 0.0 111.693 178.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -68.34 -38.48 81.53 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.015 173.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.696 HD12 ' HA ' ' A' ' 18' ' ' THR . 33.9 mt -69.19 -34.8 75.48 Favored 'General case' 0 C--O 1.212 -0.874 0 CA-C-O 118.746 -0.645 . . . . 0.0 110.954 175.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.602 HD12 ' O ' ' A' ' 18' ' ' THR . 1.6 mp -69.76 -40.73 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 120.186 1.357 . . . . 0.0 111.312 172.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.8 -42.48 67.02 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.023 -0.989 . . . . 0.0 112.291 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.27 7.55 42.21 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.116 0.966 . . . . 0.0 111.35 177.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.0 t0 39.52 52.5 2.34 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 123.209 1.48 . . . . 0.0 112.156 -178.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.3 -164.77 40.44 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 112.721 -2.036 . . . . 0.0 115.659 -173.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.9 141.44 71.75 Favored 'Cis proline' 0 C--N 1.346 0.415 0 O-C-N 124.678 1.883 . . . . 0.0 111.849 -2.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 21' ' ' LEU . 75.7 m-85 -94.52 132.92 27.78 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.248 -176.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.451 ' HG2' ' CD1' ' A' ' 58' ' ' ILE . 36.6 Cg_endo -75.12 -59.55 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.546 2.164 . . . . 0.0 111.24 -177.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -60.69 157.76 14.01 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.486 0.66 . . . . 0.0 112.436 175.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.4 t -77.43 -10.58 59.55 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 122.524 1.154 . . . . 0.0 112.215 175.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -91.6 87.56 6.4 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.624 0.726 . . . . 0.0 112.21 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 172.29 136.33 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 111.517 -2.583 . . . . 0.0 114.259 -174.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.08 28.75 16.9 Favored Glycine 0 N--CA 1.48 1.602 0 CA-C-N 113.189 -1.823 . . . . 0.0 111.729 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.446 HG23 ' OE1' ' A' ' 54' ' ' GLU . 13.2 m -123.48 146.59 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 113.6 -1.3 . . . . 0.0 109.713 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.0 t -81.95 156.79 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 125.536 1.772 . . . . 0.0 109.724 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.436 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 48.2 t80 -139.23 86.28 2.12 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.634 176.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -69.66 52.86 0.11 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 122.401 1.096 . . . . 0.0 113.629 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.2 t30 31.23 55.17 0.23 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 127.057 2.143 . . . . 0.0 109.399 -172.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.56 -31.32 62.05 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 122.454 1.121 . . . . 0.0 111.766 -175.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.557 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.7 mt-10 -79.06 -8.15 58.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 112.928 -1.942 . . . . 0.0 114.3 174.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 39.9 t 43.82 42.66 4.61 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 124.132 1.92 . . . . 0.0 111.975 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 41' ' ' GLU . 61.7 t -107.36 -18.05 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 113.301 -1.772 . . . . 0.0 109.704 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.538 HD21 ' CD1' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -89.94 147.86 38.32 Favored Pre-proline 0 C--N 1.32 -0.679 0 O-C-N 121.189 -0.944 . . . . 0.0 108.657 -176.237 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.94 57.03 5.59 Favored 'Trans proline' 0 N--CA 1.478 0.614 0 C-N-CA 122.311 2.007 . . . . 0.0 112.073 -176.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 47' ' ' GLN . 1.9 m -156.52 -144.91 0.14 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.366 -1.288 . . . . 0.0 107.718 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.461 ' H ' HG22 ' A' ' 46' ' ' THR . 3.0 tt0 168.63 -35.98 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 126.412 1.885 . . . . 0.0 110.429 -173.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.4 p -37.87 148.88 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 122.608 1.194 . . . . 0.0 113.811 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -103.53 121.97 43.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 113.23 -1.805 . . . . 0.0 111.725 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.08 -22.71 33.04 Favored Glycine 0 N--CA 1.476 1.318 0 O-C-N 125.708 1.88 . . . . 0.0 111.691 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.46 -13.9 45.19 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 124.325 1.05 . . . . 0.0 112.924 175.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.431 ' OH ' ' HB3' ' A' ' 44' ' ' LEU . 17.4 m-85 -116.78 162.44 17.69 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.412 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -158.92 159.81 35.36 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 112.515 -2.13 . . . . 0.0 111.686 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.446 ' OE1' HG23 ' A' ' 35' ' ' VAL . 1.4 mt-10 -117.64 136.39 53.34 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.85 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.501 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 86.4 m-85 -151.6 75.52 1.17 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 113.622 -1.626 . . . . 0.0 110.212 -176.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.554 HG21 ' HG2' ' A' ' 65' ' ' ARG . 52.8 m -42.91 138.56 1.98 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 122.438 1.113 . . . . 0.0 112.516 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.635 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.5 OUTLIER -98.36 106.89 19.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 112.195 -2.275 . . . . 0.0 110.073 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.451 ' CD1' ' HG2' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -39.36 147.04 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.266 172.126 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.472 HG23 ' HD2' ' A' ' 60' ' ' PRO . 3.2 m -144.44 140.65 16.9 Favored Pre-proline 0 N--CA 1.473 0.722 0 O-C-N 125.465 1.728 . . . . 0.0 112.018 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.472 ' HD2' HG23 ' A' ' 59' ' ' THR . 71.9 Cg_endo -74.34 146.31 35.44 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.066 1.844 . . . . 0.0 110.177 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.63 25.42 55.48 Favored Glycine 0 N--CA 1.485 1.937 0 CA-C-N 114.22 -1.355 . . . . 0.0 112.196 -175.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.71 91.38 6.99 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -39.96 -32.22 0.15 Allowed 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 113.585 -1.643 . . . . 0.0 113.325 176.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.0 p -131.26 -159.0 0.93 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.505 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.554 ' HG2' HG21 ' A' ' 56' ' ' THR . 0.0 OUTLIER -59.09 -18.05 31.82 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.968 -1.015 . . . . 0.0 113.585 171.642 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.33 162.5 0.59 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-O 123.697 1.721 . . . . 0.0 109.59 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.511 HG22 ' HB2' ' A' ' 85' ' ' HIS . 24.3 p -65.65 -10.73 38.72 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 113.137 -1.531 . . . . 0.0 113.241 174.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.49 ' HD2' ' HA2' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -64.94 124.46 22.1 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 123.279 1.514 . . . . 0.0 110.715 175.658 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.24 144.76 26.73 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 112.866 -1.97 . . . . 0.0 110.588 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 55' ' ' TYR . 8.4 mt -120.44 137.04 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 125.398 1.686 . . . . 0.0 108.673 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.47 ' O ' ' HD2' ' A' ' 80' ' ' TYR . 16.7 mm -127.57 102.41 8.93 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 CA-C-N 112.737 -2.029 . . . . 0.0 107.758 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.479 HG22 ' HB3' ' A' ' 79' ' ' ASP . 17.7 p -90.16 163.37 14.85 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.667 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -116.77 165.67 12.35 Favored Glycine 0 N--CA 1.471 0.981 0 CA-C-N 113.534 -1.666 . . . . 0.0 109.357 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.49 -14.9 62.9 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.701 0.763 . . . . 0.0 111.687 176.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.443 ' HB3' ' OE2' ' A' ' 78' ' ' GLU . . . -106.27 131.04 53.97 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.622 HG22 ' HG2' ' A' ' 77' ' ' GLN . 3.0 m -55.34 143.14 29.48 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 113.776 -1.556 . . . . 0.0 108.361 174.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.622 ' HG2' HG22 ' A' ' 76' ' ' THR . 0.0 OUTLIER 79.6 34.57 0.18 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.936 2.095 . . . . 0.0 111.224 179.49 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.443 ' OE2' ' HB3' ' A' ' 75' ' ' ALA . 37.9 mt-10 -129.79 49.95 2.22 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 123.232 1.491 . . . . 0.0 112.299 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.479 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -107.55 100.99 10.36 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 113.607 -1.633 . . . . 0.0 110.307 -176.64 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.47 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 22.2 m-85 -89.83 135.2 33.77 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 113.996 -1.457 . . . . 0.0 109.319 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.725 ' HB2' HD11 ' A' ' 92' ' ' ILE . 11.0 t80 -115.2 127.42 55.51 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.947 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.536 ' HB ' ' O ' ' A' ' 88' ' ' THR 0.251 0.4 OUTLIER -86.77 -68.87 0.71 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 113.012 -1.904 . . . . 0.0 111.417 176.823 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.49 ' HA2' ' HD2' ' A' ' 68' ' ' ARG . . . 69.01 1.7 27.26 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 114.047 -1.433 . . . . 0.0 113.544 -172.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.626 ' CB ' ' HB3' ' A' ' 87' ' ' ALA . 74.0 m-20 -129.9 10.47 5.49 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.237 1.015 . . . . 0.0 113.595 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.511 ' HB2' HG22 ' A' ' 67' ' ' THR . 43.6 t-80 64.88 80.13 0.24 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 128.081 2.552 . . . . 0.0 110.698 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.468 ' HB3' ' CD ' ' A' ' 41' ' ' GLU . 17.0 m-85 55.82 26.19 9.32 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 122.928 1.347 . . . . 0.0 113.413 -174.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.626 ' HB3' ' CB ' ' A' ' 84' ' ' ASP . . . -102.51 -8.86 20.69 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.54 -1.35 . . . . 0.0 112.766 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.536 ' O ' ' HB ' ' A' ' 82' ' ' THR . 12.5 p -163.14 169.37 19.47 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.621 1.568 . . . . 0.0 108.859 -176.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.538 ' CD1' HD21 ' A' ' 44' ' ' LEU . 92.5 m-85 -158.5 115.14 2.78 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -174.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.49 107.04 8.61 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 113.203 -1.817 . . . . 0.0 109.483 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.538 ' O ' HG12 ' A' ' 6' ' ' VAL . 18.0 mt -42.8 160.94 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 177.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.725 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.3 mp -110.05 113.72 45.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 O-C-N 120.982 -1.074 . . . . 0.0 109.194 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.09 87.21 7.35 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 113.833 -1.53 . . . . 0.0 109.686 176.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.529 ' HG3' HG22 ' A' ' 92' ' ' ILE . 2.4 mp0 -67.65 -31.41 71.39 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.643 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.6 t -55.64 -27.96 52.72 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.849 173.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.4 t . . . . . 0 C--O 1.253 1.265 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.887 177.691 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 p30 . . . . . 0 N--CA 1.474 0.73 0 CA-C-O 121.163 0.506 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.69 HG23 ' HD3' ' A' ' 45' ' ' PRO . 16.0 t -46.87 128.45 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.64 176.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 m -72.79 4.76 3.74 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 125.021 1.45 . . . . 0.0 113.095 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.529 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 123.09 168.89 13.18 Favored Glycine 0 C--O 1.216 -1.014 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 6' ' ' VAL . 3.4 m -76.68 174.62 10.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.653 -1.273 . . . . 0.0 110.159 -178.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.452 ' H ' HG22 ' A' ' 5' ' ' THR . 0.6 OUTLIER -140.36 109.38 3.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -175.108 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 74.9 m -47.19 125.37 7.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 112.669 -2.06 . . . . 0.0 109.367 176.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -49.81 -36.26 25.85 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 118.771 -0.633 . . . . 0.0 111.745 175.404 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.9 t -65.07 -28.52 69.52 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.889 0.852 . . . . 0.0 112.503 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 7' ' ' CYS . . . -75.22 -23.96 57.67 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.714 175.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.563 HD13 ' HB1' ' A' ' 15' ' ' ALA . 12.0 mt -83.52 160.44 59.14 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 176.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.508 ' HB2' ' OE2' ' A' ' 14' ' ' GLU . 79.1 Cg_endo -69.04 170.44 15.72 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.237 1.958 . . . . 0.0 112.826 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.35 -13.43 33.19 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.723 2.282 . . . . 0.0 114.235 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.508 ' OE2' ' HB2' ' A' ' 12' ' ' PRO . 1.5 pm0 -95.28 -3.45 47.43 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.642 175.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.721 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -72.6 -50.45 25.24 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.909 177.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.21 -24.97 45.39 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.284 -1.326 . . . . 0.0 112.204 175.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.477 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 35.0 t0 -51.44 -60.18 3.42 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.374 1.046 . . . . 0.0 110.012 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.789 ' HA ' HD12 ' A' ' 21' ' ' LEU . 16.2 m -55.95 -52.24 64.86 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.647 0.592 . . . . 0.0 112.426 177.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.58 HD11 HG21 ' A' ' 92' ' ' ILE . 6.1 mt -52.72 -34.15 51.17 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.517 0.51 . . . . 0.0 111.837 178.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -70.39 -40.72 73.76 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 124.102 0.961 . . . . 0.0 110.818 174.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.789 HD12 ' HA ' ' A' ' 18' ' ' THR . 26.5 mt -67.79 -32.21 72.63 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 119.095 -0.478 . . . . 0.0 110.23 175.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.723 HD12 ' O ' ' A' ' 18' ' ' THR . 1.6 mp -69.9 -43.08 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 120.597 1.544 . . . . 0.0 111.684 172.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.01 -42.76 72.58 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 125.034 1.459 . . . . 0.0 111.844 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.78 7.41 39.86 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.482 1.113 . . . . 0.0 111.748 177.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.6 t70 40.6 50.24 2.84 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 125.283 1.433 . . . . 0.0 110.977 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.59 -166.77 45.77 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 113.616 -1.629 . . . . 0.0 114.864 -173.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.53 141.03 69.91 Favored 'Cis proline' 0 N--CA 1.48 0.732 0 O-C-N 124.209 1.637 . . . . 0.0 111.19 0.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -91.21 136.23 27.41 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 113.051 -1.886 . . . . 0.0 111.656 -177.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.453 ' HG2' ' CD1' ' A' ' 58' ' ' ILE . 33.5 Cg_endo -74.76 -63.63 0.03 OUTLIER 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 122.463 2.108 . . . . 0.0 111.076 -178.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -59.59 150.62 26.76 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.548 0.689 . . . . 0.0 111.596 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.69 -5.71 42.26 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.024 176.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -97.38 88.89 4.54 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.957 0.884 . . . . 0.0 112.261 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 169.99 134.16 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 112.115 -2.311 . . . . 0.0 113.751 -175.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.65 17.26 33.87 Favored Glycine 0 N--CA 1.484 1.872 0 CA-C-N 112.706 -2.043 . . . . 0.0 111.846 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.466 HG23 ' HB2' ' A' ' 54' ' ' GLU . 15.9 m -109.62 150.75 12.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 123.634 0.774 . . . . 0.0 109.502 176.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.3 t -84.01 154.47 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 O-C-N 125.674 1.859 . . . . 0.0 110.473 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.556 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 57.6 t80 -131.92 92.5 3.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.549 176.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.93 47.69 0.06 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.398 1.094 . . . . 0.0 112.96 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.406 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 40.4 t30 28.91 53.0 0.08 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.459 1.503 . . . . 0.0 110.628 -173.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.89 -23.46 53.27 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 113.912 -1.494 . . . . 0.0 110.984 -172.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.597 ' O ' HG23 ' A' ' 43' ' ' VAL . 4.3 mt-10 -86.77 -12.86 46.89 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 112.684 -2.053 . . . . 0.0 113.868 173.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.4 t 43.75 43.53 5.02 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 124.605 2.145 . . . . 0.0 111.663 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 41' ' ' GLU . 79.5 t -105.75 -17.74 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 112.689 -2.051 . . . . 0.0 110.007 -178.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.552 HD21 ' CD1' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -86.23 153.98 56.98 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 117.691 -1.147 . . . . 0.0 108.878 -175.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.69 ' HD3' HG23 ' A' ' 2' ' ' VAL . 73.1 Cg_endo -75.0 50.18 2.46 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.071 2.514 . . . . 0.0 112.452 -178.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 47' ' ' GLN . 4.3 m -155.84 -138.08 0.07 Allowed 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.424 ' H ' HG22 ' A' ' 46' ' ' THR . 8.0 tt0 161.85 -34.58 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.545 1.938 . . . . 0.0 110.626 -173.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.3 p -42.95 155.52 0.05 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 123.602 1.668 . . . . 0.0 111.935 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -104.35 131.0 52.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 113.338 -1.755 . . . . 0.0 110.981 -175.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.58 -16.78 38.5 Favored Glycine 0 N--CA 1.479 1.559 0 O-C-N 125.022 1.451 . . . . 0.0 111.904 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -68.13 -9.79 49.22 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.63 0.772 . . . . 0.0 112.149 176.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.556 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 24.6 m-85 -121.3 169.4 10.62 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 124.298 1.039 . . . . 0.0 109.791 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -159.79 164.13 33.99 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 113.237 -1.801 . . . . 0.0 110.659 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.466 ' HB2' HG23 ' A' ' 35' ' ' VAL . 3.5 mp0 -118.98 139.73 51.19 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.846 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.631 ' HB3' HG23 ' A' ' 18' ' ' THR . 26.9 m-85 -153.09 61.9 0.77 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 125.81 1.944 . . . . 0.0 111.36 -175.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 23.3 m -38.24 124.39 1.22 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.362 1.077 . . . . 0.0 112.089 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.721 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -86.66 108.74 18.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 111.901 -2.409 . . . . 0.0 108.767 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.453 ' CD1' ' HG2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -38.23 146.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.443 172.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.479 ' OG1' ' HG3' ' A' ' 68' ' ' ARG . 3.4 m -137.29 140.26 30.29 Favored Pre-proline 0 C--N 1.324 -0.53 0 O-C-N 125.157 1.535 . . . . 0.0 111.654 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.499 ' HD3' ' CD ' ' A' ' 14' ' ' GLU . 71.8 Cg_endo -74.25 150.05 41.45 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.188 2.592 . . . . 0.0 109.502 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 49.73 30.96 15.18 Favored Glycine 0 N--CA 1.479 1.523 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.904 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.01 88.87 5.39 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -41.8 -29.72 0.21 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.247 -1.342 . . . . 0.0 112.794 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.7 p -126.24 -163.69 1.25 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.997 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -59.43 -15.75 19.19 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 173.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.55 153.67 0.8 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.535 HG22 ' HB2' ' A' ' 85' ' ' HIS . 24.6 p -67.23 -8.86 34.9 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 112.671 -1.765 . . . . 0.0 112.761 176.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.479 ' HG3' ' OG1' ' A' ' 59' ' ' THR . 0.0 OUTLIER -70.14 116.04 10.04 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.54 1.136 . . . . 0.0 110.413 177.039 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 0.4 OUTLIER -140.05 137.96 35.01 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.887 -1.506 . . . . 0.0 109.452 179.149 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.596 HG23 ' OD1' ' A' ' 79' ' ' ASP . 4.7 mt -109.05 141.08 25.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 113.644 -1.616 . . . . 0.0 109.097 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.492 ' HB ' ' HB2' ' A' ' 80' ' ' TYR . 19.0 mm -129.42 107.03 14.61 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 CA-C-N 113.808 -1.542 . . . . 0.0 109.309 -177.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.527 HG21 HG12 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -83.05 167.45 17.87 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 123.348 0.659 . . . . 0.0 110.861 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -120.34 173.18 15.23 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.03 -14.84 63.29 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 113.866 -1.167 . . . . 0.0 111.691 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.31 128.48 54.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.434 175.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.624 HG22 ' HG2' ' A' ' 77' ' ' GLN . 2.3 m -59.06 141.81 53.03 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 113.506 -1.679 . . . . 0.0 106.98 175.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.624 ' HG2' HG22 ' A' ' 76' ' ' THR . 0.3 OUTLIER 81.28 32.04 0.13 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 126.193 2.183 . . . . 0.0 111.002 178.327 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -133.45 57.47 1.81 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.786 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.596 ' OD1' HG23 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -99.74 122.16 42.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.53 -1.668 . . . . 0.0 110.19 178.211 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.492 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 40.4 m-85 -95.55 137.68 34.29 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 124.914 1.286 . . . . 0.0 109.373 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.71 ' HB2' HD11 ' A' ' 92' ' ' ILE . 7.1 t80 -116.64 123.74 48.05 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.717 -177.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.562 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.5 OUTLIER -86.93 -66.21 0.93 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 113.663 -1.608 . . . . 0.0 110.734 178.187 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.08 2.31 17.56 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-N 113.598 -1.637 . . . . 0.0 113.092 -173.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.642 ' CB ' ' HB3' ' A' ' 87' ' ' ALA . 80.9 m-20 -129.63 8.6 5.39 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.535 ' HB2' HG22 ' A' ' 67' ' ' THR . 45.5 t-80 67.76 80.81 0.2 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 128.213 2.605 . . . . 0.0 110.556 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.409 ' HB3' ' CD ' ' A' ' 41' ' ' GLU . 19.6 m-85 55.67 24.3 7.0 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 123.695 1.712 . . . . 0.0 112.99 -175.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.642 ' HB3' ' CB ' ' A' ' 84' ' ' ASP . . . -99.74 -10.07 22.3 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 117.954 -1.498 . . . . 0.0 112.391 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.562 ' O ' ' HB ' ' A' ' 82' ' ' THR . 15.5 p -162.89 171.98 15.82 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 -177.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.552 ' CD1' HD21 ' A' ' 44' ' ' LEU . 89.7 m-85 -159.91 114.17 2.27 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -174.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.01 104.91 7.09 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 113.854 -1.521 . . . . 0.0 108.682 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 91' ' ' LEU . 19.0 mt -42.05 164.66 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 O-C-N 124.209 0.943 . . . . 0.0 112.101 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.71 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.7 mp -111.41 134.5 53.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 O-C-N 120.699 -1.251 . . . . 0.0 108.996 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.29 93.91 4.67 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.661 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.502 HE21 ' HB2' ' A' ' 94' ' ' GLN . 0.0 OUTLIER -56.39 -38.09 71.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 123.976 0.798 . . . . 0.0 112.102 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.3 t -54.71 -46.49 74.18 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.047 1.339 . . . . 0.0 112.67 173.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 24.7 t . . . . . 0 C--O 1.249 1.029 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.43 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.405 ' HA ' ' HB3' ' A' ' 45' ' ' PRO . 3.1 p-10 . . . . . 0 CA--C 1.547 0.855 0 CA-C-O 123.464 1.602 . . . . 0.0 114.998 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.64 HG12 ' H ' ' A' ' 4' ' ' GLY . 43.9 t -107.42 139.21 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 t -69.59 -2.36 11.32 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 124.731 1.269 . . . . 0.0 112.96 176.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.64 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 124.36 169.03 12.99 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.517 1.532 . . . . 0.0 109.474 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.482 HG23 ' CB ' ' A' ' 91' ' ' LEU . 1.8 m -81.77 169.46 16.9 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.839 0.828 . . . . 0.0 110.377 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 p -140.47 107.77 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -174.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 61.5 m -47.09 136.6 8.54 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 113.542 -1.663 . . . . 0.0 111.063 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.53 HD11 ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -56.89 -32.17 65.61 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.837 -178.866 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.1 t -66.77 -29.02 68.87 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.863 173.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.13 -29.76 60.62 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.396 0.679 . . . . 0.0 111.523 175.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.59 HD13 ' HB1' ' A' ' 15' ' ' ALA . 13.5 mt -77.98 160.64 73.4 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 175.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.643 ' HB2' ' OE2' ' A' ' 14' ' ' GLU . 86.3 Cg_endo -68.72 168.01 21.33 Favored 'Trans proline' 0 CA--C 1.554 1.482 0 C-N-CA 122.559 2.173 . . . . 0.0 112.799 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.29 -12.41 34.88 Favored 'Trans proline' 0 CA--C 1.55 1.306 0 C-N-CA 123.156 2.57 . . . . 0.0 113.944 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.643 ' OE2' ' HB2' ' A' ' 12' ' ' PRO . 1.7 pm0 -93.38 -11.84 31.32 Favored 'General case' 0 C--O 1.216 -0.705 0 C-N-CA 124.998 1.319 . . . . 0.0 113.188 174.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.809 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -65.15 -50.08 67.4 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 175.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.53 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -56.05 -26.44 49.22 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.937 173.558 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.491 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 13.9 t70 -54.98 -56.84 15.27 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.153 0.981 . . . . 0.0 110.132 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.672 ' O ' HD12 ' A' ' 22' ' ' ILE . 5.5 m -57.15 -49.1 77.01 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 176.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.624 HD11 HG21 ' A' ' 92' ' ' ILE . 9.8 mt -55.85 -35.72 66.74 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.898 0.749 . . . . 0.0 111.806 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -67.91 -37.36 81.6 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.63 174.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.644 HD12 ' HA ' ' A' ' 18' ' ' THR . 28.2 mt -69.17 -32.01 71.04 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 118.494 -0.765 . . . . 0.0 111.629 173.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.672 HD12 ' O ' ' A' ' 18' ' ' THR . 1.8 mp -69.42 -43.85 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 119.668 1.122 . . . . 0.0 111.969 171.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.13 -42.99 71.87 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.119 -1.4 . . . . 0.0 112.863 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.17 4.49 50.34 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.454 1.102 . . . . 0.0 112.084 177.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.7 t0 40.94 50.39 3.1 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.495 1.518 . . . . 0.0 111.383 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.18 -164.93 28.73 Favored Glycine 0 N--CA 1.473 1.149 0 CA-C-N 111.932 -2.395 . . . . 0.0 116.524 -174.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -74.08 141.56 72.11 Favored 'Cis proline' 0 C--N 1.348 0.524 0 O-C-N 124.462 1.769 . . . . 0.0 111.79 -3.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -96.9 116.5 66.09 Favored Pre-proline 0 N--CA 1.47 0.57 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.208 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.94 -48.17 0.3 Allowed 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 122.865 2.377 . . . . 0.0 111.927 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.404 ' CE2' ' HG2' ' A' ' 65' ' ' ARG . 0.2 OUTLIER -67.3 132.44 47.73 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.104 176.14 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.8 m -70.76 56.9 0.19 Allowed 'General case' 0 N--CA 1.477 0.925 0 O-C-N 125.17 1.544 . . . . 0.0 112.771 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -157.08 73.65 0.76 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 113.566 -1.652 . . . . 0.0 111.863 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.57 144.74 1.14 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 110.987 -2.824 . . . . 0.0 113.481 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.91 23.67 37.8 Favored Glycine 0 CA--C 1.538 1.526 0 CA-C-N 113.237 -1.801 . . . . 0.0 111.839 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.8 m -122.08 145.22 29.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 C-N-CA 124.748 1.219 . . . . 0.0 110.203 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.3 t -81.44 154.13 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 O-C-N 125.969 2.043 . . . . 0.0 110.165 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.433 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 49.8 t80 -131.34 91.7 3.06 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 113.565 -1.652 . . . . 0.0 109.324 175.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.91 51.6 0.15 Allowed 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 119.614 1.097 . . . . 0.0 113.23 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 28.66 52.95 0.07 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 126.81 2.044 . . . . 0.0 110.252 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -26.21 60.75 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 121.771 0.796 . . . . 0.0 112.858 -172.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.548 ' O ' HG23 ' A' ' 43' ' ' VAL . 3.5 mt-10 -74.95 -16.79 60.63 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 112.621 -2.081 . . . . 0.0 114.593 171.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.8 t 45.86 41.1 7.39 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 124.024 1.869 . . . . 0.0 111.388 -177.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 41' ' ' GLU . 89.1 t -104.21 -11.38 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 112.758 -2.019 . . . . 0.0 109.65 -178.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.565 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.2 OUTLIER -97.5 148.88 35.07 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.523 -174.764 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.409 ' HD3' HG23 ' A' ' 2' ' ' VAL . 96.7 Cg_endo -76.87 56.21 5.23 Favored 'Trans proline' 0 N--CA 1.478 0.616 0 C-N-CA 122.925 2.416 . . . . 0.0 112.343 -174.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.554 HG22 ' H ' ' A' ' 47' ' ' GLN . 1.6 m -158.37 -152.0 0.31 Allowed 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 114.293 -1.321 . . . . 0.0 107.626 -175.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.554 ' H ' HG22 ' A' ' 46' ' ' THR . 41.7 tt0 175.56 -37.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 126.204 1.802 . . . . 0.0 110.966 -174.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.6 p -40.0 147.82 0.09 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 122.585 1.183 . . . . 0.0 113.483 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -104.01 133.69 48.53 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 113.672 -1.604 . . . . 0.0 109.823 -174.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.48 -17.33 39.81 Favored Glycine 0 N--CA 1.474 1.205 0 CA-C-N 114.03 -1.441 . . . . 0.0 112.721 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.62 -1.08 20.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.013 1.325 . . . . 0.0 113.867 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.565 ' HE2' HD12 ' A' ' 44' ' ' LEU . 18.3 m-85 -129.77 151.51 50.28 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.489 1.116 . . . . 0.0 109.598 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -147.29 155.4 42.0 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 126.278 2.236 . . . . 0.0 110.581 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.433 ' HG3' ' HB2' ' A' ' 37' ' ' PHE . 1.9 mt-10 -108.96 132.93 53.61 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.298 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.505 ' HB3' HG23 ' A' ' 18' ' ' THR . 26.4 m-85 -145.75 62.95 1.26 Allowed 'General case' 0 N--CA 1.471 0.584 0 O-C-N 125.64 1.838 . . . . 0.0 110.715 -176.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 1.2 m -38.53 127.79 1.46 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 122.194 0.997 . . . . 0.0 112.85 178.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.809 HG21 ' HA ' ' A' ' 15' ' ' ALA . 1.1 p -90.8 113.24 26.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 111.783 -2.462 . . . . 0.0 109.201 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -36.89 145.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 114.022 -1.444 . . . . 0.0 110.506 171.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.401 HG23 ' HD2' ' A' ' 60' ' ' PRO . 3.4 m -136.66 140.16 31.29 Favored Pre-proline 0 N--CA 1.476 0.839 0 O-C-N 125.472 1.733 . . . . 0.0 112.48 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.511 ' HD3' ' CD ' ' A' ' 14' ' ' GLU . 84.3 Cg_endo -74.99 145.18 31.16 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.375 2.05 . . . . 0.0 109.236 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.12 32.16 49.79 Favored Glycine 0 CA--C 1.539 1.532 0 CA-C-N 113.247 -1.797 . . . . 0.0 112.186 -176.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.72 94.42 7.28 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -40.89 -33.15 0.28 Allowed 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 113.768 -1.56 . . . . 0.0 113.913 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.7 p -124.97 -155.15 0.66 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 113.655 -1.612 . . . . 0.0 108.755 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.404 ' HG2' ' CE2' ' A' ' 30' ' ' TYR . 15.4 mtm-85 -55.5 -19.75 10.71 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 171.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.32 135.48 0.08 OUTLIER Glycine 0 CA--C 1.524 0.599 0 N-CA-C 107.717 -2.153 . . . . 0.0 107.717 -176.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 77.1 p -41.28 -33.62 0.4 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 113.429 -1.385 . . . . 0.0 113.727 175.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -39.35 128.78 1.82 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 122.719 1.247 . . . . 0.0 113.83 169.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -158.69 133.78 8.42 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 111.702 -2.499 . . . . 0.0 110.159 -176.335 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.412 ' HB ' ' O ' ' A' ' 55' ' ' TYR . 8.0 mt -112.14 132.7 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 125.817 1.948 . . . . 0.0 107.791 176.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.496 ' O ' ' HD2' ' A' ' 80' ' ' TYR . 19.9 mm -121.12 102.88 12.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 112.753 -2.021 . . . . 0.0 107.522 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.415 ' HG1' ' HD2' ' A' ' 55' ' ' TYR . 17.4 p -88.86 161.31 16.78 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.501 178.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -116.42 164.23 12.34 Favored Glycine 0 N--CA 1.475 1.262 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.444 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.15 -15.81 62.82 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 176.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.444 ' HB3' ' OE2' ' A' ' 78' ' ' GLU . . . -103.71 130.96 51.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.612 173.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.635 HG22 ' HG2' ' A' ' 77' ' ' GLN . 3.8 m -55.97 142.7 34.85 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.635 ' HG2' HG22 ' A' ' 76' ' ' THR . 0.0 OUTLIER 78.98 31.74 0.3 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 126.892 2.077 . . . . 0.0 111.499 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.444 ' OE2' ' HB3' ' A' ' 75' ' ' ALA . 16.0 mt-10 -125.49 48.81 1.99 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 123.083 1.42 . . . . 0.0 112.569 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -103.52 107.9 18.94 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.205 1.402 . . . . 0.0 109.39 -179.842 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.496 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 32.3 m-85 -96.99 132.3 42.93 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 124.885 1.366 . . . . 0.0 109.48 -177.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.619 ' HB2' HD11 ' A' ' 92' ' ' ILE . 8.5 t80 -110.39 126.18 54.01 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.089 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.537 ' HB ' ' O ' ' A' ' 88' ' ' THR 0.27 0.3 OUTLIER -87.84 -68.66 0.74 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.011 -1.45 . . . . 0.0 112.211 176.399 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.86 2.12 21.72 Favored Glycine 0 N--CA 1.482 1.726 0 CA-C-N 114.607 -1.179 . . . . 0.0 113.414 -172.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.617 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 6.8 t70 -129.82 13.17 5.82 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.349 1.059 . . . . 0.0 112.531 176.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 64.08 84.86 0.14 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.329 1.852 . . . . 0.0 111.579 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.402 ' HB3' ' OE1' ' A' ' 41' ' ' GLU . 7.4 m-85 50.81 29.54 4.4 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -175.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.617 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . . . -112.21 -3.78 14.55 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.537 ' O ' ' HB ' ' A' ' 82' ' ' THR . 2.0 p -164.5 161.32 21.22 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.958 1.703 . . . . 0.0 108.305 -174.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CD1' HD21 ' A' ' 44' ' ' LEU . 88.6 m-85 -157.83 112.01 2.58 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.023 0.929 . . . . 0.0 108.88 -174.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.3 m -131.47 106.71 8.4 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 112.863 -1.971 . . . . 0.0 109.57 -178.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.482 ' CB ' HG23 ' A' ' 5' ' ' THR . 17.5 mt -42.13 155.61 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.972 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.638 HG22 ' HG3' ' A' ' 94' ' ' GLN . 1.9 mp -102.76 111.12 31.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 O-C-N 120.489 -1.382 . . . . 0.0 108.837 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.14 85.81 6.72 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.769 0.795 . . . . 0.0 110.156 175.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.638 ' HG3' HG22 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -70.53 -32.56 70.06 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.002 179.196 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.4 t -56.19 -23.05 32.9 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.525 1.53 . . . . 0.0 113.267 173.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.6 t . . . . . 0 CA--C 1.554 1.105 0 CA-C-O 116.48 -1.724 . . . . 0.0 110.85 177.764 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.69 HG23 ' HD3' ' A' ' 45' ' ' PRO . 21.1 t -55.16 127.1 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 m -75.14 6.59 4.11 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 124.544 1.152 . . . . 0.0 113.776 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.528 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 121.22 -165.54 14.25 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 m -95.79 170.14 9.52 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.986 -1.107 . . . . 0.0 110.277 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -137.47 111.85 9.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -176.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.55 ' HB3' ' OXT' ' A' ' 96' ' ' CYS . 97.0 m -49.37 129.48 18.67 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 111.874 -2.421 . . . . 0.0 109.83 177.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.78 -33.21 66.4 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 119.217 -0.42 . . . . 0.0 111.437 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.8 t -67.24 -28.39 68.01 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.348 0.659 . . . . 0.0 112.384 174.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.33 -20.76 58.87 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.781 174.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.47 HD22 ' CZ ' ' A' ' 81' ' ' TYR . 7.2 mt -83.18 158.94 63.35 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 175.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.514 ' HB2' ' OE2' ' A' ' 14' ' ' GLU . 92.4 Cg_endo -69.03 167.02 24.69 Favored 'Trans proline' 0 CA--C 1.551 1.371 0 C-N-CA 121.964 1.776 . . . . 0.0 112.456 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.18 -17.45 45.25 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.384 2.056 . . . . 0.0 113.682 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.514 ' OE2' ' HB2' ' A' ' 12' ' ' PRO . 8.4 pm0 -87.65 -13.78 41.73 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.697 1.199 . . . . 0.0 112.674 174.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.835 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -62.78 -49.9 73.16 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.02 0.528 . . . . 0.0 112.098 176.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.11 -26.23 48.97 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.633 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.526 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 41.6 t0 -57.57 -57.48 12.53 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.805 0.842 . . . . 0.0 110.34 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.742 ' HA ' HD12 ' A' ' 21' ' ' LEU . 16.8 m -57.23 -49.1 77.1 Favored 'General case' 0 C--O 1.217 -0.621 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 175.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.509 ' CD1' HG21 ' A' ' 92' ' ' ILE . 8.0 mt -56.02 -35.13 66.49 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 124.253 0.971 . . . . 0.0 111.77 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -67.59 -39.16 84.82 Favored 'General case' 0 C--O 1.212 -0.891 0 C-N-CA 124.54 1.136 . . . . 0.0 110.957 174.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.742 HD12 ' HA ' ' A' ' 18' ' ' THR . 41.0 mt -68.53 -34.76 76.43 Favored 'General case' 0 C--O 1.211 -0.926 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.596 175.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.645 HD12 ' O ' ' A' ' 18' ' ' THR . 1.6 mp -68.93 -38.73 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 120.069 1.304 . . . . 0.0 111.872 171.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.47 -48.52 48.73 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.86 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 m -85.46 5.93 29.04 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.173 0.989 . . . . 0.0 113.314 176.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.38 36.08 1.51 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 122.748 1.261 . . . . 0.0 112.22 -176.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.44 -166.9 16.26 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.443 1.497 . . . . 0.0 115.706 -174.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.78 139.87 64.15 Favored 'Cis proline' 0 C--N 1.347 0.485 0 O-C-N 124.285 1.676 . . . . 0.0 111.255 -2.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.469 ' CD2' ' HB3' ' A' ' 21' ' ' LEU . 58.7 m-85 -90.95 135.72 28.37 Favored Pre-proline 0 N--CA 1.474 0.732 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.705 -177.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.459 ' HG2' ' CD1' ' A' ' 58' ' ' ILE . 38.1 Cg_endo -74.34 -61.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.469 2.779 . . . . 0.0 111.433 -178.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.3 m-30 -63.35 159.72 17.52 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 175.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.8 m -80.53 9.28 6.22 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 124.173 0.921 . . . . 0.0 113.476 173.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.61 78.99 1.76 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 122.022 0.915 . . . . 0.0 111.46 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -177.14 146.16 0.49 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 111.721 -2.49 . . . . 0.0 115.056 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.69 27.98 36.84 Favored Glycine 0 N--CA 1.479 1.535 0 CA-C-N 112.87 -1.968 . . . . 0.0 110.853 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.411 HG23 ' HB2' ' A' ' 54' ' ' GLU . 20.5 m -122.12 146.24 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.453 1.101 . . . . 0.0 109.54 177.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.4 t -84.39 154.07 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 125.903 2.002 . . . . 0.0 109.855 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.465 ' CD1' ' HD3' ' A' ' 40' ' ' ARG . 18.6 t80 -137.11 85.88 2.16 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 113.844 -1.525 . . . . 0.0 110.828 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.432 ' HB2' ' CD1' ' A' ' 49' ' ' TYR . 2.2 tm0? -69.38 51.91 0.1 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.9 t30 27.52 55.65 0.07 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.779 2.032 . . . . 0.0 109.634 -172.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.465 ' HD3' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -55.62 -28.37 54.85 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 122.332 1.063 . . . . 0.0 111.463 -175.2 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.555 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.2 mt-10 -74.72 -11.37 60.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 113.138 -1.846 . . . . 0.0 114.962 173.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 31.4 t 45.38 43.12 8.21 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 123.874 1.797 . . . . 0.0 111.844 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 41' ' ' GLU . 95.8 t -108.77 -20.92 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 113.78 -1.555 . . . . 0.0 110.432 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.876 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.2 OUTLIER -88.25 147.26 39.85 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -175.413 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.69 ' HD3' HG23 ' A' ' 2' ' ' VAL . 92.3 Cg_endo -75.75 54.62 4.06 Favored 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 123.3 2.666 . . . . 0.0 112.081 -176.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.535 HG22 ' H ' ' A' ' 47' ' ' GLN . 1.9 m -157.66 -149.27 0.23 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 114.023 -1.444 . . . . 0.0 107.745 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.535 ' H ' HG22 ' A' ' 46' ' ' THR . 5.8 tt0 173.36 -35.78 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.012 1.725 . . . . 0.0 110.955 -173.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.8 p -38.06 146.35 0.06 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 122.771 1.272 . . . . 0.0 114.099 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.432 ' CD1' ' HB2' ' A' ' 38' ' ' GLN . 2.4 t80 -102.54 129.21 49.01 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 113.208 -1.814 . . . . 0.0 111.744 -175.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.63 -18.84 27.73 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 113.813 -1.539 . . . . 0.0 112.258 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -67.47 -9.09 38.76 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.228 1.011 . . . . 0.0 112.396 176.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.876 ' HE2' HD12 ' A' ' 44' ' ' LEU . 19.0 m-85 -122.99 162.4 22.41 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 124.279 1.032 . . . . 0.0 109.772 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -159.51 155.85 27.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 112.296 -2.229 . . . . 0.0 111.39 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.411 ' HB2' HG23 ' A' ' 35' ' ' VAL . 3.5 mt-10 -110.68 142.34 42.72 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.758 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.415 ' HB3' HG23 ' A' ' 18' ' ' THR . 77.5 m-85 -156.57 67.11 0.56 Allowed 'General case' 0 N--CA 1.477 0.918 0 O-C-N 126.328 2.267 . . . . 0.0 110.524 -175.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.43 ' OG1' ' HD3' ' A' ' 69' ' ' ARG . 1.1 m -38.47 123.06 1.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 122.689 1.233 . . . . 0.0 112.808 176.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.835 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.5 OUTLIER -81.82 114.1 22.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 112.109 -2.314 . . . . 0.0 108.73 177.233 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.459 ' CD1' ' HG2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -41.33 150.82 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 124.806 1.316 . . . . 0.0 109.107 171.58 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.461 ' OG1' ' HG3' ' A' ' 68' ' ' ARG . 23.8 m -150.99 137.76 11.56 Favored Pre-proline 0 N--CA 1.481 1.106 0 O-C-N 125.851 1.969 . . . . 0.0 110.684 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -72.48 151.4 53.19 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 123.646 2.897 . . . . 0.0 110.588 177.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.36 20.72 30.75 Favored Glycine 0 N--CA 1.48 1.623 0 CA-C-N 114.015 -1.448 . . . . 0.0 112.88 -174.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.87 87.64 5.47 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -44.39 -30.52 0.86 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 113.99 -1.459 . . . . 0.0 112.683 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.8 p -133.03 -170.87 2.54 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.866 -1.515 . . . . 0.0 108.638 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.1 mtm-85 -46.87 -29.3 1.92 Allowed 'General case' 0 N--CA 1.484 1.254 0 O-C-N 124.273 0.983 . . . . 0.0 112.921 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.27 148.78 0.09 OUTLIER Glycine 0 N--CA 1.465 0.59 0 N-CA-C 107.26 -2.336 . . . . 0.0 107.26 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.501 HG22 ' HB2' ' A' ' 85' ' ' HIS . 19.6 p -42.86 -29.73 0.34 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.052 -1.574 . . . . 0.0 113.423 172.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.737 ' HE ' HG12 ' A' ' 57' ' ' VAL . 3.1 mmm180 -37.64 116.91 0.52 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 166.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.447 ' HB2' HG23 ' A' ' 82' ' ' THR . 0.0 OUTLIER -157.49 135.02 10.52 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 112.435 -2.166 . . . . 0.0 112.938 -176.368 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.448 ' O ' HD13 ' A' ' 71' ' ' ILE . 5.9 mt -113.7 141.05 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 112.784 -2.007 . . . . 0.0 108.471 177.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.757 HD11 ' HE1' ' A' ' 86' ' ' TYR . 17.4 mm -127.52 114.09 34.49 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 O-C-N 126.199 2.187 . . . . 0.0 108.203 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.599 HG22 ' HB3' ' A' ' 79' ' ' ASP . 19.5 p -101.05 163.92 12.05 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.248 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.67 164.87 12.04 Favored Glycine 0 CA--C 1.531 1.082 0 O-C-N 125.639 1.837 . . . . 0.0 109.694 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.86 -17.43 63.15 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.302 0.641 . . . . 0.0 112.117 175.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -104.55 128.51 52.53 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.626 HG22 ' HG2' ' A' ' 77' ' ' GLN . 24.8 m -55.54 145.82 22.06 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 114.096 -1.411 . . . . 0.0 107.354 174.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.626 ' HG2' HG22 ' A' ' 76' ' ' THR . 2.8 mt-30 82.39 32.84 0.09 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 126.299 1.839 . . . . 0.0 111.218 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -135.83 46.46 2.33 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 123.058 1.409 . . . . 0.0 112.744 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.599 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -101.2 88.61 3.54 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 113.174 -1.83 . . . . 0.0 109.843 179.495 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.472 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 65.8 m-85 -57.79 178.06 0.09 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.287 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.483 ' CE2' ' NH1' ' A' ' 68' ' ' ARG . 9.0 t80 -158.01 113.92 2.77 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.685 -176.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.58 ' HB ' ' O ' ' A' ' 88' ' ' THR 0.318 0.1 OUTLIER -87.87 -80.45 0.27 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.045 -1.434 . . . . 0.0 113.72 177.813 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.02 -5.31 59.15 Favored Glycine 0 N--CA 1.471 0.99 0 CA-C-N 115.25 -0.886 . . . . 0.0 114.382 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.55 ' CB ' ' HB3' ' A' ' 87' ' ' ALA . 1.0 OUTLIER -120.64 20.02 11.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.398 -0.901 . . . . 0.0 111.985 173.545 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.501 ' HB2' HG22 ' A' ' 67' ' ' THR . 22.5 t-80 58.47 87.02 0.08 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.25 1.82 . . . . 0.0 110.203 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.757 ' HE1' HD11 ' A' ' 71' ' ' ILE . 8.3 m-30 49.08 41.32 19.16 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 113.639 -1.619 . . . . 0.0 114.518 -174.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.55 ' HB3' ' CB ' ' A' ' 84' ' ' ASP . . . -112.46 -32.64 6.42 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.102 -1.624 . . . . 0.0 112.806 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.58 ' O ' ' HB ' ' A' ' 82' ' ' THR . 15.3 p -135.95 166.79 22.52 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.646 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -156.79 110.13 2.61 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -175.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.71 106.46 9.15 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 113.884 -1.507 . . . . 0.0 108.354 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 51.1 mt -44.08 161.72 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.576 HD13 ' O ' ' A' ' 79' ' ' ASP . 1.7 mp -110.76 131.97 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 120.881 -1.137 . . . . 0.0 108.926 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.87 94.99 5.31 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 113.204 -1.816 . . . . 0.0 107.911 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -57.41 -37.1 72.21 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 124.731 1.269 . . . . 0.0 111.912 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.3 t -58.34 -45.66 87.71 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.821 -1.082 . . . . 0.0 112.469 174.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.55 ' OXT' ' HB3' ' A' ' 7' ' ' CYS . 11.6 t . . . . . 0 C--O 1.245 0.829 0 CA-C-O 118.489 -0.767 . . . . 0.0 110.929 175.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.401 ' HA ' ' HB3' ' A' ' 45' ' ' PRO . 0.8 OUTLIER . . . . . 0 N--CA 1.477 0.893 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.702 HG23 ' HD3' ' A' ' 45' ' ' PRO . 44.4 t -95.08 142.87 12.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.1 m -77.74 5.69 8.9 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.787 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.645 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 120.53 -177.23 16.36 Favored Glycine 0 N--CA 1.473 1.115 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 6' ' ' VAL . 4.4 m -90.96 173.69 7.83 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 122.354 1.073 . . . . 0.0 109.2 -178.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.428 ' H ' HG22 ' A' ' 5' ' ' THR . 0.9 OUTLIER -139.73 112.64 5.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -175.819 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 73.3 m -50.08 124.66 10.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 111.894 -2.412 . . . . 0.0 109.601 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -50.73 -35.39 31.2 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.719 0.807 . . . . 0.0 112.232 174.13 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.9 t -63.81 -30.97 72.01 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.518 0.511 . . . . 0.0 111.992 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.48 -17.65 59.18 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.632 0.773 . . . . 0.0 111.913 174.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.463 ' HB3' ' CB ' ' A' ' 15' ' ' ALA . 7.1 mt -90.05 162.35 35.46 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 176.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.48 169.53 15.48 Favored 'Trans proline' 0 CA--C 1.547 1.135 0 C-N-CA 122.606 2.204 . . . . 0.0 112.988 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.3 -17.95 49.99 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.561 2.174 . . . . 0.0 113.058 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.495 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 26.1 tp10 -85.05 -25.22 27.76 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 175.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.863 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -48.84 -37.07 18.37 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 175.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.49 -35.27 68.14 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.873 -1.512 . . . . 0.0 112.943 173.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.545 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 9.3 t70 -54.46 -53.33 55.63 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.06 0.944 . . . . 0.0 109.828 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.818 ' HA ' HD12 ' A' ' 21' ' ' LEU . 17.1 m -59.54 -48.24 82.43 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 175.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.703 HD11 HG21 ' A' ' 92' ' ' ILE . 5.6 mt -56.81 -28.57 61.66 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 176.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -73.75 -40.35 63.57 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.704 173.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.818 HD12 ' HA ' ' A' ' 18' ' ' THR . 25.3 mt -69.5 -31.16 69.24 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 119.271 -0.395 . . . . 0.0 111.026 176.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.671 HD12 ' O ' ' A' ' 18' ' ' THR . 1.6 mp -69.74 -38.38 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 120.143 1.338 . . . . 0.0 111.508 171.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.46 -47.61 32.39 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 124.562 1.164 . . . . 0.0 111.873 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.7 m -85.91 8.4 20.45 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.42 1.488 . . . . 0.0 112.645 175.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 41.51 46.54 3.05 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 122.725 1.25 . . . . 0.0 112.525 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.48 -166.13 43.37 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-N 113.928 -1.487 . . . . 0.0 116.265 -171.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -74.25 140.6 68.17 Favored 'Cis proline' 0 N--CA 1.483 0.887 0 O-C-N 124.758 1.925 . . . . 0.0 111.543 -1.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.505 ' HA ' HD22 ' A' ' 21' ' ' LEU . 33.9 m-85 -92.21 142.67 26.44 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 113.897 -1.501 . . . . 0.0 111.679 -176.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -74.62 -65.29 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 123.283 2.655 . . . . 0.0 111.42 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 -57.56 163.0 2.63 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.834 0.826 . . . . 0.0 112.226 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 t -82.08 9.44 8.5 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 123.238 1.494 . . . . 0.0 112.269 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.403 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -112.11 99.54 8.14 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.302 -177.411 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 166.64 140.17 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 O-C-N 126.626 2.454 . . . . 0.0 115.404 -172.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.45 30.38 22.02 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-N 113.616 -1.629 . . . . 0.0 111.172 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.507 HG23 ' HB2' ' A' ' 54' ' ' GLU . 20.7 m -122.36 147.39 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 114.275 -0.963 . . . . 0.0 109.512 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.0 t -85.15 156.95 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 125.248 1.593 . . . . 0.0 109.631 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.603 ' CD1' ' HD3' ' A' ' 40' ' ' ARG . 31.0 t80 -141.26 86.26 2.01 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.811 175.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -71.72 55.44 0.26 Allowed 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 122.631 1.205 . . . . 0.0 113.318 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 45.7 t30 29.73 53.62 0.12 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.474 2.31 . . . . 0.0 109.305 -173.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.603 ' HD3' ' CD1' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -58.18 -22.97 53.8 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.701 -174.925 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.611 ' O ' HG23 ' A' ' 43' ' ' VAL . 3.0 mt-10 -83.02 -8.28 59.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 113.207 -1.815 . . . . 0.0 114.669 173.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 43.9 t 44.0 41.92 4.37 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 124.326 2.012 . . . . 0.0 111.733 -177.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 41' ' ' GLU . 57.5 t -109.81 -12.4 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 113.592 -1.64 . . . . 0.0 109.663 -178.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.494 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.2 OUTLIER -99.92 148.43 34.8 Favored Pre-proline 0 CA--C 1.545 0.775 0 O-C-N 120.721 -1.237 . . . . 0.0 108.687 -175.272 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.702 ' HD3' HG23 ' A' ' 2' ' ' VAL . 71.6 Cg_endo -78.5 59.09 7.02 Favored 'Trans proline' 0 N--CA 1.477 0.551 0 C-N-CA 122.815 2.343 . . . . 0.0 111.156 -174.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.544 HG22 ' H ' ' A' ' 47' ' ' GLN . 2.4 m -157.17 -147.49 0.19 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 113.829 -1.532 . . . . 0.0 107.505 -177.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.544 ' H ' HG22 ' A' ' 46' ' ' THR . 8.4 tt0 171.7 -35.97 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.911 1.684 . . . . 0.0 111.04 -173.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.6 p -40.89 152.23 0.05 Allowed 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 123.116 1.436 . . . . 0.0 112.917 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -106.18 126.71 52.55 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 113.178 -1.828 . . . . 0.0 109.937 -175.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.43 -21.53 28.43 Favored Glycine 0 N--CA 1.479 1.521 0 O-C-N 125.181 1.551 . . . . 0.0 112.009 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -64.44 -13.47 51.62 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.505 1.122 . . . . 0.0 112.294 176.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.494 ' HE2' HD12 ' A' ' 44' ' ' LEU . 16.4 m-85 -116.25 163.08 16.52 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.718 0.807 . . . . 0.0 109.535 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -159.65 159.65 33.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 112.016 -2.357 . . . . 0.0 111.184 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.507 ' HB2' HG23 ' A' ' 35' ' ' VAL . 32.2 mt-10 -117.31 144.7 44.6 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.645 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.406 ' HB3' HG23 ' A' ' 18' ' ' THR . 80.1 m-85 -158.96 63.92 0.41 Allowed 'General case' 0 N--CA 1.48 1.047 0 O-C-N 126.495 2.372 . . . . 0.0 111.104 -174.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 32' ' ' GLN . 1.1 m -35.35 120.89 0.57 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 122.352 1.072 . . . . 0.0 112.556 177.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.863 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -81.78 117.72 28.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 112.738 -2.028 . . . . 0.0 108.609 177.313 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.469 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -42.99 158.39 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 173.467 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.495 ' OG1' ' HG3' ' A' ' 68' ' ' ARG . 2.5 m -153.09 142.45 14.74 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 113.273 -1.785 . . . . 0.0 111.387 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.56 146.03 48.5 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.594 2.196 . . . . 0.0 110.971 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.25 22.1 55.08 Favored Glycine 0 N--CA 1.48 1.611 0 CA-C-N 113.759 -1.564 . . . . 0.0 112.459 -175.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.2 87.05 7.34 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -47.61 -26.57 1.52 Allowed 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.912 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.1 p -128.03 -158.62 0.89 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.037 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.6 mtm105 -57.06 -18.18 13.25 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 174.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.41 125.4 0.02 OUTLIER Glycine 0 N--CA 1.465 0.593 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.42 HG22 ' HB2' ' A' ' 85' ' ' HIS . 22.0 p -39.72 -31.09 0.09 Allowed 'General case' 0 CA--C 1.557 1.234 0 CA-C-N 113.699 -1.251 . . . . 0.0 113.523 175.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.495 ' HG3' ' OG1' ' A' ' 59' ' ' THR . 0.3 OUTLIER -46.05 105.61 0.07 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 123.417 1.579 . . . . 0.0 112.711 170.137 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.548 ' HB2' HG23 ' A' ' 82' ' ' THR . 0.3 OUTLIER -131.42 141.36 49.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 112.816 -1.993 . . . . 0.0 109.989 -179.442 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.9 mt -117.3 135.9 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 112.681 -2.054 . . . . 0.0 108.33 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.618 HD11 ' HE1' ' A' ' 86' ' ' TYR . 16.9 mm -124.91 101.87 9.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 CA-C-N 112.848 -1.978 . . . . 0.0 108.608 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.486 HG21 HD13 ' A' ' 22' ' ' ILE . 16.9 p -89.68 163.1 15.26 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.502 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -115.29 166.84 12.24 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-N 113.32 -1.764 . . . . 0.0 109.665 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.24 -14.09 62.58 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.355 -0.922 . . . . 0.0 111.843 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.58 130.95 55.29 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.129 174.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.55 HG22 ' HG2' ' A' ' 77' ' ' GLN . 3.4 m -55.23 143.8 26.66 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.124 -1.398 . . . . 0.0 107.495 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.55 ' HG2' HG22 ' A' ' 76' ' ' THR . 2.2 mt-30 80.06 33.82 0.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 126.127 2.142 . . . . 0.0 111.037 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -129.33 49.12 2.28 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 113.596 -1.638 . . . . 0.0 113.616 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.492 ' OD1' ' HB ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER -107.13 103.77 13.25 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.341 -178.363 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.516 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 23.9 m-85 -91.64 131.13 37.26 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 125.28 1.613 . . . . 0.0 109.916 -177.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.753 ' HB2' HD11 ' A' ' 92' ' ' ILE . 5.5 t80 -110.29 123.92 50.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.24 -1.345 . . . . 0.0 109.894 -176.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.548 HG23 ' HB2' ' A' ' 69' ' ' ARG 0.262 0.2 OUTLIER -89.74 -71.18 0.62 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 113.502 -1.681 . . . . 0.0 112.464 177.315 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.09 -8.81 56.65 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-N 113.118 -1.856 . . . . 0.0 112.197 -175.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 15.6 t70 -112.01 9.71 20.43 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 117.252 0.526 . . . . 0.0 111.838 174.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.42 ' HB2' HG22 ' A' ' 67' ' ' THR . 30.6 t-80 87.15 -20.93 0.2 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.928 1.691 . . . . 0.0 113.076 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.618 ' HE1' HD11 ' A' ' 71' ' ' ILE . 1.2 m-30 161.19 55.35 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 O-C-N 128.16 3.412 . . . . 0.0 113.684 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . . . -120.06 -41.33 2.65 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 118.994 -1.083 . . . . 0.0 113.748 175.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.528 ' O ' ' HB ' ' A' ' 82' ' ' THR . 18.4 p -128.29 165.55 20.32 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.399 -1.273 . . . . 0.0 108.402 -177.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.489 ' CD1' HD21 ' A' ' 44' ' ' LEU . 97.9 m-85 -157.41 112.7 2.78 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -173.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.2 m -131.21 112.25 12.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 113.261 -1.791 . . . . 0.0 109.286 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.474 ' HA ' HD23 ' A' ' 91' ' ' LEU . 25.1 mt -42.39 162.82 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 O-C-N 124.214 0.946 . . . . 0.0 112.428 177.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.753 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.7 mp -112.19 130.74 65.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 O-C-N 120.778 -1.201 . . . . 0.0 108.823 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.04 94.14 4.94 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.257 -1.792 . . . . 0.0 108.624 176.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -53.39 -37.22 62.26 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 124.107 0.88 . . . . 0.0 112.467 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.9 t -56.74 -49.29 75.65 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 113.801 -1.545 . . . . 0.0 113.595 174.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 34.3 t . . . . . 0 C--O 1.246 0.886 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 179.07 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.9 p30 . . . . . 0 CA--C 1.551 1.011 0 CA-C-O 122.146 0.974 . . . . 0.0 112.986 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.401 HG23 ' HD3' ' A' ' 45' ' ' PRO . 3.4 t -84.05 141.81 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.92 5.82 10.67 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.883 0.849 . . . . 0.0 112.639 177.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.38 -174.37 16.55 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.447 1.498 . . . . 0.0 109.988 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -94.18 169.39 10.28 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 122.016 0.912 . . . . 0.0 109.239 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 91' ' ' LEU . 2.0 p -137.84 111.26 7.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 122.752 1.263 . . . . 0.0 107.882 -177.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 71.6 m -48.96 128.16 15.47 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 112.256 -2.247 . . . . 0.0 109.364 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -53.04 -34.65 57.41 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.805 176.745 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.1 t -64.68 -29.77 70.77 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 174.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.14 -26.11 58.9 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.451 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.487 HD13 ' HB1' ' A' ' 15' ' ' ALA . 7.1 mt -83.92 162.57 51.94 Favored Pre-proline 0 N--CA 1.478 0.952 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.17 168.11 18.39 Favored 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 122.308 2.005 . . . . 0.0 112.952 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -65.28 -18.95 62.0 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.847 2.365 . . . . 0.0 112.666 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.549 ' HG3' HG22 ' A' ' 57' ' ' VAL . 27.4 tp10 -83.62 -26.41 29.98 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.439 -0.801 . . . . 0.0 113.066 175.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.797 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -47.62 -38.87 15.54 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 176.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.38 -34.73 72.91 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.551 -1.659 . . . . 0.0 113.328 174.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.607 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 10.7 t0 -54.52 -57.0 13.12 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 117.408 -1.282 . . . . 0.0 109.465 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.797 ' HA ' HD12 ' A' ' 21' ' ' LEU . 1.4 m -55.87 -48.42 75.59 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 174.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.722 HD11 HG21 ' A' ' 92' ' ' ILE . 7.1 mt -57.42 -33.36 67.81 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -67.75 -33.41 74.81 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.336 174.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.797 HD12 ' HA ' ' A' ' 18' ' ' THR . 18.3 mt -75.93 -31.3 59.06 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 118.773 -0.632 . . . . 0.0 110.924 176.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.679 HD12 ' O ' ' A' ' 18' ' ' THR . 1.7 mp -69.9 -40.81 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 120.267 1.394 . . . . 0.0 111.453 170.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.84 -41.78 64.46 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 125.02 1.45 . . . . 0.0 112.521 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.31 7.23 45.22 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.321 1.049 . . . . 0.0 111.781 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 44.46 34.98 1.19 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.035 1.334 . . . . 0.0 112.556 -176.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.9 -168.15 20.14 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-N 113.379 -1.737 . . . . 0.0 115.83 -174.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -74.53 140.5 67.66 Favored 'Cis proline' 0 N--CA 1.479 0.622 0 O-C-N 124.043 1.549 . . . . 0.0 111.261 -3.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.476 ' HA ' HD22 ' A' ' 21' ' ' LEU . 23.6 m-85 -89.86 136.99 28.57 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.57 -176.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -72.68 -63.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.475 0.415 0 C-N-CA 123.563 2.842 . . . . 0.0 111.413 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 -62.99 159.4 17.13 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.411 0.684 . . . . 0.0 112.744 175.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.85 8.5 5.4 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 124.714 1.259 . . . . 0.0 113.588 174.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.426 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 1.8 mt-30 -105.01 82.89 1.91 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 122.372 1.082 . . . . 0.0 111.819 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -177.32 150.83 0.74 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 110.779 -2.919 . . . . 0.0 114.999 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.01 35.43 27.58 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-N 112.52 -2.127 . . . . 0.0 110.275 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -131.88 147.1 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.546 1.138 . . . . 0.0 109.72 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.4 t -84.41 154.4 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 O-C-N 125.944 2.027 . . . . 0.0 109.868 175.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.484 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 50.0 t80 -132.31 91.33 2.92 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 113.846 -1.525 . . . . 0.0 108.419 174.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.544 ' HG3' ' CD1' ' A' ' 49' ' ' TYR . 6.5 tm0? -72.12 55.63 0.31 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 119.81 1.187 . . . . 0.0 112.361 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 26.06 55.83 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.793 2.437 . . . . 0.0 110.854 -175.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.433 ' HD3' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -56.38 -25.97 51.42 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 122.17 0.986 . . . . 0.0 111.938 -171.754 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.595 ' O ' HG23 ' A' ' 43' ' ' VAL . 4.2 mt-10 -76.35 -14.33 60.09 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 113.09 -1.868 . . . . 0.0 115.598 172.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 31.6 t 45.06 41.81 5.91 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 124.183 1.945 . . . . 0.0 111.924 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 41' ' ' GLU . 76.6 t -110.8 -10.42 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-N 113.151 -1.841 . . . . 0.0 110.739 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.63 ' HB3' ' OH ' ' A' ' 52' ' ' TYR . 4.0 mm? -103.91 150.35 38.14 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-O 117.372 -1.299 . . . . 0.0 109.29 -176.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.401 ' HD3' HG23 ' A' ' 2' ' ' VAL . 83.3 Cg_endo -74.87 60.41 5.33 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.215 2.61 . . . . 0.0 111.42 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.818 HG22 ' H ' ' A' ' 47' ' ' GLN . 3.6 m -82.25 -165.2 0.96 Allowed 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 112.915 -1.948 . . . . 0.0 107.628 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.818 ' H ' HG22 ' A' ' 46' ' ' THR . 12.9 tt0 175.86 -43.71 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.004 1.722 . . . . 0.0 110.282 -176.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.8 p -114.86 161.45 18.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.693 -176.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.544 ' CD1' ' HG3' ' A' ' 38' ' ' GLN . 4.1 t80 -90.01 129.39 36.34 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 113.312 -1.767 . . . . 0.0 110.437 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.76 5.99 70.62 Favored Glycine 0 N--CA 1.48 1.584 0 O-C-N 125.332 1.645 . . . . 0.0 112.657 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.39 15.31 3.72 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.63 ' OH ' ' HB3' ' A' ' 44' ' ' LEU . 10.7 m-85 -151.04 150.76 31.12 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.156 0.983 . . . . 0.0 109.305 -173.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -147.12 155.44 42.17 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 126.074 2.109 . . . . 0.0 111.632 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.484 ' HG3' ' HB2' ' A' ' 37' ' ' PHE . 27.3 mt-10 -109.13 145.17 36.16 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.829 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.482 ' O ' HG21 ' A' ' 18' ' ' THR . 72.5 m-85 -159.82 68.28 0.39 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 126.826 2.579 . . . . 0.0 110.64 -174.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 0.9 OUTLIER -41.19 133.92 2.22 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 122.767 1.27 . . . . 0.0 111.814 178.741 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.797 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -95.86 118.97 43.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 112.07 -2.332 . . . . 0.0 107.939 178.35 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -40.73 153.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 CA-C-O 121.853 0.835 . . . . 0.0 108.955 173.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.487 ' OG1' ' HD2' ' A' ' 68' ' ' ARG . 15.7 m -140.04 139.74 22.15 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 112.951 -1.931 . . . . 0.0 111.688 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.73 145.18 50.84 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 121.93 1.754 . . . . 0.0 111.007 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 51.77 28.48 23.37 Favored Glycine 0 CA--C 1.548 2.137 0 O-C-N 125.289 1.618 . . . . 0.0 111.895 -174.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.98 90.28 4.57 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -46.57 -27.65 1.2 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 113.603 -1.635 . . . . 0.0 113.197 176.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.2 p -126.0 -173.67 2.91 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.846 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.426 ' HD2' ' OE1' ' A' ' 32' ' ' GLN . 14.6 mtm105 -52.94 -20.72 3.6 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 175.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.22 171.27 11.89 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 124.38 2.1 . . . . 0.0 109.201 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.489 HG22 ' HB2' ' A' ' 85' ' ' HIS . 41.0 p -75.95 0.74 17.33 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 111.275 -2.463 . . . . 0.0 113.004 176.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.487 ' HD2' ' OG1' ' A' ' 59' ' ' THR . 0.0 OUTLIER -82.11 116.9 21.89 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 122.925 1.345 . . . . 0.0 111.203 176.58 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.524 ' HG2' ' HE1' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -142.35 135.67 28.87 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 112.771 -2.013 . . . . 0.0 109.323 178.444 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.2 mt -104.5 144.81 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 113.463 -1.699 . . . . 0.0 108.741 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' A' ' 80' ' ' TYR . 18.4 mm -132.73 114.75 23.04 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.737 0 CA-C-N 112.486 -2.143 . . . . 0.0 107.895 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.565 HG22 ' HB3' ' A' ' 79' ' ' ASP . 18.8 p -99.45 162.86 12.79 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.791 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -107.61 -178.26 22.39 Favored Glycine 0 N--CA 1.477 1.433 0 O-C-N 124.968 1.417 . . . . 0.0 109.953 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.8 -13.22 59.96 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 114.348 -0.926 . . . . 0.0 113.024 174.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -113.73 130.78 56.38 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 176.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.521 HG22 ' HG2' ' A' ' 77' ' ' GLN . 31.4 m -54.0 147.97 11.53 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.083 174.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.521 ' HG2' HG22 ' A' ' 76' ' ' THR . 2.4 mt-30 80.63 31.76 0.17 Allowed 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 126.585 1.954 . . . . 0.0 110.942 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.513 ' HA ' HD22 ' A' ' 91' ' ' LEU . 4.6 mt-10 -134.59 48.78 2.28 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 123.89 1.805 . . . . 0.0 113.708 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.669 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -104.34 86.74 2.58 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 113.071 -1.877 . . . . 0.0 109.417 -179.0 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.41 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 35.2 m-85 -57.35 177.88 0.08 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 125.275 1.43 . . . . 0.0 110.339 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.597 ' HB2' HD11 ' A' ' 92' ' ' ILE . 13.0 t80 -162.87 126.23 2.85 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 113.817 -1.538 . . . . 0.0 109.84 -176.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.2 OUTLIER -91.12 -71.97 0.6 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 112.672 -2.058 . . . . 0.0 111.702 176.271 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.46 1.08 34.38 Favored Glycine 0 CA--C 1.55 2.228 0 CA-C-N 113.094 -1.866 . . . . 0.0 114.835 -173.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.568 ' CB ' ' HB3' ' A' ' 87' ' ' ALA . 1.7 m-20 -127.79 15.8 6.92 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.386 0.675 . . . . 0.0 112.619 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.489 ' HB2' HG22 ' A' ' 67' ' ' THR . 52.7 t-80 61.28 83.79 0.14 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 127.093 2.157 . . . . 0.0 110.591 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.524 ' HE1' ' HG2' ' A' ' 69' ' ' ARG . 3.4 m-30 51.84 38.23 22.74 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 113.83 -1.532 . . . . 0.0 113.342 -176.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.568 ' HB3' ' CB ' ' A' ' 84' ' ' ASP . . . -109.74 -13.22 14.52 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.498 ' O ' ' HB ' ' A' ' 82' ' ' THR . 9.5 p -161.37 165.96 28.14 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.037 1.335 . . . . 0.0 107.81 -176.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.511 ' CD1' HD21 ' A' ' 44' ' ' LEU . 99.6 m-85 -157.29 113.55 2.93 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -176.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.4 m -132.33 115.94 16.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.748 -1.569 . . . . 0.0 109.399 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.513 HD22 ' HA ' ' A' ' 78' ' ' GLU . 35.0 mt -47.28 164.21 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.379 0.672 . . . . 0.0 111.946 177.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.722 HG21 HD11 ' A' ' 19' ' ' LEU . 1.7 mp -112.63 128.96 69.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 120.824 -1.173 . . . . 0.0 108.434 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.87 92.05 4.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 113.472 -1.695 . . . . 0.0 108.551 175.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -52.62 -36.4 56.4 Favored 'General case' 0 N--CA 1.484 1.225 0 O-C-N 124.173 0.92 . . . . 0.0 112.778 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.2 t -58.27 -47.05 84.82 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 114.054 -1.43 . . . . 0.0 113.387 173.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 24.3 t . . . . . 0 C--O 1.244 0.791 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.171 178.365 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.738 HG21 ' HE1' ' A' ' 80' ' ' TYR . 71.2 t -37.66 136.5 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 125.57 1.548 . . . . 0.0 109.409 171.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.5 m -70.48 3.8 2.78 Favored 'General case' 0 CA--C 1.55 0.952 0 O-C-N 125.151 1.532 . . . . 0.0 112.526 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.642 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 111.2 -179.25 19.86 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 m -77.0 170.14 17.07 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.128 -1.036 . . . . 0.0 110.423 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 p -138.49 108.6 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 78.8 m -43.55 123.51 3.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 112.565 -2.107 . . . . 0.0 109.964 176.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.74 -37.06 39.69 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.742 177.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.9 t -65.69 -28.11 68.83 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.099 0.56 . . . . 0.0 112.073 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.43 -20.55 58.8 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.83 174.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.47 HD13 ' HB1' ' A' ' 15' ' ' ALA . 14.7 mt -85.77 159.59 54.67 Favored Pre-proline 0 CA--C 1.539 0.519 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 176.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.52 169.16 19.25 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 121.953 1.769 . . . . 0.0 113.081 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.48 -13.93 38.63 Favored 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 122.627 2.218 . . . . 0.0 114.549 177.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 11.8 pm0 -93.43 -4.93 50.43 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.559 -1.201 . . . . 0.0 113.29 176.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.504 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -78.59 -50.7 11.06 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.797 175.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.96 -28.22 56.06 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.67 -1.15 . . . . 0.0 112.271 174.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.57 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 9.6 t70 -53.45 -58.63 6.47 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.428 1.08 . . . . 0.0 109.969 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.71 ' HA ' HD12 ' A' ' 21' ' ' LEU . 1.8 m -53.57 -50.43 65.59 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.612 0.968 . . . . 0.0 113.612 175.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.529 HD21 HD13 ' A' ' 70' ' ' ILE . 10.4 mt -56.15 -37.38 69.42 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.885 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -64.63 -33.26 75.52 Favored 'General case' 0 C--O 1.214 -0.787 0 C-N-CA 123.962 0.905 . . . . 0.0 110.691 173.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.71 HD12 ' HA ' ' A' ' 18' ' ' THR . 16.8 mt -76.35 -30.43 57.6 Favored 'General case' 0 C--O 1.209 -1.048 0 CA-C-O 118.364 -0.826 . . . . 0.0 110.78 176.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.667 HD12 ' O ' ' A' ' 18' ' ' THR . 1.8 mp -70.65 -40.63 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 120.217 1.371 . . . . 0.0 111.722 171.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.39 -40.97 63.9 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.006 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.18 7.72 44.25 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.355 178.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 42.99 34.84 0.67 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.577 1.151 . . . . 0.0 112.733 -176.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.67 -169.48 18.22 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 113.521 -1.672 . . . . 0.0 115.969 -173.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.57 140.76 69.1 Favored 'Cis proline' 0 CA--C 1.537 0.655 0 O-C-N 123.775 1.408 . . . . 0.0 111.102 -2.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.425 ' CD2' ' HB3' ' A' ' 21' ' ' LEU . 37.9 m-85 -91.66 136.3 26.72 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 113.686 -1.597 . . . . 0.0 111.573 -177.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.418 ' HG2' ' CD1' ' A' ' 58' ' ' ILE . 44.3 Cg_endo -73.58 -62.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.475 0.439 0 C-N-CA 122.947 2.431 . . . . 0.0 111.942 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.8 m-30 -69.3 146.35 52.31 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 118.494 -0.765 . . . . 0.0 110.793 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.4 m -62.4 -15.26 48.0 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 125.385 1.678 . . . . 0.0 113.141 174.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.507 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 2.0 mt-30 -78.64 77.96 5.11 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 122.678 1.227 . . . . 0.0 111.516 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -178.12 142.21 0.27 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 110.783 -2.917 . . . . 0.0 113.869 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.0 24.43 37.72 Favored Glycine 0 N--CA 1.481 1.656 0 CA-C-N 112.952 -1.931 . . . . 0.0 111.399 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.4 m -120.52 146.89 24.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 124.384 1.073 . . . . 0.0 109.481 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 52' ' ' TYR . 5.3 t -83.57 154.37 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 126.096 2.123 . . . . 0.0 110.206 176.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.482 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 27.7 t80 -135.03 88.53 2.43 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 113.842 -1.526 . . . . 0.0 109.988 175.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -70.91 52.44 0.15 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 122.684 1.231 . . . . 0.0 113.753 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 37.5 t30 28.43 54.26 0.08 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.06 2.144 . . . . 0.0 109.566 -172.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -56.31 -26.29 51.72 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.702 -1.136 . . . . 0.0 111.035 -175.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.581 ' O ' HG23 ' A' ' 43' ' ' VAL . 1.3 mt-10 -76.61 -11.83 59.92 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.61 -1.632 . . . . 0.0 114.562 174.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.2 t 45.54 40.9 6.29 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 123.54 1.638 . . . . 0.0 111.973 -177.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 41' ' ' GLU . 62.4 t -109.34 -18.58 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 114.16 -1.382 . . . . 0.0 110.852 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.867 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.2 OUTLIER -88.51 149.78 45.08 Favored Pre-proline 0 N--CA 1.469 0.497 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.762 -175.604 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.712 ' HD3' HG23 ' A' ' 2' ' ' VAL . 92.7 Cg_endo -75.51 52.31 3.21 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 122.958 2.439 . . . . 0.0 112.062 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.463 HG22 ' H ' ' A' ' 47' ' ' GLN . 1.7 m -157.6 -148.19 0.2 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -177.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.463 ' H ' HG22 ' A' ' 46' ' ' THR . 2.6 tt0 169.54 -35.56 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.301 1.84 . . . . 0.0 110.676 -173.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.6 p -38.74 149.21 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 122.274 1.035 . . . . 0.0 113.657 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -103.26 132.41 49.54 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 113.613 -1.631 . . . . 0.0 109.186 -175.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.26 -18.68 21.91 Favored Glycine 0 N--CA 1.483 1.82 0 O-C-N 124.971 1.419 . . . . 0.0 113.136 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.457 ' HA ' ' HB2' ' A' ' 74' ' ' GLU . 0.2 OUTLIER -74.98 1.63 12.43 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.214 1.406 . . . . 0.0 113.135 177.743 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.867 ' HE2' HD12 ' A' ' 44' ' ' LEU . 11.4 m-85 -131.05 162.88 28.83 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 123.904 0.882 . . . . 0.0 109.873 -178.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -159.18 156.8 29.62 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 125.647 1.842 . . . . 0.0 110.899 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.482 ' HG3' ' HB2' ' A' ' 37' ' ' PHE . 2.3 mt-10 -114.94 137.33 52.11 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.454 -177.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.482 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 57.1 m-85 -152.48 65.85 0.82 Allowed 'General case' 0 N--CA 1.475 0.789 0 O-C-N 125.837 1.961 . . . . 0.0 111.345 -175.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 27.4 m -39.16 134.65 1.07 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 122.811 1.291 . . . . 0.0 113.061 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.504 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.9 OUTLIER -86.97 109.0 18.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 111.354 -2.657 . . . . 0.0 107.529 178.018 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -43.19 157.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 125.635 1.834 . . . . 0.0 109.339 168.312 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -156.61 141.75 12.38 Favored Pre-proline 0 C--N 1.322 -0.613 0 O-C-N 126.063 2.102 . . . . 0.0 112.501 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.84 145.56 45.98 Favored 'Trans proline' 0 N--CA 1.475 0.407 0 C-N-CA 122.549 2.166 . . . . 0.0 110.955 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.81 28.72 57.66 Favored Glycine 0 CA--C 1.539 1.586 0 CA-C-N 113.358 -1.746 . . . . 0.0 112.422 -175.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.11 89.92 7.89 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -39.71 -32.83 0.15 Allowed 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 113.864 -1.516 . . . . 0.0 113.167 176.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.6 p -130.7 -160.65 1.06 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 113.879 -1.509 . . . . 0.0 109.755 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.507 ' HD2' ' OE1' ' A' ' 32' ' ' GLN . 3.6 mtm105 -60.21 -14.74 19.17 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 172.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.18 139.53 0.07 OUTLIER Glycine 0 C--N 1.334 0.433 0 N-CA-C 107.57 -2.212 . . . . 0.0 107.57 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.2 p -47.08 -27.9 1.53 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 113.306 -1.447 . . . . 0.0 113.428 174.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.479 ' HG2' ' CE1' ' A' ' 81' ' ' TYR . 33.9 mtm-85 -50.27 133.37 23.96 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 123.575 1.655 . . . . 0.0 112.954 170.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.475 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -159.36 133.29 7.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 111.834 -2.439 . . . . 0.0 109.99 -179.585 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.529 HD13 HD21 ' A' ' 19' ' ' LEU . 3.3 mt -104.34 140.18 23.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 113.591 -1.64 . . . . 0.0 109.099 176.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.523 ' O ' ' HD2' ' A' ' 80' ' ' TYR . 21.2 mm -129.22 111.37 22.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 112.362 -2.199 . . . . 0.0 108.88 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.722 HG22 ' HB3' ' A' ' 79' ' ' ASP . 17.2 p -98.68 163.27 12.71 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.443 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -108.03 179.95 21.84 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.083 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -76.52 -12.19 59.99 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.735 0.779 . . . . 0.0 111.888 175.669 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -117.47 129.86 56.08 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 175.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.67 HG22 ' HG2' ' A' ' 77' ' ' GLN . 17.3 m -53.88 151.25 6.73 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.537 174.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.67 ' HG2' HG22 ' A' ' 76' ' ' THR . 2.0 mt-30 83.79 32.38 0.06 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 125.936 2.022 . . . . 0.0 110.549 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.61 ' HA ' HD22 ' A' ' 91' ' ' LEU . 3.6 mt-10 -146.28 52.83 1.13 Allowed 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 123.187 1.47 . . . . 0.0 112.468 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.722 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -107.37 90.97 3.46 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 113.654 -1.612 . . . . 0.0 109.591 -179.517 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.738 ' HE1' HG21 ' A' ' 2' ' ' VAL . 62.8 m-85 -59.63 176.48 0.27 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.268 1.027 . . . . 0.0 109.679 176.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.676 ' HB2' HD11 ' A' ' 92' ' ' ILE . 8.4 t80 -164.76 89.57 0.51 Allowed 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 114.44 -1.254 . . . . 0.0 109.078 -178.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.0 OUTLIER -48.09 -74.26 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.321 -1.309 . . . . 0.0 112.558 172.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 68' ' ' ARG . . . 79.47 -9.44 42.12 Favored Glycine 0 CA--C 1.545 1.953 0 CA-C-N 113.872 -1.513 . . . . 0.0 112.131 -175.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.739 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 11.0 t70 -122.71 16.49 10.27 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.414 0.686 . . . . 0.0 112.555 175.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 66.69 87.37 0.12 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.749 1.619 . . . . 0.0 111.507 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.474 ' H ' HG21 ' A' ' 82' ' ' THR . 5.2 m-85 48.94 28.64 2.05 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 113.279 -1.782 . . . . 0.0 113.471 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.739 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . . . -108.25 -24.29 11.57 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 120.758 -1.214 . . . . 0.0 111.824 -174.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.531 ' O ' ' HB ' ' A' ' 82' ' ' THR . 12.6 p -143.82 172.63 12.58 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -178.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.477 ' O ' HG13 ' A' ' 2' ' ' VAL . 94.9 m-85 -163.23 121.02 1.93 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -175.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.1 m -139.64 107.81 5.77 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.531 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.61 HD22 ' HA ' ' A' ' 78' ' ' GLU . 90.5 mt -44.01 164.18 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.178 0.924 . . . . 0.0 111.701 178.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.676 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.7 mp -110.83 135.56 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 120.424 -1.422 . . . . 0.0 109.517 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.24 100.15 8.84 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.264 -1.334 . . . . 0.0 108.873 176.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.462 HE21 ' HB2' ' A' ' 94' ' ' GLN . 0.0 OUTLIER -62.39 -38.97 91.67 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 123.573 0.546 . . . . 0.0 111.608 -179.428 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.3 t -54.98 -45.49 75.0 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.179 1.391 . . . . 0.0 112.814 173.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 35.1 t . . . . . 0 C--O 1.25 1.105 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.653 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.9 p30 . . . . . 0 CA--C 1.541 0.602 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.589 HG12 ' H ' ' A' ' 4' ' ' GLY . 12.8 t -42.28 140.0 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.963 175.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.5 t -79.95 4.8 15.71 Favored 'General case' 0 CA--C 1.55 0.958 0 O-C-N 124.468 1.105 . . . . 0.0 112.405 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.589 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 129.59 176.25 14.36 Favored Glycine 0 N--CA 1.474 1.232 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.401 HG23 ' CB ' ' A' ' 91' ' ' LEU . 4.3 m -92.91 173.04 7.95 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.519 -0.84 . . . . 0.0 109.143 -176.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -137.51 108.37 5.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -175.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.5 m -46.05 126.66 7.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.236 -1.802 . . . . 0.0 109.977 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.98 -34.11 63.08 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.8 177.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -64.59 -29.4 70.42 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 123.774 0.671 . . . . 0.0 112.231 173.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.6 -23.06 56.4 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.938 0.895 . . . . 0.0 111.63 174.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.479 HD13 ' HB1' ' A' ' 15' ' ' ALA . 9.1 mt -83.96 164.69 43.02 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 176.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 15' ' ' ALA . 71.5 Cg_endo -69.26 172.08 12.79 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 122.412 2.074 . . . . 0.0 111.975 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.81 -18.63 36.65 Favored 'Trans proline' 0 N--CA 1.48 0.728 0 C-N-CA 122.99 2.46 . . . . 0.0 112.627 176.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.531 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 28.9 tp10 -85.57 -24.73 27.1 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.791 175.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.863 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -48.04 -39.19 19.15 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 177.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.44 -36.98 79.82 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 113.682 -1.599 . . . . 0.0 113.323 174.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.539 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 10.5 t70 -51.46 -54.69 24.39 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.754 0.822 . . . . 0.0 110.088 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.778 ' HA ' HD12 ' A' ' 21' ' ' LEU . 18.8 m -57.91 -50.61 72.75 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 176.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.905 HD11 HG21 ' A' ' 92' ' ' ILE . 48.6 mt -52.38 -30.4 28.87 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 174.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -75.46 -38.43 59.66 Favored 'General case' 0 C--O 1.209 -1.061 0 CA-C-N 114.221 -1.354 . . . . 0.0 110.134 175.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.778 HD12 ' HA ' ' A' ' 18' ' ' THR . 24.6 mt -71.2 -32.27 68.63 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 118.983 -0.532 . . . . 0.0 110.537 175.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.668 HD12 ' O ' ' A' ' 18' ' ' THR . 1.6 mp -70.64 -39.58 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-N 120.382 1.447 . . . . 0.0 111.657 172.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.22 -42.49 59.67 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.574 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.53 7.98 38.74 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.296 1.039 . . . . 0.0 111.366 177.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.8 t70 41.13 50.46 3.29 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.616 1.166 . . . . 0.0 111.105 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.56 -168.61 48.1 Favored Glycine 0 CA--C 1.538 1.493 0 CA-C-N 114.216 -1.356 . . . . 0.0 115.211 -173.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -75.42 141.2 70.56 Favored 'Cis proline' 0 N--CA 1.49 1.296 0 O-C-N 125.001 2.053 . . . . 0.0 111.33 -0.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.495 ' HA ' HD22 ' A' ' 21' ' ' LEU . 29.2 m-85 -92.93 139.59 23.27 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 113.598 -1.637 . . . . 0.0 111.564 -177.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -75.2 -64.5 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.066 2.51 . . . . 0.0 110.788 -177.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.446 ' HD2' HG22 ' A' ' 56' ' ' THR . 1.6 m-30 -58.98 160.45 5.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.667 175.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.8 m -80.77 9.89 5.68 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 122.304 1.049 . . . . 0.0 112.608 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.431 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 1.0 OUTLIER -105.52 86.88 2.48 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 122.078 0.942 . . . . 0.0 110.837 -178.926 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 176.96 144.58 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 111.342 -2.663 . . . . 0.0 113.772 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.54 30.76 23.53 Favored Glycine 0 N--CA 1.478 1.487 0 O-C-N 126.199 2.187 . . . . 0.0 110.732 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.46 149.91 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.2 t -88.27 157.05 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 O-C-N 125.164 1.54 . . . . 0.0 110.039 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.532 ' CE1' ' HD3' ' A' ' 40' ' ' ARG . 22.3 t80 -135.39 93.79 3.02 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.314 175.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.42 ' HG3' ' CD1' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -70.88 53.86 0.16 Allowed 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 118.991 0.814 . . . . 0.0 112.309 178.623 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 26.96 54.36 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.863 2.465 . . . . 0.0 110.046 -176.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.532 ' HD3' ' CE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -57.54 -24.41 55.94 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 122.364 1.078 . . . . 0.0 111.232 -171.869 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.56 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.9 mt-10 -76.5 -11.48 59.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 112.66 -2.063 . . . . 0.0 114.168 173.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.1 t 43.81 39.85 2.8 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 124.9 2.286 . . . . 0.0 110.904 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 41' ' ' GLU . 20.0 t -107.69 -14.86 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 113.196 -1.82 . . . . 0.0 109.984 -178.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.77 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -103.48 150.67 38.27 Favored Pre-proline 0 C--O 1.244 0.784 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.225 -172.751 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.513 ' HD3' HG23 ' A' ' 2' ' ' VAL . 67.3 Cg_endo -75.03 55.46 3.97 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 123.415 2.743 . . . . 0.0 110.919 -178.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.815 HG22 ' H ' ' A' ' 47' ' ' GLN . 4.2 m -74.09 -162.87 0.16 Allowed 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.815 ' H ' HG22 ' A' ' 46' ' ' THR . 7.5 tt0 169.72 -40.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.941 1.697 . . . . 0.0 110.58 -176.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.8 p -113.95 162.96 15.75 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 123.068 1.413 . . . . 0.0 110.618 -177.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.42 ' CD1' ' HG3' ' A' ' 38' ' ' GLN . 8.7 t80 -91.7 138.55 31.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 112.958 -1.928 . . . . 0.0 110.801 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.76 12.0 80.79 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 114.394 -1.275 . . . . 0.0 112.14 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -87.17 15.9 5.72 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.596 0.759 . . . . 0.0 112.346 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.77 ' HE2' HD12 ' A' ' 44' ' ' LEU . 12.6 m-85 -150.64 145.5 25.9 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.057 -175.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -142.84 157.55 44.49 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 126.533 2.395 . . . . 0.0 111.147 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -111.11 147.47 34.79 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.054 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.479 ' HB3' HG23 ' A' ' 18' ' ' THR . 79.1 m-85 -160.99 63.73 0.29 Allowed 'General case' 0 CA--C 1.543 0.677 0 O-C-N 125.823 1.952 . . . . 0.0 110.289 -175.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 0.9 OUTLIER -39.04 127.27 1.65 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 122.088 0.947 . . . . 0.0 112.07 178.854 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.863 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -83.99 120.62 35.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 111.502 -2.59 . . . . 0.0 108.708 178.107 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.514 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 0.1 OUTLIER -45.76 165.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 124.593 1.183 . . . . 0.0 108.199 173.633 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.406 HG23 ' HD2' ' A' ' 60' ' ' PRO . 2.5 m -158.97 145.8 12.82 Favored Pre-proline 0 C--O 1.24 0.556 0 CA-C-N 112.86 -1.973 . . . . 0.0 112.841 177.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.406 ' HD2' HG23 ' A' ' 59' ' ' THR . 60.9 Cg_endo -73.01 149.79 47.41 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 121.99 1.793 . . . . 0.0 111.764 175.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.86 21.18 22.28 Favored Glycine 0 N--CA 1.483 1.811 0 O-C-N 125.185 1.553 . . . . 0.0 112.458 -175.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.45 86.25 7.33 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -45.15 -27.76 0.65 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 113.276 -1.784 . . . . 0.0 112.146 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.4 p -128.08 -163.24 1.25 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.639 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.431 ' HD2' ' OE1' ' A' ' 32' ' ' GLN . 2.7 mtm105 -56.62 -18.08 10.85 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 174.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.58 131.43 0.03 OUTLIER Glycine 0 N--CA 1.465 0.59 0 N-CA-C 107.274 -2.33 . . . . 0.0 107.274 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.581 HG22 ' HB2' ' A' ' 85' ' ' HIS . 17.6 p -44.37 -41.54 6.19 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 112.044 -2.078 . . . . 0.0 113.031 176.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.6 mtp85 -40.1 102.39 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 122.968 1.366 . . . . 0.0 113.172 173.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -128.05 136.43 51.22 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 112.207 -2.27 . . . . 0.0 109.002 -177.271 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.645 HG23 ' OD1' ' A' ' 79' ' ' ASP . 7.0 mt -105.67 140.99 22.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 112.413 -2.176 . . . . 0.0 108.818 176.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.454 ' HB ' ' HB2' ' A' ' 80' ' ' TYR . 23.3 mm -130.16 105.42 11.73 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 CA-C-N 113.268 -1.787 . . . . 0.0 108.384 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.419 HG22 ' HB2' ' A' ' 79' ' ' ASP . 10.7 p -92.46 163.8 13.7 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.211 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -110.9 -172.59 19.75 Favored Glycine 0 N--CA 1.471 1.024 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.681 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.1 -15.77 60.03 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.41 -0.895 . . . . 0.0 112.303 174.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.72 132.14 54.24 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.338 1.066 . . . . 0.0 108.514 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.417 HG22 ' CG ' ' A' ' 77' ' ' GLN . 23.5 m -59.3 152.3 21.33 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.086 -1.415 . . . . 0.0 108.618 176.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.417 ' CG ' HG22 ' A' ' 76' ' ' THR . 10.3 mt-30 71.46 32.16 2.14 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 123.523 1.63 . . . . 0.0 109.889 178.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.521 ' HA ' HD22 ' A' ' 91' ' ' LEU . 3.6 mt-10 -136.8 68.42 1.43 Allowed 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.847 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.7 ' OD2' HD21 ' A' ' 19' ' ' LEU . 3.6 t0 -111.31 129.8 55.87 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-N 113.192 -1.822 . . . . 0.0 107.718 176.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.454 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 14.4 m-85 -100.36 133.92 44.07 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 125.102 1.361 . . . . 0.0 109.919 175.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.589 ' HB2' HD11 ' A' ' 92' ' ' ILE . 9.2 t80 -111.75 127.41 55.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.458 -1.246 . . . . 0.0 108.961 -177.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.5 OUTLIER -91.03 -68.74 0.77 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 112.839 -1.982 . . . . 0.0 111.959 178.039 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.08 -11.15 50.29 Favored Glycine 0 CA--C 1.542 1.741 0 CA-C-N 113.346 -1.752 . . . . 0.0 112.675 -175.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.477 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 13.5 m-20 -111.37 6.39 20.36 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 175.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.581 ' HB2' HG22 ' A' ' 67' ' ' THR . 21.3 t-80 86.76 -16.98 0.38 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 116.051 -1.928 . . . . 0.0 113.177 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.1 m-30 160.6 51.25 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 128.455 3.597 . . . . 0.0 114.804 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.477 ' HB3' ' HB2' ' A' ' 84' ' ' ASP . . . -120.1 -44.86 2.48 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 119.406 -0.918 . . . . 0.0 112.913 177.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.478 ' O ' ' HB ' ' A' ' 82' ' ' THR . 22.4 p -127.43 168.29 15.07 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.67 -177.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.689 ' CG ' HD21 ' A' ' 44' ' ' LEU . 97.7 m-85 -159.29 115.73 2.61 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -173.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.1 m -135.34 113.81 11.6 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.423 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.521 HD22 ' HA ' ' A' ' 78' ' ' GLU . 29.7 mt -40.81 161.83 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.123 0 O-C-N 124.693 1.246 . . . . 0.0 111.452 177.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.905 HG21 HD11 ' A' ' 19' ' ' LEU . 1.3 mp -106.05 129.59 58.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 O-C-N 120.902 -1.123 . . . . 0.0 108.246 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.419 ' HB3' ' HB3' ' A' ' 96' ' ' CYS . 0.3 OUTLIER -102.68 92.25 4.54 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.65 -1.614 . . . . 0.0 108.021 177.082 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -55.93 -37.75 69.36 Favored 'General case' 0 N--CA 1.484 1.225 0 O-C-N 123.981 0.8 . . . . 0.0 112.253 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.9 t -57.96 -49.67 75.99 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.783 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 93' ' ' ASP . 21.0 t . . . . . 0 N--CA 1.476 0.874 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.873 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.4 p30 . . . . . 0 N--CA 1.476 0.864 0 CA-C-O 121.045 0.45 . . . . 0.0 111.494 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.623 HG23 ' HD3' ' A' ' 45' ' ' PRO . 12.1 t -48.88 141.16 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 m -81.52 22.81 0.68 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.499 1.12 . . . . 0.0 112.379 176.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.16 -154.06 20.11 Favored Glycine 0 N--CA 1.479 1.557 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.452 HG23 ' CB ' ' A' ' 91' ' ' LEU . 2.4 m -107.56 170.07 8.2 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.956 -1.122 . . . . 0.0 110.407 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -142.41 108.77 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -174.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 94.9 m -46.2 133.66 9.13 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 113.581 -1.645 . . . . 0.0 111.038 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -59.06 -32.44 69.77 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.638 -177.749 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.2 t -67.39 -27.79 67.39 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.612 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.28 -29.64 62.87 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.642 0.777 . . . . 0.0 111.61 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 11' ' ' LEU . 12.3 mt -81.37 161.72 61.19 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 176.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.35 168.25 18.36 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.999 2.466 . . . . 0.0 112.545 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.15 -23.11 39.88 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.236 1.957 . . . . 0.0 113.544 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -83.76 -4.39 58.6 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.884 0.874 . . . . 0.0 111.827 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.746 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -71.72 -49.32 40.39 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.793 0.837 . . . . 0.0 112.278 175.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.3 -25.88 37.05 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.579 174.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.516 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 45.6 t0 -53.46 -57.77 9.47 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 124.32 1.013 . . . . 0.0 110.408 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.743 ' HA ' HD12 ' A' ' 21' ' ' LEU . 8.4 m -56.28 -50.59 70.93 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 175.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.583 HD11 HG21 ' A' ' 92' ' ' ILE . 7.9 mt -55.1 -35.14 64.29 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.279 0.987 . . . . 0.0 111.734 178.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -67.65 -39.75 84.55 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 124.163 0.985 . . . . 0.0 110.769 173.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.743 HD12 ' HA ' ' A' ' 18' ' ' THR . 25.8 mt -68.7 -31.95 71.4 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 122.779 0.431 . . . . 0.0 111.088 175.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.465 HD12 ' O ' ' A' ' 18' ' ' THR . 3.7 mt -71.31 -42.86 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 120.103 1.32 . . . . 0.0 111.534 172.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.7 -41.43 75.41 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 124.39 1.056 . . . . 0.0 112.4 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.38 5.92 48.86 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.272 1.029 . . . . 0.0 111.419 177.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 t0 42.4 44.77 3.56 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.524 1.53 . . . . 0.0 111.685 -178.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.29 -166.78 29.74 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 112.834 -1.985 . . . . 0.0 115.265 -174.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -74.87 139.74 63.4 Favored 'Cis proline' 0 N--CA 1.481 0.758 0 O-C-N 124.275 1.671 . . . . 0.0 111.342 -2.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.439 ' CD2' ' HB3' ' A' ' 21' ' ' LEU . 61.3 m-85 -90.94 139.06 25.86 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 113.244 -1.798 . . . . 0.0 111.534 -176.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.456 ' HG2' ' CD1' ' A' ' 58' ' ' ILE . 37.3 Cg_endo -75.73 -63.13 0.03 OUTLIER 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.975 2.45 . . . . 0.0 111.474 -177.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -61.85 157.79 17.45 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.141 -0.482 . . . . 0.0 112.087 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.6 t -81.17 4.83 18.79 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 122.941 1.353 . . . . 0.0 112.101 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -104.86 86.56 2.48 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.232 1.015 . . . . 0.0 111.484 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 4.5 p-10 177.96 140.31 0.09 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 110.712 -2.949 . . . . 0.0 113.715 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.71 3.22 66.51 Favored Glycine 0 N--CA 1.484 1.883 0 CA-C-N 113.017 -1.902 . . . . 0.0 112.263 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.624 HG23 ' HB2' ' A' ' 54' ' ' GLU . 7.8 m -96.91 144.78 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.342 1.057 . . . . 0.0 110.257 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.2 t -79.63 155.69 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 O-C-N 126.089 2.118 . . . . 0.0 108.865 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.659 ' HE2' HD13 ' A' ' 44' ' ' LEU . 37.0 t80 -137.71 86.32 2.17 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.645 -1.616 . . . . 0.0 108.618 174.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -72.03 51.76 0.23 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.203 -1.56 . . . . 0.0 112.414 178.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.477 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 26.6 t30 28.83 53.61 0.08 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.682 1.193 . . . . 0.0 111.778 -172.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.497 ' HD3' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -56.14 -20.69 18.7 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 113.243 -1.799 . . . . 0.0 112.285 -177.95 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.585 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -83.87 -4.75 58.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 113.443 -1.708 . . . . 0.0 114.832 174.465 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.2 t 44.05 47.11 7.29 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 123.7 1.715 . . . . 0.0 112.688 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 41' ' ' GLU . 87.0 t -124.11 -6.96 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 113.4 -1.727 . . . . 0.0 111.199 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.659 HD13 ' HE2' ' A' ' 37' ' ' PHE . 1.9 mp -110.23 155.85 41.17 Favored Pre-proline 0 N--CA 1.475 0.789 0 O-C-N 121.41 -0.806 . . . . 0.0 112.994 176.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.623 ' HD3' HG23 ' A' ' 2' ' ' VAL . 96.8 Cg_endo -78.38 68.62 7.93 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.021 1.814 . . . . 0.0 109.749 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.796 HG22 ' H ' ' A' ' 47' ' ' GLN . 6.8 m -88.97 -163.43 0.99 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 112.947 -1.933 . . . . 0.0 107.131 178.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.796 ' H ' HG22 ' A' ' 46' ' ' THR . 2.0 tt0 173.53 -48.48 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.977 1.711 . . . . 0.0 109.896 -176.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.5 p -109.72 162.82 14.08 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.293 -175.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -93.85 127.18 39.46 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 112.956 -1.929 . . . . 0.0 110.976 -177.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.99 8.23 82.62 Favored Glycine 0 N--CA 1.479 1.532 0 CA-C-N 113.327 -1.76 . . . . 0.0 112.807 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.61 -1.64 22.51 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.794 0.838 . . . . 0.0 112.509 175.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.586 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 5.5 m-85 -136.63 171.23 14.81 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.029 1.332 . . . . 0.0 110.094 -177.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -161.01 163.71 31.48 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 113.257 -1.792 . . . . 0.0 110.382 -177.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.624 ' HB2' HG23 ' A' ' 35' ' ' VAL . 1.8 mt-10 -120.03 139.43 52.54 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.096 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.551 ' HB3' HG23 ' A' ' 18' ' ' THR . 58.4 m-85 -153.01 59.33 0.79 Allowed 'General case' 0 N--CA 1.471 0.603 0 O-C-N 126.187 2.179 . . . . 0.0 110.741 -174.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 58.5 m -36.69 116.14 0.41 Allowed 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 122.957 1.36 . . . . 0.0 112.519 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.746 HG21 ' HA ' ' A' ' 15' ' ' ALA . 1.9 p -81.65 110.82 17.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 111.021 -2.809 . . . . 0.0 109.443 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.456 ' CD1' ' HG2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -38.64 147.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 113.722 -1.581 . . . . 0.0 111.296 171.822 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.45 HG23 ' HD2' ' A' ' 60' ' ' PRO . 6.1 m -136.5 141.62 36.3 Favored Pre-proline 0 N--CA 1.468 0.453 0 O-C-N 125.772 1.92 . . . . 0.0 112.901 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.45 ' HD2' HG23 ' A' ' 59' ' ' THR . 72.0 Cg_endo -75.53 143.71 27.74 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 121.619 1.546 . . . . 0.0 109.963 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.82 29.32 54.59 Favored Glycine 0 CA--C 1.544 1.882 0 CA-C-N 113.867 -1.515 . . . . 0.0 112.033 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.87 89.89 4.75 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -43.33 -30.61 0.54 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 113.324 -1.762 . . . . 0.0 113.152 177.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.0 p -128.88 -170.78 2.33 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.889 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 -47.45 -27.32 1.66 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 174.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.11 144.96 0.12 Allowed Glycine 0 N--CA 1.464 0.522 0 N-CA-C 106.676 -2.57 . . . . 0.0 106.676 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.592 HG22 ' HB2' ' A' ' 85' ' ' HIS . 20.3 p -42.72 -29.05 0.28 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.247 -1.477 . . . . 0.0 114.673 173.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.427 ' HA ' ' HA2' ' A' ' 83' ' ' GLY . 1.0 OUTLIER -45.17 130.0 7.84 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.763 1.625 . . . . 0.0 111.574 170.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.439 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -164.81 136.49 4.32 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 111.864 -2.426 . . . . 0.0 109.339 -176.689 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.4 mt -111.99 142.7 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 125.933 2.021 . . . . 0.0 108.063 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.528 ' HB ' ' HB2' ' A' ' 80' ' ' TYR . 25.5 mm -131.1 128.78 62.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 111.703 -2.499 . . . . 0.0 108.019 178.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.5 p -104.86 163.87 12.2 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 122.238 -0.289 . . . . 0.0 111.33 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -110.5 -178.54 20.7 Favored Glycine 0 CA--C 1.537 1.41 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.58 -15.22 58.8 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 121.646 0.736 . . . . 0.0 111.937 176.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.23 129.78 55.66 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.66 HG22 ' HG2' ' A' ' 77' ' ' GLN . 16.0 m -54.54 145.88 17.67 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 114.122 -1.399 . . . . 0.0 107.611 175.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.66 ' HG2' HG22 ' A' ' 76' ' ' THR . 0.0 OUTLIER 81.8 33.34 0.1 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 126.705 2.002 . . . . 0.0 110.577 179.445 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.583 ' HA ' HD22 ' A' ' 91' ' ' LEU . 6.2 mt-10 -135.28 54.55 1.92 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 123.498 1.618 . . . . 0.0 112.407 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.704 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -101.24 80.96 2.16 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 113.479 -1.692 . . . . 0.0 108.837 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.528 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 12.2 m-85 -51.18 178.99 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 125.455 1.502 . . . . 0.0 110.401 173.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.549 ' HB2' HD11 ' A' ' 92' ' ' ILE . 1.7 t80 -167.03 128.03 1.58 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.595 -1.639 . . . . 0.0 110.441 -175.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.557 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -90.64 -70.07 0.7 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 112.588 -2.096 . . . . 0.0 112.0 175.138 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 68' ' ' ARG . . . 74.22 -5.69 25.81 Favored Glycine 0 CA--C 1.542 1.769 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.692 -175.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.521 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 30.6 m-20 -125.49 17.05 8.23 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.264 1.425 . . . . 0.0 113.7 176.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.592 ' HB2' HG22 ' A' ' 67' ' ' THR . 42.2 t-80 63.25 88.07 0.1 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.393 2.277 . . . . 0.0 111.496 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.418 ' H ' HG21 ' A' ' 82' ' ' THR . 4.1 m-85 49.57 26.36 1.72 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.053 -1.43 . . . . 0.0 113.997 -176.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.521 ' HB3' ' HB2' ' A' ' 84' ' ' ASP . . . -95.77 -22.08 17.74 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 120.76 -1.213 . . . . 0.0 111.731 -175.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.557 ' O ' ' HB ' ' A' ' 82' ' ' THR . 26.5 p -157.17 173.71 16.58 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.178 1.391 . . . . 0.0 108.494 -177.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.518 ' CD1' HD11 ' A' ' 44' ' ' LEU . 98.7 m-85 -155.52 118.63 4.34 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 -176.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 m -135.06 116.5 14.67 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.583 HD22 ' HA ' ' A' ' 78' ' ' GLU . 66.1 mt -47.81 164.93 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.775 0.83 . . . . 0.0 111.424 177.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.718 HG22 ' HG3' ' A' ' 94' ' ' GLN . 1.7 mp -112.62 107.41 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 121.207 -0.933 . . . . 0.0 109.304 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.446 ' HB3' ' HB2' ' A' ' 96' ' ' CYS . 0.1 OUTLIER -77.16 89.04 3.63 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.035 -1.439 . . . . 0.0 109.088 175.862 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.718 ' HG3' HG22 ' A' ' 92' ' ' ILE . 2.6 mt-30 -79.22 5.71 11.55 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 113.602 -1.635 . . . . 0.0 111.868 177.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.0 t -121.75 -0.98 9.53 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 126.036 1.734 . . . . 0.0 112.581 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 93' ' ' ASP . 42.7 t . . . . . 0 C--O 1.256 1.424 0 CA-C-O 116.268 -1.825 . . . . 0.0 112.888 178.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 p30 . . . . . 0 N--CA 1.473 0.701 0 CA-C-O 121.88 0.847 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.634 HG23 ' HD3' ' A' ' 45' ' ' PRO . 6.9 t -51.45 128.9 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.358 175.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 m -75.25 5.21 5.8 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 177.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.475 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 130.37 170.56 12.73 Favored Glycine 0 CA--C 1.536 1.365 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.436 HG22 ' H ' ' A' ' 6' ' ' VAL . 2.5 m -86.99 172.76 9.76 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.069 -1.065 . . . . 0.0 109.103 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.436 ' H ' HG22 ' A' ' 5' ' ' THR . 1.1 t -138.82 106.71 3.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 122.978 1.37 . . . . 0.0 107.869 -175.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.3 m -49.35 126.06 12.31 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 112.62 -2.082 . . . . 0.0 109.902 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 8' ' ' LEU . 14.4 tp -57.06 -34.18 67.99 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 118.938 -0.553 . . . . 0.0 111.353 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.7 t -62.21 -30.23 70.94 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.624 171.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.17 -27.81 53.86 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.64 0.776 . . . . 0.0 112.349 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.44 HD13 ' HB1' ' A' ' 15' ' ' ALA . 14.3 mt -75.4 160.8 78.92 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 174.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.437 ' HD2' HD22 ' A' ' 11' ' ' LEU . 72.2 Cg_endo -68.65 168.32 20.32 Favored 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 122.715 2.276 . . . . 0.0 112.201 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.09 -15.27 39.44 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.416 2.077 . . . . 0.0 113.087 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.43 ' O ' HG22 ' A' ' 57' ' ' VAL . 1.7 mt-10 -92.89 2.11 56.95 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.273 1.029 . . . . 0.0 111.843 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.759 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -77.95 -50.0 13.04 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.214 1.006 . . . . 0.0 112.169 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 0.4 OUTLIER -58.49 -22.2 54.25 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.217 174.121 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -51.26 -59.73 3.89 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.128 0.971 . . . . 0.0 110.306 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.68 HG21 ' O ' ' A' ' 55' ' ' TYR . 39.9 m -64.14 -44.66 91.49 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.523 178.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.541 ' CD2' HD13 ' A' ' 70' ' ' ILE . 0.5 OUTLIER -54.97 -33.48 62.43 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 175.314 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 16' ' ' THR . 4.0 t-20 -73.9 -38.63 64.3 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.995 174.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.54 HD12 ' HA ' ' A' ' 18' ' ' THR . 51.1 mt -69.12 -33.78 74.0 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 175.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.471 ' CD1' HG22 ' A' ' 18' ' ' THR . 3.9 mt -68.75 -41.91 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 123.365 0.666 . . . . 0.0 111.268 172.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.89 -43.76 64.87 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.468 1.105 . . . . 0.0 112.436 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.72 -10.1 59.65 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.058 1.343 . . . . 0.0 111.793 177.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.74 43.26 25.53 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 122.714 1.245 . . . . 0.0 110.718 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.67 -166.92 43.83 Favored Glycine 0 CA--C 1.541 1.676 0 CA-C-N 113.247 -1.797 . . . . 0.0 115.044 -175.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.51 140.5 67.63 Favored 'Cis proline' 0 CA--C 1.537 0.629 0 O-C-N 124.558 1.82 . . . . 0.0 111.058 -1.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.433 ' CD2' ' HB3' ' A' ' 21' ' ' LEU . 46.0 m-85 -90.95 136.55 27.43 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 112.996 -1.911 . . . . 0.0 111.185 -176.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.07 -62.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.188 2.592 . . . . 0.0 111.701 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -59.84 155.07 17.0 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.82 176.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.76 2.29 20.25 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 122.812 1.291 . . . . 0.0 112.313 175.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.4 78.53 2.7 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.622 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -178.48 142.37 0.24 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 112.069 -2.332 . . . . 0.0 113.871 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.14 30.94 12.7 Favored Glycine 0 CA--C 1.537 1.467 0 O-C-N 125.212 1.57 . . . . 0.0 111.645 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.522 HG23 ' HB2' ' A' ' 54' ' ' GLU . 22.2 m -124.26 146.03 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 113.982 -1.109 . . . . 0.0 109.591 178.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.7 t -84.06 156.32 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 125.743 1.902 . . . . 0.0 109.768 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.526 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 81.2 t80 -137.66 87.89 2.29 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 113.968 -1.469 . . . . 0.0 108.791 174.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.403 ' HG3' ' HA ' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -69.91 53.45 0.12 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.808 -1.183 . . . . 0.0 112.648 179.409 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.4 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 50.7 t30 29.21 51.19 0.06 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.418 1.487 . . . . 0.0 111.081 -173.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.46 ' HD3' ' CD1' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -58.15 -20.75 43.09 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.522 -175.519 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.7 mt-10 -84.31 -8.06 59.13 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 113.087 -1.869 . . . . 0.0 114.668 172.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.9 t 43.45 42.58 3.94 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 123.917 1.818 . . . . 0.0 112.135 -177.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 41' ' ' GLU . 86.3 t -112.39 -12.52 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 113.322 -1.763 . . . . 0.0 109.728 -178.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.511 HD21 ' CD1' ' A' ' 89' ' ' PHE . 0.4 OUTLIER -94.72 151.46 39.12 Favored Pre-proline 0 C--N 1.317 -0.814 0 O-C-N 120.979 -1.075 . . . . 0.0 108.436 -175.821 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.634 ' HD3' HG23 ' A' ' 2' ' ' VAL . 84.7 Cg_endo -75.82 51.25 3.0 Favored 'Trans proline' 0 N--CA 1.482 0.811 0 C-N-CA 122.948 2.432 . . . . 0.0 112.567 -177.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.48 HG22 ' H ' ' A' ' 47' ' ' GLN . 3.4 m -156.23 -142.86 0.11 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.48 ' H ' HG22 ' A' ' 46' ' ' THR . 25.8 tt0 164.94 -35.96 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 126.732 2.013 . . . . 0.0 110.959 -173.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.3 p -42.03 154.74 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 123.026 1.393 . . . . 0.0 113.077 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.403 ' HA ' ' HG3' ' A' ' 38' ' ' GLN . 10.9 t80 -99.76 132.04 45.36 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 113.471 -1.695 . . . . 0.0 109.847 -175.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.14 -8.63 44.36 Favored Glycine 0 N--CA 1.482 1.758 0 O-C-N 125.098 1.499 . . . . 0.0 113.301 177.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -75.77 0.45 17.9 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.267 1.027 . . . . 0.0 112.508 177.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.526 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 16.6 m-85 -136.95 165.38 26.13 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.47 1.108 . . . . 0.0 109.103 -177.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -159.66 158.86 32.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 112.647 -2.069 . . . . 0.0 111.463 -178.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.522 ' HB2' HG23 ' A' ' 35' ' ' VAL . 12.0 mt-10 -113.95 143.01 45.42 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.592 -178.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.68 ' O ' HG21 ' A' ' 18' ' ' THR . 76.8 m-85 -159.97 68.52 0.39 Allowed 'General case' 0 N--CA 1.475 0.796 0 O-C-N 126.244 2.215 . . . . 0.0 109.466 -174.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -36.86 141.51 0.12 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 176.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.759 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -97.77 115.45 37.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 112.9 -1.955 . . . . 0.0 109.385 175.609 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -43.17 151.31 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.662 170.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.458 HG23 ' HD2' ' A' ' 60' ' ' PRO . 2.4 m -150.23 140.84 14.32 Favored Pre-proline 0 N--CA 1.476 0.849 0 O-C-N 125.459 1.725 . . . . 0.0 111.733 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.458 ' HD2' HG23 ' A' ' 59' ' ' THR . 76.6 Cg_endo -73.72 147.14 39.47 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 121.622 1.548 . . . . 0.0 109.735 178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 52.48 34.96 43.32 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.023 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.65 92.67 6.33 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -42.0 -31.39 0.34 Allowed 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 113.641 -1.618 . . . . 0.0 113.323 176.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.5 p -123.36 -164.05 1.18 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.968 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -59.88 -14.0 13.39 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 173.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.62 146.01 3.72 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.214 -1.955 . . . . 0.0 108.214 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.547 HG22 ' HB2' ' A' ' 85' ' ' HIS . 41.0 p -69.93 -5.51 26.62 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 111.772 -2.214 . . . . 0.0 113.105 176.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.567 ' HD2' ' HA2' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -80.02 85.27 5.63 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 123.939 1.828 . . . . 0.0 110.384 178.777 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.84 142.58 34.14 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 112.581 -2.1 . . . . 0.0 109.342 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.592 HG23 ' OD1' ' A' ' 79' ' ' ASP . 9.6 mt -117.76 132.62 67.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 125.601 1.813 . . . . 0.0 109.404 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.477 ' O ' ' HD2' ' A' ' 80' ' ' TYR . 17.5 mm -125.82 106.67 16.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 O-C-N 125.27 1.606 . . . . 0.0 109.048 -176.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.437 HG21 HG21 ' A' ' 22' ' ' ILE . 0.9 OUTLIER -82.39 165.99 19.81 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.301 -0.874 . . . . 0.0 111.194 179.368 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -120.73 171.44 14.74 Favored Glycine 0 N--CA 1.469 0.881 0 CA-C-N 113.424 -1.717 . . . . 0.0 109.799 177.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.45 -14.54 61.17 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.756 0.789 . . . . 0.0 112.251 174.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.18 129.76 53.5 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 122.361 1.077 . . . . 0.0 108.233 174.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.568 HG22 ' HG2' ' A' ' 77' ' ' GLN . 3.1 m -61.87 142.55 57.3 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 113.833 -1.531 . . . . 0.0 107.575 175.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.568 ' HG2' HG22 ' A' ' 76' ' ' THR . 0.5 OUTLIER 77.78 29.36 0.51 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 126.618 1.967 . . . . 0.0 111.279 179.519 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -126.98 56.04 1.53 Allowed 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 123.083 1.421 . . . . 0.0 111.92 177.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.592 ' OD1' HG23 ' A' ' 70' ' ' ILE . 0.5 OUTLIER -99.63 119.59 38.33 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 113.267 -1.788 . . . . 0.0 109.287 178.346 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.477 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 36.5 m-85 -92.71 139.41 30.58 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.14 1.376 . . . . 0.0 108.943 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.643 ' HB2' HD11 ' A' ' 92' ' ' ILE . 27.8 t80 -118.43 121.48 40.41 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.665 -175.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.0 OUTLIER -80.88 -64.53 1.17 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 113.317 -1.765 . . . . 0.0 110.761 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.567 ' HA2' ' HD2' ' A' ' 68' ' ' ARG . . . 70.37 -6.04 6.28 Favored Glycine 0 CA--C 1.545 1.943 0 CA-C-N 114.886 -1.052 . . . . 0.0 113.104 -173.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.578 ' CB ' ' HB3' ' A' ' 87' ' ' ALA . 80.1 m-20 -126.58 6.19 6.85 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.547 ' HB2' HG22 ' A' ' 67' ' ' THR . 48.4 t-80 66.59 82.57 0.18 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 128.256 2.622 . . . . 0.0 110.374 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 57.28 17.69 3.82 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 113.428 -1.715 . . . . 0.0 114.247 -174.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.578 ' HB3' ' CB ' ' A' ' 84' ' ' ASP . . . -99.84 -3.54 32.37 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.177 -0.952 . . . . 0.0 112.595 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.411 ' O ' ' HB ' ' A' ' 82' ' ' THR . 2.2 p -167.75 168.85 12.15 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.016 1.727 . . . . 0.0 109.161 -176.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.511 ' CD1' HD21 ' A' ' 44' ' ' LEU . 80.2 m-85 -160.41 109.83 1.73 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.068 0.947 . . . . 0.0 108.972 -173.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.8 m -128.23 108.4 10.58 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.991 -176.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.424 ' CB ' HG23 ' A' ' 5' ' ' THR . 21.7 mt -42.73 161.14 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.643 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.4 mp -107.3 129.45 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 O-C-N 120.671 -1.268 . . . . 0.0 108.792 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 96' ' ' CYS . 0.3 OUTLIER -103.47 94.18 5.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.376 178.655 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.44 HE22 ' HB3' ' A' ' 77' ' ' GLN . 0.9 OUTLIER -68.92 -8.46 44.56 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 124.94 1.4 . . . . 0.0 112.524 178.614 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 t -93.18 -41.9 9.66 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 127.141 2.176 . . . . 0.0 113.1 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 93' ' ' ASP . 45.2 t . . . . . 0 C--O 1.25 1.105 0 CA-C-O 117.695 -1.145 . . . . 0.0 110.931 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.3 p30 . . . . . 0 N--CA 1.476 0.847 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.67 HG23 ' HD3' ' A' ' 45' ' ' PRO . 11.1 t -64.22 135.9 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.5 m -77.34 7.97 4.68 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 177.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.407 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 119.42 -172.49 14.71 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.27 1.414 . . . . 0.0 109.735 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -90.22 169.51 11.07 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 122.452 1.12 . . . . 0.0 109.735 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.635 HG13 HD11 ' A' ' 11' ' ' LEU . 4.9 p -143.12 112.0 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 114.222 -1.354 . . . . 0.0 108.285 -176.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 73.7 m -50.22 133.42 23.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 112.427 -2.169 . . . . 0.0 109.592 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.708 ' HA ' HD12 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -55.51 -35.92 66.13 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 119.156 -0.449 . . . . 0.0 111.933 179.688 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.1 t -69.0 -15.48 63.49 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.246 174.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.65 -33.27 35.76 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.396 0.678 . . . . 0.0 112.182 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.708 HD12 ' HA ' ' A' ' 8' ' ' LEU . 6.2 mt -83.64 176.41 3.81 Favored Pre-proline 0 CA--C 1.558 1.272 0 C-N-CA 125.72 1.608 . . . . 0.0 111.095 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 57.8 Cg_endo -65.51 167.12 17.66 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.285 1.99 . . . . 0.0 113.417 174.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -64.77 -21.4 64.76 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 C-N-CA 122.515 2.143 . . . . 0.0 113.064 174.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 5.0 tp10 -82.23 -19.25 40.07 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 175.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.832 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -52.11 -25.5 8.97 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 173.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.643 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -79.48 -33.98 41.79 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 172.547 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.633 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 11.4 t70 -49.83 -53.78 23.37 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.222 1.009 . . . . 0.0 110.059 -177.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.834 ' HA ' HD12 ' A' ' 21' ' ' LEU . 10.5 m -53.99 -52.46 60.69 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 174.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.646 HD11 HG21 ' A' ' 92' ' ' ILE . 9.6 mt -54.67 -37.61 65.97 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 124.624 1.202 . . . . 0.0 111.746 178.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -64.69 -38.01 89.53 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.629 0.772 . . . . 0.0 111.724 173.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.834 HD12 ' HA ' ' A' ' 18' ' ' THR . 12.8 mt -73.16 -32.87 65.14 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 118.518 -0.754 . . . . 0.0 111.312 176.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.61 HD12 ' O ' ' A' ' 18' ' ' THR . 2.1 mp -66.39 -39.35 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-N 120.37 1.441 . . . . 0.0 111.61 169.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.78 -48.42 46.69 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.198 0.999 . . . . 0.0 112.316 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 m -86.11 6.39 29.35 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.916 1.286 . . . . 0.0 113.547 175.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 43.74 36.0 1.18 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.333 1.453 . . . . 0.0 112.532 -174.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.96 -168.48 18.12 Favored Glycine 0 CA--C 1.542 1.773 0 CA-C-N 113.296 -1.774 . . . . 0.0 115.504 -175.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -75.0 138.29 55.21 Favored 'Cis proline' 0 N--CA 1.488 1.203 0 O-C-N 123.868 1.457 . . . . 0.0 111.412 -3.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.499 ' HA ' HD22 ' A' ' 21' ' ' LEU . 63.7 m-85 -85.83 149.79 51.67 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-N 113.02 -1.9 . . . . 0.0 112.461 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.97 -69.77 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 123.127 2.551 . . . . 0.0 111.717 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.576 ' CZ ' HG12 ' A' ' 58' ' ' ILE . 18.9 m-30 -74.45 168.84 18.92 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.56 0.744 . . . . 0.0 110.355 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.3 m -72.6 -3.87 27.41 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 122.138 0.971 . . . . 0.0 113.603 174.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -83.28 82.48 8.25 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.751 -1.113 . . . . 0.0 112.083 -178.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 179.0 145.64 0.15 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 110.393 -3.094 . . . . 0.0 116.117 -176.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.18 33.64 39.64 Favored Glycine 0 N--CA 1.473 1.135 0 CA-C-N 112.191 -2.277 . . . . 0.0 110.951 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.1 m -129.88 144.52 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 113.574 -1.313 . . . . 0.0 109.917 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.1 t -83.87 151.18 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 O-C-N 126.66 2.475 . . . . 0.0 109.76 176.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.402 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 41.0 t80 -128.92 95.7 4.16 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.004 173.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -74.13 52.03 0.44 Allowed 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.158 -0.964 . . . . 0.0 111.622 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 26.78 55.56 0.06 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.73 2.412 . . . . 0.0 111.684 -174.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.17 -22.59 41.51 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.26 -173.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.61 ' O ' HG23 ' A' ' 43' ' ' VAL . 13.5 mt-10 -75.84 -15.01 60.29 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 172.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.2 t 48.16 35.61 5.58 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 123.989 1.852 . . . . 0.0 112.336 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 41' ' ' GLU . 95.3 t -110.84 -14.47 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-O 123.368 1.556 . . . . 0.0 110.555 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.592 ' HB3' ' OH ' ' A' ' 52' ' ' TYR . 2.6 mm? -100.44 146.1 31.43 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-O 117.098 -1.43 . . . . 0.0 108.274 -174.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.67 ' HD3' HG23 ' A' ' 2' ' ' VAL . 92.4 Cg_endo -74.48 60.09 4.92 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.588 3.525 . . . . 0.0 112.121 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.723 HG22 ' H ' ' A' ' 47' ' ' GLN . 2.2 m -83.56 -171.5 3.62 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 112.244 -2.253 . . . . 0.0 107.626 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.723 ' H ' HG22 ' A' ' 46' ' ' THR . 36.1 tt0 176.99 -40.23 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 113.886 -1.506 . . . . 0.0 110.63 -173.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.9 p -118.94 161.95 19.33 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 122.849 1.309 . . . . 0.0 111.715 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -85.02 144.01 28.55 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 112.525 -2.125 . . . . 0.0 110.056 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.04 11.88 52.96 Favored Glycine 0 N--CA 1.483 1.773 0 CA-C-N 114.937 -1.028 . . . . 0.0 112.95 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.414 ' HA ' ' HB2' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -85.98 13.11 8.04 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.448 1.099 . . . . 0.0 112.54 -178.773 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.592 ' OH ' ' HB3' ' A' ' 44' ' ' LEU . 10.6 m-85 -151.39 148.48 28.17 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 125.33 1.452 . . . . 0.0 109.732 -173.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -145.11 159.91 42.24 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 125.417 1.698 . . . . 0.0 111.31 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.402 ' HG3' ' HB2' ' A' ' 37' ' ' PHE . 1.4 mt-10 -117.24 140.88 48.99 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.391 -177.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.423 ' HE2' ' HG1' ' A' ' 72' ' ' THR . 65.6 m-85 -157.96 67.96 0.49 Allowed 'General case' 0 C--O 1.239 0.517 0 O-C-N 125.696 1.872 . . . . 0.0 110.982 -173.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 52.8 m -41.95 119.16 1.26 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 123.563 1.649 . . . . 0.0 112.884 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.832 HG21 ' HA ' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -78.83 116.28 22.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 110.192 -3.185 . . . . 0.0 108.673 178.757 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.576 HG12 ' CZ ' ' A' ' 30' ' ' TYR . 4.4 mt -40.49 148.26 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-O 122.655 1.216 . . . . 0.0 108.642 174.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.9 m -133.1 138.93 32.82 Favored Pre-proline 0 C--O 1.24 0.558 0 CA-C-N 112.16 -2.291 . . . . 0.0 112.45 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.83 143.06 49.3 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.033 1.822 . . . . 0.0 109.943 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.47 30.19 40.94 Favored Glycine 0 CA--C 1.54 1.645 0 CA-C-N 114.313 -1.312 . . . . 0.0 113.113 -176.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.77 94.5 6.37 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -40.63 -35.16 0.44 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.336 176.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.8 p -127.17 -155.59 0.7 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.075 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.3 mtm180 -53.11 -23.87 9.03 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 170.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.76 156.5 0.33 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 -176.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 81.4 p -47.9 -29.35 3.25 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 112.901 -1.65 . . . . 0.0 112.518 173.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.533 ' HA ' ' HA2' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -47.15 139.28 6.13 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 122.199 0.999 . . . . 0.0 112.724 173.629 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -168.0 139.41 2.88 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 112.1 -2.318 . . . . 0.0 109.76 -176.731 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.8 mt -115.99 144.99 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 112.596 -2.093 . . . . 0.0 108.66 175.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' A' ' 80' ' ' TYR . 11.6 mm -131.49 121.36 48.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 O-C-N 126.319 2.262 . . . . 0.0 107.326 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.493 HG22 ' HB3' ' A' ' 79' ' ' ASP . 22.0 p -104.06 163.34 12.45 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.271 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -108.6 177.55 20.67 Favored Glycine 0 N--CA 1.477 1.406 0 O-C-N 125.211 1.569 . . . . 0.0 110.562 178.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -74.89 -14.91 60.71 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 122.124 0.964 . . . . 0.0 113.055 175.422 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -112.77 129.94 56.25 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 175.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.63 HG22 ' HG2' ' A' ' 77' ' ' GLN . 25.9 m -53.67 149.59 8.13 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 114.27 -1.332 . . . . 0.0 108.041 174.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.63 ' HG2' HG22 ' A' ' 76' ' ' THR . 0.1 OUTLIER 81.03 32.84 0.13 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 126.53 1.932 . . . . 0.0 111.425 179.802 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.582 ' HA ' HD22 ' A' ' 91' ' ' LEU . 10.0 mt-10 -139.17 51.73 1.78 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 123.764 1.745 . . . . 0.0 112.716 179.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.531 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -103.9 83.91 2.18 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 113.552 -1.658 . . . . 0.0 109.1 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.426 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 31.4 m-85 -56.02 173.67 0.15 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.912 1.685 . . . . 0.0 110.673 174.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.529 ' HB2' HD11 ' A' ' 92' ' ' ILE . 11.7 t80 -158.41 126.92 5.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.426 -176.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 88' ' ' THR 0.275 0.1 OUTLIER -91.73 -69.25 0.75 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 112.657 -2.065 . . . . 0.0 112.643 173.391 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' A' ' 68' ' ' ARG . . . 64.36 17.86 62.38 Favored Glycine 0 CA--C 1.54 1.617 0 CA-C-N 115.124 -0.944 . . . . 0.0 113.219 -173.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.504 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 38.0 t0 -148.0 26.19 1.0 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.732 1.213 . . . . 0.0 112.417 175.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 56.8 83.55 0.1 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.586 1.555 . . . . 0.0 110.968 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 47.97 51.17 14.85 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 113.333 -1.758 . . . . 0.0 114.681 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . . . -120.84 -35.88 3.26 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.175 -1.375 . . . . 0.0 113.948 -178.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.498 ' O ' ' HB ' ' A' ' 82' ' ' THR . 16.3 p -136.77 166.6 23.22 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.653 1.181 . . . . 0.0 108.095 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.431 ' CD1' HD21 ' A' ' 44' ' ' LEU . 94.9 m-85 -156.9 111.83 2.8 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -174.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.2 m -133.76 115.34 14.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.292 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.582 HD22 ' HA ' ' A' ' 78' ' ' GLU . 87.5 mt -46.31 160.77 0.06 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.721 0.808 . . . . 0.0 111.989 178.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.646 HG21 HD11 ' A' ' 19' ' ' LEU . 1.7 mp -109.52 127.37 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 120.667 -1.27 . . . . 0.0 109.433 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.45 95.22 5.67 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 113.567 -1.652 . . . . 0.0 108.985 175.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -58.95 -42.35 89.6 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 124.502 1.126 . . . . 0.0 111.55 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.2 t -50.91 -31.95 19.13 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.692 1.597 . . . . 0.0 113.446 171.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 19.1 t . . . . . 0 CA--C 1.554 1.126 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.795 177.35 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.427 ' N ' HG13 ' A' ' 43' ' ' VAL . 2.1 p30 . . . . . 0 N--CA 1.474 0.749 0 CA-C-O 122.04 0.924 . . . . 0.0 112.147 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.598 HG11 ' HG ' ' A' ' 91' ' ' LEU . 2.0 t -68.39 111.14 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.1 p -78.38 14.21 1.3 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 122.396 1.094 . . . . 0.0 113.487 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 120.83 -163.31 14.39 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.439 1.495 . . . . 0.0 109.719 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -100.98 171.06 7.87 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 112.63 -1.785 . . . . 0.0 109.741 -177.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 91' ' ' LEU . 9.8 p -142.27 107.22 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.627 -1.169 . . . . 0.0 107.947 -175.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.425 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 86.0 m -45.76 128.44 8.68 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 111.986 -2.37 . . . . 0.0 109.126 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.782 ' HA ' HD12 ' A' ' 11' ' ' LEU . 15.5 tp -53.16 -36.95 61.42 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.778 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -65.03 -19.72 66.14 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.984 172.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 7' ' ' CYS . . . -79.09 -31.88 44.47 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.197 0.522 . . . . 0.0 111.731 175.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.782 HD12 ' HA ' ' A' ' 8' ' ' LEU . 10.4 mt -83.5 173.55 7.27 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 125.26 1.424 . . . . 0.0 110.221 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 92.2 Cg_endo -70.3 169.38 19.73 Favored 'Trans proline' 0 CA--C 1.555 1.534 0 C-N-CA 122.008 1.805 . . . . 0.0 113.817 176.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.87 -15.99 40.91 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.745 2.297 . . . . 0.0 114.257 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.412 ' HG3' ' HA ' ' A' ' 59' ' ' THR . 10.8 pm0 -87.05 2.8 48.47 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.061 1.344 . . . . 0.0 113.306 175.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.519 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -76.48 -55.3 5.66 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.155 0.982 . . . . 0.0 111.585 176.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.664 ' OG1' HD21 ' A' ' 8' ' ' LEU . 0.5 OUTLIER -53.8 -29.11 38.97 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 114.827 -1.079 . . . . 0.0 112.363 174.175 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.556 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 44.6 t0 -51.12 -58.04 7.15 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 125.129 1.518 . . . . 0.0 110.514 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.738 ' HA ' HD12 ' A' ' 21' ' ' LEU . 18.0 m -55.26 -51.1 67.75 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.914 HD11 HG21 ' A' ' 92' ' ' ILE . 7.5 mt -56.7 -35.02 68.0 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 123.782 0.676 . . . . 0.0 112.678 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -66.95 -36.55 82.46 Favored 'General case' 0 C--O 1.217 -0.634 0 C-N-CA 124.478 1.111 . . . . 0.0 110.386 174.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.738 HD12 ' HA ' ' A' ' 18' ' ' THR . 33.2 mt -72.84 -32.67 65.63 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 119.025 -0.512 . . . . 0.0 111.137 175.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.698 HD12 ' O ' ' A' ' 18' ' ' THR . 1.7 mp -70.43 -40.34 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 120.325 1.42 . . . . 0.0 111.881 171.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.28 -42.16 65.87 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 124.602 1.189 . . . . 0.0 112.474 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.32 7.47 44.28 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.505 178.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 42.99 37.32 1.08 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 123.158 1.456 . . . . 0.0 112.539 -177.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.52 -167.26 17.57 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 112.959 -1.928 . . . . 0.0 116.036 -173.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -74.44 139.44 61.65 Favored 'Cis proline' 0 N--CA 1.488 1.154 0 O-C-N 123.917 1.483 . . . . 0.0 111.639 -2.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.51 ' CD2' ' HB3' ' A' ' 21' ' ' LEU . 65.3 m-85 -91.22 135.23 28.55 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.583 -177.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -76.45 -58.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.634 2.223 . . . . 0.0 111.936 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -66.13 159.56 25.92 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.102 0.561 . . . . 0.0 112.063 175.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.1 m -77.14 1.31 18.64 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 173.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.58 84.95 4.05 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 122.055 0.931 . . . . 0.0 111.489 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 178.2 147.72 0.16 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 110.665 -2.97 . . . . 0.0 115.113 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.94 30.81 37.29 Favored Glycine 0 N--CA 1.478 1.476 0 CA-C-N 112.373 -2.194 . . . . 0.0 110.997 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.1 146.76 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.468 1.107 . . . . 0.0 109.797 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.2 t -83.59 153.93 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 126.49 2.369 . . . . 0.0 110.299 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.519 ' CE1' ' HD3' ' A' ' 40' ' ' ARG . 29.3 t80 -129.39 94.31 3.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 113.557 -1.656 . . . . 0.0 109.44 175.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.497 ' HG3' ' CD1' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -73.1 50.14 0.27 Allowed 'General case' 0 N--CA 1.484 1.229 0 O-C-N 120.923 -1.111 . . . . 0.0 112.938 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.485 ' ND2' ' H ' ' A' ' 44' ' ' LEU . 17.8 t30 22.86 60.51 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.526 1.931 . . . . 0.0 111.611 -173.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.519 ' HD3' ' CE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -58.63 -25.5 62.76 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 113.477 -1.692 . . . . 0.0 111.389 -175.612 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.589 ' O ' HG23 ' A' ' 43' ' ' VAL . 1.4 mt-10 -75.46 -7.93 55.4 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.023 -1.444 . . . . 0.0 114.633 174.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.7 t 44.18 42.86 5.35 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 124.387 2.041 . . . . 0.0 112.188 -177.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 41' ' ' GLU . 65.8 t -110.76 -21.97 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 113.543 -1.662 . . . . 0.0 110.448 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.85 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -99.71 142.42 24.58 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.815 -173.218 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.36 68.23 6.86 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 121.288 1.326 . . . . 0.0 110.801 -177.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.766 HG22 ' H ' ' A' ' 47' ' ' GLN . 4.4 m -73.49 -166.11 0.32 Allowed 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 113.224 -1.807 . . . . 0.0 107.825 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.766 ' H ' HG22 ' A' ' 46' ' ' THR . 48.1 tt0 -179.84 -45.74 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.623 1.569 . . . . 0.0 110.642 -178.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.9 p -117.89 158.48 24.78 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.017 -1.447 . . . . 0.0 111.339 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.497 ' CD1' ' HG3' ' A' ' 38' ' ' GLN . 8.8 t80 -85.17 136.84 33.36 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 112.967 -1.924 . . . . 0.0 110.46 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.63 6.7 88.3 Favored Glycine 0 N--CA 1.478 1.474 0 CA-C-N 114.469 -1.241 . . . . 0.0 113.365 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -79.81 7.52 8.53 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.419 1.087 . . . . 0.0 112.824 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.85 ' HE2' HD12 ' A' ' 44' ' ' LEU . 13.2 m-85 -143.91 144.26 31.64 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -174.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -142.32 157.01 45.28 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 126.297 2.248 . . . . 0.0 110.29 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -113.48 143.71 44.05 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.863 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.421 ' HB3' HG23 ' A' ' 18' ' ' THR . 77.0 m-85 -159.26 70.47 0.48 Allowed 'General case' 0 N--CA 1.472 0.645 0 O-C-N 125.378 1.674 . . . . 0.0 111.043 -175.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 1.2 m -39.49 126.98 1.87 Allowed 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 122.332 1.063 . . . . 0.0 112.772 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.519 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.8 OUTLIER -70.12 108.18 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 111.632 -2.531 . . . . 0.0 108.468 176.402 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -39.37 153.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 CA-C-N 115.307 -0.86 . . . . 0.0 108.878 170.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.412 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 1.5 m -156.35 140.02 11.32 Favored Pre-proline 0 N--CA 1.48 1.052 0 O-C-N 125.658 1.849 . . . . 0.0 110.78 177.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.62 152.16 53.32 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.944 2.429 . . . . 0.0 110.18 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 52.41 26.71 23.24 Favored Glycine 0 N--CA 1.481 1.69 0 CA-C-N 113.993 -1.458 . . . . 0.0 112.144 -175.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.43 89.72 7.98 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -40.42 -31.83 0.16 Allowed 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 113.72 -1.582 . . . . 0.0 112.764 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.4 p -134.23 -145.11 0.23 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.618 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 60.3 mtm180 -72.81 -18.67 61.44 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 173.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.08 142.61 0.02 OUTLIER Glycine 0 CA--C 1.531 1.053 0 N-CA-C 108.929 -1.669 . . . . 0.0 108.929 -175.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.2 p -41.85 -32.43 0.41 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 113.887 -1.157 . . . . 0.0 114.057 174.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.406 ' HG3' ' OH ' ' A' ' 81' ' ' TYR . 2.8 mpt_? -44.58 120.02 2.1 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 122.723 1.249 . . . . 0.0 112.461 170.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.477 ' HB3' HG23 ' A' ' 82' ' ' THR . 1.6 tpt180 -149.26 128.46 12.84 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 112.337 -2.21 . . . . 0.0 109.048 -178.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.423 HD12 HG23 ' A' ' 57' ' ' VAL . 3.2 mt -103.79 143.47 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 113.646 -1.615 . . . . 0.0 108.965 173.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.743 HD11 ' HE1' ' A' ' 86' ' ' TYR . 13.8 mm -129.84 102.55 7.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 112.777 -2.011 . . . . 0.0 108.35 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.675 HG22 ' HB3' ' A' ' 79' ' ' ASP . 24.9 p -94.71 165.19 12.62 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.655 0.741 . . . . 0.0 110.371 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -118.88 167.54 13.14 Favored Glycine 0 N--CA 1.473 1.162 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.231 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -61.61 -19.05 61.81 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.579 0.704 . . . . 0.0 111.886 174.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.78 129.56 49.47 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.013 175.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.563 HG22 ' HG2' ' A' ' 77' ' ' GLN . 19.2 m -60.04 144.17 50.1 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 114.114 -1.403 . . . . 0.0 107.311 175.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.563 ' HG2' HG22 ' A' ' 76' ' ' THR . 1.6 mt-30 80.46 33.19 0.16 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 126.82 2.048 . . . . 0.0 111.696 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.411 ' HA ' HD22 ' A' ' 91' ' ' LEU . 23.9 mt-10 -134.55 52.65 2.04 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 113.51 -1.677 . . . . 0.0 112.994 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.675 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.4 OUTLIER -107.95 94.29 4.99 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 113.648 -1.614 . . . . 0.0 110.062 -178.557 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.502 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 12.0 m-85 -82.74 129.07 34.91 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 125.017 1.327 . . . . 0.0 109.642 -177.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.864 ' HB2' HD11 ' A' ' 92' ' ' ILE . 64.2 t80 -113.66 136.61 52.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.103 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.545 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.6 OUTLIER -95.43 -67.27 0.86 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 112.196 -2.275 . . . . 0.0 112.001 176.137 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.88 -0.95 26.37 Favored Glycine 0 CA--C 1.549 2.21 0 CA-C-N 114.031 -1.441 . . . . 0.0 113.496 -174.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.555 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 80.1 m-20 -127.98 17.17 6.74 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 175.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 63.13 86.25 0.12 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.666 1.986 . . . . 0.0 111.12 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.743 ' HE1' HD11 ' A' ' 71' ' ' ILE . 6.1 m-30 49.48 30.56 3.48 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 113.944 -1.48 . . . . 0.0 114.776 -176.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.555 ' HB3' ' HB2' ' A' ' 84' ' ' ASP . . . -99.74 -18.78 17.07 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.733 -0.787 . . . . 0.0 112.561 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.545 ' O ' ' HB ' ' A' ' 82' ' ' THR . 25.2 p -158.93 171.06 20.73 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.623 1.569 . . . . 0.0 108.868 -177.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.577 ' CG ' HD21 ' A' ' 44' ' ' LEU . 94.0 m-85 -157.15 116.54 3.38 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.157 0.983 . . . . 0.0 108.818 -174.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.61 109.91 7.86 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 113.583 -1.644 . . . . 0.0 106.93 -178.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.598 ' HG ' HG11 ' A' ' 2' ' ' VAL . 52.2 mt -41.75 158.81 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.653 177.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.914 HG21 HD11 ' A' ' 19' ' ' LEU . 1.7 mp -112.92 121.86 65.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 120.789 -1.194 . . . . 0.0 109.218 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.27 96.76 7.67 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 113.226 -1.806 . . . . 0.0 108.78 176.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -60.86 -39.2 88.26 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 124.879 1.362 . . . . 0.0 111.803 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.7 t -52.54 -32.01 38.56 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.068 -1.423 . . . . 0.0 113.533 172.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 19.9 t . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.407 176.743 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.415 ' N ' HG13 ' A' ' 43' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.471 0.625 0 CA-C-O 122.031 0.919 . . . . 0.0 111.91 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.474 HG11 ' HG ' ' A' ' 91' ' ' LEU . 2.1 t -74.22 116.16 16.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 113.745 -1.57 . . . . 0.0 107.327 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.81 7.9 5.26 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.682 1.239 . . . . 0.0 112.196 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.22 -166.73 21.48 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.001 1.286 . . . . 0.0 110.471 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 6' ' ' VAL . 3.3 m -101.64 172.91 6.67 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.231 -1.484 . . . . 0.0 108.942 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.411 ' H ' HG22 ' A' ' 5' ' ' THR . 0.7 OUTLIER -142.27 107.69 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 -175.217 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 88.5 m -47.1 132.48 12.2 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 112.92 -1.946 . . . . 0.0 109.586 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.423 HD11 ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -55.55 -33.61 64.0 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.962 -178.208 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.0 t -64.82 -28.86 69.84 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.634 173.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.46 -31.49 62.26 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.605 0.762 . . . . 0.0 111.194 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.413 HD11 HD11 ' A' ' 92' ' ' ILE . 12.4 mt -74.63 162.26 74.42 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 175.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.41 ' HD2' HD22 ' A' ' 11' ' ' LEU . 59.4 Cg_endo -68.65 167.51 22.62 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.567 2.178 . . . . 0.0 111.948 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.86 -16.14 32.92 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.837 2.358 . . . . 0.0 112.632 177.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.423 ' CD ' ' HD3' ' A' ' 60' ' ' PRO . 1.7 mt-10 -93.71 -2.57 53.65 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.324 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.94 -39.43 18.16 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.757 175.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.423 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -60.82 -28.75 69.03 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.195 175.037 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.463 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 18.1 t0 -54.24 -51.94 62.89 Favored 'General case' 0 C--O 1.213 -0.835 0 O-C-N 124.881 1.363 . . . . 0.0 110.146 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.669 ' OG1' HG12 ' A' ' 57' ' ' VAL . 28.2 m -64.06 -49.26 73.02 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.572 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.593 HD21 HD13 ' A' ' 70' ' ' ILE . 19.6 mt -53.52 -31.41 46.09 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.972 0.795 . . . . 0.0 112.529 175.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -71.93 -42.44 66.64 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.373 173.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.648 HD12 ' HA ' ' A' ' 18' ' ' THR . 33.8 mt -67.79 -35.59 78.93 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.993 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.564 HD12 ' O ' ' A' ' 18' ' ' THR . 2.1 mt -65.64 -40.03 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 119.73 1.15 . . . . 0.0 110.806 172.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.75 -46.34 46.44 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 124.043 0.839 . . . . 0.0 111.9 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.78 -1.18 37.57 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.327 1.051 . . . . 0.0 111.413 176.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 49.48 39.25 16.28 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 122.555 1.169 . . . . 0.0 110.913 -178.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.57 -169.34 37.25 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-N 113.66 -1.609 . . . . 0.0 115.23 -174.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -75.15 140.73 68.78 Favored 'Cis proline' 0 CA--C 1.535 0.546 0 O-C-N 124.911 2.006 . . . . 0.0 111.51 -0.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.427 ' CD2' ' HB3' ' A' ' 21' ' ' LEU . 20.9 m-85 -89.51 137.6 28.79 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 113.32 -1.764 . . . . 0.0 111.034 -176.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -74.29 -62.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.528 2.819 . . . . 0.0 111.296 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.528 ' CE2' HG13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -56.18 155.57 6.52 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.964 0.79 . . . . 0.0 110.604 177.712 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.31 7.13 14.77 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 122.186 0.993 . . . . 0.0 111.592 175.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.31 82.56 1.76 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 122.081 0.943 . . . . 0.0 111.558 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -179.22 146.03 0.28 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 112.616 -2.084 . . . . 0.0 112.972 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.39 36.1 10.04 Favored Glycine 0 N--CA 1.484 1.879 0 O-C-N 126.312 2.257 . . . . 0.0 110.756 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.9 m -135.58 151.03 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 114.388 -0.906 . . . . 0.0 109.216 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.3 t -86.86 157.46 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 125.619 1.825 . . . . 0.0 109.534 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.536 ' CE2' ' HA ' ' A' ' 39' ' ' ASN . 79.4 t80 -136.08 88.97 2.43 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 113.695 -1.593 . . . . 0.0 108.713 177.065 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -72.24 51.29 0.24 Allowed 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.313 -0.867 . . . . 0.0 111.683 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.536 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 33.2 t30 25.32 57.42 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.977 2.111 . . . . 0.0 110.667 -173.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -21.43 22.44 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 113.265 -1.789 . . . . 0.0 111.406 -177.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.666 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.0 mt-10 -83.71 -4.72 58.85 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 114.074 -1.421 . . . . 0.0 113.894 174.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.416 ' HA ' ' ND2' ' A' ' 39' ' ' ASN . 41.3 t 43.02 46.36 4.74 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 124.535 2.112 . . . . 0.0 112.623 -177.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 41' ' ' GLU . 88.0 t -115.73 -23.82 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 113.989 -1.46 . . . . 0.0 109.687 -176.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.6 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.6 OUTLIER -99.67 138.27 20.38 Favored Pre-proline 0 N--CA 1.471 0.598 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.98 -175.221 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.06 69.47 6.32 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 121.538 1.492 . . . . 0.0 110.065 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.717 HG22 ' CZ ' ' A' ' 52' ' ' TYR . 42.4 p -66.5 -153.56 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 113.061 -1.881 . . . . 0.0 108.236 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 177.34 -43.38 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 122.204 1.002 . . . . 0.0 110.294 178.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.7 p -124.28 160.59 27.66 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 113.866 -1.515 . . . . 0.0 111.036 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -82.46 145.22 29.95 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 113.098 -1.864 . . . . 0.0 109.075 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.71 10.98 56.48 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.743 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.96 10.17 10.51 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.485 1.114 . . . . 0.0 112.274 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.717 ' CZ ' HG22 ' A' ' 46' ' ' THR . 10.1 m-85 -144.0 143.52 31.25 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -175.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -144.07 155.69 44.07 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 126.395 2.309 . . . . 0.0 110.857 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -110.22 142.27 42.03 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.68 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.592 ' O ' HG21 ' A' ' 18' ' ' THR . 76.9 m-85 -155.66 64.16 0.6 Allowed 'General case' 0 N--CA 1.467 0.388 0 O-C-N 125.796 1.935 . . . . 0.0 110.462 -176.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.552 HG21 ' CG ' ' A' ' 65' ' ' ARG . 0.3 OUTLIER -41.44 136.32 1.79 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 122.322 1.058 . . . . 0.0 112.911 178.941 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.669 HG12 ' OG1' ' A' ' 18' ' ' THR . 9.7 m -95.55 117.43 39.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 112.18 -2.282 . . . . 0.0 108.082 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.528 HG13 ' CE2' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -42.86 149.02 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 O-C-N 125.527 1.767 . . . . 0.0 109.949 173.856 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.453 HG23 ' HD2' ' A' ' 60' ' ' PRO . 8.3 m -139.96 142.3 30.21 Favored Pre-proline 0 N--CA 1.48 1.052 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.414 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.453 ' HD2' HG23 ' A' ' 59' ' ' THR . 57.2 Cg_endo -76.01 145.49 28.16 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.066 1.844 . . . . 0.0 109.916 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.87 25.13 44.12 Favored Glycine 0 CA--C 1.542 1.767 0 CA-C-N 114.061 -1.427 . . . . 0.0 112.274 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.98 90.96 5.76 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -38.4 -33.87 0.11 Allowed 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.359 177.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.4 p -140.32 -148.77 0.26 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.143 -1.39 . . . . 0.0 109.077 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.552 ' CG ' HG21 ' A' ' 56' ' ' THR . 5.0 ttp180 -69.71 -6.85 34.57 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 174.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.23 -129.15 13.37 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.212 1.387 . . . . 0.0 109.635 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.573 HG22 ' HB2' ' A' ' 85' ' ' HIS . 22.0 p -112.72 -34.13 5.9 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 112.26 -1.97 . . . . 0.0 113.384 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -41.33 133.29 2.47 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.277 -1.329 . . . . 0.0 111.581 174.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.44 141.54 3.66 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 112.5 -2.137 . . . . 0.0 110.869 -176.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.66 HD12 HG11 ' A' ' 57' ' ' VAL . 1.0 OUTLIER -120.42 133.31 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 126.72 2.512 . . . . 0.0 109.165 176.877 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.461 ' O ' ' HD2' ' A' ' 80' ' ' TYR . 13.3 mm -122.52 101.47 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 113.25 -1.796 . . . . 0.0 107.857 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.508 HG22 ' HB3' ' A' ' 79' ' ' ASP . 12.7 p -87.43 161.92 17.58 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.635 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -108.12 -176.51 22.12 Favored Glycine 0 N--CA 1.471 0.97 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.303 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.3 -11.45 59.94 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.404 175.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -122.05 131.55 54.04 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.599 HG22 ' HG2' ' A' ' 77' ' ' GLN . 23.9 m -51.12 149.24 3.86 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.624 176.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.599 ' HG2' HG22 ' A' ' 76' ' ' THR . 2.6 mt-30 83.59 33.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 125.505 1.753 . . . . 0.0 110.467 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -140.86 49.29 1.68 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.133 -1.394 . . . . 0.0 113.038 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.614 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -105.47 90.7 3.49 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.458 -178.212 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.461 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 22.0 m-85 -75.28 131.93 40.67 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.144 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.709 ' HB2' HD11 ' A' ' 92' ' ' ILE . 4.9 t80 -114.02 128.5 56.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.941 -177.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.548 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.5 OUTLIER -90.0 -67.97 0.81 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.122 178.481 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.81 2.95 19.34 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-N 113.897 -1.502 . . . . 0.0 113.077 -173.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.533 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 50.6 t0 -130.55 14.73 5.47 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.666 0.786 . . . . 0.0 112.118 175.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.573 ' HB2' HG22 ' A' ' 67' ' ' THR . 34.4 t-80 64.1 85.83 0.13 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.071 1.748 . . . . 0.0 111.044 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.436 ' HB3' ' CD ' ' A' ' 41' ' ' GLU . 6.6 m-85 50.2 28.62 3.2 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 114.274 -1.33 . . . . 0.0 114.398 -177.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.533 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . . . -105.77 -19.37 13.77 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.296 -1.32 . . . . 0.0 111.256 -175.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.548 ' O ' ' HB ' ' A' ' 82' ' ' THR . 15.7 p -153.59 169.01 24.29 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.327 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.584 ' CD1' HD21 ' A' ' 44' ' ' LEU . 90.0 m-85 -158.45 113.16 2.56 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -173.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -132.35 105.05 7.06 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 113.968 -1.469 . . . . 0.0 107.328 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.474 ' HG ' HG11 ' A' ' 2' ' ' VAL . 23.0 mt -41.04 163.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.62 177.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.709 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.7 mp -112.99 135.78 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 120.383 -1.448 . . . . 0.0 109.738 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -113.74 92.33 3.95 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 113.906 -1.497 . . . . 0.0 108.765 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.05 -37.11 85.9 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.236 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 t -54.61 -24.67 22.39 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 114.484 -1.235 . . . . 0.0 113.414 171.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 5.6 t . . . . . 0 C--O 1.261 1.7 0 CA-C-O 117.624 -1.179 . . . . 0.0 111.118 175.71 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.5 p30 . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.443 HG23 ' HD3' ' A' ' 45' ' ' PRO . 6.9 t -45.06 130.59 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.209 1.004 . . . . 0.0 108.671 177.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.17 8.1 4.35 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 124.886 1.366 . . . . 0.0 113.099 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 121.04 -162.56 14.73 Favored Glycine 0 N--CA 1.478 1.44 0 C-N-CA 125.499 1.523 . . . . 0.0 109.653 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 m -103.49 170.13 8.13 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 113.765 -1.217 . . . . 0.0 109.455 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 p -141.33 113.94 4.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -176.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.5 m -50.77 132.82 26.51 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 112.149 -2.296 . . . . 0.0 110.132 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.495 HD11 ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -59.56 -31.75 69.71 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.921 -178.143 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.0 t -64.63 -29.49 70.5 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.083 0.953 . . . . 0.0 113.224 173.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.38 -24.47 54.12 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.844 174.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 11' ' ' LEU . 8.6 mt -83.4 160.58 59.15 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 176.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.526 ' HG2' ' HB2' ' A' ' 15' ' ' ALA . 57.9 Cg_endo -66.42 166.17 22.52 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.546 2.164 . . . . 0.0 113.123 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -67.42 -35.43 23.5 Favored 'Trans proline' 0 N--CA 1.485 1.001 0 C-N-CA 122.572 2.182 . . . . 0.0 112.292 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.463 ' HB3' HG22 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -76.35 -8.77 57.81 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.512 179.085 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.526 ' HB2' ' HG2' ' A' ' 12' ' ' PRO . . . -68.61 -43.45 76.39 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.867 0.867 . . . . 0.0 112.013 172.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.495 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -63.13 -32.98 74.49 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.156 174.951 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.508 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 22.6 t0 -50.01 -49.12 51.8 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.019 0.928 . . . . 0.0 110.262 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.652 ' HA ' HD12 ' A' ' 21' ' ' LEU . 7.7 m -58.99 -50.52 73.78 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.567 HD21 ' OD2' ' A' ' 79' ' ' ASP . 39.0 mt -51.81 -32.79 32.97 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 175.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.01 -43.97 64.19 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.225 1.01 . . . . 0.0 111.858 172.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.671 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 68.4 mt -65.16 -34.32 78.1 Favored 'General case' 0 C--O 1.211 -0.946 0 C-N-CA 123.768 0.827 . . . . 0.0 112.092 176.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.525 HD13 HG21 ' A' ' 72' ' ' THR . 5.6 mt -67.87 -42.52 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 120.567 -1.333 . . . . 0.0 111.55 171.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.76 -47.69 62.05 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 124.29 0.994 . . . . 0.0 112.682 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 m -84.87 5.93 26.84 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.63 1.172 . . . . 0.0 113.904 175.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 44.78 39.92 3.85 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.926 1.29 . . . . 0.0 112.025 -177.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.71 -164.28 14.57 Favored Glycine 0 CA--C 1.541 1.718 0 C-N-CA 125.572 1.558 . . . . 0.0 114.461 -174.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.21 135.66 41.29 Favored 'Cis proline' 0 N--CA 1.485 0.996 0 CA-C-O 122.927 1.136 . . . . 0.0 110.947 -2.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.671 ' CE1' ' HB3' ' A' ' 21' ' ' LEU . 79.7 m-85 -85.0 153.41 60.05 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 111.509 -2.587 . . . . 0.0 111.879 -176.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.535 ' HG3' HD12 ' A' ' 58' ' ' ILE . 56.0 Cg_endo -71.28 -59.13 0.07 OUTLIER 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.111 1.874 . . . . 0.0 113.409 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.521 ' CZ ' HG22 ' A' ' 56' ' ' THR . 0.1 OUTLIER -118.02 -179.97 3.92 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.452 1.501 . . . . 0.0 110.547 -179.445 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.0 m -68.0 -8.5 37.95 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 175.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.638 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 11.7 mt-30 -73.74 54.04 0.47 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 122.741 1.258 . . . . 0.0 113.238 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 0.8 OUTLIER 172.67 127.39 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 111.81 -2.45 . . . . 0.0 113.432 -176.24 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.25 -14.61 20.93 Favored Glycine 0 N--CA 1.482 1.746 0 CA-C-N 113.698 -1.592 . . . . 0.0 112.535 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.712 HG22 ' CD ' ' A' ' 54' ' ' GLU . 2.1 m -90.79 150.39 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-O 121.896 0.855 . . . . 0.0 109.908 176.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.6 t -75.01 155.51 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 114.172 -1.377 . . . . 0.0 110.39 175.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.465 ' CE1' ' HD3' ' A' ' 40' ' ' ARG . 65.1 t80 -128.11 93.34 3.64 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 113.402 -1.726 . . . . 0.0 109.69 175.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.407 ' HG3' ' CD1' ' A' ' 49' ' ' TYR . 1.3 tm0? -71.29 47.8 0.12 Allowed 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.699 1.238 . . . . 0.0 112.984 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.441 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 35.8 t30 29.49 56.32 0.14 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.188 1.395 . . . . 0.0 111.151 -173.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.465 ' HD3' ' CE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -55.31 -30.06 59.47 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.853 -175.164 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.583 ' O ' HG23 ' A' ' 43' ' ' VAL . 1.3 mt-10 -75.97 -7.46 54.67 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 112.924 -1.944 . . . . 0.0 114.646 175.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.8 t 45.56 37.85 3.47 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 123.482 1.611 . . . . 0.0 112.292 -176.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 41' ' ' GLU . 70.8 t -109.55 -20.0 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.938 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.609 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.3 OUTLIER -93.52 152.53 41.0 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.172 -173.772 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.443 ' HD3' HG23 ' A' ' 2' ' ' VAL . 78.2 Cg_endo -68.88 -165.13 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 121.058 1.172 . . . . 0.0 109.581 178.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m 67.67 -68.14 0.17 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.49 1.516 . . . . 0.0 113.008 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 83.25 -23.26 0.2 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 128.475 2.71 . . . . 0.0 112.837 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.5 p -50.45 158.92 0.55 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 123.549 1.642 . . . . 0.0 110.925 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.407 ' CD1' ' HG3' ' A' ' 38' ' ' GLN . 3.8 t80 -103.4 135.11 45.62 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 112.851 -1.977 . . . . 0.0 110.579 -175.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.62 -21.67 24.84 Favored Glycine 0 CA--C 1.542 1.73 0 CA-C-N 114.361 -1.29 . . . . 0.0 113.135 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -71.15 -7.54 47.35 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.568 1.147 . . . . 0.0 113.751 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.609 ' HE2' HD12 ' A' ' 44' ' ' LEU . 21.9 m-85 -119.91 162.85 18.46 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 125.515 1.526 . . . . 0.0 109.327 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -160.19 165.56 31.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 112.678 -2.056 . . . . 0.0 110.715 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.712 ' CD ' HG22 ' A' ' 35' ' ' VAL . 1.5 pm0 -120.42 152.27 38.17 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.786 0.834 . . . . 0.0 109.461 -177.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.412 ' CB ' HG23 ' A' ' 18' ' ' THR . 48.3 m-85 -163.12 66.39 0.19 Allowed 'General case' 0 N--CA 1.473 0.708 0 O-C-N 123.982 0.801 . . . . 0.0 109.646 -178.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.638 ' HB ' ' HB3' ' A' ' 32' ' ' GLN . 0.9 OUTLIER -38.78 135.24 0.87 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.45 -0.781 . . . . 0.0 112.887 177.715 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.453 HG11 ' HA ' ' A' ' 15' ' ' ALA . 26.8 m -91.66 123.53 43.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 112.539 -2.119 . . . . 0.0 109.212 178.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.535 HD12 ' HG3' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -51.74 159.12 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 113.83 -1.532 . . . . 0.0 110.189 173.125 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.4 m -153.61 141.61 13.88 Favored Pre-proline 0 N--CA 1.475 0.793 0 O-C-N 124.625 1.203 . . . . 0.0 110.762 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.07 141.59 33.08 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 121.765 1.643 . . . . 0.0 110.676 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.7 26.94 65.62 Favored Glycine 0 CA--C 1.54 1.635 0 CA-C-N 114.022 -1.444 . . . . 0.0 112.857 -174.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.21 91.59 6.75 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 177.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -42.45 -30.96 0.37 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.516 -1.22 . . . . 0.0 113.448 176.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 59.3 p -128.22 -113.41 0.27 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 113.814 -1.539 . . . . 0.0 109.166 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -115.51 -12.47 11.66 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.78 1.632 . . . . 0.0 111.563 177.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.98 167.34 7.35 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 123.722 1.734 . . . . 0.0 110.441 -176.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.431 HG22 ' HB2' ' A' ' 85' ' ' HIS . 42.5 p -74.43 -6.63 49.33 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 112.349 -1.926 . . . . 0.0 112.941 176.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.437 ' HD2' ' HA2' ' A' ' 83' ' ' GLY . 0.1 OUTLIER -68.73 134.61 50.05 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 120.927 -1.108 . . . . 0.0 109.816 176.199 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.461 ' NH1' ' HG2' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -159.79 139.96 11.78 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.139 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.524 HG23 ' OD1' ' A' ' 79' ' ' ASP . 3.1 mt -113.97 139.22 40.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 O-C-N 125.223 1.577 . . . . 0.0 108.808 176.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 70' ' ' ILE . 20.5 mm -129.25 106.42 13.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 O-C-N 125.287 1.617 . . . . 0.0 108.582 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.525 HG21 HD13 ' A' ' 22' ' ' ILE . 7.9 p -94.69 162.83 13.62 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.436 -0.79 . . . . 0.0 110.937 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.32 -175.19 21.26 Favored Glycine 0 CA--C 1.538 1.477 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.832 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.66 -14.62 62.1 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.955 0.883 . . . . 0.0 112.896 175.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.28 128.6 55.2 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.428 HG22 ' HG2' ' A' ' 77' ' ' GLN . 30.1 m -61.65 151.19 34.24 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.374 175.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.428 ' HG2' HG22 ' A' ' 76' ' ' THR . 4.3 mt-30 75.71 31.79 0.71 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 126.527 1.931 . . . . 0.0 110.821 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.596 ' HA ' HD22 ' A' ' 91' ' ' LEU . 18.0 mt-10 -138.98 60.09 1.6 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 113.1 -1.864 . . . . 0.0 112.702 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.567 ' OD2' HD21 ' A' ' 19' ' ' LEU . 0.6 OUTLIER -101.77 123.19 45.33 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 112.71 -2.041 . . . . 0.0 107.973 175.002 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.466 ' HB3' ' HB3' ' A' ' 89' ' ' PHE . 23.0 m-85 -92.6 126.69 37.8 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 124.715 1.26 . . . . 0.0 109.209 174.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.789 ' HB2' HD11 ' A' ' 92' ' ' ILE . 27.3 t80 -108.85 121.58 45.38 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.017 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.533 ' HB ' ' O ' ' A' ' 88' ' ' THR 0.291 0.1 OUTLIER -79.99 -70.92 0.48 Allowed 'General case' 0 N--CA 1.485 1.293 0 O-C-N 125.497 1.748 . . . . 0.0 113.014 173.604 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.437 ' HA2' ' HD2' ' A' ' 68' ' ' ARG . . . 66.34 16.93 65.64 Favored Glycine 0 CA--C 1.539 1.578 0 CA-C-N 114.253 -1.339 . . . . 0.0 113.069 -173.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.505 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 45.0 t0 -146.5 24.82 1.23 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.567 1.147 . . . . 0.0 112.483 175.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.431 ' HB2' HG22 ' A' ' 67' ' ' THR . 41.1 t-80 56.35 83.55 0.1 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.002 2.121 . . . . 0.0 110.813 177.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 46.38 53.58 9.49 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 113.009 -1.905 . . . . 0.0 114.022 -175.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . . . -123.88 -34.83 2.94 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.381 -1.281 . . . . 0.0 114.024 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.533 ' O ' ' HB ' ' A' ' 82' ' ' THR . 11.3 p -135.37 168.01 19.98 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.47 1.108 . . . . 0.0 108.493 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.49 ' CG ' HD21 ' A' ' 44' ' ' LEU . 98.6 m-85 -159.54 115.83 2.55 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -174.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.5 m -135.65 111.07 9.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 112.82 -1.991 . . . . 0.0 108.586 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.596 HD22 ' HA ' ' A' ' 78' ' ' GLU . 16.9 mt -41.68 159.96 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.441 176.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.789 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.6 mp -110.7 129.47 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 121.38 -0.825 . . . . 0.0 109.592 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.09 92.02 3.88 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 113.157 -1.838 . . . . 0.0 109.172 176.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -60.1 -31.77 70.35 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 114.218 -1.356 . . . . 0.0 111.199 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.3 t -54.98 -34.87 63.75 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.656 1.582 . . . . 0.0 112.972 172.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 8.6 t . . . . . 0 C--O 1.254 1.299 0 CA-C-O 117.813 -1.089 . . . . 0.0 110.824 178.773 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.4 p30 . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 119.758 -0.163 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.7 t -41.81 137.93 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.643 1.177 . . . . 0.0 109.429 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.6 m -80.85 19.58 0.84 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.085 -0.962 . . . . 0.0 113.014 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.86 -175.18 29.76 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.505 HG22 ' H ' ' A' ' 6' ' ' VAL . 2.4 m -85.29 174.61 9.47 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.445 0.641 . . . . 0.0 110.517 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.526 HG13 HD11 ' A' ' 11' ' ' LEU . 0.3 OUTLIER -148.93 115.28 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -174.657 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.448 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 72.0 m -48.05 128.23 13.45 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 111.807 -2.451 . . . . 0.0 111.126 177.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.67 HD11 ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -46.38 -38.52 9.02 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.603 1.161 . . . . 0.0 112.721 173.704 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.8 t -70.04 -14.52 62.72 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 172.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 7' ' ' CYS . . . -80.36 -26.3 38.71 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.359 0.664 . . . . 0.0 111.865 175.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.635 HD12 ' HA ' ' A' ' 8' ' ' LEU . 0.9 OUTLIER -93.47 169.7 9.78 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 124.17 0.988 . . . . 0.0 111.404 178.701 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 59.6 Cg_endo -66.88 169.29 15.06 Favored 'Trans proline' 0 CA--C 1.548 1.179 0 C-N-CA 122.4 2.067 . . . . 0.0 113.405 176.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -69.72 -21.97 32.91 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 122.276 1.984 . . . . 0.0 113.055 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -86.43 -10.24 54.65 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.857 178.923 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.448 ' HA ' ' CG1' ' A' ' 57' ' ' VAL . . . -67.87 -37.49 81.86 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.007 0.923 . . . . 0.0 112.478 172.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.67 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -67.87 -40.16 83.62 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.423 175.35 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.484 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 7.4 t70 -45.74 -44.77 14.01 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.68 -177.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.717 ' OG1' HG12 ' A' ' 57' ' ' VAL . 1.3 m -65.58 -51.69 57.83 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.066 -1.425 . . . . 0.0 111.593 177.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.595 HD11 HG21 ' A' ' 92' ' ' ILE . 17.6 mt -49.88 -33.36 16.89 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 174.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.31 -48.01 58.53 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.637 0.775 . . . . 0.0 111.941 171.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.502 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 66.6 mt -62.4 -34.37 76.6 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-O 118.73 -0.652 . . . . 0.0 112.243 175.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.607 HD12 ' O ' ' A' ' 18' ' ' THR . 1.8 mp -69.74 -43.95 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 119.497 1.044 . . . . 0.0 111.389 172.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.15 -43.7 81.67 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 124.455 1.097 . . . . 0.0 111.876 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.5 t -85.4 0.47 52.09 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.809 1.244 . . . . 0.0 112.293 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 46.3 35.82 2.95 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 122.368 1.08 . . . . 0.0 112.344 -176.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.47 -172.35 14.67 Favored Glycine 0 CA--C 1.548 2.129 0 CA-C-N 113.711 -1.586 . . . . 0.0 114.309 -175.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.451 ' O ' HD22 ' A' ' 21' ' ' LEU . 55.4 Cg_endo -73.29 135.8 41.57 Favored 'Cis proline' 0 CA--C 1.534 0.515 0 O-C-N 123.003 1.002 . . . . 0.0 111.091 -2.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.502 ' CE1' ' HB3' ' A' ' 21' ' ' LEU . 16.5 m-85 -84.98 103.12 2.88 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 112.81 -1.995 . . . . 0.0 111.722 -177.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.2 -36.7 5.32 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.624 2.216 . . . . 0.0 111.581 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.522 ' CE2' HG13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -77.43 168.69 19.59 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 124.052 0.845 . . . . 0.0 111.991 175.52 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.57 17.74 22.88 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 122.461 1.124 . . . . 0.0 112.911 172.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.91 13.98 20.91 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.734 -1.121 . . . . 0.0 113.67 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -130.86 107.58 9.23 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.764 -1.562 . . . . 0.0 112.556 -174.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.5 -0.2 7.41 Favored Glycine 0 N--CA 1.485 1.937 0 CA-C-N 113.045 -1.889 . . . . 0.0 113.324 -175.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.9 m -92.41 145.96 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.651 0.781 . . . . 0.0 110.072 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.5 t -77.12 157.6 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 125.141 1.526 . . . . 0.0 109.8 176.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.575 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 81.0 t80 -138.56 87.32 2.22 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 113.927 -1.488 . . . . 0.0 109.442 176.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.503 ' HG3' ' CD2' ' A' ' 49' ' ' TYR . 1.7 tt0 -72.59 50.16 0.23 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 122.537 1.161 . . . . 0.0 113.301 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.565 ' CG ' ' HB2' ' A' ' 44' ' ' LEU . 34.9 t30 29.51 54.21 0.12 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.286 1.834 . . . . 0.0 110.873 -173.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.89 -21.89 33.03 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 113.712 -1.586 . . . . 0.0 112.266 -177.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.613 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.1 mt-10 -80.93 -7.6 59.54 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 113.819 -1.537 . . . . 0.0 114.12 173.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.4 t 43.83 37.91 1.87 Allowed 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 123.997 1.856 . . . . 0.0 112.204 -175.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 41' ' ' GLU . 72.1 t -114.36 -16.75 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-N 113.472 -1.695 . . . . 0.0 111.18 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.75 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.5 OUTLIER -88.7 157.85 48.77 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.228 -178.346 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.66 -160.07 0.07 OUTLIER 'Trans proline' 0 N--CA 1.477 0.557 0 C-N-CA 121.013 1.142 . . . . 0.0 109.498 178.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.505 HG22 ' H ' ' A' ' 47' ' ' GLN . 20.2 m 48.88 -131.34 1.76 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.337 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.505 ' H ' HG22 ' A' ' 46' ' ' THR . 37.7 tt0 168.9 -38.18 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.779 1.631 . . . . 0.0 110.482 -178.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.5 p -35.93 139.44 0.15 Allowed 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 122.589 1.185 . . . . 0.0 112.923 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.503 ' CD2' ' HG3' ' A' ' 38' ' ' GLN . 8.7 t80 -87.35 132.62 33.89 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.045 -1.888 . . . . 0.0 108.113 -175.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.16 -20.81 9.27 Favored Glycine 0 CA--C 1.537 1.46 0 O-C-N 124.863 1.352 . . . . 0.0 113.35 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 74' ' ' GLU . 0.5 OUTLIER -59.77 -19.68 51.9 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.402 1.081 . . . . 0.0 113.423 176.081 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.75 ' HE2' HD12 ' A' ' 44' ' ' LEU . 26.7 m-85 -104.2 166.62 10.28 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 125.091 1.356 . . . . 0.0 109.168 178.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -166.22 166.21 17.02 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 112.301 -2.227 . . . . 0.0 111.206 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.575 ' HG3' ' HB2' ' A' ' 37' ' ' PHE . 28.8 mt-10 -124.55 143.44 50.68 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.239 1.016 . . . . 0.0 110.063 -175.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.661 ' O ' HG21 ' A' ' 18' ' ' THR . 39.8 m-85 -157.68 72.2 0.65 Allowed 'General case' 0 N--CA 1.469 0.477 0 O-C-N 126.28 2.237 . . . . 0.0 109.723 -174.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.415 HG21 ' HG2' ' A' ' 65' ' ' ARG . 0.5 OUTLIER -44.36 144.26 1.06 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.612 0.72 . . . . 0.0 112.405 177.371 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.717 HG12 ' OG1' ' A' ' 18' ' ' THR . 30.4 m -94.72 113.69 29.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.605 176.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.522 HG13 ' CE2' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -43.11 157.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 125.057 1.473 . . . . 0.0 109.096 173.385 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.581 HG22 ' HB2' ' A' ' 62' ' ' ALA . 1.4 m -153.63 143.41 15.23 Favored Pre-proline 0 N--CA 1.477 0.916 0 O-C-N 124.443 1.09 . . . . 0.0 111.226 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.405 ' HD2' HG23 ' A' ' 59' ' ' THR . 64.9 Cg_endo -74.54 144.04 31.52 Favored 'Trans proline' 0 N--CA 1.479 0.66 0 C-N-CA 121.575 1.516 . . . . 0.0 110.788 176.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.51 22.05 30.1 Favored Glycine 0 CA--C 1.544 1.848 0 CA-C-N 114.35 -1.296 . . . . 0.0 112.525 -175.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.581 ' HB2' HG22 ' A' ' 59' ' ' THR . . . -82.53 89.8 6.7 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 178.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -40.97 -30.48 0.13 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.696 -1.593 . . . . 0.0 112.953 176.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.8 p -124.93 -146.25 0.35 Allowed 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 113.776 -1.556 . . . . 0.0 109.569 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.415 ' HG2' HG21 ' A' ' 56' ' ' THR . 18.2 mtm180 -82.31 -2.01 51.4 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 174.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.48 142.41 0.02 OUTLIER Glycine 0 N--CA 1.475 1.25 0 CA-C-O 123.717 1.732 . . . . 0.0 108.879 -173.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.8 p -52.85 -27.65 19.32 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 123.209 1.481 . . . . 0.0 112.165 174.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.529 ' NH1' HG21 ' A' ' 59' ' ' THR . 0.6 OUTLIER -54.23 127.65 27.89 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 120.009 -1.682 . . . . 0.0 111.786 174.445 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.547 ' HB2' HG23 ' A' ' 82' ' ' THR . 0.0 OUTLIER -144.02 149.88 37.37 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.321 179.899 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.475 ' O ' HD13 ' A' ' 71' ' ' ILE . 2.9 mt -122.37 140.17 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 126.04 2.087 . . . . 0.0 109.247 176.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.66 HD11 ' HE1' ' A' ' 86' ' ' TYR . 17.1 mm -132.43 108.84 14.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 O-C-N 125.6 1.812 . . . . 0.0 107.173 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.721 HG22 ' HB3' ' A' ' 79' ' ' ASP . 14.8 p -102.92 162.97 12.49 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.422 0.63 . . . . 0.0 110.363 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -115.3 171.26 13.62 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.996 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.418 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -64.58 -16.89 63.39 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 114.479 -0.86 . . . . 0.0 112.214 174.829 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.36 129.42 48.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 122.33 1.062 . . . . 0.0 108.866 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.593 HG22 ' HG2' ' A' ' 77' ' ' GLN . 24.1 m -61.49 147.57 44.86 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 113.776 -1.556 . . . . 0.0 107.494 175.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.593 ' HG2' HG22 ' A' ' 76' ' ' THR . 2.2 mt-30 80.7 31.48 0.17 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 127.0 2.12 . . . . 0.0 111.078 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.581 ' HA ' HD22 ' A' ' 91' ' ' LEU . 34.6 mt-10 -135.73 50.41 2.1 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 113.622 -1.626 . . . . 0.0 113.385 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.721 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.2 OUTLIER -104.63 83.9 2.1 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 113.418 -1.719 . . . . 0.0 110.845 -179.646 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.455 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 8.9 m-85 -68.53 131.53 45.41 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.558 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.576 ' HB2' HD11 ' A' ' 92' ' ' ILE . 68.8 t80 -122.12 130.43 53.23 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.554 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.558 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.5 OUTLIER -85.2 -66.87 0.85 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 111.626 -2.533 . . . . 0.0 112.383 175.595 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 68' ' ' ARG . . . 69.49 22.35 76.47 Favored Glycine 0 N--CA 1.48 1.577 0 CA-C-N 112.996 -1.911 . . . . 0.0 113.58 -174.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.497 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 54.6 m-20 -157.66 24.56 0.28 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.015 1.326 . . . . 0.0 113.278 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 61.66 83.17 0.15 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.324 1.85 . . . . 0.0 112.013 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.66 ' HE1' HD11 ' A' ' 71' ' ' ILE . 11.6 m-30 46.81 38.87 6.46 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 113.424 -1.716 . . . . 0.0 114.057 -176.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' ' 84' ' ' ASP . . . -99.96 -18.37 17.1 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.029 -176.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.558 ' O ' ' HB ' ' A' ' 82' ' ' THR . 5.4 p -164.46 176.99 8.51 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.325 1.45 . . . . 0.0 108.358 -175.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.559 ' CD1' HD21 ' A' ' 44' ' ' LEU . 96.1 m-85 -160.06 115.73 2.38 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -175.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.5 m -135.51 111.46 9.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 112.828 -1.987 . . . . 0.0 108.864 -179.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.581 HD22 ' HA ' ' A' ' 78' ' ' GLU . 15.4 mt -41.58 159.92 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.654 0.596 . . . . 0.0 112.325 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.625 HD13 ' O ' ' A' ' 79' ' ' ASP . 1.6 mp -107.24 123.94 62.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 O-C-N 120.715 -1.241 . . . . 0.0 110.022 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.06 93.49 7.87 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 113.756 -1.566 . . . . 0.0 107.722 177.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -54.81 -42.47 71.9 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.6 t -52.88 -30.1 32.04 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 113.438 -1.71 . . . . 0.0 114.45 173.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.418 ' OXT' ' N ' ' A' ' 8' ' ' LEU . 49.7 t . . . . . 0 C--O 1.246 0.911 0 CA-C-O 123.323 1.535 . . . . 0.0 107.014 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 110.733 -0.099 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.517 HG21 ' CE1' ' A' ' 80' ' ' TYR . 54.4 t -31.85 133.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 126.469 1.908 . . . . 0.0 109.27 169.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.2 m -56.34 -13.01 1.88 Allowed 'General case' 0 N--CA 1.474 0.762 0 O-C-N 125.006 1.441 . . . . 0.0 114.553 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.471 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 127.71 -169.74 19.39 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 176.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -84.41 168.77 15.24 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 122.28 1.038 . . . . 0.0 111.048 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.579 HG12 ' O ' ' A' ' 91' ' ' LEU . 8.4 p -146.49 110.8 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 114.361 -1.291 . . . . 0.0 107.588 -176.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 70.9 m -43.34 131.04 4.86 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 111.946 -2.388 . . . . 0.0 109.74 177.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.795 ' HA ' HD12 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -52.41 -36.55 54.49 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.3 177.42 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.5 t -67.42 -17.02 64.55 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.338 1.055 . . . . 0.0 113.3 174.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.01 -33.8 33.38 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.918 0.487 . . . . 0.0 111.731 176.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.795 HD12 ' HA ' ' A' ' 8' ' ' LEU . 4.0 mt -81.07 173.23 8.04 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 125.683 1.593 . . . . 0.0 110.557 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.557 ' HB2' ' OE2' ' A' ' 14' ' ' GLU . 72.7 Cg_endo -66.95 166.47 22.66 Favored 'Trans proline' 0 CA--C 1.551 1.342 0 C-N-CA 121.847 1.698 . . . . 0.0 113.885 175.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -66.68 -22.45 50.33 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.983 2.456 . . . . 0.0 113.715 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.557 ' OE2' ' HB2' ' A' ' 12' ' ' PRO . 1.0 OUTLIER -82.97 -8.58 59.55 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 173.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.811 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -65.32 -29.61 70.37 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 174.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.616 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -73.88 -29.41 62.07 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.816 173.513 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.485 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 45.7 t0 -52.66 -54.49 32.68 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.781 0.676 . . . . 0.0 109.534 -176.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.627 ' HA ' HD12 ' A' ' 21' ' ' LEU . 24.4 m -54.78 -49.31 71.22 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 175.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.859 HD11 HG21 ' A' ' 92' ' ' ILE . 11.5 mt -56.01 -34.78 66.13 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 177.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -70.58 -41.05 72.89 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.471 172.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.627 HD12 ' HA ' ' A' ' 18' ' ' THR . 48.9 mt -66.77 -33.98 76.82 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 123.272 0.629 . . . . 0.0 112.16 175.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.66 HD13 HG21 ' A' ' 72' ' ' THR . 5.8 mt -69.22 -44.41 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 119.486 1.039 . . . . 0.0 111.161 172.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.48 -43.94 75.87 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 124.665 1.228 . . . . 0.0 112.24 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.42 5.85 47.74 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.105 0.962 . . . . 0.0 112.041 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 43.77 36.64 1.36 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.997 1.319 . . . . 0.0 112.528 -176.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.96 -165.28 13.24 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 113.667 -1.606 . . . . 0.0 115.619 -175.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -73.95 137.67 51.32 Favored 'Cis proline' 0 CA--C 1.537 0.644 0 O-C-N 124.644 1.865 . . . . 0.0 112.424 -4.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.522 ' CE2' ' HB3' ' A' ' 21' ' ' LEU . 81.4 m-85 -85.74 153.17 57.85 Favored Pre-proline 0 N--CA 1.472 0.632 0 CA-C-N 113.301 -1.772 . . . . 0.0 112.611 -178.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.02 -56.9 0.14 Allowed 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.409 2.072 . . . . 0.0 113.344 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.48 ' CD1' ' HB2' ' A' ' 32' ' ' GLN . 0.1 OUTLIER -112.97 168.93 9.29 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.438 1.495 . . . . 0.0 110.531 179.344 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.7 m -71.42 56.98 0.25 Allowed 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 123.55 1.643 . . . . 0.0 114.015 174.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.48 ' HB2' ' CD1' ' A' ' 30' ' ' TYR . 3.9 mt-30 -131.1 67.6 1.51 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 123.497 1.618 . . . . 0.0 112.066 177.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -173.7 155.22 2.63 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 110.19 -3.187 . . . . 0.0 114.733 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 71.82 10.83 72.91 Favored Glycine 0 N--CA 1.481 1.641 0 CA-C-N 112.181 -2.281 . . . . 0.0 111.635 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.678 HG23 ' HB2' ' A' ' 54' ' ' GLU . 13.0 m -97.74 142.22 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.402 1.081 . . . . 0.0 109.72 174.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.6 t -87.59 155.24 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 O-C-N 125.867 1.979 . . . . 0.0 110.276 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.51 ' HB3' ' HB3' ' A' ' 52' ' ' TYR . 51.6 t80 -121.45 103.03 8.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.392 173.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.83 45.17 0.19 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.199 0.6 . . . . 0.0 112.037 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 21.07 57.82 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 124.116 1.912 . . . . 0.0 113.359 -174.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.503 ' HD3' ' CE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -79.19 7.0 8.34 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 113.527 -1.67 . . . . 0.0 112.297 -175.835 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.566 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.2 mt-10 -111.55 -17.05 13.14 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.479 -1.691 . . . . 0.0 113.847 177.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.9 t 46.22 39.66 6.44 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 123.99 1.852 . . . . 0.0 112.972 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 41' ' ' GLU . 89.1 t -111.35 -15.97 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.438 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.484 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -100.15 162.74 19.99 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -173.213 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.51 ' HD3' HG23 ' A' ' 2' ' ' VAL . 84.7 Cg_endo -68.1 -160.39 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.423 2.082 . . . . 0.0 110.423 177.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.426 HG22 ' H ' ' A' ' 47' ' ' GLN . 19.5 m 43.73 -128.07 0.87 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.27 1.428 . . . . 0.0 108.821 -178.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.426 ' H ' HG22 ' A' ' 46' ' ' THR . 10.9 tt0 165.55 -43.76 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.699 1.999 . . . . 0.0 110.875 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.0 p -39.66 141.25 0.42 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 114.027 -1.442 . . . . 0.0 113.445 -178.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -81.68 135.76 35.51 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 112.584 -2.098 . . . . 0.0 110.642 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.23 -24.85 25.18 Favored Glycine 0 N--CA 1.476 1.334 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.842 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -61.82 -14.2 31.01 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.844 1.258 . . . . 0.0 112.789 175.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.51 ' HB3' ' HB3' ' A' ' 37' ' ' PHE . 28.3 m-85 -121.59 147.14 46.23 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.675 1.19 . . . . 0.0 109.789 -178.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -141.73 160.04 41.0 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 113.706 -1.588 . . . . 0.0 111.79 177.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.678 ' HB2' HG23 ' A' ' 35' ' ' VAL . 8.0 mt-10 -114.94 138.57 50.66 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.918 -178.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.436 ' HB3' HG23 ' A' ' 18' ' ' THR . 90.8 m-85 -155.54 73.63 0.85 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 112.739 -2.028 . . . . 0.0 110.079 -176.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 68' ' ' ARG . 24.6 m -45.04 130.88 7.59 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 122.246 1.022 . . . . 0.0 111.534 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.811 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.8 OUTLIER -86.59 125.4 40.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 111.52 -2.582 . . . . 0.0 110.102 179.384 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.424 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -48.12 148.77 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 O-C-N 125.734 1.896 . . . . 0.0 108.99 174.046 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.492 ' OG1' ' HG3' ' A' ' 68' ' ' ARG . 2.6 m -148.31 140.63 14.69 Favored Pre-proline 0 N--CA 1.471 0.613 0 O-C-N 125.981 2.05 . . . . 0.0 110.999 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.462 ' HD3' ' CD ' ' A' ' 14' ' ' GLU . 73.4 Cg_endo -72.64 145.55 41.91 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.784 2.323 . . . . 0.0 110.034 176.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.04 22.74 56.01 Favored Glycine 0 CA--C 1.543 1.816 0 CA-C-N 113.681 -1.599 . . . . 0.0 113.321 -174.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -89.05 90.88 8.59 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 176.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.5 -33.29 0.42 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 113.711 -1.586 . . . . 0.0 113.623 176.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.0 p -133.66 -149.23 0.36 Allowed 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 113.624 -1.625 . . . . 0.0 107.848 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -60.52 -18.83 54.59 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 125.282 1.433 . . . . 0.0 111.813 173.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.76 167.27 1.43 Allowed Glycine 0 CA--C 1.532 1.139 0 CA-C-O 123.747 1.748 . . . . 0.0 110.017 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 46.6 p -65.11 -17.36 64.4 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 112.977 -1.612 . . . . 0.0 112.393 173.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.553 ' O ' HG23 ' A' ' 56' ' ' THR . 0.1 OUTLIER -63.41 126.72 28.41 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 120.937 -1.102 . . . . 0.0 110.34 176.843 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 1.3 tpt180 -151.56 132.95 14.62 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.349 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.431 ' HB ' ' O ' ' A' ' 55' ' ' TYR . 4.1 mt -105.8 138.91 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 173.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.7 mm -123.5 106.2 16.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 112.697 -2.047 . . . . 0.0 107.417 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.66 HG21 HD13 ' A' ' 22' ' ' ILE . 13.9 p -92.07 164.37 13.63 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.094 0.473 . . . . 0.0 111.604 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -104.46 -175.81 25.09 Favored Glycine 0 N--CA 1.471 1.026 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.298 178.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -80.62 -14.83 57.84 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.544 -0.828 . . . . 0.0 112.172 177.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.3 130.86 55.61 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 175.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.429 HG22 ' HG2' ' A' ' 77' ' ' GLN . 53.7 m -49.76 149.17 2.64 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.645 173.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.429 ' HG2' HG22 ' A' ' 76' ' ' THR . 4.4 mt-30 81.19 34.33 0.11 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 126.561 1.945 . . . . 0.0 111.057 -178.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.548 ' HA ' HD22 ' A' ' 91' ' ' LEU . 43.9 mt-10 -139.26 50.38 1.8 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 113.474 -1.693 . . . . 0.0 113.578 -178.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.482 ' OD2' HD22 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -108.45 95.56 5.75 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.365 1.466 . . . . 0.0 110.678 -176.692 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.517 ' CE1' HG21 ' A' ' 2' ' ' VAL . 15.9 m-85 -81.62 123.19 28.47 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 126.058 1.743 . . . . 0.0 110.255 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.853 ' HB2' HD11 ' A' ' 92' ' ' ILE . 5.8 t80 -104.81 127.79 52.74 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.052 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 88' ' ' THR 0.301 0.0 OUTLIER -88.24 -71.62 0.57 Allowed 'General case' 0 C--N 1.323 -0.569 0 O-C-N 125.948 2.03 . . . . 0.0 113.713 172.641 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 68' ' ' ARG . . . 68.06 16.37 68.54 Favored Glycine 0 N--CA 1.476 1.332 0 CA-C-N 113.898 -1.501 . . . . 0.0 113.979 -173.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.558 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 75.1 m-20 -145.93 22.7 1.4 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.795 1.238 . . . . 0.0 113.041 176.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 57.89 82.27 0.13 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 127.177 2.191 . . . . 0.0 111.289 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.449 ' HB3' ' OE2' ' A' ' 41' ' ' GLU . 25.1 m-85 49.55 54.28 11.27 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 113.514 -1.676 . . . . 0.0 113.387 -174.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.558 ' HB3' ' HB2' ' A' ' 84' ' ' ASP . . . -120.16 -41.06 2.65 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.454 ' O ' ' HB ' ' A' ' 82' ' ' THR . 15.6 p -130.91 163.52 27.29 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.043 0.937 . . . . 0.0 108.73 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.434 ' HB3' ' HB3' ' A' ' 80' ' ' TYR . 97.5 m-85 -154.95 119.79 4.86 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -175.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.5 m -140.76 113.82 8.45 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 112.312 -2.222 . . . . 0.0 108.906 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.579 ' O ' HG12 ' A' ' 6' ' ' VAL . 14.7 mt -43.61 156.57 0.06 Allowed 'General case' 0 N--CA 1.48 1.074 0 O-C-N 124.109 0.881 . . . . 0.0 112.369 175.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.859 HG21 HD11 ' A' ' 19' ' ' LEU . 1.7 mp -111.14 137.65 42.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 122.15 0.976 . . . . 0.0 108.456 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -113.01 99.08 7.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 113.14 -1.845 . . . . 0.0 108.746 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -58.74 -41.42 86.42 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.89 0.744 . . . . 0.0 112.033 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 t -54.94 -44.5 74.36 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 114.471 -1.24 . . . . 0.0 113.437 175.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 35.3 t . . . . . 0 C--O 1.241 0.643 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.21 178.596 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.8 p30 . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 121.062 0.458 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.562 HG11 ' H ' ' A' ' 91' ' ' LEU . 4.1 t -47.71 140.42 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.983 176.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 m -77.61 5.86 8.35 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 124.723 1.264 . . . . 0.0 114.303 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.34 169.28 12.59 Favored Glycine 0 N--CA 1.474 1.171 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 m -86.67 171.48 10.94 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.312 -0.944 . . . . 0.0 109.818 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p -138.14 113.48 9.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 -176.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 71.4 m -50.73 125.03 12.22 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 112.05 -2.341 . . . . 0.0 109.854 177.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -53.81 -36.93 63.02 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.883 175.013 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.7 t -65.61 -29.05 69.59 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.361 0.6 . . . . 0.0 112.511 174.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.28 -22.81 47.72 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.759 174.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.433 HD22 ' HD2' ' A' ' 12' ' ' PRO . 10.7 mt -80.68 164.13 52.82 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.318 176.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.761 ' HG2' ' HB2' ' A' ' 15' ' ' ALA . 69.0 Cg_endo -67.01 173.96 7.57 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.019 2.48 . . . . 0.0 115.056 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -71.67 -53.62 0.17 Allowed 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.813 2.342 . . . . 0.0 112.771 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.464 ' HG2' ' HD3' ' A' ' 60' ' ' PRO . 1.9 pp20? -60.2 -12.49 8.86 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.528 172.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.761 ' HB2' ' HG2' ' A' ' 12' ' ' PRO . . . -57.11 -41.85 79.75 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.725 -0.609 . . . . 0.0 111.9 176.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.16 -22.6 66.94 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 113.634 -1.621 . . . . 0.0 112.893 174.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.577 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 63.7 t0 -55.03 -58.02 9.35 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.582 0.753 . . . . 0.0 109.896 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.567 ' O ' HD12 ' A' ' 22' ' ' ILE . 61.5 m -54.5 -47.31 73.21 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 176.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.547 HD21 ' OD2' ' A' ' 79' ' ' ASP . 17.3 mt -54.05 -37.11 63.8 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 175.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -69.57 -37.73 77.11 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.226 173.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 17' ' ' ASP . 30.1 mt -72.52 -33.02 66.59 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 118.689 -0.672 . . . . 0.0 111.202 176.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.567 HD12 ' O ' ' A' ' 18' ' ' THR . 1.3 mp -68.9 -41.26 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 120.117 1.326 . . . . 0.0 111.613 171.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.32 -43.39 67.15 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 124.279 0.987 . . . . 0.0 112.164 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.39 5.09 48.92 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.363 1.065 . . . . 0.0 111.293 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.5 t70 41.15 49.77 3.22 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.203 1.401 . . . . 0.0 111.288 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.68 -164.76 30.49 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 112.767 -2.015 . . . . 0.0 116.165 -173.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -75.1 142.85 75.87 Favored 'Cis proline' 0 C--N 1.35 0.639 0 O-C-N 124.419 1.747 . . . . 0.0 111.656 -2.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.416 ' CE2' ' HB3' ' A' ' 21' ' ' LEU . 78.5 m-85 -99.27 123.26 49.26 Favored Pre-proline 0 N--CA 1.471 0.625 0 CA-C-N 113.419 -1.719 . . . . 0.0 111.102 -176.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.91 -56.74 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.01 1.807 . . . . 0.0 111.629 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -158.78 21.99 0.21 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.864 0.866 . . . . 0.0 112.096 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.508 ' HB3' HD12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -76.98 43.7 0.36 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.118 -178.635 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.53 ' HB2' ' HD2' ' A' ' 65' ' ' ARG . 1.4 tt0 20.15 64.72 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 128.968 2.907 . . . . 0.0 112.686 -175.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -103.31 175.34 5.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 110.883 -2.871 . . . . 0.0 111.458 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.29 44.95 97.42 Favored Glycine 0 N--CA 1.478 1.494 0 CA-C-N 112.731 -2.031 . . . . 0.0 110.082 176.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.0 m -142.3 147.12 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 114.007 -1.097 . . . . 0.0 108.665 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.0 t -90.81 154.92 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 125.642 1.839 . . . . 0.0 109.798 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -137.96 91.61 2.59 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.851 174.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.453 ' HG3' ' CD1' ' A' ' 49' ' ' TYR . 2.2 tm0? -70.46 51.34 0.13 Allowed 'General case' 0 N--CA 1.483 1.214 0 O-C-N 120.945 -1.097 . . . . 0.0 112.97 178.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.409 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 15.8 p-10 29.23 52.58 0.08 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.611 1.964 . . . . 0.0 110.499 -177.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.75 -24.25 56.11 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.886 -169.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.609 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.0 mt-10 -76.84 -7.15 54.93 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 112.05 -2.341 . . . . 0.0 114.933 172.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.9 t 45.68 39.03 4.62 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 123.72 1.724 . . . . 0.0 111.585 -178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 41' ' ' GLU . 54.5 t -112.73 -12.15 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 123.361 1.553 . . . . 0.0 110.369 -178.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.495 HD12 ' CE1' ' A' ' 52' ' ' TYR . 0.2 OUTLIER -99.2 145.4 29.96 Favored Pre-proline 0 C--O 1.243 0.719 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 -172.257 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -65.41 -166.45 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.051 2.501 . . . . 0.0 110.004 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.581 HG22 ' H ' ' A' ' 48' ' ' SER . 36.6 m 62.86 -71.62 0.05 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.078 1.751 . . . . 0.0 112.203 -177.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 96.17 -24.03 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 128.508 2.723 . . . . 0.0 112.431 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.581 ' H ' HG22 ' A' ' 46' ' ' THR . 83.9 p -48.3 156.08 0.44 Allowed 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 123.216 1.484 . . . . 0.0 111.247 178.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.453 ' CD1' ' HG3' ' A' ' 38' ' ' GLN . 4.3 t80 -101.84 134.03 45.66 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 112.235 -2.257 . . . . 0.0 110.291 -175.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.4 -24.78 9.07 Favored Glycine 0 N--CA 1.472 1.096 0 CA-C-N 114.084 -1.417 . . . . 0.0 112.14 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.402 ' HB3' ' OG ' ' A' ' 48' ' ' SER . 4.7 t80 -60.45 -20.46 59.94 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 174.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.495 ' CE1' HD12 ' A' ' 44' ' ' LEU . 26.4 m-85 -104.38 147.75 27.19 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.449 -1.25 . . . . 0.0 108.804 -178.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -147.28 152.84 38.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 112.934 -1.939 . . . . 0.0 111.218 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -105.36 143.07 34.03 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.435 -178.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.431 ' HB3' HG23 ' A' ' 18' ' ' THR . 99.9 m-85 -149.81 65.57 0.99 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 112.216 -2.265 . . . . 0.0 111.36 -176.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.5 m -33.99 130.01 0.33 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.602 1.192 . . . . 0.0 112.382 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.72 HG21 ' HA ' ' A' ' 15' ' ' ALA . 1.5 p -88.98 98.66 8.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 C-N-CA 118.574 -1.251 . . . . 0.0 110.11 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.508 HD12 ' HB3' ' A' ' 31' ' ' SER . 1.1 mp -25.76 128.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.773 176.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.432 HG22 ' HB2' ' A' ' 62' ' ' ALA . 4.1 m -127.05 141.76 41.66 Favored Pre-proline 0 N--CA 1.479 1.025 0 CA-C-N 118.529 0.604 . . . . 0.0 111.723 -177.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.464 ' HD3' ' HG2' ' A' ' 14' ' ' GLU . 74.2 Cg_endo -72.59 148.05 46.8 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.129 1.886 . . . . 0.0 110.441 176.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 52.74 22.67 12.32 Favored Glycine 0 CA--C 1.543 1.807 0 CA-C-N 114.278 -1.328 . . . . 0.0 113.03 -175.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.432 ' HB2' HG22 ' A' ' 59' ' ' THR . . . -93.37 90.67 6.85 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -39.12 -33.68 0.14 Allowed 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 112.987 -1.915 . . . . 0.0 112.61 175.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.8 p -129.13 -143.22 0.26 Allowed 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 113.695 -1.593 . . . . 0.0 108.84 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.53 ' HD2' ' HB2' ' A' ' 32' ' ' GLN . 64.9 mtm-85 -79.69 -14.03 59.05 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 172.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 57.33 -177.82 1.09 Allowed Glycine 0 CA--C 1.534 1.245 0 CA-C-O 123.892 1.829 . . . . 0.0 110.602 -173.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.421 ' HA ' ' HB2' ' A' ' 85' ' ' HIS . 46.0 p -66.31 -36.34 82.7 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 112.462 -1.869 . . . . 0.0 112.845 177.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.42 ' HA ' ' HA2' ' A' ' 83' ' ' GLY . 1.1 mtp85 -44.36 125.54 4.7 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.705 174.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.09 139.61 14.88 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 112.916 -1.947 . . . . 0.0 109.715 -177.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.654 HG23 ' OD1' ' A' ' 79' ' ' ASP . 4.6 mt -114.74 136.45 51.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 111.321 -2.672 . . . . 0.0 108.162 177.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.721 HD11 ' HE1' ' A' ' 86' ' ' TYR . 20.2 mm -124.9 106.1 16.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 113.057 -1.883 . . . . 0.0 107.701 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.623 HG22 ' HB2' ' A' ' 79' ' ' ASP . 32.0 p -99.5 163.07 12.66 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.319 0.581 . . . . 0.0 110.507 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -118.38 167.08 12.91 Favored Glycine 0 N--CA 1.476 1.334 0 CA-C-N 114.181 -1.372 . . . . 0.0 109.728 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.79 -22.67 25.67 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 114.691 -0.754 . . . . 0.0 112.338 172.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.91 129.49 34.82 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.581 1.181 . . . . 0.0 109.702 173.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.604 HG22 ' HG3' ' A' ' 77' ' ' GLN . 2.7 m -63.4 146.84 52.74 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.931 -1.486 . . . . 0.0 109.976 176.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.604 ' HG3' HG22 ' A' ' 76' ' ' THR . 61.8 mt-30 62.69 49.92 3.64 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.98 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.498 ' HA ' HD22 ' A' ' 91' ' ' LEU . 4.2 mt-10 -145.89 61.1 1.26 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.346 -1.752 . . . . 0.0 111.901 -177.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.654 ' OD1' HG23 ' A' ' 70' ' ' ILE . 5.9 t0 -106.28 119.82 40.25 Favored 'General case' 0 C--O 1.212 -0.887 0 CA-C-N 113.084 -1.871 . . . . 0.0 108.187 175.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.472 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 16.8 m-85 -92.51 127.75 38.11 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 125.341 1.651 . . . . 0.0 109.392 175.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.73 ' HB2' HD11 ' A' ' 92' ' ' ILE . 2.7 t80 -107.4 126.63 52.72 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 114.077 -1.42 . . . . 0.0 109.631 -178.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -89.77 -67.24 0.86 Allowed 'General case' 0 N--CA 1.484 1.229 0 O-C-N 125.709 1.88 . . . . 0.0 112.551 175.323 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 68' ' ' ARG . . . 62.02 21.42 61.39 Favored Glycine 0 CA--C 1.539 1.558 0 CA-C-N 114.148 -1.387 . . . . 0.0 112.444 -173.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.561 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 58.0 m-20 -147.42 20.04 1.2 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.794 1.238 . . . . 0.0 112.621 176.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 67' ' ' THR . 21.9 t-80 56.79 80.41 0.16 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.844 1.657 . . . . 0.0 110.251 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.721 ' HE1' HD11 ' A' ' 71' ' ' ILE . 15.4 m-30 48.87 54.27 11.08 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 113.321 -1.763 . . . . 0.0 113.837 -175.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 84' ' ' ASP . . . -120.73 -32.66 3.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.276 -1.329 . . . . 0.0 113.065 176.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.501 ' O ' ' HB ' ' A' ' 82' ' ' THR . 17.2 p -140.32 166.64 24.15 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.453 ' CD1' HD21 ' A' ' 44' ' ' LEU . 93.5 m-85 -156.72 118.11 3.78 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -173.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.2 m -139.41 107.8 5.83 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 125.871 1.982 . . . . 0.0 110.047 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.562 ' H ' HG11 ' A' ' 2' ' ' VAL . 22.7 mt -40.86 159.29 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.123 178.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.73 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.7 mp -108.67 128.74 64.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 O-C-N 120.612 -1.305 . . . . 0.0 109.415 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.35 95.58 5.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 113.836 -1.529 . . . . 0.0 108.698 177.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.5 -36.81 67.07 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 124.312 1.007 . . . . 0.0 112.044 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.1 t -56.59 -48.59 77.07 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.901 1.28 . . . . 0.0 113.232 174.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 44.0 t . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.779 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 121.381 0.61 . . . . 0.0 111.426 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.618 HG23 ' HD3' ' A' ' 45' ' ' PRO . 3.7 t -63.91 143.32 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.8 m -80.39 -3.24 48.89 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 176.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.48 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 137.87 179.94 17.57 Favored Glycine 0 N--CA 1.473 1.162 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 6' ' ' VAL . 3.0 m -89.33 174.46 7.81 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 122.109 0.957 . . . . 0.0 109.783 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.435 ' H ' HG22 ' A' ' 5' ' ' THR . 1.0 OUTLIER -142.96 112.31 2.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 122.659 1.218 . . . . 0.0 107.834 -176.387 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.4 ' HA ' ' HB3' ' A' ' 96' ' ' CYS . 93.1 m -52.12 133.71 33.25 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 112.152 -2.295 . . . . 0.0 109.887 177.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -31.53 68.02 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.083 0.864 . . . . 0.0 111.878 -178.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.4 t -66.08 -28.76 69.07 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.661 0.784 . . . . 0.0 112.902 173.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.52 -18.54 56.93 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.712 0.805 . . . . 0.0 111.81 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 11' ' ' LEU . 7.0 mt -86.34 161.28 49.32 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 175.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.552 ' HB2' ' OE2' ' A' ' 14' ' ' GLU . 98.3 Cg_endo -69.67 170.24 16.93 Favored 'Trans proline' 0 CA--C 1.552 1.393 0 C-N-CA 122.192 1.928 . . . . 0.0 112.484 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.04 -34.83 12.9 Favored 'Trans proline' 0 N--CA 1.482 0.827 0 C-N-CA 122.652 2.234 . . . . 0.0 113.024 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.661 ' HB2' HG22 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -73.73 -9.43 58.66 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 114.695 -1.139 . . . . 0.0 114.069 175.2 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.412 ' HB2' ' HG2' ' A' ' 12' ' ' PRO . . . -66.48 -40.4 89.28 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.052 173.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.55 -33.13 74.32 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.081 175.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.434 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 5.5 t0 -54.02 -49.85 67.97 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.792 -178.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.632 HG21 ' O ' ' A' ' 55' ' ' TYR . 2.2 m -64.69 -49.3 71.47 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-O 117.953 -1.022 . . . . 0.0 112.479 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.5 mt -52.05 -34.22 42.38 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 124.293 0.996 . . . . 0.0 111.794 175.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.27 -45.68 54.34 Favored 'General case' 0 C--O 1.213 -0.867 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.262 173.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.565 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 55.3 mt -64.21 -33.7 76.41 Favored 'General case' 0 C--O 1.212 -0.913 0 C-N-CA 122.956 0.502 . . . . 0.0 111.964 174.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.521 HG21 HG21 ' A' ' 72' ' ' THR . 5.9 mt -71.16 -41.72 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 O-C-N 119.716 -1.865 . . . . 0.0 110.424 174.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.65 -43.14 66.63 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 124.68 1.238 . . . . 0.0 111.932 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.5 8.48 33.68 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.762 1.225 . . . . 0.0 112.057 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.8 t70 41.12 53.66 3.41 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 123.109 1.433 . . . . 0.0 111.952 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.09 -165.89 14.46 Favored Glycine 0 CA--C 1.538 1.53 0 CA-C-N 113.456 -1.702 . . . . 0.0 113.804 -175.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.529 ' O ' HD22 ' A' ' 21' ' ' LEU . 59.3 Cg_endo -73.77 138.16 54.09 Favored 'Cis proline' 0 N--CA 1.481 0.785 0 O-C-N 123.54 1.284 . . . . 0.0 111.768 -2.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.565 ' CE1' ' HB3' ' A' ' 21' ' ' LEU . 49.4 m-85 -94.81 106.52 25.24 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 113.316 -1.765 . . . . 0.0 111.952 -176.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -71.13 -46.3 0.72 Allowed 'Trans proline' 0 N--CA 1.477 0.531 0 C-N-CA 122.033 1.822 . . . . 0.0 111.742 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.463 ' C ' ' H ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -173.67 23.1 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.463 1.105 . . . . 0.0 112.805 -179.548 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.2 m -69.34 37.25 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.494 -174.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.463 ' H ' ' C ' ' A' ' 30' ' ' TYR . 0.0 OUTLIER 32.13 42.63 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.191 2.596 . . . . 0.0 112.975 -176.941 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.535 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 2.7 p30 -105.35 174.47 5.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 110.986 -2.825 . . . . 0.0 111.157 -172.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.91 -2.15 75.96 Favored Glycine 0 N--CA 1.482 1.704 0 O-C-N 126.195 2.185 . . . . 0.0 111.137 -175.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.412 HG23 ' OE1' ' A' ' 54' ' ' GLU . 27.2 m -102.21 143.93 14.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.935 0.894 . . . . 0.0 110.465 175.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.08 153.34 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 125.386 1.679 . . . . 0.0 109.588 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.491 ' CD2' HG21 ' A' ' 71' ' ' ILE . 44.9 t80 -131.65 89.26 2.68 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 112.936 -1.938 . . . . 0.0 109.878 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -72.54 51.25 0.26 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 118.692 0.678 . . . . 0.0 112.67 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 14.1 p-10 29.43 51.49 0.08 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.022 2.529 . . . . 0.0 109.397 -177.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.459 ' HD3' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -56.76 -21.81 31.11 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.121 -173.766 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.631 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.8 mt-10 -78.27 -6.52 55.24 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.405 -1.725 . . . . 0.0 114.787 172.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 43.5 t 44.85 35.91 1.67 Allowed 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 124.782 2.23 . . . . 0.0 112.269 -176.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 41' ' ' GLU . 70.9 t -111.74 -9.87 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 113.376 -1.738 . . . . 0.0 109.758 -178.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.573 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -98.5 150.16 36.44 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -175.449 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.618 ' HD3' HG23 ' A' ' 2' ' ' VAL . 72.0 Cg_endo -69.14 -159.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.75 2.3 . . . . 0.0 109.746 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 96.1 m 56.86 -111.26 0.6 Allowed 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 116.342 -1.789 . . . . 0.0 107.779 -177.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 146.33 -43.12 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 127.697 2.399 . . . . 0.0 110.743 -177.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.5 p -37.25 143.44 0.09 Allowed 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 123.687 1.708 . . . . 0.0 112.196 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -90.73 135.4 33.74 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 112.843 -1.981 . . . . 0.0 108.229 -175.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.87 -19.12 17.54 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 124.712 1.258 . . . . 0.0 113.548 176.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.458 ' CE2' ' HB3' ' A' ' 74' ' ' GLU . 1.3 t80 -65.59 -13.89 59.98 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.363 1.065 . . . . 0.0 113.214 176.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.573 ' HE2' HD12 ' A' ' 44' ' ' LEU . 23.6 m-85 -108.58 155.25 20.87 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.362 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -154.03 161.14 42.15 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 112.968 -1.923 . . . . 0.0 110.832 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' A' ' 33' ' ' ASP . 1.7 mp0 -116.86 149.4 40.12 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.516 -177.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.632 ' O ' HG21 ' A' ' 18' ' ' THR . 76.2 m-85 -159.96 82.4 0.72 Allowed 'General case' 0 CA--C 1.545 0.758 0 O-C-N 125.239 1.587 . . . . 0.0 109.335 -172.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.559 HG22 ' H ' ' A' ' 58' ' ' ILE . 88.5 m -49.83 146.33 4.61 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 123.086 1.422 . . . . 0.0 111.434 175.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.497 ' CG1' HD12 ' A' ' 70' ' ' ILE . 1.2 m -105.81 19.0 5.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 113.01 -1.904 . . . . 0.0 113.019 -173.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.661 HG22 ' HB2' ' A' ' 14' ' ' GLU . 0.1 OUTLIER 53.32 179.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 O-C-N 124.827 1.329 . . . . 0.0 108.857 -165.833 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.3 m -156.11 139.99 11.43 Favored Pre-proline 0 N--CA 1.477 0.905 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.801 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.623 ' HD3' ' CD ' ' A' ' 14' ' ' GLU . 71.3 Cg_endo -74.2 142.91 31.22 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.002 2.468 . . . . 0.0 110.023 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 48.01 27.99 5.46 Favored Glycine 0 CA--C 1.541 1.718 0 CA-C-N 114.188 -1.369 . . . . 0.0 112.623 -176.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.09 95.07 6.59 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.69 -29.2 0.72 Allowed 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 111.603 -2.544 . . . . 0.0 112.428 175.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.8 p -112.07 -165.18 0.97 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.514 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.7 mtm105 -66.54 -12.11 56.08 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 174.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.63 165.54 7.18 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-O 123.838 1.799 . . . . 0.0 110.335 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.442 ' HA ' ' HB2' ' A' ' 85' ' ' HIS . 40.8 p -74.2 -15.49 61.01 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 112.631 -1.785 . . . . 0.0 112.439 178.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.521 ' HD2' ' HA2' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -66.85 136.53 55.55 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 120.931 -1.106 . . . . 0.0 110.245 177.082 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.462 ' HB2' HG23 ' A' ' 82' ' ' THR . 0.0 OUTLIER -158.53 156.12 29.64 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.418 -1.719 . . . . 0.0 110.447 -178.839 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.497 HD12 ' CG1' ' A' ' 57' ' ' VAL . 1.0 OUTLIER -130.16 140.96 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 O-C-N 125.325 1.641 . . . . 0.0 109.215 176.802 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.491 HG21 ' CD2' ' A' ' 37' ' ' PHE . 13.6 mm -128.87 106.11 13.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 113.22 -1.809 . . . . 0.0 107.82 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.64 HG22 ' HB3' ' A' ' 79' ' ' ASP . 20.7 p -98.61 162.16 13.28 Favored 'General case' 0 C--N 1.314 -0.971 0 O-C-N 121.477 -0.765 . . . . 0.0 110.584 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.21 166.61 12.52 Favored Glycine 0 N--CA 1.48 1.605 0 CA-C-N 113.663 -1.608 . . . . 0.0 109.469 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.458 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -61.37 -18.25 57.84 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.562 -0.819 . . . . 0.0 112.6 174.471 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -101.03 129.99 46.96 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.578 174.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.65 HG22 ' HG2' ' A' ' 77' ' ' GLN . 3.0 m -59.82 143.75 50.37 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 113.675 -1.602 . . . . 0.0 107.883 175.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.65 ' HG2' HG22 ' A' ' 76' ' ' THR . 0.0 OUTLIER 80.74 35.99 0.11 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.741 2.016 . . . . 0.0 110.474 179.035 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.447 ' HA ' ' CD2' ' A' ' 91' ' ' LEU . 3.7 mt-10 -134.02 47.43 2.43 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 113.45 -1.705 . . . . 0.0 113.204 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.64 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.1 OUTLIER -103.64 89.29 3.3 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.884 1.274 . . . . 0.0 110.19 -178.997 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.454 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 8.2 m-85 -78.45 131.88 37.06 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 125.228 1.411 . . . . 0.0 109.553 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.79 ' HB2' HD11 ' A' ' 92' ' ' ILE . 16.2 t80 -116.5 132.44 56.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.726 -1.124 . . . . 0.0 109.513 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -86.76 -72.28 0.51 Allowed 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 112.468 -2.151 . . . . 0.0 112.687 175.596 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.521 ' HA2' ' HD2' ' A' ' 68' ' ' ARG . . . 71.13 21.24 78.4 Favored Glycine 0 N--CA 1.473 1.119 0 CA-C-N 112.926 -1.943 . . . . 0.0 113.277 -175.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.612 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 63.0 m-20 -154.41 23.01 0.48 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.811 1.245 . . . . 0.0 112.963 177.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.442 ' HB2' ' HA ' ' A' ' 67' ' ' THR . 23.0 t-80 56.8 82.67 0.11 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.896 2.078 . . . . 0.0 110.005 178.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 7.7 m-30 51.2 48.67 22.6 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 113.04 -1.891 . . . . 0.0 114.163 -176.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.612 ' HB3' ' HB2' ' A' ' 84' ' ' ASP . . . -115.2 -30.59 6.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.823 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.498 ' O ' ' HB ' ' A' ' 82' ' ' THR . 22.3 p -147.97 169.67 19.38 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -178.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.502 ' CD1' HD21 ' A' ' 44' ' ' LEU . 89.5 m-85 -157.88 116.31 3.12 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -173.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.8 m -137.95 113.2 9.32 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 125.858 1.974 . . . . 0.0 110.099 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 91' ' ' LEU . 14.7 mt -41.56 160.52 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 O-C-N 124.465 1.103 . . . . 0.0 112.812 178.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.79 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.6 mp -110.08 128.32 66.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 O-C-N 121.58 -0.7 . . . . 0.0 109.38 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.69 92.19 3.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 113.721 -1.581 . . . . 0.0 108.812 176.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.23 -30.13 69.2 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.935 178.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.1 t -56.31 -33.21 65.35 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.077 -1.419 . . . . 0.0 112.851 172.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.4 ' HB3' ' HA ' ' A' ' 7' ' ' CYS . 6.4 t . . . . . 0 C--O 1.257 1.464 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.973 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.61 HG21 ' HE1' ' A' ' 80' ' ' TYR . 24.7 t . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -78.08 12.88 1.62 Allowed 'General case' 0 N--CA 1.48 1.065 0 O-C-N 124.182 0.927 . . . . 0.0 113.342 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.97 179.05 23.55 Favored Glycine 0 N--CA 1.468 0.797 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.459 HG22 ' H ' ' A' ' 6' ' ' VAL . 2.9 m -80.9 173.83 12.22 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 122.174 0.988 . . . . 0.0 110.746 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.459 ' H ' HG22 ' A' ' 5' ' ' THR . 1.4 p -143.6 110.45 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -174.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.59 ' HB3' ' OXT' ' A' ' 96' ' ' CYS . 86.7 m -46.57 128.89 10.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 111.853 -2.431 . . . . 0.0 110.101 177.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.466 HD11 ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -56.57 -33.27 66.01 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.586 -177.584 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.4 t -65.99 -27.44 68.14 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.786 173.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.71 -20.48 58.33 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.44 0.696 . . . . 0.0 111.396 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.486 HD13 ' HB1' ' A' ' 15' ' ' ALA . 9.7 mt -86.25 158.66 54.92 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -69.34 167.44 23.88 Favored 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 122.174 1.916 . . . . 0.0 112.375 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.72 -14.01 38.28 Favored 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 122.626 2.217 . . . . 0.0 114.292 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 9.3 pm0 -92.91 -6.16 49.2 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.844 1.258 . . . . 0.0 113.955 176.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.486 ' HB1' HD13 ' A' ' 11' ' ' LEU . . . -81.58 -43.24 18.94 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.717 175.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.466 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -59.1 -28.99 67.03 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.566 174.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.527 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 47.3 t0 -51.09 -58.07 7.06 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 124.258 1.023 . . . . 0.0 110.149 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.742 ' HA ' HD12 ' A' ' 21' ' ' LEU . 24.1 m -54.6 -50.03 69.0 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 176.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.586 HD11 HG21 ' A' ' 92' ' ' ILE . 9.5 mt -55.0 -35.33 64.26 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 123.627 0.579 . . . . 0.0 112.518 177.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -71.28 -39.42 71.54 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.892 173.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.742 HD12 ' HA ' ' A' ' 18' ' ' THR . 33.1 mt -70.22 -32.67 70.65 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 123.086 0.554 . . . . 0.0 111.104 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.495 HD13 HG21 ' A' ' 72' ' ' THR . 2.9 mt -72.7 -38.22 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 119.959 -1.713 . . . . 0.0 111.356 172.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.16 -42.65 62.57 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.693 -1.14 . . . . 0.0 112.303 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.39 8.66 39.63 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.661 1.184 . . . . 0.0 111.877 177.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.7 t0 39.77 49.97 2.22 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.078 1.351 . . . . 0.0 111.932 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.95 -166.92 39.48 Favored Glycine 0 N--CA 1.47 0.924 0 CA-C-N 113.056 -1.884 . . . . 0.0 115.598 -173.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.24 141.61 70.83 Favored 'Cis proline' 0 N--CA 1.48 0.71 0 O-C-N 124.014 1.534 . . . . 0.0 111.346 -0.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.504 ' CD2' ' HB3' ' A' ' 21' ' ' LEU . 51.6 m-85 -93.98 136.43 23.74 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 113.822 -1.536 . . . . 0.0 111.426 -175.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.443 ' HG2' ' CD1' ' A' ' 58' ' ' ILE . 29.9 Cg_endo -75.71 -61.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.478 0.573 0 C-N-CA 122.813 2.342 . . . . 0.0 110.719 -176.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.418 ' HD2' HG22 ' A' ' 56' ' ' THR . 0.6 OUTLIER -59.59 158.87 9.22 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.417 175.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 m -71.58 -15.21 62.26 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.938 0.875 . . . . 0.0 112.755 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.448 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -88.26 95.41 10.17 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.09 -176.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 166.58 136.1 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 111.813 -2.449 . . . . 0.0 115.35 -173.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.96 38.34 8.0 Favored Glycine 0 CA--C 1.54 1.619 0 CA-C-N 113.39 -1.732 . . . . 0.0 111.118 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.414 HG23 ' OE1' ' A' ' 54' ' ' GLU . 35.7 m -135.39 148.88 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 113.536 -1.332 . . . . 0.0 109.445 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.6 t -85.87 154.78 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 O-C-N 126.081 2.113 . . . . 0.0 109.875 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.498 ' CE2' ' HA ' ' A' ' 39' ' ' ASN . 84.8 t80 -135.15 89.54 2.53 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.428 176.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.432 ' HG3' ' CD1' ' A' ' 49' ' ' TYR . 11.5 tm0? -70.28 54.1 0.14 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 120.103 1.32 . . . . 0.0 111.695 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.498 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 15.1 p-10 25.47 52.33 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 127.837 2.455 . . . . 0.0 110.813 -175.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.82 -21.18 27.08 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.27 -173.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.603 ' O ' HG23 ' A' ' 43' ' ' VAL . 3.2 mt-10 -78.39 -12.04 59.98 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 112.956 -1.929 . . . . 0.0 115.094 172.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.7 t 45.4 39.17 4.24 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 124.081 1.896 . . . . 0.0 112.014 -177.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 41' ' ' GLU . 52.3 t -110.57 -13.32 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-O 123.634 1.683 . . . . 0.0 110.583 -177.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.567 ' HB3' ' OH ' ' A' ' 52' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 114.124 -1.398 . . . . 0.0 107.268 -172.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.432 ' CD1' ' HG3' ' A' ' 38' ' ' GLN . 9.1 t80 . . . . . 0 N--CA 1.468 0.462 0 CA-C-O 121.375 0.607 . . . . 0.0 110.09 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.94 8.66 78.53 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.664 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.478 ' HA ' ' HB2' ' A' ' 74' ' ' GLU . 71.0 t80 -81.83 13.4 3.27 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.813 1.245 . . . . 0.0 111.085 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.567 ' OH ' ' HB3' ' A' ' 44' ' ' LEU . 9.4 m-85 -149.43 156.52 42.15 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -173.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -152.15 154.99 36.94 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 125.49 1.744 . . . . 0.0 111.349 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.414 ' OE1' HG23 ' A' ' 35' ' ' VAL . 1.4 mt-10 -110.02 145.06 37.66 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.064 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.585 ' HB3' HG23 ' A' ' 18' ' ' THR . 76.8 m-85 -161.32 62.13 0.27 Allowed 'General case' 0 N--CA 1.475 0.788 0 O-C-N 125.882 1.989 . . . . 0.0 110.75 -174.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 0.9 OUTLIER -40.14 129.61 2.22 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 122.485 1.136 . . . . 0.0 111.952 177.495 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.618 HG21 ' HE1' ' A' ' 81' ' ' TYR . 14.0 m -83.65 121.15 35.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 111.515 -2.584 . . . . 0.0 108.72 176.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.453 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -42.3 162.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 O-C-N 125.363 1.665 . . . . 0.0 109.884 171.465 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.564 HG22 ' HB2' ' A' ' 62' ' ' ALA . 1.4 m -157.01 138.52 9.83 Favored Pre-proline 0 N--CA 1.482 1.146 0 O-C-N 125.374 1.672 . . . . 0.0 111.649 176.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.36 144.33 32.6 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.096 2.531 . . . . 0.0 109.463 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.61 26.64 39.55 Favored Glycine 0 CA--C 1.545 1.909 0 CA-C-N 113.081 -1.872 . . . . 0.0 112.01 -175.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.564 ' HB2' HG22 ' A' ' 59' ' ' THR . . . -86.95 89.06 7.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -40.16 -31.89 0.15 Allowed 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.908 176.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.6 p -129.79 -162.3 1.19 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.587 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.448 ' HD2' ' OE1' ' A' ' 32' ' ' GLN . 3.0 mtm105 -59.51 -14.63 13.54 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 172.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.0 137.12 0.08 OUTLIER Glycine 0 N--CA 1.467 0.722 0 N-CA-C 107.442 -2.263 . . . . 0.0 107.442 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.1 p -46.16 -28.69 1.31 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 113.43 -1.385 . . . . 0.0 113.077 174.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.422 ' HG2' ' CZ ' ' A' ' 81' ' ' TYR . 20.8 mtm-85 -50.27 139.14 15.41 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 121.02 -1.05 . . . . 0.0 113.045 170.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.527 ' HB3' ' CG2' ' A' ' 82' ' ' THR . 0.0 OUTLIER -165.14 137.94 4.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.099 -1.864 . . . . 0.0 109.15 -179.487 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.428 HD13 HD21 ' A' ' 19' ' ' LEU . 3.2 mt -105.1 138.48 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 112.694 -2.048 . . . . 0.0 109.548 173.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.539 ' O ' ' HD2' ' A' ' 80' ' ' TYR . 21.8 mm -127.86 103.39 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 112.628 -2.078 . . . . 0.0 108.365 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.642 HG22 ' HB3' ' A' ' 79' ' ' ASP . 13.1 p -88.41 162.86 16.28 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.972 178.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -104.22 -171.46 25.04 Favored Glycine 0 N--CA 1.48 1.605 0 O-C-N 125.273 1.608 . . . . 0.0 110.152 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -86.26 -11.07 53.31 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.533 0.682 . . . . 0.0 112.157 175.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.69 132.14 54.48 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 176.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.629 HG22 ' HG2' ' A' ' 77' ' ' GLN . 12.1 m -49.09 144.72 4.66 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.026 175.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.629 ' HG2' HG22 ' A' ' 76' ' ' THR . 1.4 mt-30 81.24 56.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 126.006 2.066 . . . . 0.0 109.856 177.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.592 ' HA ' HD22 ' A' ' 91' ' ' LEU . 3.7 mt-10 -166.44 54.93 0.09 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 113.222 -1.808 . . . . 0.0 114.247 -177.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.642 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.2 OUTLIER -112.68 93.2 4.31 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.939 1.296 . . . . 0.0 110.788 -177.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.61 ' HE1' HG21 ' A' ' 2' ' ' VAL . 25.2 m-85 -74.18 135.91 42.81 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 124.508 1.123 . . . . 0.0 110.325 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.678 ' HB2' HD11 ' A' ' 92' ' ' ILE . 62.3 t80 -121.56 91.9 3.62 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.527 ' CG2' ' HB3' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -44.49 -75.94 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 113.638 -1.619 . . . . 0.0 112.856 171.608 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.63 8.32 86.09 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-N 113.361 -1.745 . . . . 0.0 112.435 -175.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.533 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 34.6 m-20 -139.79 17.51 2.5 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 176.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 69.09 83.83 0.15 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.685 1.594 . . . . 0.0 111.815 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.43 ' HB3' ' CD ' ' A' ' 41' ' ' GLU . 13.0 m-85 50.12 25.92 1.92 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 113.189 -1.823 . . . . 0.0 113.894 -175.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.533 ' HB3' ' HB2' ' A' ' 84' ' ' ASP . . . -94.93 -57.96 2.29 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 120.43 -1.419 . . . . 0.0 110.825 -173.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 82' ' ' THR . 27.7 p -112.02 178.62 4.25 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.433 ' CE1' HD21 ' A' ' 44' ' ' LEU . 95.6 m-85 -161.56 122.21 2.7 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -175.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.7 m -140.39 107.93 5.59 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 126.169 2.168 . . . . 0.0 108.694 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.592 HD22 ' HA ' ' A' ' 78' ' ' GLU . 13.1 mt -43.22 161.89 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.678 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.7 mp -110.87 122.34 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 120.96 -1.087 . . . . 0.0 109.54 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.21 97.21 8.33 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 113.231 -1.804 . . . . 0.0 108.792 175.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -60.04 -40.23 88.65 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 125.321 1.638 . . . . 0.0 111.125 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.3 t -53.38 -37.45 62.46 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 114.354 -1.293 . . . . 0.0 112.651 172.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.59 ' OXT' ' HB3' ' A' ' 7' ' ' CYS . 12.0 t . . . . . 0 C--O 1.249 1.074 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.343 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.572 HG12 ' H ' ' A' ' 4' ' ' GLY . 47.7 t . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.66 5.21 5.1 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 124.323 1.014 . . . . 0.0 112.824 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.572 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 123.74 -165.67 16.47 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.183 1.373 . . . . 0.0 109.831 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 m -99.81 170.79 8.3 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.936 -1.132 . . . . 0.0 109.829 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 91' ' ' LEU . 2.2 p -140.85 109.28 2.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -175.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 82.0 m -44.99 133.42 6.39 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.016 -1.902 . . . . 0.0 111.068 177.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.52 HD11 ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -58.35 -31.65 67.79 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.676 0.61 . . . . 0.0 111.66 -178.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -65.4 -28.69 69.44 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.538 173.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.16 -30.96 60.88 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.598 0.759 . . . . 0.0 111.432 175.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.7 mt -81.22 161.45 62.54 Favored Pre-proline 0 N--CA 1.475 0.784 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -66.94 168.67 16.56 Favored 'Trans proline' 0 CA--C 1.544 1.004 0 C-N-CA 122.671 2.247 . . . . 0.0 112.759 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.82 -32.36 18.46 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.768 2.312 . . . . 0.0 112.447 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.87 -5.96 44.26 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.448 1.099 . . . . 0.0 112.017 176.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.758 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -71.28 -57.03 4.86 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.418 1.087 . . . . 0.0 112.487 176.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.52 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -56.81 -24.2 49.14 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 174.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -49.08 -55.32 12.54 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.671 1.189 . . . . 0.0 111.527 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.648 HG21 ' O ' ' A' ' 55' ' ' TYR . 94.9 m -66.28 -43.02 87.57 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 176.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.656 HD21 ' OD2' ' A' ' 79' ' ' ASP . 95.6 mt -52.36 -35.5 51.45 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 173.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -67.35 -41.14 85.63 Favored 'General case' 0 C--O 1.207 -1.181 0 CA-C-N 113.868 -1.515 . . . . 0.0 110.77 175.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 18' ' ' THR . 31.5 mt -67.2 -36.17 81.17 Favored 'General case' 0 C--O 1.213 -0.857 0 CA-C-O 118.12 -0.943 . . . . 0.0 112.093 175.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.581 HD12 ' O ' ' A' ' 18' ' ' THR . 2.4 mt -64.33 -43.0 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 118.852 0.751 . . . . 0.0 111.616 172.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.36 -46.56 63.84 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.689 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.1 t -72.76 -12.03 60.84 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.267 1.827 . . . . 0.0 111.542 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 t0 54.52 40.62 31.96 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.256 1.422 . . . . 0.0 110.289 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.03 -170.52 39.68 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 113.055 -1.884 . . . . 0.0 115.969 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -74.67 139.81 63.78 Favored 'Cis proline' 0 C--N 1.347 0.454 0 O-C-N 124.096 1.577 . . . . 0.0 111.976 -1.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -90.55 135.53 29.2 Favored Pre-proline 0 N--CA 1.481 1.085 0 CA-C-N 113.723 -1.58 . . . . 0.0 110.849 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -72.5 -61.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.475 0.423 0 C-N-CA 123.216 2.611 . . . . 0.0 112.073 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.402 ' CD1' HD11 ' A' ' 58' ' ' ILE . 3.0 m-30 -64.15 146.95 53.37 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 118.847 -0.597 . . . . 0.0 110.658 176.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.6 t -65.38 -13.69 59.18 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 125.4 1.688 . . . . 0.0 112.956 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -80.96 77.38 7.87 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 122.734 1.254 . . . . 0.0 112.355 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -177.54 148.5 0.57 Allowed 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 111.104 -2.771 . . . . 0.0 113.307 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.4 31.98 29.35 Favored Glycine 0 N--CA 1.479 1.521 0 CA-C-N 113.084 -1.871 . . . . 0.0 111.306 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.64 146.85 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.218 1.007 . . . . 0.0 109.905 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.0 t -86.58 152.87 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 125.949 2.031 . . . . 0.0 110.014 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.521 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 44.8 t80 -130.28 93.75 3.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 113.518 -1.674 . . . . 0.0 108.838 175.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.508 ' HG3' ' CD1' ' A' ' 49' ' ' TYR . 7.6 tm0? -71.93 54.0 0.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.087 -1.008 . . . . 0.0 111.969 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.408 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 16.5 p-10 26.18 56.12 0.05 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.413 2.285 . . . . 0.0 111.035 -176.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -25.87 55.22 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.03 -172.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.567 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.8 mt-10 -78.0 -13.26 59.94 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-N 112.981 -1.918 . . . . 0.0 115.125 172.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.9 t 45.24 41.67 6.29 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 123.847 1.784 . . . . 0.0 111.886 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 41' ' ' GLU . 44.2 t -107.72 -14.14 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 113.732 -1.577 . . . . 0.0 110.126 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.812 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.317 -0.819 0 CA-C-O 117.662 -1.161 . . . . 0.0 108.451 -171.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.508 ' CD1' ' HG3' ' A' ' 38' ' ' GLN . 9.8 t80 . . . . . 0 N--CA 1.478 0.95 0 CA-C-O 121.075 0.464 . . . . 0.0 110.117 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.06 9.99 77.17 Favored Glycine 0 CA--C 1.542 1.773 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.851 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.456 ' HD2' ' CE1' ' A' ' 52' ' ' TYR . 57.5 t80 -82.09 8.79 9.86 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.474 1.109 . . . . 0.0 111.391 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.812 ' HE2' HD12 ' A' ' 44' ' ' LEU . 11.7 m-85 -146.73 145.84 30.1 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -141.36 157.2 45.5 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 126.541 2.401 . . . . 0.0 110.883 178.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -110.4 143.07 41.21 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.864 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.648 ' O ' HG21 ' A' ' 18' ' ' THR . 79.6 m-85 -158.78 69.67 0.49 Allowed 'General case' 0 N--CA 1.471 0.579 0 O-C-N 126.107 2.13 . . . . 0.0 110.144 -175.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 6.3 m -43.37 129.06 5.0 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 122.971 1.367 . . . . 0.0 112.197 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.758 HG21 ' HA ' ' A' ' 15' ' ' ALA . 1.8 p -89.3 118.12 33.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 111.109 -2.769 . . . . 0.0 109.965 178.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.402 HD11 ' CD1' ' A' ' 30' ' ' TYR . 0.4 OUTLIER -43.32 151.69 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.227 170.309 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.567 ' OG1' ' HG3' ' A' ' 68' ' ' ARG . 3.4 m -145.29 142.85 18.78 Favored Pre-proline 0 N--CA 1.475 0.823 0 CA-C-N 113.64 -1.618 . . . . 0.0 111.647 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.433 ' HD2' HG23 ' A' ' 59' ' ' THR . 73.4 Cg_endo -75.57 145.12 29.21 Favored 'Trans proline' 0 N--CA 1.479 0.658 0 C-N-CA 121.824 1.683 . . . . 0.0 110.216 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.86 28.16 57.16 Favored Glycine 0 CA--C 1.546 2.01 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.189 -175.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.7 92.44 6.58 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -39.41 -33.64 0.17 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 114.204 -1.362 . . . . 0.0 113.296 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 57.7 p -130.57 -160.56 1.05 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.888 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.2 mtm180 -56.08 -19.79 14.49 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 172.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.16 167.55 3.19 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 123.889 1.827 . . . . 0.0 109.379 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.435 HG22 ' HB2' ' A' ' 85' ' ' HIS . 40.7 p -71.27 -5.26 30.85 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 112.423 -1.888 . . . . 0.0 113.286 176.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.567 ' HG3' ' OG1' ' A' ' 59' ' ' THR . 0.2 OUTLIER -73.0 117.03 14.23 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.561 1.172 . . . . 0.0 110.161 177.624 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 0.8 OUTLIER -140.24 133.8 30.16 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 113.865 -1.516 . . . . 0.0 109.191 179.28 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.526 HG23 ' OD1' ' A' ' 79' ' ' ASP . 4.7 mt -105.42 133.67 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 125.923 2.014 . . . . 0.0 107.835 175.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.505 ' O ' ' HD2' ' A' ' 80' ' ' TYR . 23.3 mm -123.5 107.16 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 113.525 -1.67 . . . . 0.0 107.415 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.5 p -93.5 163.87 13.4 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 120.969 0.414 . . . . 0.0 110.696 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.57 -172.17 23.8 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.256 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.64 -14.15 60.0 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.322 0.582 . . . . 0.0 112.158 175.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -115.93 131.57 56.9 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.553 HG22 ' HG2' ' A' ' 77' ' ' GLN . 7.5 m -56.34 151.53 12.77 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.836 175.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.553 ' HG2' HG22 ' A' ' 76' ' ' THR . 1.0 OUTLIER 74.82 32.97 0.8 Allowed 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 123.508 1.623 . . . . 0.0 110.766 -179.54 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.413 ' HA ' HD22 ' A' ' 91' ' ' LEU . 1.2 mt-10 -138.76 57.09 1.69 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 113.547 -1.66 . . . . 0.0 112.479 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.656 ' OD2' HD21 ' A' ' 19' ' ' LEU . 1.8 t0 -101.98 130.03 48.41 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 113.882 -1.508 . . . . 0.0 108.461 174.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.526 ' CE1' HG21 ' A' ' 2' ' ' VAL . 26.6 m-85 -102.27 129.15 48.6 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.714 -1.584 . . . . 0.0 109.465 175.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.732 ' HB2' HD11 ' A' ' 92' ' ' ILE . 10.1 t80 -108.21 124.37 50.18 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 113.641 -1.618 . . . . 0.0 109.001 -177.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.54 ' HB ' ' O ' ' A' ' 88' ' ' THR 0.265 0.5 OUTLIER -86.0 -68.4 0.74 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 113.09 -1.868 . . . . 0.0 112.037 176.161 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.453 ' HA2' ' HD2' ' A' ' 68' ' ' ARG . . . 68.87 1.65 26.04 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 114.605 -1.179 . . . . 0.0 113.876 -172.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.57 ' CB ' ' HB3' ' A' ' 87' ' ' ALA . 59.0 m-20 -129.7 12.13 5.78 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.392 1.077 . . . . 0.0 113.631 178.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.435 ' HB2' HG22 ' A' ' 67' ' ' THR . 40.4 t-80 61.92 81.28 0.2 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.513 2.325 . . . . 0.0 111.647 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.434 ' HB3' ' OE1' ' A' ' 41' ' ' GLU . 17.0 m-85 54.2 33.29 17.73 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 114.424 -1.262 . . . . 0.0 113.997 -175.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.57 ' HB3' ' CB ' ' A' ' 84' ' ' ASP . . . -111.71 -6.76 14.3 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.54 ' O ' ' HB ' ' A' ' 82' ' ' THR . 6.5 p -163.91 165.17 22.98 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.768 1.627 . . . . 0.0 108.122 -177.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.616 ' CG ' HD21 ' A' ' 44' ' ' LEU . 86.1 m-85 -159.55 117.91 2.79 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 -174.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.52 106.5 5.97 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.357 -1.747 . . . . 0.0 108.432 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 91' ' ' LEU . 18.1 mt -40.47 157.29 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.638 177.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.732 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.7 mp -104.29 133.18 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.045 -1.035 . . . . 0.0 109.517 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.99 89.37 2.98 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 113.329 -1.76 . . . . 0.0 109.338 177.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -63.7 -40.46 96.85 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.409 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 t -51.39 -40.01 58.35 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 125.295 1.622 . . . . 0.0 112.813 172.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 8.4 t . . . . . 0 C--O 1.258 1.51 0 CA-C-O 116.733 -1.604 . . . . 0.0 110.747 178.445 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.6 m -64.37 -8.26 12.57 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 175.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.46 169.46 12.68 Favored Glycine 0 N--CA 1.474 1.196 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.454 HG23 ' HB3' ' A' ' 91' ' ' LEU . 1.8 m -78.76 172.02 14.33 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.566 -0.817 . . . . 0.0 110.782 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 91' ' ' LEU . 3.9 p -145.65 108.06 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -174.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 57.6 m -42.9 138.32 2.05 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 113.266 -1.788 . . . . 0.0 111.658 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.719 ' HA ' HD12 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -59.84 -33.03 71.24 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.756 0.66 . . . . 0.0 111.962 -178.493 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.4 t -70.85 -15.79 62.66 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.773 174.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.13 -37.45 46.14 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.65 0.738 . . . . 0.0 111.832 176.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.719 HD12 ' HA ' ' A' ' 8' ' ' LEU . 2.3 mt -77.83 166.28 44.83 Favored Pre-proline 0 N--CA 1.475 0.788 0 C-N-CA 124.531 1.133 . . . . 0.0 111.111 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.67 169.89 15.02 Favored 'Trans proline' 0 CA--C 1.553 1.471 0 C-N-CA 122.713 2.275 . . . . 0.0 113.353 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.3 -15.88 39.12 Favored 'Trans proline' 0 N--CA 1.484 0.932 0 C-N-CA 122.305 2.004 . . . . 0.0 113.437 175.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.416 ' CD ' ' HD3' ' A' ' 60' ' ' PRO . 1.9 mt-10 -93.81 4.81 53.37 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.935 0.894 . . . . 0.0 112.111 178.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.635 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -80.86 -48.11 12.86 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.96 176.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.568 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -58.28 -23.03 54.92 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.413 -1.267 . . . . 0.0 112.701 174.381 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.461 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 9.9 t0 -49.97 -58.01 6.34 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.289 1.035 . . . . 0.0 110.324 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.696 ' HA ' HD12 ' A' ' 21' ' ' LEU . 44.7 m -56.63 -49.49 74.84 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 177.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.691 HD11 HG21 ' A' ' 92' ' ' ILE . 7.8 mt -55.53 -35.73 65.98 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 123.805 0.69 . . . . 0.0 111.693 178.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -68.34 -38.48 81.53 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.015 173.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.696 HD12 ' HA ' ' A' ' 18' ' ' THR . 33.9 mt -69.19 -34.8 75.48 Favored 'General case' 0 C--O 1.212 -0.874 0 CA-C-O 118.746 -0.645 . . . . 0.0 110.954 175.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.602 HD12 ' O ' ' A' ' 18' ' ' THR . 1.6 mp -69.76 -40.73 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 120.186 1.357 . . . . 0.0 111.312 172.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.8 -42.48 67.02 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.023 -0.989 . . . . 0.0 112.291 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.27 7.55 42.21 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.116 0.966 . . . . 0.0 111.35 177.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.0 t0 39.52 52.5 2.34 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 123.209 1.48 . . . . 0.0 112.156 -178.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.3 -164.77 40.44 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 112.721 -2.036 . . . . 0.0 115.659 -173.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.9 141.44 71.75 Favored 'Cis proline' 0 C--N 1.346 0.415 0 O-C-N 124.678 1.883 . . . . 0.0 111.849 -2.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 21' ' ' LEU . 75.7 m-85 -94.52 132.92 27.78 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.248 -176.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.451 ' HG2' ' CD1' ' A' ' 58' ' ' ILE . 36.6 Cg_endo -75.12 -59.55 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.546 2.164 . . . . 0.0 111.24 -177.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -60.69 157.76 14.01 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.486 0.66 . . . . 0.0 112.436 175.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.4 t -77.43 -10.58 59.55 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 122.524 1.154 . . . . 0.0 112.215 175.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -91.6 87.56 6.4 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.624 0.726 . . . . 0.0 112.21 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 172.29 136.33 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 111.517 -2.583 . . . . 0.0 114.259 -174.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.08 28.75 16.9 Favored Glycine 0 N--CA 1.48 1.602 0 CA-C-N 113.189 -1.823 . . . . 0.0 111.729 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.446 HG23 ' OE1' ' A' ' 54' ' ' GLU . 13.2 m -123.48 146.59 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 113.6 -1.3 . . . . 0.0 109.713 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.0 t -81.95 156.79 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 125.536 1.772 . . . . 0.0 109.724 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.436 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 48.2 t80 -139.23 86.28 2.12 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.634 176.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -69.66 52.86 0.11 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 122.401 1.096 . . . . 0.0 113.629 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.2 t30 31.23 55.17 0.23 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 127.057 2.143 . . . . 0.0 109.399 -172.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.56 -31.32 62.05 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 122.454 1.121 . . . . 0.0 111.766 -175.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.557 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.7 mt-10 -79.06 -8.15 58.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 112.928 -1.942 . . . . 0.0 114.3 174.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 39.9 t 43.82 42.66 4.61 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 124.132 1.92 . . . . 0.0 111.975 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 41' ' ' GLU . 61.7 t -107.36 -18.05 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 113.301 -1.772 . . . . 0.0 109.704 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.538 HD21 ' CD1' ' A' ' 89' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--N 1.32 -0.679 0 O-C-N 121.189 -0.944 . . . . 0.0 108.657 -176.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.6 t80 . . . . . 0 N--CA 1.464 0.253 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.08 -22.71 33.04 Favored Glycine 0 N--CA 1.476 1.318 0 O-C-N 125.708 1.88 . . . . 0.0 111.691 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.46 -13.9 45.19 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 124.325 1.05 . . . . 0.0 112.924 175.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.431 ' OH ' ' HB3' ' A' ' 44' ' ' LEU . 17.4 m-85 -116.78 162.44 17.69 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.412 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -158.92 159.81 35.36 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 112.515 -2.13 . . . . 0.0 111.686 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.446 ' OE1' HG23 ' A' ' 35' ' ' VAL . 1.4 mt-10 -117.64 136.39 53.34 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.85 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.501 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 86.4 m-85 -151.6 75.52 1.17 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 113.622 -1.626 . . . . 0.0 110.212 -176.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.554 HG21 ' HG2' ' A' ' 65' ' ' ARG . 52.8 m -42.91 138.56 1.98 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 122.438 1.113 . . . . 0.0 112.516 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.635 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.5 OUTLIER -98.36 106.89 19.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 112.195 -2.275 . . . . 0.0 110.073 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.451 ' CD1' ' HG2' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -39.36 147.04 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.266 172.126 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.472 HG23 ' HD2' ' A' ' 60' ' ' PRO . 3.2 m -144.44 140.65 16.9 Favored Pre-proline 0 N--CA 1.473 0.722 0 O-C-N 125.465 1.728 . . . . 0.0 112.018 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.472 ' HD2' HG23 ' A' ' 59' ' ' THR . 71.9 Cg_endo -74.34 146.31 35.44 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.066 1.844 . . . . 0.0 110.177 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.63 25.42 55.48 Favored Glycine 0 N--CA 1.485 1.937 0 CA-C-N 114.22 -1.355 . . . . 0.0 112.196 -175.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.71 91.38 6.99 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -39.96 -32.22 0.15 Allowed 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 113.585 -1.643 . . . . 0.0 113.325 176.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.0 p -131.26 -159.0 0.93 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.505 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.554 ' HG2' HG21 ' A' ' 56' ' ' THR . 0.0 OUTLIER -59.09 -18.05 31.82 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.968 -1.015 . . . . 0.0 113.585 171.642 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.33 162.5 0.59 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-O 123.697 1.721 . . . . 0.0 109.59 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.511 HG22 ' HB2' ' A' ' 85' ' ' HIS . 24.3 p -65.65 -10.73 38.72 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 113.137 -1.531 . . . . 0.0 113.241 174.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.49 ' HD2' ' HA2' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -64.94 124.46 22.1 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 123.279 1.514 . . . . 0.0 110.715 175.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.24 144.76 26.73 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 112.866 -1.97 . . . . 0.0 110.588 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 55' ' ' TYR . 8.4 mt -120.44 137.04 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 125.398 1.686 . . . . 0.0 108.673 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.47 ' O ' ' HD2' ' A' ' 80' ' ' TYR . 16.7 mm -127.57 102.41 8.93 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 CA-C-N 112.737 -2.029 . . . . 0.0 107.758 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.479 HG22 ' HB3' ' A' ' 79' ' ' ASP . 17.7 p -90.16 163.37 14.85 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.667 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -116.77 165.67 12.35 Favored Glycine 0 N--CA 1.471 0.981 0 CA-C-N 113.534 -1.666 . . . . 0.0 109.357 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.49 -14.9 62.9 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.701 0.763 . . . . 0.0 111.687 176.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.443 ' HB3' ' OE2' ' A' ' 78' ' ' GLU . . . -106.27 131.04 53.97 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.622 HG22 ' HG2' ' A' ' 77' ' ' GLN . 3.0 m -55.34 143.14 29.48 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 113.776 -1.556 . . . . 0.0 108.361 174.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.622 ' HG2' HG22 ' A' ' 76' ' ' THR . 0.0 OUTLIER 79.6 34.57 0.18 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.936 2.095 . . . . 0.0 111.224 179.49 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.443 ' OE2' ' HB3' ' A' ' 75' ' ' ALA . 37.9 mt-10 -129.79 49.95 2.22 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 123.232 1.491 . . . . 0.0 112.299 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.479 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -107.55 100.99 10.36 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 113.607 -1.633 . . . . 0.0 110.307 -176.64 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.47 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 22.2 m-85 -89.83 135.2 33.77 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 113.996 -1.457 . . . . 0.0 109.319 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.725 ' HB2' HD11 ' A' ' 92' ' ' ILE . 11.0 t80 -115.2 127.42 55.51 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.947 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.536 ' HB ' ' O ' ' A' ' 88' ' ' THR 0.251 0.4 OUTLIER -86.77 -68.87 0.71 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 113.012 -1.904 . . . . 0.0 111.417 176.823 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.49 ' HA2' ' HD2' ' A' ' 68' ' ' ARG . . . 69.01 1.7 27.26 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 114.047 -1.433 . . . . 0.0 113.544 -172.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.626 ' CB ' ' HB3' ' A' ' 87' ' ' ALA . 74.0 m-20 -129.9 10.47 5.49 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.237 1.015 . . . . 0.0 113.595 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.511 ' HB2' HG22 ' A' ' 67' ' ' THR . 43.6 t-80 64.88 80.13 0.24 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 128.081 2.552 . . . . 0.0 110.698 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.468 ' HB3' ' CD ' ' A' ' 41' ' ' GLU . 17.0 m-85 55.82 26.19 9.32 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 122.928 1.347 . . . . 0.0 113.413 -174.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.626 ' HB3' ' CB ' ' A' ' 84' ' ' ASP . . . -102.51 -8.86 20.69 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.54 -1.35 . . . . 0.0 112.766 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.536 ' O ' ' HB ' ' A' ' 82' ' ' THR . 12.5 p -163.14 169.37 19.47 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.621 1.568 . . . . 0.0 108.859 -176.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.538 ' CD1' HD21 ' A' ' 44' ' ' LEU . 92.5 m-85 -158.5 115.14 2.78 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -174.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.49 107.04 8.61 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 113.203 -1.817 . . . . 0.0 109.483 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.538 ' O ' HG12 ' A' ' 6' ' ' VAL . 18.0 mt -42.8 160.94 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 177.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.725 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.3 mp -110.05 113.72 45.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 O-C-N 120.982 -1.074 . . . . 0.0 109.194 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.09 87.21 7.35 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 113.833 -1.53 . . . . 0.0 109.686 176.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.529 ' HG3' HG22 ' A' ' 92' ' ' ILE . 2.4 mp0 -67.65 -31.41 71.39 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.643 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.6 t -55.64 -27.96 52.72 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.849 173.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.4 t . . . . . 0 C--O 1.253 1.265 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.887 177.691 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.529 HG12 ' H ' ' A' ' 4' ' ' GLY . 16.0 t . . . . . 0 N--CA 1.469 0.518 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 m -72.79 4.76 3.74 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 125.021 1.45 . . . . 0.0 113.095 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.529 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 123.09 168.89 13.18 Favored Glycine 0 C--O 1.216 -1.014 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 6' ' ' VAL . 3.4 m -76.68 174.62 10.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.653 -1.273 . . . . 0.0 110.159 -178.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.452 ' H ' HG22 ' A' ' 5' ' ' THR . 0.6 OUTLIER -140.36 109.38 3.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -175.108 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 74.9 m -47.19 125.37 7.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 112.669 -2.06 . . . . 0.0 109.367 176.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -49.81 -36.26 25.85 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 118.771 -0.633 . . . . 0.0 111.745 175.404 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.9 t -65.07 -28.52 69.52 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.889 0.852 . . . . 0.0 112.503 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 7' ' ' CYS . . . -75.22 -23.96 57.67 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.714 175.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.563 HD13 ' HB1' ' A' ' 15' ' ' ALA . 12.0 mt -83.52 160.44 59.14 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 176.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.508 ' HB2' ' OE2' ' A' ' 14' ' ' GLU . 79.1 Cg_endo -69.04 170.44 15.72 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.237 1.958 . . . . 0.0 112.826 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.35 -13.43 33.19 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.723 2.282 . . . . 0.0 114.235 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.508 ' OE2' ' HB2' ' A' ' 12' ' ' PRO . 1.5 pm0 -95.28 -3.45 47.43 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.642 175.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.721 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -72.6 -50.45 25.24 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.909 177.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.21 -24.97 45.39 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.284 -1.326 . . . . 0.0 112.204 175.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.477 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 35.0 t0 -51.44 -60.18 3.42 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.374 1.046 . . . . 0.0 110.012 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.789 ' HA ' HD12 ' A' ' 21' ' ' LEU . 16.2 m -55.95 -52.24 64.86 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.647 0.592 . . . . 0.0 112.426 177.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.58 HD11 HG21 ' A' ' 92' ' ' ILE . 6.1 mt -52.72 -34.15 51.17 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.517 0.51 . . . . 0.0 111.837 178.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -70.39 -40.72 73.76 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 124.102 0.961 . . . . 0.0 110.818 174.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.789 HD12 ' HA ' ' A' ' 18' ' ' THR . 26.5 mt -67.79 -32.21 72.63 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 119.095 -0.478 . . . . 0.0 110.23 175.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.723 HD12 ' O ' ' A' ' 18' ' ' THR . 1.6 mp -69.9 -43.08 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 120.597 1.544 . . . . 0.0 111.684 172.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.01 -42.76 72.58 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 125.034 1.459 . . . . 0.0 111.844 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.78 7.41 39.86 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.482 1.113 . . . . 0.0 111.748 177.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.6 t70 40.6 50.24 2.84 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 125.283 1.433 . . . . 0.0 110.977 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.59 -166.77 45.77 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 113.616 -1.629 . . . . 0.0 114.864 -173.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.53 141.03 69.91 Favored 'Cis proline' 0 N--CA 1.48 0.732 0 O-C-N 124.209 1.637 . . . . 0.0 111.19 0.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -91.21 136.23 27.41 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 113.051 -1.886 . . . . 0.0 111.656 -177.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.453 ' HG2' ' CD1' ' A' ' 58' ' ' ILE . 33.5 Cg_endo -74.76 -63.63 0.03 OUTLIER 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 122.463 2.108 . . . . 0.0 111.076 -178.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -59.59 150.62 26.76 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.548 0.689 . . . . 0.0 111.596 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.69 -5.71 42.26 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.024 176.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.451 ' NE2' HG21 ' A' ' 56' ' ' THR . 13.4 mt-30 -97.38 88.89 4.54 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.957 0.884 . . . . 0.0 112.261 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 169.99 134.16 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 112.115 -2.311 . . . . 0.0 113.751 -175.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.65 17.26 33.87 Favored Glycine 0 N--CA 1.484 1.872 0 CA-C-N 112.706 -2.043 . . . . 0.0 111.846 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.466 HG23 ' HB2' ' A' ' 54' ' ' GLU . 15.9 m -109.62 150.75 12.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 123.634 0.774 . . . . 0.0 109.502 176.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.3 t -84.01 154.47 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 O-C-N 125.674 1.859 . . . . 0.0 110.473 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.556 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 57.6 t80 -131.92 92.5 3.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.549 176.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -68.93 47.69 0.06 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.398 1.094 . . . . 0.0 112.96 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.406 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 40.4 t30 28.91 53.0 0.08 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.459 1.503 . . . . 0.0 110.628 -173.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.89 -23.46 53.27 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 113.912 -1.494 . . . . 0.0 110.984 -172.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.597 ' O ' HG23 ' A' ' 43' ' ' VAL . 4.3 mt-10 -86.77 -12.86 46.89 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 112.684 -2.053 . . . . 0.0 113.868 173.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.4 t 43.75 43.53 5.02 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 124.605 2.145 . . . . 0.0 111.663 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 41' ' ' GLU . 79.5 t -105.75 -17.74 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 112.689 -2.051 . . . . 0.0 110.007 -178.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.552 HD21 ' CD1' ' A' ' 89' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.51 0 CA-C-O 117.691 -1.147 . . . . 0.0 108.878 -175.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.9 t80 . . . . . 0 N--CA 1.463 0.202 0 CA-C-O 120.05 -0.024 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.58 -16.78 38.5 Favored Glycine 0 N--CA 1.479 1.559 0 O-C-N 125.022 1.451 . . . . 0.0 111.904 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -68.13 -9.79 49.22 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.63 0.772 . . . . 0.0 112.149 176.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.556 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 24.6 m-85 -121.3 169.4 10.62 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 124.298 1.039 . . . . 0.0 109.791 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -159.79 164.13 33.99 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 113.237 -1.801 . . . . 0.0 110.659 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.466 ' HB2' HG23 ' A' ' 35' ' ' VAL . 3.5 mp0 -118.98 139.73 51.19 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.846 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.631 ' HB3' HG23 ' A' ' 18' ' ' THR . 26.9 m-85 -153.09 61.9 0.77 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 125.81 1.944 . . . . 0.0 111.36 -175.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 23.3 m -38.24 124.39 1.22 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.362 1.077 . . . . 0.0 112.089 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.721 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -86.66 108.74 18.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 111.901 -2.409 . . . . 0.0 108.767 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.453 ' CD1' ' HG2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -38.23 146.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.443 172.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.479 ' OG1' ' HG3' ' A' ' 68' ' ' ARG . 3.4 m -137.29 140.26 30.29 Favored Pre-proline 0 C--N 1.324 -0.53 0 O-C-N 125.157 1.535 . . . . 0.0 111.654 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.499 ' HD3' ' CD ' ' A' ' 14' ' ' GLU . 71.8 Cg_endo -74.25 150.05 41.45 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.188 2.592 . . . . 0.0 109.502 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 49.73 30.96 15.18 Favored Glycine 0 N--CA 1.479 1.523 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.904 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.01 88.87 5.39 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -41.8 -29.72 0.21 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.247 -1.342 . . . . 0.0 112.794 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.7 p -126.24 -163.69 1.25 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.997 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -59.43 -15.75 19.19 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 173.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.55 153.67 0.8 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.535 HG22 ' HB2' ' A' ' 85' ' ' HIS . 24.6 p -67.23 -8.86 34.9 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 112.671 -1.765 . . . . 0.0 112.761 176.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.479 ' HG3' ' OG1' ' A' ' 59' ' ' THR . 0.0 OUTLIER -70.14 116.04 10.04 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.54 1.136 . . . . 0.0 110.413 177.039 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 0.4 OUTLIER -140.05 137.96 35.01 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.887 -1.506 . . . . 0.0 109.452 179.149 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.596 HG23 ' OD1' ' A' ' 79' ' ' ASP . 4.7 mt -109.05 141.08 25.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 113.644 -1.616 . . . . 0.0 109.097 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.492 ' HB ' ' HB2' ' A' ' 80' ' ' TYR . 19.0 mm -129.42 107.03 14.61 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 CA-C-N 113.808 -1.542 . . . . 0.0 109.309 -177.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.527 HG21 HG12 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -83.05 167.45 17.87 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 123.348 0.659 . . . . 0.0 110.861 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -120.34 173.18 15.23 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.03 -14.84 63.29 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 113.866 -1.167 . . . . 0.0 111.691 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.31 128.48 54.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.434 175.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.624 HG22 ' HG2' ' A' ' 77' ' ' GLN . 2.3 m -59.06 141.81 53.03 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 113.506 -1.679 . . . . 0.0 106.98 175.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.624 ' HG2' HG22 ' A' ' 76' ' ' THR . 0.3 OUTLIER 81.28 32.04 0.13 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 126.193 2.183 . . . . 0.0 111.002 178.327 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -133.45 57.47 1.81 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.786 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.596 ' OD1' HG23 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -99.74 122.16 42.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.53 -1.668 . . . . 0.0 110.19 178.211 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.492 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 40.4 m-85 -95.55 137.68 34.29 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 124.914 1.286 . . . . 0.0 109.373 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.71 ' HB2' HD11 ' A' ' 92' ' ' ILE . 7.1 t80 -116.64 123.74 48.05 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.717 -177.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.562 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.5 OUTLIER -86.93 -66.21 0.93 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 113.663 -1.608 . . . . 0.0 110.734 178.187 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.08 2.31 17.56 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-N 113.598 -1.637 . . . . 0.0 113.092 -173.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.642 ' CB ' ' HB3' ' A' ' 87' ' ' ALA . 80.9 m-20 -129.63 8.6 5.39 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.535 ' HB2' HG22 ' A' ' 67' ' ' THR . 45.5 t-80 67.76 80.81 0.2 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 128.213 2.605 . . . . 0.0 110.556 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.409 ' HB3' ' CD ' ' A' ' 41' ' ' GLU . 19.6 m-85 55.67 24.3 7.0 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 123.695 1.712 . . . . 0.0 112.99 -175.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.642 ' HB3' ' CB ' ' A' ' 84' ' ' ASP . . . -99.74 -10.07 22.3 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 117.954 -1.498 . . . . 0.0 112.391 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.562 ' O ' ' HB ' ' A' ' 82' ' ' THR . 15.5 p -162.89 171.98 15.82 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 -177.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.552 ' CD1' HD21 ' A' ' 44' ' ' LEU . 89.7 m-85 -159.91 114.17 2.27 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -174.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.01 104.91 7.09 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 113.854 -1.521 . . . . 0.0 108.682 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 91' ' ' LEU . 19.0 mt -42.05 164.66 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 O-C-N 124.209 0.943 . . . . 0.0 112.101 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.71 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.7 mp -111.41 134.5 53.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 O-C-N 120.699 -1.251 . . . . 0.0 108.996 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.29 93.91 4.67 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.661 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.497 HE22 ' HB3' ' A' ' 77' ' ' GLN . 3.3 mp0 -56.39 -38.09 71.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 123.976 0.798 . . . . 0.0 112.102 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.3 t -54.71 -46.49 74.18 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.047 1.339 . . . . 0.0 112.67 173.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 24.7 t . . . . . 0 C--O 1.249 1.029 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.43 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.64 HG12 ' H ' ' A' ' 4' ' ' GLY . 43.9 t . . . . . 0 N--CA 1.472 0.659 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 t -69.59 -2.36 11.32 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 124.731 1.269 . . . . 0.0 112.96 176.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.64 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 124.36 169.03 12.99 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.517 1.532 . . . . 0.0 109.474 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.482 HG23 ' CB ' ' A' ' 91' ' ' LEU . 1.8 m -81.77 169.46 16.9 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.839 0.828 . . . . 0.0 110.377 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 p -140.47 107.77 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -174.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 61.5 m -47.09 136.6 8.54 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 113.542 -1.663 . . . . 0.0 111.063 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.53 HD11 ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -56.89 -32.17 65.61 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.837 -178.866 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.1 t -66.77 -29.02 68.87 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.863 173.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.13 -29.76 60.62 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.396 0.679 . . . . 0.0 111.523 175.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.59 HD13 ' HB1' ' A' ' 15' ' ' ALA . 13.5 mt -77.98 160.64 73.4 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 175.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.643 ' HB2' ' OE2' ' A' ' 14' ' ' GLU . 86.3 Cg_endo -68.72 168.01 21.33 Favored 'Trans proline' 0 CA--C 1.554 1.482 0 C-N-CA 122.559 2.173 . . . . 0.0 112.799 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.29 -12.41 34.88 Favored 'Trans proline' 0 CA--C 1.55 1.306 0 C-N-CA 123.156 2.57 . . . . 0.0 113.944 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.643 ' OE2' ' HB2' ' A' ' 12' ' ' PRO . 1.7 pm0 -93.38 -11.84 31.32 Favored 'General case' 0 C--O 1.216 -0.705 0 C-N-CA 124.998 1.319 . . . . 0.0 113.188 174.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.809 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -65.15 -50.08 67.4 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 175.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.53 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -56.05 -26.44 49.22 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.937 173.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.491 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 13.9 t70 -54.98 -56.84 15.27 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.153 0.981 . . . . 0.0 110.132 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.672 ' O ' HD12 ' A' ' 22' ' ' ILE . 5.5 m -57.15 -49.1 77.01 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 176.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.624 HD11 HG21 ' A' ' 92' ' ' ILE . 9.8 mt -55.85 -35.72 66.74 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.898 0.749 . . . . 0.0 111.806 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -67.91 -37.36 81.6 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.63 174.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.644 HD12 ' HA ' ' A' ' 18' ' ' THR . 28.2 mt -69.17 -32.01 71.04 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 118.494 -0.765 . . . . 0.0 111.629 173.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.672 HD12 ' O ' ' A' ' 18' ' ' THR . 1.8 mp -69.42 -43.85 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 119.668 1.122 . . . . 0.0 111.969 171.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.13 -42.99 71.87 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.119 -1.4 . . . . 0.0 112.863 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.17 4.49 50.34 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.454 1.102 . . . . 0.0 112.084 177.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.7 t0 40.94 50.39 3.1 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.495 1.518 . . . . 0.0 111.383 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.18 -164.93 28.73 Favored Glycine 0 N--CA 1.473 1.149 0 CA-C-N 111.932 -2.395 . . . . 0.0 116.524 -174.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -74.08 141.56 72.11 Favored 'Cis proline' 0 C--N 1.348 0.524 0 O-C-N 124.462 1.769 . . . . 0.0 111.79 -3.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -96.9 116.5 66.09 Favored Pre-proline 0 N--CA 1.47 0.57 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.208 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.94 -48.17 0.3 Allowed 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 122.865 2.377 . . . . 0.0 111.927 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.404 ' CE2' ' HG2' ' A' ' 65' ' ' ARG . 0.2 OUTLIER -67.3 132.44 47.73 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.104 176.14 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.8 m -70.76 56.9 0.19 Allowed 'General case' 0 N--CA 1.477 0.925 0 O-C-N 125.17 1.544 . . . . 0.0 112.771 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -157.08 73.65 0.76 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 113.566 -1.652 . . . . 0.0 111.863 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.57 144.74 1.14 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 110.987 -2.824 . . . . 0.0 113.481 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.91 23.67 37.8 Favored Glycine 0 CA--C 1.538 1.526 0 CA-C-N 113.237 -1.801 . . . . 0.0 111.839 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.8 m -122.08 145.22 29.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 C-N-CA 124.748 1.219 . . . . 0.0 110.203 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.3 t -81.44 154.13 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 O-C-N 125.969 2.043 . . . . 0.0 110.165 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.433 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 49.8 t80 -131.34 91.7 3.06 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 113.565 -1.652 . . . . 0.0 109.324 175.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.91 51.6 0.15 Allowed 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 119.614 1.097 . . . . 0.0 113.23 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 28.66 52.95 0.07 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 126.81 2.044 . . . . 0.0 110.252 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -26.21 60.75 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 121.771 0.796 . . . . 0.0 112.858 -172.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.548 ' O ' HG23 ' A' ' 43' ' ' VAL . 3.5 mt-10 -74.95 -16.79 60.63 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 112.621 -2.081 . . . . 0.0 114.593 171.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.8 t 45.86 41.1 7.39 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 124.024 1.869 . . . . 0.0 111.388 -177.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 41' ' ' GLU . 89.1 t -104.21 -11.38 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 112.758 -2.019 . . . . 0.0 109.65 -178.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.565 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.2 OUTLIER . . . . . 0 CA--C 1.547 0.832 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.523 -174.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.6 t80 . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.48 -17.33 39.81 Favored Glycine 0 N--CA 1.474 1.205 0 CA-C-N 114.03 -1.441 . . . . 0.0 112.721 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.62 -1.08 20.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.013 1.325 . . . . 0.0 113.867 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.565 ' HE2' HD12 ' A' ' 44' ' ' LEU . 18.3 m-85 -129.77 151.51 50.28 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.489 1.116 . . . . 0.0 109.598 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -147.29 155.4 42.0 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 126.278 2.236 . . . . 0.0 110.581 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.433 ' HG3' ' HB2' ' A' ' 37' ' ' PHE . 1.9 mt-10 -108.96 132.93 53.61 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.298 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.505 ' HB3' HG23 ' A' ' 18' ' ' THR . 26.4 m-85 -145.75 62.95 1.26 Allowed 'General case' 0 N--CA 1.471 0.584 0 O-C-N 125.64 1.838 . . . . 0.0 110.715 -176.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 1.2 m -38.53 127.79 1.46 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 122.194 0.997 . . . . 0.0 112.85 178.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.809 HG21 ' HA ' ' A' ' 15' ' ' ALA . 1.1 p -90.8 113.24 26.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 111.783 -2.462 . . . . 0.0 109.201 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -36.89 145.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 114.022 -1.444 . . . . 0.0 110.506 171.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.401 HG23 ' HD2' ' A' ' 60' ' ' PRO . 3.4 m -136.66 140.16 31.29 Favored Pre-proline 0 N--CA 1.476 0.839 0 O-C-N 125.472 1.733 . . . . 0.0 112.48 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.511 ' HD3' ' CD ' ' A' ' 14' ' ' GLU . 84.3 Cg_endo -74.99 145.18 31.16 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.375 2.05 . . . . 0.0 109.236 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.12 32.16 49.79 Favored Glycine 0 CA--C 1.539 1.532 0 CA-C-N 113.247 -1.797 . . . . 0.0 112.186 -176.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.72 94.42 7.28 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -40.89 -33.15 0.28 Allowed 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 113.768 -1.56 . . . . 0.0 113.913 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.7 p -124.97 -155.15 0.66 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 113.655 -1.612 . . . . 0.0 108.755 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.404 ' HG2' ' CE2' ' A' ' 30' ' ' TYR . 15.4 mtm-85 -55.5 -19.75 10.71 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 171.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.32 135.48 0.08 OUTLIER Glycine 0 CA--C 1.524 0.599 0 N-CA-C 107.717 -2.153 . . . . 0.0 107.717 -176.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 77.1 p -41.28 -33.62 0.4 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 113.429 -1.385 . . . . 0.0 113.727 175.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -39.35 128.78 1.82 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 122.719 1.247 . . . . 0.0 113.83 169.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -158.69 133.78 8.42 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 111.702 -2.499 . . . . 0.0 110.159 -176.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.412 ' HB ' ' O ' ' A' ' 55' ' ' TYR . 8.0 mt -112.14 132.7 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 125.817 1.948 . . . . 0.0 107.791 176.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.496 ' O ' ' HD2' ' A' ' 80' ' ' TYR . 19.9 mm -121.12 102.88 12.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 112.753 -2.021 . . . . 0.0 107.522 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.415 ' HG1' ' HD2' ' A' ' 55' ' ' TYR . 17.4 p -88.86 161.31 16.78 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.501 178.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -116.42 164.23 12.34 Favored Glycine 0 N--CA 1.475 1.262 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.444 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.15 -15.81 62.82 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 176.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.444 ' HB3' ' OE2' ' A' ' 78' ' ' GLU . . . -103.71 130.96 51.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.612 173.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.635 HG22 ' HG2' ' A' ' 77' ' ' GLN . 3.8 m -55.97 142.7 34.85 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.635 ' HG2' HG22 ' A' ' 76' ' ' THR . 0.0 OUTLIER 78.98 31.74 0.3 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 126.892 2.077 . . . . 0.0 111.499 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.444 ' OE2' ' HB3' ' A' ' 75' ' ' ALA . 16.0 mt-10 -125.49 48.81 1.99 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 123.083 1.42 . . . . 0.0 112.569 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -103.52 107.9 18.94 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.205 1.402 . . . . 0.0 109.39 -179.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.496 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 32.3 m-85 -96.99 132.3 42.93 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 124.885 1.366 . . . . 0.0 109.48 -177.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.619 ' HB2' HD11 ' A' ' 92' ' ' ILE . 8.5 t80 -110.39 126.18 54.01 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.089 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.537 ' HB ' ' O ' ' A' ' 88' ' ' THR 0.27 0.3 OUTLIER -87.84 -68.66 0.74 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.011 -1.45 . . . . 0.0 112.211 176.399 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.86 2.12 21.72 Favored Glycine 0 N--CA 1.482 1.726 0 CA-C-N 114.607 -1.179 . . . . 0.0 113.414 -172.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.617 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 6.8 t70 -129.82 13.17 5.82 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.349 1.059 . . . . 0.0 112.531 176.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 64.08 84.86 0.14 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.329 1.852 . . . . 0.0 111.579 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.402 ' HB3' ' OE1' ' A' ' 41' ' ' GLU . 7.4 m-85 50.81 29.54 4.4 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -175.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.617 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . . . -112.21 -3.78 14.55 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.537 ' O ' ' HB ' ' A' ' 82' ' ' THR . 2.0 p -164.5 161.32 21.22 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.958 1.703 . . . . 0.0 108.305 -174.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CD1' HD21 ' A' ' 44' ' ' LEU . 88.6 m-85 -157.83 112.01 2.58 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.023 0.929 . . . . 0.0 108.88 -174.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.3 m -131.47 106.71 8.4 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 112.863 -1.971 . . . . 0.0 109.57 -178.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.482 ' CB ' HG23 ' A' ' 5' ' ' THR . 17.5 mt -42.13 155.61 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.972 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.638 HG22 ' HG3' ' A' ' 94' ' ' GLN . 1.9 mp -102.76 111.12 31.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 O-C-N 120.489 -1.382 . . . . 0.0 108.837 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.14 85.81 6.72 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.769 0.795 . . . . 0.0 110.156 175.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.638 ' HG3' HG22 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -70.53 -32.56 70.06 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.002 179.196 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.4 t -56.19 -23.05 32.9 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.525 1.53 . . . . 0.0 113.267 173.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.6 t . . . . . 0 CA--C 1.554 1.105 0 CA-C-O 116.48 -1.724 . . . . 0.0 110.85 177.764 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.528 HG12 ' H ' ' A' ' 4' ' ' GLY . 21.1 t . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 m -75.14 6.59 4.11 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 124.544 1.152 . . . . 0.0 113.776 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.528 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 121.22 -165.54 14.25 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 m -95.79 170.14 9.52 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.986 -1.107 . . . . 0.0 110.277 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -137.47 111.85 9.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -176.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.55 ' HB3' ' OXT' ' A' ' 96' ' ' CYS . 97.0 m -49.37 129.48 18.67 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 111.874 -2.421 . . . . 0.0 109.83 177.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.78 -33.21 66.4 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 119.217 -0.42 . . . . 0.0 111.437 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.8 t -67.24 -28.39 68.01 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.348 0.659 . . . . 0.0 112.384 174.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.33 -20.76 58.87 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.781 174.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.47 HD22 ' CZ ' ' A' ' 81' ' ' TYR . 7.2 mt -83.18 158.94 63.35 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 175.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.514 ' HB2' ' OE2' ' A' ' 14' ' ' GLU . 92.4 Cg_endo -69.03 167.02 24.69 Favored 'Trans proline' 0 CA--C 1.551 1.371 0 C-N-CA 121.964 1.776 . . . . 0.0 112.456 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.18 -17.45 45.25 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.384 2.056 . . . . 0.0 113.682 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.514 ' OE2' ' HB2' ' A' ' 12' ' ' PRO . 8.4 pm0 -87.65 -13.78 41.73 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.697 1.199 . . . . 0.0 112.674 174.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.835 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -62.78 -49.9 73.16 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.02 0.528 . . . . 0.0 112.098 176.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.11 -26.23 48.97 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.633 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.526 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 41.6 t0 -57.57 -57.48 12.53 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.805 0.842 . . . . 0.0 110.34 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.742 ' HA ' HD12 ' A' ' 21' ' ' LEU . 16.8 m -57.23 -49.1 77.1 Favored 'General case' 0 C--O 1.217 -0.621 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 175.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.509 ' CD1' HG21 ' A' ' 92' ' ' ILE . 8.0 mt -56.02 -35.13 66.49 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 124.253 0.971 . . . . 0.0 111.77 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -67.59 -39.16 84.82 Favored 'General case' 0 C--O 1.212 -0.891 0 C-N-CA 124.54 1.136 . . . . 0.0 110.957 174.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.742 HD12 ' HA ' ' A' ' 18' ' ' THR . 41.0 mt -68.53 -34.76 76.43 Favored 'General case' 0 C--O 1.211 -0.926 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.596 175.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.645 HD12 ' O ' ' A' ' 18' ' ' THR . 1.6 mp -68.93 -38.73 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 120.069 1.304 . . . . 0.0 111.872 171.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.47 -48.52 48.73 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.86 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 m -85.46 5.93 29.04 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.173 0.989 . . . . 0.0 113.314 176.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.38 36.08 1.51 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 122.748 1.261 . . . . 0.0 112.22 -176.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.44 -166.9 16.26 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.443 1.497 . . . . 0.0 115.706 -174.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.78 139.87 64.15 Favored 'Cis proline' 0 C--N 1.347 0.485 0 O-C-N 124.285 1.676 . . . . 0.0 111.255 -2.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.469 ' CD2' ' HB3' ' A' ' 21' ' ' LEU . 58.7 m-85 -90.95 135.72 28.37 Favored Pre-proline 0 N--CA 1.474 0.732 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.705 -177.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.459 ' HG2' ' CD1' ' A' ' 58' ' ' ILE . 38.1 Cg_endo -74.34 -61.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.469 2.779 . . . . 0.0 111.433 -178.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.3 m-30 -63.35 159.72 17.52 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 175.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.8 m -80.53 9.28 6.22 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 124.173 0.921 . . . . 0.0 113.476 173.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.61 78.99 1.76 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 122.022 0.915 . . . . 0.0 111.46 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -177.14 146.16 0.49 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 111.721 -2.49 . . . . 0.0 115.056 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.69 27.98 36.84 Favored Glycine 0 N--CA 1.479 1.535 0 CA-C-N 112.87 -1.968 . . . . 0.0 110.853 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.411 HG23 ' HB2' ' A' ' 54' ' ' GLU . 20.5 m -122.12 146.24 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.453 1.101 . . . . 0.0 109.54 177.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.4 t -84.39 154.07 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 125.903 2.002 . . . . 0.0 109.855 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.465 ' CD1' ' HD3' ' A' ' 40' ' ' ARG . 18.6 t80 -137.11 85.88 2.16 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 113.844 -1.525 . . . . 0.0 110.828 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.432 ' HB2' ' CD1' ' A' ' 49' ' ' TYR . 2.2 tm0? -69.38 51.91 0.1 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.9 t30 27.52 55.65 0.07 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.779 2.032 . . . . 0.0 109.634 -172.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.465 ' HD3' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -55.62 -28.37 54.85 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 122.332 1.063 . . . . 0.0 111.463 -175.2 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.555 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.2 mt-10 -74.72 -11.37 60.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 113.138 -1.846 . . . . 0.0 114.962 173.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 31.4 t 45.38 43.12 8.21 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 123.874 1.797 . . . . 0.0 111.844 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 41' ' ' GLU . 95.8 t -108.77 -20.92 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 113.78 -1.555 . . . . 0.0 110.432 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.876 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.627 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -175.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.432 ' CD1' ' HB2' ' A' ' 38' ' ' GLN . 2.4 t80 . . . . . 0 N--CA 1.469 0.501 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.63 -18.84 27.73 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 113.813 -1.539 . . . . 0.0 112.258 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -67.47 -9.09 38.76 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.228 1.011 . . . . 0.0 112.396 176.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.876 ' HE2' HD12 ' A' ' 44' ' ' LEU . 19.0 m-85 -122.99 162.4 22.41 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 124.279 1.032 . . . . 0.0 109.772 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -159.51 155.85 27.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 112.296 -2.229 . . . . 0.0 111.39 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.411 ' HB2' HG23 ' A' ' 35' ' ' VAL . 3.5 mt-10 -110.68 142.34 42.72 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.758 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.415 ' HB3' HG23 ' A' ' 18' ' ' THR . 77.5 m-85 -156.57 67.11 0.56 Allowed 'General case' 0 N--CA 1.477 0.918 0 O-C-N 126.328 2.267 . . . . 0.0 110.524 -175.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.43 ' OG1' ' HD3' ' A' ' 69' ' ' ARG . 1.1 m -38.47 123.06 1.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 122.689 1.233 . . . . 0.0 112.808 176.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.835 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.5 OUTLIER -81.82 114.1 22.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 112.109 -2.314 . . . . 0.0 108.73 177.233 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.459 ' CD1' ' HG2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -41.33 150.82 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 124.806 1.316 . . . . 0.0 109.107 171.58 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.461 ' OG1' ' HG3' ' A' ' 68' ' ' ARG . 23.8 m -150.99 137.76 11.56 Favored Pre-proline 0 N--CA 1.481 1.106 0 O-C-N 125.851 1.969 . . . . 0.0 110.684 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -72.48 151.4 53.19 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 123.646 2.897 . . . . 0.0 110.588 177.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.36 20.72 30.75 Favored Glycine 0 N--CA 1.48 1.623 0 CA-C-N 114.015 -1.448 . . . . 0.0 112.88 -174.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.87 87.64 5.47 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -44.39 -30.52 0.86 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 113.99 -1.459 . . . . 0.0 112.683 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.8 p -133.03 -170.87 2.54 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.866 -1.515 . . . . 0.0 108.638 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.1 mtm-85 -46.87 -29.3 1.92 Allowed 'General case' 0 N--CA 1.484 1.254 0 O-C-N 124.273 0.983 . . . . 0.0 112.921 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.27 148.78 0.09 OUTLIER Glycine 0 N--CA 1.465 0.59 0 N-CA-C 107.26 -2.336 . . . . 0.0 107.26 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.501 HG22 ' HB2' ' A' ' 85' ' ' HIS . 19.6 p -42.86 -29.73 0.34 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.052 -1.574 . . . . 0.0 113.423 172.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.737 ' HE ' HG12 ' A' ' 57' ' ' VAL . 3.1 mmm180 -37.64 116.91 0.52 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 166.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.447 ' HB2' HG23 ' A' ' 82' ' ' THR . 0.0 OUTLIER -157.49 135.02 10.52 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 112.435 -2.166 . . . . 0.0 112.938 -176.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.448 ' O ' HD13 ' A' ' 71' ' ' ILE . 5.9 mt -113.7 141.05 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 112.784 -2.007 . . . . 0.0 108.471 177.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.757 HD11 ' HE1' ' A' ' 86' ' ' TYR . 17.4 mm -127.52 114.09 34.49 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 O-C-N 126.199 2.187 . . . . 0.0 108.203 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.599 HG22 ' HB3' ' A' ' 79' ' ' ASP . 19.5 p -101.05 163.92 12.05 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.248 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.67 164.87 12.04 Favored Glycine 0 CA--C 1.531 1.082 0 O-C-N 125.639 1.837 . . . . 0.0 109.694 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.86 -17.43 63.15 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.302 0.641 . . . . 0.0 112.117 175.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -104.55 128.51 52.53 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.626 HG22 ' HG2' ' A' ' 77' ' ' GLN . 24.8 m -55.54 145.82 22.06 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 114.096 -1.411 . . . . 0.0 107.354 174.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.626 ' HG2' HG22 ' A' ' 76' ' ' THR . 0.0 OUTLIER 82.39 32.84 0.09 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 126.299 1.839 . . . . 0.0 111.218 179.047 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -135.83 46.46 2.33 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 123.058 1.409 . . . . 0.0 112.744 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.599 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -101.2 88.61 3.54 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 113.174 -1.83 . . . . 0.0 109.843 179.495 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.472 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 65.8 m-85 -57.79 178.06 0.09 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.287 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.483 ' CE2' ' NH1' ' A' ' 68' ' ' ARG . 9.0 t80 -158.01 113.92 2.77 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.685 -176.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.58 ' HB ' ' O ' ' A' ' 88' ' ' THR 0.318 0.1 OUTLIER -87.87 -80.45 0.27 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.045 -1.434 . . . . 0.0 113.72 177.813 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.02 -5.31 59.15 Favored Glycine 0 N--CA 1.471 0.99 0 CA-C-N 115.25 -0.886 . . . . 0.0 114.382 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.55 ' CB ' ' HB3' ' A' ' 87' ' ' ALA . 1.0 OUTLIER -120.64 20.02 11.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.398 -0.901 . . . . 0.0 111.985 173.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.501 ' HB2' HG22 ' A' ' 67' ' ' THR . 22.5 t-80 58.47 87.02 0.08 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.25 1.82 . . . . 0.0 110.203 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.757 ' HE1' HD11 ' A' ' 71' ' ' ILE . 8.3 m-30 49.08 41.32 19.16 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 113.639 -1.619 . . . . 0.0 114.518 -174.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.55 ' HB3' ' CB ' ' A' ' 84' ' ' ASP . . . -112.46 -32.64 6.42 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.102 -1.624 . . . . 0.0 112.806 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.58 ' O ' ' HB ' ' A' ' 82' ' ' THR . 15.3 p -135.95 166.79 22.52 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.646 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -156.79 110.13 2.61 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -175.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.71 106.46 9.15 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 113.884 -1.507 . . . . 0.0 108.354 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 51.1 mt -44.08 161.72 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.576 HD13 ' O ' ' A' ' 79' ' ' ASP . 1.7 mp -110.76 131.97 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 120.881 -1.137 . . . . 0.0 108.926 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.87 94.99 5.31 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 113.204 -1.816 . . . . 0.0 107.911 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -57.41 -37.1 72.21 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 124.731 1.269 . . . . 0.0 111.912 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.3 t -58.34 -45.66 87.71 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.821 -1.082 . . . . 0.0 112.469 174.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.55 ' OXT' ' HB3' ' A' ' 7' ' ' CYS . 11.6 t . . . . . 0 C--O 1.245 0.829 0 CA-C-O 118.489 -0.767 . . . . 0.0 110.929 175.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.645 HG12 ' H ' ' A' ' 4' ' ' GLY . 44.4 t . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.1 m -77.74 5.69 8.9 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.787 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.645 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 120.53 -177.23 16.36 Favored Glycine 0 N--CA 1.473 1.115 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 6' ' ' VAL . 4.4 m -90.96 173.69 7.83 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 122.354 1.073 . . . . 0.0 109.2 -178.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.428 ' H ' HG22 ' A' ' 5' ' ' THR . 0.9 OUTLIER -139.73 112.64 5.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -175.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 73.3 m -50.08 124.66 10.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 111.894 -2.412 . . . . 0.0 109.601 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -50.73 -35.39 31.2 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.719 0.807 . . . . 0.0 112.232 174.13 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.9 t -63.81 -30.97 72.01 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.518 0.511 . . . . 0.0 111.992 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.48 -17.65 59.18 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.632 0.773 . . . . 0.0 111.913 174.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.463 ' HB3' ' CB ' ' A' ' 15' ' ' ALA . 7.1 mt -90.05 162.35 35.46 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 176.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.48 169.53 15.48 Favored 'Trans proline' 0 CA--C 1.547 1.135 0 C-N-CA 122.606 2.204 . . . . 0.0 112.988 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.3 -17.95 49.99 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.561 2.174 . . . . 0.0 113.058 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.495 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 26.1 tp10 -85.05 -25.22 27.76 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 175.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.863 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -48.84 -37.07 18.37 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 175.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.49 -35.27 68.14 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.873 -1.512 . . . . 0.0 112.943 173.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.545 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 9.3 t70 -54.46 -53.33 55.63 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.06 0.944 . . . . 0.0 109.828 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.818 ' HA ' HD12 ' A' ' 21' ' ' LEU . 17.1 m -59.54 -48.24 82.43 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 175.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.703 HD11 HG21 ' A' ' 92' ' ' ILE . 5.6 mt -56.81 -28.57 61.66 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 176.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -73.75 -40.35 63.57 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.704 173.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.818 HD12 ' HA ' ' A' ' 18' ' ' THR . 25.3 mt -69.5 -31.16 69.24 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 119.271 -0.395 . . . . 0.0 111.026 176.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.671 HD12 ' O ' ' A' ' 18' ' ' THR . 1.6 mp -69.74 -38.38 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 120.143 1.338 . . . . 0.0 111.508 171.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.46 -47.61 32.39 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 124.562 1.164 . . . . 0.0 111.873 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.7 m -85.91 8.4 20.45 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.42 1.488 . . . . 0.0 112.645 175.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 41.51 46.54 3.05 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 122.725 1.25 . . . . 0.0 112.525 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.48 -166.13 43.37 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-N 113.928 -1.487 . . . . 0.0 116.265 -171.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -74.25 140.6 68.17 Favored 'Cis proline' 0 N--CA 1.483 0.887 0 O-C-N 124.758 1.925 . . . . 0.0 111.543 -1.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.505 ' HA ' HD22 ' A' ' 21' ' ' LEU . 33.9 m-85 -92.21 142.67 26.44 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 113.897 -1.501 . . . . 0.0 111.679 -176.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -74.62 -65.29 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 123.283 2.655 . . . . 0.0 111.42 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 -57.56 163.0 2.63 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.834 0.826 . . . . 0.0 112.226 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 t -82.08 9.44 8.5 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 123.238 1.494 . . . . 0.0 112.269 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.403 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -112.11 99.54 8.14 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.302 -177.411 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 166.64 140.17 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 O-C-N 126.626 2.454 . . . . 0.0 115.404 -172.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.45 30.38 22.02 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-N 113.616 -1.629 . . . . 0.0 111.172 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.507 HG23 ' HB2' ' A' ' 54' ' ' GLU . 20.7 m -122.36 147.39 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 114.275 -0.963 . . . . 0.0 109.512 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.0 t -85.15 156.95 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 125.248 1.593 . . . . 0.0 109.631 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.603 ' CD1' ' HD3' ' A' ' 40' ' ' ARG . 31.0 t80 -141.26 86.26 2.01 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.811 175.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.72 55.44 0.26 Allowed 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 122.631 1.205 . . . . 0.0 113.318 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 45.7 t30 29.73 53.62 0.12 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.474 2.31 . . . . 0.0 109.305 -173.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.603 ' HD3' ' CD1' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -58.18 -22.97 53.8 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.701 -174.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.611 ' O ' HG23 ' A' ' 43' ' ' VAL . 3.0 mt-10 -83.02 -8.28 59.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 113.207 -1.815 . . . . 0.0 114.669 173.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 43.9 t 44.0 41.92 4.37 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 124.326 2.012 . . . . 0.0 111.733 -177.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 41' ' ' GLU . 57.5 t -109.81 -12.4 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 113.592 -1.64 . . . . 0.0 109.663 -178.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.494 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.2 OUTLIER . . . . . 0 CA--C 1.545 0.775 0 O-C-N 120.721 -1.237 . . . . 0.0 108.687 -175.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.3 t80 . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.43 -21.53 28.43 Favored Glycine 0 N--CA 1.479 1.521 0 O-C-N 125.181 1.551 . . . . 0.0 112.009 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -64.44 -13.47 51.62 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.505 1.122 . . . . 0.0 112.294 176.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.494 ' HE2' HD12 ' A' ' 44' ' ' LEU . 16.4 m-85 -116.25 163.08 16.52 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.718 0.807 . . . . 0.0 109.535 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -159.65 159.65 33.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 112.016 -2.357 . . . . 0.0 111.184 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.507 ' HB2' HG23 ' A' ' 35' ' ' VAL . 32.2 mt-10 -117.31 144.7 44.6 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.645 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.406 ' HB3' HG23 ' A' ' 18' ' ' THR . 80.1 m-85 -158.96 63.92 0.41 Allowed 'General case' 0 N--CA 1.48 1.047 0 O-C-N 126.495 2.372 . . . . 0.0 111.104 -174.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 32' ' ' GLN . 1.1 m -35.35 120.89 0.57 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 122.352 1.072 . . . . 0.0 112.556 177.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.863 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -81.78 117.72 28.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 112.738 -2.028 . . . . 0.0 108.609 177.313 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.469 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -42.99 158.39 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 173.467 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.495 ' OG1' ' HG3' ' A' ' 68' ' ' ARG . 2.5 m -153.09 142.45 14.74 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 113.273 -1.785 . . . . 0.0 111.387 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.56 146.03 48.5 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.594 2.196 . . . . 0.0 110.971 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.25 22.1 55.08 Favored Glycine 0 N--CA 1.48 1.611 0 CA-C-N 113.759 -1.564 . . . . 0.0 112.459 -175.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.2 87.05 7.34 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -47.61 -26.57 1.52 Allowed 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.912 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.1 p -128.03 -158.62 0.89 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.037 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.6 mtm105 -57.06 -18.18 13.25 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 174.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.41 125.4 0.02 OUTLIER Glycine 0 N--CA 1.465 0.593 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.42 HG22 ' HB2' ' A' ' 85' ' ' HIS . 22.0 p -39.72 -31.09 0.09 Allowed 'General case' 0 CA--C 1.557 1.234 0 CA-C-N 113.699 -1.251 . . . . 0.0 113.523 175.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.495 ' HG3' ' OG1' ' A' ' 59' ' ' THR . 0.3 OUTLIER -46.05 105.61 0.07 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 123.417 1.579 . . . . 0.0 112.711 170.137 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.548 ' HB2' HG23 ' A' ' 82' ' ' THR . 0.3 OUTLIER -131.42 141.36 49.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 112.816 -1.993 . . . . 0.0 109.989 -179.442 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.9 mt -117.3 135.9 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 112.681 -2.054 . . . . 0.0 108.33 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.618 HD11 ' HE1' ' A' ' 86' ' ' TYR . 16.9 mm -124.91 101.87 9.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 CA-C-N 112.848 -1.978 . . . . 0.0 108.608 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.486 HG21 HD13 ' A' ' 22' ' ' ILE . 16.9 p -89.68 163.1 15.26 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.502 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -115.29 166.84 12.24 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-N 113.32 -1.764 . . . . 0.0 109.665 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.24 -14.09 62.58 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.355 -0.922 . . . . 0.0 111.843 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.58 130.95 55.29 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.129 174.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.55 HG22 ' HG2' ' A' ' 77' ' ' GLN . 3.4 m -55.23 143.8 26.66 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.124 -1.398 . . . . 0.0 107.495 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.55 ' HG2' HG22 ' A' ' 76' ' ' THR . 2.2 mt-30 80.06 33.82 0.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 126.127 2.142 . . . . 0.0 111.037 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -129.33 49.12 2.28 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 113.596 -1.638 . . . . 0.0 113.616 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.492 ' OD1' ' HB ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER -107.13 103.77 13.25 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.341 -178.363 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.516 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 23.9 m-85 -91.64 131.13 37.26 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 125.28 1.613 . . . . 0.0 109.916 -177.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.753 ' HB2' HD11 ' A' ' 92' ' ' ILE . 5.5 t80 -110.29 123.92 50.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.24 -1.345 . . . . 0.0 109.894 -176.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.548 HG23 ' HB2' ' A' ' 69' ' ' ARG 0.262 0.2 OUTLIER -89.74 -71.18 0.62 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 113.502 -1.681 . . . . 0.0 112.464 177.315 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.09 -8.81 56.65 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-N 113.118 -1.856 . . . . 0.0 112.197 -175.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 15.6 t70 -112.01 9.71 20.43 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 117.252 0.526 . . . . 0.0 111.838 174.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.42 ' HB2' HG22 ' A' ' 67' ' ' THR . 30.6 t-80 87.15 -20.93 0.2 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.928 1.691 . . . . 0.0 113.076 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.618 ' HE1' HD11 ' A' ' 71' ' ' ILE . 1.2 m-30 161.19 55.35 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 O-C-N 128.16 3.412 . . . . 0.0 113.684 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . . . -120.06 -41.33 2.65 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 118.994 -1.083 . . . . 0.0 113.748 175.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.528 ' O ' ' HB ' ' A' ' 82' ' ' THR . 18.4 p -128.29 165.55 20.32 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.399 -1.273 . . . . 0.0 108.402 -177.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.489 ' CD1' HD21 ' A' ' 44' ' ' LEU . 97.9 m-85 -157.41 112.7 2.78 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -173.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.2 m -131.21 112.25 12.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 113.261 -1.791 . . . . 0.0 109.286 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.474 ' HA ' HD23 ' A' ' 91' ' ' LEU . 25.1 mt -42.39 162.82 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 O-C-N 124.214 0.946 . . . . 0.0 112.428 177.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.753 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.7 mp -112.19 130.74 65.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 O-C-N 120.778 -1.201 . . . . 0.0 108.823 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.04 94.14 4.94 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.257 -1.792 . . . . 0.0 108.624 176.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -53.39 -37.22 62.26 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 124.107 0.88 . . . . 0.0 112.467 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.9 t -56.74 -49.29 75.65 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 113.801 -1.545 . . . . 0.0 113.595 174.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 34.3 t . . . . . 0 C--O 1.246 0.886 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 179.07 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.92 5.82 10.67 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.883 0.849 . . . . 0.0 112.639 177.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.38 -174.37 16.55 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.447 1.498 . . . . 0.0 109.988 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -94.18 169.39 10.28 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 122.016 0.912 . . . . 0.0 109.239 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 91' ' ' LEU . 2.0 p -137.84 111.26 7.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 122.752 1.263 . . . . 0.0 107.882 -177.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 71.6 m -48.96 128.16 15.47 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 112.256 -2.247 . . . . 0.0 109.364 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -53.04 -34.65 57.41 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.805 176.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.1 t -64.68 -29.77 70.77 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 174.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.14 -26.11 58.9 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.451 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.487 HD13 ' HB1' ' A' ' 15' ' ' ALA . 7.1 mt -83.92 162.57 51.94 Favored Pre-proline 0 N--CA 1.478 0.952 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.17 168.11 18.39 Favored 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 122.308 2.005 . . . . 0.0 112.952 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -65.28 -18.95 62.0 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.847 2.365 . . . . 0.0 112.666 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.549 ' HG3' HG22 ' A' ' 57' ' ' VAL . 27.4 tp10 -83.62 -26.41 29.98 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.439 -0.801 . . . . 0.0 113.066 175.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.797 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -47.62 -38.87 15.54 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 176.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.38 -34.73 72.91 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.551 -1.659 . . . . 0.0 113.328 174.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.607 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 10.7 t0 -54.52 -57.0 13.12 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 117.408 -1.282 . . . . 0.0 109.465 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.797 ' HA ' HD12 ' A' ' 21' ' ' LEU . 1.4 m -55.87 -48.42 75.59 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 174.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.722 HD11 HG21 ' A' ' 92' ' ' ILE . 7.1 mt -57.42 -33.36 67.81 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -67.75 -33.41 74.81 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.336 174.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.797 HD12 ' HA ' ' A' ' 18' ' ' THR . 18.3 mt -75.93 -31.3 59.06 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 118.773 -0.632 . . . . 0.0 110.924 176.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.679 HD12 ' O ' ' A' ' 18' ' ' THR . 1.7 mp -69.9 -40.81 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 120.267 1.394 . . . . 0.0 111.453 170.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.84 -41.78 64.46 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 125.02 1.45 . . . . 0.0 112.521 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.31 7.23 45.22 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.321 1.049 . . . . 0.0 111.781 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 44.46 34.98 1.19 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.035 1.334 . . . . 0.0 112.556 -176.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.9 -168.15 20.14 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-N 113.379 -1.737 . . . . 0.0 115.83 -174.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -74.53 140.5 67.66 Favored 'Cis proline' 0 N--CA 1.479 0.622 0 O-C-N 124.043 1.549 . . . . 0.0 111.261 -3.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.476 ' HA ' HD22 ' A' ' 21' ' ' LEU . 23.6 m-85 -89.86 136.99 28.57 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.57 -176.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -72.68 -63.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.475 0.415 0 C-N-CA 123.563 2.842 . . . . 0.0 111.413 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 -62.99 159.4 17.13 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.411 0.684 . . . . 0.0 112.744 175.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.85 8.5 5.4 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 124.714 1.259 . . . . 0.0 113.588 174.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.426 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 1.8 mt-30 -105.01 82.89 1.91 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 122.372 1.082 . . . . 0.0 111.819 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -177.32 150.83 0.74 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 110.779 -2.919 . . . . 0.0 114.999 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.01 35.43 27.58 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-N 112.52 -2.127 . . . . 0.0 110.275 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -131.88 147.1 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.546 1.138 . . . . 0.0 109.72 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.4 t -84.41 154.4 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 O-C-N 125.944 2.027 . . . . 0.0 109.868 175.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.484 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 50.0 t80 -132.31 91.33 2.92 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 113.846 -1.525 . . . . 0.0 108.419 174.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.544 ' HG3' ' CD1' ' A' ' 49' ' ' TYR . 6.5 tm0? -72.12 55.63 0.31 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 119.81 1.187 . . . . 0.0 112.361 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 26.06 55.83 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.793 2.437 . . . . 0.0 110.854 -175.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.433 ' HD3' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -56.38 -25.97 51.42 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 122.17 0.986 . . . . 0.0 111.938 -171.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.595 ' O ' HG23 ' A' ' 43' ' ' VAL . 4.2 mt-10 -76.35 -14.33 60.09 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 113.09 -1.868 . . . . 0.0 115.598 172.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 31.6 t 45.06 41.81 5.91 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 124.183 1.945 . . . . 0.0 111.924 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 41' ' ' GLU . 76.6 t -110.8 -10.42 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-N 113.151 -1.841 . . . . 0.0 110.739 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.63 ' HB3' ' OH ' ' A' ' 52' ' ' TYR . 4.0 mm? . . . . . 0 C--N 1.319 -0.76 0 CA-C-O 117.372 -1.299 . . . . 0.0 109.29 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.544 ' CD1' ' HG3' ' A' ' 38' ' ' GLN . 4.1 t80 . . . . . 0 CA--C 1.539 0.524 0 N-CA-C 110.437 -0.208 . . . . 0.0 110.437 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.76 5.99 70.62 Favored Glycine 0 N--CA 1.48 1.584 0 O-C-N 125.332 1.645 . . . . 0.0 112.657 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.39 15.31 3.72 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.63 ' OH ' ' HB3' ' A' ' 44' ' ' LEU . 10.7 m-85 -151.04 150.76 31.12 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.156 0.983 . . . . 0.0 109.305 -173.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -147.12 155.44 42.17 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 126.074 2.109 . . . . 0.0 111.632 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.484 ' HG3' ' HB2' ' A' ' 37' ' ' PHE . 27.3 mt-10 -109.13 145.17 36.16 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.829 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.482 ' O ' HG21 ' A' ' 18' ' ' THR . 72.5 m-85 -159.82 68.28 0.39 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 126.826 2.579 . . . . 0.0 110.64 -174.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 0.9 OUTLIER -41.19 133.92 2.22 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 122.767 1.27 . . . . 0.0 111.814 178.741 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.797 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -95.86 118.97 43.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 112.07 -2.332 . . . . 0.0 107.939 178.35 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -40.73 153.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 CA-C-O 121.853 0.835 . . . . 0.0 108.955 173.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.487 ' OG1' ' HD2' ' A' ' 68' ' ' ARG . 15.7 m -140.04 139.74 22.15 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 112.951 -1.931 . . . . 0.0 111.688 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.73 145.18 50.84 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 121.93 1.754 . . . . 0.0 111.007 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 51.77 28.48 23.37 Favored Glycine 0 CA--C 1.548 2.137 0 O-C-N 125.289 1.618 . . . . 0.0 111.895 -174.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.98 90.28 4.57 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -46.57 -27.65 1.2 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 113.603 -1.635 . . . . 0.0 113.197 176.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.2 p -126.0 -173.67 2.91 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.846 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.426 ' HD2' ' OE1' ' A' ' 32' ' ' GLN . 14.6 mtm105 -52.94 -20.72 3.6 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 175.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.22 171.27 11.89 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 124.38 2.1 . . . . 0.0 109.201 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.489 HG22 ' HB2' ' A' ' 85' ' ' HIS . 41.0 p -75.95 0.74 17.33 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 111.275 -2.463 . . . . 0.0 113.004 176.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.487 ' HD2' ' OG1' ' A' ' 59' ' ' THR . 0.0 OUTLIER -82.11 116.9 21.89 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 122.925 1.345 . . . . 0.0 111.203 176.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.524 ' HG2' ' HE1' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -142.35 135.67 28.87 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 112.771 -2.013 . . . . 0.0 109.323 178.444 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.2 mt -104.5 144.81 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 113.463 -1.699 . . . . 0.0 108.741 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' A' ' 80' ' ' TYR . 18.4 mm -132.73 114.75 23.04 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.737 0 CA-C-N 112.486 -2.143 . . . . 0.0 107.895 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.565 HG22 ' HB3' ' A' ' 79' ' ' ASP . 18.8 p -99.45 162.86 12.79 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.791 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -107.61 -178.26 22.39 Favored Glycine 0 N--CA 1.477 1.433 0 O-C-N 124.968 1.417 . . . . 0.0 109.953 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.8 -13.22 59.96 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 114.348 -0.926 . . . . 0.0 113.024 174.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -113.73 130.78 56.38 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 176.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.521 HG22 ' HG2' ' A' ' 77' ' ' GLN . 31.4 m -54.0 147.97 11.53 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.083 174.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.521 ' HG2' HG22 ' A' ' 76' ' ' THR . 2.4 mt-30 80.63 31.76 0.17 Allowed 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 126.585 1.954 . . . . 0.0 110.942 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.513 ' HA ' HD22 ' A' ' 91' ' ' LEU . 4.6 mt-10 -134.59 48.78 2.28 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 123.89 1.805 . . . . 0.0 113.708 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.669 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -104.34 86.74 2.58 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 113.071 -1.877 . . . . 0.0 109.417 -179.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.41 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 35.2 m-85 -57.35 177.88 0.08 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 125.275 1.43 . . . . 0.0 110.339 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.597 ' HB2' HD11 ' A' ' 92' ' ' ILE . 13.0 t80 -162.87 126.23 2.85 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 113.817 -1.538 . . . . 0.0 109.84 -176.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.2 OUTLIER -91.12 -71.97 0.6 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 112.672 -2.058 . . . . 0.0 111.702 176.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.46 1.08 34.38 Favored Glycine 0 CA--C 1.55 2.228 0 CA-C-N 113.094 -1.866 . . . . 0.0 114.835 -173.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.568 ' CB ' ' HB3' ' A' ' 87' ' ' ALA . 1.7 m-20 -127.79 15.8 6.92 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.386 0.675 . . . . 0.0 112.619 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.489 ' HB2' HG22 ' A' ' 67' ' ' THR . 52.7 t-80 61.28 83.79 0.14 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 127.093 2.157 . . . . 0.0 110.591 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.524 ' HE1' ' HG2' ' A' ' 69' ' ' ARG . 3.4 m-30 51.84 38.23 22.74 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 113.83 -1.532 . . . . 0.0 113.342 -176.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.568 ' HB3' ' CB ' ' A' ' 84' ' ' ASP . . . -109.74 -13.22 14.52 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.498 ' O ' ' HB ' ' A' ' 82' ' ' THR . 9.5 p -161.37 165.96 28.14 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.037 1.335 . . . . 0.0 107.81 -176.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.511 ' CD1' HD21 ' A' ' 44' ' ' LEU . 99.6 m-85 -157.29 113.55 2.93 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -176.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.4 m -132.33 115.94 16.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.748 -1.569 . . . . 0.0 109.399 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.513 HD22 ' HA ' ' A' ' 78' ' ' GLU . 35.0 mt -47.28 164.21 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.379 0.672 . . . . 0.0 111.946 177.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.722 HG21 HD11 ' A' ' 19' ' ' LEU . 1.7 mp -112.63 128.96 69.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 120.824 -1.173 . . . . 0.0 108.434 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.87 92.05 4.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 113.472 -1.695 . . . . 0.0 108.551 175.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -52.62 -36.4 56.4 Favored 'General case' 0 N--CA 1.484 1.225 0 O-C-N 124.173 0.92 . . . . 0.0 112.778 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.2 t -58.27 -47.05 84.82 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 114.054 -1.43 . . . . 0.0 113.387 173.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 24.3 t . . . . . 0 C--O 1.244 0.791 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.171 178.365 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.738 HG21 ' HE1' ' A' ' 80' ' ' TYR . 71.2 t . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.5 m -70.48 3.8 2.78 Favored 'General case' 0 CA--C 1.55 0.952 0 O-C-N 125.151 1.532 . . . . 0.0 112.526 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.642 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 111.2 -179.25 19.86 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 m -77.0 170.14 17.07 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.128 -1.036 . . . . 0.0 110.423 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 p -138.49 108.6 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 78.8 m -43.55 123.51 3.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 112.565 -2.107 . . . . 0.0 109.964 176.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.74 -37.06 39.69 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.742 177.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.9 t -65.69 -28.11 68.83 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.099 0.56 . . . . 0.0 112.073 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.43 -20.55 58.8 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.83 174.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.47 HD13 ' HB1' ' A' ' 15' ' ' ALA . 14.7 mt -85.77 159.59 54.67 Favored Pre-proline 0 CA--C 1.539 0.519 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 176.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.52 169.16 19.25 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 121.953 1.769 . . . . 0.0 113.081 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.48 -13.93 38.63 Favored 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 122.627 2.218 . . . . 0.0 114.549 177.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 11.8 pm0 -93.43 -4.93 50.43 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.559 -1.201 . . . . 0.0 113.29 176.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.504 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -78.59 -50.7 11.06 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.797 175.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.96 -28.22 56.06 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.67 -1.15 . . . . 0.0 112.271 174.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.57 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 9.6 t70 -53.45 -58.63 6.47 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.428 1.08 . . . . 0.0 109.969 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.71 ' HA ' HD12 ' A' ' 21' ' ' LEU . 1.8 m -53.57 -50.43 65.59 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.612 0.968 . . . . 0.0 113.612 175.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.529 HD21 HD13 ' A' ' 70' ' ' ILE . 10.4 mt -56.15 -37.38 69.42 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.885 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -64.63 -33.26 75.52 Favored 'General case' 0 C--O 1.214 -0.787 0 C-N-CA 123.962 0.905 . . . . 0.0 110.691 173.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.71 HD12 ' HA ' ' A' ' 18' ' ' THR . 16.8 mt -76.35 -30.43 57.6 Favored 'General case' 0 C--O 1.209 -1.048 0 CA-C-O 118.364 -0.826 . . . . 0.0 110.78 176.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.667 HD12 ' O ' ' A' ' 18' ' ' THR . 1.8 mp -70.65 -40.63 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 120.217 1.371 . . . . 0.0 111.722 171.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.39 -40.97 63.9 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.006 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.18 7.72 44.25 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.355 178.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 42.99 34.84 0.67 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.577 1.151 . . . . 0.0 112.733 -176.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.67 -169.48 18.22 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 113.521 -1.672 . . . . 0.0 115.969 -173.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.57 140.76 69.1 Favored 'Cis proline' 0 CA--C 1.537 0.655 0 O-C-N 123.775 1.408 . . . . 0.0 111.102 -2.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.425 ' CD2' ' HB3' ' A' ' 21' ' ' LEU . 37.9 m-85 -91.66 136.3 26.72 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 113.686 -1.597 . . . . 0.0 111.573 -177.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.418 ' HG2' ' CD1' ' A' ' 58' ' ' ILE . 44.3 Cg_endo -73.58 -62.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.475 0.439 0 C-N-CA 122.947 2.431 . . . . 0.0 111.942 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.8 m-30 -69.3 146.35 52.31 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 118.494 -0.765 . . . . 0.0 110.793 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.4 m -62.4 -15.26 48.0 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 125.385 1.678 . . . . 0.0 113.141 174.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.507 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 2.0 mt-30 -78.64 77.96 5.11 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 122.678 1.227 . . . . 0.0 111.516 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -178.12 142.21 0.27 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 110.783 -2.917 . . . . 0.0 113.869 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.0 24.43 37.72 Favored Glycine 0 N--CA 1.481 1.656 0 CA-C-N 112.952 -1.931 . . . . 0.0 111.399 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.4 m -120.52 146.89 24.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 124.384 1.073 . . . . 0.0 109.481 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 52' ' ' TYR . 5.3 t -83.57 154.37 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 126.096 2.123 . . . . 0.0 110.206 176.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.482 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 27.7 t80 -135.03 88.53 2.43 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 113.842 -1.526 . . . . 0.0 109.988 175.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -70.91 52.44 0.15 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 122.684 1.231 . . . . 0.0 113.753 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 37.5 t30 28.43 54.26 0.08 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.06 2.144 . . . . 0.0 109.566 -172.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -56.31 -26.29 51.72 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.702 -1.136 . . . . 0.0 111.035 -175.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.581 ' O ' HG23 ' A' ' 43' ' ' VAL . 1.3 mt-10 -76.61 -11.83 59.92 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.61 -1.632 . . . . 0.0 114.562 174.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.2 t 45.54 40.9 6.29 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 123.54 1.638 . . . . 0.0 111.973 -177.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 41' ' ' GLU . 62.4 t -109.34 -18.58 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 114.16 -1.382 . . . . 0.0 110.852 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.867 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.469 0.497 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.762 -175.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.5 t80 . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.26 -18.68 21.91 Favored Glycine 0 N--CA 1.483 1.82 0 O-C-N 124.971 1.419 . . . . 0.0 113.136 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.457 ' HA ' ' HB2' ' A' ' 74' ' ' GLU . 0.2 OUTLIER -74.98 1.63 12.43 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.214 1.406 . . . . 0.0 113.135 177.743 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.867 ' HE2' HD12 ' A' ' 44' ' ' LEU . 11.4 m-85 -131.05 162.88 28.83 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 123.904 0.882 . . . . 0.0 109.873 -178.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -159.18 156.8 29.62 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 125.647 1.842 . . . . 0.0 110.899 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.482 ' HG3' ' HB2' ' A' ' 37' ' ' PHE . 2.3 mt-10 -114.94 137.33 52.11 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.454 -177.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.482 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 57.1 m-85 -152.48 65.85 0.82 Allowed 'General case' 0 N--CA 1.475 0.789 0 O-C-N 125.837 1.961 . . . . 0.0 111.345 -175.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 27.4 m -39.16 134.65 1.07 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 122.811 1.291 . . . . 0.0 113.061 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.504 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.9 OUTLIER -86.97 109.0 18.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 111.354 -2.657 . . . . 0.0 107.529 178.018 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -43.19 157.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 125.635 1.834 . . . . 0.0 109.339 168.312 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -156.61 141.75 12.38 Favored Pre-proline 0 C--N 1.322 -0.613 0 O-C-N 126.063 2.102 . . . . 0.0 112.501 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.84 145.56 45.98 Favored 'Trans proline' 0 N--CA 1.475 0.407 0 C-N-CA 122.549 2.166 . . . . 0.0 110.955 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.81 28.72 57.66 Favored Glycine 0 CA--C 1.539 1.586 0 CA-C-N 113.358 -1.746 . . . . 0.0 112.422 -175.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.11 89.92 7.89 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -39.71 -32.83 0.15 Allowed 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 113.864 -1.516 . . . . 0.0 113.167 176.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.6 p -130.7 -160.65 1.06 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 113.879 -1.509 . . . . 0.0 109.755 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.507 ' HD2' ' OE1' ' A' ' 32' ' ' GLN . 3.6 mtm105 -60.21 -14.74 19.17 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 172.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.18 139.53 0.07 OUTLIER Glycine 0 C--N 1.334 0.433 0 N-CA-C 107.57 -2.212 . . . . 0.0 107.57 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.2 p -47.08 -27.9 1.53 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 113.306 -1.447 . . . . 0.0 113.428 174.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.479 ' HG2' ' CE1' ' A' ' 81' ' ' TYR . 33.9 mtm-85 -50.27 133.37 23.96 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 123.575 1.655 . . . . 0.0 112.954 170.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.475 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -159.36 133.29 7.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 111.834 -2.439 . . . . 0.0 109.99 -179.585 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.529 HD13 HD21 ' A' ' 19' ' ' LEU . 3.3 mt -104.34 140.18 23.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 113.591 -1.64 . . . . 0.0 109.099 176.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.523 ' O ' ' HD2' ' A' ' 80' ' ' TYR . 21.2 mm -129.22 111.37 22.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 112.362 -2.199 . . . . 0.0 108.88 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.722 HG22 ' HB3' ' A' ' 79' ' ' ASP . 17.2 p -98.68 163.27 12.71 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.443 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -108.03 179.95 21.84 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.083 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -76.52 -12.19 59.99 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.735 0.779 . . . . 0.0 111.888 175.669 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -117.47 129.86 56.08 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 175.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.67 HG22 ' HG2' ' A' ' 77' ' ' GLN . 17.3 m -53.88 151.25 6.73 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.537 174.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.67 ' HG2' HG22 ' A' ' 76' ' ' THR . 0.0 OUTLIER 83.79 32.38 0.06 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 125.936 2.022 . . . . 0.0 110.549 178.212 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.61 ' HA ' HD22 ' A' ' 91' ' ' LEU . 3.6 mt-10 -146.28 52.83 1.13 Allowed 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 123.187 1.47 . . . . 0.0 112.468 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.722 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -107.37 90.97 3.46 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 113.654 -1.612 . . . . 0.0 109.591 -179.517 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.738 ' HE1' HG21 ' A' ' 2' ' ' VAL . 62.8 m-85 -59.63 176.48 0.27 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.268 1.027 . . . . 0.0 109.679 176.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.676 ' HB2' HD11 ' A' ' 92' ' ' ILE . 8.4 t80 -164.76 89.57 0.51 Allowed 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 114.44 -1.254 . . . . 0.0 109.078 -178.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.0 OUTLIER -48.09 -74.26 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.321 -1.309 . . . . 0.0 112.558 172.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 68' ' ' ARG . . . 79.47 -9.44 42.12 Favored Glycine 0 CA--C 1.545 1.953 0 CA-C-N 113.872 -1.513 . . . . 0.0 112.131 -175.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.739 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 11.0 t70 -122.71 16.49 10.27 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.414 0.686 . . . . 0.0 112.555 175.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 66.69 87.37 0.12 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.749 1.619 . . . . 0.0 111.507 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.474 ' H ' HG21 ' A' ' 82' ' ' THR . 5.2 m-85 48.94 28.64 2.05 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 113.279 -1.782 . . . . 0.0 113.471 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.739 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . . . -108.25 -24.29 11.57 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 120.758 -1.214 . . . . 0.0 111.824 -174.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.531 ' O ' ' HB ' ' A' ' 82' ' ' THR . 12.6 p -143.82 172.63 12.58 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -178.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.477 ' O ' HG13 ' A' ' 2' ' ' VAL . 94.9 m-85 -163.23 121.02 1.93 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -175.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.1 m -139.64 107.81 5.77 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.531 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.61 HD22 ' HA ' ' A' ' 78' ' ' GLU . 90.5 mt -44.01 164.18 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.178 0.924 . . . . 0.0 111.701 178.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.676 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.7 mp -110.83 135.56 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 120.424 -1.422 . . . . 0.0 109.517 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.24 100.15 8.84 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.264 -1.334 . . . . 0.0 108.873 176.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -62.39 -38.97 91.67 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 123.573 0.546 . . . . 0.0 111.608 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.3 t -54.98 -45.49 75.0 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.179 1.391 . . . . 0.0 112.814 173.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 35.1 t . . . . . 0 C--O 1.25 1.105 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.653 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.589 HG12 ' H ' ' A' ' 4' ' ' GLY . 12.8 t . . . . . 0 N--CA 1.478 0.947 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.5 t -79.95 4.8 15.71 Favored 'General case' 0 CA--C 1.55 0.958 0 O-C-N 124.468 1.105 . . . . 0.0 112.405 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.589 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 129.59 176.25 14.36 Favored Glycine 0 N--CA 1.474 1.232 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.401 HG23 ' CB ' ' A' ' 91' ' ' LEU . 4.3 m -92.91 173.04 7.95 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.519 -0.84 . . . . 0.0 109.143 -176.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -137.51 108.37 5.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -175.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.5 m -46.05 126.66 7.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.236 -1.802 . . . . 0.0 109.977 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.98 -34.11 63.08 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.8 177.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -64.59 -29.4 70.42 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 123.774 0.671 . . . . 0.0 112.231 173.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.6 -23.06 56.4 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.938 0.895 . . . . 0.0 111.63 174.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.479 HD13 ' HB1' ' A' ' 15' ' ' ALA . 9.1 mt -83.96 164.69 43.02 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 176.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 15' ' ' ALA . 71.5 Cg_endo -69.26 172.08 12.79 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 122.412 2.074 . . . . 0.0 111.975 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.81 -18.63 36.65 Favored 'Trans proline' 0 N--CA 1.48 0.728 0 C-N-CA 122.99 2.46 . . . . 0.0 112.627 176.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.531 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 28.9 tp10 -85.57 -24.73 27.1 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.791 175.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.863 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -48.04 -39.19 19.15 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 177.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.44 -36.98 79.82 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 113.682 -1.599 . . . . 0.0 113.323 174.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.539 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 10.5 t70 -51.46 -54.69 24.39 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.754 0.822 . . . . 0.0 110.088 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.778 ' HA ' HD12 ' A' ' 21' ' ' LEU . 18.8 m -57.91 -50.61 72.75 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 176.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.905 HD11 HG21 ' A' ' 92' ' ' ILE . 48.6 mt -52.38 -30.4 28.87 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 174.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -75.46 -38.43 59.66 Favored 'General case' 0 C--O 1.209 -1.061 0 CA-C-N 114.221 -1.354 . . . . 0.0 110.134 175.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.778 HD12 ' HA ' ' A' ' 18' ' ' THR . 24.6 mt -71.2 -32.27 68.63 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 118.983 -0.532 . . . . 0.0 110.537 175.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.668 HD12 ' O ' ' A' ' 18' ' ' THR . 1.6 mp -70.64 -39.58 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-N 120.382 1.447 . . . . 0.0 111.657 172.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.22 -42.49 59.67 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.574 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.53 7.98 38.74 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.296 1.039 . . . . 0.0 111.366 177.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.8 t70 41.13 50.46 3.29 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.616 1.166 . . . . 0.0 111.105 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.56 -168.61 48.1 Favored Glycine 0 CA--C 1.538 1.493 0 CA-C-N 114.216 -1.356 . . . . 0.0 115.211 -173.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -75.42 141.2 70.56 Favored 'Cis proline' 0 N--CA 1.49 1.296 0 O-C-N 125.001 2.053 . . . . 0.0 111.33 -0.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.495 ' HA ' HD22 ' A' ' 21' ' ' LEU . 29.2 m-85 -92.93 139.59 23.27 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 113.598 -1.637 . . . . 0.0 111.564 -177.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -75.2 -64.5 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.066 2.51 . . . . 0.0 110.788 -177.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.446 ' HD2' HG22 ' A' ' 56' ' ' THR . 1.6 m-30 -58.98 160.45 5.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.667 175.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.8 m -80.77 9.89 5.68 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 122.304 1.049 . . . . 0.0 112.608 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.431 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 1.0 OUTLIER -105.52 86.88 2.48 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 122.078 0.942 . . . . 0.0 110.837 -178.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 176.96 144.58 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 111.342 -2.663 . . . . 0.0 113.772 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.54 30.76 23.53 Favored Glycine 0 N--CA 1.478 1.487 0 O-C-N 126.199 2.187 . . . . 0.0 110.732 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.46 149.91 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.2 t -88.27 157.05 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 O-C-N 125.164 1.54 . . . . 0.0 110.039 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.532 ' CE1' ' HD3' ' A' ' 40' ' ' ARG . 22.3 t80 -135.39 93.79 3.02 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.314 175.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.42 ' HG3' ' CD1' ' A' ' 49' ' ' TYR . 1.1 tm0? -70.88 53.86 0.16 Allowed 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 118.991 0.814 . . . . 0.0 112.309 178.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 26.96 54.36 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.863 2.465 . . . . 0.0 110.046 -176.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.532 ' HD3' ' CE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -57.54 -24.41 55.94 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 122.364 1.078 . . . . 0.0 111.232 -171.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.56 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.9 mt-10 -76.5 -11.48 59.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 112.66 -2.063 . . . . 0.0 114.168 173.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.1 t 43.81 39.85 2.8 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 124.9 2.286 . . . . 0.0 110.904 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 41' ' ' GLU . 20.0 t -107.69 -14.86 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 113.196 -1.82 . . . . 0.0 109.984 -178.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.77 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--O 1.244 0.784 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.225 -172.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.42 ' CD1' ' HG3' ' A' ' 38' ' ' GLN . 8.7 t80 . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.996 0.426 . . . . 0.0 110.801 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.76 12.0 80.79 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 114.394 -1.275 . . . . 0.0 112.14 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -87.17 15.9 5.72 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.596 0.759 . . . . 0.0 112.346 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.77 ' HE2' HD12 ' A' ' 44' ' ' LEU . 12.6 m-85 -150.64 145.5 25.9 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.057 -175.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -142.84 157.55 44.49 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 126.533 2.395 . . . . 0.0 111.147 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -111.11 147.47 34.79 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.054 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.479 ' HB3' HG23 ' A' ' 18' ' ' THR . 79.1 m-85 -160.99 63.73 0.29 Allowed 'General case' 0 CA--C 1.543 0.677 0 O-C-N 125.823 1.952 . . . . 0.0 110.289 -175.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 0.9 OUTLIER -39.04 127.27 1.65 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 122.088 0.947 . . . . 0.0 112.07 178.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.863 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -83.99 120.62 35.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 111.502 -2.59 . . . . 0.0 108.708 178.107 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.514 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 0.1 OUTLIER -45.76 165.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 124.593 1.183 . . . . 0.0 108.199 173.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.406 HG23 ' HD2' ' A' ' 60' ' ' PRO . 2.5 m -158.97 145.8 12.82 Favored Pre-proline 0 C--O 1.24 0.556 0 CA-C-N 112.86 -1.973 . . . . 0.0 112.841 177.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.406 ' HD2' HG23 ' A' ' 59' ' ' THR . 60.9 Cg_endo -73.01 149.79 47.41 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 121.99 1.793 . . . . 0.0 111.764 175.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.86 21.18 22.28 Favored Glycine 0 N--CA 1.483 1.811 0 O-C-N 125.185 1.553 . . . . 0.0 112.458 -175.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.45 86.25 7.33 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -45.15 -27.76 0.65 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 113.276 -1.784 . . . . 0.0 112.146 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.4 p -128.08 -163.24 1.25 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.639 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.431 ' HD2' ' OE1' ' A' ' 32' ' ' GLN . 2.7 mtm105 -56.62 -18.08 10.85 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 174.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.58 131.43 0.03 OUTLIER Glycine 0 N--CA 1.465 0.59 0 N-CA-C 107.274 -2.33 . . . . 0.0 107.274 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.581 HG22 ' HB2' ' A' ' 85' ' ' HIS . 17.6 p -44.37 -41.54 6.19 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 112.044 -2.078 . . . . 0.0 113.031 176.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.6 mtp85 -40.1 102.39 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 122.968 1.366 . . . . 0.0 113.172 173.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -128.05 136.43 51.22 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 112.207 -2.27 . . . . 0.0 109.002 -177.271 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.645 HG23 ' OD1' ' A' ' 79' ' ' ASP . 7.0 mt -105.67 140.99 22.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 112.413 -2.176 . . . . 0.0 108.818 176.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.454 ' HB ' ' HB2' ' A' ' 80' ' ' TYR . 23.3 mm -130.16 105.42 11.73 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 CA-C-N 113.268 -1.787 . . . . 0.0 108.384 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.419 HG22 ' HB2' ' A' ' 79' ' ' ASP . 10.7 p -92.46 163.8 13.7 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.211 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -110.9 -172.59 19.75 Favored Glycine 0 N--CA 1.471 1.024 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.681 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.1 -15.77 60.03 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.41 -0.895 . . . . 0.0 112.303 174.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.72 132.14 54.24 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.338 1.066 . . . . 0.0 108.514 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.417 HG22 ' CG ' ' A' ' 77' ' ' GLN . 23.5 m -59.3 152.3 21.33 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.086 -1.415 . . . . 0.0 108.618 176.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.417 ' CG ' HG22 ' A' ' 76' ' ' THR . 10.3 mt-30 71.46 32.16 2.14 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 123.523 1.63 . . . . 0.0 109.889 178.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.521 ' HA ' HD22 ' A' ' 91' ' ' LEU . 3.6 mt-10 -136.8 68.42 1.43 Allowed 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.847 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.7 ' OD2' HD21 ' A' ' 19' ' ' LEU . 3.6 t0 -111.31 129.8 55.87 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-N 113.192 -1.822 . . . . 0.0 107.718 176.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.454 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 14.4 m-85 -100.36 133.92 44.07 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 125.102 1.361 . . . . 0.0 109.919 175.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.589 ' HB2' HD11 ' A' ' 92' ' ' ILE . 9.2 t80 -111.75 127.41 55.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.458 -1.246 . . . . 0.0 108.961 -177.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.5 OUTLIER -91.03 -68.74 0.77 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 112.839 -1.982 . . . . 0.0 111.959 178.039 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.08 -11.15 50.29 Favored Glycine 0 CA--C 1.542 1.741 0 CA-C-N 113.346 -1.752 . . . . 0.0 112.675 -175.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.477 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 13.5 m-20 -111.37 6.39 20.36 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 175.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.581 ' HB2' HG22 ' A' ' 67' ' ' THR . 21.3 t-80 86.76 -16.98 0.38 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 116.051 -1.928 . . . . 0.0 113.177 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.1 m-30 160.6 51.25 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 128.455 3.597 . . . . 0.0 114.804 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.477 ' HB3' ' HB2' ' A' ' 84' ' ' ASP . . . -120.1 -44.86 2.48 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 119.406 -0.918 . . . . 0.0 112.913 177.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.478 ' O ' ' HB ' ' A' ' 82' ' ' THR . 22.4 p -127.43 168.29 15.07 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.67 -177.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.689 ' CG ' HD21 ' A' ' 44' ' ' LEU . 97.7 m-85 -159.29 115.73 2.61 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -173.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.1 m -135.34 113.81 11.6 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.423 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.521 HD22 ' HA ' ' A' ' 78' ' ' GLU . 29.7 mt -40.81 161.83 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.123 0 O-C-N 124.693 1.246 . . . . 0.0 111.452 177.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.905 HG21 HD11 ' A' ' 19' ' ' LEU . 1.3 mp -106.05 129.59 58.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 O-C-N 120.902 -1.123 . . . . 0.0 108.246 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.419 ' HB3' ' HB3' ' A' ' 96' ' ' CYS . 0.3 OUTLIER -102.68 92.25 4.54 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.65 -1.614 . . . . 0.0 108.021 177.082 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -55.93 -37.75 69.36 Favored 'General case' 0 N--CA 1.484 1.225 0 O-C-N 123.981 0.8 . . . . 0.0 112.253 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.9 t -57.96 -49.67 75.99 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.783 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 93' ' ' ASP . 21.0 t . . . . . 0 N--CA 1.476 0.874 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.873 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.419 HG21 ' CE1' ' A' ' 80' ' ' TYR . 12.1 t . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 m -81.52 22.81 0.68 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.499 1.12 . . . . 0.0 112.379 176.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.16 -154.06 20.11 Favored Glycine 0 N--CA 1.479 1.557 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.452 HG23 ' CB ' ' A' ' 91' ' ' LEU . 2.4 m -107.56 170.07 8.2 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.956 -1.122 . . . . 0.0 110.407 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -142.41 108.77 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -174.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 94.9 m -46.2 133.66 9.13 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 113.581 -1.645 . . . . 0.0 111.038 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -59.06 -32.44 69.77 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.638 -177.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.2 t -67.39 -27.79 67.39 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.612 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.28 -29.64 62.87 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.642 0.777 . . . . 0.0 111.61 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 11' ' ' LEU . 12.3 mt -81.37 161.72 61.19 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 176.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.35 168.25 18.36 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.999 2.466 . . . . 0.0 112.545 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.15 -23.11 39.88 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.236 1.957 . . . . 0.0 113.544 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -83.76 -4.39 58.6 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.884 0.874 . . . . 0.0 111.827 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.746 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -71.72 -49.32 40.39 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.793 0.837 . . . . 0.0 112.278 175.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.3 -25.88 37.05 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.579 174.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.516 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 45.6 t0 -53.46 -57.77 9.47 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 124.32 1.013 . . . . 0.0 110.408 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.743 ' HA ' HD12 ' A' ' 21' ' ' LEU . 8.4 m -56.28 -50.59 70.93 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 175.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.583 HD11 HG21 ' A' ' 92' ' ' ILE . 7.9 mt -55.1 -35.14 64.29 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.279 0.987 . . . . 0.0 111.734 178.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -67.65 -39.75 84.55 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 124.163 0.985 . . . . 0.0 110.769 173.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.743 HD12 ' HA ' ' A' ' 18' ' ' THR . 25.8 mt -68.7 -31.95 71.4 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 122.779 0.431 . . . . 0.0 111.088 175.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.465 HD12 ' O ' ' A' ' 18' ' ' THR . 3.7 mt -71.31 -42.86 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 120.103 1.32 . . . . 0.0 111.534 172.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.7 -41.43 75.41 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 124.39 1.056 . . . . 0.0 112.4 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.38 5.92 48.86 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.272 1.029 . . . . 0.0 111.419 177.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 t0 42.4 44.77 3.56 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.524 1.53 . . . . 0.0 111.685 -178.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.29 -166.78 29.74 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 112.834 -1.985 . . . . 0.0 115.265 -174.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -74.87 139.74 63.4 Favored 'Cis proline' 0 N--CA 1.481 0.758 0 O-C-N 124.275 1.671 . . . . 0.0 111.342 -2.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.439 ' CD2' ' HB3' ' A' ' 21' ' ' LEU . 61.3 m-85 -90.94 139.06 25.86 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 113.244 -1.798 . . . . 0.0 111.534 -176.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.456 ' HG2' ' CD1' ' A' ' 58' ' ' ILE . 37.3 Cg_endo -75.73 -63.13 0.03 OUTLIER 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.975 2.45 . . . . 0.0 111.474 -177.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -61.85 157.79 17.45 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.141 -0.482 . . . . 0.0 112.087 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.6 t -81.17 4.83 18.79 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 122.941 1.353 . . . . 0.0 112.101 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -104.86 86.56 2.48 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.232 1.015 . . . . 0.0 111.484 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 4.5 p-10 177.96 140.31 0.09 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 110.712 -2.949 . . . . 0.0 113.715 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.71 3.22 66.51 Favored Glycine 0 N--CA 1.484 1.883 0 CA-C-N 113.017 -1.902 . . . . 0.0 112.263 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.624 HG23 ' HB2' ' A' ' 54' ' ' GLU . 7.8 m -96.91 144.78 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.342 1.057 . . . . 0.0 110.257 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.2 t -79.63 155.69 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 O-C-N 126.089 2.118 . . . . 0.0 108.865 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.659 ' HE2' HD13 ' A' ' 44' ' ' LEU . 37.0 t80 -137.71 86.32 2.17 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.645 -1.616 . . . . 0.0 108.618 174.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -72.03 51.76 0.23 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.203 -1.56 . . . . 0.0 112.414 178.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.477 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 26.6 t30 28.83 53.61 0.08 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.682 1.193 . . . . 0.0 111.778 -172.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.497 ' HD3' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -56.14 -20.69 18.7 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 113.243 -1.799 . . . . 0.0 112.285 -177.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.585 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -83.87 -4.75 58.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 113.443 -1.708 . . . . 0.0 114.832 174.465 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.2 t 44.05 47.11 7.29 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 123.7 1.715 . . . . 0.0 112.688 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 41' ' ' GLU . 87.0 t -124.11 -6.96 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 113.4 -1.727 . . . . 0.0 111.199 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.659 HD13 ' HE2' ' A' ' 37' ' ' PHE . 1.9 mp . . . . . 0 N--CA 1.475 0.789 0 O-C-N 121.41 -0.806 . . . . 0.0 112.994 176.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.3 t80 . . . . . 0 CA--C 1.537 0.469 0 CA-C-O 121.093 0.473 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.99 8.23 82.62 Favored Glycine 0 N--CA 1.479 1.532 0 CA-C-N 113.327 -1.76 . . . . 0.0 112.807 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.61 -1.64 22.51 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.794 0.838 . . . . 0.0 112.509 175.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.586 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 5.5 m-85 -136.63 171.23 14.81 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.029 1.332 . . . . 0.0 110.094 -177.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -161.01 163.71 31.48 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 113.257 -1.792 . . . . 0.0 110.382 -177.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.624 ' HB2' HG23 ' A' ' 35' ' ' VAL . 1.8 mt-10 -120.03 139.43 52.54 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.096 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.551 ' HB3' HG23 ' A' ' 18' ' ' THR . 58.4 m-85 -153.01 59.33 0.79 Allowed 'General case' 0 N--CA 1.471 0.603 0 O-C-N 126.187 2.179 . . . . 0.0 110.741 -174.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 58.5 m -36.69 116.14 0.41 Allowed 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 122.957 1.36 . . . . 0.0 112.519 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.746 HG21 ' HA ' ' A' ' 15' ' ' ALA . 1.9 p -81.65 110.82 17.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 111.021 -2.809 . . . . 0.0 109.443 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.456 ' CD1' ' HG2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -38.64 147.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 113.722 -1.581 . . . . 0.0 111.296 171.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.45 HG23 ' HD2' ' A' ' 60' ' ' PRO . 6.1 m -136.5 141.62 36.3 Favored Pre-proline 0 N--CA 1.468 0.453 0 O-C-N 125.772 1.92 . . . . 0.0 112.901 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.45 ' HD2' HG23 ' A' ' 59' ' ' THR . 72.0 Cg_endo -75.53 143.71 27.74 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 121.619 1.546 . . . . 0.0 109.963 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.82 29.32 54.59 Favored Glycine 0 CA--C 1.544 1.882 0 CA-C-N 113.867 -1.515 . . . . 0.0 112.033 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.87 89.89 4.75 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -43.33 -30.61 0.54 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 113.324 -1.762 . . . . 0.0 113.152 177.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.0 p -128.88 -170.78 2.33 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.889 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 -47.45 -27.32 1.66 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 174.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.11 144.96 0.12 Allowed Glycine 0 N--CA 1.464 0.522 0 N-CA-C 106.676 -2.57 . . . . 0.0 106.676 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.592 HG22 ' HB2' ' A' ' 85' ' ' HIS . 20.3 p -42.72 -29.05 0.28 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.247 -1.477 . . . . 0.0 114.673 173.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.427 ' HA ' ' HA2' ' A' ' 83' ' ' GLY . 1.0 OUTLIER -45.17 130.0 7.84 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.763 1.625 . . . . 0.0 111.574 170.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.439 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -164.81 136.49 4.32 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 111.864 -2.426 . . . . 0.0 109.339 -176.689 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.4 mt -111.99 142.7 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 125.933 2.021 . . . . 0.0 108.063 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.528 ' HB ' ' HB2' ' A' ' 80' ' ' TYR . 25.5 mm -131.1 128.78 62.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 111.703 -2.499 . . . . 0.0 108.019 178.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.5 p -104.86 163.87 12.2 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 122.238 -0.289 . . . . 0.0 111.33 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -110.5 -178.54 20.7 Favored Glycine 0 CA--C 1.537 1.41 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.58 -15.22 58.8 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 121.646 0.736 . . . . 0.0 111.937 176.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.23 129.78 55.66 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.66 HG22 ' HG2' ' A' ' 77' ' ' GLN . 16.0 m -54.54 145.88 17.67 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 114.122 -1.399 . . . . 0.0 107.611 175.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.66 ' HG2' HG22 ' A' ' 76' ' ' THR . 0.0 OUTLIER 81.8 33.34 0.1 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 126.705 2.002 . . . . 0.0 110.577 179.445 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.583 ' HA ' HD22 ' A' ' 91' ' ' LEU . 6.2 mt-10 -135.28 54.55 1.92 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 123.498 1.618 . . . . 0.0 112.407 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.704 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -101.24 80.96 2.16 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 113.479 -1.692 . . . . 0.0 108.837 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.528 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 12.2 m-85 -51.18 178.99 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 125.455 1.502 . . . . 0.0 110.401 173.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.549 ' HB2' HD11 ' A' ' 92' ' ' ILE . 1.7 t80 -167.03 128.03 1.58 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.595 -1.639 . . . . 0.0 110.441 -175.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.557 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -90.64 -70.07 0.7 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 112.588 -2.096 . . . . 0.0 112.0 175.138 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 68' ' ' ARG . . . 74.22 -5.69 25.81 Favored Glycine 0 CA--C 1.542 1.769 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.692 -175.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.521 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 30.6 m-20 -125.49 17.05 8.23 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.264 1.425 . . . . 0.0 113.7 176.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.592 ' HB2' HG22 ' A' ' 67' ' ' THR . 42.2 t-80 63.25 88.07 0.1 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.393 2.277 . . . . 0.0 111.496 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.418 ' H ' HG21 ' A' ' 82' ' ' THR . 4.1 m-85 49.57 26.36 1.72 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.053 -1.43 . . . . 0.0 113.997 -176.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.521 ' HB3' ' HB2' ' A' ' 84' ' ' ASP . . . -95.77 -22.08 17.74 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 120.76 -1.213 . . . . 0.0 111.731 -175.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.557 ' O ' ' HB ' ' A' ' 82' ' ' THR . 26.5 p -157.17 173.71 16.58 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.178 1.391 . . . . 0.0 108.494 -177.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.518 ' CD1' HD11 ' A' ' 44' ' ' LEU . 98.7 m-85 -155.52 118.63 4.34 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 -176.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 m -135.06 116.5 14.67 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.583 HD22 ' HA ' ' A' ' 78' ' ' GLU . 66.1 mt -47.81 164.93 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.775 0.83 . . . . 0.0 111.424 177.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.718 HG22 ' HG3' ' A' ' 94' ' ' GLN . 1.7 mp -112.62 107.41 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 121.207 -0.933 . . . . 0.0 109.304 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.446 ' HB3' ' HB2' ' A' ' 96' ' ' CYS . 0.1 OUTLIER -77.16 89.04 3.63 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.035 -1.439 . . . . 0.0 109.088 175.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.718 ' HG3' HG22 ' A' ' 92' ' ' ILE . 2.6 mt-30 -79.22 5.71 11.55 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 113.602 -1.635 . . . . 0.0 111.868 177.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.0 t -121.75 -0.98 9.53 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 126.036 1.734 . . . . 0.0 112.581 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 93' ' ' ASP . 42.7 t . . . . . 0 C--O 1.256 1.424 0 CA-C-O 116.268 -1.825 . . . . 0.0 112.888 178.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 4' ' ' GLY . 6.9 t . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 m -75.25 5.21 5.8 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 177.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.475 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 130.37 170.56 12.73 Favored Glycine 0 CA--C 1.536 1.365 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.436 HG22 ' H ' ' A' ' 6' ' ' VAL . 2.5 m -86.99 172.76 9.76 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.069 -1.065 . . . . 0.0 109.103 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.436 ' H ' HG22 ' A' ' 5' ' ' THR . 1.1 t -138.82 106.71 3.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 122.978 1.37 . . . . 0.0 107.869 -175.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.3 m -49.35 126.06 12.31 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 112.62 -2.082 . . . . 0.0 109.902 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 8' ' ' LEU . 14.4 tp -57.06 -34.18 67.99 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 118.938 -0.553 . . . . 0.0 111.353 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.7 t -62.21 -30.23 70.94 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.624 171.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.17 -27.81 53.86 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.64 0.776 . . . . 0.0 112.349 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.44 HD13 ' HB1' ' A' ' 15' ' ' ALA . 14.3 mt -75.4 160.8 78.92 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 174.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.437 ' HD2' HD22 ' A' ' 11' ' ' LEU . 72.2 Cg_endo -68.65 168.32 20.32 Favored 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 122.715 2.276 . . . . 0.0 112.201 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.09 -15.27 39.44 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.416 2.077 . . . . 0.0 113.087 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.43 ' O ' HG22 ' A' ' 57' ' ' VAL . 1.7 mt-10 -92.89 2.11 56.95 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.273 1.029 . . . . 0.0 111.843 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.759 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -77.95 -50.0 13.04 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.214 1.006 . . . . 0.0 112.169 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 0.4 OUTLIER -58.49 -22.2 54.25 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.217 174.121 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -51.26 -59.73 3.89 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.128 0.971 . . . . 0.0 110.306 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.68 HG21 ' O ' ' A' ' 55' ' ' TYR . 39.9 m -64.14 -44.66 91.49 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.523 178.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.541 ' CD2' HD13 ' A' ' 70' ' ' ILE . 0.5 OUTLIER -54.97 -33.48 62.43 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 175.314 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 16' ' ' THR . 4.0 t-20 -73.9 -38.63 64.3 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.995 174.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.54 HD12 ' HA ' ' A' ' 18' ' ' THR . 51.1 mt -69.12 -33.78 74.0 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 175.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.471 ' CD1' HG22 ' A' ' 18' ' ' THR . 3.9 mt -68.75 -41.91 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 123.365 0.666 . . . . 0.0 111.268 172.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.89 -43.76 64.87 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.468 1.105 . . . . 0.0 112.436 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.72 -10.1 59.65 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.058 1.343 . . . . 0.0 111.793 177.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.74 43.26 25.53 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 122.714 1.245 . . . . 0.0 110.718 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.67 -166.92 43.83 Favored Glycine 0 CA--C 1.541 1.676 0 CA-C-N 113.247 -1.797 . . . . 0.0 115.044 -175.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.51 140.5 67.63 Favored 'Cis proline' 0 CA--C 1.537 0.629 0 O-C-N 124.558 1.82 . . . . 0.0 111.058 -1.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.433 ' CD2' ' HB3' ' A' ' 21' ' ' LEU . 46.0 m-85 -90.95 136.55 27.43 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 112.996 -1.911 . . . . 0.0 111.185 -176.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.07 -62.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.188 2.592 . . . . 0.0 111.701 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -59.84 155.07 17.0 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.82 176.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.76 2.29 20.25 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 122.812 1.291 . . . . 0.0 112.313 175.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.4 78.53 2.7 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.622 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -178.48 142.37 0.24 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 112.069 -2.332 . . . . 0.0 113.871 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.14 30.94 12.7 Favored Glycine 0 CA--C 1.537 1.467 0 O-C-N 125.212 1.57 . . . . 0.0 111.645 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.522 HG23 ' HB2' ' A' ' 54' ' ' GLU . 22.2 m -124.26 146.03 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 113.982 -1.109 . . . . 0.0 109.591 178.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.7 t -84.06 156.32 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 125.743 1.902 . . . . 0.0 109.768 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.526 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 81.2 t80 -137.66 87.89 2.29 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 113.968 -1.469 . . . . 0.0 108.791 174.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.403 ' HG3' ' HA ' ' A' ' 49' ' ' TYR . 1.7 tt0 -69.91 53.45 0.12 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.808 -1.183 . . . . 0.0 112.648 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.4 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 50.7 t30 29.21 51.19 0.06 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.418 1.487 . . . . 0.0 111.081 -173.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.46 ' HD3' ' CD1' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -58.15 -20.75 43.09 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.522 -175.519 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.7 mt-10 -84.31 -8.06 59.13 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 113.087 -1.869 . . . . 0.0 114.668 172.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.9 t 43.45 42.58 3.94 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 123.917 1.818 . . . . 0.0 112.135 -177.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 41' ' ' GLU . 86.3 t -112.39 -12.52 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 113.322 -1.763 . . . . 0.0 109.728 -178.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.511 HD21 ' CD1' ' A' ' 89' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.317 -0.814 0 O-C-N 120.979 -1.075 . . . . 0.0 108.436 -175.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.403 ' HA ' ' HG3' ' A' ' 38' ' ' GLN . 10.9 t80 . . . . . 0 N--CA 1.473 0.708 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.14 -8.63 44.36 Favored Glycine 0 N--CA 1.482 1.758 0 O-C-N 125.098 1.499 . . . . 0.0 113.301 177.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -75.77 0.45 17.9 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.267 1.027 . . . . 0.0 112.508 177.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.526 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 16.6 m-85 -136.95 165.38 26.13 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.47 1.108 . . . . 0.0 109.103 -177.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -159.66 158.86 32.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 112.647 -2.069 . . . . 0.0 111.463 -178.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.522 ' HB2' HG23 ' A' ' 35' ' ' VAL . 12.0 mt-10 -113.95 143.01 45.42 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.592 -178.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.68 ' O ' HG21 ' A' ' 18' ' ' THR . 76.8 m-85 -159.97 68.52 0.39 Allowed 'General case' 0 N--CA 1.475 0.796 0 O-C-N 126.244 2.215 . . . . 0.0 109.466 -174.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -36.86 141.51 0.12 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 176.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.759 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -97.77 115.45 37.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 112.9 -1.955 . . . . 0.0 109.385 175.609 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -43.17 151.31 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.662 170.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.458 HG23 ' HD2' ' A' ' 60' ' ' PRO . 2.4 m -150.23 140.84 14.32 Favored Pre-proline 0 N--CA 1.476 0.849 0 O-C-N 125.459 1.725 . . . . 0.0 111.733 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.458 ' HD2' HG23 ' A' ' 59' ' ' THR . 76.6 Cg_endo -73.72 147.14 39.47 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 121.622 1.548 . . . . 0.0 109.735 178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 52.48 34.96 43.32 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.023 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.65 92.67 6.33 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -42.0 -31.39 0.34 Allowed 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 113.641 -1.618 . . . . 0.0 113.323 176.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.5 p -123.36 -164.05 1.18 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.968 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -59.88 -14.0 13.39 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 173.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.62 146.01 3.72 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.214 -1.955 . . . . 0.0 108.214 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.547 HG22 ' HB2' ' A' ' 85' ' ' HIS . 41.0 p -69.93 -5.51 26.62 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 111.772 -2.214 . . . . 0.0 113.105 176.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.567 ' HD2' ' HA2' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -80.02 85.27 5.63 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 123.939 1.828 . . . . 0.0 110.384 178.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.84 142.58 34.14 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 112.581 -2.1 . . . . 0.0 109.342 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.592 HG23 ' OD1' ' A' ' 79' ' ' ASP . 9.6 mt -117.76 132.62 67.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 125.601 1.813 . . . . 0.0 109.404 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.477 ' O ' ' HD2' ' A' ' 80' ' ' TYR . 17.5 mm -125.82 106.67 16.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 O-C-N 125.27 1.606 . . . . 0.0 109.048 -176.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.437 HG21 HG21 ' A' ' 22' ' ' ILE . 0.9 OUTLIER -82.39 165.99 19.81 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.301 -0.874 . . . . 0.0 111.194 179.368 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -120.73 171.44 14.74 Favored Glycine 0 N--CA 1.469 0.881 0 CA-C-N 113.424 -1.717 . . . . 0.0 109.799 177.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.45 -14.54 61.17 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.756 0.789 . . . . 0.0 112.251 174.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.18 129.76 53.5 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 122.361 1.077 . . . . 0.0 108.233 174.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.568 HG22 ' HG2' ' A' ' 77' ' ' GLN . 3.1 m -61.87 142.55 57.3 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 113.833 -1.531 . . . . 0.0 107.575 175.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.568 ' HG2' HG22 ' A' ' 76' ' ' THR . 0.5 OUTLIER 77.78 29.36 0.51 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 126.618 1.967 . . . . 0.0 111.279 179.519 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -126.98 56.04 1.53 Allowed 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 123.083 1.421 . . . . 0.0 111.92 177.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.592 ' OD1' HG23 ' A' ' 70' ' ' ILE . 0.5 OUTLIER -99.63 119.59 38.33 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 113.267 -1.788 . . . . 0.0 109.287 178.346 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.477 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 36.5 m-85 -92.71 139.41 30.58 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.14 1.376 . . . . 0.0 108.943 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.643 ' HB2' HD11 ' A' ' 92' ' ' ILE . 27.8 t80 -118.43 121.48 40.41 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.665 -175.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.0 OUTLIER -80.88 -64.53 1.17 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 113.317 -1.765 . . . . 0.0 110.761 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.567 ' HA2' ' HD2' ' A' ' 68' ' ' ARG . . . 70.37 -6.04 6.28 Favored Glycine 0 CA--C 1.545 1.943 0 CA-C-N 114.886 -1.052 . . . . 0.0 113.104 -173.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.578 ' CB ' ' HB3' ' A' ' 87' ' ' ALA . 80.1 m-20 -126.58 6.19 6.85 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.547 ' HB2' HG22 ' A' ' 67' ' ' THR . 48.4 t-80 66.59 82.57 0.18 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 128.256 2.622 . . . . 0.0 110.374 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 57.28 17.69 3.82 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 113.428 -1.715 . . . . 0.0 114.247 -174.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.578 ' HB3' ' CB ' ' A' ' 84' ' ' ASP . . . -99.84 -3.54 32.37 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.177 -0.952 . . . . 0.0 112.595 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.411 ' O ' ' HB ' ' A' ' 82' ' ' THR . 2.2 p -167.75 168.85 12.15 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.016 1.727 . . . . 0.0 109.161 -176.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.511 ' CD1' HD21 ' A' ' 44' ' ' LEU . 80.2 m-85 -160.41 109.83 1.73 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.068 0.947 . . . . 0.0 108.972 -173.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.8 m -128.23 108.4 10.58 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.991 -176.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.424 ' CB ' HG23 ' A' ' 5' ' ' THR . 21.7 mt -42.73 161.14 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.643 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.4 mp -107.3 129.45 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 O-C-N 120.671 -1.268 . . . . 0.0 108.792 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 96' ' ' CYS . 0.3 OUTLIER -103.47 94.18 5.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.376 178.655 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.44 HE22 ' HB3' ' A' ' 77' ' ' GLN . 0.9 OUTLIER -68.92 -8.46 44.56 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 124.94 1.4 . . . . 0.0 112.524 178.614 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 t -93.18 -41.9 9.66 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 127.141 2.176 . . . . 0.0 113.1 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 93' ' ' ASP . 45.2 t . . . . . 0 C--O 1.25 1.105 0 CA-C-O 117.695 -1.145 . . . . 0.0 110.931 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.407 HG12 ' H ' ' A' ' 4' ' ' GLY . 11.1 t . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.5 m -77.34 7.97 4.68 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 177.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.407 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 119.42 -172.49 14.71 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.27 1.414 . . . . 0.0 109.735 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -90.22 169.51 11.07 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 122.452 1.12 . . . . 0.0 109.735 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.635 HG13 HD11 ' A' ' 11' ' ' LEU . 4.9 p -143.12 112.0 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 114.222 -1.354 . . . . 0.0 108.285 -176.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 73.7 m -50.22 133.42 23.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 112.427 -2.169 . . . . 0.0 109.592 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.708 ' HA ' HD12 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -55.51 -35.92 66.13 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 119.156 -0.449 . . . . 0.0 111.933 179.688 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.1 t -69.0 -15.48 63.49 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.246 174.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.65 -33.27 35.76 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.396 0.678 . . . . 0.0 112.182 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.708 HD12 ' HA ' ' A' ' 8' ' ' LEU . 6.2 mt -83.64 176.41 3.81 Favored Pre-proline 0 CA--C 1.558 1.272 0 C-N-CA 125.72 1.608 . . . . 0.0 111.095 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 57.8 Cg_endo -65.51 167.12 17.66 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.285 1.99 . . . . 0.0 113.417 174.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -64.77 -21.4 64.76 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 C-N-CA 122.515 2.143 . . . . 0.0 113.064 174.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 5.0 tp10 -82.23 -19.25 40.07 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 175.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.832 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -52.11 -25.5 8.97 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 173.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.643 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -79.48 -33.98 41.79 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 172.547 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.633 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 11.4 t70 -49.83 -53.78 23.37 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.222 1.009 . . . . 0.0 110.059 -177.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.834 ' HA ' HD12 ' A' ' 21' ' ' LEU . 10.5 m -53.99 -52.46 60.69 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 174.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.646 HD11 HG21 ' A' ' 92' ' ' ILE . 9.6 mt -54.67 -37.61 65.97 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 124.624 1.202 . . . . 0.0 111.746 178.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -64.69 -38.01 89.53 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.629 0.772 . . . . 0.0 111.724 173.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.834 HD12 ' HA ' ' A' ' 18' ' ' THR . 12.8 mt -73.16 -32.87 65.14 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 118.518 -0.754 . . . . 0.0 111.312 176.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.61 HD12 ' O ' ' A' ' 18' ' ' THR . 2.1 mp -66.39 -39.35 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-N 120.37 1.441 . . . . 0.0 111.61 169.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.78 -48.42 46.69 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.198 0.999 . . . . 0.0 112.316 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 m -86.11 6.39 29.35 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.916 1.286 . . . . 0.0 113.547 175.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 43.74 36.0 1.18 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.333 1.453 . . . . 0.0 112.532 -174.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.96 -168.48 18.12 Favored Glycine 0 CA--C 1.542 1.773 0 CA-C-N 113.296 -1.774 . . . . 0.0 115.504 -175.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -75.0 138.29 55.21 Favored 'Cis proline' 0 N--CA 1.488 1.203 0 O-C-N 123.868 1.457 . . . . 0.0 111.412 -3.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.499 ' HA ' HD22 ' A' ' 21' ' ' LEU . 63.7 m-85 -85.83 149.79 51.67 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-N 113.02 -1.9 . . . . 0.0 112.461 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.97 -69.77 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 123.127 2.551 . . . . 0.0 111.717 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.576 ' CZ ' HG12 ' A' ' 58' ' ' ILE . 18.9 m-30 -74.45 168.84 18.92 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.56 0.744 . . . . 0.0 110.355 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.3 m -72.6 -3.87 27.41 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 122.138 0.971 . . . . 0.0 113.603 174.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -83.28 82.48 8.25 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.751 -1.113 . . . . 0.0 112.083 -178.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 179.0 145.64 0.15 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 110.393 -3.094 . . . . 0.0 116.117 -176.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.18 33.64 39.64 Favored Glycine 0 N--CA 1.473 1.135 0 CA-C-N 112.191 -2.277 . . . . 0.0 110.951 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.1 m -129.88 144.52 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 113.574 -1.313 . . . . 0.0 109.917 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.1 t -83.87 151.18 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 O-C-N 126.66 2.475 . . . . 0.0 109.76 176.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.402 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 41.0 t80 -128.92 95.7 4.16 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.004 173.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -74.13 52.03 0.44 Allowed 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.158 -0.964 . . . . 0.0 111.622 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 26.78 55.56 0.06 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.73 2.412 . . . . 0.0 111.684 -174.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.17 -22.59 41.51 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.26 -173.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.61 ' O ' HG23 ' A' ' 43' ' ' VAL . 13.5 mt-10 -75.84 -15.01 60.29 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 172.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.2 t 48.16 35.61 5.58 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 123.989 1.852 . . . . 0.0 112.336 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 41' ' ' GLU . 95.3 t -110.84 -14.47 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-O 123.368 1.556 . . . . 0.0 110.555 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.592 ' HB3' ' OH ' ' A' ' 52' ' ' TYR . 2.6 mm? . . . . . 0 CA--C 1.547 0.862 0 CA-C-O 117.098 -1.43 . . . . 0.0 108.274 -174.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 54.6 t80 . . . . . 0 N--CA 1.471 0.609 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.04 11.88 52.96 Favored Glycine 0 N--CA 1.483 1.773 0 CA-C-N 114.937 -1.028 . . . . 0.0 112.95 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.414 ' HA ' ' HB2' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -85.98 13.11 8.04 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.448 1.099 . . . . 0.0 112.54 -178.773 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.592 ' OH ' ' HB3' ' A' ' 44' ' ' LEU . 10.6 m-85 -151.39 148.48 28.17 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 125.33 1.452 . . . . 0.0 109.732 -173.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -145.11 159.91 42.24 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 125.417 1.698 . . . . 0.0 111.31 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.402 ' HG3' ' HB2' ' A' ' 37' ' ' PHE . 1.4 mt-10 -117.24 140.88 48.99 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.391 -177.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.423 ' HE2' ' HG1' ' A' ' 72' ' ' THR . 65.6 m-85 -157.96 67.96 0.49 Allowed 'General case' 0 C--O 1.239 0.517 0 O-C-N 125.696 1.872 . . . . 0.0 110.982 -173.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 52.8 m -41.95 119.16 1.26 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 123.563 1.649 . . . . 0.0 112.884 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.832 HG21 ' HA ' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -78.83 116.28 22.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 110.192 -3.185 . . . . 0.0 108.673 178.757 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.576 HG12 ' CZ ' ' A' ' 30' ' ' TYR . 4.4 mt -40.49 148.26 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-O 122.655 1.216 . . . . 0.0 108.642 174.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.9 m -133.1 138.93 32.82 Favored Pre-proline 0 C--O 1.24 0.558 0 CA-C-N 112.16 -2.291 . . . . 0.0 112.45 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.83 143.06 49.3 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.033 1.822 . . . . 0.0 109.943 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.47 30.19 40.94 Favored Glycine 0 CA--C 1.54 1.645 0 CA-C-N 114.313 -1.312 . . . . 0.0 113.113 -176.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.77 94.5 6.37 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -40.63 -35.16 0.44 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.336 176.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.8 p -127.17 -155.59 0.7 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.075 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.3 mtm180 -53.11 -23.87 9.03 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 170.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.76 156.5 0.33 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 -176.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 81.4 p -47.9 -29.35 3.25 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 112.901 -1.65 . . . . 0.0 112.518 173.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.533 ' HA ' ' HA2' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -47.15 139.28 6.13 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 122.199 0.999 . . . . 0.0 112.724 173.629 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -168.0 139.41 2.88 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 112.1 -2.318 . . . . 0.0 109.76 -176.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.8 mt -115.99 144.99 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 112.596 -2.093 . . . . 0.0 108.66 175.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' A' ' 80' ' ' TYR . 11.6 mm -131.49 121.36 48.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 O-C-N 126.319 2.262 . . . . 0.0 107.326 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.493 HG22 ' HB3' ' A' ' 79' ' ' ASP . 22.0 p -104.06 163.34 12.45 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.271 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -108.6 177.55 20.67 Favored Glycine 0 N--CA 1.477 1.406 0 O-C-N 125.211 1.569 . . . . 0.0 110.562 178.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -74.89 -14.91 60.71 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 122.124 0.964 . . . . 0.0 113.055 175.422 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -112.77 129.94 56.25 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 175.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.63 HG22 ' HG2' ' A' ' 77' ' ' GLN . 25.9 m -53.67 149.59 8.13 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 114.27 -1.332 . . . . 0.0 108.041 174.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.63 ' HG2' HG22 ' A' ' 76' ' ' THR . 0.1 OUTLIER 81.03 32.84 0.13 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 126.53 1.932 . . . . 0.0 111.425 179.802 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.582 ' HA ' HD22 ' A' ' 91' ' ' LEU . 10.0 mt-10 -139.17 51.73 1.78 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 123.764 1.745 . . . . 0.0 112.716 179.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.531 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -103.9 83.91 2.18 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 113.552 -1.658 . . . . 0.0 109.1 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.426 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 31.4 m-85 -56.02 173.67 0.15 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.912 1.685 . . . . 0.0 110.673 174.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.529 ' HB2' HD11 ' A' ' 92' ' ' ILE . 11.7 t80 -158.41 126.92 5.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.426 -176.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 88' ' ' THR 0.275 0.1 OUTLIER -91.73 -69.25 0.75 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 112.657 -2.065 . . . . 0.0 112.643 173.391 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' A' ' 68' ' ' ARG . . . 64.36 17.86 62.38 Favored Glycine 0 CA--C 1.54 1.617 0 CA-C-N 115.124 -0.944 . . . . 0.0 113.219 -173.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.504 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 38.0 t0 -148.0 26.19 1.0 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.732 1.213 . . . . 0.0 112.417 175.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 56.8 83.55 0.1 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.586 1.555 . . . . 0.0 110.968 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 47.97 51.17 14.85 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 113.333 -1.758 . . . . 0.0 114.681 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . . . -120.84 -35.88 3.26 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.175 -1.375 . . . . 0.0 113.948 -178.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.498 ' O ' ' HB ' ' A' ' 82' ' ' THR . 16.3 p -136.77 166.6 23.22 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.653 1.181 . . . . 0.0 108.095 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.431 ' CD1' HD21 ' A' ' 44' ' ' LEU . 94.9 m-85 -156.9 111.83 2.8 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -174.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.2 m -133.76 115.34 14.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.292 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.582 HD22 ' HA ' ' A' ' 78' ' ' GLU . 87.5 mt -46.31 160.77 0.06 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.721 0.808 . . . . 0.0 111.989 178.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.646 HG21 HD11 ' A' ' 19' ' ' LEU . 1.7 mp -109.52 127.37 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 120.667 -1.27 . . . . 0.0 109.433 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.45 95.22 5.67 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 113.567 -1.652 . . . . 0.0 108.985 175.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -58.95 -42.35 89.6 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 124.502 1.126 . . . . 0.0 111.55 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.2 t -50.91 -31.95 19.13 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.692 1.597 . . . . 0.0 113.446 171.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 19.1 t . . . . . 0 CA--C 1.554 1.126 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.795 177.35 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.598 HG11 ' HG ' ' A' ' 91' ' ' LEU . 2.0 t . . . . . 0 N--CA 1.468 0.443 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.1 p -78.38 14.21 1.3 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 122.396 1.094 . . . . 0.0 113.487 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 120.83 -163.31 14.39 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.439 1.495 . . . . 0.0 109.719 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -100.98 171.06 7.87 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 112.63 -1.785 . . . . 0.0 109.741 -177.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 91' ' ' LEU . 9.8 p -142.27 107.22 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.627 -1.169 . . . . 0.0 107.947 -175.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.425 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 86.0 m -45.76 128.44 8.68 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 111.986 -2.37 . . . . 0.0 109.126 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.782 ' HA ' HD12 ' A' ' 11' ' ' LEU . 15.5 tp -53.16 -36.95 61.42 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.778 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -65.03 -19.72 66.14 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.984 172.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 7' ' ' CYS . . . -79.09 -31.88 44.47 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.197 0.522 . . . . 0.0 111.731 175.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.782 HD12 ' HA ' ' A' ' 8' ' ' LEU . 10.4 mt -83.5 173.55 7.27 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 125.26 1.424 . . . . 0.0 110.221 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 92.2 Cg_endo -70.3 169.38 19.73 Favored 'Trans proline' 0 CA--C 1.555 1.534 0 C-N-CA 122.008 1.805 . . . . 0.0 113.817 176.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.87 -15.99 40.91 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.745 2.297 . . . . 0.0 114.257 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.412 ' HG3' ' HA ' ' A' ' 59' ' ' THR . 10.8 pm0 -87.05 2.8 48.47 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.061 1.344 . . . . 0.0 113.306 175.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.519 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -76.48 -55.3 5.66 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.155 0.982 . . . . 0.0 111.585 176.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.664 ' OG1' HD21 ' A' ' 8' ' ' LEU . 0.5 OUTLIER -53.8 -29.11 38.97 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 114.827 -1.079 . . . . 0.0 112.363 174.175 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.556 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 44.6 t0 -51.12 -58.04 7.15 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 125.129 1.518 . . . . 0.0 110.514 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.738 ' HA ' HD12 ' A' ' 21' ' ' LEU . 18.0 m -55.26 -51.1 67.75 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.914 HD11 HG21 ' A' ' 92' ' ' ILE . 7.5 mt -56.7 -35.02 68.0 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 123.782 0.676 . . . . 0.0 112.678 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -66.95 -36.55 82.46 Favored 'General case' 0 C--O 1.217 -0.634 0 C-N-CA 124.478 1.111 . . . . 0.0 110.386 174.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.738 HD12 ' HA ' ' A' ' 18' ' ' THR . 33.2 mt -72.84 -32.67 65.63 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 119.025 -0.512 . . . . 0.0 111.137 175.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.698 HD12 ' O ' ' A' ' 18' ' ' THR . 1.7 mp -70.43 -40.34 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 120.325 1.42 . . . . 0.0 111.881 171.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.28 -42.16 65.87 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 124.602 1.189 . . . . 0.0 112.474 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.32 7.47 44.28 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.505 178.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 42.99 37.32 1.08 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 123.158 1.456 . . . . 0.0 112.539 -177.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.52 -167.26 17.57 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 112.959 -1.928 . . . . 0.0 116.036 -173.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -74.44 139.44 61.65 Favored 'Cis proline' 0 N--CA 1.488 1.154 0 O-C-N 123.917 1.483 . . . . 0.0 111.639 -2.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.51 ' CD2' ' HB3' ' A' ' 21' ' ' LEU . 65.3 m-85 -91.22 135.23 28.55 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.583 -177.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -76.45 -58.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.634 2.223 . . . . 0.0 111.936 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -66.13 159.56 25.92 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.102 0.561 . . . . 0.0 112.063 175.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.1 m -77.14 1.31 18.64 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 173.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.58 84.95 4.05 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 122.055 0.931 . . . . 0.0 111.489 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 178.2 147.72 0.16 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 110.665 -2.97 . . . . 0.0 115.113 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.94 30.81 37.29 Favored Glycine 0 N--CA 1.478 1.476 0 CA-C-N 112.373 -2.194 . . . . 0.0 110.997 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.1 146.76 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.468 1.107 . . . . 0.0 109.797 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.2 t -83.59 153.93 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 126.49 2.369 . . . . 0.0 110.299 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.519 ' CE1' ' HD3' ' A' ' 40' ' ' ARG . 29.3 t80 -129.39 94.31 3.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 113.557 -1.656 . . . . 0.0 109.44 175.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.497 ' HG3' ' CD1' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -73.1 50.14 0.27 Allowed 'General case' 0 N--CA 1.484 1.229 0 O-C-N 120.923 -1.111 . . . . 0.0 112.938 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.485 ' ND2' ' H ' ' A' ' 44' ' ' LEU . 17.8 t30 22.86 60.51 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.526 1.931 . . . . 0.0 111.611 -173.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.519 ' HD3' ' CE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -58.63 -25.5 62.76 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 113.477 -1.692 . . . . 0.0 111.389 -175.612 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.589 ' O ' HG23 ' A' ' 43' ' ' VAL . 1.4 mt-10 -75.46 -7.93 55.4 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.023 -1.444 . . . . 0.0 114.633 174.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.7 t 44.18 42.86 5.35 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 124.387 2.041 . . . . 0.0 112.188 -177.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 41' ' ' GLU . 65.8 t -110.76 -21.97 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 113.543 -1.662 . . . . 0.0 110.448 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.85 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.32 -0.678 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.815 -173.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.497 ' CD1' ' HG3' ' A' ' 38' ' ' GLN . 8.8 t80 . . . . . 0 N--CA 1.465 0.286 0 CA-C-O 120.745 0.307 . . . . 0.0 110.46 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.63 6.7 88.3 Favored Glycine 0 N--CA 1.478 1.474 0 CA-C-N 114.469 -1.241 . . . . 0.0 113.365 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -79.81 7.52 8.53 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.419 1.087 . . . . 0.0 112.824 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.85 ' HE2' HD12 ' A' ' 44' ' ' LEU . 13.2 m-85 -143.91 144.26 31.64 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -174.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -142.32 157.01 45.28 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 126.297 2.248 . . . . 0.0 110.29 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -113.48 143.71 44.05 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.863 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.421 ' HB3' HG23 ' A' ' 18' ' ' THR . 77.0 m-85 -159.26 70.47 0.48 Allowed 'General case' 0 N--CA 1.472 0.645 0 O-C-N 125.378 1.674 . . . . 0.0 111.043 -175.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 1.2 m -39.49 126.98 1.87 Allowed 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 122.332 1.063 . . . . 0.0 112.772 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.519 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.8 OUTLIER -70.12 108.18 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 111.632 -2.531 . . . . 0.0 108.468 176.402 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -39.37 153.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 CA-C-N 115.307 -0.86 . . . . 0.0 108.878 170.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.412 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 1.5 m -156.35 140.02 11.32 Favored Pre-proline 0 N--CA 1.48 1.052 0 O-C-N 125.658 1.849 . . . . 0.0 110.78 177.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.62 152.16 53.32 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.944 2.429 . . . . 0.0 110.18 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 52.41 26.71 23.24 Favored Glycine 0 N--CA 1.481 1.69 0 CA-C-N 113.993 -1.458 . . . . 0.0 112.144 -175.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.43 89.72 7.98 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -40.42 -31.83 0.16 Allowed 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 113.72 -1.582 . . . . 0.0 112.764 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.4 p -134.23 -145.11 0.23 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.618 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 60.3 mtm180 -72.81 -18.67 61.44 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 173.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.08 142.61 0.02 OUTLIER Glycine 0 CA--C 1.531 1.053 0 N-CA-C 108.929 -1.669 . . . . 0.0 108.929 -175.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.2 p -41.85 -32.43 0.41 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 113.887 -1.157 . . . . 0.0 114.057 174.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.406 ' HG3' ' OH ' ' A' ' 81' ' ' TYR . 2.8 mpt_? -44.58 120.02 2.1 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 122.723 1.249 . . . . 0.0 112.461 170.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.477 ' HB3' HG23 ' A' ' 82' ' ' THR . 1.6 tpt180 -149.26 128.46 12.84 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 112.337 -2.21 . . . . 0.0 109.048 -178.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.423 HD12 HG23 ' A' ' 57' ' ' VAL . 3.2 mt -103.79 143.47 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 113.646 -1.615 . . . . 0.0 108.965 173.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.743 HD11 ' HE1' ' A' ' 86' ' ' TYR . 13.8 mm -129.84 102.55 7.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 112.777 -2.011 . . . . 0.0 108.35 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.675 HG22 ' HB3' ' A' ' 79' ' ' ASP . 24.9 p -94.71 165.19 12.62 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.655 0.741 . . . . 0.0 110.371 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -118.88 167.54 13.14 Favored Glycine 0 N--CA 1.473 1.162 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.231 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -61.61 -19.05 61.81 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.579 0.704 . . . . 0.0 111.886 174.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.78 129.56 49.47 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.013 175.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.563 HG22 ' HG2' ' A' ' 77' ' ' GLN . 19.2 m -60.04 144.17 50.1 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 114.114 -1.403 . . . . 0.0 107.311 175.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.563 ' HG2' HG22 ' A' ' 76' ' ' THR . 1.6 mt-30 80.46 33.19 0.16 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 126.82 2.048 . . . . 0.0 111.696 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.411 ' HA ' HD22 ' A' ' 91' ' ' LEU . 23.9 mt-10 -134.55 52.65 2.04 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 113.51 -1.677 . . . . 0.0 112.994 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.675 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.4 OUTLIER -107.95 94.29 4.99 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 113.648 -1.614 . . . . 0.0 110.062 -178.557 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.502 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 12.0 m-85 -82.74 129.07 34.91 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 125.017 1.327 . . . . 0.0 109.642 -177.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.864 ' HB2' HD11 ' A' ' 92' ' ' ILE . 64.2 t80 -113.66 136.61 52.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.103 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.545 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.6 OUTLIER -95.43 -67.27 0.86 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 112.196 -2.275 . . . . 0.0 112.001 176.137 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.88 -0.95 26.37 Favored Glycine 0 CA--C 1.549 2.21 0 CA-C-N 114.031 -1.441 . . . . 0.0 113.496 -174.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.555 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 80.1 m-20 -127.98 17.17 6.74 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 175.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 63.13 86.25 0.12 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.666 1.986 . . . . 0.0 111.12 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.743 ' HE1' HD11 ' A' ' 71' ' ' ILE . 6.1 m-30 49.48 30.56 3.48 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 113.944 -1.48 . . . . 0.0 114.776 -176.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.555 ' HB3' ' HB2' ' A' ' 84' ' ' ASP . . . -99.74 -18.78 17.07 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.733 -0.787 . . . . 0.0 112.561 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.545 ' O ' ' HB ' ' A' ' 82' ' ' THR . 25.2 p -158.93 171.06 20.73 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.623 1.569 . . . . 0.0 108.868 -177.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.577 ' CG ' HD21 ' A' ' 44' ' ' LEU . 94.0 m-85 -157.15 116.54 3.38 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.157 0.983 . . . . 0.0 108.818 -174.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.61 109.91 7.86 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 113.583 -1.644 . . . . 0.0 106.93 -178.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.598 ' HG ' HG11 ' A' ' 2' ' ' VAL . 52.2 mt -41.75 158.81 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.653 177.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.914 HG21 HD11 ' A' ' 19' ' ' LEU . 1.7 mp -112.92 121.86 65.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 120.789 -1.194 . . . . 0.0 109.218 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.27 96.76 7.67 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 113.226 -1.806 . . . . 0.0 108.78 176.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -60.86 -39.2 88.26 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 124.879 1.362 . . . . 0.0 111.803 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.7 t -52.54 -32.01 38.56 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.068 -1.423 . . . . 0.0 113.533 172.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 19.9 t . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.407 176.743 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.474 HG11 ' HG ' ' A' ' 91' ' ' LEU . 2.1 t . . . . . 0 N--CA 1.467 0.409 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.81 7.9 5.26 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.682 1.239 . . . . 0.0 112.196 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.22 -166.73 21.48 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.001 1.286 . . . . 0.0 110.471 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 6' ' ' VAL . 3.3 m -101.64 172.91 6.67 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.231 -1.484 . . . . 0.0 108.942 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.411 ' H ' HG22 ' A' ' 5' ' ' THR . 0.7 OUTLIER -142.27 107.69 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 -175.217 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 88.5 m -47.1 132.48 12.2 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 112.92 -1.946 . . . . 0.0 109.586 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.423 HD11 ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -55.55 -33.61 64.0 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.962 -178.208 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.0 t -64.82 -28.86 69.84 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.634 173.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.46 -31.49 62.26 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.605 0.762 . . . . 0.0 111.194 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.413 HD11 HD11 ' A' ' 92' ' ' ILE . 12.4 mt -74.63 162.26 74.42 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 175.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.41 ' HD2' HD22 ' A' ' 11' ' ' LEU . 59.4 Cg_endo -68.65 167.51 22.62 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.567 2.178 . . . . 0.0 111.948 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.86 -16.14 32.92 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.837 2.358 . . . . 0.0 112.632 177.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.423 ' CD ' ' HD3' ' A' ' 60' ' ' PRO . 1.7 mt-10 -93.71 -2.57 53.65 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.324 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.94 -39.43 18.16 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.757 175.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.423 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -60.82 -28.75 69.03 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.195 175.037 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.463 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 18.1 t0 -54.24 -51.94 62.89 Favored 'General case' 0 C--O 1.213 -0.835 0 O-C-N 124.881 1.363 . . . . 0.0 110.146 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.669 ' OG1' HG12 ' A' ' 57' ' ' VAL . 28.2 m -64.06 -49.26 73.02 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.572 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.593 HD21 HD13 ' A' ' 70' ' ' ILE . 19.6 mt -53.52 -31.41 46.09 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.972 0.795 . . . . 0.0 112.529 175.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -71.93 -42.44 66.64 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.373 173.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.648 HD12 ' HA ' ' A' ' 18' ' ' THR . 33.8 mt -67.79 -35.59 78.93 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.993 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.564 HD12 ' O ' ' A' ' 18' ' ' THR . 2.1 mt -65.64 -40.03 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 119.73 1.15 . . . . 0.0 110.806 172.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.75 -46.34 46.44 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 124.043 0.839 . . . . 0.0 111.9 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.78 -1.18 37.57 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.327 1.051 . . . . 0.0 111.413 176.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 49.48 39.25 16.28 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 122.555 1.169 . . . . 0.0 110.913 -178.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.57 -169.34 37.25 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-N 113.66 -1.609 . . . . 0.0 115.23 -174.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -75.15 140.73 68.78 Favored 'Cis proline' 0 CA--C 1.535 0.546 0 O-C-N 124.911 2.006 . . . . 0.0 111.51 -0.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.427 ' CD2' ' HB3' ' A' ' 21' ' ' LEU . 20.9 m-85 -89.51 137.6 28.79 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 113.32 -1.764 . . . . 0.0 111.034 -176.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -74.29 -62.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.528 2.819 . . . . 0.0 111.296 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.528 ' CE2' HG13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -56.18 155.57 6.52 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.964 0.79 . . . . 0.0 110.604 177.712 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.31 7.13 14.77 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 122.186 0.993 . . . . 0.0 111.592 175.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.31 82.56 1.76 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 122.081 0.943 . . . . 0.0 111.558 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -179.22 146.03 0.28 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 112.616 -2.084 . . . . 0.0 112.972 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.39 36.1 10.04 Favored Glycine 0 N--CA 1.484 1.879 0 O-C-N 126.312 2.257 . . . . 0.0 110.756 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.9 m -135.58 151.03 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 114.388 -0.906 . . . . 0.0 109.216 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.3 t -86.86 157.46 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 125.619 1.825 . . . . 0.0 109.534 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.536 ' CE2' ' HA ' ' A' ' 39' ' ' ASN . 79.4 t80 -136.08 88.97 2.43 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 113.695 -1.593 . . . . 0.0 108.713 177.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -72.24 51.29 0.24 Allowed 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.313 -0.867 . . . . 0.0 111.683 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.536 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 33.2 t30 25.32 57.42 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.977 2.111 . . . . 0.0 110.667 -173.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -21.43 22.44 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 113.265 -1.789 . . . . 0.0 111.406 -177.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.666 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.0 mt-10 -83.71 -4.72 58.85 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 114.074 -1.421 . . . . 0.0 113.894 174.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.416 ' HA ' ' ND2' ' A' ' 39' ' ' ASN . 41.3 t 43.02 46.36 4.74 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 124.535 2.112 . . . . 0.0 112.623 -177.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 41' ' ' GLU . 88.0 t -115.73 -23.82 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 113.989 -1.46 . . . . 0.0 109.687 -176.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.6 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.471 0.598 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.98 -175.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 18.6 t80 . . . . . 0 CA--C 1.536 0.428 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.71 10.98 56.48 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.743 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.96 10.17 10.51 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.485 1.114 . . . . 0.0 112.274 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.6 ' HE2' HD12 ' A' ' 44' ' ' LEU . 10.1 m-85 -144.0 143.52 31.25 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -175.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -144.07 155.69 44.07 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 126.395 2.309 . . . . 0.0 110.857 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -110.22 142.27 42.03 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.68 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.592 ' O ' HG21 ' A' ' 18' ' ' THR . 76.9 m-85 -155.66 64.16 0.6 Allowed 'General case' 0 N--CA 1.467 0.388 0 O-C-N 125.796 1.935 . . . . 0.0 110.462 -176.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.552 HG21 ' CG ' ' A' ' 65' ' ' ARG . 0.3 OUTLIER -41.44 136.32 1.79 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 122.322 1.058 . . . . 0.0 112.911 178.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.669 HG12 ' OG1' ' A' ' 18' ' ' THR . 9.7 m -95.55 117.43 39.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 112.18 -2.282 . . . . 0.0 108.082 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.528 HG13 ' CE2' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -42.86 149.02 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 O-C-N 125.527 1.767 . . . . 0.0 109.949 173.856 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.453 HG23 ' HD2' ' A' ' 60' ' ' PRO . 8.3 m -139.96 142.3 30.21 Favored Pre-proline 0 N--CA 1.48 1.052 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.414 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.453 ' HD2' HG23 ' A' ' 59' ' ' THR . 57.2 Cg_endo -76.01 145.49 28.16 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.066 1.844 . . . . 0.0 109.916 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.87 25.13 44.12 Favored Glycine 0 CA--C 1.542 1.767 0 CA-C-N 114.061 -1.427 . . . . 0.0 112.274 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.98 90.96 5.76 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -38.4 -33.87 0.11 Allowed 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.359 177.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.4 p -140.32 -148.77 0.26 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.143 -1.39 . . . . 0.0 109.077 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.552 ' CG ' HG21 ' A' ' 56' ' ' THR . 5.0 ttp180 -69.71 -6.85 34.57 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 174.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.23 -129.15 13.37 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.212 1.387 . . . . 0.0 109.635 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.573 HG22 ' HB2' ' A' ' 85' ' ' HIS . 22.0 p -112.72 -34.13 5.9 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 112.26 -1.97 . . . . 0.0 113.384 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -41.33 133.29 2.47 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.277 -1.329 . . . . 0.0 111.581 174.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.44 141.54 3.66 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 112.5 -2.137 . . . . 0.0 110.869 -176.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.66 HD12 HG11 ' A' ' 57' ' ' VAL . 1.0 OUTLIER -120.42 133.31 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 126.72 2.512 . . . . 0.0 109.165 176.877 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.461 ' O ' ' HD2' ' A' ' 80' ' ' TYR . 13.3 mm -122.52 101.47 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 113.25 -1.796 . . . . 0.0 107.857 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.508 HG22 ' HB3' ' A' ' 79' ' ' ASP . 12.7 p -87.43 161.92 17.58 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.635 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -108.12 -176.51 22.12 Favored Glycine 0 N--CA 1.471 0.97 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.303 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.3 -11.45 59.94 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.404 175.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -122.05 131.55 54.04 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.599 HG22 ' HG2' ' A' ' 77' ' ' GLN . 23.9 m -51.12 149.24 3.86 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.624 176.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.599 ' HG2' HG22 ' A' ' 76' ' ' THR . 2.6 mt-30 83.59 33.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 125.505 1.753 . . . . 0.0 110.467 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -140.86 49.29 1.68 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.133 -1.394 . . . . 0.0 113.038 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.614 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -105.47 90.7 3.49 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.458 -178.212 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.461 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 22.0 m-85 -75.28 131.93 40.67 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.144 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.709 ' HB2' HD11 ' A' ' 92' ' ' ILE . 4.9 t80 -114.02 128.5 56.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.941 -177.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.548 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.5 OUTLIER -90.0 -67.97 0.81 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.122 178.481 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.81 2.95 19.34 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-N 113.897 -1.502 . . . . 0.0 113.077 -173.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.533 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 50.6 t0 -130.55 14.73 5.47 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.666 0.786 . . . . 0.0 112.118 175.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.573 ' HB2' HG22 ' A' ' 67' ' ' THR . 34.4 t-80 64.1 85.83 0.13 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.071 1.748 . . . . 0.0 111.044 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.436 ' HB3' ' CD ' ' A' ' 41' ' ' GLU . 6.6 m-85 50.2 28.62 3.2 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 114.274 -1.33 . . . . 0.0 114.398 -177.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.533 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . . . -105.77 -19.37 13.77 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.296 -1.32 . . . . 0.0 111.256 -175.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.548 ' O ' ' HB ' ' A' ' 82' ' ' THR . 15.7 p -153.59 169.01 24.29 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.327 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.584 ' CD1' HD21 ' A' ' 44' ' ' LEU . 90.0 m-85 -158.45 113.16 2.56 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -173.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -132.35 105.05 7.06 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 113.968 -1.469 . . . . 0.0 107.328 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.474 ' HG ' HG11 ' A' ' 2' ' ' VAL . 23.0 mt -41.04 163.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.62 177.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.709 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.7 mp -112.99 135.78 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 120.383 -1.448 . . . . 0.0 109.738 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -113.74 92.33 3.95 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 113.906 -1.497 . . . . 0.0 108.765 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.05 -37.11 85.9 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.236 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 t -54.61 -24.67 22.39 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 114.484 -1.235 . . . . 0.0 113.414 171.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 5.6 t . . . . . 0 C--O 1.261 1.7 0 CA-C-O 117.624 -1.179 . . . . 0.0 111.118 175.71 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.419 HG21 ' HE1' ' A' ' 80' ' ' TYR . 6.9 t . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.17 8.1 4.35 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 124.886 1.366 . . . . 0.0 113.099 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 121.04 -162.56 14.73 Favored Glycine 0 N--CA 1.478 1.44 0 C-N-CA 125.499 1.523 . . . . 0.0 109.653 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 m -103.49 170.13 8.13 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 113.765 -1.217 . . . . 0.0 109.455 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 p -141.33 113.94 4.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -176.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.5 m -50.77 132.82 26.51 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 112.149 -2.296 . . . . 0.0 110.132 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.495 HD11 ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -59.56 -31.75 69.71 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.921 -178.143 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.0 t -64.63 -29.49 70.5 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.083 0.953 . . . . 0.0 113.224 173.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.38 -24.47 54.12 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.844 174.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 11' ' ' LEU . 8.6 mt -83.4 160.58 59.15 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 176.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.526 ' HG2' ' HB2' ' A' ' 15' ' ' ALA . 57.9 Cg_endo -66.42 166.17 22.52 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.546 2.164 . . . . 0.0 113.123 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -67.42 -35.43 23.5 Favored 'Trans proline' 0 N--CA 1.485 1.001 0 C-N-CA 122.572 2.182 . . . . 0.0 112.292 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.463 ' HB3' HG22 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -76.35 -8.77 57.81 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.512 179.085 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.526 ' HB2' ' HG2' ' A' ' 12' ' ' PRO . . . -68.61 -43.45 76.39 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.867 0.867 . . . . 0.0 112.013 172.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.495 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -63.13 -32.98 74.49 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.156 174.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.508 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 22.6 t0 -50.01 -49.12 51.8 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.019 0.928 . . . . 0.0 110.262 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.652 ' HA ' HD12 ' A' ' 21' ' ' LEU . 7.7 m -58.99 -50.52 73.78 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.567 HD21 ' OD2' ' A' ' 79' ' ' ASP . 39.0 mt -51.81 -32.79 32.97 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 175.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.01 -43.97 64.19 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.225 1.01 . . . . 0.0 111.858 172.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.671 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 68.4 mt -65.16 -34.32 78.1 Favored 'General case' 0 C--O 1.211 -0.946 0 C-N-CA 123.768 0.827 . . . . 0.0 112.092 176.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.525 HD13 HG21 ' A' ' 72' ' ' THR . 5.6 mt -67.87 -42.52 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 120.567 -1.333 . . . . 0.0 111.55 171.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.76 -47.69 62.05 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 124.29 0.994 . . . . 0.0 112.682 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 m -84.87 5.93 26.84 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.63 1.172 . . . . 0.0 113.904 175.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 44.78 39.92 3.85 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.926 1.29 . . . . 0.0 112.025 -177.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.71 -164.28 14.57 Favored Glycine 0 CA--C 1.541 1.718 0 C-N-CA 125.572 1.558 . . . . 0.0 114.461 -174.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.21 135.66 41.29 Favored 'Cis proline' 0 N--CA 1.485 0.996 0 CA-C-O 122.927 1.136 . . . . 0.0 110.947 -2.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.671 ' CE1' ' HB3' ' A' ' 21' ' ' LEU . 79.7 m-85 -85.0 153.41 60.05 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 111.509 -2.587 . . . . 0.0 111.879 -176.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.535 ' HG3' HD12 ' A' ' 58' ' ' ILE . 56.0 Cg_endo -71.28 -59.13 0.07 OUTLIER 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.111 1.874 . . . . 0.0 113.409 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.521 ' CZ ' HG22 ' A' ' 56' ' ' THR . 0.1 OUTLIER -118.02 -179.97 3.92 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.452 1.501 . . . . 0.0 110.547 -179.445 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.0 m -68.0 -8.5 37.95 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 175.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.638 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 11.7 mt-30 -73.74 54.04 0.47 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 122.741 1.258 . . . . 0.0 113.238 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 0.8 OUTLIER 172.67 127.39 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 111.81 -2.45 . . . . 0.0 113.432 -176.24 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.25 -14.61 20.93 Favored Glycine 0 N--CA 1.482 1.746 0 CA-C-N 113.698 -1.592 . . . . 0.0 112.535 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.712 HG22 ' CD ' ' A' ' 54' ' ' GLU . 2.1 m -90.79 150.39 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-O 121.896 0.855 . . . . 0.0 109.908 176.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.6 t -75.01 155.51 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 114.172 -1.377 . . . . 0.0 110.39 175.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.465 ' CE1' ' HD3' ' A' ' 40' ' ' ARG . 65.1 t80 -128.11 93.34 3.64 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 113.402 -1.726 . . . . 0.0 109.69 175.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.407 ' HG3' ' CD1' ' A' ' 49' ' ' TYR . 1.3 tm0? -71.29 47.8 0.12 Allowed 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.699 1.238 . . . . 0.0 112.984 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.441 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 35.8 t30 29.49 56.32 0.14 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.188 1.395 . . . . 0.0 111.151 -173.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.465 ' HD3' ' CE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -55.31 -30.06 59.47 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.853 -175.164 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.583 ' O ' HG23 ' A' ' 43' ' ' VAL . 1.3 mt-10 -75.97 -7.46 54.67 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 112.924 -1.944 . . . . 0.0 114.646 175.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.8 t 45.56 37.85 3.47 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 123.482 1.611 . . . . 0.0 112.292 -176.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 41' ' ' GLU . 70.8 t -109.55 -20.0 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.938 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.609 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.3 OUTLIER . . . . . 0 CA--C 1.544 0.714 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.172 -173.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.407 ' CD1' ' HG3' ' A' ' 38' ' ' GLN . 3.8 t80 . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 120.802 0.334 . . . . 0.0 110.579 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.62 -21.67 24.84 Favored Glycine 0 CA--C 1.542 1.73 0 CA-C-N 114.361 -1.29 . . . . 0.0 113.135 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -71.15 -7.54 47.35 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.568 1.147 . . . . 0.0 113.751 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.609 ' HE2' HD12 ' A' ' 44' ' ' LEU . 21.9 m-85 -119.91 162.85 18.46 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 125.515 1.526 . . . . 0.0 109.327 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -160.19 165.56 31.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 112.678 -2.056 . . . . 0.0 110.715 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.712 ' CD ' HG22 ' A' ' 35' ' ' VAL . 1.5 pm0 -120.42 152.27 38.17 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.786 0.834 . . . . 0.0 109.461 -177.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.412 ' CB ' HG23 ' A' ' 18' ' ' THR . 48.3 m-85 -163.12 66.39 0.19 Allowed 'General case' 0 N--CA 1.473 0.708 0 O-C-N 123.982 0.801 . . . . 0.0 109.646 -178.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.638 ' HB ' ' HB3' ' A' ' 32' ' ' GLN . 0.9 OUTLIER -38.78 135.24 0.87 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.45 -0.781 . . . . 0.0 112.887 177.715 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.453 HG11 ' HA ' ' A' ' 15' ' ' ALA . 26.8 m -91.66 123.53 43.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 112.539 -2.119 . . . . 0.0 109.212 178.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.535 HD12 ' HG3' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -51.74 159.12 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 113.83 -1.532 . . . . 0.0 110.189 173.125 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.4 m -153.61 141.61 13.88 Favored Pre-proline 0 N--CA 1.475 0.793 0 O-C-N 124.625 1.203 . . . . 0.0 110.762 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.07 141.59 33.08 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 121.765 1.643 . . . . 0.0 110.676 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.7 26.94 65.62 Favored Glycine 0 CA--C 1.54 1.635 0 CA-C-N 114.022 -1.444 . . . . 0.0 112.857 -174.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.21 91.59 6.75 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 177.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -42.45 -30.96 0.37 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.516 -1.22 . . . . 0.0 113.448 176.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 59.3 p -128.22 -113.41 0.27 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 113.814 -1.539 . . . . 0.0 109.166 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -115.51 -12.47 11.66 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.78 1.632 . . . . 0.0 111.563 177.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.98 167.34 7.35 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 123.722 1.734 . . . . 0.0 110.441 -176.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.431 HG22 ' HB2' ' A' ' 85' ' ' HIS . 42.5 p -74.43 -6.63 49.33 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 112.349 -1.926 . . . . 0.0 112.941 176.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.437 ' HD2' ' HA2' ' A' ' 83' ' ' GLY . 0.1 OUTLIER -68.73 134.61 50.05 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 120.927 -1.108 . . . . 0.0 109.816 176.199 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.461 ' NH1' ' HG2' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -159.79 139.96 11.78 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.139 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.524 HG23 ' OD1' ' A' ' 79' ' ' ASP . 3.1 mt -113.97 139.22 40.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 O-C-N 125.223 1.577 . . . . 0.0 108.808 176.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 70' ' ' ILE . 20.5 mm -129.25 106.42 13.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 O-C-N 125.287 1.617 . . . . 0.0 108.582 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.525 HG21 HD13 ' A' ' 22' ' ' ILE . 7.9 p -94.69 162.83 13.62 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.436 -0.79 . . . . 0.0 110.937 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.32 -175.19 21.26 Favored Glycine 0 CA--C 1.538 1.477 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.832 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.66 -14.62 62.1 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.955 0.883 . . . . 0.0 112.896 175.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.28 128.6 55.2 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.428 HG22 ' HG2' ' A' ' 77' ' ' GLN . 30.1 m -61.65 151.19 34.24 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.374 175.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.428 ' HG2' HG22 ' A' ' 76' ' ' THR . 4.3 mt-30 75.71 31.79 0.71 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 126.527 1.931 . . . . 0.0 110.821 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.596 ' HA ' HD22 ' A' ' 91' ' ' LEU . 18.0 mt-10 -138.98 60.09 1.6 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 113.1 -1.864 . . . . 0.0 112.702 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.567 ' OD2' HD21 ' A' ' 19' ' ' LEU . 0.6 OUTLIER -101.77 123.19 45.33 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 112.71 -2.041 . . . . 0.0 107.973 175.002 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.466 ' HB3' ' HB3' ' A' ' 89' ' ' PHE . 23.0 m-85 -92.6 126.69 37.8 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 124.715 1.26 . . . . 0.0 109.209 174.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.789 ' HB2' HD11 ' A' ' 92' ' ' ILE . 27.3 t80 -108.85 121.58 45.38 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.017 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.533 ' HB ' ' O ' ' A' ' 88' ' ' THR 0.291 0.1 OUTLIER -79.99 -70.92 0.48 Allowed 'General case' 0 N--CA 1.485 1.293 0 O-C-N 125.497 1.748 . . . . 0.0 113.014 173.604 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.437 ' HA2' ' HD2' ' A' ' 68' ' ' ARG . . . 66.34 16.93 65.64 Favored Glycine 0 CA--C 1.539 1.578 0 CA-C-N 114.253 -1.339 . . . . 0.0 113.069 -173.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.505 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 45.0 t0 -146.5 24.82 1.23 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.567 1.147 . . . . 0.0 112.483 175.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.431 ' HB2' HG22 ' A' ' 67' ' ' THR . 41.1 t-80 56.35 83.55 0.1 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.002 2.121 . . . . 0.0 110.813 177.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 46.38 53.58 9.49 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 113.009 -1.905 . . . . 0.0 114.022 -175.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . . . -123.88 -34.83 2.94 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.381 -1.281 . . . . 0.0 114.024 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.533 ' O ' ' HB ' ' A' ' 82' ' ' THR . 11.3 p -135.37 168.01 19.98 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.47 1.108 . . . . 0.0 108.493 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.49 ' CG ' HD21 ' A' ' 44' ' ' LEU . 98.6 m-85 -159.54 115.83 2.55 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -174.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.5 m -135.65 111.07 9.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 112.82 -1.991 . . . . 0.0 108.586 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.596 HD22 ' HA ' ' A' ' 78' ' ' GLU . 16.9 mt -41.68 159.96 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.441 176.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.789 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.6 mp -110.7 129.47 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 121.38 -0.825 . . . . 0.0 109.592 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.09 92.02 3.88 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 113.157 -1.838 . . . . 0.0 109.172 176.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -60.1 -31.77 70.35 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 114.218 -1.356 . . . . 0.0 111.199 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.3 t -54.98 -34.87 63.75 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.656 1.582 . . . . 0.0 112.972 172.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 8.6 t . . . . . 0 C--O 1.254 1.299 0 CA-C-O 117.813 -1.089 . . . . 0.0 110.824 178.773 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.7 t . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.6 m -80.85 19.58 0.84 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.085 -0.962 . . . . 0.0 113.014 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.86 -175.18 29.76 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.505 HG22 ' H ' ' A' ' 6' ' ' VAL . 2.4 m -85.29 174.61 9.47 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.445 0.641 . . . . 0.0 110.517 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.526 HG13 HD11 ' A' ' 11' ' ' LEU . 0.3 OUTLIER -148.93 115.28 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -174.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.448 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 72.0 m -48.05 128.23 13.45 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 111.807 -2.451 . . . . 0.0 111.126 177.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.67 HD11 ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -46.38 -38.52 9.02 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.603 1.161 . . . . 0.0 112.721 173.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.8 t -70.04 -14.52 62.72 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 172.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 7' ' ' CYS . . . -80.36 -26.3 38.71 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.359 0.664 . . . . 0.0 111.865 175.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.635 HD12 ' HA ' ' A' ' 8' ' ' LEU . 0.9 OUTLIER -93.47 169.7 9.78 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 124.17 0.988 . . . . 0.0 111.404 178.701 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 59.6 Cg_endo -66.88 169.29 15.06 Favored 'Trans proline' 0 CA--C 1.548 1.179 0 C-N-CA 122.4 2.067 . . . . 0.0 113.405 176.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -69.72 -21.97 32.91 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 122.276 1.984 . . . . 0.0 113.055 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -86.43 -10.24 54.65 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.857 178.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.448 ' HA ' ' CG1' ' A' ' 57' ' ' VAL . . . -67.87 -37.49 81.86 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.007 0.923 . . . . 0.0 112.478 172.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.67 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -67.87 -40.16 83.62 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.423 175.35 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.484 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 7.4 t70 -45.74 -44.77 14.01 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.68 -177.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.717 ' OG1' HG12 ' A' ' 57' ' ' VAL . 1.3 m -65.58 -51.69 57.83 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.066 -1.425 . . . . 0.0 111.593 177.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.595 HD11 HG21 ' A' ' 92' ' ' ILE . 17.6 mt -49.88 -33.36 16.89 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 174.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.31 -48.01 58.53 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.637 0.775 . . . . 0.0 111.941 171.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.502 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 66.6 mt -62.4 -34.37 76.6 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-O 118.73 -0.652 . . . . 0.0 112.243 175.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.607 HD12 ' O ' ' A' ' 18' ' ' THR . 1.8 mp -69.74 -43.95 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 119.497 1.044 . . . . 0.0 111.389 172.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.15 -43.7 81.67 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 124.455 1.097 . . . . 0.0 111.876 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.5 t -85.4 0.47 52.09 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.809 1.244 . . . . 0.0 112.293 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 46.3 35.82 2.95 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 122.368 1.08 . . . . 0.0 112.344 -176.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.47 -172.35 14.67 Favored Glycine 0 CA--C 1.548 2.129 0 CA-C-N 113.711 -1.586 . . . . 0.0 114.309 -175.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.451 ' O ' HD22 ' A' ' 21' ' ' LEU . 55.4 Cg_endo -73.29 135.8 41.57 Favored 'Cis proline' 0 CA--C 1.534 0.515 0 O-C-N 123.003 1.002 . . . . 0.0 111.091 -2.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.502 ' CE1' ' HB3' ' A' ' 21' ' ' LEU . 16.5 m-85 -84.98 103.12 2.88 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 112.81 -1.995 . . . . 0.0 111.722 -177.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.2 -36.7 5.32 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.624 2.216 . . . . 0.0 111.581 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.522 ' CE2' HG13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -77.43 168.69 19.59 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 124.052 0.845 . . . . 0.0 111.991 175.52 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.57 17.74 22.88 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 122.461 1.124 . . . . 0.0 112.911 172.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.91 13.98 20.91 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.734 -1.121 . . . . 0.0 113.67 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -130.86 107.58 9.23 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.764 -1.562 . . . . 0.0 112.556 -174.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.5 -0.2 7.41 Favored Glycine 0 N--CA 1.485 1.937 0 CA-C-N 113.045 -1.889 . . . . 0.0 113.324 -175.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.9 m -92.41 145.96 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.651 0.781 . . . . 0.0 110.072 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.5 t -77.12 157.6 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 125.141 1.526 . . . . 0.0 109.8 176.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.575 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 81.0 t80 -138.56 87.32 2.22 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 113.927 -1.488 . . . . 0.0 109.442 176.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.503 ' HG3' ' CD2' ' A' ' 49' ' ' TYR . 1.7 tt0 -72.59 50.16 0.23 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 122.537 1.161 . . . . 0.0 113.301 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.565 ' CG ' ' HB2' ' A' ' 44' ' ' LEU . 34.9 t30 29.51 54.21 0.12 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.286 1.834 . . . . 0.0 110.873 -173.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.89 -21.89 33.03 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 113.712 -1.586 . . . . 0.0 112.266 -177.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.613 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.1 mt-10 -80.93 -7.6 59.54 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 113.819 -1.537 . . . . 0.0 114.12 173.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.4 t 43.83 37.91 1.87 Allowed 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 123.997 1.856 . . . . 0.0 112.204 -175.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 41' ' ' GLU . 72.1 t -114.36 -16.75 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-N 113.472 -1.695 . . . . 0.0 111.18 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.75 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.5 OUTLIER . . . . . 0 CA--C 1.536 0.408 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.228 -178.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.503 ' CD2' ' HG3' ' A' ' 38' ' ' GLN . 8.7 t80 . . . . . 0 N--CA 1.471 0.596 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.16 -20.81 9.27 Favored Glycine 0 CA--C 1.537 1.46 0 O-C-N 124.863 1.352 . . . . 0.0 113.35 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 74' ' ' GLU . 0.5 OUTLIER -59.77 -19.68 51.9 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.402 1.081 . . . . 0.0 113.423 176.081 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.75 ' HE2' HD12 ' A' ' 44' ' ' LEU . 26.7 m-85 -104.2 166.62 10.28 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 125.091 1.356 . . . . 0.0 109.168 178.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -166.22 166.21 17.02 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 112.301 -2.227 . . . . 0.0 111.206 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.575 ' HG3' ' HB2' ' A' ' 37' ' ' PHE . 28.8 mt-10 -124.55 143.44 50.68 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.239 1.016 . . . . 0.0 110.063 -175.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.661 ' O ' HG21 ' A' ' 18' ' ' THR . 39.8 m-85 -157.68 72.2 0.65 Allowed 'General case' 0 N--CA 1.469 0.477 0 O-C-N 126.28 2.237 . . . . 0.0 109.723 -174.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.415 HG21 ' HG2' ' A' ' 65' ' ' ARG . 0.5 OUTLIER -44.36 144.26 1.06 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.612 0.72 . . . . 0.0 112.405 177.371 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.717 HG12 ' OG1' ' A' ' 18' ' ' THR . 30.4 m -94.72 113.69 29.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.605 176.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.522 HG13 ' CE2' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -43.11 157.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 125.057 1.473 . . . . 0.0 109.096 173.385 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.581 HG22 ' HB2' ' A' ' 62' ' ' ALA . 1.4 m -153.63 143.41 15.23 Favored Pre-proline 0 N--CA 1.477 0.916 0 O-C-N 124.443 1.09 . . . . 0.0 111.226 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.405 ' HD2' HG23 ' A' ' 59' ' ' THR . 64.9 Cg_endo -74.54 144.04 31.52 Favored 'Trans proline' 0 N--CA 1.479 0.66 0 C-N-CA 121.575 1.516 . . . . 0.0 110.788 176.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.51 22.05 30.1 Favored Glycine 0 CA--C 1.544 1.848 0 CA-C-N 114.35 -1.296 . . . . 0.0 112.525 -175.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.581 ' HB2' HG22 ' A' ' 59' ' ' THR . . . -82.53 89.8 6.7 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 178.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -40.97 -30.48 0.13 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.696 -1.593 . . . . 0.0 112.953 176.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.8 p -124.93 -146.25 0.35 Allowed 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 113.776 -1.556 . . . . 0.0 109.569 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.415 ' HG2' HG21 ' A' ' 56' ' ' THR . 18.2 mtm180 -82.31 -2.01 51.4 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 174.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.48 142.41 0.02 OUTLIER Glycine 0 N--CA 1.475 1.25 0 CA-C-O 123.717 1.732 . . . . 0.0 108.879 -173.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.8 p -52.85 -27.65 19.32 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 123.209 1.481 . . . . 0.0 112.165 174.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.529 ' NH1' HG21 ' A' ' 59' ' ' THR . 0.6 OUTLIER -54.23 127.65 27.89 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 120.009 -1.682 . . . . 0.0 111.786 174.445 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.547 ' HB2' HG23 ' A' ' 82' ' ' THR . 0.0 OUTLIER -144.02 149.88 37.37 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.321 179.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.475 ' O ' HD13 ' A' ' 71' ' ' ILE . 2.9 mt -122.37 140.17 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 126.04 2.087 . . . . 0.0 109.247 176.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.66 HD11 ' HE1' ' A' ' 86' ' ' TYR . 17.1 mm -132.43 108.84 14.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 O-C-N 125.6 1.812 . . . . 0.0 107.173 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.721 HG22 ' HB3' ' A' ' 79' ' ' ASP . 14.8 p -102.92 162.97 12.49 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.422 0.63 . . . . 0.0 110.363 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -115.3 171.26 13.62 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.996 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.418 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -64.58 -16.89 63.39 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 114.479 -0.86 . . . . 0.0 112.214 174.829 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.36 129.42 48.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 122.33 1.062 . . . . 0.0 108.866 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.593 HG22 ' HG2' ' A' ' 77' ' ' GLN . 24.1 m -61.49 147.57 44.86 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 113.776 -1.556 . . . . 0.0 107.494 175.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.593 ' HG2' HG22 ' A' ' 76' ' ' THR . 2.2 mt-30 80.7 31.48 0.17 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 127.0 2.12 . . . . 0.0 111.078 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.581 ' HA ' HD22 ' A' ' 91' ' ' LEU . 34.6 mt-10 -135.73 50.41 2.1 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 113.622 -1.626 . . . . 0.0 113.385 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.721 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.2 OUTLIER -104.63 83.9 2.1 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 113.418 -1.719 . . . . 0.0 110.845 -179.646 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.455 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 8.9 m-85 -68.53 131.53 45.41 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.558 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.576 ' HB2' HD11 ' A' ' 92' ' ' ILE . 68.8 t80 -122.12 130.43 53.23 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.554 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.558 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.5 OUTLIER -85.2 -66.87 0.85 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 111.626 -2.533 . . . . 0.0 112.383 175.595 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 68' ' ' ARG . . . 69.49 22.35 76.47 Favored Glycine 0 N--CA 1.48 1.577 0 CA-C-N 112.996 -1.911 . . . . 0.0 113.58 -174.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.497 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 54.6 m-20 -157.66 24.56 0.28 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.015 1.326 . . . . 0.0 113.278 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 61.66 83.17 0.15 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.324 1.85 . . . . 0.0 112.013 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.66 ' HE1' HD11 ' A' ' 71' ' ' ILE . 11.6 m-30 46.81 38.87 6.46 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 113.424 -1.716 . . . . 0.0 114.057 -176.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' ' 84' ' ' ASP . . . -99.96 -18.37 17.1 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.029 -176.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.558 ' O ' ' HB ' ' A' ' 82' ' ' THR . 5.4 p -164.46 176.99 8.51 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.325 1.45 . . . . 0.0 108.358 -175.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.559 ' CD1' HD21 ' A' ' 44' ' ' LEU . 96.1 m-85 -160.06 115.73 2.38 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -175.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.5 m -135.51 111.46 9.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 112.828 -1.987 . . . . 0.0 108.864 -179.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.581 HD22 ' HA ' ' A' ' 78' ' ' GLU . 15.4 mt -41.58 159.92 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.654 0.596 . . . . 0.0 112.325 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.625 HD13 ' O ' ' A' ' 79' ' ' ASP . 1.6 mp -107.24 123.94 62.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 O-C-N 120.715 -1.241 . . . . 0.0 110.022 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.06 93.49 7.87 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 113.756 -1.566 . . . . 0.0 107.722 177.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -54.81 -42.47 71.9 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.6 t -52.88 -30.1 32.04 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 113.438 -1.71 . . . . 0.0 114.45 173.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.418 ' OXT' ' N ' ' A' ' 8' ' ' LEU . 49.7 t . . . . . 0 C--O 1.246 0.911 0 CA-C-O 123.323 1.535 . . . . 0.0 107.014 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.517 HG21 ' CE1' ' A' ' 80' ' ' TYR . 54.4 t . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.2 m -56.34 -13.01 1.88 Allowed 'General case' 0 N--CA 1.474 0.762 0 O-C-N 125.006 1.441 . . . . 0.0 114.553 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.471 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 127.71 -169.74 19.39 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 176.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -84.41 168.77 15.24 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 122.28 1.038 . . . . 0.0 111.048 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.579 HG12 ' O ' ' A' ' 91' ' ' LEU . 8.4 p -146.49 110.8 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 114.361 -1.291 . . . . 0.0 107.588 -176.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 70.9 m -43.34 131.04 4.86 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 111.946 -2.388 . . . . 0.0 109.74 177.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.795 ' HA ' HD12 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -52.41 -36.55 54.49 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.3 177.42 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.5 t -67.42 -17.02 64.55 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.338 1.055 . . . . 0.0 113.3 174.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.01 -33.8 33.38 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.918 0.487 . . . . 0.0 111.731 176.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.795 HD12 ' HA ' ' A' ' 8' ' ' LEU . 4.0 mt -81.07 173.23 8.04 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 125.683 1.593 . . . . 0.0 110.557 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.557 ' HB2' ' OE2' ' A' ' 14' ' ' GLU . 72.7 Cg_endo -66.95 166.47 22.66 Favored 'Trans proline' 0 CA--C 1.551 1.342 0 C-N-CA 121.847 1.698 . . . . 0.0 113.885 175.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -66.68 -22.45 50.33 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.983 2.456 . . . . 0.0 113.715 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.557 ' OE2' ' HB2' ' A' ' 12' ' ' PRO . 1.0 OUTLIER -82.97 -8.58 59.55 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 173.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.811 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -65.32 -29.61 70.37 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 174.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.616 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -73.88 -29.41 62.07 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.816 173.513 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.485 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 45.7 t0 -52.66 -54.49 32.68 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.781 0.676 . . . . 0.0 109.534 -176.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.627 ' HA ' HD12 ' A' ' 21' ' ' LEU . 24.4 m -54.78 -49.31 71.22 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 175.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.859 HD11 HG21 ' A' ' 92' ' ' ILE . 11.5 mt -56.01 -34.78 66.13 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 177.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -70.58 -41.05 72.89 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.471 172.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.627 HD12 ' HA ' ' A' ' 18' ' ' THR . 48.9 mt -66.77 -33.98 76.82 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 123.272 0.629 . . . . 0.0 112.16 175.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.66 HD13 HG21 ' A' ' 72' ' ' THR . 5.8 mt -69.22 -44.41 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 119.486 1.039 . . . . 0.0 111.161 172.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.48 -43.94 75.87 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 124.665 1.228 . . . . 0.0 112.24 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.42 5.85 47.74 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.105 0.962 . . . . 0.0 112.041 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 43.77 36.64 1.36 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.997 1.319 . . . . 0.0 112.528 -176.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.96 -165.28 13.24 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 113.667 -1.606 . . . . 0.0 115.619 -175.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -73.95 137.67 51.32 Favored 'Cis proline' 0 CA--C 1.537 0.644 0 O-C-N 124.644 1.865 . . . . 0.0 112.424 -4.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.522 ' CE2' ' HB3' ' A' ' 21' ' ' LEU . 81.4 m-85 -85.74 153.17 57.85 Favored Pre-proline 0 N--CA 1.472 0.632 0 CA-C-N 113.301 -1.772 . . . . 0.0 112.611 -178.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.02 -56.9 0.14 Allowed 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.409 2.072 . . . . 0.0 113.344 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.48 ' CD1' ' HB2' ' A' ' 32' ' ' GLN . 0.1 OUTLIER -112.97 168.93 9.29 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.438 1.495 . . . . 0.0 110.531 179.344 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.7 m -71.42 56.98 0.25 Allowed 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 123.55 1.643 . . . . 0.0 114.015 174.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.48 ' HB2' ' CD1' ' A' ' 30' ' ' TYR . 3.9 mt-30 -131.1 67.6 1.51 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 123.497 1.618 . . . . 0.0 112.066 177.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -173.7 155.22 2.63 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 110.19 -3.187 . . . . 0.0 114.733 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 71.82 10.83 72.91 Favored Glycine 0 N--CA 1.481 1.641 0 CA-C-N 112.181 -2.281 . . . . 0.0 111.635 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.678 HG23 ' HB2' ' A' ' 54' ' ' GLU . 13.0 m -97.74 142.22 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.402 1.081 . . . . 0.0 109.72 174.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.6 t -87.59 155.24 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 O-C-N 125.867 1.979 . . . . 0.0 110.276 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.51 ' HB3' ' HB3' ' A' ' 52' ' ' TYR . 51.6 t80 -121.45 103.03 8.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.392 173.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.83 45.17 0.19 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.199 0.6 . . . . 0.0 112.037 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 21.07 57.82 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 124.116 1.912 . . . . 0.0 113.359 -174.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.503 ' HD3' ' CE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -79.19 7.0 8.34 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 113.527 -1.67 . . . . 0.0 112.297 -175.835 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.566 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.2 mt-10 -111.55 -17.05 13.14 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.479 -1.691 . . . . 0.0 113.847 177.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.9 t 46.22 39.66 6.44 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 123.99 1.852 . . . . 0.0 112.972 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 41' ' ' GLU . 89.1 t -111.35 -15.97 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.438 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.484 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.5 OUTLIER . . . . . 0 CA--C 1.549 0.907 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -173.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.8 t80 . . . . . 0 N--CA 1.469 0.511 0 CA-C-O 120.579 0.228 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.23 -24.85 25.18 Favored Glycine 0 N--CA 1.476 1.334 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.842 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -61.82 -14.2 31.01 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.844 1.258 . . . . 0.0 112.789 175.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.51 ' HB3' ' HB3' ' A' ' 37' ' ' PHE . 28.3 m-85 -121.59 147.14 46.23 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.675 1.19 . . . . 0.0 109.789 -178.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -141.73 160.04 41.0 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 113.706 -1.588 . . . . 0.0 111.79 177.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.678 ' HB2' HG23 ' A' ' 35' ' ' VAL . 8.0 mt-10 -114.94 138.57 50.66 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.918 -178.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.436 ' HB3' HG23 ' A' ' 18' ' ' THR . 90.8 m-85 -155.54 73.63 0.85 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 112.739 -2.028 . . . . 0.0 110.079 -176.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 68' ' ' ARG . 24.6 m -45.04 130.88 7.59 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 122.246 1.022 . . . . 0.0 111.534 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.811 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.8 OUTLIER -86.59 125.4 40.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 111.52 -2.582 . . . . 0.0 110.102 179.384 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.424 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -48.12 148.77 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 O-C-N 125.734 1.896 . . . . 0.0 108.99 174.046 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.492 ' OG1' ' HG3' ' A' ' 68' ' ' ARG . 2.6 m -148.31 140.63 14.69 Favored Pre-proline 0 N--CA 1.471 0.613 0 O-C-N 125.981 2.05 . . . . 0.0 110.999 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.462 ' HD3' ' CD ' ' A' ' 14' ' ' GLU . 73.4 Cg_endo -72.64 145.55 41.91 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.784 2.323 . . . . 0.0 110.034 176.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.04 22.74 56.01 Favored Glycine 0 CA--C 1.543 1.816 0 CA-C-N 113.681 -1.599 . . . . 0.0 113.321 -174.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -89.05 90.88 8.59 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 176.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.5 -33.29 0.42 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 113.711 -1.586 . . . . 0.0 113.623 176.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.0 p -133.66 -149.23 0.36 Allowed 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 113.624 -1.625 . . . . 0.0 107.848 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -60.52 -18.83 54.59 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 125.282 1.433 . . . . 0.0 111.813 173.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.76 167.27 1.43 Allowed Glycine 0 CA--C 1.532 1.139 0 CA-C-O 123.747 1.748 . . . . 0.0 110.017 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 46.6 p -65.11 -17.36 64.4 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 112.977 -1.612 . . . . 0.0 112.393 173.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.553 ' O ' HG23 ' A' ' 56' ' ' THR . 0.1 OUTLIER -63.41 126.72 28.41 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 120.937 -1.102 . . . . 0.0 110.34 176.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 1.3 tpt180 -151.56 132.95 14.62 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.349 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.431 ' HB ' ' O ' ' A' ' 55' ' ' TYR . 4.1 mt -105.8 138.91 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 173.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.7 mm -123.5 106.2 16.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 112.697 -2.047 . . . . 0.0 107.417 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.66 HG21 HD13 ' A' ' 22' ' ' ILE . 13.9 p -92.07 164.37 13.63 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.094 0.473 . . . . 0.0 111.604 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -104.46 -175.81 25.09 Favored Glycine 0 N--CA 1.471 1.026 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.298 178.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -80.62 -14.83 57.84 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.544 -0.828 . . . . 0.0 112.172 177.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.3 130.86 55.61 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 175.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.429 HG22 ' HG2' ' A' ' 77' ' ' GLN . 53.7 m -49.76 149.17 2.64 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.645 173.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.429 ' HG2' HG22 ' A' ' 76' ' ' THR . 4.4 mt-30 81.19 34.33 0.11 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 126.561 1.945 . . . . 0.0 111.057 -178.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.548 ' HA ' HD22 ' A' ' 91' ' ' LEU . 43.9 mt-10 -139.26 50.38 1.8 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 113.474 -1.693 . . . . 0.0 113.578 -178.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.482 ' OD2' HD22 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -108.45 95.56 5.75 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.365 1.466 . . . . 0.0 110.678 -176.692 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.517 ' CE1' HG21 ' A' ' 2' ' ' VAL . 15.9 m-85 -81.62 123.19 28.47 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 126.058 1.743 . . . . 0.0 110.255 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.853 ' HB2' HD11 ' A' ' 92' ' ' ILE . 5.8 t80 -104.81 127.79 52.74 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.052 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 88' ' ' THR 0.301 0.0 OUTLIER -88.24 -71.62 0.57 Allowed 'General case' 0 C--N 1.323 -0.569 0 O-C-N 125.948 2.03 . . . . 0.0 113.713 172.641 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 68' ' ' ARG . . . 68.06 16.37 68.54 Favored Glycine 0 N--CA 1.476 1.332 0 CA-C-N 113.898 -1.501 . . . . 0.0 113.979 -173.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.558 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 75.1 m-20 -145.93 22.7 1.4 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.795 1.238 . . . . 0.0 113.041 176.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 57.89 82.27 0.13 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 127.177 2.191 . . . . 0.0 111.289 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.449 ' HB3' ' OE2' ' A' ' 41' ' ' GLU . 25.1 m-85 49.55 54.28 11.27 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 113.514 -1.676 . . . . 0.0 113.387 -174.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.558 ' HB3' ' HB2' ' A' ' 84' ' ' ASP . . . -120.16 -41.06 2.65 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.454 ' O ' ' HB ' ' A' ' 82' ' ' THR . 15.6 p -130.91 163.52 27.29 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.043 0.937 . . . . 0.0 108.73 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.434 ' HB3' ' HB3' ' A' ' 80' ' ' TYR . 97.5 m-85 -154.95 119.79 4.86 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -175.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.5 m -140.76 113.82 8.45 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 112.312 -2.222 . . . . 0.0 108.906 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.579 ' O ' HG12 ' A' ' 6' ' ' VAL . 14.7 mt -43.61 156.57 0.06 Allowed 'General case' 0 N--CA 1.48 1.074 0 O-C-N 124.109 0.881 . . . . 0.0 112.369 175.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.859 HG21 HD11 ' A' ' 19' ' ' LEU . 1.7 mp -111.14 137.65 42.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 122.15 0.976 . . . . 0.0 108.456 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -113.01 99.08 7.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 113.14 -1.845 . . . . 0.0 108.746 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -58.74 -41.42 86.42 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.89 0.744 . . . . 0.0 112.033 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 t -54.94 -44.5 74.36 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 114.471 -1.24 . . . . 0.0 113.437 175.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 35.3 t . . . . . 0 C--O 1.241 0.643 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.21 178.596 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.562 HG11 ' H ' ' A' ' 91' ' ' LEU . 4.1 t . . . . . 0 N--CA 1.487 1.377 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 m -77.61 5.86 8.35 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 124.723 1.264 . . . . 0.0 114.303 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.34 169.28 12.59 Favored Glycine 0 N--CA 1.474 1.171 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 m -86.67 171.48 10.94 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.312 -0.944 . . . . 0.0 109.818 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p -138.14 113.48 9.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 -176.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 71.4 m -50.73 125.03 12.22 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 112.05 -2.341 . . . . 0.0 109.854 177.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -53.81 -36.93 63.02 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.883 175.013 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.7 t -65.61 -29.05 69.59 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.361 0.6 . . . . 0.0 112.511 174.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.28 -22.81 47.72 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.759 174.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.433 HD22 ' HD2' ' A' ' 12' ' ' PRO . 10.7 mt -80.68 164.13 52.82 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.318 176.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.761 ' HG2' ' HB2' ' A' ' 15' ' ' ALA . 69.0 Cg_endo -67.01 173.96 7.57 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.019 2.48 . . . . 0.0 115.056 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -71.67 -53.62 0.17 Allowed 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.813 2.342 . . . . 0.0 112.771 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.464 ' HG2' ' HD3' ' A' ' 60' ' ' PRO . 1.9 pp20? -60.2 -12.49 8.86 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.528 172.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.761 ' HB2' ' HG2' ' A' ' 12' ' ' PRO . . . -57.11 -41.85 79.75 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.725 -0.609 . . . . 0.0 111.9 176.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.16 -22.6 66.94 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 113.634 -1.621 . . . . 0.0 112.893 174.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.577 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 63.7 t0 -55.03 -58.02 9.35 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.582 0.753 . . . . 0.0 109.896 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.567 ' O ' HD12 ' A' ' 22' ' ' ILE . 61.5 m -54.5 -47.31 73.21 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 176.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.547 HD21 ' OD2' ' A' ' 79' ' ' ASP . 17.3 mt -54.05 -37.11 63.8 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 175.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -69.57 -37.73 77.11 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.226 173.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 17' ' ' ASP . 30.1 mt -72.52 -33.02 66.59 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 118.689 -0.672 . . . . 0.0 111.202 176.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.567 HD12 ' O ' ' A' ' 18' ' ' THR . 1.3 mp -68.9 -41.26 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 120.117 1.326 . . . . 0.0 111.613 171.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.32 -43.39 67.15 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 124.279 0.987 . . . . 0.0 112.164 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.39 5.09 48.92 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.363 1.065 . . . . 0.0 111.293 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.5 t70 41.15 49.77 3.22 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.203 1.401 . . . . 0.0 111.288 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.68 -164.76 30.49 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 112.767 -2.015 . . . . 0.0 116.165 -173.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -75.1 142.85 75.87 Favored 'Cis proline' 0 C--N 1.35 0.639 0 O-C-N 124.419 1.747 . . . . 0.0 111.656 -2.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.416 ' CE2' ' HB3' ' A' ' 21' ' ' LEU . 78.5 m-85 -99.27 123.26 49.26 Favored Pre-proline 0 N--CA 1.471 0.625 0 CA-C-N 113.419 -1.719 . . . . 0.0 111.102 -176.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.91 -56.74 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.01 1.807 . . . . 0.0 111.629 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -158.78 21.99 0.21 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.864 0.866 . . . . 0.0 112.096 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.508 ' HB3' HD12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -76.98 43.7 0.36 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.118 -178.635 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.53 ' HB2' ' HD2' ' A' ' 65' ' ' ARG . 1.4 tt0 20.15 64.72 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 128.968 2.907 . . . . 0.0 112.686 -175.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -103.31 175.34 5.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 110.883 -2.871 . . . . 0.0 111.458 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.29 44.95 97.42 Favored Glycine 0 N--CA 1.478 1.494 0 CA-C-N 112.731 -2.031 . . . . 0.0 110.082 176.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.0 m -142.3 147.12 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 114.007 -1.097 . . . . 0.0 108.665 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.0 t -90.81 154.92 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 125.642 1.839 . . . . 0.0 109.798 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -137.96 91.61 2.59 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.851 174.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.453 ' HG3' ' CD1' ' A' ' 49' ' ' TYR . 2.2 tm0? -70.46 51.34 0.13 Allowed 'General case' 0 N--CA 1.483 1.214 0 O-C-N 120.945 -1.097 . . . . 0.0 112.97 178.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.409 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 15.8 p-10 29.23 52.58 0.08 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.611 1.964 . . . . 0.0 110.499 -177.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.75 -24.25 56.11 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.886 -169.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.609 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.0 mt-10 -76.84 -7.15 54.93 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 112.05 -2.341 . . . . 0.0 114.933 172.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.9 t 45.68 39.03 4.62 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 123.72 1.724 . . . . 0.0 111.585 -178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 41' ' ' GLU . 54.5 t -112.73 -12.15 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 123.361 1.553 . . . . 0.0 110.369 -178.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.495 HD12 ' CE1' ' A' ' 52' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.243 0.719 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 -172.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.453 ' CD1' ' HG3' ' A' ' 38' ' ' GLN . 4.3 t80 . . . . . 0 CA--C 1.534 0.338 0 CA-C-O 120.923 0.392 . . . . 0.0 110.291 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.4 -24.78 9.07 Favored Glycine 0 N--CA 1.472 1.096 0 CA-C-N 114.084 -1.417 . . . . 0.0 112.14 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -60.45 -20.46 59.94 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 174.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.495 ' CE1' HD12 ' A' ' 44' ' ' LEU . 26.4 m-85 -104.38 147.75 27.19 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.449 -1.25 . . . . 0.0 108.804 -178.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -147.28 152.84 38.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 112.934 -1.939 . . . . 0.0 111.218 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -105.36 143.07 34.03 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.435 -178.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.431 ' HB3' HG23 ' A' ' 18' ' ' THR . 99.9 m-85 -149.81 65.57 0.99 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 112.216 -2.265 . . . . 0.0 111.36 -176.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.5 m -33.99 130.01 0.33 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.602 1.192 . . . . 0.0 112.382 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.72 HG21 ' HA ' ' A' ' 15' ' ' ALA . 1.5 p -88.98 98.66 8.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 C-N-CA 118.574 -1.251 . . . . 0.0 110.11 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.508 HD12 ' HB3' ' A' ' 31' ' ' SER . 1.1 mp -25.76 128.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.773 176.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.432 HG22 ' HB2' ' A' ' 62' ' ' ALA . 4.1 m -127.05 141.76 41.66 Favored Pre-proline 0 N--CA 1.479 1.025 0 CA-C-N 118.529 0.604 . . . . 0.0 111.723 -177.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.464 ' HD3' ' HG2' ' A' ' 14' ' ' GLU . 74.2 Cg_endo -72.59 148.05 46.8 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.129 1.886 . . . . 0.0 110.441 176.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 52.74 22.67 12.32 Favored Glycine 0 CA--C 1.543 1.807 0 CA-C-N 114.278 -1.328 . . . . 0.0 113.03 -175.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.432 ' HB2' HG22 ' A' ' 59' ' ' THR . . . -93.37 90.67 6.85 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -39.12 -33.68 0.14 Allowed 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 112.987 -1.915 . . . . 0.0 112.61 175.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.8 p -129.13 -143.22 0.26 Allowed 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 113.695 -1.593 . . . . 0.0 108.84 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.53 ' HD2' ' HB2' ' A' ' 32' ' ' GLN . 64.9 mtm-85 -79.69 -14.03 59.05 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 172.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 57.33 -177.82 1.09 Allowed Glycine 0 CA--C 1.534 1.245 0 CA-C-O 123.892 1.829 . . . . 0.0 110.602 -173.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.421 ' HA ' ' HB2' ' A' ' 85' ' ' HIS . 46.0 p -66.31 -36.34 82.7 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 112.462 -1.869 . . . . 0.0 112.845 177.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.42 ' HA ' ' HA2' ' A' ' 83' ' ' GLY . 1.1 mtp85 -44.36 125.54 4.7 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.705 174.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.09 139.61 14.88 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 112.916 -1.947 . . . . 0.0 109.715 -177.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.654 HG23 ' OD1' ' A' ' 79' ' ' ASP . 4.6 mt -114.74 136.45 51.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 111.321 -2.672 . . . . 0.0 108.162 177.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.721 HD11 ' HE1' ' A' ' 86' ' ' TYR . 20.2 mm -124.9 106.1 16.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 113.057 -1.883 . . . . 0.0 107.701 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.623 HG22 ' HB2' ' A' ' 79' ' ' ASP . 32.0 p -99.5 163.07 12.66 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.319 0.581 . . . . 0.0 110.507 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -118.38 167.08 12.91 Favored Glycine 0 N--CA 1.476 1.334 0 CA-C-N 114.181 -1.372 . . . . 0.0 109.728 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.79 -22.67 25.67 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 114.691 -0.754 . . . . 0.0 112.338 172.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.91 129.49 34.82 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.581 1.181 . . . . 0.0 109.702 173.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.604 HG22 ' HG3' ' A' ' 77' ' ' GLN . 2.7 m -63.4 146.84 52.74 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.931 -1.486 . . . . 0.0 109.976 176.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.604 ' HG3' HG22 ' A' ' 76' ' ' THR . 61.8 mt-30 62.69 49.92 3.64 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.98 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.498 ' HA ' HD22 ' A' ' 91' ' ' LEU . 4.2 mt-10 -145.89 61.1 1.26 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.346 -1.752 . . . . 0.0 111.901 -177.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.654 ' OD1' HG23 ' A' ' 70' ' ' ILE . 5.9 t0 -106.28 119.82 40.25 Favored 'General case' 0 C--O 1.212 -0.887 0 CA-C-N 113.084 -1.871 . . . . 0.0 108.187 175.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.472 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 16.8 m-85 -92.51 127.75 38.11 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 125.341 1.651 . . . . 0.0 109.392 175.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.73 ' HB2' HD11 ' A' ' 92' ' ' ILE . 2.7 t80 -107.4 126.63 52.72 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 114.077 -1.42 . . . . 0.0 109.631 -178.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -89.77 -67.24 0.86 Allowed 'General case' 0 N--CA 1.484 1.229 0 O-C-N 125.709 1.88 . . . . 0.0 112.551 175.323 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 68' ' ' ARG . . . 62.02 21.42 61.39 Favored Glycine 0 CA--C 1.539 1.558 0 CA-C-N 114.148 -1.387 . . . . 0.0 112.444 -173.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.561 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 58.0 m-20 -147.42 20.04 1.2 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.794 1.238 . . . . 0.0 112.621 176.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 67' ' ' THR . 21.9 t-80 56.79 80.41 0.16 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.844 1.657 . . . . 0.0 110.251 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.721 ' HE1' HD11 ' A' ' 71' ' ' ILE . 15.4 m-30 48.87 54.27 11.08 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 113.321 -1.763 . . . . 0.0 113.837 -175.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 84' ' ' ASP . . . -120.73 -32.66 3.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.276 -1.329 . . . . 0.0 113.065 176.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.501 ' O ' ' HB ' ' A' ' 82' ' ' THR . 17.2 p -140.32 166.64 24.15 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.453 ' CD1' HD21 ' A' ' 44' ' ' LEU . 93.5 m-85 -156.72 118.11 3.78 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -173.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.2 m -139.41 107.8 5.83 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 125.871 1.982 . . . . 0.0 110.047 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.562 ' H ' HG11 ' A' ' 2' ' ' VAL . 22.7 mt -40.86 159.29 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.123 178.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.73 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.7 mp -108.67 128.74 64.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 O-C-N 120.612 -1.305 . . . . 0.0 109.415 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.35 95.58 5.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 113.836 -1.529 . . . . 0.0 108.698 177.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.5 -36.81 67.07 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 124.312 1.007 . . . . 0.0 112.044 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.1 t -56.59 -48.59 77.07 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.901 1.28 . . . . 0.0 113.232 174.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 44.0 t . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.779 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.48 HG12 ' H ' ' A' ' 4' ' ' GLY . 3.7 t . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.8 m -80.39 -3.24 48.89 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 176.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.48 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 137.87 179.94 17.57 Favored Glycine 0 N--CA 1.473 1.162 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 6' ' ' VAL . 3.0 m -89.33 174.46 7.81 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 122.109 0.957 . . . . 0.0 109.783 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.435 ' H ' HG22 ' A' ' 5' ' ' THR . 1.0 OUTLIER -142.96 112.31 2.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 122.659 1.218 . . . . 0.0 107.834 -176.387 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.4 ' HA ' ' HB3' ' A' ' 96' ' ' CYS . 93.1 m -52.12 133.71 33.25 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 112.152 -2.295 . . . . 0.0 109.887 177.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -31.53 68.02 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.083 0.864 . . . . 0.0 111.878 -178.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.4 t -66.08 -28.76 69.07 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.661 0.784 . . . . 0.0 112.902 173.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.52 -18.54 56.93 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.712 0.805 . . . . 0.0 111.81 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 11' ' ' LEU . 7.0 mt -86.34 161.28 49.32 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 175.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.552 ' HB2' ' OE2' ' A' ' 14' ' ' GLU . 98.3 Cg_endo -69.67 170.24 16.93 Favored 'Trans proline' 0 CA--C 1.552 1.393 0 C-N-CA 122.192 1.928 . . . . 0.0 112.484 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.04 -34.83 12.9 Favored 'Trans proline' 0 N--CA 1.482 0.827 0 C-N-CA 122.652 2.234 . . . . 0.0 113.024 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.661 ' HB2' HG22 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -73.73 -9.43 58.66 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 114.695 -1.139 . . . . 0.0 114.069 175.2 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.412 ' HB2' ' HG2' ' A' ' 12' ' ' PRO . . . -66.48 -40.4 89.28 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.052 173.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.55 -33.13 74.32 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.081 175.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.434 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 5.5 t0 -54.02 -49.85 67.97 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.792 -178.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.632 HG21 ' O ' ' A' ' 55' ' ' TYR . 2.2 m -64.69 -49.3 71.47 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-O 117.953 -1.022 . . . . 0.0 112.479 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.5 mt -52.05 -34.22 42.38 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 124.293 0.996 . . . . 0.0 111.794 175.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.27 -45.68 54.34 Favored 'General case' 0 C--O 1.213 -0.867 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.262 173.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.565 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 55.3 mt -64.21 -33.7 76.41 Favored 'General case' 0 C--O 1.212 -0.913 0 C-N-CA 122.956 0.502 . . . . 0.0 111.964 174.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.521 HG21 HG21 ' A' ' 72' ' ' THR . 5.9 mt -71.16 -41.72 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 O-C-N 119.716 -1.865 . . . . 0.0 110.424 174.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.65 -43.14 66.63 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 124.68 1.238 . . . . 0.0 111.932 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.5 8.48 33.68 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.762 1.225 . . . . 0.0 112.057 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.8 t70 41.12 53.66 3.41 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 123.109 1.433 . . . . 0.0 111.952 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.09 -165.89 14.46 Favored Glycine 0 CA--C 1.538 1.53 0 CA-C-N 113.456 -1.702 . . . . 0.0 113.804 -175.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.529 ' O ' HD22 ' A' ' 21' ' ' LEU . 59.3 Cg_endo -73.77 138.16 54.09 Favored 'Cis proline' 0 N--CA 1.481 0.785 0 O-C-N 123.54 1.284 . . . . 0.0 111.768 -2.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.565 ' CE1' ' HB3' ' A' ' 21' ' ' LEU . 49.4 m-85 -94.81 106.52 25.24 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 113.316 -1.765 . . . . 0.0 111.952 -176.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -71.13 -46.3 0.72 Allowed 'Trans proline' 0 N--CA 1.477 0.531 0 C-N-CA 122.033 1.822 . . . . 0.0 111.742 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.463 ' C ' ' H ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -173.67 23.1 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.463 1.105 . . . . 0.0 112.805 -179.548 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.2 m -69.34 37.25 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.494 -174.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.463 ' H ' ' C ' ' A' ' 30' ' ' TYR . 0.0 OUTLIER 32.13 42.63 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.191 2.596 . . . . 0.0 112.975 -176.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.535 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 2.7 p30 -105.35 174.47 5.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 110.986 -2.825 . . . . 0.0 111.157 -172.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.91 -2.15 75.96 Favored Glycine 0 N--CA 1.482 1.704 0 O-C-N 126.195 2.185 . . . . 0.0 111.137 -175.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.412 HG23 ' OE1' ' A' ' 54' ' ' GLU . 27.2 m -102.21 143.93 14.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.935 0.894 . . . . 0.0 110.465 175.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.08 153.34 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 125.386 1.679 . . . . 0.0 109.588 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.491 ' CD2' HG21 ' A' ' 71' ' ' ILE . 44.9 t80 -131.65 89.26 2.68 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 112.936 -1.938 . . . . 0.0 109.878 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -72.54 51.25 0.26 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 118.692 0.678 . . . . 0.0 112.67 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 14.1 p-10 29.43 51.49 0.08 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.022 2.529 . . . . 0.0 109.397 -177.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.459 ' HD3' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -56.76 -21.81 31.11 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.121 -173.766 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.631 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.8 mt-10 -78.27 -6.52 55.24 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.405 -1.725 . . . . 0.0 114.787 172.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 43.5 t 44.85 35.91 1.67 Allowed 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 124.782 2.23 . . . . 0.0 112.269 -176.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 41' ' ' GLU . 70.9 t -111.74 -9.87 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 113.376 -1.738 . . . . 0.0 109.758 -178.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.573 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.318 -0.767 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -175.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.0 t80 . . . . . 0 N--CA 1.47 0.569 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.87 -19.12 17.54 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 124.712 1.258 . . . . 0.0 113.548 176.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.458 ' CE2' ' HB3' ' A' ' 74' ' ' GLU . 1.3 t80 -65.59 -13.89 59.98 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.363 1.065 . . . . 0.0 113.214 176.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.573 ' HE2' HD12 ' A' ' 44' ' ' LEU . 23.6 m-85 -108.58 155.25 20.87 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.362 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -154.03 161.14 42.15 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 112.968 -1.923 . . . . 0.0 110.832 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' A' ' 33' ' ' ASP . 1.7 mp0 -116.86 149.4 40.12 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.516 -177.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.632 ' O ' HG21 ' A' ' 18' ' ' THR . 76.2 m-85 -159.96 82.4 0.72 Allowed 'General case' 0 CA--C 1.545 0.758 0 O-C-N 125.239 1.587 . . . . 0.0 109.335 -172.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.559 HG22 ' H ' ' A' ' 58' ' ' ILE . 88.5 m -49.83 146.33 4.61 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 123.086 1.422 . . . . 0.0 111.434 175.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.497 ' CG1' HD12 ' A' ' 70' ' ' ILE . 1.2 m -105.81 19.0 5.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 113.01 -1.904 . . . . 0.0 113.019 -173.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.661 HG22 ' HB2' ' A' ' 14' ' ' GLU . 0.1 OUTLIER 53.32 179.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 O-C-N 124.827 1.329 . . . . 0.0 108.857 -165.833 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.3 m -156.11 139.99 11.43 Favored Pre-proline 0 N--CA 1.477 0.905 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.801 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.623 ' HD3' ' CD ' ' A' ' 14' ' ' GLU . 71.3 Cg_endo -74.2 142.91 31.22 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.002 2.468 . . . . 0.0 110.023 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 48.01 27.99 5.46 Favored Glycine 0 CA--C 1.541 1.718 0 CA-C-N 114.188 -1.369 . . . . 0.0 112.623 -176.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.09 95.07 6.59 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.69 -29.2 0.72 Allowed 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 111.603 -2.544 . . . . 0.0 112.428 175.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.8 p -112.07 -165.18 0.97 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.514 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.7 mtm105 -66.54 -12.11 56.08 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 174.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.63 165.54 7.18 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-O 123.838 1.799 . . . . 0.0 110.335 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.442 ' HA ' ' HB2' ' A' ' 85' ' ' HIS . 40.8 p -74.2 -15.49 61.01 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 112.631 -1.785 . . . . 0.0 112.439 178.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.521 ' HD2' ' HA2' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -66.85 136.53 55.55 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 120.931 -1.106 . . . . 0.0 110.245 177.082 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.462 ' HB2' HG23 ' A' ' 82' ' ' THR . 0.0 OUTLIER -158.53 156.12 29.64 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.418 -1.719 . . . . 0.0 110.447 -178.839 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.497 HD12 ' CG1' ' A' ' 57' ' ' VAL . 1.0 OUTLIER -130.16 140.96 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 O-C-N 125.325 1.641 . . . . 0.0 109.215 176.802 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.491 HG21 ' CD2' ' A' ' 37' ' ' PHE . 13.6 mm -128.87 106.11 13.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 113.22 -1.809 . . . . 0.0 107.82 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.64 HG22 ' HB3' ' A' ' 79' ' ' ASP . 20.7 p -98.61 162.16 13.28 Favored 'General case' 0 C--N 1.314 -0.971 0 O-C-N 121.477 -0.765 . . . . 0.0 110.584 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.21 166.61 12.52 Favored Glycine 0 N--CA 1.48 1.605 0 CA-C-N 113.663 -1.608 . . . . 0.0 109.469 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.458 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -61.37 -18.25 57.84 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.562 -0.819 . . . . 0.0 112.6 174.471 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -101.03 129.99 46.96 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.578 174.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.65 HG22 ' HG2' ' A' ' 77' ' ' GLN . 3.0 m -59.82 143.75 50.37 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 113.675 -1.602 . . . . 0.0 107.883 175.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.65 ' HG2' HG22 ' A' ' 76' ' ' THR . 0.0 OUTLIER 80.74 35.99 0.11 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.741 2.016 . . . . 0.0 110.474 179.035 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.447 ' HA ' ' CD2' ' A' ' 91' ' ' LEU . 3.7 mt-10 -134.02 47.43 2.43 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 113.45 -1.705 . . . . 0.0 113.204 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.64 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.1 OUTLIER -103.64 89.29 3.3 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.884 1.274 . . . . 0.0 110.19 -178.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.454 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 8.2 m-85 -78.45 131.88 37.06 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 125.228 1.411 . . . . 0.0 109.553 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.79 ' HB2' HD11 ' A' ' 92' ' ' ILE . 16.2 t80 -116.5 132.44 56.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.726 -1.124 . . . . 0.0 109.513 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -86.76 -72.28 0.51 Allowed 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 112.468 -2.151 . . . . 0.0 112.687 175.596 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.521 ' HA2' ' HD2' ' A' ' 68' ' ' ARG . . . 71.13 21.24 78.4 Favored Glycine 0 N--CA 1.473 1.119 0 CA-C-N 112.926 -1.943 . . . . 0.0 113.277 -175.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.612 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 63.0 m-20 -154.41 23.01 0.48 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.811 1.245 . . . . 0.0 112.963 177.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.442 ' HB2' ' HA ' ' A' ' 67' ' ' THR . 23.0 t-80 56.8 82.67 0.11 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.896 2.078 . . . . 0.0 110.005 178.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 7.7 m-30 51.2 48.67 22.6 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 113.04 -1.891 . . . . 0.0 114.163 -176.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.612 ' HB3' ' HB2' ' A' ' 84' ' ' ASP . . . -115.2 -30.59 6.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.823 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.498 ' O ' ' HB ' ' A' ' 82' ' ' THR . 22.3 p -147.97 169.67 19.38 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -178.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.502 ' CD1' HD21 ' A' ' 44' ' ' LEU . 89.5 m-85 -157.88 116.31 3.12 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -173.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.8 m -137.95 113.2 9.32 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 125.858 1.974 . . . . 0.0 110.099 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 91' ' ' LEU . 14.7 mt -41.56 160.52 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 O-C-N 124.465 1.103 . . . . 0.0 112.812 178.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.79 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.6 mp -110.08 128.32 66.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 O-C-N 121.58 -0.7 . . . . 0.0 109.38 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.69 92.19 3.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 113.721 -1.581 . . . . 0.0 108.812 176.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.23 -30.13 69.2 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.935 178.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.1 t -56.31 -33.21 65.35 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.077 -1.419 . . . . 0.0 112.851 172.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.4 ' HB3' ' HA ' ' A' ' 7' ' ' CYS . 6.4 t . . . . . 0 C--O 1.257 1.464 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.973 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.4 p30 . . . . . 0 CA--C 1.548 0.878 0 CA-C-O 120.874 0.368 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.61 HG21 ' HE1' ' A' ' 80' ' ' TYR . 24.7 t -41.91 142.04 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.347 1.059 . . . . 0.0 109.315 175.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -78.08 12.88 1.62 Allowed 'General case' 0 N--CA 1.48 1.065 0 O-C-N 124.182 0.927 . . . . 0.0 113.342 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.97 179.05 23.55 Favored Glycine 0 N--CA 1.468 0.797 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.459 HG22 ' H ' ' A' ' 6' ' ' VAL . 2.9 m -80.9 173.83 12.22 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 122.174 0.988 . . . . 0.0 110.746 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.459 ' H ' HG22 ' A' ' 5' ' ' THR . 1.4 p -143.6 110.45 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -174.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.59 ' HB3' ' OXT' ' A' ' 96' ' ' CYS . 86.7 m -46.57 128.89 10.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 111.853 -2.431 . . . . 0.0 110.101 177.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.466 HD11 ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -56.57 -33.27 66.01 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.586 -177.584 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.4 t -65.99 -27.44 68.14 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.786 173.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.71 -20.48 58.33 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.44 0.696 . . . . 0.0 111.396 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.486 HD13 ' HB1' ' A' ' 15' ' ' ALA . 9.7 mt -86.25 158.66 54.92 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -69.34 167.44 23.88 Favored 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 122.174 1.916 . . . . 0.0 112.375 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.72 -14.01 38.28 Favored 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 122.626 2.217 . . . . 0.0 114.292 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 9.3 pm0 -92.91 -6.16 49.2 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.844 1.258 . . . . 0.0 113.955 176.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.486 ' HB1' HD13 ' A' ' 11' ' ' LEU . . . -81.58 -43.24 18.94 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.717 175.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.466 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -59.1 -28.99 67.03 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.566 174.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.527 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 47.3 t0 -51.09 -58.07 7.06 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 124.258 1.023 . . . . 0.0 110.149 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.742 ' HA ' HD12 ' A' ' 21' ' ' LEU . 24.1 m -54.6 -50.03 69.0 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 176.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.586 HD11 HG21 ' A' ' 92' ' ' ILE . 9.5 mt -55.0 -35.33 64.26 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 123.627 0.579 . . . . 0.0 112.518 177.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -71.28 -39.42 71.54 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.892 173.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.742 HD12 ' HA ' ' A' ' 18' ' ' THR . 33.1 mt -70.22 -32.67 70.65 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 123.086 0.554 . . . . 0.0 111.104 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.495 HD13 HG21 ' A' ' 72' ' ' THR . 2.9 mt -72.7 -38.22 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 119.959 -1.713 . . . . 0.0 111.356 172.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.16 -42.65 62.57 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.693 -1.14 . . . . 0.0 112.303 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.39 8.66 39.63 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.661 1.184 . . . . 0.0 111.877 177.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.7 t0 39.77 49.97 2.22 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.078 1.351 . . . . 0.0 111.932 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.95 -166.92 39.48 Favored Glycine 0 N--CA 1.47 0.924 0 CA-C-N 113.056 -1.884 . . . . 0.0 115.598 -173.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.24 141.61 70.83 Favored 'Cis proline' 0 N--CA 1.48 0.71 0 O-C-N 124.014 1.534 . . . . 0.0 111.346 -0.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.504 ' CD2' ' HB3' ' A' ' 21' ' ' LEU . 51.6 m-85 -93.98 136.43 23.74 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 113.822 -1.536 . . . . 0.0 111.426 -175.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.443 ' HG2' ' CD1' ' A' ' 58' ' ' ILE . 29.9 Cg_endo -75.71 -61.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.478 0.573 0 C-N-CA 122.813 2.342 . . . . 0.0 110.719 -176.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.418 ' HD2' HG22 ' A' ' 56' ' ' THR . 0.6 OUTLIER -59.59 158.87 9.22 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.417 175.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 m -71.58 -15.21 62.26 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.938 0.875 . . . . 0.0 112.755 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.448 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -88.26 95.41 10.17 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.09 -176.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 166.58 136.1 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 111.813 -2.449 . . . . 0.0 115.35 -173.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.96 38.34 8.0 Favored Glycine 0 CA--C 1.54 1.619 0 CA-C-N 113.39 -1.732 . . . . 0.0 111.118 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.414 HG23 ' OE1' ' A' ' 54' ' ' GLU . 35.7 m -135.39 148.88 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 113.536 -1.332 . . . . 0.0 109.445 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.6 t -85.87 154.78 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 O-C-N 126.081 2.113 . . . . 0.0 109.875 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.498 ' CE2' ' HA ' ' A' ' 39' ' ' ASN . 84.8 t80 -135.15 89.54 2.53 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.428 176.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.432 ' HG3' ' CD1' ' A' ' 49' ' ' TYR . 11.5 tm0? -70.28 54.1 0.14 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 120.103 1.32 . . . . 0.0 111.695 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.498 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 15.1 p-10 25.47 52.33 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 127.837 2.455 . . . . 0.0 110.813 -175.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.82 -21.18 27.08 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.27 -173.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.603 ' O ' HG23 ' A' ' 43' ' ' VAL . 3.2 mt-10 -78.39 -12.04 59.98 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 112.956 -1.929 . . . . 0.0 115.094 172.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.7 t 45.4 39.17 4.24 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 124.081 1.896 . . . . 0.0 112.014 -177.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 41' ' ' GLU . 52.3 t -110.57 -13.32 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-O 123.634 1.683 . . . . 0.0 110.583 -177.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.567 ' HB3' ' OH ' ' A' ' 52' ' ' TYR . 0.3 OUTLIER -104.26 148.93 36.73 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 114.124 -1.398 . . . . 0.0 107.268 -172.081 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.555 ' HD3' HG23 ' A' ' 2' ' ' VAL . 90.8 Cg_endo -74.44 56.08 3.82 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 124.03 3.153 . . . . 0.0 111.462 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.841 HG22 ' H ' ' A' ' 47' ' ' GLN . 3.2 m -80.83 -162.29 0.47 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.363 -1.744 . . . . 0.0 107.252 177.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.841 ' H ' HG22 ' A' ' 46' ' ' THR . 12.0 tt0 170.7 -39.66 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.855 1.662 . . . . 0.0 110.495 -175.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.4 p -115.06 162.9 16.38 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 122.497 1.141 . . . . 0.0 111.241 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.432 ' CD1' ' HG3' ' A' ' 38' ' ' GLN . 9.1 t80 -91.73 138.65 31.39 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 112.956 -1.929 . . . . 0.0 110.09 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.94 8.66 78.53 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.664 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.478 ' HA ' ' HB2' ' A' ' 74' ' ' GLU . 71.0 t80 -81.83 13.4 3.27 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.813 1.245 . . . . 0.0 111.085 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.567 ' OH ' ' HB3' ' A' ' 44' ' ' LEU . 9.4 m-85 -149.43 156.52 42.15 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -173.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -152.15 154.99 36.94 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 125.49 1.744 . . . . 0.0 111.349 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.414 ' OE1' HG23 ' A' ' 35' ' ' VAL . 1.4 mt-10 -110.02 145.06 37.66 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.064 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.585 ' HB3' HG23 ' A' ' 18' ' ' THR . 76.8 m-85 -161.32 62.13 0.27 Allowed 'General case' 0 N--CA 1.475 0.788 0 O-C-N 125.882 1.989 . . . . 0.0 110.75 -174.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 0.9 OUTLIER -40.14 129.61 2.22 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 122.485 1.136 . . . . 0.0 111.952 177.495 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.618 HG21 ' HE1' ' A' ' 81' ' ' TYR . 14.0 m -83.65 121.15 35.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 111.515 -2.584 . . . . 0.0 108.72 176.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.453 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -42.3 162.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 O-C-N 125.363 1.665 . . . . 0.0 109.884 171.465 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.564 HG22 ' HB2' ' A' ' 62' ' ' ALA . 1.4 m -157.01 138.52 9.83 Favored Pre-proline 0 N--CA 1.482 1.146 0 O-C-N 125.374 1.672 . . . . 0.0 111.649 176.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.36 144.33 32.6 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.096 2.531 . . . . 0.0 109.463 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.61 26.64 39.55 Favored Glycine 0 CA--C 1.545 1.909 0 CA-C-N 113.081 -1.872 . . . . 0.0 112.01 -175.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.564 ' HB2' HG22 ' A' ' 59' ' ' THR . . . -86.95 89.06 7.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -40.16 -31.89 0.15 Allowed 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.908 176.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.6 p -129.79 -162.3 1.19 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.587 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.448 ' HD2' ' OE1' ' A' ' 32' ' ' GLN . 3.0 mtm105 -59.51 -14.63 13.54 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 172.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.0 137.12 0.08 OUTLIER Glycine 0 N--CA 1.467 0.722 0 N-CA-C 107.442 -2.263 . . . . 0.0 107.442 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.1 p -46.16 -28.69 1.31 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 113.43 -1.385 . . . . 0.0 113.077 174.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.422 ' HG2' ' CZ ' ' A' ' 81' ' ' TYR . 20.8 mtm-85 -50.27 139.14 15.41 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 121.02 -1.05 . . . . 0.0 113.045 170.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.527 ' HB3' ' CG2' ' A' ' 82' ' ' THR . 0.0 OUTLIER -165.14 137.94 4.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.099 -1.864 . . . . 0.0 109.15 -179.487 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.428 HD13 HD21 ' A' ' 19' ' ' LEU . 3.2 mt -105.1 138.48 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 112.694 -2.048 . . . . 0.0 109.548 173.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.539 ' O ' ' HD2' ' A' ' 80' ' ' TYR . 21.8 mm -127.86 103.39 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 112.628 -2.078 . . . . 0.0 108.365 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.642 HG22 ' HB3' ' A' ' 79' ' ' ASP . 13.1 p -88.41 162.86 16.28 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.972 178.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -104.22 -171.46 25.04 Favored Glycine 0 N--CA 1.48 1.605 0 O-C-N 125.273 1.608 . . . . 0.0 110.152 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -86.26 -11.07 53.31 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.533 0.682 . . . . 0.0 112.157 175.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.69 132.14 54.48 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 176.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.629 HG22 ' HG2' ' A' ' 77' ' ' GLN . 12.1 m -49.09 144.72 4.66 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.026 175.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.629 ' HG2' HG22 ' A' ' 76' ' ' THR . 1.4 mt-30 81.24 56.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 126.006 2.066 . . . . 0.0 109.856 177.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.592 ' HA ' HD22 ' A' ' 91' ' ' LEU . 3.7 mt-10 -166.44 54.93 0.09 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 113.222 -1.808 . . . . 0.0 114.247 -177.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.642 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.2 OUTLIER -112.68 93.2 4.31 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.939 1.296 . . . . 0.0 110.788 -177.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.61 ' HE1' HG21 ' A' ' 2' ' ' VAL . 25.2 m-85 -74.18 135.91 42.81 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 124.508 1.123 . . . . 0.0 110.325 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.678 ' HB2' HD11 ' A' ' 92' ' ' ILE . 62.3 t80 -121.56 91.9 3.62 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.527 ' CG2' ' HB3' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -44.49 -75.94 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 113.638 -1.619 . . . . 0.0 112.856 171.608 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.63 8.32 86.09 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-N 113.361 -1.745 . . . . 0.0 112.435 -175.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.533 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 34.6 m-20 -139.79 17.51 2.5 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 176.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 69.09 83.83 0.15 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.685 1.594 . . . . 0.0 111.815 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.43 ' HB3' ' CD ' ' A' ' 41' ' ' GLU . 13.0 m-85 50.12 25.92 1.92 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 113.189 -1.823 . . . . 0.0 113.894 -175.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.533 ' HB3' ' HB2' ' A' ' 84' ' ' ASP . . . -94.93 -57.96 2.29 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 120.43 -1.419 . . . . 0.0 110.825 -173.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 82' ' ' THR . 27.7 p -112.02 178.62 4.25 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.433 ' CE1' HD21 ' A' ' 44' ' ' LEU . 95.6 m-85 -161.56 122.21 2.7 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -175.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.7 m -140.39 107.93 5.59 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 126.169 2.168 . . . . 0.0 108.694 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.592 HD22 ' HA ' ' A' ' 78' ' ' GLU . 13.1 mt -43.22 161.89 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.678 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.7 mp -110.87 122.34 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 120.96 -1.087 . . . . 0.0 109.54 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.21 97.21 8.33 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 113.231 -1.804 . . . . 0.0 108.792 175.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -60.04 -40.23 88.65 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 125.321 1.638 . . . . 0.0 111.125 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.3 t -53.38 -37.45 62.46 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 114.354 -1.293 . . . . 0.0 112.651 172.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.59 ' OXT' ' HB3' ' A' ' 7' ' ' CYS . 12.0 t . . . . . 0 C--O 1.249 1.074 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.343 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 6.0 p-10 . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.572 HG12 ' H ' ' A' ' 4' ' ' GLY . 47.7 t -37.34 135.21 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.494 1.518 . . . . 0.0 109.751 173.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.66 5.21 5.1 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 124.323 1.014 . . . . 0.0 112.824 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.572 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 123.74 -165.67 16.47 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.183 1.373 . . . . 0.0 109.831 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 m -99.81 170.79 8.3 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.936 -1.132 . . . . 0.0 109.829 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 91' ' ' LEU . 2.2 p -140.85 109.28 2.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -175.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 82.0 m -44.99 133.42 6.39 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.016 -1.902 . . . . 0.0 111.068 177.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.52 HD11 ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -58.35 -31.65 67.79 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.676 0.61 . . . . 0.0 111.66 -178.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -65.4 -28.69 69.44 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.538 173.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.16 -30.96 60.88 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.598 0.759 . . . . 0.0 111.432 175.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.7 mt -81.22 161.45 62.54 Favored Pre-proline 0 N--CA 1.475 0.784 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -66.94 168.67 16.56 Favored 'Trans proline' 0 CA--C 1.544 1.004 0 C-N-CA 122.671 2.247 . . . . 0.0 112.759 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.82 -32.36 18.46 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.768 2.312 . . . . 0.0 112.447 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.87 -5.96 44.26 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.448 1.099 . . . . 0.0 112.017 176.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.758 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -71.28 -57.03 4.86 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.418 1.087 . . . . 0.0 112.487 176.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.52 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -56.81 -24.2 49.14 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 174.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -49.08 -55.32 12.54 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.671 1.189 . . . . 0.0 111.527 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.648 HG21 ' O ' ' A' ' 55' ' ' TYR . 94.9 m -66.28 -43.02 87.57 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 176.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.656 HD21 ' OD2' ' A' ' 79' ' ' ASP . 95.6 mt -52.36 -35.5 51.45 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 173.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -67.35 -41.14 85.63 Favored 'General case' 0 C--O 1.207 -1.181 0 CA-C-N 113.868 -1.515 . . . . 0.0 110.77 175.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 18' ' ' THR . 31.5 mt -67.2 -36.17 81.17 Favored 'General case' 0 C--O 1.213 -0.857 0 CA-C-O 118.12 -0.943 . . . . 0.0 112.093 175.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.581 HD12 ' O ' ' A' ' 18' ' ' THR . 2.4 mt -64.33 -43.0 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 118.852 0.751 . . . . 0.0 111.616 172.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.36 -46.56 63.84 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.689 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.1 t -72.76 -12.03 60.84 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.267 1.827 . . . . 0.0 111.542 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 t0 54.52 40.62 31.96 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.256 1.422 . . . . 0.0 110.289 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.03 -170.52 39.68 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 113.055 -1.884 . . . . 0.0 115.969 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -74.67 139.81 63.78 Favored 'Cis proline' 0 C--N 1.347 0.454 0 O-C-N 124.096 1.577 . . . . 0.0 111.976 -1.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -90.55 135.53 29.2 Favored Pre-proline 0 N--CA 1.481 1.085 0 CA-C-N 113.723 -1.58 . . . . 0.0 110.849 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -72.5 -61.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.475 0.423 0 C-N-CA 123.216 2.611 . . . . 0.0 112.073 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.402 ' CD1' HD11 ' A' ' 58' ' ' ILE . 3.0 m-30 -64.15 146.95 53.37 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 118.847 -0.597 . . . . 0.0 110.658 176.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.6 t -65.38 -13.69 59.18 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 125.4 1.688 . . . . 0.0 112.956 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -80.96 77.38 7.87 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 122.734 1.254 . . . . 0.0 112.355 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -177.54 148.5 0.57 Allowed 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 111.104 -2.771 . . . . 0.0 113.307 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.4 31.98 29.35 Favored Glycine 0 N--CA 1.479 1.521 0 CA-C-N 113.084 -1.871 . . . . 0.0 111.306 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.64 146.85 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.218 1.007 . . . . 0.0 109.905 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.0 t -86.58 152.87 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 125.949 2.031 . . . . 0.0 110.014 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.521 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 44.8 t80 -130.28 93.75 3.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 113.518 -1.674 . . . . 0.0 108.838 175.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.508 ' HG3' ' CD1' ' A' ' 49' ' ' TYR . 7.6 tm0? -71.93 54.0 0.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.087 -1.008 . . . . 0.0 111.969 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.408 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 16.5 p-10 26.18 56.12 0.05 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.413 2.285 . . . . 0.0 111.035 -176.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -25.87 55.22 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.03 -172.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.567 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.8 mt-10 -78.0 -13.26 59.94 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-N 112.981 -1.918 . . . . 0.0 115.125 172.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.9 t 45.24 41.67 6.29 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 123.847 1.784 . . . . 0.0 111.886 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 41' ' ' GLU . 44.2 t -107.72 -14.14 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 113.732 -1.577 . . . . 0.0 110.126 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.812 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -104.82 148.75 36.6 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-O 117.662 -1.161 . . . . 0.0 108.451 -171.128 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.442 ' HD3' HG23 ' A' ' 2' ' ' VAL . 90.1 Cg_endo -73.85 56.77 3.64 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.278 2.652 . . . . 0.0 111.898 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.807 HG22 ' H ' ' A' ' 47' ' ' GLN . 3.1 m -75.43 -165.2 0.39 Allowed 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 113.612 -1.631 . . . . 0.0 107.564 176.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.807 ' H ' HG22 ' A' ' 46' ' ' THR . 5.6 tm0? 168.5 -38.81 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 126.608 1.963 . . . . 0.0 110.453 -175.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.2 p -114.33 160.23 19.33 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.166 0.984 . . . . 0.0 112.158 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.508 ' CD1' ' HG3' ' A' ' 38' ' ' GLN . 9.8 t80 -88.84 139.85 30.04 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 113.032 -1.895 . . . . 0.0 110.117 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.06 9.99 77.17 Favored Glycine 0 CA--C 1.542 1.773 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.851 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.456 ' HD2' ' CE1' ' A' ' 52' ' ' TYR . 57.5 t80 -82.09 8.79 9.86 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.474 1.109 . . . . 0.0 111.391 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.812 ' HE2' HD12 ' A' ' 44' ' ' LEU . 11.7 m-85 -146.73 145.84 30.1 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -141.36 157.2 45.5 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 126.541 2.401 . . . . 0.0 110.883 178.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -110.4 143.07 41.21 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.864 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.648 ' O ' HG21 ' A' ' 18' ' ' THR . 79.6 m-85 -158.78 69.67 0.49 Allowed 'General case' 0 N--CA 1.471 0.579 0 O-C-N 126.107 2.13 . . . . 0.0 110.144 -175.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 6.3 m -43.37 129.06 5.0 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 122.971 1.367 . . . . 0.0 112.197 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.758 HG21 ' HA ' ' A' ' 15' ' ' ALA . 1.8 p -89.3 118.12 33.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 111.109 -2.769 . . . . 0.0 109.965 178.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.402 HD11 ' CD1' ' A' ' 30' ' ' TYR . 0.4 OUTLIER -43.32 151.69 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.227 170.309 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.567 ' OG1' ' HG3' ' A' ' 68' ' ' ARG . 3.4 m -145.29 142.85 18.78 Favored Pre-proline 0 N--CA 1.475 0.823 0 CA-C-N 113.64 -1.618 . . . . 0.0 111.647 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.433 ' HD2' HG23 ' A' ' 59' ' ' THR . 73.4 Cg_endo -75.57 145.12 29.21 Favored 'Trans proline' 0 N--CA 1.479 0.658 0 C-N-CA 121.824 1.683 . . . . 0.0 110.216 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.86 28.16 57.16 Favored Glycine 0 CA--C 1.546 2.01 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.189 -175.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.7 92.44 6.58 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -39.41 -33.64 0.17 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 114.204 -1.362 . . . . 0.0 113.296 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 57.7 p -130.57 -160.56 1.05 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.888 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.2 mtm180 -56.08 -19.79 14.49 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 172.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.16 167.55 3.19 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 123.889 1.827 . . . . 0.0 109.379 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.435 HG22 ' HB2' ' A' ' 85' ' ' HIS . 40.7 p -71.27 -5.26 30.85 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 112.423 -1.888 . . . . 0.0 113.286 176.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.567 ' HG3' ' OG1' ' A' ' 59' ' ' THR . 0.2 OUTLIER -73.0 117.03 14.23 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.561 1.172 . . . . 0.0 110.161 177.624 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 0.8 OUTLIER -140.24 133.8 30.16 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 113.865 -1.516 . . . . 0.0 109.191 179.28 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.526 HG23 ' OD1' ' A' ' 79' ' ' ASP . 4.7 mt -105.42 133.67 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 125.923 2.014 . . . . 0.0 107.835 175.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.505 ' O ' ' HD2' ' A' ' 80' ' ' TYR . 23.3 mm -123.5 107.16 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 113.525 -1.67 . . . . 0.0 107.415 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.5 p -93.5 163.87 13.4 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 120.969 0.414 . . . . 0.0 110.696 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.57 -172.17 23.8 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.256 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.64 -14.15 60.0 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.322 0.582 . . . . 0.0 112.158 175.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -115.93 131.57 56.9 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.553 HG22 ' HG2' ' A' ' 77' ' ' GLN . 7.5 m -56.34 151.53 12.77 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.836 175.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.553 ' HG2' HG22 ' A' ' 76' ' ' THR . 1.0 OUTLIER 74.82 32.97 0.8 Allowed 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 123.508 1.623 . . . . 0.0 110.766 -179.54 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.413 ' HA ' HD22 ' A' ' 91' ' ' LEU . 1.2 mt-10 -138.76 57.09 1.69 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 113.547 -1.66 . . . . 0.0 112.479 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.656 ' OD2' HD21 ' A' ' 19' ' ' LEU . 1.8 t0 -101.98 130.03 48.41 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 113.882 -1.508 . . . . 0.0 108.461 174.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.526 ' CE1' HG21 ' A' ' 2' ' ' VAL . 26.6 m-85 -102.27 129.15 48.6 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.714 -1.584 . . . . 0.0 109.465 175.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.732 ' HB2' HD11 ' A' ' 92' ' ' ILE . 10.1 t80 -108.21 124.37 50.18 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 113.641 -1.618 . . . . 0.0 109.001 -177.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.54 ' HB ' ' O ' ' A' ' 88' ' ' THR 0.265 0.5 OUTLIER -86.0 -68.4 0.74 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 113.09 -1.868 . . . . 0.0 112.037 176.161 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.453 ' HA2' ' HD2' ' A' ' 68' ' ' ARG . . . 68.87 1.65 26.04 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 114.605 -1.179 . . . . 0.0 113.876 -172.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.57 ' CB ' ' HB3' ' A' ' 87' ' ' ALA . 59.0 m-20 -129.7 12.13 5.78 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.392 1.077 . . . . 0.0 113.631 178.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.435 ' HB2' HG22 ' A' ' 67' ' ' THR . 40.4 t-80 61.92 81.28 0.2 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.513 2.325 . . . . 0.0 111.647 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.434 ' HB3' ' OE1' ' A' ' 41' ' ' GLU . 17.0 m-85 54.2 33.29 17.73 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 114.424 -1.262 . . . . 0.0 113.997 -175.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.57 ' HB3' ' CB ' ' A' ' 84' ' ' ASP . . . -111.71 -6.76 14.3 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.54 ' O ' ' HB ' ' A' ' 82' ' ' THR . 6.5 p -163.91 165.17 22.98 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.768 1.627 . . . . 0.0 108.122 -177.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.616 ' CG ' HD21 ' A' ' 44' ' ' LEU . 86.1 m-85 -159.55 117.91 2.79 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 -174.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.52 106.5 5.97 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.357 -1.747 . . . . 0.0 108.432 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 91' ' ' LEU . 18.1 mt -40.47 157.29 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.638 177.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.732 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.7 mp -104.29 133.18 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.045 -1.035 . . . . 0.0 109.517 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.99 89.37 2.98 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 113.329 -1.76 . . . . 0.0 109.338 177.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -63.7 -40.46 96.85 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.409 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 t -51.39 -40.01 58.35 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 125.295 1.622 . . . . 0.0 112.813 172.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 8.4 t . . . . . 0 C--O 1.258 1.51 0 CA-C-O 116.733 -1.604 . . . . 0.0 110.747 178.445 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.8 p30 . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 122.212 1.006 . . . . 0.0 112.669 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 t -78.87 134.29 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.6 m -64.37 -8.26 12.57 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 175.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.46 169.46 12.68 Favored Glycine 0 N--CA 1.474 1.196 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.454 HG23 ' HB3' ' A' ' 91' ' ' LEU . 1.8 m -78.76 172.02 14.33 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.566 -0.817 . . . . 0.0 110.782 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 91' ' ' LEU . 3.9 p -145.65 108.06 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -174.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 57.6 m -42.9 138.32 2.05 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 113.266 -1.788 . . . . 0.0 111.658 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.719 ' HA ' HD12 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -59.84 -33.03 71.24 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.756 0.66 . . . . 0.0 111.962 -178.493 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.4 t -70.85 -15.79 62.66 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.773 174.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.13 -37.45 46.14 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.65 0.738 . . . . 0.0 111.832 176.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.719 HD12 ' HA ' ' A' ' 8' ' ' LEU . 2.3 mt -77.83 166.28 44.83 Favored Pre-proline 0 N--CA 1.475 0.788 0 C-N-CA 124.531 1.133 . . . . 0.0 111.111 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.67 169.89 15.02 Favored 'Trans proline' 0 CA--C 1.553 1.471 0 C-N-CA 122.713 2.275 . . . . 0.0 113.353 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.3 -15.88 39.12 Favored 'Trans proline' 0 N--CA 1.484 0.932 0 C-N-CA 122.305 2.004 . . . . 0.0 113.437 175.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.416 ' CD ' ' HD3' ' A' ' 60' ' ' PRO . 1.9 mt-10 -93.81 4.81 53.37 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.935 0.894 . . . . 0.0 112.111 178.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.635 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -80.86 -48.11 12.86 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.96 176.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.568 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -58.28 -23.03 54.92 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.413 -1.267 . . . . 0.0 112.701 174.381 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.461 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 9.9 t0 -49.97 -58.01 6.34 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.289 1.035 . . . . 0.0 110.324 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.696 ' HA ' HD12 ' A' ' 21' ' ' LEU . 44.7 m -56.63 -49.49 74.84 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 177.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.691 HD11 HG21 ' A' ' 92' ' ' ILE . 7.8 mt -55.53 -35.73 65.98 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 123.805 0.69 . . . . 0.0 111.693 178.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -68.34 -38.48 81.53 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.015 173.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.696 HD12 ' HA ' ' A' ' 18' ' ' THR . 33.9 mt -69.19 -34.8 75.48 Favored 'General case' 0 C--O 1.212 -0.874 0 CA-C-O 118.746 -0.645 . . . . 0.0 110.954 175.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.602 HD12 ' O ' ' A' ' 18' ' ' THR . 1.6 mp -69.76 -40.73 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 120.186 1.357 . . . . 0.0 111.312 172.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.8 -42.48 67.02 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.023 -0.989 . . . . 0.0 112.291 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.27 7.55 42.21 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.116 0.966 . . . . 0.0 111.35 177.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.0 t0 39.52 52.5 2.34 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 123.209 1.48 . . . . 0.0 112.156 -178.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.3 -164.77 40.44 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 112.721 -2.036 . . . . 0.0 115.659 -173.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.9 141.44 71.75 Favored 'Cis proline' 0 C--N 1.346 0.415 0 O-C-N 124.678 1.883 . . . . 0.0 111.849 -2.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 21' ' ' LEU . 75.7 m-85 -94.52 132.92 27.78 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.248 -176.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.451 ' HG2' ' CD1' ' A' ' 58' ' ' ILE . 36.6 Cg_endo -75.12 -59.55 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.546 2.164 . . . . 0.0 111.24 -177.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -60.69 157.76 14.01 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.486 0.66 . . . . 0.0 112.436 175.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.4 t -77.43 -10.58 59.55 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 122.524 1.154 . . . . 0.0 112.215 175.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -91.6 87.56 6.4 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.624 0.726 . . . . 0.0 112.21 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 172.29 136.33 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 111.517 -2.583 . . . . 0.0 114.259 -174.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.08 28.75 16.9 Favored Glycine 0 N--CA 1.48 1.602 0 CA-C-N 113.189 -1.823 . . . . 0.0 111.729 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.446 HG23 ' OE1' ' A' ' 54' ' ' GLU . 13.2 m -123.48 146.59 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 113.6 -1.3 . . . . 0.0 109.713 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.0 t -81.95 156.79 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 125.536 1.772 . . . . 0.0 109.724 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.436 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 48.2 t80 -139.23 86.28 2.12 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.634 176.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -69.66 52.86 0.11 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 122.401 1.096 . . . . 0.0 113.629 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.2 t30 31.23 55.17 0.23 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 127.057 2.143 . . . . 0.0 109.399 -172.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.56 -31.32 62.05 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 122.454 1.121 . . . . 0.0 111.766 -175.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.557 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.7 mt-10 -79.06 -8.15 58.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 112.928 -1.942 . . . . 0.0 114.3 174.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 39.9 t 43.82 42.66 4.61 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 124.132 1.92 . . . . 0.0 111.975 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 41' ' ' GLU . 61.7 t -107.36 -18.05 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 113.301 -1.772 . . . . 0.0 109.704 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.538 HD21 ' CD1' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -89.94 147.86 38.32 Favored Pre-proline 0 C--N 1.32 -0.679 0 O-C-N 121.189 -0.944 . . . . 0.0 108.657 -176.237 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.94 57.03 5.59 Favored 'Trans proline' 0 N--CA 1.478 0.614 0 C-N-CA 122.311 2.007 . . . . 0.0 112.073 -176.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 47' ' ' GLN . 1.9 m -156.52 -144.91 0.14 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.366 -1.288 . . . . 0.0 107.718 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.461 ' H ' HG22 ' A' ' 46' ' ' THR . 3.0 tt0 168.63 -35.98 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 126.412 1.885 . . . . 0.0 110.429 -173.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.4 p -37.87 148.88 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 122.608 1.194 . . . . 0.0 113.811 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -103.53 121.97 43.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 113.23 -1.805 . . . . 0.0 111.725 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.08 -22.71 33.04 Favored Glycine 0 N--CA 1.476 1.318 0 O-C-N 125.708 1.88 . . . . 0.0 111.691 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.46 -13.9 45.19 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 124.325 1.05 . . . . 0.0 112.924 175.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.431 ' OH ' ' HB3' ' A' ' 44' ' ' LEU . 17.4 m-85 -116.78 162.44 17.69 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.412 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -158.92 159.81 35.36 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 112.515 -2.13 . . . . 0.0 111.686 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.446 ' OE1' HG23 ' A' ' 35' ' ' VAL . 1.4 mt-10 -117.64 136.39 53.34 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.85 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.501 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 86.4 m-85 -151.6 75.52 1.17 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 113.622 -1.626 . . . . 0.0 110.212 -176.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.554 HG21 ' HG2' ' A' ' 65' ' ' ARG . 52.8 m -42.91 138.56 1.98 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 122.438 1.113 . . . . 0.0 112.516 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.635 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.5 OUTLIER -98.36 106.89 19.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 112.195 -2.275 . . . . 0.0 110.073 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.451 ' CD1' ' HG2' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -39.36 147.04 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.266 172.126 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.472 HG23 ' HD2' ' A' ' 60' ' ' PRO . 3.2 m -144.44 140.65 16.9 Favored Pre-proline 0 N--CA 1.473 0.722 0 O-C-N 125.465 1.728 . . . . 0.0 112.018 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.472 ' HD2' HG23 ' A' ' 59' ' ' THR . 71.9 Cg_endo -74.34 146.31 35.44 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.066 1.844 . . . . 0.0 110.177 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.63 25.42 55.48 Favored Glycine 0 N--CA 1.485 1.937 0 CA-C-N 114.22 -1.355 . . . . 0.0 112.196 -175.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.71 91.38 6.99 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -39.96 -32.22 0.15 Allowed 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 113.585 -1.643 . . . . 0.0 113.325 176.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.0 p -131.26 -159.0 0.93 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.505 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.554 ' HG2' HG21 ' A' ' 56' ' ' THR . 0.0 OUTLIER -59.09 -18.05 31.82 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.968 -1.015 . . . . 0.0 113.585 171.642 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.33 162.5 0.59 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-O 123.697 1.721 . . . . 0.0 109.59 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.511 HG22 ' HB2' ' A' ' 85' ' ' HIS . 24.3 p -65.65 -10.73 38.72 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 113.137 -1.531 . . . . 0.0 113.241 174.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.49 ' HD2' ' HA2' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -64.94 124.46 22.1 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 123.279 1.514 . . . . 0.0 110.715 175.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.24 144.76 26.73 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 112.866 -1.97 . . . . 0.0 110.588 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 55' ' ' TYR . 8.4 mt -120.44 137.04 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 125.398 1.686 . . . . 0.0 108.673 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.47 ' O ' ' HD2' ' A' ' 80' ' ' TYR . 16.7 mm -127.57 102.41 8.93 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 CA-C-N 112.737 -2.029 . . . . 0.0 107.758 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.479 HG22 ' HB3' ' A' ' 79' ' ' ASP . 17.7 p -90.16 163.37 14.85 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.667 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -116.77 165.67 12.35 Favored Glycine 0 N--CA 1.471 0.981 0 CA-C-N 113.534 -1.666 . . . . 0.0 109.357 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.49 -14.9 62.9 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.701 0.763 . . . . 0.0 111.687 176.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.443 ' HB3' ' OE2' ' A' ' 78' ' ' GLU . . . -106.27 131.04 53.97 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.622 HG22 ' HG2' ' A' ' 77' ' ' GLN . 3.0 m -55.34 143.14 29.48 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 113.776 -1.556 . . . . 0.0 108.361 174.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.622 ' HG2' HG22 ' A' ' 76' ' ' THR . 0.0 OUTLIER 79.6 34.57 0.18 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.936 2.095 . . . . 0.0 111.224 179.49 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.443 ' OE2' ' HB3' ' A' ' 75' ' ' ALA . 37.9 mt-10 -129.79 49.95 2.22 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 123.232 1.491 . . . . 0.0 112.299 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.479 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -107.55 100.99 10.36 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 113.607 -1.633 . . . . 0.0 110.307 -176.64 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.47 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 22.2 m-85 -89.83 135.2 33.77 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 113.996 -1.457 . . . . 0.0 109.319 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.725 ' HB2' HD11 ' A' ' 92' ' ' ILE . 11.0 t80 -115.2 127.42 55.51 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.947 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.536 ' HB ' ' O ' ' A' ' 88' ' ' THR 0.251 0.4 OUTLIER -86.77 -68.87 0.71 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 113.012 -1.904 . . . . 0.0 111.417 176.823 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.49 ' HA2' ' HD2' ' A' ' 68' ' ' ARG . . . 69.01 1.7 27.26 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 114.047 -1.433 . . . . 0.0 113.544 -172.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.626 ' CB ' ' HB3' ' A' ' 87' ' ' ALA . 74.0 m-20 -129.9 10.47 5.49 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.237 1.015 . . . . 0.0 113.595 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.511 ' HB2' HG22 ' A' ' 67' ' ' THR . 43.6 t-80 64.88 80.13 0.24 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 128.081 2.552 . . . . 0.0 110.698 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.468 ' HB3' ' CD ' ' A' ' 41' ' ' GLU . 17.0 m-85 55.82 26.19 9.32 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 122.928 1.347 . . . . 0.0 113.413 -174.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.626 ' HB3' ' CB ' ' A' ' 84' ' ' ASP . . . -102.51 -8.86 20.69 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.54 -1.35 . . . . 0.0 112.766 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.536 ' O ' ' HB ' ' A' ' 82' ' ' THR . 12.5 p -163.14 169.37 19.47 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.621 1.568 . . . . 0.0 108.859 -176.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.538 ' CD1' HD21 ' A' ' 44' ' ' LEU . 92.5 m-85 -158.5 115.14 2.78 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -174.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.49 107.04 8.61 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 113.203 -1.817 . . . . 0.0 109.483 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.538 ' O ' HG12 ' A' ' 6' ' ' VAL . 18.0 mt -42.8 160.94 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 177.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.725 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.3 mp -110.05 113.72 45.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 O-C-N 120.982 -1.074 . . . . 0.0 109.194 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.09 87.21 7.35 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 113.833 -1.53 . . . . 0.0 109.686 176.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.529 ' HG3' HG22 ' A' ' 92' ' ' ILE . 2.4 mp0 -67.65 -31.41 71.39 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.643 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.6 t -55.64 -27.96 52.72 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.849 173.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.4 t . . . . . 0 C--O 1.253 1.265 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.887 177.691 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 p30 . . . . . 0 N--CA 1.474 0.73 0 CA-C-O 121.163 0.506 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.69 HG23 ' HD3' ' A' ' 45' ' ' PRO . 16.0 t -46.87 128.45 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.64 176.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 m -72.79 4.76 3.74 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 125.021 1.45 . . . . 0.0 113.095 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.529 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 123.09 168.89 13.18 Favored Glycine 0 C--O 1.216 -1.014 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 6' ' ' VAL . 3.4 m -76.68 174.62 10.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.653 -1.273 . . . . 0.0 110.159 -178.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.452 ' H ' HG22 ' A' ' 5' ' ' THR . 0.6 OUTLIER -140.36 109.38 3.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -175.108 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 74.9 m -47.19 125.37 7.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 112.669 -2.06 . . . . 0.0 109.367 176.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -49.81 -36.26 25.85 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 118.771 -0.633 . . . . 0.0 111.745 175.404 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.9 t -65.07 -28.52 69.52 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.889 0.852 . . . . 0.0 112.503 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 7' ' ' CYS . . . -75.22 -23.96 57.67 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.714 175.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.563 HD13 ' HB1' ' A' ' 15' ' ' ALA . 12.0 mt -83.52 160.44 59.14 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 176.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.508 ' HB2' ' OE2' ' A' ' 14' ' ' GLU . 79.1 Cg_endo -69.04 170.44 15.72 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.237 1.958 . . . . 0.0 112.826 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.35 -13.43 33.19 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.723 2.282 . . . . 0.0 114.235 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.508 ' OE2' ' HB2' ' A' ' 12' ' ' PRO . 1.5 pm0 -95.28 -3.45 47.43 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.642 175.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.721 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -72.6 -50.45 25.24 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.909 177.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.21 -24.97 45.39 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.284 -1.326 . . . . 0.0 112.204 175.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.477 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 35.0 t0 -51.44 -60.18 3.42 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.374 1.046 . . . . 0.0 110.012 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.789 ' HA ' HD12 ' A' ' 21' ' ' LEU . 16.2 m -55.95 -52.24 64.86 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.647 0.592 . . . . 0.0 112.426 177.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.58 HD11 HG21 ' A' ' 92' ' ' ILE . 6.1 mt -52.72 -34.15 51.17 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.517 0.51 . . . . 0.0 111.837 178.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -70.39 -40.72 73.76 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 124.102 0.961 . . . . 0.0 110.818 174.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.789 HD12 ' HA ' ' A' ' 18' ' ' THR . 26.5 mt -67.79 -32.21 72.63 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 119.095 -0.478 . . . . 0.0 110.23 175.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.723 HD12 ' O ' ' A' ' 18' ' ' THR . 1.6 mp -69.9 -43.08 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 120.597 1.544 . . . . 0.0 111.684 172.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.01 -42.76 72.58 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 125.034 1.459 . . . . 0.0 111.844 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.78 7.41 39.86 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.482 1.113 . . . . 0.0 111.748 177.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.6 t70 40.6 50.24 2.84 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 125.283 1.433 . . . . 0.0 110.977 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.59 -166.77 45.77 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 113.616 -1.629 . . . . 0.0 114.864 -173.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.53 141.03 69.91 Favored 'Cis proline' 0 N--CA 1.48 0.732 0 O-C-N 124.209 1.637 . . . . 0.0 111.19 0.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -91.21 136.23 27.41 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 113.051 -1.886 . . . . 0.0 111.656 -177.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.453 ' HG2' ' CD1' ' A' ' 58' ' ' ILE . 33.5 Cg_endo -74.76 -63.63 0.03 OUTLIER 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 122.463 2.108 . . . . 0.0 111.076 -178.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -59.59 150.62 26.76 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.548 0.689 . . . . 0.0 111.596 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.69 -5.71 42.26 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.024 176.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.451 ' NE2' HG21 ' A' ' 56' ' ' THR . 13.4 mt-30 -97.38 88.89 4.54 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.957 0.884 . . . . 0.0 112.261 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 169.99 134.16 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 112.115 -2.311 . . . . 0.0 113.751 -175.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.65 17.26 33.87 Favored Glycine 0 N--CA 1.484 1.872 0 CA-C-N 112.706 -2.043 . . . . 0.0 111.846 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.466 HG23 ' HB2' ' A' ' 54' ' ' GLU . 15.9 m -109.62 150.75 12.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 123.634 0.774 . . . . 0.0 109.502 176.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.3 t -84.01 154.47 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 O-C-N 125.674 1.859 . . . . 0.0 110.473 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.556 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 57.6 t80 -131.92 92.5 3.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.549 176.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -68.93 47.69 0.06 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.398 1.094 . . . . 0.0 112.96 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.406 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 40.4 t30 28.91 53.0 0.08 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.459 1.503 . . . . 0.0 110.628 -173.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.89 -23.46 53.27 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 113.912 -1.494 . . . . 0.0 110.984 -172.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.597 ' O ' HG23 ' A' ' 43' ' ' VAL . 4.3 mt-10 -86.77 -12.86 46.89 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 112.684 -2.053 . . . . 0.0 113.868 173.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.4 t 43.75 43.53 5.02 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 124.605 2.145 . . . . 0.0 111.663 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 41' ' ' GLU . 79.5 t -105.75 -17.74 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 112.689 -2.051 . . . . 0.0 110.007 -178.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.552 HD21 ' CD1' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -86.23 153.98 56.98 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 117.691 -1.147 . . . . 0.0 108.878 -175.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.69 ' HD3' HG23 ' A' ' 2' ' ' VAL . 73.1 Cg_endo -75.0 50.18 2.46 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.071 2.514 . . . . 0.0 112.452 -178.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 47' ' ' GLN . 4.3 m -155.84 -138.08 0.07 Allowed 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.424 ' H ' HG22 ' A' ' 46' ' ' THR . 8.0 tt0 161.85 -34.58 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.545 1.938 . . . . 0.0 110.626 -173.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.3 p -42.95 155.52 0.05 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 123.602 1.668 . . . . 0.0 111.935 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -104.35 131.0 52.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 113.338 -1.755 . . . . 0.0 110.981 -175.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.58 -16.78 38.5 Favored Glycine 0 N--CA 1.479 1.559 0 O-C-N 125.022 1.451 . . . . 0.0 111.904 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -68.13 -9.79 49.22 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.63 0.772 . . . . 0.0 112.149 176.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.556 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 24.6 m-85 -121.3 169.4 10.62 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 124.298 1.039 . . . . 0.0 109.791 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -159.79 164.13 33.99 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 113.237 -1.801 . . . . 0.0 110.659 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.466 ' HB2' HG23 ' A' ' 35' ' ' VAL . 3.5 mp0 -118.98 139.73 51.19 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.846 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.631 ' HB3' HG23 ' A' ' 18' ' ' THR . 26.9 m-85 -153.09 61.9 0.77 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 125.81 1.944 . . . . 0.0 111.36 -175.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 23.3 m -38.24 124.39 1.22 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.362 1.077 . . . . 0.0 112.089 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.721 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -86.66 108.74 18.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 111.901 -2.409 . . . . 0.0 108.767 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.453 ' CD1' ' HG2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -38.23 146.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.443 172.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.479 ' OG1' ' HG3' ' A' ' 68' ' ' ARG . 3.4 m -137.29 140.26 30.29 Favored Pre-proline 0 C--N 1.324 -0.53 0 O-C-N 125.157 1.535 . . . . 0.0 111.654 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.499 ' HD3' ' CD ' ' A' ' 14' ' ' GLU . 71.8 Cg_endo -74.25 150.05 41.45 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.188 2.592 . . . . 0.0 109.502 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 49.73 30.96 15.18 Favored Glycine 0 N--CA 1.479 1.523 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.904 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.01 88.87 5.39 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -41.8 -29.72 0.21 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.247 -1.342 . . . . 0.0 112.794 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.7 p -126.24 -163.69 1.25 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.997 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -59.43 -15.75 19.19 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 173.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.55 153.67 0.8 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.535 HG22 ' HB2' ' A' ' 85' ' ' HIS . 24.6 p -67.23 -8.86 34.9 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 112.671 -1.765 . . . . 0.0 112.761 176.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.479 ' HG3' ' OG1' ' A' ' 59' ' ' THR . 0.0 OUTLIER -70.14 116.04 10.04 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.54 1.136 . . . . 0.0 110.413 177.039 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 0.4 OUTLIER -140.05 137.96 35.01 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.887 -1.506 . . . . 0.0 109.452 179.149 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.596 HG23 ' OD1' ' A' ' 79' ' ' ASP . 4.7 mt -109.05 141.08 25.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 113.644 -1.616 . . . . 0.0 109.097 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.492 ' HB ' ' HB2' ' A' ' 80' ' ' TYR . 19.0 mm -129.42 107.03 14.61 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 CA-C-N 113.808 -1.542 . . . . 0.0 109.309 -177.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.527 HG21 HG12 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -83.05 167.45 17.87 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 123.348 0.659 . . . . 0.0 110.861 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -120.34 173.18 15.23 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.03 -14.84 63.29 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 113.866 -1.167 . . . . 0.0 111.691 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.31 128.48 54.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.434 175.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.624 HG22 ' HG2' ' A' ' 77' ' ' GLN . 2.3 m -59.06 141.81 53.03 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 113.506 -1.679 . . . . 0.0 106.98 175.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.624 ' HG2' HG22 ' A' ' 76' ' ' THR . 0.3 OUTLIER 81.28 32.04 0.13 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 126.193 2.183 . . . . 0.0 111.002 178.327 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -133.45 57.47 1.81 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.786 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.596 ' OD1' HG23 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -99.74 122.16 42.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.53 -1.668 . . . . 0.0 110.19 178.211 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.492 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 40.4 m-85 -95.55 137.68 34.29 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 124.914 1.286 . . . . 0.0 109.373 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.71 ' HB2' HD11 ' A' ' 92' ' ' ILE . 7.1 t80 -116.64 123.74 48.05 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.717 -177.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.562 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.5 OUTLIER -86.93 -66.21 0.93 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 113.663 -1.608 . . . . 0.0 110.734 178.187 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.08 2.31 17.56 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-N 113.598 -1.637 . . . . 0.0 113.092 -173.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.642 ' CB ' ' HB3' ' A' ' 87' ' ' ALA . 80.9 m-20 -129.63 8.6 5.39 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.535 ' HB2' HG22 ' A' ' 67' ' ' THR . 45.5 t-80 67.76 80.81 0.2 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 128.213 2.605 . . . . 0.0 110.556 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.409 ' HB3' ' CD ' ' A' ' 41' ' ' GLU . 19.6 m-85 55.67 24.3 7.0 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 123.695 1.712 . . . . 0.0 112.99 -175.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.642 ' HB3' ' CB ' ' A' ' 84' ' ' ASP . . . -99.74 -10.07 22.3 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 117.954 -1.498 . . . . 0.0 112.391 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.562 ' O ' ' HB ' ' A' ' 82' ' ' THR . 15.5 p -162.89 171.98 15.82 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 -177.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.552 ' CD1' HD21 ' A' ' 44' ' ' LEU . 89.7 m-85 -159.91 114.17 2.27 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -174.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.01 104.91 7.09 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 113.854 -1.521 . . . . 0.0 108.682 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 91' ' ' LEU . 19.0 mt -42.05 164.66 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 O-C-N 124.209 0.943 . . . . 0.0 112.101 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.71 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.7 mp -111.41 134.5 53.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 O-C-N 120.699 -1.251 . . . . 0.0 108.996 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.29 93.91 4.67 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.661 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.497 HE22 ' HB3' ' A' ' 77' ' ' GLN . 3.3 mp0 -56.39 -38.09 71.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 123.976 0.798 . . . . 0.0 112.102 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.3 t -54.71 -46.49 74.18 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.047 1.339 . . . . 0.0 112.67 173.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 24.7 t . . . . . 0 C--O 1.249 1.029 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.43 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.405 ' HA ' ' HB3' ' A' ' 45' ' ' PRO . 3.1 p-10 . . . . . 0 CA--C 1.547 0.855 0 CA-C-O 123.464 1.602 . . . . 0.0 114.998 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.64 HG12 ' H ' ' A' ' 4' ' ' GLY . 43.9 t -107.42 139.21 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 t -69.59 -2.36 11.32 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 124.731 1.269 . . . . 0.0 112.96 176.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.64 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 124.36 169.03 12.99 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.517 1.532 . . . . 0.0 109.474 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.482 HG23 ' CB ' ' A' ' 91' ' ' LEU . 1.8 m -81.77 169.46 16.9 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.839 0.828 . . . . 0.0 110.377 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 p -140.47 107.77 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -174.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 61.5 m -47.09 136.6 8.54 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 113.542 -1.663 . . . . 0.0 111.063 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.53 HD11 ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -56.89 -32.17 65.61 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.837 -178.866 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.1 t -66.77 -29.02 68.87 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.863 173.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.13 -29.76 60.62 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.396 0.679 . . . . 0.0 111.523 175.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.59 HD13 ' HB1' ' A' ' 15' ' ' ALA . 13.5 mt -77.98 160.64 73.4 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 175.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.643 ' HB2' ' OE2' ' A' ' 14' ' ' GLU . 86.3 Cg_endo -68.72 168.01 21.33 Favored 'Trans proline' 0 CA--C 1.554 1.482 0 C-N-CA 122.559 2.173 . . . . 0.0 112.799 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.29 -12.41 34.88 Favored 'Trans proline' 0 CA--C 1.55 1.306 0 C-N-CA 123.156 2.57 . . . . 0.0 113.944 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.643 ' OE2' ' HB2' ' A' ' 12' ' ' PRO . 1.7 pm0 -93.38 -11.84 31.32 Favored 'General case' 0 C--O 1.216 -0.705 0 C-N-CA 124.998 1.319 . . . . 0.0 113.188 174.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.809 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -65.15 -50.08 67.4 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 175.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.53 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -56.05 -26.44 49.22 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.937 173.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.491 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 13.9 t70 -54.98 -56.84 15.27 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.153 0.981 . . . . 0.0 110.132 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.672 ' O ' HD12 ' A' ' 22' ' ' ILE . 5.5 m -57.15 -49.1 77.01 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 176.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.624 HD11 HG21 ' A' ' 92' ' ' ILE . 9.8 mt -55.85 -35.72 66.74 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.898 0.749 . . . . 0.0 111.806 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -67.91 -37.36 81.6 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.63 174.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.644 HD12 ' HA ' ' A' ' 18' ' ' THR . 28.2 mt -69.17 -32.01 71.04 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 118.494 -0.765 . . . . 0.0 111.629 173.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.672 HD12 ' O ' ' A' ' 18' ' ' THR . 1.8 mp -69.42 -43.85 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 119.668 1.122 . . . . 0.0 111.969 171.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.13 -42.99 71.87 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.119 -1.4 . . . . 0.0 112.863 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.17 4.49 50.34 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.454 1.102 . . . . 0.0 112.084 177.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.7 t0 40.94 50.39 3.1 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.495 1.518 . . . . 0.0 111.383 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.18 -164.93 28.73 Favored Glycine 0 N--CA 1.473 1.149 0 CA-C-N 111.932 -2.395 . . . . 0.0 116.524 -174.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -74.08 141.56 72.11 Favored 'Cis proline' 0 C--N 1.348 0.524 0 O-C-N 124.462 1.769 . . . . 0.0 111.79 -3.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -96.9 116.5 66.09 Favored Pre-proline 0 N--CA 1.47 0.57 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.208 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.94 -48.17 0.3 Allowed 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 122.865 2.377 . . . . 0.0 111.927 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.404 ' CE2' ' HG2' ' A' ' 65' ' ' ARG . 0.2 OUTLIER -67.3 132.44 47.73 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.104 176.14 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.8 m -70.76 56.9 0.19 Allowed 'General case' 0 N--CA 1.477 0.925 0 O-C-N 125.17 1.544 . . . . 0.0 112.771 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -157.08 73.65 0.76 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 113.566 -1.652 . . . . 0.0 111.863 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.57 144.74 1.14 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 110.987 -2.824 . . . . 0.0 113.481 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.91 23.67 37.8 Favored Glycine 0 CA--C 1.538 1.526 0 CA-C-N 113.237 -1.801 . . . . 0.0 111.839 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.8 m -122.08 145.22 29.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 C-N-CA 124.748 1.219 . . . . 0.0 110.203 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.3 t -81.44 154.13 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 O-C-N 125.969 2.043 . . . . 0.0 110.165 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.433 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 49.8 t80 -131.34 91.7 3.06 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 113.565 -1.652 . . . . 0.0 109.324 175.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.91 51.6 0.15 Allowed 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 119.614 1.097 . . . . 0.0 113.23 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 28.66 52.95 0.07 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 126.81 2.044 . . . . 0.0 110.252 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -26.21 60.75 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 121.771 0.796 . . . . 0.0 112.858 -172.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.548 ' O ' HG23 ' A' ' 43' ' ' VAL . 3.5 mt-10 -74.95 -16.79 60.63 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 112.621 -2.081 . . . . 0.0 114.593 171.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.8 t 45.86 41.1 7.39 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 124.024 1.869 . . . . 0.0 111.388 -177.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 41' ' ' GLU . 89.1 t -104.21 -11.38 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 112.758 -2.019 . . . . 0.0 109.65 -178.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.565 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.2 OUTLIER -97.5 148.88 35.07 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.523 -174.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.409 ' HD3' HG23 ' A' ' 2' ' ' VAL . 96.7 Cg_endo -76.87 56.21 5.23 Favored 'Trans proline' 0 N--CA 1.478 0.616 0 C-N-CA 122.925 2.416 . . . . 0.0 112.343 -174.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.554 HG22 ' H ' ' A' ' 47' ' ' GLN . 1.6 m -158.37 -152.0 0.31 Allowed 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 114.293 -1.321 . . . . 0.0 107.626 -175.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.554 ' H ' HG22 ' A' ' 46' ' ' THR . 41.7 tt0 175.56 -37.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 126.204 1.802 . . . . 0.0 110.966 -174.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.6 p -40.0 147.82 0.09 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 122.585 1.183 . . . . 0.0 113.483 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -104.01 133.69 48.53 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 113.672 -1.604 . . . . 0.0 109.823 -174.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.48 -17.33 39.81 Favored Glycine 0 N--CA 1.474 1.205 0 CA-C-N 114.03 -1.441 . . . . 0.0 112.721 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.62 -1.08 20.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.013 1.325 . . . . 0.0 113.867 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.565 ' HE2' HD12 ' A' ' 44' ' ' LEU . 18.3 m-85 -129.77 151.51 50.28 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.489 1.116 . . . . 0.0 109.598 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -147.29 155.4 42.0 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 126.278 2.236 . . . . 0.0 110.581 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.433 ' HG3' ' HB2' ' A' ' 37' ' ' PHE . 1.9 mt-10 -108.96 132.93 53.61 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.298 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.505 ' HB3' HG23 ' A' ' 18' ' ' THR . 26.4 m-85 -145.75 62.95 1.26 Allowed 'General case' 0 N--CA 1.471 0.584 0 O-C-N 125.64 1.838 . . . . 0.0 110.715 -176.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 1.2 m -38.53 127.79 1.46 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 122.194 0.997 . . . . 0.0 112.85 178.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.809 HG21 ' HA ' ' A' ' 15' ' ' ALA . 1.1 p -90.8 113.24 26.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 111.783 -2.462 . . . . 0.0 109.201 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -36.89 145.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 114.022 -1.444 . . . . 0.0 110.506 171.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.401 HG23 ' HD2' ' A' ' 60' ' ' PRO . 3.4 m -136.66 140.16 31.29 Favored Pre-proline 0 N--CA 1.476 0.839 0 O-C-N 125.472 1.733 . . . . 0.0 112.48 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.511 ' HD3' ' CD ' ' A' ' 14' ' ' GLU . 84.3 Cg_endo -74.99 145.18 31.16 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.375 2.05 . . . . 0.0 109.236 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.12 32.16 49.79 Favored Glycine 0 CA--C 1.539 1.532 0 CA-C-N 113.247 -1.797 . . . . 0.0 112.186 -176.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.72 94.42 7.28 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -40.89 -33.15 0.28 Allowed 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 113.768 -1.56 . . . . 0.0 113.913 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.7 p -124.97 -155.15 0.66 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 113.655 -1.612 . . . . 0.0 108.755 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.404 ' HG2' ' CE2' ' A' ' 30' ' ' TYR . 15.4 mtm-85 -55.5 -19.75 10.71 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 171.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.32 135.48 0.08 OUTLIER Glycine 0 CA--C 1.524 0.599 0 N-CA-C 107.717 -2.153 . . . . 0.0 107.717 -176.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 77.1 p -41.28 -33.62 0.4 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 113.429 -1.385 . . . . 0.0 113.727 175.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -39.35 128.78 1.82 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 122.719 1.247 . . . . 0.0 113.83 169.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -158.69 133.78 8.42 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 111.702 -2.499 . . . . 0.0 110.159 -176.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.412 ' HB ' ' O ' ' A' ' 55' ' ' TYR . 8.0 mt -112.14 132.7 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 125.817 1.948 . . . . 0.0 107.791 176.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.496 ' O ' ' HD2' ' A' ' 80' ' ' TYR . 19.9 mm -121.12 102.88 12.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 112.753 -2.021 . . . . 0.0 107.522 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.415 ' HG1' ' HD2' ' A' ' 55' ' ' TYR . 17.4 p -88.86 161.31 16.78 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.501 178.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -116.42 164.23 12.34 Favored Glycine 0 N--CA 1.475 1.262 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.444 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.15 -15.81 62.82 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 176.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.444 ' HB3' ' OE2' ' A' ' 78' ' ' GLU . . . -103.71 130.96 51.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.612 173.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.635 HG22 ' HG2' ' A' ' 77' ' ' GLN . 3.8 m -55.97 142.7 34.85 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.635 ' HG2' HG22 ' A' ' 76' ' ' THR . 0.0 OUTLIER 78.98 31.74 0.3 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 126.892 2.077 . . . . 0.0 111.499 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.444 ' OE2' ' HB3' ' A' ' 75' ' ' ALA . 16.0 mt-10 -125.49 48.81 1.99 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 123.083 1.42 . . . . 0.0 112.569 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -103.52 107.9 18.94 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.205 1.402 . . . . 0.0 109.39 -179.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.496 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 32.3 m-85 -96.99 132.3 42.93 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 124.885 1.366 . . . . 0.0 109.48 -177.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.619 ' HB2' HD11 ' A' ' 92' ' ' ILE . 8.5 t80 -110.39 126.18 54.01 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.089 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.537 ' HB ' ' O ' ' A' ' 88' ' ' THR 0.27 0.3 OUTLIER -87.84 -68.66 0.74 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.011 -1.45 . . . . 0.0 112.211 176.399 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.86 2.12 21.72 Favored Glycine 0 N--CA 1.482 1.726 0 CA-C-N 114.607 -1.179 . . . . 0.0 113.414 -172.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.617 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 6.8 t70 -129.82 13.17 5.82 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.349 1.059 . . . . 0.0 112.531 176.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 64.08 84.86 0.14 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.329 1.852 . . . . 0.0 111.579 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.402 ' HB3' ' OE1' ' A' ' 41' ' ' GLU . 7.4 m-85 50.81 29.54 4.4 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -175.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.617 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . . . -112.21 -3.78 14.55 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.537 ' O ' ' HB ' ' A' ' 82' ' ' THR . 2.0 p -164.5 161.32 21.22 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.958 1.703 . . . . 0.0 108.305 -174.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CD1' HD21 ' A' ' 44' ' ' LEU . 88.6 m-85 -157.83 112.01 2.58 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.023 0.929 . . . . 0.0 108.88 -174.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.3 m -131.47 106.71 8.4 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 112.863 -1.971 . . . . 0.0 109.57 -178.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.482 ' CB ' HG23 ' A' ' 5' ' ' THR . 17.5 mt -42.13 155.61 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.972 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.638 HG22 ' HG3' ' A' ' 94' ' ' GLN . 1.9 mp -102.76 111.12 31.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 O-C-N 120.489 -1.382 . . . . 0.0 108.837 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.14 85.81 6.72 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.769 0.795 . . . . 0.0 110.156 175.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.638 ' HG3' HG22 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -70.53 -32.56 70.06 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.002 179.196 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.4 t -56.19 -23.05 32.9 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.525 1.53 . . . . 0.0 113.267 173.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.6 t . . . . . 0 CA--C 1.554 1.105 0 CA-C-O 116.48 -1.724 . . . . 0.0 110.85 177.764 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.69 HG23 ' HD3' ' A' ' 45' ' ' PRO . 21.1 t -55.16 127.1 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 m -75.14 6.59 4.11 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 124.544 1.152 . . . . 0.0 113.776 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.528 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 121.22 -165.54 14.25 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 m -95.79 170.14 9.52 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.986 -1.107 . . . . 0.0 110.277 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -137.47 111.85 9.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -176.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.55 ' HB3' ' OXT' ' A' ' 96' ' ' CYS . 97.0 m -49.37 129.48 18.67 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 111.874 -2.421 . . . . 0.0 109.83 177.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.78 -33.21 66.4 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 119.217 -0.42 . . . . 0.0 111.437 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.8 t -67.24 -28.39 68.01 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.348 0.659 . . . . 0.0 112.384 174.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.33 -20.76 58.87 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.781 174.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.47 HD22 ' CZ ' ' A' ' 81' ' ' TYR . 7.2 mt -83.18 158.94 63.35 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 175.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.514 ' HB2' ' OE2' ' A' ' 14' ' ' GLU . 92.4 Cg_endo -69.03 167.02 24.69 Favored 'Trans proline' 0 CA--C 1.551 1.371 0 C-N-CA 121.964 1.776 . . . . 0.0 112.456 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.18 -17.45 45.25 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.384 2.056 . . . . 0.0 113.682 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.514 ' OE2' ' HB2' ' A' ' 12' ' ' PRO . 8.4 pm0 -87.65 -13.78 41.73 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.697 1.199 . . . . 0.0 112.674 174.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.835 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -62.78 -49.9 73.16 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.02 0.528 . . . . 0.0 112.098 176.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.11 -26.23 48.97 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.633 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.526 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 41.6 t0 -57.57 -57.48 12.53 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.805 0.842 . . . . 0.0 110.34 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.742 ' HA ' HD12 ' A' ' 21' ' ' LEU . 16.8 m -57.23 -49.1 77.1 Favored 'General case' 0 C--O 1.217 -0.621 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 175.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.509 ' CD1' HG21 ' A' ' 92' ' ' ILE . 8.0 mt -56.02 -35.13 66.49 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 124.253 0.971 . . . . 0.0 111.77 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -67.59 -39.16 84.82 Favored 'General case' 0 C--O 1.212 -0.891 0 C-N-CA 124.54 1.136 . . . . 0.0 110.957 174.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.742 HD12 ' HA ' ' A' ' 18' ' ' THR . 41.0 mt -68.53 -34.76 76.43 Favored 'General case' 0 C--O 1.211 -0.926 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.596 175.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.645 HD12 ' O ' ' A' ' 18' ' ' THR . 1.6 mp -68.93 -38.73 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 120.069 1.304 . . . . 0.0 111.872 171.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.47 -48.52 48.73 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.86 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 m -85.46 5.93 29.04 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.173 0.989 . . . . 0.0 113.314 176.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.38 36.08 1.51 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 122.748 1.261 . . . . 0.0 112.22 -176.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.44 -166.9 16.26 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.443 1.497 . . . . 0.0 115.706 -174.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.78 139.87 64.15 Favored 'Cis proline' 0 C--N 1.347 0.485 0 O-C-N 124.285 1.676 . . . . 0.0 111.255 -2.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.469 ' CD2' ' HB3' ' A' ' 21' ' ' LEU . 58.7 m-85 -90.95 135.72 28.37 Favored Pre-proline 0 N--CA 1.474 0.732 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.705 -177.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.459 ' HG2' ' CD1' ' A' ' 58' ' ' ILE . 38.1 Cg_endo -74.34 -61.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.469 2.779 . . . . 0.0 111.433 -178.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.3 m-30 -63.35 159.72 17.52 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 175.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.8 m -80.53 9.28 6.22 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 124.173 0.921 . . . . 0.0 113.476 173.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.61 78.99 1.76 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 122.022 0.915 . . . . 0.0 111.46 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -177.14 146.16 0.49 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 111.721 -2.49 . . . . 0.0 115.056 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.69 27.98 36.84 Favored Glycine 0 N--CA 1.479 1.535 0 CA-C-N 112.87 -1.968 . . . . 0.0 110.853 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.411 HG23 ' HB2' ' A' ' 54' ' ' GLU . 20.5 m -122.12 146.24 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.453 1.101 . . . . 0.0 109.54 177.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.4 t -84.39 154.07 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 125.903 2.002 . . . . 0.0 109.855 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.465 ' CD1' ' HD3' ' A' ' 40' ' ' ARG . 18.6 t80 -137.11 85.88 2.16 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 113.844 -1.525 . . . . 0.0 110.828 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.432 ' HB2' ' CD1' ' A' ' 49' ' ' TYR . 2.2 tm0? -69.38 51.91 0.1 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.9 t30 27.52 55.65 0.07 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.779 2.032 . . . . 0.0 109.634 -172.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.465 ' HD3' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -55.62 -28.37 54.85 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 122.332 1.063 . . . . 0.0 111.463 -175.2 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.555 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.2 mt-10 -74.72 -11.37 60.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 113.138 -1.846 . . . . 0.0 114.962 173.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 31.4 t 45.38 43.12 8.21 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 123.874 1.797 . . . . 0.0 111.844 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 41' ' ' GLU . 95.8 t -108.77 -20.92 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 113.78 -1.555 . . . . 0.0 110.432 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.876 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.2 OUTLIER -88.25 147.26 39.85 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -175.413 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.69 ' HD3' HG23 ' A' ' 2' ' ' VAL . 92.3 Cg_endo -75.75 54.62 4.06 Favored 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 123.3 2.666 . . . . 0.0 112.081 -176.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.535 HG22 ' H ' ' A' ' 47' ' ' GLN . 1.9 m -157.66 -149.27 0.23 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 114.023 -1.444 . . . . 0.0 107.745 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.535 ' H ' HG22 ' A' ' 46' ' ' THR . 5.8 tt0 173.36 -35.78 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.012 1.725 . . . . 0.0 110.955 -173.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.8 p -38.06 146.35 0.06 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 122.771 1.272 . . . . 0.0 114.099 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.432 ' CD1' ' HB2' ' A' ' 38' ' ' GLN . 2.4 t80 -102.54 129.21 49.01 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 113.208 -1.814 . . . . 0.0 111.744 -175.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.63 -18.84 27.73 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 113.813 -1.539 . . . . 0.0 112.258 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -67.47 -9.09 38.76 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.228 1.011 . . . . 0.0 112.396 176.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.876 ' HE2' HD12 ' A' ' 44' ' ' LEU . 19.0 m-85 -122.99 162.4 22.41 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 124.279 1.032 . . . . 0.0 109.772 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -159.51 155.85 27.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 112.296 -2.229 . . . . 0.0 111.39 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.411 ' HB2' HG23 ' A' ' 35' ' ' VAL . 3.5 mt-10 -110.68 142.34 42.72 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.758 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.415 ' HB3' HG23 ' A' ' 18' ' ' THR . 77.5 m-85 -156.57 67.11 0.56 Allowed 'General case' 0 N--CA 1.477 0.918 0 O-C-N 126.328 2.267 . . . . 0.0 110.524 -175.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.43 ' OG1' ' HD3' ' A' ' 69' ' ' ARG . 1.1 m -38.47 123.06 1.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 122.689 1.233 . . . . 0.0 112.808 176.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.835 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.5 OUTLIER -81.82 114.1 22.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 112.109 -2.314 . . . . 0.0 108.73 177.233 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.459 ' CD1' ' HG2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -41.33 150.82 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 124.806 1.316 . . . . 0.0 109.107 171.58 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.461 ' OG1' ' HG3' ' A' ' 68' ' ' ARG . 23.8 m -150.99 137.76 11.56 Favored Pre-proline 0 N--CA 1.481 1.106 0 O-C-N 125.851 1.969 . . . . 0.0 110.684 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -72.48 151.4 53.19 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 123.646 2.897 . . . . 0.0 110.588 177.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.36 20.72 30.75 Favored Glycine 0 N--CA 1.48 1.623 0 CA-C-N 114.015 -1.448 . . . . 0.0 112.88 -174.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.87 87.64 5.47 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -44.39 -30.52 0.86 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 113.99 -1.459 . . . . 0.0 112.683 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.8 p -133.03 -170.87 2.54 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.866 -1.515 . . . . 0.0 108.638 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.1 mtm-85 -46.87 -29.3 1.92 Allowed 'General case' 0 N--CA 1.484 1.254 0 O-C-N 124.273 0.983 . . . . 0.0 112.921 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.27 148.78 0.09 OUTLIER Glycine 0 N--CA 1.465 0.59 0 N-CA-C 107.26 -2.336 . . . . 0.0 107.26 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.501 HG22 ' HB2' ' A' ' 85' ' ' HIS . 19.6 p -42.86 -29.73 0.34 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.052 -1.574 . . . . 0.0 113.423 172.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.737 ' HE ' HG12 ' A' ' 57' ' ' VAL . 3.1 mmm180 -37.64 116.91 0.52 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 166.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.447 ' HB2' HG23 ' A' ' 82' ' ' THR . 0.0 OUTLIER -157.49 135.02 10.52 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 112.435 -2.166 . . . . 0.0 112.938 -176.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.448 ' O ' HD13 ' A' ' 71' ' ' ILE . 5.9 mt -113.7 141.05 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 112.784 -2.007 . . . . 0.0 108.471 177.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.757 HD11 ' HE1' ' A' ' 86' ' ' TYR . 17.4 mm -127.52 114.09 34.49 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 O-C-N 126.199 2.187 . . . . 0.0 108.203 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.599 HG22 ' HB3' ' A' ' 79' ' ' ASP . 19.5 p -101.05 163.92 12.05 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.248 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.67 164.87 12.04 Favored Glycine 0 CA--C 1.531 1.082 0 O-C-N 125.639 1.837 . . . . 0.0 109.694 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.86 -17.43 63.15 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.302 0.641 . . . . 0.0 112.117 175.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -104.55 128.51 52.53 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.626 HG22 ' HG2' ' A' ' 77' ' ' GLN . 24.8 m -55.54 145.82 22.06 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 114.096 -1.411 . . . . 0.0 107.354 174.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.626 ' HG2' HG22 ' A' ' 76' ' ' THR . 0.0 OUTLIER 82.39 32.84 0.09 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 126.299 1.839 . . . . 0.0 111.218 179.047 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -135.83 46.46 2.33 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 123.058 1.409 . . . . 0.0 112.744 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.599 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -101.2 88.61 3.54 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 113.174 -1.83 . . . . 0.0 109.843 179.495 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.472 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 65.8 m-85 -57.79 178.06 0.09 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.287 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.483 ' CE2' ' NH1' ' A' ' 68' ' ' ARG . 9.0 t80 -158.01 113.92 2.77 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.685 -176.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.58 ' HB ' ' O ' ' A' ' 88' ' ' THR 0.318 0.1 OUTLIER -87.87 -80.45 0.27 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.045 -1.434 . . . . 0.0 113.72 177.813 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.02 -5.31 59.15 Favored Glycine 0 N--CA 1.471 0.99 0 CA-C-N 115.25 -0.886 . . . . 0.0 114.382 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.55 ' CB ' ' HB3' ' A' ' 87' ' ' ALA . 1.0 OUTLIER -120.64 20.02 11.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.398 -0.901 . . . . 0.0 111.985 173.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.501 ' HB2' HG22 ' A' ' 67' ' ' THR . 22.5 t-80 58.47 87.02 0.08 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.25 1.82 . . . . 0.0 110.203 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.757 ' HE1' HD11 ' A' ' 71' ' ' ILE . 8.3 m-30 49.08 41.32 19.16 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 113.639 -1.619 . . . . 0.0 114.518 -174.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.55 ' HB3' ' CB ' ' A' ' 84' ' ' ASP . . . -112.46 -32.64 6.42 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.102 -1.624 . . . . 0.0 112.806 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.58 ' O ' ' HB ' ' A' ' 82' ' ' THR . 15.3 p -135.95 166.79 22.52 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.646 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -156.79 110.13 2.61 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -175.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.71 106.46 9.15 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 113.884 -1.507 . . . . 0.0 108.354 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 51.1 mt -44.08 161.72 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.576 HD13 ' O ' ' A' ' 79' ' ' ASP . 1.7 mp -110.76 131.97 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 120.881 -1.137 . . . . 0.0 108.926 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.87 94.99 5.31 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 113.204 -1.816 . . . . 0.0 107.911 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -57.41 -37.1 72.21 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 124.731 1.269 . . . . 0.0 111.912 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.3 t -58.34 -45.66 87.71 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.821 -1.082 . . . . 0.0 112.469 174.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.55 ' OXT' ' HB3' ' A' ' 7' ' ' CYS . 11.6 t . . . . . 0 C--O 1.245 0.829 0 CA-C-O 118.489 -0.767 . . . . 0.0 110.929 175.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.401 ' HA ' ' HB3' ' A' ' 45' ' ' PRO . 0.8 OUTLIER . . . . . 0 N--CA 1.477 0.893 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.702 HG23 ' HD3' ' A' ' 45' ' ' PRO . 44.4 t -95.08 142.87 12.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.1 m -77.74 5.69 8.9 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.787 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.645 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 120.53 -177.23 16.36 Favored Glycine 0 N--CA 1.473 1.115 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 6' ' ' VAL . 4.4 m -90.96 173.69 7.83 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 122.354 1.073 . . . . 0.0 109.2 -178.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.428 ' H ' HG22 ' A' ' 5' ' ' THR . 0.9 OUTLIER -139.73 112.64 5.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -175.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 73.3 m -50.08 124.66 10.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 111.894 -2.412 . . . . 0.0 109.601 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -50.73 -35.39 31.2 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.719 0.807 . . . . 0.0 112.232 174.13 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.9 t -63.81 -30.97 72.01 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.518 0.511 . . . . 0.0 111.992 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.48 -17.65 59.18 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.632 0.773 . . . . 0.0 111.913 174.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.463 ' HB3' ' CB ' ' A' ' 15' ' ' ALA . 7.1 mt -90.05 162.35 35.46 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 176.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.48 169.53 15.48 Favored 'Trans proline' 0 CA--C 1.547 1.135 0 C-N-CA 122.606 2.204 . . . . 0.0 112.988 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.3 -17.95 49.99 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.561 2.174 . . . . 0.0 113.058 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.495 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 26.1 tp10 -85.05 -25.22 27.76 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 175.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.863 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -48.84 -37.07 18.37 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 175.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.49 -35.27 68.14 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.873 -1.512 . . . . 0.0 112.943 173.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.545 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 9.3 t70 -54.46 -53.33 55.63 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.06 0.944 . . . . 0.0 109.828 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.818 ' HA ' HD12 ' A' ' 21' ' ' LEU . 17.1 m -59.54 -48.24 82.43 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 175.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.703 HD11 HG21 ' A' ' 92' ' ' ILE . 5.6 mt -56.81 -28.57 61.66 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 176.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -73.75 -40.35 63.57 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.704 173.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.818 HD12 ' HA ' ' A' ' 18' ' ' THR . 25.3 mt -69.5 -31.16 69.24 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 119.271 -0.395 . . . . 0.0 111.026 176.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.671 HD12 ' O ' ' A' ' 18' ' ' THR . 1.6 mp -69.74 -38.38 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 120.143 1.338 . . . . 0.0 111.508 171.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.46 -47.61 32.39 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 124.562 1.164 . . . . 0.0 111.873 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.7 m -85.91 8.4 20.45 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.42 1.488 . . . . 0.0 112.645 175.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 41.51 46.54 3.05 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 122.725 1.25 . . . . 0.0 112.525 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.48 -166.13 43.37 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-N 113.928 -1.487 . . . . 0.0 116.265 -171.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -74.25 140.6 68.17 Favored 'Cis proline' 0 N--CA 1.483 0.887 0 O-C-N 124.758 1.925 . . . . 0.0 111.543 -1.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.505 ' HA ' HD22 ' A' ' 21' ' ' LEU . 33.9 m-85 -92.21 142.67 26.44 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 113.897 -1.501 . . . . 0.0 111.679 -176.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -74.62 -65.29 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 123.283 2.655 . . . . 0.0 111.42 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 -57.56 163.0 2.63 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.834 0.826 . . . . 0.0 112.226 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 t -82.08 9.44 8.5 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 123.238 1.494 . . . . 0.0 112.269 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.403 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -112.11 99.54 8.14 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.302 -177.411 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 166.64 140.17 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 O-C-N 126.626 2.454 . . . . 0.0 115.404 -172.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.45 30.38 22.02 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-N 113.616 -1.629 . . . . 0.0 111.172 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.507 HG23 ' HB2' ' A' ' 54' ' ' GLU . 20.7 m -122.36 147.39 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 114.275 -0.963 . . . . 0.0 109.512 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.0 t -85.15 156.95 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 125.248 1.593 . . . . 0.0 109.631 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.603 ' CD1' ' HD3' ' A' ' 40' ' ' ARG . 31.0 t80 -141.26 86.26 2.01 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.811 175.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.72 55.44 0.26 Allowed 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 122.631 1.205 . . . . 0.0 113.318 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 45.7 t30 29.73 53.62 0.12 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.474 2.31 . . . . 0.0 109.305 -173.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.603 ' HD3' ' CD1' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -58.18 -22.97 53.8 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.701 -174.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.611 ' O ' HG23 ' A' ' 43' ' ' VAL . 3.0 mt-10 -83.02 -8.28 59.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 113.207 -1.815 . . . . 0.0 114.669 173.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 43.9 t 44.0 41.92 4.37 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 124.326 2.012 . . . . 0.0 111.733 -177.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 41' ' ' GLU . 57.5 t -109.81 -12.4 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 113.592 -1.64 . . . . 0.0 109.663 -178.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.494 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.2 OUTLIER -99.92 148.43 34.8 Favored Pre-proline 0 CA--C 1.545 0.775 0 O-C-N 120.721 -1.237 . . . . 0.0 108.687 -175.272 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.702 ' HD3' HG23 ' A' ' 2' ' ' VAL . 71.6 Cg_endo -78.5 59.09 7.02 Favored 'Trans proline' 0 N--CA 1.477 0.551 0 C-N-CA 122.815 2.343 . . . . 0.0 111.156 -174.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.544 HG22 ' H ' ' A' ' 47' ' ' GLN . 2.4 m -157.17 -147.49 0.19 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 113.829 -1.532 . . . . 0.0 107.505 -177.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.544 ' H ' HG22 ' A' ' 46' ' ' THR . 8.4 tt0 171.7 -35.97 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.911 1.684 . . . . 0.0 111.04 -173.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.6 p -40.89 152.23 0.05 Allowed 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 123.116 1.436 . . . . 0.0 112.917 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -106.18 126.71 52.55 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 113.178 -1.828 . . . . 0.0 109.937 -175.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.43 -21.53 28.43 Favored Glycine 0 N--CA 1.479 1.521 0 O-C-N 125.181 1.551 . . . . 0.0 112.009 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -64.44 -13.47 51.62 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.505 1.122 . . . . 0.0 112.294 176.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.494 ' HE2' HD12 ' A' ' 44' ' ' LEU . 16.4 m-85 -116.25 163.08 16.52 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.718 0.807 . . . . 0.0 109.535 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -159.65 159.65 33.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 112.016 -2.357 . . . . 0.0 111.184 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.507 ' HB2' HG23 ' A' ' 35' ' ' VAL . 32.2 mt-10 -117.31 144.7 44.6 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.645 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.406 ' HB3' HG23 ' A' ' 18' ' ' THR . 80.1 m-85 -158.96 63.92 0.41 Allowed 'General case' 0 N--CA 1.48 1.047 0 O-C-N 126.495 2.372 . . . . 0.0 111.104 -174.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 32' ' ' GLN . 1.1 m -35.35 120.89 0.57 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 122.352 1.072 . . . . 0.0 112.556 177.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.863 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -81.78 117.72 28.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 112.738 -2.028 . . . . 0.0 108.609 177.313 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.469 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -42.99 158.39 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 173.467 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.495 ' OG1' ' HG3' ' A' ' 68' ' ' ARG . 2.5 m -153.09 142.45 14.74 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 113.273 -1.785 . . . . 0.0 111.387 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.56 146.03 48.5 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.594 2.196 . . . . 0.0 110.971 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.25 22.1 55.08 Favored Glycine 0 N--CA 1.48 1.611 0 CA-C-N 113.759 -1.564 . . . . 0.0 112.459 -175.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.2 87.05 7.34 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -47.61 -26.57 1.52 Allowed 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.912 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.1 p -128.03 -158.62 0.89 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.037 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.6 mtm105 -57.06 -18.18 13.25 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 174.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.41 125.4 0.02 OUTLIER Glycine 0 N--CA 1.465 0.593 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.42 HG22 ' HB2' ' A' ' 85' ' ' HIS . 22.0 p -39.72 -31.09 0.09 Allowed 'General case' 0 CA--C 1.557 1.234 0 CA-C-N 113.699 -1.251 . . . . 0.0 113.523 175.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.495 ' HG3' ' OG1' ' A' ' 59' ' ' THR . 0.3 OUTLIER -46.05 105.61 0.07 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 123.417 1.579 . . . . 0.0 112.711 170.137 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.548 ' HB2' HG23 ' A' ' 82' ' ' THR . 0.3 OUTLIER -131.42 141.36 49.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 112.816 -1.993 . . . . 0.0 109.989 -179.442 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.9 mt -117.3 135.9 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 112.681 -2.054 . . . . 0.0 108.33 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.618 HD11 ' HE1' ' A' ' 86' ' ' TYR . 16.9 mm -124.91 101.87 9.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 CA-C-N 112.848 -1.978 . . . . 0.0 108.608 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.486 HG21 HD13 ' A' ' 22' ' ' ILE . 16.9 p -89.68 163.1 15.26 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.502 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -115.29 166.84 12.24 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-N 113.32 -1.764 . . . . 0.0 109.665 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.24 -14.09 62.58 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.355 -0.922 . . . . 0.0 111.843 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.58 130.95 55.29 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.129 174.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.55 HG22 ' HG2' ' A' ' 77' ' ' GLN . 3.4 m -55.23 143.8 26.66 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.124 -1.398 . . . . 0.0 107.495 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.55 ' HG2' HG22 ' A' ' 76' ' ' THR . 2.2 mt-30 80.06 33.82 0.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 126.127 2.142 . . . . 0.0 111.037 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -129.33 49.12 2.28 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 113.596 -1.638 . . . . 0.0 113.616 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.492 ' OD1' ' HB ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER -107.13 103.77 13.25 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.341 -178.363 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.516 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 23.9 m-85 -91.64 131.13 37.26 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 125.28 1.613 . . . . 0.0 109.916 -177.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.753 ' HB2' HD11 ' A' ' 92' ' ' ILE . 5.5 t80 -110.29 123.92 50.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.24 -1.345 . . . . 0.0 109.894 -176.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.548 HG23 ' HB2' ' A' ' 69' ' ' ARG 0.262 0.2 OUTLIER -89.74 -71.18 0.62 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 113.502 -1.681 . . . . 0.0 112.464 177.315 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.09 -8.81 56.65 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-N 113.118 -1.856 . . . . 0.0 112.197 -175.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 15.6 t70 -112.01 9.71 20.43 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 117.252 0.526 . . . . 0.0 111.838 174.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.42 ' HB2' HG22 ' A' ' 67' ' ' THR . 30.6 t-80 87.15 -20.93 0.2 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.928 1.691 . . . . 0.0 113.076 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.618 ' HE1' HD11 ' A' ' 71' ' ' ILE . 1.2 m-30 161.19 55.35 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 O-C-N 128.16 3.412 . . . . 0.0 113.684 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . . . -120.06 -41.33 2.65 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 118.994 -1.083 . . . . 0.0 113.748 175.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.528 ' O ' ' HB ' ' A' ' 82' ' ' THR . 18.4 p -128.29 165.55 20.32 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.399 -1.273 . . . . 0.0 108.402 -177.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.489 ' CD1' HD21 ' A' ' 44' ' ' LEU . 97.9 m-85 -157.41 112.7 2.78 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -173.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.2 m -131.21 112.25 12.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 113.261 -1.791 . . . . 0.0 109.286 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.474 ' HA ' HD23 ' A' ' 91' ' ' LEU . 25.1 mt -42.39 162.82 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 O-C-N 124.214 0.946 . . . . 0.0 112.428 177.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.753 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.7 mp -112.19 130.74 65.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 O-C-N 120.778 -1.201 . . . . 0.0 108.823 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.04 94.14 4.94 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.257 -1.792 . . . . 0.0 108.624 176.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -53.39 -37.22 62.26 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 124.107 0.88 . . . . 0.0 112.467 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.9 t -56.74 -49.29 75.65 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 113.801 -1.545 . . . . 0.0 113.595 174.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 34.3 t . . . . . 0 C--O 1.246 0.886 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 179.07 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.9 p30 . . . . . 0 CA--C 1.551 1.011 0 CA-C-O 122.146 0.974 . . . . 0.0 112.986 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.401 HG23 ' HD3' ' A' ' 45' ' ' PRO . 3.4 t -84.05 141.81 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.92 5.82 10.67 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.883 0.849 . . . . 0.0 112.639 177.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.38 -174.37 16.55 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.447 1.498 . . . . 0.0 109.988 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -94.18 169.39 10.28 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 122.016 0.912 . . . . 0.0 109.239 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 91' ' ' LEU . 2.0 p -137.84 111.26 7.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 122.752 1.263 . . . . 0.0 107.882 -177.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 71.6 m -48.96 128.16 15.47 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 112.256 -2.247 . . . . 0.0 109.364 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -53.04 -34.65 57.41 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.805 176.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.1 t -64.68 -29.77 70.77 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 174.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.14 -26.11 58.9 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.451 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.487 HD13 ' HB1' ' A' ' 15' ' ' ALA . 7.1 mt -83.92 162.57 51.94 Favored Pre-proline 0 N--CA 1.478 0.952 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.17 168.11 18.39 Favored 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 122.308 2.005 . . . . 0.0 112.952 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -65.28 -18.95 62.0 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.847 2.365 . . . . 0.0 112.666 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.549 ' HG3' HG22 ' A' ' 57' ' ' VAL . 27.4 tp10 -83.62 -26.41 29.98 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.439 -0.801 . . . . 0.0 113.066 175.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.797 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -47.62 -38.87 15.54 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 176.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.38 -34.73 72.91 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.551 -1.659 . . . . 0.0 113.328 174.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.607 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 10.7 t0 -54.52 -57.0 13.12 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 117.408 -1.282 . . . . 0.0 109.465 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.797 ' HA ' HD12 ' A' ' 21' ' ' LEU . 1.4 m -55.87 -48.42 75.59 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 174.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.722 HD11 HG21 ' A' ' 92' ' ' ILE . 7.1 mt -57.42 -33.36 67.81 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -67.75 -33.41 74.81 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.336 174.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.797 HD12 ' HA ' ' A' ' 18' ' ' THR . 18.3 mt -75.93 -31.3 59.06 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 118.773 -0.632 . . . . 0.0 110.924 176.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.679 HD12 ' O ' ' A' ' 18' ' ' THR . 1.7 mp -69.9 -40.81 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 120.267 1.394 . . . . 0.0 111.453 170.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.84 -41.78 64.46 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 125.02 1.45 . . . . 0.0 112.521 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.31 7.23 45.22 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.321 1.049 . . . . 0.0 111.781 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 44.46 34.98 1.19 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.035 1.334 . . . . 0.0 112.556 -176.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.9 -168.15 20.14 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-N 113.379 -1.737 . . . . 0.0 115.83 -174.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -74.53 140.5 67.66 Favored 'Cis proline' 0 N--CA 1.479 0.622 0 O-C-N 124.043 1.549 . . . . 0.0 111.261 -3.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.476 ' HA ' HD22 ' A' ' 21' ' ' LEU . 23.6 m-85 -89.86 136.99 28.57 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.57 -176.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -72.68 -63.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.475 0.415 0 C-N-CA 123.563 2.842 . . . . 0.0 111.413 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 -62.99 159.4 17.13 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.411 0.684 . . . . 0.0 112.744 175.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.85 8.5 5.4 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 124.714 1.259 . . . . 0.0 113.588 174.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.426 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 1.8 mt-30 -105.01 82.89 1.91 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 122.372 1.082 . . . . 0.0 111.819 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -177.32 150.83 0.74 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 110.779 -2.919 . . . . 0.0 114.999 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.01 35.43 27.58 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-N 112.52 -2.127 . . . . 0.0 110.275 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -131.88 147.1 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.546 1.138 . . . . 0.0 109.72 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.4 t -84.41 154.4 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 O-C-N 125.944 2.027 . . . . 0.0 109.868 175.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.484 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 50.0 t80 -132.31 91.33 2.92 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 113.846 -1.525 . . . . 0.0 108.419 174.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.544 ' HG3' ' CD1' ' A' ' 49' ' ' TYR . 6.5 tm0? -72.12 55.63 0.31 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 119.81 1.187 . . . . 0.0 112.361 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 26.06 55.83 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.793 2.437 . . . . 0.0 110.854 -175.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.433 ' HD3' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -56.38 -25.97 51.42 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 122.17 0.986 . . . . 0.0 111.938 -171.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.595 ' O ' HG23 ' A' ' 43' ' ' VAL . 4.2 mt-10 -76.35 -14.33 60.09 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 113.09 -1.868 . . . . 0.0 115.598 172.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 31.6 t 45.06 41.81 5.91 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 124.183 1.945 . . . . 0.0 111.924 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 41' ' ' GLU . 76.6 t -110.8 -10.42 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-N 113.151 -1.841 . . . . 0.0 110.739 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.63 ' HB3' ' OH ' ' A' ' 52' ' ' TYR . 4.0 mm? -103.91 150.35 38.14 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-O 117.372 -1.299 . . . . 0.0 109.29 -176.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.401 ' HD3' HG23 ' A' ' 2' ' ' VAL . 83.3 Cg_endo -74.87 60.41 5.33 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.215 2.61 . . . . 0.0 111.42 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.818 HG22 ' H ' ' A' ' 47' ' ' GLN . 3.6 m -82.25 -165.2 0.96 Allowed 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 112.915 -1.948 . . . . 0.0 107.628 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.818 ' H ' HG22 ' A' ' 46' ' ' THR . 12.9 tt0 175.86 -43.71 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.004 1.722 . . . . 0.0 110.282 -176.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.8 p -114.86 161.45 18.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.693 -176.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.544 ' CD1' ' HG3' ' A' ' 38' ' ' GLN . 4.1 t80 -90.01 129.39 36.34 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 113.312 -1.767 . . . . 0.0 110.437 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.76 5.99 70.62 Favored Glycine 0 N--CA 1.48 1.584 0 O-C-N 125.332 1.645 . . . . 0.0 112.657 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.39 15.31 3.72 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.63 ' OH ' ' HB3' ' A' ' 44' ' ' LEU . 10.7 m-85 -151.04 150.76 31.12 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.156 0.983 . . . . 0.0 109.305 -173.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -147.12 155.44 42.17 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 126.074 2.109 . . . . 0.0 111.632 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.484 ' HG3' ' HB2' ' A' ' 37' ' ' PHE . 27.3 mt-10 -109.13 145.17 36.16 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.829 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.482 ' O ' HG21 ' A' ' 18' ' ' THR . 72.5 m-85 -159.82 68.28 0.39 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 126.826 2.579 . . . . 0.0 110.64 -174.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 0.9 OUTLIER -41.19 133.92 2.22 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 122.767 1.27 . . . . 0.0 111.814 178.741 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.797 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -95.86 118.97 43.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 112.07 -2.332 . . . . 0.0 107.939 178.35 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -40.73 153.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 CA-C-O 121.853 0.835 . . . . 0.0 108.955 173.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.487 ' OG1' ' HD2' ' A' ' 68' ' ' ARG . 15.7 m -140.04 139.74 22.15 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 112.951 -1.931 . . . . 0.0 111.688 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.73 145.18 50.84 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 121.93 1.754 . . . . 0.0 111.007 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 51.77 28.48 23.37 Favored Glycine 0 CA--C 1.548 2.137 0 O-C-N 125.289 1.618 . . . . 0.0 111.895 -174.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.98 90.28 4.57 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -46.57 -27.65 1.2 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 113.603 -1.635 . . . . 0.0 113.197 176.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.2 p -126.0 -173.67 2.91 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.846 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.426 ' HD2' ' OE1' ' A' ' 32' ' ' GLN . 14.6 mtm105 -52.94 -20.72 3.6 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 175.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.22 171.27 11.89 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 124.38 2.1 . . . . 0.0 109.201 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.489 HG22 ' HB2' ' A' ' 85' ' ' HIS . 41.0 p -75.95 0.74 17.33 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 111.275 -2.463 . . . . 0.0 113.004 176.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.487 ' HD2' ' OG1' ' A' ' 59' ' ' THR . 0.0 OUTLIER -82.11 116.9 21.89 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 122.925 1.345 . . . . 0.0 111.203 176.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.524 ' HG2' ' HE1' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -142.35 135.67 28.87 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 112.771 -2.013 . . . . 0.0 109.323 178.444 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.2 mt -104.5 144.81 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 113.463 -1.699 . . . . 0.0 108.741 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' A' ' 80' ' ' TYR . 18.4 mm -132.73 114.75 23.04 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.737 0 CA-C-N 112.486 -2.143 . . . . 0.0 107.895 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.565 HG22 ' HB3' ' A' ' 79' ' ' ASP . 18.8 p -99.45 162.86 12.79 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.791 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -107.61 -178.26 22.39 Favored Glycine 0 N--CA 1.477 1.433 0 O-C-N 124.968 1.417 . . . . 0.0 109.953 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.8 -13.22 59.96 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 114.348 -0.926 . . . . 0.0 113.024 174.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -113.73 130.78 56.38 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 176.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.521 HG22 ' HG2' ' A' ' 77' ' ' GLN . 31.4 m -54.0 147.97 11.53 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.083 174.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.521 ' HG2' HG22 ' A' ' 76' ' ' THR . 2.4 mt-30 80.63 31.76 0.17 Allowed 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 126.585 1.954 . . . . 0.0 110.942 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.513 ' HA ' HD22 ' A' ' 91' ' ' LEU . 4.6 mt-10 -134.59 48.78 2.28 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 123.89 1.805 . . . . 0.0 113.708 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.669 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -104.34 86.74 2.58 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 113.071 -1.877 . . . . 0.0 109.417 -179.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.41 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 35.2 m-85 -57.35 177.88 0.08 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 125.275 1.43 . . . . 0.0 110.339 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.597 ' HB2' HD11 ' A' ' 92' ' ' ILE . 13.0 t80 -162.87 126.23 2.85 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 113.817 -1.538 . . . . 0.0 109.84 -176.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.2 OUTLIER -91.12 -71.97 0.6 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 112.672 -2.058 . . . . 0.0 111.702 176.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.46 1.08 34.38 Favored Glycine 0 CA--C 1.55 2.228 0 CA-C-N 113.094 -1.866 . . . . 0.0 114.835 -173.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.568 ' CB ' ' HB3' ' A' ' 87' ' ' ALA . 1.7 m-20 -127.79 15.8 6.92 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.386 0.675 . . . . 0.0 112.619 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.489 ' HB2' HG22 ' A' ' 67' ' ' THR . 52.7 t-80 61.28 83.79 0.14 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 127.093 2.157 . . . . 0.0 110.591 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.524 ' HE1' ' HG2' ' A' ' 69' ' ' ARG . 3.4 m-30 51.84 38.23 22.74 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 113.83 -1.532 . . . . 0.0 113.342 -176.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.568 ' HB3' ' CB ' ' A' ' 84' ' ' ASP . . . -109.74 -13.22 14.52 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.498 ' O ' ' HB ' ' A' ' 82' ' ' THR . 9.5 p -161.37 165.96 28.14 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.037 1.335 . . . . 0.0 107.81 -176.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.511 ' CD1' HD21 ' A' ' 44' ' ' LEU . 99.6 m-85 -157.29 113.55 2.93 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -176.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.4 m -132.33 115.94 16.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.748 -1.569 . . . . 0.0 109.399 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.513 HD22 ' HA ' ' A' ' 78' ' ' GLU . 35.0 mt -47.28 164.21 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.379 0.672 . . . . 0.0 111.946 177.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.722 HG21 HD11 ' A' ' 19' ' ' LEU . 1.7 mp -112.63 128.96 69.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 120.824 -1.173 . . . . 0.0 108.434 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.87 92.05 4.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 113.472 -1.695 . . . . 0.0 108.551 175.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -52.62 -36.4 56.4 Favored 'General case' 0 N--CA 1.484 1.225 0 O-C-N 124.173 0.92 . . . . 0.0 112.778 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.2 t -58.27 -47.05 84.82 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 114.054 -1.43 . . . . 0.0 113.387 173.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 24.3 t . . . . . 0 C--O 1.244 0.791 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.171 178.365 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.738 HG21 ' HE1' ' A' ' 80' ' ' TYR . 71.2 t -37.66 136.5 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 125.57 1.548 . . . . 0.0 109.409 171.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.5 m -70.48 3.8 2.78 Favored 'General case' 0 CA--C 1.55 0.952 0 O-C-N 125.151 1.532 . . . . 0.0 112.526 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.642 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 111.2 -179.25 19.86 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 m -77.0 170.14 17.07 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.128 -1.036 . . . . 0.0 110.423 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 p -138.49 108.6 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 78.8 m -43.55 123.51 3.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 112.565 -2.107 . . . . 0.0 109.964 176.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.74 -37.06 39.69 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.742 177.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.9 t -65.69 -28.11 68.83 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.099 0.56 . . . . 0.0 112.073 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.43 -20.55 58.8 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.83 174.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.47 HD13 ' HB1' ' A' ' 15' ' ' ALA . 14.7 mt -85.77 159.59 54.67 Favored Pre-proline 0 CA--C 1.539 0.519 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 176.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.52 169.16 19.25 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 121.953 1.769 . . . . 0.0 113.081 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.48 -13.93 38.63 Favored 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 122.627 2.218 . . . . 0.0 114.549 177.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 11.8 pm0 -93.43 -4.93 50.43 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.559 -1.201 . . . . 0.0 113.29 176.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.504 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -78.59 -50.7 11.06 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.797 175.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.96 -28.22 56.06 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.67 -1.15 . . . . 0.0 112.271 174.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.57 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 9.6 t70 -53.45 -58.63 6.47 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.428 1.08 . . . . 0.0 109.969 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.71 ' HA ' HD12 ' A' ' 21' ' ' LEU . 1.8 m -53.57 -50.43 65.59 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.612 0.968 . . . . 0.0 113.612 175.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.529 HD21 HD13 ' A' ' 70' ' ' ILE . 10.4 mt -56.15 -37.38 69.42 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.885 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -64.63 -33.26 75.52 Favored 'General case' 0 C--O 1.214 -0.787 0 C-N-CA 123.962 0.905 . . . . 0.0 110.691 173.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.71 HD12 ' HA ' ' A' ' 18' ' ' THR . 16.8 mt -76.35 -30.43 57.6 Favored 'General case' 0 C--O 1.209 -1.048 0 CA-C-O 118.364 -0.826 . . . . 0.0 110.78 176.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.667 HD12 ' O ' ' A' ' 18' ' ' THR . 1.8 mp -70.65 -40.63 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 120.217 1.371 . . . . 0.0 111.722 171.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.39 -40.97 63.9 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.006 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.18 7.72 44.25 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.355 178.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 42.99 34.84 0.67 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.577 1.151 . . . . 0.0 112.733 -176.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.67 -169.48 18.22 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 113.521 -1.672 . . . . 0.0 115.969 -173.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.57 140.76 69.1 Favored 'Cis proline' 0 CA--C 1.537 0.655 0 O-C-N 123.775 1.408 . . . . 0.0 111.102 -2.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.425 ' CD2' ' HB3' ' A' ' 21' ' ' LEU . 37.9 m-85 -91.66 136.3 26.72 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 113.686 -1.597 . . . . 0.0 111.573 -177.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.418 ' HG2' ' CD1' ' A' ' 58' ' ' ILE . 44.3 Cg_endo -73.58 -62.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.475 0.439 0 C-N-CA 122.947 2.431 . . . . 0.0 111.942 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.8 m-30 -69.3 146.35 52.31 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 118.494 -0.765 . . . . 0.0 110.793 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.4 m -62.4 -15.26 48.0 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 125.385 1.678 . . . . 0.0 113.141 174.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.507 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 2.0 mt-30 -78.64 77.96 5.11 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 122.678 1.227 . . . . 0.0 111.516 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -178.12 142.21 0.27 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 110.783 -2.917 . . . . 0.0 113.869 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.0 24.43 37.72 Favored Glycine 0 N--CA 1.481 1.656 0 CA-C-N 112.952 -1.931 . . . . 0.0 111.399 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.4 m -120.52 146.89 24.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 124.384 1.073 . . . . 0.0 109.481 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 52' ' ' TYR . 5.3 t -83.57 154.37 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 126.096 2.123 . . . . 0.0 110.206 176.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.482 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 27.7 t80 -135.03 88.53 2.43 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 113.842 -1.526 . . . . 0.0 109.988 175.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -70.91 52.44 0.15 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 122.684 1.231 . . . . 0.0 113.753 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 37.5 t30 28.43 54.26 0.08 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.06 2.144 . . . . 0.0 109.566 -172.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -56.31 -26.29 51.72 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.702 -1.136 . . . . 0.0 111.035 -175.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.581 ' O ' HG23 ' A' ' 43' ' ' VAL . 1.3 mt-10 -76.61 -11.83 59.92 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.61 -1.632 . . . . 0.0 114.562 174.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.2 t 45.54 40.9 6.29 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 123.54 1.638 . . . . 0.0 111.973 -177.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 41' ' ' GLU . 62.4 t -109.34 -18.58 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 114.16 -1.382 . . . . 0.0 110.852 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.867 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.2 OUTLIER -88.51 149.78 45.08 Favored Pre-proline 0 N--CA 1.469 0.497 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.762 -175.604 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.712 ' HD3' HG23 ' A' ' 2' ' ' VAL . 92.7 Cg_endo -75.51 52.31 3.21 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 122.958 2.439 . . . . 0.0 112.062 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.463 HG22 ' H ' ' A' ' 47' ' ' GLN . 1.7 m -157.6 -148.19 0.2 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -177.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.463 ' H ' HG22 ' A' ' 46' ' ' THR . 2.6 tt0 169.54 -35.56 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.301 1.84 . . . . 0.0 110.676 -173.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.6 p -38.74 149.21 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 122.274 1.035 . . . . 0.0 113.657 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -103.26 132.41 49.54 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 113.613 -1.631 . . . . 0.0 109.186 -175.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.26 -18.68 21.91 Favored Glycine 0 N--CA 1.483 1.82 0 O-C-N 124.971 1.419 . . . . 0.0 113.136 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.457 ' HA ' ' HB2' ' A' ' 74' ' ' GLU . 0.2 OUTLIER -74.98 1.63 12.43 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.214 1.406 . . . . 0.0 113.135 177.743 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.867 ' HE2' HD12 ' A' ' 44' ' ' LEU . 11.4 m-85 -131.05 162.88 28.83 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 123.904 0.882 . . . . 0.0 109.873 -178.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -159.18 156.8 29.62 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 125.647 1.842 . . . . 0.0 110.899 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.482 ' HG3' ' HB2' ' A' ' 37' ' ' PHE . 2.3 mt-10 -114.94 137.33 52.11 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.454 -177.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.482 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 57.1 m-85 -152.48 65.85 0.82 Allowed 'General case' 0 N--CA 1.475 0.789 0 O-C-N 125.837 1.961 . . . . 0.0 111.345 -175.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 27.4 m -39.16 134.65 1.07 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 122.811 1.291 . . . . 0.0 113.061 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.504 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.9 OUTLIER -86.97 109.0 18.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 111.354 -2.657 . . . . 0.0 107.529 178.018 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -43.19 157.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 125.635 1.834 . . . . 0.0 109.339 168.312 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -156.61 141.75 12.38 Favored Pre-proline 0 C--N 1.322 -0.613 0 O-C-N 126.063 2.102 . . . . 0.0 112.501 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.84 145.56 45.98 Favored 'Trans proline' 0 N--CA 1.475 0.407 0 C-N-CA 122.549 2.166 . . . . 0.0 110.955 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.81 28.72 57.66 Favored Glycine 0 CA--C 1.539 1.586 0 CA-C-N 113.358 -1.746 . . . . 0.0 112.422 -175.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.11 89.92 7.89 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -39.71 -32.83 0.15 Allowed 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 113.864 -1.516 . . . . 0.0 113.167 176.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.6 p -130.7 -160.65 1.06 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 113.879 -1.509 . . . . 0.0 109.755 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.507 ' HD2' ' OE1' ' A' ' 32' ' ' GLN . 3.6 mtm105 -60.21 -14.74 19.17 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 172.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.18 139.53 0.07 OUTLIER Glycine 0 C--N 1.334 0.433 0 N-CA-C 107.57 -2.212 . . . . 0.0 107.57 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.2 p -47.08 -27.9 1.53 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 113.306 -1.447 . . . . 0.0 113.428 174.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.479 ' HG2' ' CE1' ' A' ' 81' ' ' TYR . 33.9 mtm-85 -50.27 133.37 23.96 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 123.575 1.655 . . . . 0.0 112.954 170.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.475 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -159.36 133.29 7.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 111.834 -2.439 . . . . 0.0 109.99 -179.585 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.529 HD13 HD21 ' A' ' 19' ' ' LEU . 3.3 mt -104.34 140.18 23.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 113.591 -1.64 . . . . 0.0 109.099 176.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.523 ' O ' ' HD2' ' A' ' 80' ' ' TYR . 21.2 mm -129.22 111.37 22.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 112.362 -2.199 . . . . 0.0 108.88 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.722 HG22 ' HB3' ' A' ' 79' ' ' ASP . 17.2 p -98.68 163.27 12.71 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.443 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -108.03 179.95 21.84 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.083 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -76.52 -12.19 59.99 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.735 0.779 . . . . 0.0 111.888 175.669 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -117.47 129.86 56.08 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 175.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.67 HG22 ' HG2' ' A' ' 77' ' ' GLN . 17.3 m -53.88 151.25 6.73 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.537 174.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.67 ' HG2' HG22 ' A' ' 76' ' ' THR . 0.0 OUTLIER 83.79 32.38 0.06 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 125.936 2.022 . . . . 0.0 110.549 178.212 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.61 ' HA ' HD22 ' A' ' 91' ' ' LEU . 3.6 mt-10 -146.28 52.83 1.13 Allowed 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 123.187 1.47 . . . . 0.0 112.468 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.722 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -107.37 90.97 3.46 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 113.654 -1.612 . . . . 0.0 109.591 -179.517 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.738 ' HE1' HG21 ' A' ' 2' ' ' VAL . 62.8 m-85 -59.63 176.48 0.27 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.268 1.027 . . . . 0.0 109.679 176.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.676 ' HB2' HD11 ' A' ' 92' ' ' ILE . 8.4 t80 -164.76 89.57 0.51 Allowed 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 114.44 -1.254 . . . . 0.0 109.078 -178.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.0 OUTLIER -48.09 -74.26 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.321 -1.309 . . . . 0.0 112.558 172.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 68' ' ' ARG . . . 79.47 -9.44 42.12 Favored Glycine 0 CA--C 1.545 1.953 0 CA-C-N 113.872 -1.513 . . . . 0.0 112.131 -175.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.739 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 11.0 t70 -122.71 16.49 10.27 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.414 0.686 . . . . 0.0 112.555 175.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 66.69 87.37 0.12 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.749 1.619 . . . . 0.0 111.507 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.474 ' H ' HG21 ' A' ' 82' ' ' THR . 5.2 m-85 48.94 28.64 2.05 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 113.279 -1.782 . . . . 0.0 113.471 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.739 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . . . -108.25 -24.29 11.57 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 120.758 -1.214 . . . . 0.0 111.824 -174.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.531 ' O ' ' HB ' ' A' ' 82' ' ' THR . 12.6 p -143.82 172.63 12.58 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -178.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.477 ' O ' HG13 ' A' ' 2' ' ' VAL . 94.9 m-85 -163.23 121.02 1.93 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -175.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.1 m -139.64 107.81 5.77 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.531 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.61 HD22 ' HA ' ' A' ' 78' ' ' GLU . 90.5 mt -44.01 164.18 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.178 0.924 . . . . 0.0 111.701 178.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.676 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.7 mp -110.83 135.56 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 120.424 -1.422 . . . . 0.0 109.517 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.24 100.15 8.84 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.264 -1.334 . . . . 0.0 108.873 176.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -62.39 -38.97 91.67 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 123.573 0.546 . . . . 0.0 111.608 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.3 t -54.98 -45.49 75.0 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.179 1.391 . . . . 0.0 112.814 173.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 35.1 t . . . . . 0 C--O 1.25 1.105 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.653 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.9 p30 . . . . . 0 CA--C 1.541 0.602 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.589 HG12 ' H ' ' A' ' 4' ' ' GLY . 12.8 t -42.28 140.0 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.963 175.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.5 t -79.95 4.8 15.71 Favored 'General case' 0 CA--C 1.55 0.958 0 O-C-N 124.468 1.105 . . . . 0.0 112.405 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.589 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 129.59 176.25 14.36 Favored Glycine 0 N--CA 1.474 1.232 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.401 HG23 ' CB ' ' A' ' 91' ' ' LEU . 4.3 m -92.91 173.04 7.95 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.519 -0.84 . . . . 0.0 109.143 -176.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -137.51 108.37 5.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -175.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.5 m -46.05 126.66 7.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.236 -1.802 . . . . 0.0 109.977 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.98 -34.11 63.08 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.8 177.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -64.59 -29.4 70.42 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 123.774 0.671 . . . . 0.0 112.231 173.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.6 -23.06 56.4 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.938 0.895 . . . . 0.0 111.63 174.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.479 HD13 ' HB1' ' A' ' 15' ' ' ALA . 9.1 mt -83.96 164.69 43.02 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 176.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 15' ' ' ALA . 71.5 Cg_endo -69.26 172.08 12.79 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 122.412 2.074 . . . . 0.0 111.975 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.81 -18.63 36.65 Favored 'Trans proline' 0 N--CA 1.48 0.728 0 C-N-CA 122.99 2.46 . . . . 0.0 112.627 176.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.531 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 28.9 tp10 -85.57 -24.73 27.1 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.791 175.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.863 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -48.04 -39.19 19.15 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 177.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.44 -36.98 79.82 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 113.682 -1.599 . . . . 0.0 113.323 174.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.539 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 10.5 t70 -51.46 -54.69 24.39 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.754 0.822 . . . . 0.0 110.088 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.778 ' HA ' HD12 ' A' ' 21' ' ' LEU . 18.8 m -57.91 -50.61 72.75 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 176.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.905 HD11 HG21 ' A' ' 92' ' ' ILE . 48.6 mt -52.38 -30.4 28.87 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 174.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -75.46 -38.43 59.66 Favored 'General case' 0 C--O 1.209 -1.061 0 CA-C-N 114.221 -1.354 . . . . 0.0 110.134 175.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.778 HD12 ' HA ' ' A' ' 18' ' ' THR . 24.6 mt -71.2 -32.27 68.63 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 118.983 -0.532 . . . . 0.0 110.537 175.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.668 HD12 ' O ' ' A' ' 18' ' ' THR . 1.6 mp -70.64 -39.58 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-N 120.382 1.447 . . . . 0.0 111.657 172.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.22 -42.49 59.67 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.574 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.53 7.98 38.74 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.296 1.039 . . . . 0.0 111.366 177.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.8 t70 41.13 50.46 3.29 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.616 1.166 . . . . 0.0 111.105 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.56 -168.61 48.1 Favored Glycine 0 CA--C 1.538 1.493 0 CA-C-N 114.216 -1.356 . . . . 0.0 115.211 -173.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -75.42 141.2 70.56 Favored 'Cis proline' 0 N--CA 1.49 1.296 0 O-C-N 125.001 2.053 . . . . 0.0 111.33 -0.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.495 ' HA ' HD22 ' A' ' 21' ' ' LEU . 29.2 m-85 -92.93 139.59 23.27 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 113.598 -1.637 . . . . 0.0 111.564 -177.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -75.2 -64.5 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.066 2.51 . . . . 0.0 110.788 -177.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.446 ' HD2' HG22 ' A' ' 56' ' ' THR . 1.6 m-30 -58.98 160.45 5.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.667 175.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.8 m -80.77 9.89 5.68 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 122.304 1.049 . . . . 0.0 112.608 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.431 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 1.0 OUTLIER -105.52 86.88 2.48 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 122.078 0.942 . . . . 0.0 110.837 -178.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 176.96 144.58 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 111.342 -2.663 . . . . 0.0 113.772 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.54 30.76 23.53 Favored Glycine 0 N--CA 1.478 1.487 0 O-C-N 126.199 2.187 . . . . 0.0 110.732 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.46 149.91 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.2 t -88.27 157.05 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 O-C-N 125.164 1.54 . . . . 0.0 110.039 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.532 ' CE1' ' HD3' ' A' ' 40' ' ' ARG . 22.3 t80 -135.39 93.79 3.02 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.314 175.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.42 ' HG3' ' CD1' ' A' ' 49' ' ' TYR . 1.1 tm0? -70.88 53.86 0.16 Allowed 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 118.991 0.814 . . . . 0.0 112.309 178.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 26.96 54.36 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.863 2.465 . . . . 0.0 110.046 -176.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.532 ' HD3' ' CE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -57.54 -24.41 55.94 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 122.364 1.078 . . . . 0.0 111.232 -171.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.56 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.9 mt-10 -76.5 -11.48 59.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 112.66 -2.063 . . . . 0.0 114.168 173.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.1 t 43.81 39.85 2.8 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 124.9 2.286 . . . . 0.0 110.904 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 41' ' ' GLU . 20.0 t -107.69 -14.86 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 113.196 -1.82 . . . . 0.0 109.984 -178.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.77 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -103.48 150.67 38.27 Favored Pre-proline 0 C--O 1.244 0.784 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.225 -172.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.513 ' HD3' HG23 ' A' ' 2' ' ' VAL . 67.3 Cg_endo -75.03 55.46 3.97 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 123.415 2.743 . . . . 0.0 110.919 -178.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.815 HG22 ' H ' ' A' ' 47' ' ' GLN . 4.2 m -74.09 -162.87 0.16 Allowed 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.815 ' H ' HG22 ' A' ' 46' ' ' THR . 7.5 tt0 169.72 -40.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.941 1.697 . . . . 0.0 110.58 -176.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.8 p -113.95 162.96 15.75 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 123.068 1.413 . . . . 0.0 110.618 -177.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.42 ' CD1' ' HG3' ' A' ' 38' ' ' GLN . 8.7 t80 -91.7 138.55 31.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 112.958 -1.928 . . . . 0.0 110.801 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.76 12.0 80.79 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 114.394 -1.275 . . . . 0.0 112.14 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -87.17 15.9 5.72 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.596 0.759 . . . . 0.0 112.346 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.77 ' HE2' HD12 ' A' ' 44' ' ' LEU . 12.6 m-85 -150.64 145.5 25.9 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.057 -175.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -142.84 157.55 44.49 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 126.533 2.395 . . . . 0.0 111.147 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -111.11 147.47 34.79 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.054 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.479 ' HB3' HG23 ' A' ' 18' ' ' THR . 79.1 m-85 -160.99 63.73 0.29 Allowed 'General case' 0 CA--C 1.543 0.677 0 O-C-N 125.823 1.952 . . . . 0.0 110.289 -175.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 0.9 OUTLIER -39.04 127.27 1.65 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 122.088 0.947 . . . . 0.0 112.07 178.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.863 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -83.99 120.62 35.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 111.502 -2.59 . . . . 0.0 108.708 178.107 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.514 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 0.1 OUTLIER -45.76 165.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 124.593 1.183 . . . . 0.0 108.199 173.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.406 HG23 ' HD2' ' A' ' 60' ' ' PRO . 2.5 m -158.97 145.8 12.82 Favored Pre-proline 0 C--O 1.24 0.556 0 CA-C-N 112.86 -1.973 . . . . 0.0 112.841 177.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.406 ' HD2' HG23 ' A' ' 59' ' ' THR . 60.9 Cg_endo -73.01 149.79 47.41 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 121.99 1.793 . . . . 0.0 111.764 175.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.86 21.18 22.28 Favored Glycine 0 N--CA 1.483 1.811 0 O-C-N 125.185 1.553 . . . . 0.0 112.458 -175.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.45 86.25 7.33 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -45.15 -27.76 0.65 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 113.276 -1.784 . . . . 0.0 112.146 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.4 p -128.08 -163.24 1.25 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.639 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.431 ' HD2' ' OE1' ' A' ' 32' ' ' GLN . 2.7 mtm105 -56.62 -18.08 10.85 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 174.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.58 131.43 0.03 OUTLIER Glycine 0 N--CA 1.465 0.59 0 N-CA-C 107.274 -2.33 . . . . 0.0 107.274 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.581 HG22 ' HB2' ' A' ' 85' ' ' HIS . 17.6 p -44.37 -41.54 6.19 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 112.044 -2.078 . . . . 0.0 113.031 176.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.6 mtp85 -40.1 102.39 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 122.968 1.366 . . . . 0.0 113.172 173.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -128.05 136.43 51.22 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 112.207 -2.27 . . . . 0.0 109.002 -177.271 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.645 HG23 ' OD1' ' A' ' 79' ' ' ASP . 7.0 mt -105.67 140.99 22.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 112.413 -2.176 . . . . 0.0 108.818 176.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.454 ' HB ' ' HB2' ' A' ' 80' ' ' TYR . 23.3 mm -130.16 105.42 11.73 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 CA-C-N 113.268 -1.787 . . . . 0.0 108.384 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.419 HG22 ' HB2' ' A' ' 79' ' ' ASP . 10.7 p -92.46 163.8 13.7 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.211 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -110.9 -172.59 19.75 Favored Glycine 0 N--CA 1.471 1.024 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.681 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.1 -15.77 60.03 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.41 -0.895 . . . . 0.0 112.303 174.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.72 132.14 54.24 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.338 1.066 . . . . 0.0 108.514 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.417 HG22 ' CG ' ' A' ' 77' ' ' GLN . 23.5 m -59.3 152.3 21.33 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.086 -1.415 . . . . 0.0 108.618 176.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.417 ' CG ' HG22 ' A' ' 76' ' ' THR . 10.3 mt-30 71.46 32.16 2.14 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 123.523 1.63 . . . . 0.0 109.889 178.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.521 ' HA ' HD22 ' A' ' 91' ' ' LEU . 3.6 mt-10 -136.8 68.42 1.43 Allowed 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.847 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.7 ' OD2' HD21 ' A' ' 19' ' ' LEU . 3.6 t0 -111.31 129.8 55.87 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-N 113.192 -1.822 . . . . 0.0 107.718 176.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.454 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 14.4 m-85 -100.36 133.92 44.07 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 125.102 1.361 . . . . 0.0 109.919 175.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.589 ' HB2' HD11 ' A' ' 92' ' ' ILE . 9.2 t80 -111.75 127.41 55.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.458 -1.246 . . . . 0.0 108.961 -177.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.5 OUTLIER -91.03 -68.74 0.77 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 112.839 -1.982 . . . . 0.0 111.959 178.039 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.08 -11.15 50.29 Favored Glycine 0 CA--C 1.542 1.741 0 CA-C-N 113.346 -1.752 . . . . 0.0 112.675 -175.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.477 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 13.5 m-20 -111.37 6.39 20.36 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 175.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.581 ' HB2' HG22 ' A' ' 67' ' ' THR . 21.3 t-80 86.76 -16.98 0.38 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 116.051 -1.928 . . . . 0.0 113.177 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.1 m-30 160.6 51.25 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 128.455 3.597 . . . . 0.0 114.804 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.477 ' HB3' ' HB2' ' A' ' 84' ' ' ASP . . . -120.1 -44.86 2.48 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 119.406 -0.918 . . . . 0.0 112.913 177.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.478 ' O ' ' HB ' ' A' ' 82' ' ' THR . 22.4 p -127.43 168.29 15.07 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.67 -177.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.689 ' CG ' HD21 ' A' ' 44' ' ' LEU . 97.7 m-85 -159.29 115.73 2.61 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -173.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.1 m -135.34 113.81 11.6 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.423 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.521 HD22 ' HA ' ' A' ' 78' ' ' GLU . 29.7 mt -40.81 161.83 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.123 0 O-C-N 124.693 1.246 . . . . 0.0 111.452 177.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.905 HG21 HD11 ' A' ' 19' ' ' LEU . 1.3 mp -106.05 129.59 58.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 O-C-N 120.902 -1.123 . . . . 0.0 108.246 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.419 ' HB3' ' HB3' ' A' ' 96' ' ' CYS . 0.3 OUTLIER -102.68 92.25 4.54 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.65 -1.614 . . . . 0.0 108.021 177.082 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -55.93 -37.75 69.36 Favored 'General case' 0 N--CA 1.484 1.225 0 O-C-N 123.981 0.8 . . . . 0.0 112.253 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.9 t -57.96 -49.67 75.99 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.783 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 93' ' ' ASP . 21.0 t . . . . . 0 N--CA 1.476 0.874 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.873 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.4 p30 . . . . . 0 N--CA 1.476 0.864 0 CA-C-O 121.045 0.45 . . . . 0.0 111.494 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.623 HG23 ' HD3' ' A' ' 45' ' ' PRO . 12.1 t -48.88 141.16 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 m -81.52 22.81 0.68 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.499 1.12 . . . . 0.0 112.379 176.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.16 -154.06 20.11 Favored Glycine 0 N--CA 1.479 1.557 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.452 HG23 ' CB ' ' A' ' 91' ' ' LEU . 2.4 m -107.56 170.07 8.2 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.956 -1.122 . . . . 0.0 110.407 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -142.41 108.77 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -174.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 94.9 m -46.2 133.66 9.13 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 113.581 -1.645 . . . . 0.0 111.038 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -59.06 -32.44 69.77 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.638 -177.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.2 t -67.39 -27.79 67.39 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.612 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.28 -29.64 62.87 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.642 0.777 . . . . 0.0 111.61 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 11' ' ' LEU . 12.3 mt -81.37 161.72 61.19 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 176.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.35 168.25 18.36 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.999 2.466 . . . . 0.0 112.545 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.15 -23.11 39.88 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.236 1.957 . . . . 0.0 113.544 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -83.76 -4.39 58.6 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.884 0.874 . . . . 0.0 111.827 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.746 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -71.72 -49.32 40.39 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.793 0.837 . . . . 0.0 112.278 175.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.3 -25.88 37.05 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.579 174.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.516 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 45.6 t0 -53.46 -57.77 9.47 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 124.32 1.013 . . . . 0.0 110.408 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.743 ' HA ' HD12 ' A' ' 21' ' ' LEU . 8.4 m -56.28 -50.59 70.93 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 175.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.583 HD11 HG21 ' A' ' 92' ' ' ILE . 7.9 mt -55.1 -35.14 64.29 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.279 0.987 . . . . 0.0 111.734 178.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -67.65 -39.75 84.55 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 124.163 0.985 . . . . 0.0 110.769 173.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.743 HD12 ' HA ' ' A' ' 18' ' ' THR . 25.8 mt -68.7 -31.95 71.4 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 122.779 0.431 . . . . 0.0 111.088 175.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.465 HD12 ' O ' ' A' ' 18' ' ' THR . 3.7 mt -71.31 -42.86 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 120.103 1.32 . . . . 0.0 111.534 172.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.7 -41.43 75.41 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 124.39 1.056 . . . . 0.0 112.4 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.38 5.92 48.86 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.272 1.029 . . . . 0.0 111.419 177.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 t0 42.4 44.77 3.56 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.524 1.53 . . . . 0.0 111.685 -178.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.29 -166.78 29.74 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 112.834 -1.985 . . . . 0.0 115.265 -174.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -74.87 139.74 63.4 Favored 'Cis proline' 0 N--CA 1.481 0.758 0 O-C-N 124.275 1.671 . . . . 0.0 111.342 -2.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.439 ' CD2' ' HB3' ' A' ' 21' ' ' LEU . 61.3 m-85 -90.94 139.06 25.86 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 113.244 -1.798 . . . . 0.0 111.534 -176.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.456 ' HG2' ' CD1' ' A' ' 58' ' ' ILE . 37.3 Cg_endo -75.73 -63.13 0.03 OUTLIER 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.975 2.45 . . . . 0.0 111.474 -177.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -61.85 157.79 17.45 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.141 -0.482 . . . . 0.0 112.087 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.6 t -81.17 4.83 18.79 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 122.941 1.353 . . . . 0.0 112.101 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -104.86 86.56 2.48 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.232 1.015 . . . . 0.0 111.484 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 4.5 p-10 177.96 140.31 0.09 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 110.712 -2.949 . . . . 0.0 113.715 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.71 3.22 66.51 Favored Glycine 0 N--CA 1.484 1.883 0 CA-C-N 113.017 -1.902 . . . . 0.0 112.263 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.624 HG23 ' HB2' ' A' ' 54' ' ' GLU . 7.8 m -96.91 144.78 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.342 1.057 . . . . 0.0 110.257 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.2 t -79.63 155.69 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 O-C-N 126.089 2.118 . . . . 0.0 108.865 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.659 ' HE2' HD13 ' A' ' 44' ' ' LEU . 37.0 t80 -137.71 86.32 2.17 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.645 -1.616 . . . . 0.0 108.618 174.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -72.03 51.76 0.23 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.203 -1.56 . . . . 0.0 112.414 178.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.477 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 26.6 t30 28.83 53.61 0.08 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.682 1.193 . . . . 0.0 111.778 -172.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.497 ' HD3' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -56.14 -20.69 18.7 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 113.243 -1.799 . . . . 0.0 112.285 -177.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.585 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -83.87 -4.75 58.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 113.443 -1.708 . . . . 0.0 114.832 174.465 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.2 t 44.05 47.11 7.29 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 123.7 1.715 . . . . 0.0 112.688 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 41' ' ' GLU . 87.0 t -124.11 -6.96 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 113.4 -1.727 . . . . 0.0 111.199 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.659 HD13 ' HE2' ' A' ' 37' ' ' PHE . 1.9 mp -110.23 155.85 41.17 Favored Pre-proline 0 N--CA 1.475 0.789 0 O-C-N 121.41 -0.806 . . . . 0.0 112.994 176.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.623 ' HD3' HG23 ' A' ' 2' ' ' VAL . 96.8 Cg_endo -78.38 68.62 7.93 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.021 1.814 . . . . 0.0 109.749 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.796 HG22 ' H ' ' A' ' 47' ' ' GLN . 6.8 m -88.97 -163.43 0.99 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 112.947 -1.933 . . . . 0.0 107.131 178.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.796 ' H ' HG22 ' A' ' 46' ' ' THR . 2.0 tt0 173.53 -48.48 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.977 1.711 . . . . 0.0 109.896 -176.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.5 p -109.72 162.82 14.08 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.293 -175.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -93.85 127.18 39.46 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 112.956 -1.929 . . . . 0.0 110.976 -177.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.99 8.23 82.62 Favored Glycine 0 N--CA 1.479 1.532 0 CA-C-N 113.327 -1.76 . . . . 0.0 112.807 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.61 -1.64 22.51 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.794 0.838 . . . . 0.0 112.509 175.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.586 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 5.5 m-85 -136.63 171.23 14.81 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.029 1.332 . . . . 0.0 110.094 -177.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -161.01 163.71 31.48 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 113.257 -1.792 . . . . 0.0 110.382 -177.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.624 ' HB2' HG23 ' A' ' 35' ' ' VAL . 1.8 mt-10 -120.03 139.43 52.54 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.096 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.551 ' HB3' HG23 ' A' ' 18' ' ' THR . 58.4 m-85 -153.01 59.33 0.79 Allowed 'General case' 0 N--CA 1.471 0.603 0 O-C-N 126.187 2.179 . . . . 0.0 110.741 -174.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 58.5 m -36.69 116.14 0.41 Allowed 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 122.957 1.36 . . . . 0.0 112.519 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.746 HG21 ' HA ' ' A' ' 15' ' ' ALA . 1.9 p -81.65 110.82 17.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 111.021 -2.809 . . . . 0.0 109.443 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.456 ' CD1' ' HG2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -38.64 147.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 113.722 -1.581 . . . . 0.0 111.296 171.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.45 HG23 ' HD2' ' A' ' 60' ' ' PRO . 6.1 m -136.5 141.62 36.3 Favored Pre-proline 0 N--CA 1.468 0.453 0 O-C-N 125.772 1.92 . . . . 0.0 112.901 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.45 ' HD2' HG23 ' A' ' 59' ' ' THR . 72.0 Cg_endo -75.53 143.71 27.74 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 121.619 1.546 . . . . 0.0 109.963 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.82 29.32 54.59 Favored Glycine 0 CA--C 1.544 1.882 0 CA-C-N 113.867 -1.515 . . . . 0.0 112.033 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.87 89.89 4.75 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -43.33 -30.61 0.54 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 113.324 -1.762 . . . . 0.0 113.152 177.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.0 p -128.88 -170.78 2.33 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.889 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 -47.45 -27.32 1.66 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 174.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.11 144.96 0.12 Allowed Glycine 0 N--CA 1.464 0.522 0 N-CA-C 106.676 -2.57 . . . . 0.0 106.676 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.592 HG22 ' HB2' ' A' ' 85' ' ' HIS . 20.3 p -42.72 -29.05 0.28 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.247 -1.477 . . . . 0.0 114.673 173.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.427 ' HA ' ' HA2' ' A' ' 83' ' ' GLY . 1.0 OUTLIER -45.17 130.0 7.84 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.763 1.625 . . . . 0.0 111.574 170.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.439 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -164.81 136.49 4.32 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 111.864 -2.426 . . . . 0.0 109.339 -176.689 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.4 mt -111.99 142.7 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 125.933 2.021 . . . . 0.0 108.063 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.528 ' HB ' ' HB2' ' A' ' 80' ' ' TYR . 25.5 mm -131.1 128.78 62.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 111.703 -2.499 . . . . 0.0 108.019 178.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.5 p -104.86 163.87 12.2 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 122.238 -0.289 . . . . 0.0 111.33 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -110.5 -178.54 20.7 Favored Glycine 0 CA--C 1.537 1.41 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.58 -15.22 58.8 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 121.646 0.736 . . . . 0.0 111.937 176.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.23 129.78 55.66 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.66 HG22 ' HG2' ' A' ' 77' ' ' GLN . 16.0 m -54.54 145.88 17.67 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 114.122 -1.399 . . . . 0.0 107.611 175.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.66 ' HG2' HG22 ' A' ' 76' ' ' THR . 0.0 OUTLIER 81.8 33.34 0.1 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 126.705 2.002 . . . . 0.0 110.577 179.445 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.583 ' HA ' HD22 ' A' ' 91' ' ' LEU . 6.2 mt-10 -135.28 54.55 1.92 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 123.498 1.618 . . . . 0.0 112.407 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.704 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -101.24 80.96 2.16 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 113.479 -1.692 . . . . 0.0 108.837 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.528 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 12.2 m-85 -51.18 178.99 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 125.455 1.502 . . . . 0.0 110.401 173.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.549 ' HB2' HD11 ' A' ' 92' ' ' ILE . 1.7 t80 -167.03 128.03 1.58 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.595 -1.639 . . . . 0.0 110.441 -175.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.557 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -90.64 -70.07 0.7 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 112.588 -2.096 . . . . 0.0 112.0 175.138 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 68' ' ' ARG . . . 74.22 -5.69 25.81 Favored Glycine 0 CA--C 1.542 1.769 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.692 -175.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.521 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 30.6 m-20 -125.49 17.05 8.23 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.264 1.425 . . . . 0.0 113.7 176.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.592 ' HB2' HG22 ' A' ' 67' ' ' THR . 42.2 t-80 63.25 88.07 0.1 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.393 2.277 . . . . 0.0 111.496 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.418 ' H ' HG21 ' A' ' 82' ' ' THR . 4.1 m-85 49.57 26.36 1.72 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.053 -1.43 . . . . 0.0 113.997 -176.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.521 ' HB3' ' HB2' ' A' ' 84' ' ' ASP . . . -95.77 -22.08 17.74 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 120.76 -1.213 . . . . 0.0 111.731 -175.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.557 ' O ' ' HB ' ' A' ' 82' ' ' THR . 26.5 p -157.17 173.71 16.58 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.178 1.391 . . . . 0.0 108.494 -177.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.518 ' CD1' HD11 ' A' ' 44' ' ' LEU . 98.7 m-85 -155.52 118.63 4.34 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 -176.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 m -135.06 116.5 14.67 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.583 HD22 ' HA ' ' A' ' 78' ' ' GLU . 66.1 mt -47.81 164.93 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.775 0.83 . . . . 0.0 111.424 177.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.718 HG22 ' HG3' ' A' ' 94' ' ' GLN . 1.7 mp -112.62 107.41 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 121.207 -0.933 . . . . 0.0 109.304 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.446 ' HB3' ' HB2' ' A' ' 96' ' ' CYS . 0.1 OUTLIER -77.16 89.04 3.63 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.035 -1.439 . . . . 0.0 109.088 175.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.718 ' HG3' HG22 ' A' ' 92' ' ' ILE . 2.6 mt-30 -79.22 5.71 11.55 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 113.602 -1.635 . . . . 0.0 111.868 177.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.0 t -121.75 -0.98 9.53 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 126.036 1.734 . . . . 0.0 112.581 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 93' ' ' ASP . 42.7 t . . . . . 0 C--O 1.256 1.424 0 CA-C-O 116.268 -1.825 . . . . 0.0 112.888 178.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 p30 . . . . . 0 N--CA 1.473 0.701 0 CA-C-O 121.88 0.847 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.634 HG23 ' HD3' ' A' ' 45' ' ' PRO . 6.9 t -51.45 128.9 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.358 175.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 m -75.25 5.21 5.8 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 177.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.475 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 130.37 170.56 12.73 Favored Glycine 0 CA--C 1.536 1.365 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.436 HG22 ' H ' ' A' ' 6' ' ' VAL . 2.5 m -86.99 172.76 9.76 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.069 -1.065 . . . . 0.0 109.103 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.436 ' H ' HG22 ' A' ' 5' ' ' THR . 1.1 t -138.82 106.71 3.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 122.978 1.37 . . . . 0.0 107.869 -175.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.3 m -49.35 126.06 12.31 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 112.62 -2.082 . . . . 0.0 109.902 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 8' ' ' LEU . 14.4 tp -57.06 -34.18 67.99 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 118.938 -0.553 . . . . 0.0 111.353 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.7 t -62.21 -30.23 70.94 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.624 171.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.17 -27.81 53.86 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.64 0.776 . . . . 0.0 112.349 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.44 HD13 ' HB1' ' A' ' 15' ' ' ALA . 14.3 mt -75.4 160.8 78.92 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 174.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.437 ' HD2' HD22 ' A' ' 11' ' ' LEU . 72.2 Cg_endo -68.65 168.32 20.32 Favored 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 122.715 2.276 . . . . 0.0 112.201 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.09 -15.27 39.44 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.416 2.077 . . . . 0.0 113.087 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.43 ' O ' HG22 ' A' ' 57' ' ' VAL . 1.7 mt-10 -92.89 2.11 56.95 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.273 1.029 . . . . 0.0 111.843 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.759 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -77.95 -50.0 13.04 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.214 1.006 . . . . 0.0 112.169 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 0.4 OUTLIER -58.49 -22.2 54.25 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.217 174.121 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -51.26 -59.73 3.89 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.128 0.971 . . . . 0.0 110.306 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.68 HG21 ' O ' ' A' ' 55' ' ' TYR . 39.9 m -64.14 -44.66 91.49 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.523 178.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.541 ' CD2' HD13 ' A' ' 70' ' ' ILE . 0.5 OUTLIER -54.97 -33.48 62.43 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 175.314 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 16' ' ' THR . 4.0 t-20 -73.9 -38.63 64.3 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.995 174.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.54 HD12 ' HA ' ' A' ' 18' ' ' THR . 51.1 mt -69.12 -33.78 74.0 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 175.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.471 ' CD1' HG22 ' A' ' 18' ' ' THR . 3.9 mt -68.75 -41.91 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 123.365 0.666 . . . . 0.0 111.268 172.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.89 -43.76 64.87 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.468 1.105 . . . . 0.0 112.436 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.72 -10.1 59.65 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.058 1.343 . . . . 0.0 111.793 177.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.74 43.26 25.53 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 122.714 1.245 . . . . 0.0 110.718 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.67 -166.92 43.83 Favored Glycine 0 CA--C 1.541 1.676 0 CA-C-N 113.247 -1.797 . . . . 0.0 115.044 -175.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.51 140.5 67.63 Favored 'Cis proline' 0 CA--C 1.537 0.629 0 O-C-N 124.558 1.82 . . . . 0.0 111.058 -1.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.433 ' CD2' ' HB3' ' A' ' 21' ' ' LEU . 46.0 m-85 -90.95 136.55 27.43 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 112.996 -1.911 . . . . 0.0 111.185 -176.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.07 -62.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.188 2.592 . . . . 0.0 111.701 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -59.84 155.07 17.0 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.82 176.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.76 2.29 20.25 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 122.812 1.291 . . . . 0.0 112.313 175.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.4 78.53 2.7 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.622 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -178.48 142.37 0.24 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 112.069 -2.332 . . . . 0.0 113.871 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.14 30.94 12.7 Favored Glycine 0 CA--C 1.537 1.467 0 O-C-N 125.212 1.57 . . . . 0.0 111.645 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.522 HG23 ' HB2' ' A' ' 54' ' ' GLU . 22.2 m -124.26 146.03 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 113.982 -1.109 . . . . 0.0 109.591 178.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.7 t -84.06 156.32 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 125.743 1.902 . . . . 0.0 109.768 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.526 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 81.2 t80 -137.66 87.89 2.29 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 113.968 -1.469 . . . . 0.0 108.791 174.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.403 ' HG3' ' HA ' ' A' ' 49' ' ' TYR . 1.7 tt0 -69.91 53.45 0.12 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.808 -1.183 . . . . 0.0 112.648 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.4 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 50.7 t30 29.21 51.19 0.06 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.418 1.487 . . . . 0.0 111.081 -173.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.46 ' HD3' ' CD1' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -58.15 -20.75 43.09 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.522 -175.519 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.7 mt-10 -84.31 -8.06 59.13 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 113.087 -1.869 . . . . 0.0 114.668 172.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.9 t 43.45 42.58 3.94 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 123.917 1.818 . . . . 0.0 112.135 -177.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 41' ' ' GLU . 86.3 t -112.39 -12.52 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 113.322 -1.763 . . . . 0.0 109.728 -178.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.511 HD21 ' CD1' ' A' ' 89' ' ' PHE . 0.4 OUTLIER -94.72 151.46 39.12 Favored Pre-proline 0 C--N 1.317 -0.814 0 O-C-N 120.979 -1.075 . . . . 0.0 108.436 -175.821 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.634 ' HD3' HG23 ' A' ' 2' ' ' VAL . 84.7 Cg_endo -75.82 51.25 3.0 Favored 'Trans proline' 0 N--CA 1.482 0.811 0 C-N-CA 122.948 2.432 . . . . 0.0 112.567 -177.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.48 HG22 ' H ' ' A' ' 47' ' ' GLN . 3.4 m -156.23 -142.86 0.11 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.48 ' H ' HG22 ' A' ' 46' ' ' THR . 25.8 tt0 164.94 -35.96 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 126.732 2.013 . . . . 0.0 110.959 -173.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.3 p -42.03 154.74 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 123.026 1.393 . . . . 0.0 113.077 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.403 ' HA ' ' HG3' ' A' ' 38' ' ' GLN . 10.9 t80 -99.76 132.04 45.36 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 113.471 -1.695 . . . . 0.0 109.847 -175.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.14 -8.63 44.36 Favored Glycine 0 N--CA 1.482 1.758 0 O-C-N 125.098 1.499 . . . . 0.0 113.301 177.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -75.77 0.45 17.9 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.267 1.027 . . . . 0.0 112.508 177.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.526 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 16.6 m-85 -136.95 165.38 26.13 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.47 1.108 . . . . 0.0 109.103 -177.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -159.66 158.86 32.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 112.647 -2.069 . . . . 0.0 111.463 -178.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.522 ' HB2' HG23 ' A' ' 35' ' ' VAL . 12.0 mt-10 -113.95 143.01 45.42 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.592 -178.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.68 ' O ' HG21 ' A' ' 18' ' ' THR . 76.8 m-85 -159.97 68.52 0.39 Allowed 'General case' 0 N--CA 1.475 0.796 0 O-C-N 126.244 2.215 . . . . 0.0 109.466 -174.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -36.86 141.51 0.12 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 176.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.759 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -97.77 115.45 37.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 112.9 -1.955 . . . . 0.0 109.385 175.609 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -43.17 151.31 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.662 170.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.458 HG23 ' HD2' ' A' ' 60' ' ' PRO . 2.4 m -150.23 140.84 14.32 Favored Pre-proline 0 N--CA 1.476 0.849 0 O-C-N 125.459 1.725 . . . . 0.0 111.733 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.458 ' HD2' HG23 ' A' ' 59' ' ' THR . 76.6 Cg_endo -73.72 147.14 39.47 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 121.622 1.548 . . . . 0.0 109.735 178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 52.48 34.96 43.32 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.023 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.65 92.67 6.33 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -42.0 -31.39 0.34 Allowed 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 113.641 -1.618 . . . . 0.0 113.323 176.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.5 p -123.36 -164.05 1.18 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.968 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -59.88 -14.0 13.39 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 173.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.62 146.01 3.72 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.214 -1.955 . . . . 0.0 108.214 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.547 HG22 ' HB2' ' A' ' 85' ' ' HIS . 41.0 p -69.93 -5.51 26.62 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 111.772 -2.214 . . . . 0.0 113.105 176.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.567 ' HD2' ' HA2' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -80.02 85.27 5.63 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 123.939 1.828 . . . . 0.0 110.384 178.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.84 142.58 34.14 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 112.581 -2.1 . . . . 0.0 109.342 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.592 HG23 ' OD1' ' A' ' 79' ' ' ASP . 9.6 mt -117.76 132.62 67.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 125.601 1.813 . . . . 0.0 109.404 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.477 ' O ' ' HD2' ' A' ' 80' ' ' TYR . 17.5 mm -125.82 106.67 16.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 O-C-N 125.27 1.606 . . . . 0.0 109.048 -176.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.437 HG21 HG21 ' A' ' 22' ' ' ILE . 0.9 OUTLIER -82.39 165.99 19.81 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.301 -0.874 . . . . 0.0 111.194 179.368 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -120.73 171.44 14.74 Favored Glycine 0 N--CA 1.469 0.881 0 CA-C-N 113.424 -1.717 . . . . 0.0 109.799 177.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.45 -14.54 61.17 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.756 0.789 . . . . 0.0 112.251 174.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.18 129.76 53.5 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 122.361 1.077 . . . . 0.0 108.233 174.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.568 HG22 ' HG2' ' A' ' 77' ' ' GLN . 3.1 m -61.87 142.55 57.3 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 113.833 -1.531 . . . . 0.0 107.575 175.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.568 ' HG2' HG22 ' A' ' 76' ' ' THR . 0.5 OUTLIER 77.78 29.36 0.51 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 126.618 1.967 . . . . 0.0 111.279 179.519 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -126.98 56.04 1.53 Allowed 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 123.083 1.421 . . . . 0.0 111.92 177.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.592 ' OD1' HG23 ' A' ' 70' ' ' ILE . 0.5 OUTLIER -99.63 119.59 38.33 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 113.267 -1.788 . . . . 0.0 109.287 178.346 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.477 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 36.5 m-85 -92.71 139.41 30.58 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.14 1.376 . . . . 0.0 108.943 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.643 ' HB2' HD11 ' A' ' 92' ' ' ILE . 27.8 t80 -118.43 121.48 40.41 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.665 -175.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.0 OUTLIER -80.88 -64.53 1.17 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 113.317 -1.765 . . . . 0.0 110.761 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.567 ' HA2' ' HD2' ' A' ' 68' ' ' ARG . . . 70.37 -6.04 6.28 Favored Glycine 0 CA--C 1.545 1.943 0 CA-C-N 114.886 -1.052 . . . . 0.0 113.104 -173.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.578 ' CB ' ' HB3' ' A' ' 87' ' ' ALA . 80.1 m-20 -126.58 6.19 6.85 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.547 ' HB2' HG22 ' A' ' 67' ' ' THR . 48.4 t-80 66.59 82.57 0.18 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 128.256 2.622 . . . . 0.0 110.374 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 57.28 17.69 3.82 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 113.428 -1.715 . . . . 0.0 114.247 -174.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.578 ' HB3' ' CB ' ' A' ' 84' ' ' ASP . . . -99.84 -3.54 32.37 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.177 -0.952 . . . . 0.0 112.595 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.411 ' O ' ' HB ' ' A' ' 82' ' ' THR . 2.2 p -167.75 168.85 12.15 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.016 1.727 . . . . 0.0 109.161 -176.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.511 ' CD1' HD21 ' A' ' 44' ' ' LEU . 80.2 m-85 -160.41 109.83 1.73 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.068 0.947 . . . . 0.0 108.972 -173.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.8 m -128.23 108.4 10.58 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.991 -176.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.424 ' CB ' HG23 ' A' ' 5' ' ' THR . 21.7 mt -42.73 161.14 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.643 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.4 mp -107.3 129.45 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 O-C-N 120.671 -1.268 . . . . 0.0 108.792 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 96' ' ' CYS . 0.3 OUTLIER -103.47 94.18 5.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.376 178.655 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.44 HE22 ' HB3' ' A' ' 77' ' ' GLN . 0.9 OUTLIER -68.92 -8.46 44.56 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 124.94 1.4 . . . . 0.0 112.524 178.614 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 t -93.18 -41.9 9.66 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 127.141 2.176 . . . . 0.0 113.1 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 93' ' ' ASP . 45.2 t . . . . . 0 C--O 1.25 1.105 0 CA-C-O 117.695 -1.145 . . . . 0.0 110.931 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.3 p30 . . . . . 0 N--CA 1.476 0.847 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.67 HG23 ' HD3' ' A' ' 45' ' ' PRO . 11.1 t -64.22 135.9 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.5 m -77.34 7.97 4.68 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 177.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.407 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 119.42 -172.49 14.71 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.27 1.414 . . . . 0.0 109.735 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -90.22 169.51 11.07 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 122.452 1.12 . . . . 0.0 109.735 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.635 HG13 HD11 ' A' ' 11' ' ' LEU . 4.9 p -143.12 112.0 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 114.222 -1.354 . . . . 0.0 108.285 -176.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 73.7 m -50.22 133.42 23.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 112.427 -2.169 . . . . 0.0 109.592 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.708 ' HA ' HD12 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -55.51 -35.92 66.13 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 119.156 -0.449 . . . . 0.0 111.933 179.688 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.1 t -69.0 -15.48 63.49 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.246 174.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.65 -33.27 35.76 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.396 0.678 . . . . 0.0 112.182 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.708 HD12 ' HA ' ' A' ' 8' ' ' LEU . 6.2 mt -83.64 176.41 3.81 Favored Pre-proline 0 CA--C 1.558 1.272 0 C-N-CA 125.72 1.608 . . . . 0.0 111.095 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 57.8 Cg_endo -65.51 167.12 17.66 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.285 1.99 . . . . 0.0 113.417 174.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -64.77 -21.4 64.76 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 C-N-CA 122.515 2.143 . . . . 0.0 113.064 174.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 5.0 tp10 -82.23 -19.25 40.07 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 175.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.832 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -52.11 -25.5 8.97 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 173.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.643 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -79.48 -33.98 41.79 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 172.547 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.633 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 11.4 t70 -49.83 -53.78 23.37 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.222 1.009 . . . . 0.0 110.059 -177.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.834 ' HA ' HD12 ' A' ' 21' ' ' LEU . 10.5 m -53.99 -52.46 60.69 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 174.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.646 HD11 HG21 ' A' ' 92' ' ' ILE . 9.6 mt -54.67 -37.61 65.97 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 124.624 1.202 . . . . 0.0 111.746 178.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -64.69 -38.01 89.53 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.629 0.772 . . . . 0.0 111.724 173.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.834 HD12 ' HA ' ' A' ' 18' ' ' THR . 12.8 mt -73.16 -32.87 65.14 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 118.518 -0.754 . . . . 0.0 111.312 176.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.61 HD12 ' O ' ' A' ' 18' ' ' THR . 2.1 mp -66.39 -39.35 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-N 120.37 1.441 . . . . 0.0 111.61 169.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.78 -48.42 46.69 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.198 0.999 . . . . 0.0 112.316 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 m -86.11 6.39 29.35 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.916 1.286 . . . . 0.0 113.547 175.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 43.74 36.0 1.18 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.333 1.453 . . . . 0.0 112.532 -174.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.96 -168.48 18.12 Favored Glycine 0 CA--C 1.542 1.773 0 CA-C-N 113.296 -1.774 . . . . 0.0 115.504 -175.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -75.0 138.29 55.21 Favored 'Cis proline' 0 N--CA 1.488 1.203 0 O-C-N 123.868 1.457 . . . . 0.0 111.412 -3.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.499 ' HA ' HD22 ' A' ' 21' ' ' LEU . 63.7 m-85 -85.83 149.79 51.67 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-N 113.02 -1.9 . . . . 0.0 112.461 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.97 -69.77 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 123.127 2.551 . . . . 0.0 111.717 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.576 ' CZ ' HG12 ' A' ' 58' ' ' ILE . 18.9 m-30 -74.45 168.84 18.92 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.56 0.744 . . . . 0.0 110.355 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.3 m -72.6 -3.87 27.41 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 122.138 0.971 . . . . 0.0 113.603 174.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -83.28 82.48 8.25 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.751 -1.113 . . . . 0.0 112.083 -178.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 179.0 145.64 0.15 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 110.393 -3.094 . . . . 0.0 116.117 -176.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.18 33.64 39.64 Favored Glycine 0 N--CA 1.473 1.135 0 CA-C-N 112.191 -2.277 . . . . 0.0 110.951 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.1 m -129.88 144.52 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 113.574 -1.313 . . . . 0.0 109.917 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.1 t -83.87 151.18 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 O-C-N 126.66 2.475 . . . . 0.0 109.76 176.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.402 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 41.0 t80 -128.92 95.7 4.16 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.004 173.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -74.13 52.03 0.44 Allowed 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.158 -0.964 . . . . 0.0 111.622 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 26.78 55.56 0.06 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.73 2.412 . . . . 0.0 111.684 -174.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.17 -22.59 41.51 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.26 -173.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.61 ' O ' HG23 ' A' ' 43' ' ' VAL . 13.5 mt-10 -75.84 -15.01 60.29 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 172.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.2 t 48.16 35.61 5.58 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 123.989 1.852 . . . . 0.0 112.336 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 41' ' ' GLU . 95.3 t -110.84 -14.47 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-O 123.368 1.556 . . . . 0.0 110.555 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.592 ' HB3' ' OH ' ' A' ' 52' ' ' TYR . 2.6 mm? -100.44 146.1 31.43 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-O 117.098 -1.43 . . . . 0.0 108.274 -174.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.67 ' HD3' HG23 ' A' ' 2' ' ' VAL . 92.4 Cg_endo -74.48 60.09 4.92 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.588 3.525 . . . . 0.0 112.121 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.723 HG22 ' H ' ' A' ' 47' ' ' GLN . 2.2 m -83.56 -171.5 3.62 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 112.244 -2.253 . . . . 0.0 107.626 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.723 ' H ' HG22 ' A' ' 46' ' ' THR . 36.1 tt0 176.99 -40.23 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 113.886 -1.506 . . . . 0.0 110.63 -173.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.9 p -118.94 161.95 19.33 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 122.849 1.309 . . . . 0.0 111.715 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -85.02 144.01 28.55 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 112.525 -2.125 . . . . 0.0 110.056 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.04 11.88 52.96 Favored Glycine 0 N--CA 1.483 1.773 0 CA-C-N 114.937 -1.028 . . . . 0.0 112.95 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.414 ' HA ' ' HB2' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -85.98 13.11 8.04 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.448 1.099 . . . . 0.0 112.54 -178.773 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.592 ' OH ' ' HB3' ' A' ' 44' ' ' LEU . 10.6 m-85 -151.39 148.48 28.17 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 125.33 1.452 . . . . 0.0 109.732 -173.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -145.11 159.91 42.24 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 125.417 1.698 . . . . 0.0 111.31 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.402 ' HG3' ' HB2' ' A' ' 37' ' ' PHE . 1.4 mt-10 -117.24 140.88 48.99 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.391 -177.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.423 ' HE2' ' HG1' ' A' ' 72' ' ' THR . 65.6 m-85 -157.96 67.96 0.49 Allowed 'General case' 0 C--O 1.239 0.517 0 O-C-N 125.696 1.872 . . . . 0.0 110.982 -173.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 52.8 m -41.95 119.16 1.26 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 123.563 1.649 . . . . 0.0 112.884 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.832 HG21 ' HA ' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -78.83 116.28 22.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 110.192 -3.185 . . . . 0.0 108.673 178.757 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.576 HG12 ' CZ ' ' A' ' 30' ' ' TYR . 4.4 mt -40.49 148.26 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-O 122.655 1.216 . . . . 0.0 108.642 174.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.9 m -133.1 138.93 32.82 Favored Pre-proline 0 C--O 1.24 0.558 0 CA-C-N 112.16 -2.291 . . . . 0.0 112.45 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.83 143.06 49.3 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.033 1.822 . . . . 0.0 109.943 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.47 30.19 40.94 Favored Glycine 0 CA--C 1.54 1.645 0 CA-C-N 114.313 -1.312 . . . . 0.0 113.113 -176.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.77 94.5 6.37 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -40.63 -35.16 0.44 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.336 176.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.8 p -127.17 -155.59 0.7 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.075 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.3 mtm180 -53.11 -23.87 9.03 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 170.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.76 156.5 0.33 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 -176.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 81.4 p -47.9 -29.35 3.25 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 112.901 -1.65 . . . . 0.0 112.518 173.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.533 ' HA ' ' HA2' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -47.15 139.28 6.13 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 122.199 0.999 . . . . 0.0 112.724 173.629 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -168.0 139.41 2.88 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 112.1 -2.318 . . . . 0.0 109.76 -176.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.8 mt -115.99 144.99 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 112.596 -2.093 . . . . 0.0 108.66 175.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' A' ' 80' ' ' TYR . 11.6 mm -131.49 121.36 48.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 O-C-N 126.319 2.262 . . . . 0.0 107.326 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.493 HG22 ' HB3' ' A' ' 79' ' ' ASP . 22.0 p -104.06 163.34 12.45 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.271 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -108.6 177.55 20.67 Favored Glycine 0 N--CA 1.477 1.406 0 O-C-N 125.211 1.569 . . . . 0.0 110.562 178.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -74.89 -14.91 60.71 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 122.124 0.964 . . . . 0.0 113.055 175.422 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -112.77 129.94 56.25 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 175.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.63 HG22 ' HG2' ' A' ' 77' ' ' GLN . 25.9 m -53.67 149.59 8.13 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 114.27 -1.332 . . . . 0.0 108.041 174.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.63 ' HG2' HG22 ' A' ' 76' ' ' THR . 0.1 OUTLIER 81.03 32.84 0.13 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 126.53 1.932 . . . . 0.0 111.425 179.802 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.582 ' HA ' HD22 ' A' ' 91' ' ' LEU . 10.0 mt-10 -139.17 51.73 1.78 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 123.764 1.745 . . . . 0.0 112.716 179.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.531 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -103.9 83.91 2.18 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 113.552 -1.658 . . . . 0.0 109.1 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.426 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 31.4 m-85 -56.02 173.67 0.15 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.912 1.685 . . . . 0.0 110.673 174.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.529 ' HB2' HD11 ' A' ' 92' ' ' ILE . 11.7 t80 -158.41 126.92 5.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.426 -176.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 88' ' ' THR 0.275 0.1 OUTLIER -91.73 -69.25 0.75 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 112.657 -2.065 . . . . 0.0 112.643 173.391 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' A' ' 68' ' ' ARG . . . 64.36 17.86 62.38 Favored Glycine 0 CA--C 1.54 1.617 0 CA-C-N 115.124 -0.944 . . . . 0.0 113.219 -173.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.504 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 38.0 t0 -148.0 26.19 1.0 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.732 1.213 . . . . 0.0 112.417 175.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 56.8 83.55 0.1 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.586 1.555 . . . . 0.0 110.968 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 47.97 51.17 14.85 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 113.333 -1.758 . . . . 0.0 114.681 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . . . -120.84 -35.88 3.26 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.175 -1.375 . . . . 0.0 113.948 -178.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.498 ' O ' ' HB ' ' A' ' 82' ' ' THR . 16.3 p -136.77 166.6 23.22 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.653 1.181 . . . . 0.0 108.095 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.431 ' CD1' HD21 ' A' ' 44' ' ' LEU . 94.9 m-85 -156.9 111.83 2.8 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -174.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.2 m -133.76 115.34 14.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.292 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.582 HD22 ' HA ' ' A' ' 78' ' ' GLU . 87.5 mt -46.31 160.77 0.06 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.721 0.808 . . . . 0.0 111.989 178.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.646 HG21 HD11 ' A' ' 19' ' ' LEU . 1.7 mp -109.52 127.37 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 120.667 -1.27 . . . . 0.0 109.433 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.45 95.22 5.67 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 113.567 -1.652 . . . . 0.0 108.985 175.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -58.95 -42.35 89.6 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 124.502 1.126 . . . . 0.0 111.55 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.2 t -50.91 -31.95 19.13 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.692 1.597 . . . . 0.0 113.446 171.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 19.1 t . . . . . 0 CA--C 1.554 1.126 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.795 177.35 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.427 ' N ' HG13 ' A' ' 43' ' ' VAL . 2.1 p30 . . . . . 0 N--CA 1.474 0.749 0 CA-C-O 122.04 0.924 . . . . 0.0 112.147 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.598 HG11 ' HG ' ' A' ' 91' ' ' LEU . 2.0 t -68.39 111.14 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.1 p -78.38 14.21 1.3 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 122.396 1.094 . . . . 0.0 113.487 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 120.83 -163.31 14.39 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.439 1.495 . . . . 0.0 109.719 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -100.98 171.06 7.87 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 112.63 -1.785 . . . . 0.0 109.741 -177.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 91' ' ' LEU . 9.8 p -142.27 107.22 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.627 -1.169 . . . . 0.0 107.947 -175.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.425 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 86.0 m -45.76 128.44 8.68 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 111.986 -2.37 . . . . 0.0 109.126 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.782 ' HA ' HD12 ' A' ' 11' ' ' LEU . 15.5 tp -53.16 -36.95 61.42 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.778 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -65.03 -19.72 66.14 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.984 172.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 7' ' ' CYS . . . -79.09 -31.88 44.47 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.197 0.522 . . . . 0.0 111.731 175.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.782 HD12 ' HA ' ' A' ' 8' ' ' LEU . 10.4 mt -83.5 173.55 7.27 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 125.26 1.424 . . . . 0.0 110.221 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 92.2 Cg_endo -70.3 169.38 19.73 Favored 'Trans proline' 0 CA--C 1.555 1.534 0 C-N-CA 122.008 1.805 . . . . 0.0 113.817 176.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.87 -15.99 40.91 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.745 2.297 . . . . 0.0 114.257 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.412 ' HG3' ' HA ' ' A' ' 59' ' ' THR . 10.8 pm0 -87.05 2.8 48.47 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.061 1.344 . . . . 0.0 113.306 175.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.519 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -76.48 -55.3 5.66 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.155 0.982 . . . . 0.0 111.585 176.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.664 ' OG1' HD21 ' A' ' 8' ' ' LEU . 0.5 OUTLIER -53.8 -29.11 38.97 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 114.827 -1.079 . . . . 0.0 112.363 174.175 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.556 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 44.6 t0 -51.12 -58.04 7.15 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 125.129 1.518 . . . . 0.0 110.514 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.738 ' HA ' HD12 ' A' ' 21' ' ' LEU . 18.0 m -55.26 -51.1 67.75 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.914 HD11 HG21 ' A' ' 92' ' ' ILE . 7.5 mt -56.7 -35.02 68.0 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 123.782 0.676 . . . . 0.0 112.678 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -66.95 -36.55 82.46 Favored 'General case' 0 C--O 1.217 -0.634 0 C-N-CA 124.478 1.111 . . . . 0.0 110.386 174.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.738 HD12 ' HA ' ' A' ' 18' ' ' THR . 33.2 mt -72.84 -32.67 65.63 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 119.025 -0.512 . . . . 0.0 111.137 175.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.698 HD12 ' O ' ' A' ' 18' ' ' THR . 1.7 mp -70.43 -40.34 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 120.325 1.42 . . . . 0.0 111.881 171.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.28 -42.16 65.87 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 124.602 1.189 . . . . 0.0 112.474 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.32 7.47 44.28 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.505 178.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 42.99 37.32 1.08 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 123.158 1.456 . . . . 0.0 112.539 -177.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.52 -167.26 17.57 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 112.959 -1.928 . . . . 0.0 116.036 -173.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -74.44 139.44 61.65 Favored 'Cis proline' 0 N--CA 1.488 1.154 0 O-C-N 123.917 1.483 . . . . 0.0 111.639 -2.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.51 ' CD2' ' HB3' ' A' ' 21' ' ' LEU . 65.3 m-85 -91.22 135.23 28.55 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.583 -177.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -76.45 -58.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.634 2.223 . . . . 0.0 111.936 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -66.13 159.56 25.92 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.102 0.561 . . . . 0.0 112.063 175.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.1 m -77.14 1.31 18.64 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 173.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.58 84.95 4.05 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 122.055 0.931 . . . . 0.0 111.489 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 178.2 147.72 0.16 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 110.665 -2.97 . . . . 0.0 115.113 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.94 30.81 37.29 Favored Glycine 0 N--CA 1.478 1.476 0 CA-C-N 112.373 -2.194 . . . . 0.0 110.997 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.1 146.76 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.468 1.107 . . . . 0.0 109.797 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.2 t -83.59 153.93 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 126.49 2.369 . . . . 0.0 110.299 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.519 ' CE1' ' HD3' ' A' ' 40' ' ' ARG . 29.3 t80 -129.39 94.31 3.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 113.557 -1.656 . . . . 0.0 109.44 175.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.497 ' HG3' ' CD1' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -73.1 50.14 0.27 Allowed 'General case' 0 N--CA 1.484 1.229 0 O-C-N 120.923 -1.111 . . . . 0.0 112.938 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.485 ' ND2' ' H ' ' A' ' 44' ' ' LEU . 17.8 t30 22.86 60.51 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.526 1.931 . . . . 0.0 111.611 -173.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.519 ' HD3' ' CE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -58.63 -25.5 62.76 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 113.477 -1.692 . . . . 0.0 111.389 -175.612 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.589 ' O ' HG23 ' A' ' 43' ' ' VAL . 1.4 mt-10 -75.46 -7.93 55.4 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.023 -1.444 . . . . 0.0 114.633 174.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.7 t 44.18 42.86 5.35 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 124.387 2.041 . . . . 0.0 112.188 -177.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 41' ' ' GLU . 65.8 t -110.76 -21.97 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 113.543 -1.662 . . . . 0.0 110.448 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.85 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -99.71 142.42 24.58 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.815 -173.218 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.36 68.23 6.86 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 121.288 1.326 . . . . 0.0 110.801 -177.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.766 HG22 ' H ' ' A' ' 47' ' ' GLN . 4.4 m -73.49 -166.11 0.32 Allowed 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 113.224 -1.807 . . . . 0.0 107.825 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.766 ' H ' HG22 ' A' ' 46' ' ' THR . 48.1 tt0 -179.84 -45.74 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.623 1.569 . . . . 0.0 110.642 -178.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.9 p -117.89 158.48 24.78 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.017 -1.447 . . . . 0.0 111.339 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.497 ' CD1' ' HG3' ' A' ' 38' ' ' GLN . 8.8 t80 -85.17 136.84 33.36 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 112.967 -1.924 . . . . 0.0 110.46 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.63 6.7 88.3 Favored Glycine 0 N--CA 1.478 1.474 0 CA-C-N 114.469 -1.241 . . . . 0.0 113.365 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -79.81 7.52 8.53 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.419 1.087 . . . . 0.0 112.824 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.85 ' HE2' HD12 ' A' ' 44' ' ' LEU . 13.2 m-85 -143.91 144.26 31.64 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -174.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -142.32 157.01 45.28 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 126.297 2.248 . . . . 0.0 110.29 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -113.48 143.71 44.05 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.863 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.421 ' HB3' HG23 ' A' ' 18' ' ' THR . 77.0 m-85 -159.26 70.47 0.48 Allowed 'General case' 0 N--CA 1.472 0.645 0 O-C-N 125.378 1.674 . . . . 0.0 111.043 -175.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 1.2 m -39.49 126.98 1.87 Allowed 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 122.332 1.063 . . . . 0.0 112.772 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.519 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.8 OUTLIER -70.12 108.18 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 111.632 -2.531 . . . . 0.0 108.468 176.402 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -39.37 153.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 CA-C-N 115.307 -0.86 . . . . 0.0 108.878 170.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.412 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 1.5 m -156.35 140.02 11.32 Favored Pre-proline 0 N--CA 1.48 1.052 0 O-C-N 125.658 1.849 . . . . 0.0 110.78 177.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.62 152.16 53.32 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.944 2.429 . . . . 0.0 110.18 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 52.41 26.71 23.24 Favored Glycine 0 N--CA 1.481 1.69 0 CA-C-N 113.993 -1.458 . . . . 0.0 112.144 -175.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.43 89.72 7.98 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -40.42 -31.83 0.16 Allowed 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 113.72 -1.582 . . . . 0.0 112.764 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.4 p -134.23 -145.11 0.23 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.618 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 60.3 mtm180 -72.81 -18.67 61.44 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 173.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.08 142.61 0.02 OUTLIER Glycine 0 CA--C 1.531 1.053 0 N-CA-C 108.929 -1.669 . . . . 0.0 108.929 -175.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.2 p -41.85 -32.43 0.41 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 113.887 -1.157 . . . . 0.0 114.057 174.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.406 ' HG3' ' OH ' ' A' ' 81' ' ' TYR . 2.8 mpt_? -44.58 120.02 2.1 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 122.723 1.249 . . . . 0.0 112.461 170.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.477 ' HB3' HG23 ' A' ' 82' ' ' THR . 1.6 tpt180 -149.26 128.46 12.84 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 112.337 -2.21 . . . . 0.0 109.048 -178.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.423 HD12 HG23 ' A' ' 57' ' ' VAL . 3.2 mt -103.79 143.47 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 113.646 -1.615 . . . . 0.0 108.965 173.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.743 HD11 ' HE1' ' A' ' 86' ' ' TYR . 13.8 mm -129.84 102.55 7.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 112.777 -2.011 . . . . 0.0 108.35 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.675 HG22 ' HB3' ' A' ' 79' ' ' ASP . 24.9 p -94.71 165.19 12.62 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.655 0.741 . . . . 0.0 110.371 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -118.88 167.54 13.14 Favored Glycine 0 N--CA 1.473 1.162 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.231 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -61.61 -19.05 61.81 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.579 0.704 . . . . 0.0 111.886 174.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.78 129.56 49.47 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.013 175.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.563 HG22 ' HG2' ' A' ' 77' ' ' GLN . 19.2 m -60.04 144.17 50.1 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 114.114 -1.403 . . . . 0.0 107.311 175.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.563 ' HG2' HG22 ' A' ' 76' ' ' THR . 1.6 mt-30 80.46 33.19 0.16 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 126.82 2.048 . . . . 0.0 111.696 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.411 ' HA ' HD22 ' A' ' 91' ' ' LEU . 23.9 mt-10 -134.55 52.65 2.04 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 113.51 -1.677 . . . . 0.0 112.994 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.675 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.4 OUTLIER -107.95 94.29 4.99 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 113.648 -1.614 . . . . 0.0 110.062 -178.557 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.502 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 12.0 m-85 -82.74 129.07 34.91 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 125.017 1.327 . . . . 0.0 109.642 -177.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.864 ' HB2' HD11 ' A' ' 92' ' ' ILE . 64.2 t80 -113.66 136.61 52.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.103 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.545 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.6 OUTLIER -95.43 -67.27 0.86 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 112.196 -2.275 . . . . 0.0 112.001 176.137 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.88 -0.95 26.37 Favored Glycine 0 CA--C 1.549 2.21 0 CA-C-N 114.031 -1.441 . . . . 0.0 113.496 -174.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.555 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 80.1 m-20 -127.98 17.17 6.74 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 175.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 63.13 86.25 0.12 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.666 1.986 . . . . 0.0 111.12 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.743 ' HE1' HD11 ' A' ' 71' ' ' ILE . 6.1 m-30 49.48 30.56 3.48 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 113.944 -1.48 . . . . 0.0 114.776 -176.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.555 ' HB3' ' HB2' ' A' ' 84' ' ' ASP . . . -99.74 -18.78 17.07 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.733 -0.787 . . . . 0.0 112.561 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.545 ' O ' ' HB ' ' A' ' 82' ' ' THR . 25.2 p -158.93 171.06 20.73 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.623 1.569 . . . . 0.0 108.868 -177.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.577 ' CG ' HD21 ' A' ' 44' ' ' LEU . 94.0 m-85 -157.15 116.54 3.38 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.157 0.983 . . . . 0.0 108.818 -174.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.61 109.91 7.86 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 113.583 -1.644 . . . . 0.0 106.93 -178.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.598 ' HG ' HG11 ' A' ' 2' ' ' VAL . 52.2 mt -41.75 158.81 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.653 177.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.914 HG21 HD11 ' A' ' 19' ' ' LEU . 1.7 mp -112.92 121.86 65.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 120.789 -1.194 . . . . 0.0 109.218 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.27 96.76 7.67 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 113.226 -1.806 . . . . 0.0 108.78 176.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -60.86 -39.2 88.26 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 124.879 1.362 . . . . 0.0 111.803 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.7 t -52.54 -32.01 38.56 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.068 -1.423 . . . . 0.0 113.533 172.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 19.9 t . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.407 176.743 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.415 ' N ' HG13 ' A' ' 43' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.471 0.625 0 CA-C-O 122.031 0.919 . . . . 0.0 111.91 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.474 HG11 ' HG ' ' A' ' 91' ' ' LEU . 2.1 t -74.22 116.16 16.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 113.745 -1.57 . . . . 0.0 107.327 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.81 7.9 5.26 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.682 1.239 . . . . 0.0 112.196 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.22 -166.73 21.48 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.001 1.286 . . . . 0.0 110.471 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 6' ' ' VAL . 3.3 m -101.64 172.91 6.67 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.231 -1.484 . . . . 0.0 108.942 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.411 ' H ' HG22 ' A' ' 5' ' ' THR . 0.7 OUTLIER -142.27 107.69 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 -175.217 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 88.5 m -47.1 132.48 12.2 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 112.92 -1.946 . . . . 0.0 109.586 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.423 HD11 ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -55.55 -33.61 64.0 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.962 -178.208 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.0 t -64.82 -28.86 69.84 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.634 173.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.46 -31.49 62.26 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.605 0.762 . . . . 0.0 111.194 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.413 HD11 HD11 ' A' ' 92' ' ' ILE . 12.4 mt -74.63 162.26 74.42 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 175.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.41 ' HD2' HD22 ' A' ' 11' ' ' LEU . 59.4 Cg_endo -68.65 167.51 22.62 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.567 2.178 . . . . 0.0 111.948 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.86 -16.14 32.92 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.837 2.358 . . . . 0.0 112.632 177.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.423 ' CD ' ' HD3' ' A' ' 60' ' ' PRO . 1.7 mt-10 -93.71 -2.57 53.65 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.324 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.94 -39.43 18.16 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.757 175.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.423 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -60.82 -28.75 69.03 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.195 175.037 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.463 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 18.1 t0 -54.24 -51.94 62.89 Favored 'General case' 0 C--O 1.213 -0.835 0 O-C-N 124.881 1.363 . . . . 0.0 110.146 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.669 ' OG1' HG12 ' A' ' 57' ' ' VAL . 28.2 m -64.06 -49.26 73.02 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.572 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.593 HD21 HD13 ' A' ' 70' ' ' ILE . 19.6 mt -53.52 -31.41 46.09 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.972 0.795 . . . . 0.0 112.529 175.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -71.93 -42.44 66.64 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.373 173.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.648 HD12 ' HA ' ' A' ' 18' ' ' THR . 33.8 mt -67.79 -35.59 78.93 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.993 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.564 HD12 ' O ' ' A' ' 18' ' ' THR . 2.1 mt -65.64 -40.03 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 119.73 1.15 . . . . 0.0 110.806 172.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.75 -46.34 46.44 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 124.043 0.839 . . . . 0.0 111.9 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.78 -1.18 37.57 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.327 1.051 . . . . 0.0 111.413 176.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 49.48 39.25 16.28 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 122.555 1.169 . . . . 0.0 110.913 -178.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.57 -169.34 37.25 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-N 113.66 -1.609 . . . . 0.0 115.23 -174.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -75.15 140.73 68.78 Favored 'Cis proline' 0 CA--C 1.535 0.546 0 O-C-N 124.911 2.006 . . . . 0.0 111.51 -0.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.427 ' CD2' ' HB3' ' A' ' 21' ' ' LEU . 20.9 m-85 -89.51 137.6 28.79 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 113.32 -1.764 . . . . 0.0 111.034 -176.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -74.29 -62.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.528 2.819 . . . . 0.0 111.296 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.528 ' CE2' HG13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -56.18 155.57 6.52 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.964 0.79 . . . . 0.0 110.604 177.712 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.31 7.13 14.77 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 122.186 0.993 . . . . 0.0 111.592 175.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.31 82.56 1.76 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 122.081 0.943 . . . . 0.0 111.558 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -179.22 146.03 0.28 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 112.616 -2.084 . . . . 0.0 112.972 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.39 36.1 10.04 Favored Glycine 0 N--CA 1.484 1.879 0 O-C-N 126.312 2.257 . . . . 0.0 110.756 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.9 m -135.58 151.03 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 114.388 -0.906 . . . . 0.0 109.216 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.3 t -86.86 157.46 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 125.619 1.825 . . . . 0.0 109.534 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.536 ' CE2' ' HA ' ' A' ' 39' ' ' ASN . 79.4 t80 -136.08 88.97 2.43 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 113.695 -1.593 . . . . 0.0 108.713 177.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -72.24 51.29 0.24 Allowed 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.313 -0.867 . . . . 0.0 111.683 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.536 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 33.2 t30 25.32 57.42 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.977 2.111 . . . . 0.0 110.667 -173.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -21.43 22.44 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 113.265 -1.789 . . . . 0.0 111.406 -177.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.666 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.0 mt-10 -83.71 -4.72 58.85 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 114.074 -1.421 . . . . 0.0 113.894 174.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.416 ' HA ' ' ND2' ' A' ' 39' ' ' ASN . 41.3 t 43.02 46.36 4.74 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 124.535 2.112 . . . . 0.0 112.623 -177.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 41' ' ' GLU . 88.0 t -115.73 -23.82 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 113.989 -1.46 . . . . 0.0 109.687 -176.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.6 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.6 OUTLIER -99.67 138.27 20.38 Favored Pre-proline 0 N--CA 1.471 0.598 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.98 -175.221 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.06 69.47 6.32 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 121.538 1.492 . . . . 0.0 110.065 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.717 HG22 ' CZ ' ' A' ' 52' ' ' TYR . 42.4 p -66.5 -153.56 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 113.061 -1.881 . . . . 0.0 108.236 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 177.34 -43.38 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 122.204 1.002 . . . . 0.0 110.294 178.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.7 p -124.28 160.59 27.66 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 113.866 -1.515 . . . . 0.0 111.036 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -82.46 145.22 29.95 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 113.098 -1.864 . . . . 0.0 109.075 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.71 10.98 56.48 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.743 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.96 10.17 10.51 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.485 1.114 . . . . 0.0 112.274 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.717 ' CZ ' HG22 ' A' ' 46' ' ' THR . 10.1 m-85 -144.0 143.52 31.25 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -175.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -144.07 155.69 44.07 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 126.395 2.309 . . . . 0.0 110.857 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -110.22 142.27 42.03 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.68 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.592 ' O ' HG21 ' A' ' 18' ' ' THR . 76.9 m-85 -155.66 64.16 0.6 Allowed 'General case' 0 N--CA 1.467 0.388 0 O-C-N 125.796 1.935 . . . . 0.0 110.462 -176.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.552 HG21 ' CG ' ' A' ' 65' ' ' ARG . 0.3 OUTLIER -41.44 136.32 1.79 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 122.322 1.058 . . . . 0.0 112.911 178.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.669 HG12 ' OG1' ' A' ' 18' ' ' THR . 9.7 m -95.55 117.43 39.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 112.18 -2.282 . . . . 0.0 108.082 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.528 HG13 ' CE2' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -42.86 149.02 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 O-C-N 125.527 1.767 . . . . 0.0 109.949 173.856 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.453 HG23 ' HD2' ' A' ' 60' ' ' PRO . 8.3 m -139.96 142.3 30.21 Favored Pre-proline 0 N--CA 1.48 1.052 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.414 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.453 ' HD2' HG23 ' A' ' 59' ' ' THR . 57.2 Cg_endo -76.01 145.49 28.16 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.066 1.844 . . . . 0.0 109.916 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.87 25.13 44.12 Favored Glycine 0 CA--C 1.542 1.767 0 CA-C-N 114.061 -1.427 . . . . 0.0 112.274 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.98 90.96 5.76 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -38.4 -33.87 0.11 Allowed 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.359 177.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.4 p -140.32 -148.77 0.26 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.143 -1.39 . . . . 0.0 109.077 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.552 ' CG ' HG21 ' A' ' 56' ' ' THR . 5.0 ttp180 -69.71 -6.85 34.57 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 174.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.23 -129.15 13.37 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.212 1.387 . . . . 0.0 109.635 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.573 HG22 ' HB2' ' A' ' 85' ' ' HIS . 22.0 p -112.72 -34.13 5.9 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 112.26 -1.97 . . . . 0.0 113.384 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -41.33 133.29 2.47 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.277 -1.329 . . . . 0.0 111.581 174.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.44 141.54 3.66 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 112.5 -2.137 . . . . 0.0 110.869 -176.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.66 HD12 HG11 ' A' ' 57' ' ' VAL . 1.0 OUTLIER -120.42 133.31 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 126.72 2.512 . . . . 0.0 109.165 176.877 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.461 ' O ' ' HD2' ' A' ' 80' ' ' TYR . 13.3 mm -122.52 101.47 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 113.25 -1.796 . . . . 0.0 107.857 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.508 HG22 ' HB3' ' A' ' 79' ' ' ASP . 12.7 p -87.43 161.92 17.58 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.635 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -108.12 -176.51 22.12 Favored Glycine 0 N--CA 1.471 0.97 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.303 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.3 -11.45 59.94 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.404 175.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -122.05 131.55 54.04 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.599 HG22 ' HG2' ' A' ' 77' ' ' GLN . 23.9 m -51.12 149.24 3.86 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.624 176.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.599 ' HG2' HG22 ' A' ' 76' ' ' THR . 2.6 mt-30 83.59 33.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 125.505 1.753 . . . . 0.0 110.467 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -140.86 49.29 1.68 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.133 -1.394 . . . . 0.0 113.038 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.614 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -105.47 90.7 3.49 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.458 -178.212 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.461 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 22.0 m-85 -75.28 131.93 40.67 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.144 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.709 ' HB2' HD11 ' A' ' 92' ' ' ILE . 4.9 t80 -114.02 128.5 56.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.941 -177.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.548 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.5 OUTLIER -90.0 -67.97 0.81 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.122 178.481 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.81 2.95 19.34 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-N 113.897 -1.502 . . . . 0.0 113.077 -173.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.533 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 50.6 t0 -130.55 14.73 5.47 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.666 0.786 . . . . 0.0 112.118 175.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.573 ' HB2' HG22 ' A' ' 67' ' ' THR . 34.4 t-80 64.1 85.83 0.13 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.071 1.748 . . . . 0.0 111.044 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.436 ' HB3' ' CD ' ' A' ' 41' ' ' GLU . 6.6 m-85 50.2 28.62 3.2 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 114.274 -1.33 . . . . 0.0 114.398 -177.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.533 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . . . -105.77 -19.37 13.77 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.296 -1.32 . . . . 0.0 111.256 -175.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.548 ' O ' ' HB ' ' A' ' 82' ' ' THR . 15.7 p -153.59 169.01 24.29 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.327 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.584 ' CD1' HD21 ' A' ' 44' ' ' LEU . 90.0 m-85 -158.45 113.16 2.56 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -173.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -132.35 105.05 7.06 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 113.968 -1.469 . . . . 0.0 107.328 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.474 ' HG ' HG11 ' A' ' 2' ' ' VAL . 23.0 mt -41.04 163.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.62 177.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.709 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.7 mp -112.99 135.78 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 120.383 -1.448 . . . . 0.0 109.738 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -113.74 92.33 3.95 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 113.906 -1.497 . . . . 0.0 108.765 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.05 -37.11 85.9 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.236 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 t -54.61 -24.67 22.39 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 114.484 -1.235 . . . . 0.0 113.414 171.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 5.6 t . . . . . 0 C--O 1.261 1.7 0 CA-C-O 117.624 -1.179 . . . . 0.0 111.118 175.71 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.5 p30 . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.443 HG23 ' HD3' ' A' ' 45' ' ' PRO . 6.9 t -45.06 130.59 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.209 1.004 . . . . 0.0 108.671 177.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.17 8.1 4.35 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 124.886 1.366 . . . . 0.0 113.099 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 121.04 -162.56 14.73 Favored Glycine 0 N--CA 1.478 1.44 0 C-N-CA 125.499 1.523 . . . . 0.0 109.653 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 m -103.49 170.13 8.13 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 113.765 -1.217 . . . . 0.0 109.455 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 p -141.33 113.94 4.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -176.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.5 m -50.77 132.82 26.51 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 112.149 -2.296 . . . . 0.0 110.132 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.495 HD11 ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -59.56 -31.75 69.71 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.921 -178.143 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.0 t -64.63 -29.49 70.5 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.083 0.953 . . . . 0.0 113.224 173.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.38 -24.47 54.12 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.844 174.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 11' ' ' LEU . 8.6 mt -83.4 160.58 59.15 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 176.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.526 ' HG2' ' HB2' ' A' ' 15' ' ' ALA . 57.9 Cg_endo -66.42 166.17 22.52 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.546 2.164 . . . . 0.0 113.123 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -67.42 -35.43 23.5 Favored 'Trans proline' 0 N--CA 1.485 1.001 0 C-N-CA 122.572 2.182 . . . . 0.0 112.292 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.463 ' HB3' HG22 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -76.35 -8.77 57.81 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.512 179.085 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.526 ' HB2' ' HG2' ' A' ' 12' ' ' PRO . . . -68.61 -43.45 76.39 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.867 0.867 . . . . 0.0 112.013 172.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.495 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -63.13 -32.98 74.49 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.156 174.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.508 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 22.6 t0 -50.01 -49.12 51.8 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.019 0.928 . . . . 0.0 110.262 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.652 ' HA ' HD12 ' A' ' 21' ' ' LEU . 7.7 m -58.99 -50.52 73.78 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.567 HD21 ' OD2' ' A' ' 79' ' ' ASP . 39.0 mt -51.81 -32.79 32.97 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 175.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.01 -43.97 64.19 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.225 1.01 . . . . 0.0 111.858 172.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.671 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 68.4 mt -65.16 -34.32 78.1 Favored 'General case' 0 C--O 1.211 -0.946 0 C-N-CA 123.768 0.827 . . . . 0.0 112.092 176.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.525 HD13 HG21 ' A' ' 72' ' ' THR . 5.6 mt -67.87 -42.52 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 120.567 -1.333 . . . . 0.0 111.55 171.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.76 -47.69 62.05 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 124.29 0.994 . . . . 0.0 112.682 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 m -84.87 5.93 26.84 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.63 1.172 . . . . 0.0 113.904 175.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 44.78 39.92 3.85 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.926 1.29 . . . . 0.0 112.025 -177.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.71 -164.28 14.57 Favored Glycine 0 CA--C 1.541 1.718 0 C-N-CA 125.572 1.558 . . . . 0.0 114.461 -174.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.21 135.66 41.29 Favored 'Cis proline' 0 N--CA 1.485 0.996 0 CA-C-O 122.927 1.136 . . . . 0.0 110.947 -2.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.671 ' CE1' ' HB3' ' A' ' 21' ' ' LEU . 79.7 m-85 -85.0 153.41 60.05 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 111.509 -2.587 . . . . 0.0 111.879 -176.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.535 ' HG3' HD12 ' A' ' 58' ' ' ILE . 56.0 Cg_endo -71.28 -59.13 0.07 OUTLIER 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.111 1.874 . . . . 0.0 113.409 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.521 ' CZ ' HG22 ' A' ' 56' ' ' THR . 0.1 OUTLIER -118.02 -179.97 3.92 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.452 1.501 . . . . 0.0 110.547 -179.445 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.0 m -68.0 -8.5 37.95 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 175.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.638 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 11.7 mt-30 -73.74 54.04 0.47 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 122.741 1.258 . . . . 0.0 113.238 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 0.8 OUTLIER 172.67 127.39 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 111.81 -2.45 . . . . 0.0 113.432 -176.24 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.25 -14.61 20.93 Favored Glycine 0 N--CA 1.482 1.746 0 CA-C-N 113.698 -1.592 . . . . 0.0 112.535 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.712 HG22 ' CD ' ' A' ' 54' ' ' GLU . 2.1 m -90.79 150.39 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-O 121.896 0.855 . . . . 0.0 109.908 176.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.6 t -75.01 155.51 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 114.172 -1.377 . . . . 0.0 110.39 175.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.465 ' CE1' ' HD3' ' A' ' 40' ' ' ARG . 65.1 t80 -128.11 93.34 3.64 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 113.402 -1.726 . . . . 0.0 109.69 175.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.407 ' HG3' ' CD1' ' A' ' 49' ' ' TYR . 1.3 tm0? -71.29 47.8 0.12 Allowed 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.699 1.238 . . . . 0.0 112.984 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.441 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 35.8 t30 29.49 56.32 0.14 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.188 1.395 . . . . 0.0 111.151 -173.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.465 ' HD3' ' CE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -55.31 -30.06 59.47 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.853 -175.164 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.583 ' O ' HG23 ' A' ' 43' ' ' VAL . 1.3 mt-10 -75.97 -7.46 54.67 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 112.924 -1.944 . . . . 0.0 114.646 175.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.8 t 45.56 37.85 3.47 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 123.482 1.611 . . . . 0.0 112.292 -176.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 41' ' ' GLU . 70.8 t -109.55 -20.0 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.938 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.609 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.3 OUTLIER -93.52 152.53 41.0 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.172 -173.772 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.443 ' HD3' HG23 ' A' ' 2' ' ' VAL . 78.2 Cg_endo -68.88 -165.13 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 121.058 1.172 . . . . 0.0 109.581 178.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m 67.67 -68.14 0.17 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.49 1.516 . . . . 0.0 113.008 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 83.25 -23.26 0.2 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 128.475 2.71 . . . . 0.0 112.837 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.5 p -50.45 158.92 0.55 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 123.549 1.642 . . . . 0.0 110.925 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.407 ' CD1' ' HG3' ' A' ' 38' ' ' GLN . 3.8 t80 -103.4 135.11 45.62 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 112.851 -1.977 . . . . 0.0 110.579 -175.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.62 -21.67 24.84 Favored Glycine 0 CA--C 1.542 1.73 0 CA-C-N 114.361 -1.29 . . . . 0.0 113.135 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -71.15 -7.54 47.35 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.568 1.147 . . . . 0.0 113.751 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.609 ' HE2' HD12 ' A' ' 44' ' ' LEU . 21.9 m-85 -119.91 162.85 18.46 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 125.515 1.526 . . . . 0.0 109.327 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -160.19 165.56 31.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 112.678 -2.056 . . . . 0.0 110.715 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.712 ' CD ' HG22 ' A' ' 35' ' ' VAL . 1.5 pm0 -120.42 152.27 38.17 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.786 0.834 . . . . 0.0 109.461 -177.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.412 ' CB ' HG23 ' A' ' 18' ' ' THR . 48.3 m-85 -163.12 66.39 0.19 Allowed 'General case' 0 N--CA 1.473 0.708 0 O-C-N 123.982 0.801 . . . . 0.0 109.646 -178.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.638 ' HB ' ' HB3' ' A' ' 32' ' ' GLN . 0.9 OUTLIER -38.78 135.24 0.87 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.45 -0.781 . . . . 0.0 112.887 177.715 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.453 HG11 ' HA ' ' A' ' 15' ' ' ALA . 26.8 m -91.66 123.53 43.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 112.539 -2.119 . . . . 0.0 109.212 178.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.535 HD12 ' HG3' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -51.74 159.12 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 113.83 -1.532 . . . . 0.0 110.189 173.125 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.4 m -153.61 141.61 13.88 Favored Pre-proline 0 N--CA 1.475 0.793 0 O-C-N 124.625 1.203 . . . . 0.0 110.762 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.07 141.59 33.08 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 121.765 1.643 . . . . 0.0 110.676 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.7 26.94 65.62 Favored Glycine 0 CA--C 1.54 1.635 0 CA-C-N 114.022 -1.444 . . . . 0.0 112.857 -174.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.21 91.59 6.75 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 177.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -42.45 -30.96 0.37 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.516 -1.22 . . . . 0.0 113.448 176.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 59.3 p -128.22 -113.41 0.27 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 113.814 -1.539 . . . . 0.0 109.166 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -115.51 -12.47 11.66 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.78 1.632 . . . . 0.0 111.563 177.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.98 167.34 7.35 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 123.722 1.734 . . . . 0.0 110.441 -176.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.431 HG22 ' HB2' ' A' ' 85' ' ' HIS . 42.5 p -74.43 -6.63 49.33 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 112.349 -1.926 . . . . 0.0 112.941 176.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.437 ' HD2' ' HA2' ' A' ' 83' ' ' GLY . 0.1 OUTLIER -68.73 134.61 50.05 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 120.927 -1.108 . . . . 0.0 109.816 176.199 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.461 ' NH1' ' HG2' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -159.79 139.96 11.78 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.139 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.524 HG23 ' OD1' ' A' ' 79' ' ' ASP . 3.1 mt -113.97 139.22 40.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 O-C-N 125.223 1.577 . . . . 0.0 108.808 176.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 70' ' ' ILE . 20.5 mm -129.25 106.42 13.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 O-C-N 125.287 1.617 . . . . 0.0 108.582 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.525 HG21 HD13 ' A' ' 22' ' ' ILE . 7.9 p -94.69 162.83 13.62 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.436 -0.79 . . . . 0.0 110.937 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.32 -175.19 21.26 Favored Glycine 0 CA--C 1.538 1.477 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.832 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.66 -14.62 62.1 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.955 0.883 . . . . 0.0 112.896 175.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.28 128.6 55.2 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.428 HG22 ' HG2' ' A' ' 77' ' ' GLN . 30.1 m -61.65 151.19 34.24 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.374 175.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.428 ' HG2' HG22 ' A' ' 76' ' ' THR . 4.3 mt-30 75.71 31.79 0.71 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 126.527 1.931 . . . . 0.0 110.821 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.596 ' HA ' HD22 ' A' ' 91' ' ' LEU . 18.0 mt-10 -138.98 60.09 1.6 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 113.1 -1.864 . . . . 0.0 112.702 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.567 ' OD2' HD21 ' A' ' 19' ' ' LEU . 0.6 OUTLIER -101.77 123.19 45.33 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 112.71 -2.041 . . . . 0.0 107.973 175.002 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.466 ' HB3' ' HB3' ' A' ' 89' ' ' PHE . 23.0 m-85 -92.6 126.69 37.8 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 124.715 1.26 . . . . 0.0 109.209 174.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.789 ' HB2' HD11 ' A' ' 92' ' ' ILE . 27.3 t80 -108.85 121.58 45.38 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.017 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.533 ' HB ' ' O ' ' A' ' 88' ' ' THR 0.291 0.1 OUTLIER -79.99 -70.92 0.48 Allowed 'General case' 0 N--CA 1.485 1.293 0 O-C-N 125.497 1.748 . . . . 0.0 113.014 173.604 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.437 ' HA2' ' HD2' ' A' ' 68' ' ' ARG . . . 66.34 16.93 65.64 Favored Glycine 0 CA--C 1.539 1.578 0 CA-C-N 114.253 -1.339 . . . . 0.0 113.069 -173.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.505 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 45.0 t0 -146.5 24.82 1.23 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.567 1.147 . . . . 0.0 112.483 175.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.431 ' HB2' HG22 ' A' ' 67' ' ' THR . 41.1 t-80 56.35 83.55 0.1 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.002 2.121 . . . . 0.0 110.813 177.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 46.38 53.58 9.49 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 113.009 -1.905 . . . . 0.0 114.022 -175.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . . . -123.88 -34.83 2.94 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.381 -1.281 . . . . 0.0 114.024 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.533 ' O ' ' HB ' ' A' ' 82' ' ' THR . 11.3 p -135.37 168.01 19.98 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.47 1.108 . . . . 0.0 108.493 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.49 ' CG ' HD21 ' A' ' 44' ' ' LEU . 98.6 m-85 -159.54 115.83 2.55 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -174.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.5 m -135.65 111.07 9.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 112.82 -1.991 . . . . 0.0 108.586 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.596 HD22 ' HA ' ' A' ' 78' ' ' GLU . 16.9 mt -41.68 159.96 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.441 176.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.789 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.6 mp -110.7 129.47 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 121.38 -0.825 . . . . 0.0 109.592 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.09 92.02 3.88 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 113.157 -1.838 . . . . 0.0 109.172 176.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -60.1 -31.77 70.35 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 114.218 -1.356 . . . . 0.0 111.199 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.3 t -54.98 -34.87 63.75 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.656 1.582 . . . . 0.0 112.972 172.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 8.6 t . . . . . 0 C--O 1.254 1.299 0 CA-C-O 117.813 -1.089 . . . . 0.0 110.824 178.773 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.4 p30 . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 119.758 -0.163 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.7 t -41.81 137.93 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.643 1.177 . . . . 0.0 109.429 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.6 m -80.85 19.58 0.84 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.085 -0.962 . . . . 0.0 113.014 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.86 -175.18 29.76 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.505 HG22 ' H ' ' A' ' 6' ' ' VAL . 2.4 m -85.29 174.61 9.47 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.445 0.641 . . . . 0.0 110.517 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.526 HG13 HD11 ' A' ' 11' ' ' LEU . 0.3 OUTLIER -148.93 115.28 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -174.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.448 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 72.0 m -48.05 128.23 13.45 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 111.807 -2.451 . . . . 0.0 111.126 177.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.67 HD11 ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -46.38 -38.52 9.02 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.603 1.161 . . . . 0.0 112.721 173.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.8 t -70.04 -14.52 62.72 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 172.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 7' ' ' CYS . . . -80.36 -26.3 38.71 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.359 0.664 . . . . 0.0 111.865 175.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.635 HD12 ' HA ' ' A' ' 8' ' ' LEU . 0.9 OUTLIER -93.47 169.7 9.78 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 124.17 0.988 . . . . 0.0 111.404 178.701 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 59.6 Cg_endo -66.88 169.29 15.06 Favored 'Trans proline' 0 CA--C 1.548 1.179 0 C-N-CA 122.4 2.067 . . . . 0.0 113.405 176.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -69.72 -21.97 32.91 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 122.276 1.984 . . . . 0.0 113.055 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -86.43 -10.24 54.65 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.857 178.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.448 ' HA ' ' CG1' ' A' ' 57' ' ' VAL . . . -67.87 -37.49 81.86 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.007 0.923 . . . . 0.0 112.478 172.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.67 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -67.87 -40.16 83.62 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.423 175.35 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.484 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 7.4 t70 -45.74 -44.77 14.01 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.68 -177.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.717 ' OG1' HG12 ' A' ' 57' ' ' VAL . 1.3 m -65.58 -51.69 57.83 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.066 -1.425 . . . . 0.0 111.593 177.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.595 HD11 HG21 ' A' ' 92' ' ' ILE . 17.6 mt -49.88 -33.36 16.89 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 174.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.31 -48.01 58.53 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.637 0.775 . . . . 0.0 111.941 171.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.502 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 66.6 mt -62.4 -34.37 76.6 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-O 118.73 -0.652 . . . . 0.0 112.243 175.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.607 HD12 ' O ' ' A' ' 18' ' ' THR . 1.8 mp -69.74 -43.95 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 119.497 1.044 . . . . 0.0 111.389 172.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.15 -43.7 81.67 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 124.455 1.097 . . . . 0.0 111.876 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.5 t -85.4 0.47 52.09 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.809 1.244 . . . . 0.0 112.293 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 46.3 35.82 2.95 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 122.368 1.08 . . . . 0.0 112.344 -176.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.47 -172.35 14.67 Favored Glycine 0 CA--C 1.548 2.129 0 CA-C-N 113.711 -1.586 . . . . 0.0 114.309 -175.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.451 ' O ' HD22 ' A' ' 21' ' ' LEU . 55.4 Cg_endo -73.29 135.8 41.57 Favored 'Cis proline' 0 CA--C 1.534 0.515 0 O-C-N 123.003 1.002 . . . . 0.0 111.091 -2.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.502 ' CE1' ' HB3' ' A' ' 21' ' ' LEU . 16.5 m-85 -84.98 103.12 2.88 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 112.81 -1.995 . . . . 0.0 111.722 -177.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.2 -36.7 5.32 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.624 2.216 . . . . 0.0 111.581 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.522 ' CE2' HG13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -77.43 168.69 19.59 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 124.052 0.845 . . . . 0.0 111.991 175.52 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.57 17.74 22.88 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 122.461 1.124 . . . . 0.0 112.911 172.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.91 13.98 20.91 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.734 -1.121 . . . . 0.0 113.67 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -130.86 107.58 9.23 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.764 -1.562 . . . . 0.0 112.556 -174.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.5 -0.2 7.41 Favored Glycine 0 N--CA 1.485 1.937 0 CA-C-N 113.045 -1.889 . . . . 0.0 113.324 -175.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.9 m -92.41 145.96 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.651 0.781 . . . . 0.0 110.072 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.5 t -77.12 157.6 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 125.141 1.526 . . . . 0.0 109.8 176.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.575 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 81.0 t80 -138.56 87.32 2.22 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 113.927 -1.488 . . . . 0.0 109.442 176.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.503 ' HG3' ' CD2' ' A' ' 49' ' ' TYR . 1.7 tt0 -72.59 50.16 0.23 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 122.537 1.161 . . . . 0.0 113.301 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.565 ' CG ' ' HB2' ' A' ' 44' ' ' LEU . 34.9 t30 29.51 54.21 0.12 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.286 1.834 . . . . 0.0 110.873 -173.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.89 -21.89 33.03 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 113.712 -1.586 . . . . 0.0 112.266 -177.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.613 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.1 mt-10 -80.93 -7.6 59.54 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 113.819 -1.537 . . . . 0.0 114.12 173.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.4 t 43.83 37.91 1.87 Allowed 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 123.997 1.856 . . . . 0.0 112.204 -175.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 41' ' ' GLU . 72.1 t -114.36 -16.75 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-N 113.472 -1.695 . . . . 0.0 111.18 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.75 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.5 OUTLIER -88.7 157.85 48.77 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.228 -178.346 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.66 -160.07 0.07 OUTLIER 'Trans proline' 0 N--CA 1.477 0.557 0 C-N-CA 121.013 1.142 . . . . 0.0 109.498 178.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.505 HG22 ' H ' ' A' ' 47' ' ' GLN . 20.2 m 48.88 -131.34 1.76 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.337 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.505 ' H ' HG22 ' A' ' 46' ' ' THR . 37.7 tt0 168.9 -38.18 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.779 1.631 . . . . 0.0 110.482 -178.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.5 p -35.93 139.44 0.15 Allowed 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 122.589 1.185 . . . . 0.0 112.923 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.503 ' CD2' ' HG3' ' A' ' 38' ' ' GLN . 8.7 t80 -87.35 132.62 33.89 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.045 -1.888 . . . . 0.0 108.113 -175.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.16 -20.81 9.27 Favored Glycine 0 CA--C 1.537 1.46 0 O-C-N 124.863 1.352 . . . . 0.0 113.35 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 74' ' ' GLU . 0.5 OUTLIER -59.77 -19.68 51.9 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.402 1.081 . . . . 0.0 113.423 176.081 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.75 ' HE2' HD12 ' A' ' 44' ' ' LEU . 26.7 m-85 -104.2 166.62 10.28 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 125.091 1.356 . . . . 0.0 109.168 178.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -166.22 166.21 17.02 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 112.301 -2.227 . . . . 0.0 111.206 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.575 ' HG3' ' HB2' ' A' ' 37' ' ' PHE . 28.8 mt-10 -124.55 143.44 50.68 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.239 1.016 . . . . 0.0 110.063 -175.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.661 ' O ' HG21 ' A' ' 18' ' ' THR . 39.8 m-85 -157.68 72.2 0.65 Allowed 'General case' 0 N--CA 1.469 0.477 0 O-C-N 126.28 2.237 . . . . 0.0 109.723 -174.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.415 HG21 ' HG2' ' A' ' 65' ' ' ARG . 0.5 OUTLIER -44.36 144.26 1.06 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.612 0.72 . . . . 0.0 112.405 177.371 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.717 HG12 ' OG1' ' A' ' 18' ' ' THR . 30.4 m -94.72 113.69 29.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.605 176.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.522 HG13 ' CE2' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -43.11 157.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 125.057 1.473 . . . . 0.0 109.096 173.385 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.581 HG22 ' HB2' ' A' ' 62' ' ' ALA . 1.4 m -153.63 143.41 15.23 Favored Pre-proline 0 N--CA 1.477 0.916 0 O-C-N 124.443 1.09 . . . . 0.0 111.226 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.405 ' HD2' HG23 ' A' ' 59' ' ' THR . 64.9 Cg_endo -74.54 144.04 31.52 Favored 'Trans proline' 0 N--CA 1.479 0.66 0 C-N-CA 121.575 1.516 . . . . 0.0 110.788 176.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.51 22.05 30.1 Favored Glycine 0 CA--C 1.544 1.848 0 CA-C-N 114.35 -1.296 . . . . 0.0 112.525 -175.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.581 ' HB2' HG22 ' A' ' 59' ' ' THR . . . -82.53 89.8 6.7 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 178.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -40.97 -30.48 0.13 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.696 -1.593 . . . . 0.0 112.953 176.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.8 p -124.93 -146.25 0.35 Allowed 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 113.776 -1.556 . . . . 0.0 109.569 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.415 ' HG2' HG21 ' A' ' 56' ' ' THR . 18.2 mtm180 -82.31 -2.01 51.4 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 174.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.48 142.41 0.02 OUTLIER Glycine 0 N--CA 1.475 1.25 0 CA-C-O 123.717 1.732 . . . . 0.0 108.879 -173.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.8 p -52.85 -27.65 19.32 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 123.209 1.481 . . . . 0.0 112.165 174.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.529 ' NH1' HG21 ' A' ' 59' ' ' THR . 0.6 OUTLIER -54.23 127.65 27.89 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 120.009 -1.682 . . . . 0.0 111.786 174.445 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.547 ' HB2' HG23 ' A' ' 82' ' ' THR . 0.0 OUTLIER -144.02 149.88 37.37 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.321 179.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.475 ' O ' HD13 ' A' ' 71' ' ' ILE . 2.9 mt -122.37 140.17 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 126.04 2.087 . . . . 0.0 109.247 176.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.66 HD11 ' HE1' ' A' ' 86' ' ' TYR . 17.1 mm -132.43 108.84 14.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 O-C-N 125.6 1.812 . . . . 0.0 107.173 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.721 HG22 ' HB3' ' A' ' 79' ' ' ASP . 14.8 p -102.92 162.97 12.49 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.422 0.63 . . . . 0.0 110.363 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -115.3 171.26 13.62 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.996 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.418 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -64.58 -16.89 63.39 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 114.479 -0.86 . . . . 0.0 112.214 174.829 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.36 129.42 48.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 122.33 1.062 . . . . 0.0 108.866 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.593 HG22 ' HG2' ' A' ' 77' ' ' GLN . 24.1 m -61.49 147.57 44.86 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 113.776 -1.556 . . . . 0.0 107.494 175.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.593 ' HG2' HG22 ' A' ' 76' ' ' THR . 2.2 mt-30 80.7 31.48 0.17 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 127.0 2.12 . . . . 0.0 111.078 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.581 ' HA ' HD22 ' A' ' 91' ' ' LEU . 34.6 mt-10 -135.73 50.41 2.1 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 113.622 -1.626 . . . . 0.0 113.385 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.721 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.2 OUTLIER -104.63 83.9 2.1 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 113.418 -1.719 . . . . 0.0 110.845 -179.646 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.455 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 8.9 m-85 -68.53 131.53 45.41 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.558 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.576 ' HB2' HD11 ' A' ' 92' ' ' ILE . 68.8 t80 -122.12 130.43 53.23 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.554 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.558 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.5 OUTLIER -85.2 -66.87 0.85 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 111.626 -2.533 . . . . 0.0 112.383 175.595 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 68' ' ' ARG . . . 69.49 22.35 76.47 Favored Glycine 0 N--CA 1.48 1.577 0 CA-C-N 112.996 -1.911 . . . . 0.0 113.58 -174.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.497 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 54.6 m-20 -157.66 24.56 0.28 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.015 1.326 . . . . 0.0 113.278 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 61.66 83.17 0.15 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.324 1.85 . . . . 0.0 112.013 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.66 ' HE1' HD11 ' A' ' 71' ' ' ILE . 11.6 m-30 46.81 38.87 6.46 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 113.424 -1.716 . . . . 0.0 114.057 -176.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' ' 84' ' ' ASP . . . -99.96 -18.37 17.1 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.029 -176.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.558 ' O ' ' HB ' ' A' ' 82' ' ' THR . 5.4 p -164.46 176.99 8.51 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.325 1.45 . . . . 0.0 108.358 -175.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.559 ' CD1' HD21 ' A' ' 44' ' ' LEU . 96.1 m-85 -160.06 115.73 2.38 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -175.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.5 m -135.51 111.46 9.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 112.828 -1.987 . . . . 0.0 108.864 -179.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.581 HD22 ' HA ' ' A' ' 78' ' ' GLU . 15.4 mt -41.58 159.92 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.654 0.596 . . . . 0.0 112.325 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.625 HD13 ' O ' ' A' ' 79' ' ' ASP . 1.6 mp -107.24 123.94 62.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 O-C-N 120.715 -1.241 . . . . 0.0 110.022 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.06 93.49 7.87 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 113.756 -1.566 . . . . 0.0 107.722 177.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -54.81 -42.47 71.9 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.6 t -52.88 -30.1 32.04 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 113.438 -1.71 . . . . 0.0 114.45 173.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.418 ' OXT' ' N ' ' A' ' 8' ' ' LEU . 49.7 t . . . . . 0 C--O 1.246 0.911 0 CA-C-O 123.323 1.535 . . . . 0.0 107.014 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 110.733 -0.099 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.517 HG21 ' CE1' ' A' ' 80' ' ' TYR . 54.4 t -31.85 133.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 126.469 1.908 . . . . 0.0 109.27 169.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.2 m -56.34 -13.01 1.88 Allowed 'General case' 0 N--CA 1.474 0.762 0 O-C-N 125.006 1.441 . . . . 0.0 114.553 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.471 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 127.71 -169.74 19.39 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 176.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -84.41 168.77 15.24 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 122.28 1.038 . . . . 0.0 111.048 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.579 HG12 ' O ' ' A' ' 91' ' ' LEU . 8.4 p -146.49 110.8 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 114.361 -1.291 . . . . 0.0 107.588 -176.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 70.9 m -43.34 131.04 4.86 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 111.946 -2.388 . . . . 0.0 109.74 177.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.795 ' HA ' HD12 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -52.41 -36.55 54.49 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.3 177.42 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.5 t -67.42 -17.02 64.55 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.338 1.055 . . . . 0.0 113.3 174.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.01 -33.8 33.38 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.918 0.487 . . . . 0.0 111.731 176.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.795 HD12 ' HA ' ' A' ' 8' ' ' LEU . 4.0 mt -81.07 173.23 8.04 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 125.683 1.593 . . . . 0.0 110.557 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.557 ' HB2' ' OE2' ' A' ' 14' ' ' GLU . 72.7 Cg_endo -66.95 166.47 22.66 Favored 'Trans proline' 0 CA--C 1.551 1.342 0 C-N-CA 121.847 1.698 . . . . 0.0 113.885 175.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -66.68 -22.45 50.33 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.983 2.456 . . . . 0.0 113.715 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.557 ' OE2' ' HB2' ' A' ' 12' ' ' PRO . 1.0 OUTLIER -82.97 -8.58 59.55 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 173.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.811 ' HA ' HG21 ' A' ' 57' ' ' VAL . . . -65.32 -29.61 70.37 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 174.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.616 ' OG1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -73.88 -29.41 62.07 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.816 173.513 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.485 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 45.7 t0 -52.66 -54.49 32.68 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.781 0.676 . . . . 0.0 109.534 -176.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.627 ' HA ' HD12 ' A' ' 21' ' ' LEU . 24.4 m -54.78 -49.31 71.22 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 175.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.859 HD11 HG21 ' A' ' 92' ' ' ILE . 11.5 mt -56.01 -34.78 66.13 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 177.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -70.58 -41.05 72.89 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.471 172.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.627 HD12 ' HA ' ' A' ' 18' ' ' THR . 48.9 mt -66.77 -33.98 76.82 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 123.272 0.629 . . . . 0.0 112.16 175.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.66 HD13 HG21 ' A' ' 72' ' ' THR . 5.8 mt -69.22 -44.41 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 119.486 1.039 . . . . 0.0 111.161 172.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.48 -43.94 75.87 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 124.665 1.228 . . . . 0.0 112.24 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.42 5.85 47.74 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.105 0.962 . . . . 0.0 112.041 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 43.77 36.64 1.36 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.997 1.319 . . . . 0.0 112.528 -176.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.96 -165.28 13.24 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 113.667 -1.606 . . . . 0.0 115.619 -175.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -73.95 137.67 51.32 Favored 'Cis proline' 0 CA--C 1.537 0.644 0 O-C-N 124.644 1.865 . . . . 0.0 112.424 -4.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.522 ' CE2' ' HB3' ' A' ' 21' ' ' LEU . 81.4 m-85 -85.74 153.17 57.85 Favored Pre-proline 0 N--CA 1.472 0.632 0 CA-C-N 113.301 -1.772 . . . . 0.0 112.611 -178.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.02 -56.9 0.14 Allowed 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.409 2.072 . . . . 0.0 113.344 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.48 ' CD1' ' HB2' ' A' ' 32' ' ' GLN . 0.1 OUTLIER -112.97 168.93 9.29 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.438 1.495 . . . . 0.0 110.531 179.344 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.7 m -71.42 56.98 0.25 Allowed 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 123.55 1.643 . . . . 0.0 114.015 174.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.48 ' HB2' ' CD1' ' A' ' 30' ' ' TYR . 3.9 mt-30 -131.1 67.6 1.51 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 123.497 1.618 . . . . 0.0 112.066 177.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -173.7 155.22 2.63 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 110.19 -3.187 . . . . 0.0 114.733 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 71.82 10.83 72.91 Favored Glycine 0 N--CA 1.481 1.641 0 CA-C-N 112.181 -2.281 . . . . 0.0 111.635 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.678 HG23 ' HB2' ' A' ' 54' ' ' GLU . 13.0 m -97.74 142.22 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.402 1.081 . . . . 0.0 109.72 174.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.6 t -87.59 155.24 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 O-C-N 125.867 1.979 . . . . 0.0 110.276 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.51 ' HB3' ' HB3' ' A' ' 52' ' ' TYR . 51.6 t80 -121.45 103.03 8.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.392 173.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.83 45.17 0.19 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.199 0.6 . . . . 0.0 112.037 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 21.07 57.82 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 124.116 1.912 . . . . 0.0 113.359 -174.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.503 ' HD3' ' CE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -79.19 7.0 8.34 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 113.527 -1.67 . . . . 0.0 112.297 -175.835 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.566 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.2 mt-10 -111.55 -17.05 13.14 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.479 -1.691 . . . . 0.0 113.847 177.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.9 t 46.22 39.66 6.44 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 123.99 1.852 . . . . 0.0 112.972 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 41' ' ' GLU . 89.1 t -111.35 -15.97 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.438 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.484 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -100.15 162.74 19.99 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -173.213 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.51 ' HD3' HG23 ' A' ' 2' ' ' VAL . 84.7 Cg_endo -68.1 -160.39 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.423 2.082 . . . . 0.0 110.423 177.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.426 HG22 ' H ' ' A' ' 47' ' ' GLN . 19.5 m 43.73 -128.07 0.87 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.27 1.428 . . . . 0.0 108.821 -178.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.426 ' H ' HG22 ' A' ' 46' ' ' THR . 10.9 tt0 165.55 -43.76 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.699 1.999 . . . . 0.0 110.875 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.0 p -39.66 141.25 0.42 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 114.027 -1.442 . . . . 0.0 113.445 -178.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -81.68 135.76 35.51 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 112.584 -2.098 . . . . 0.0 110.642 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.23 -24.85 25.18 Favored Glycine 0 N--CA 1.476 1.334 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.842 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -61.82 -14.2 31.01 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.844 1.258 . . . . 0.0 112.789 175.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.51 ' HB3' ' HB3' ' A' ' 37' ' ' PHE . 28.3 m-85 -121.59 147.14 46.23 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.675 1.19 . . . . 0.0 109.789 -178.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -141.73 160.04 41.0 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 113.706 -1.588 . . . . 0.0 111.79 177.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.678 ' HB2' HG23 ' A' ' 35' ' ' VAL . 8.0 mt-10 -114.94 138.57 50.66 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.918 -178.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.436 ' HB3' HG23 ' A' ' 18' ' ' THR . 90.8 m-85 -155.54 73.63 0.85 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 112.739 -2.028 . . . . 0.0 110.079 -176.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 68' ' ' ARG . 24.6 m -45.04 130.88 7.59 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 122.246 1.022 . . . . 0.0 111.534 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.811 HG21 ' HA ' ' A' ' 15' ' ' ALA . 0.8 OUTLIER -86.59 125.4 40.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 111.52 -2.582 . . . . 0.0 110.102 179.384 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.424 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -48.12 148.77 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 O-C-N 125.734 1.896 . . . . 0.0 108.99 174.046 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.492 ' OG1' ' HG3' ' A' ' 68' ' ' ARG . 2.6 m -148.31 140.63 14.69 Favored Pre-proline 0 N--CA 1.471 0.613 0 O-C-N 125.981 2.05 . . . . 0.0 110.999 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.462 ' HD3' ' CD ' ' A' ' 14' ' ' GLU . 73.4 Cg_endo -72.64 145.55 41.91 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.784 2.323 . . . . 0.0 110.034 176.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.04 22.74 56.01 Favored Glycine 0 CA--C 1.543 1.816 0 CA-C-N 113.681 -1.599 . . . . 0.0 113.321 -174.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -89.05 90.88 8.59 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 176.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.5 -33.29 0.42 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 113.711 -1.586 . . . . 0.0 113.623 176.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.0 p -133.66 -149.23 0.36 Allowed 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 113.624 -1.625 . . . . 0.0 107.848 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -60.52 -18.83 54.59 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 125.282 1.433 . . . . 0.0 111.813 173.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.76 167.27 1.43 Allowed Glycine 0 CA--C 1.532 1.139 0 CA-C-O 123.747 1.748 . . . . 0.0 110.017 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 46.6 p -65.11 -17.36 64.4 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 112.977 -1.612 . . . . 0.0 112.393 173.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.553 ' O ' HG23 ' A' ' 56' ' ' THR . 0.1 OUTLIER -63.41 126.72 28.41 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 120.937 -1.102 . . . . 0.0 110.34 176.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 1.3 tpt180 -151.56 132.95 14.62 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.349 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.431 ' HB ' ' O ' ' A' ' 55' ' ' TYR . 4.1 mt -105.8 138.91 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 173.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.7 mm -123.5 106.2 16.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 112.697 -2.047 . . . . 0.0 107.417 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.66 HG21 HD13 ' A' ' 22' ' ' ILE . 13.9 p -92.07 164.37 13.63 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.094 0.473 . . . . 0.0 111.604 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -104.46 -175.81 25.09 Favored Glycine 0 N--CA 1.471 1.026 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.298 178.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -80.62 -14.83 57.84 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.544 -0.828 . . . . 0.0 112.172 177.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.3 130.86 55.61 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 175.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.429 HG22 ' HG2' ' A' ' 77' ' ' GLN . 53.7 m -49.76 149.17 2.64 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.645 173.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.429 ' HG2' HG22 ' A' ' 76' ' ' THR . 4.4 mt-30 81.19 34.33 0.11 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 126.561 1.945 . . . . 0.0 111.057 -178.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.548 ' HA ' HD22 ' A' ' 91' ' ' LEU . 43.9 mt-10 -139.26 50.38 1.8 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 113.474 -1.693 . . . . 0.0 113.578 -178.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.482 ' OD2' HD22 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -108.45 95.56 5.75 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.365 1.466 . . . . 0.0 110.678 -176.692 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.517 ' CE1' HG21 ' A' ' 2' ' ' VAL . 15.9 m-85 -81.62 123.19 28.47 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 126.058 1.743 . . . . 0.0 110.255 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.853 ' HB2' HD11 ' A' ' 92' ' ' ILE . 5.8 t80 -104.81 127.79 52.74 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.052 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 88' ' ' THR 0.301 0.0 OUTLIER -88.24 -71.62 0.57 Allowed 'General case' 0 C--N 1.323 -0.569 0 O-C-N 125.948 2.03 . . . . 0.0 113.713 172.641 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 68' ' ' ARG . . . 68.06 16.37 68.54 Favored Glycine 0 N--CA 1.476 1.332 0 CA-C-N 113.898 -1.501 . . . . 0.0 113.979 -173.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.558 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 75.1 m-20 -145.93 22.7 1.4 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.795 1.238 . . . . 0.0 113.041 176.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 57.89 82.27 0.13 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 127.177 2.191 . . . . 0.0 111.289 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.449 ' HB3' ' OE2' ' A' ' 41' ' ' GLU . 25.1 m-85 49.55 54.28 11.27 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 113.514 -1.676 . . . . 0.0 113.387 -174.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.558 ' HB3' ' HB2' ' A' ' 84' ' ' ASP . . . -120.16 -41.06 2.65 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.454 ' O ' ' HB ' ' A' ' 82' ' ' THR . 15.6 p -130.91 163.52 27.29 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.043 0.937 . . . . 0.0 108.73 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.434 ' HB3' ' HB3' ' A' ' 80' ' ' TYR . 97.5 m-85 -154.95 119.79 4.86 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -175.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.5 m -140.76 113.82 8.45 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 112.312 -2.222 . . . . 0.0 108.906 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.579 ' O ' HG12 ' A' ' 6' ' ' VAL . 14.7 mt -43.61 156.57 0.06 Allowed 'General case' 0 N--CA 1.48 1.074 0 O-C-N 124.109 0.881 . . . . 0.0 112.369 175.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.859 HG21 HD11 ' A' ' 19' ' ' LEU . 1.7 mp -111.14 137.65 42.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 122.15 0.976 . . . . 0.0 108.456 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -113.01 99.08 7.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 113.14 -1.845 . . . . 0.0 108.746 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -58.74 -41.42 86.42 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.89 0.744 . . . . 0.0 112.033 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 t -54.94 -44.5 74.36 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 114.471 -1.24 . . . . 0.0 113.437 175.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 35.3 t . . . . . 0 C--O 1.241 0.643 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.21 178.596 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.8 p30 . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 121.062 0.458 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.562 HG11 ' H ' ' A' ' 91' ' ' LEU . 4.1 t -47.71 140.42 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.983 176.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 m -77.61 5.86 8.35 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 124.723 1.264 . . . . 0.0 114.303 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.34 169.28 12.59 Favored Glycine 0 N--CA 1.474 1.171 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 m -86.67 171.48 10.94 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.312 -0.944 . . . . 0.0 109.818 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p -138.14 113.48 9.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 -176.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 71.4 m -50.73 125.03 12.22 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 112.05 -2.341 . . . . 0.0 109.854 177.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -53.81 -36.93 63.02 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.883 175.013 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.7 t -65.61 -29.05 69.59 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.361 0.6 . . . . 0.0 112.511 174.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.28 -22.81 47.72 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.759 174.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.433 HD22 ' HD2' ' A' ' 12' ' ' PRO . 10.7 mt -80.68 164.13 52.82 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.318 176.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.761 ' HG2' ' HB2' ' A' ' 15' ' ' ALA . 69.0 Cg_endo -67.01 173.96 7.57 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.019 2.48 . . . . 0.0 115.056 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -71.67 -53.62 0.17 Allowed 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.813 2.342 . . . . 0.0 112.771 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.464 ' HG2' ' HD3' ' A' ' 60' ' ' PRO . 1.9 pp20? -60.2 -12.49 8.86 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.528 172.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.761 ' HB2' ' HG2' ' A' ' 12' ' ' PRO . . . -57.11 -41.85 79.75 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.725 -0.609 . . . . 0.0 111.9 176.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.16 -22.6 66.94 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 113.634 -1.621 . . . . 0.0 112.893 174.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.577 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 63.7 t0 -55.03 -58.02 9.35 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.582 0.753 . . . . 0.0 109.896 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.567 ' O ' HD12 ' A' ' 22' ' ' ILE . 61.5 m -54.5 -47.31 73.21 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 176.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.547 HD21 ' OD2' ' A' ' 79' ' ' ASP . 17.3 mt -54.05 -37.11 63.8 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 175.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -69.57 -37.73 77.11 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.226 173.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 17' ' ' ASP . 30.1 mt -72.52 -33.02 66.59 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 118.689 -0.672 . . . . 0.0 111.202 176.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.567 HD12 ' O ' ' A' ' 18' ' ' THR . 1.3 mp -68.9 -41.26 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 120.117 1.326 . . . . 0.0 111.613 171.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.32 -43.39 67.15 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 124.279 0.987 . . . . 0.0 112.164 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.39 5.09 48.92 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.363 1.065 . . . . 0.0 111.293 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.5 t70 41.15 49.77 3.22 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.203 1.401 . . . . 0.0 111.288 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.68 -164.76 30.49 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 112.767 -2.015 . . . . 0.0 116.165 -173.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -75.1 142.85 75.87 Favored 'Cis proline' 0 C--N 1.35 0.639 0 O-C-N 124.419 1.747 . . . . 0.0 111.656 -2.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.416 ' CE2' ' HB3' ' A' ' 21' ' ' LEU . 78.5 m-85 -99.27 123.26 49.26 Favored Pre-proline 0 N--CA 1.471 0.625 0 CA-C-N 113.419 -1.719 . . . . 0.0 111.102 -176.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.91 -56.74 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.01 1.807 . . . . 0.0 111.629 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -158.78 21.99 0.21 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.864 0.866 . . . . 0.0 112.096 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.508 ' HB3' HD12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -76.98 43.7 0.36 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.118 -178.635 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.53 ' HB2' ' HD2' ' A' ' 65' ' ' ARG . 1.4 tt0 20.15 64.72 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 128.968 2.907 . . . . 0.0 112.686 -175.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -103.31 175.34 5.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 110.883 -2.871 . . . . 0.0 111.458 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.29 44.95 97.42 Favored Glycine 0 N--CA 1.478 1.494 0 CA-C-N 112.731 -2.031 . . . . 0.0 110.082 176.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.0 m -142.3 147.12 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 114.007 -1.097 . . . . 0.0 108.665 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.0 t -90.81 154.92 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 125.642 1.839 . . . . 0.0 109.798 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -137.96 91.61 2.59 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.851 174.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.453 ' HG3' ' CD1' ' A' ' 49' ' ' TYR . 2.2 tm0? -70.46 51.34 0.13 Allowed 'General case' 0 N--CA 1.483 1.214 0 O-C-N 120.945 -1.097 . . . . 0.0 112.97 178.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.409 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 15.8 p-10 29.23 52.58 0.08 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.611 1.964 . . . . 0.0 110.499 -177.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.75 -24.25 56.11 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.886 -169.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.609 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.0 mt-10 -76.84 -7.15 54.93 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 112.05 -2.341 . . . . 0.0 114.933 172.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.9 t 45.68 39.03 4.62 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 123.72 1.724 . . . . 0.0 111.585 -178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 41' ' ' GLU . 54.5 t -112.73 -12.15 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 123.361 1.553 . . . . 0.0 110.369 -178.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.495 HD12 ' CE1' ' A' ' 52' ' ' TYR . 0.2 OUTLIER -99.2 145.4 29.96 Favored Pre-proline 0 C--O 1.243 0.719 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 -172.257 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -65.41 -166.45 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.051 2.501 . . . . 0.0 110.004 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.581 HG22 ' H ' ' A' ' 48' ' ' SER . 36.6 m 62.86 -71.62 0.05 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.078 1.751 . . . . 0.0 112.203 -177.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 96.17 -24.03 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 128.508 2.723 . . . . 0.0 112.431 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.581 ' H ' HG22 ' A' ' 46' ' ' THR . 83.9 p -48.3 156.08 0.44 Allowed 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 123.216 1.484 . . . . 0.0 111.247 178.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.453 ' CD1' ' HG3' ' A' ' 38' ' ' GLN . 4.3 t80 -101.84 134.03 45.66 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 112.235 -2.257 . . . . 0.0 110.291 -175.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.4 -24.78 9.07 Favored Glycine 0 N--CA 1.472 1.096 0 CA-C-N 114.084 -1.417 . . . . 0.0 112.14 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.402 ' HB3' ' OG ' ' A' ' 48' ' ' SER . 4.7 t80 -60.45 -20.46 59.94 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 174.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.495 ' CE1' HD12 ' A' ' 44' ' ' LEU . 26.4 m-85 -104.38 147.75 27.19 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.449 -1.25 . . . . 0.0 108.804 -178.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -147.28 152.84 38.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 112.934 -1.939 . . . . 0.0 111.218 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -105.36 143.07 34.03 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.435 -178.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.431 ' HB3' HG23 ' A' ' 18' ' ' THR . 99.9 m-85 -149.81 65.57 0.99 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 112.216 -2.265 . . . . 0.0 111.36 -176.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.5 m -33.99 130.01 0.33 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.602 1.192 . . . . 0.0 112.382 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.72 HG21 ' HA ' ' A' ' 15' ' ' ALA . 1.5 p -88.98 98.66 8.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 C-N-CA 118.574 -1.251 . . . . 0.0 110.11 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.508 HD12 ' HB3' ' A' ' 31' ' ' SER . 1.1 mp -25.76 128.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.773 176.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.432 HG22 ' HB2' ' A' ' 62' ' ' ALA . 4.1 m -127.05 141.76 41.66 Favored Pre-proline 0 N--CA 1.479 1.025 0 CA-C-N 118.529 0.604 . . . . 0.0 111.723 -177.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.464 ' HD3' ' HG2' ' A' ' 14' ' ' GLU . 74.2 Cg_endo -72.59 148.05 46.8 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.129 1.886 . . . . 0.0 110.441 176.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 52.74 22.67 12.32 Favored Glycine 0 CA--C 1.543 1.807 0 CA-C-N 114.278 -1.328 . . . . 0.0 113.03 -175.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.432 ' HB2' HG22 ' A' ' 59' ' ' THR . . . -93.37 90.67 6.85 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -39.12 -33.68 0.14 Allowed 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 112.987 -1.915 . . . . 0.0 112.61 175.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.8 p -129.13 -143.22 0.26 Allowed 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 113.695 -1.593 . . . . 0.0 108.84 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.53 ' HD2' ' HB2' ' A' ' 32' ' ' GLN . 64.9 mtm-85 -79.69 -14.03 59.05 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 172.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 57.33 -177.82 1.09 Allowed Glycine 0 CA--C 1.534 1.245 0 CA-C-O 123.892 1.829 . . . . 0.0 110.602 -173.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.421 ' HA ' ' HB2' ' A' ' 85' ' ' HIS . 46.0 p -66.31 -36.34 82.7 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 112.462 -1.869 . . . . 0.0 112.845 177.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.42 ' HA ' ' HA2' ' A' ' 83' ' ' GLY . 1.1 mtp85 -44.36 125.54 4.7 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.705 174.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.09 139.61 14.88 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 112.916 -1.947 . . . . 0.0 109.715 -177.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.654 HG23 ' OD1' ' A' ' 79' ' ' ASP . 4.6 mt -114.74 136.45 51.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 111.321 -2.672 . . . . 0.0 108.162 177.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.721 HD11 ' HE1' ' A' ' 86' ' ' TYR . 20.2 mm -124.9 106.1 16.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 113.057 -1.883 . . . . 0.0 107.701 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.623 HG22 ' HB2' ' A' ' 79' ' ' ASP . 32.0 p -99.5 163.07 12.66 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.319 0.581 . . . . 0.0 110.507 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -118.38 167.08 12.91 Favored Glycine 0 N--CA 1.476 1.334 0 CA-C-N 114.181 -1.372 . . . . 0.0 109.728 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.79 -22.67 25.67 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 114.691 -0.754 . . . . 0.0 112.338 172.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.91 129.49 34.82 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.581 1.181 . . . . 0.0 109.702 173.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.604 HG22 ' HG3' ' A' ' 77' ' ' GLN . 2.7 m -63.4 146.84 52.74 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.931 -1.486 . . . . 0.0 109.976 176.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.604 ' HG3' HG22 ' A' ' 76' ' ' THR . 61.8 mt-30 62.69 49.92 3.64 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.98 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.498 ' HA ' HD22 ' A' ' 91' ' ' LEU . 4.2 mt-10 -145.89 61.1 1.26 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.346 -1.752 . . . . 0.0 111.901 -177.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.654 ' OD1' HG23 ' A' ' 70' ' ' ILE . 5.9 t0 -106.28 119.82 40.25 Favored 'General case' 0 C--O 1.212 -0.887 0 CA-C-N 113.084 -1.871 . . . . 0.0 108.187 175.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.472 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 16.8 m-85 -92.51 127.75 38.11 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 125.341 1.651 . . . . 0.0 109.392 175.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.73 ' HB2' HD11 ' A' ' 92' ' ' ILE . 2.7 t80 -107.4 126.63 52.72 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 114.077 -1.42 . . . . 0.0 109.631 -178.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -89.77 -67.24 0.86 Allowed 'General case' 0 N--CA 1.484 1.229 0 O-C-N 125.709 1.88 . . . . 0.0 112.551 175.323 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 68' ' ' ARG . . . 62.02 21.42 61.39 Favored Glycine 0 CA--C 1.539 1.558 0 CA-C-N 114.148 -1.387 . . . . 0.0 112.444 -173.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.561 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 58.0 m-20 -147.42 20.04 1.2 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.794 1.238 . . . . 0.0 112.621 176.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 67' ' ' THR . 21.9 t-80 56.79 80.41 0.16 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.844 1.657 . . . . 0.0 110.251 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.721 ' HE1' HD11 ' A' ' 71' ' ' ILE . 15.4 m-30 48.87 54.27 11.08 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 113.321 -1.763 . . . . 0.0 113.837 -175.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 84' ' ' ASP . . . -120.73 -32.66 3.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.276 -1.329 . . . . 0.0 113.065 176.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.501 ' O ' ' HB ' ' A' ' 82' ' ' THR . 17.2 p -140.32 166.64 24.15 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.453 ' CD1' HD21 ' A' ' 44' ' ' LEU . 93.5 m-85 -156.72 118.11 3.78 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -173.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.2 m -139.41 107.8 5.83 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 125.871 1.982 . . . . 0.0 110.047 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.562 ' H ' HG11 ' A' ' 2' ' ' VAL . 22.7 mt -40.86 159.29 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.123 178.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.73 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.7 mp -108.67 128.74 64.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 O-C-N 120.612 -1.305 . . . . 0.0 109.415 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.35 95.58 5.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 113.836 -1.529 . . . . 0.0 108.698 177.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.5 -36.81 67.07 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 124.312 1.007 . . . . 0.0 112.044 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.1 t -56.59 -48.59 77.07 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.901 1.28 . . . . 0.0 113.232 174.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 44.0 t . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.779 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 121.381 0.61 . . . . 0.0 111.426 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.618 HG23 ' HD3' ' A' ' 45' ' ' PRO . 3.7 t -63.91 143.32 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.8 m -80.39 -3.24 48.89 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 176.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.48 ' H ' HG12 ' A' ' 2' ' ' VAL . . . 137.87 179.94 17.57 Favored Glycine 0 N--CA 1.473 1.162 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 6' ' ' VAL . 3.0 m -89.33 174.46 7.81 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 122.109 0.957 . . . . 0.0 109.783 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.435 ' H ' HG22 ' A' ' 5' ' ' THR . 1.0 OUTLIER -142.96 112.31 2.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 122.659 1.218 . . . . 0.0 107.834 -176.387 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.4 ' HA ' ' HB3' ' A' ' 96' ' ' CYS . 93.1 m -52.12 133.71 33.25 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 112.152 -2.295 . . . . 0.0 109.887 177.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -31.53 68.02 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.083 0.864 . . . . 0.0 111.878 -178.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.4 t -66.08 -28.76 69.07 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.661 0.784 . . . . 0.0 112.902 173.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.52 -18.54 56.93 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.712 0.805 . . . . 0.0 111.81 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 11' ' ' LEU . 7.0 mt -86.34 161.28 49.32 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 175.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.552 ' HB2' ' OE2' ' A' ' 14' ' ' GLU . 98.3 Cg_endo -69.67 170.24 16.93 Favored 'Trans proline' 0 CA--C 1.552 1.393 0 C-N-CA 122.192 1.928 . . . . 0.0 112.484 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.04 -34.83 12.9 Favored 'Trans proline' 0 N--CA 1.482 0.827 0 C-N-CA 122.652 2.234 . . . . 0.0 113.024 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.661 ' HB2' HG22 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -73.73 -9.43 58.66 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 114.695 -1.139 . . . . 0.0 114.069 175.2 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.412 ' HB2' ' HG2' ' A' ' 12' ' ' PRO . . . -66.48 -40.4 89.28 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.052 173.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.55 -33.13 74.32 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.081 175.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.434 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 5.5 t0 -54.02 -49.85 67.97 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.792 -178.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.632 HG21 ' O ' ' A' ' 55' ' ' TYR . 2.2 m -64.69 -49.3 71.47 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-O 117.953 -1.022 . . . . 0.0 112.479 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.5 mt -52.05 -34.22 42.38 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 124.293 0.996 . . . . 0.0 111.794 175.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.27 -45.68 54.34 Favored 'General case' 0 C--O 1.213 -0.867 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.262 173.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.565 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 55.3 mt -64.21 -33.7 76.41 Favored 'General case' 0 C--O 1.212 -0.913 0 C-N-CA 122.956 0.502 . . . . 0.0 111.964 174.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.521 HG21 HG21 ' A' ' 72' ' ' THR . 5.9 mt -71.16 -41.72 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 O-C-N 119.716 -1.865 . . . . 0.0 110.424 174.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.65 -43.14 66.63 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 124.68 1.238 . . . . 0.0 111.932 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.5 8.48 33.68 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.762 1.225 . . . . 0.0 112.057 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.8 t70 41.12 53.66 3.41 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 123.109 1.433 . . . . 0.0 111.952 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.09 -165.89 14.46 Favored Glycine 0 CA--C 1.538 1.53 0 CA-C-N 113.456 -1.702 . . . . 0.0 113.804 -175.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.529 ' O ' HD22 ' A' ' 21' ' ' LEU . 59.3 Cg_endo -73.77 138.16 54.09 Favored 'Cis proline' 0 N--CA 1.481 0.785 0 O-C-N 123.54 1.284 . . . . 0.0 111.768 -2.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.565 ' CE1' ' HB3' ' A' ' 21' ' ' LEU . 49.4 m-85 -94.81 106.52 25.24 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 113.316 -1.765 . . . . 0.0 111.952 -176.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -71.13 -46.3 0.72 Allowed 'Trans proline' 0 N--CA 1.477 0.531 0 C-N-CA 122.033 1.822 . . . . 0.0 111.742 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.463 ' C ' ' H ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -173.67 23.1 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.463 1.105 . . . . 0.0 112.805 -179.548 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.2 m -69.34 37.25 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.494 -174.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.463 ' H ' ' C ' ' A' ' 30' ' ' TYR . 0.0 OUTLIER 32.13 42.63 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.191 2.596 . . . . 0.0 112.975 -176.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.535 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 2.7 p30 -105.35 174.47 5.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 110.986 -2.825 . . . . 0.0 111.157 -172.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.91 -2.15 75.96 Favored Glycine 0 N--CA 1.482 1.704 0 O-C-N 126.195 2.185 . . . . 0.0 111.137 -175.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.412 HG23 ' OE1' ' A' ' 54' ' ' GLU . 27.2 m -102.21 143.93 14.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.935 0.894 . . . . 0.0 110.465 175.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.08 153.34 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 125.386 1.679 . . . . 0.0 109.588 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.491 ' CD2' HG21 ' A' ' 71' ' ' ILE . 44.9 t80 -131.65 89.26 2.68 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 112.936 -1.938 . . . . 0.0 109.878 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -72.54 51.25 0.26 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 118.692 0.678 . . . . 0.0 112.67 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 14.1 p-10 29.43 51.49 0.08 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.022 2.529 . . . . 0.0 109.397 -177.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.459 ' HD3' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -56.76 -21.81 31.11 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.121 -173.766 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.631 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.8 mt-10 -78.27 -6.52 55.24 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.405 -1.725 . . . . 0.0 114.787 172.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 43.5 t 44.85 35.91 1.67 Allowed 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 124.782 2.23 . . . . 0.0 112.269 -176.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 41' ' ' GLU . 70.9 t -111.74 -9.87 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 113.376 -1.738 . . . . 0.0 109.758 -178.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.573 HD12 ' HE2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -98.5 150.16 36.44 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -175.449 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.618 ' HD3' HG23 ' A' ' 2' ' ' VAL . 72.0 Cg_endo -69.14 -159.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.75 2.3 . . . . 0.0 109.746 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 96.1 m 56.86 -111.26 0.6 Allowed 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 116.342 -1.789 . . . . 0.0 107.779 -177.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 146.33 -43.12 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 127.697 2.399 . . . . 0.0 110.743 -177.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.5 p -37.25 143.44 0.09 Allowed 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 123.687 1.708 . . . . 0.0 112.196 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -90.73 135.4 33.74 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 112.843 -1.981 . . . . 0.0 108.229 -175.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.87 -19.12 17.54 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 124.712 1.258 . . . . 0.0 113.548 176.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.458 ' CE2' ' HB3' ' A' ' 74' ' ' GLU . 1.3 t80 -65.59 -13.89 59.98 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.363 1.065 . . . . 0.0 113.214 176.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.573 ' HE2' HD12 ' A' ' 44' ' ' LEU . 23.6 m-85 -108.58 155.25 20.87 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.362 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -154.03 161.14 42.15 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 112.968 -1.923 . . . . 0.0 110.832 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' A' ' 33' ' ' ASP . 1.7 mp0 -116.86 149.4 40.12 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.516 -177.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.632 ' O ' HG21 ' A' ' 18' ' ' THR . 76.2 m-85 -159.96 82.4 0.72 Allowed 'General case' 0 CA--C 1.545 0.758 0 O-C-N 125.239 1.587 . . . . 0.0 109.335 -172.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.559 HG22 ' H ' ' A' ' 58' ' ' ILE . 88.5 m -49.83 146.33 4.61 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 123.086 1.422 . . . . 0.0 111.434 175.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.497 ' CG1' HD12 ' A' ' 70' ' ' ILE . 1.2 m -105.81 19.0 5.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 113.01 -1.904 . . . . 0.0 113.019 -173.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.661 HG22 ' HB2' ' A' ' 14' ' ' GLU . 0.1 OUTLIER 53.32 179.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 O-C-N 124.827 1.329 . . . . 0.0 108.857 -165.833 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.3 m -156.11 139.99 11.43 Favored Pre-proline 0 N--CA 1.477 0.905 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.801 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.623 ' HD3' ' CD ' ' A' ' 14' ' ' GLU . 71.3 Cg_endo -74.2 142.91 31.22 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.002 2.468 . . . . 0.0 110.023 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 48.01 27.99 5.46 Favored Glycine 0 CA--C 1.541 1.718 0 CA-C-N 114.188 -1.369 . . . . 0.0 112.623 -176.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.09 95.07 6.59 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.69 -29.2 0.72 Allowed 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 111.603 -2.544 . . . . 0.0 112.428 175.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.8 p -112.07 -165.18 0.97 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.514 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.7 mtm105 -66.54 -12.11 56.08 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 174.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.63 165.54 7.18 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-O 123.838 1.799 . . . . 0.0 110.335 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.442 ' HA ' ' HB2' ' A' ' 85' ' ' HIS . 40.8 p -74.2 -15.49 61.01 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 112.631 -1.785 . . . . 0.0 112.439 178.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.521 ' HD2' ' HA2' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -66.85 136.53 55.55 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 120.931 -1.106 . . . . 0.0 110.245 177.082 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.462 ' HB2' HG23 ' A' ' 82' ' ' THR . 0.0 OUTLIER -158.53 156.12 29.64 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.418 -1.719 . . . . 0.0 110.447 -178.839 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.497 HD12 ' CG1' ' A' ' 57' ' ' VAL . 1.0 OUTLIER -130.16 140.96 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 O-C-N 125.325 1.641 . . . . 0.0 109.215 176.802 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.491 HG21 ' CD2' ' A' ' 37' ' ' PHE . 13.6 mm -128.87 106.11 13.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 113.22 -1.809 . . . . 0.0 107.82 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.64 HG22 ' HB3' ' A' ' 79' ' ' ASP . 20.7 p -98.61 162.16 13.28 Favored 'General case' 0 C--N 1.314 -0.971 0 O-C-N 121.477 -0.765 . . . . 0.0 110.584 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.21 166.61 12.52 Favored Glycine 0 N--CA 1.48 1.605 0 CA-C-N 113.663 -1.608 . . . . 0.0 109.469 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.458 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -61.37 -18.25 57.84 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.562 -0.819 . . . . 0.0 112.6 174.471 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -101.03 129.99 46.96 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.578 174.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.65 HG22 ' HG2' ' A' ' 77' ' ' GLN . 3.0 m -59.82 143.75 50.37 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 113.675 -1.602 . . . . 0.0 107.883 175.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.65 ' HG2' HG22 ' A' ' 76' ' ' THR . 0.0 OUTLIER 80.74 35.99 0.11 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.741 2.016 . . . . 0.0 110.474 179.035 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.447 ' HA ' ' CD2' ' A' ' 91' ' ' LEU . 3.7 mt-10 -134.02 47.43 2.43 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 113.45 -1.705 . . . . 0.0 113.204 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.64 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.1 OUTLIER -103.64 89.29 3.3 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.884 1.274 . . . . 0.0 110.19 -178.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.454 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 8.2 m-85 -78.45 131.88 37.06 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 125.228 1.411 . . . . 0.0 109.553 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.79 ' HB2' HD11 ' A' ' 92' ' ' ILE . 16.2 t80 -116.5 132.44 56.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.726 -1.124 . . . . 0.0 109.513 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -86.76 -72.28 0.51 Allowed 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 112.468 -2.151 . . . . 0.0 112.687 175.596 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.521 ' HA2' ' HD2' ' A' ' 68' ' ' ARG . . . 71.13 21.24 78.4 Favored Glycine 0 N--CA 1.473 1.119 0 CA-C-N 112.926 -1.943 . . . . 0.0 113.277 -175.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.612 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 63.0 m-20 -154.41 23.01 0.48 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.811 1.245 . . . . 0.0 112.963 177.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.442 ' HB2' ' HA ' ' A' ' 67' ' ' THR . 23.0 t-80 56.8 82.67 0.11 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.896 2.078 . . . . 0.0 110.005 178.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 7.7 m-30 51.2 48.67 22.6 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 113.04 -1.891 . . . . 0.0 114.163 -176.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.612 ' HB3' ' HB2' ' A' ' 84' ' ' ASP . . . -115.2 -30.59 6.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.823 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.498 ' O ' ' HB ' ' A' ' 82' ' ' THR . 22.3 p -147.97 169.67 19.38 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -178.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.502 ' CD1' HD21 ' A' ' 44' ' ' LEU . 89.5 m-85 -157.88 116.31 3.12 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -173.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.8 m -137.95 113.2 9.32 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 125.858 1.974 . . . . 0.0 110.099 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 91' ' ' LEU . 14.7 mt -41.56 160.52 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 O-C-N 124.465 1.103 . . . . 0.0 112.812 178.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.79 HD11 ' HB2' ' A' ' 81' ' ' TYR . 1.6 mp -110.08 128.32 66.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 O-C-N 121.58 -0.7 . . . . 0.0 109.38 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.69 92.19 3.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 113.721 -1.581 . . . . 0.0 108.812 176.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.23 -30.13 69.2 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.935 178.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.1 t -56.31 -33.21 65.35 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.077 -1.419 . . . . 0.0 112.851 172.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.4 ' HB3' ' HA ' ' A' ' 7' ' ' CYS . 6.4 t . . . . . 0 C--O 1.257 1.464 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.973 178.621 . . . . . . . . 1 1 . 1 stop_ save_